14640
platelet count ≥ 100 x 109/l
platelet count ≥ 100 x 109/l
['platelet count  100 x 109/l']
{'platelet count  100 x 109/l': {'277200003': 'Platelets/liter '}}
{'platelet count  100 x 109/l': {'277200003': ('unit', 'Platelets/liter ', ['767524001'])}}

33570
>= 1 prescription claim for any medication in the pre- period and post-index period
>= 1 prescription claim for any medication in the pre- period and post-index period
['= 1 prescription claim for any medication', 'in the pre  period', 'post index period']
{'= 1 prescription claim for any medication': {'451231000124103': 'greater than one', '182817000': 'Drug prescription '}, 'in the pre  period': {'236874000': 'Status pre- ', '288556008': 'before', '259037005': 'per period ', '272117007': 'Time periods ', '272113006': 'Before values '}, 'post index period': {'288563008': 'After values ', '419205000': '% index ', '259037005': 'per period ', '272117007': 'Time periods '}}
{'= 1 prescription claim for any medication': {'182817000': ('situation with explicit context', 'Drug prescription ', ['129125009'])}, 'in the pre  period': {'259037005': ('unit', 'per period ', ['767524001']), '272117007': ('qualifier value', 'Time periods ', ['272099008']), '272113006': ('qualifier value', 'Before values ', ['272099008'])}, 'post index period': {'288563008': ('qualifier value', 'After values ', ['272099008']), '419205000': ('unit', '% index ', ['767524001']), '259037005': ('unit', 'per period ', ['767524001']), '272117007': ('qualifier value', 'Time periods ', ['272099008'])}}

39119
healthy adult volunteers, man or woman, ages between 20 and 40 years
healthy adult volunteers, man or woman, ,
['healthy adult volunteers,', 'man', 'woman,']
{'healthy adult volunteers,': {'102512003': 'Well adult ', '160772005': 'Voluntary worker ', '276035002': 'Voluntary helper ', '276037005': 'Volunteer helper '}, 'man': {'339947000': 'Man ', '278412004': 'Human - origin ', '337915000': 'Homo sapiens ', '10052007': 'Male structure ', '248153007': 'Male '}, 'woman,': {'224526002': 'Woman '}}
{'healthy adult volunteers,': {'102512003': ('clinical finding', 'Well adult ', ['250171008'])}, 'man': {'339947000': ('person', 'Man ', ['133936004']), '278412004': ('qualifier value', 'Human - origin ', ['272099008']), '248153007': ('clinical finding', 'Male ', ['365860008'])}, 'woman,': {'224526002': ('person', 'Woman ', ['133936004'])}}

43547
no prior radiotherapy for colorectal cancers including in the neoadjuvant setting or adjuvant setting within 12 months of development of metastases
prior radiotherapy for colorectal cancers including in the neoadjuvant setting or adjuvant setting within 12 months of development of metastases
['prior radiotherapy for colorectal cancers', 'including in the neoadjuvant setting', 'adjuvant setting within 12 months of development of metastases']
{'prior radiotherapy for colorectal cancers': {'236874000': 'Status pre- ', '288556008': 'before', '264267007': 'Colorectal ', '108290001': 'Radiation oncology AND/OR radiotherapy ', '53438000': 'Radiation therapy procedure or service '}, 'including in the neoadjuvant setting': {'55919000': 'Including '}, 'adjuvant setting within 12 months of development of metastases': {'372861001': 'Immune enhancement agent ', '427067006': 'Immunologic adjuvant ', '81759008': 'Immune enhancement agent ', '258706009': 'month ', '278923009': 'Developmental ', '128462008': 'Secondary malignant neoplastic disease ', '14799000': 'Neoplasm, metastatic ', '79282002': 'Carcinoma, metastatic '}}
{'including in the neoadjuvant setting': {'55919000': ('qualifier value', 'Including ', ['272099008'])}, 'adjuvant setting within 12 months of development of metastases': {'427067006': ('product', 'Immunologic adjuvant ', ['115668003']), '81759008': ('product', 'Immune enhancement agent ', ['763158003']), '258706009': ('unit', 'month ', ['767524001']), '278923009': ('qualifier value', 'Developmental ', ['272099008']), '128462008': ('clinical finding', 'Secondary malignant neoplastic disease ', ['64572001'])}}

51067
bmi = or greater than 19
bmi = or greater than 19
['bmi', 'greater than 19']
{'bmi': {'301331008': 'Finding of body mass index '}, 'greater than 19': {'276140008': 'Greater-than symbol > '}}
{'bmi': {'301331008': ('clinical finding', 'Finding of body mass index ', ['250171008'])}}

52224
suprax
suprax
[]
{}
{}

52799
treated with photon/proton at mayo clinic rochester in radiation oncology
treated with photon/proton at mayo clinic rochester in radiation oncology
['treated with photon/proton', 'at mayo clinic rochester in radiation oncology']
{'treated with photon/proton': {'28995006': 'treated with', '290006006': 'Photon ', '89177007': 'Proton '}, 'at mayo clinic rochester in radiation oncology': {'223807006': 'Mayo ', '35971002': 'Ambulatory care site ', '419815003': 'Radiation oncology ', '30821001': 'Electromagnetic radiation ', '702931005': 'Oncology clinic ', '257585005': 'Clinic ', '282717008': 'Unit of radiation dose ', '82107009': 'Radiation ', '108290001': 'Radiation oncology AND/OR radiotherapy ', '53438000': 'Radiation therapy procedure or service '}}
{'treated with photon/proton': {'290006006': ('product', 'Photon ', ['312413002']), '89177007': ('product', 'Proton ', ['312413002'])}, 'at mayo clinic rochester in radiation oncology': {'282717008': ('unit', 'Unit of radiation dose ', ['767524001'])}}

53798
or
or
[]
{}
{}

59648
adult patients with advanced ctcl
adult patients with advanced ctcl
['adult patients with advanced ctcl']
{'adult patients with advanced ctcl': {'133936004': 'Adult ', '116154003': 'Patient ', '86005002': 'Advanced ', '28054005': 'Cutaneous T-cell lymphoma, no International Classification of Diseases for Oncology subtype ', '400122007': 'Primary cutaneous T-cell lymphoma '}}
{'adult patients with advanced ctcl': {'86005002': ('qualifier value', 'Advanced ', ['272099008']), '400122007': ('clinical finding', 'Primary cutaneous T-cell lymphoma ', ['64572001', '118234003'])}}

76206
12 months of spontaneous amenorrhea;
12 months of spontaneous amenorrhea;
['12 months of spontaneous amenorrhea']
{'12 months of spontaneous amenorrhea': {'258706009': 'month ', '5054005': 'Spontaneous ', '14302001': 'Amenorrhea '}}
{'12 months of spontaneous amenorrhea': {'258706009': ('unit', 'month ', ['767524001']), '5054005': ('qualifier value', 'Spontaneous ', ['272099008']), '14302001': ('clinical finding', 'Amenorrhea ', ['118234003'])}}

80675
chronic, stable phase of recovery
chronic, stable phase of recovery
['chronic, stable phase of recovery']
{'chronic, stable phase of recovery': {'278177007': 'Chronic phase ', '58158008': 'Stable '}}
{'chronic, stable phase of recovery': {'278177007': ('qualifier value', 'Chronic phase ', ['272099008']), '58158008': ('qualifier value', 'Stable ', ['272099008'])}}

80740
absolute neutrophil count >= 1000/mm^3 independent of growth factor support
absolute neutrophil count >= 1000/mm^3 independent of growth factor support
['absolute neutrophil count', '= 1000/mm^3 independent of growth factor support']
{'absolute neutrophil count': {'56136002': 'Absolute ', '30630007': 'Neutrophil count ', '116708001': 'Polymorphonuclear leukocyte count '}, '= 1000/mm^3 independent of growth factor support': {'58091002': 'independent of', '81286007': 'Growth factor ', '9096001': 'Support, device '}}
{'absolute neutrophil count': {'56136002': ('qualifier value', 'Absolute ', ['272099008']), '30630007': ('procedure', 'Neutrophil count ', ['128927009']), '116708001': ('procedure', 'Polymorphonuclear leukocyte count ', ['128927009'])}, '= 1000/mm^3 independent of growth factor support': {'81286007': ('product', 'Growth factor ', ['115668003'])}}

85956
willing to adhere and comply to the protocol requirements as evi-dence by written informed consent
willing to adhere and comply to the protocol requirements as evi-dence by written informed consent
['willing', 'to', 'comply to the protocol requirements', 'as evi dence by written informed consent']
{'willing': {'225466006': 'Willing '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'comply to the protocol requirements': {'258049002': 'Protocols '}, 'as evi dence by written informed consent': {'12261009': 'Writing ', '108968006': 'Oprelvekin ', '410938009': 'Oprelvekin ', '223458004': 'Informing '}}
{'willing': {'225466006': ('clinical finding', 'Willing ', ['250171008'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'as evi dence by written informed consent': {'12261009': ('observable entity', 'Writing ', ['246464006']), '108968006': ('product', 'Oprelvekin ', ['406455002', '312413002', '115668003']), '410938009': ('product', 'Oprelvekin ', ['763158003'])}}

89574
current or ex-smokers with a smoking history of >= 10 pack-years
current or ex-smokers with a smoking , >= 10 pack-years
['current', 'ex smokers with a smoking', '= 10 pack years']
{'current': {'15240007': 'Current '}, 'ex smokers with a smoking': {'8517006': 'Ex-smoker ', '365981007': 'Finding of tobacco smoking behavior '}, '= 10 pack years': {'315609007': 'Pack years '}}
{'ex smokers with a smoking': {'8517006': ('clinical finding', 'Ex-smoker ', ['250171008', '365981007']), '365981007': ('clinical finding', 'Finding of tobacco smoking behavior ', ['250171008'])}}

90316-1
fitzpatrick skin type l, ll and/or lll for uvb testing.
fitzpatrick skin type l, ll and/or lll for uvb testing.
['fitzpatrick skin type l,', 'lll for uvb testing']
{'fitzpatrick skin type l,': {'119325001': 'Skin ', '608969007': 'Specimen from skin ', '261664005': 'Types ', '35362001': 'type - attribute', '410656007': 'Type ', '410657003': 'type - attribute', '704318007': 'type - attribute', '39937001': 'Skin structure '}, 'lll for uvb testing': {'41224006': 'Structure of lower lobe of left lung ', '229588000': 'Ultraviolet B therapy ', '272393004': 'Tests ', '286632006': 'Ultraviolet B radiation '}}
{'fitzpatrick skin type l,': {'261664005': ('qualifier value', 'Types ', ['272396007'])}, 'lll for uvb testing': {'229588000': ('procedure', 'Ultraviolet B therapy ', ['128927009'])}}

90316-2
fitzpatrick skin type ll, lll and/or lv for uva testing.
fitzpatrick skin type ll, lll and/or lv for uva testing.
['fitzpatrick skin type', 'lll', 'lv for uva testing']
{'fitzpatrick skin type': {'119325001': 'Skin ', '608969007': 'Specimen from skin ', '261664005': 'Types ', '35362001': 'type - attribute', '410656007': 'Type ', '410657003': 'type - attribute', '704318007': 'type - attribute', '39937001': 'Skin structure '}, 'lll': {'41224006': 'Structure of lower lobe of left lung '}, 'lv for uva testing': {'223652006': 'Latvia ', '272393004': 'Tests ', '111157006': 'Calcium leucovorin preparation ', '126223008': 'Calcium leucovorin '}}
{'fitzpatrick skin type': {'261664005': ('qualifier value', 'Types ', ['272396007'])}, 'lv for uva testing': {'111157006': ('product', 'Calcium leucovorin preparation ', ['763158003']), '126223008': ('product', 'Calcium leucovorin ', ['312413002'])}}

93859
written consent
written consent
['written consent']
{'written consent': {'12261009': 'Writing '}}
{'written consent': {'12261009': ('observable entity', 'Writing ', ['246464006'])}}

105249
ability to complete follow-up period of 180 days after final study vaccination as required by the protocol
complete follow-up period of 180 days after final study vaccination as required by the protocol
['complete', 'follow up period of 180 days', 'after final study vaccination', 'required by the protocol']
{'complete': {'255594003': 'Complete '}, 'follow up period of 180 days': {'308273005': 'Follow-up status ', '259037005': 'per period ', '732554007': '180', '258703001': 'day ', '272117007': 'Time periods '}, 'after final study vaccination': {'42796001': 'End-stage ', '224699009': 'Study ', '33879002': 'Administration of vaccine to produce active immunity '}, 'required by the protocol': {'258049002': 'Protocols '}}
{'complete': {'255594003': ('qualifier value', 'Complete ', ['272099008'])}, 'follow up period of 180 days': {'259037005': ('unit', 'per period ', ['767524001']), '258703001': ('unit', 'day ', ['767524001']), '272117007': ('qualifier value', 'Time periods ', ['272099008'])}, 'after final study vaccination': {'33879002': ('procedure', 'Administration of vaccine to produce active immunity ', ['128927009'])}}

132912-1
have measurable disease based on recist v1.1.
have measurable disease based on recist v1.1.
['measurable disease', 'based on recist v1 1']
{'measurable disease': {'64572001': 'Disease '}, 'based on recist v1 1': {'63813000': 'Alkali ', '113300000': 'Area striata structure ', '67302005': 'V1 stage '}}
{'based on recist v1 1': {'63813000': ('product', 'Alkali ', ['312413002']), '67302005': ('clinical finding', 'V1 stage ', ['441742003', '250171008'])}}

132912-2
for solid tumors
for solid tumors
['for solid tumors']
{'for solid tumors': {'35702001': 'Solid ', '108369006': 'Neoplasm ', '78910004': 'Solid substance ', '421378002': 'Solid dose form '}}
{'for solid tumors': {'35702001': ('qualifier value', 'Solid ', ['272099008']), '78910004': ('product', 'Solid substance ', ['115669006'])}}

138376
adult patients undergoing cardiac surgery with cardiopulmonary bypass
adult patients undergoing cardiac surgery with cardiopulmonary bypass
['adult patients', 'cardiac surgery with cardiopulmonary bypass']
{'adult patients': {'133936004': 'Adult ', '116154003': 'Patient '}, 'cardiac surgery with cardiopulmonary bypass': {'232717009': 'Coronary artery bypass grafting ', '67166004': 'Aortocoronary artery bypass graft ', '90205004': 'Cardiac revascularization with bypass anastomosis '}}
{'cardiac surgery with cardiopulmonary bypass': {'232717009': ('procedure', 'Coronary artery bypass grafting ', ['362958002', '128927009']), '67166004': ('procedure', 'Aortocoronary artery bypass graft ', ['362958002', '128927009']), '90205004': ('procedure', 'Cardiac revascularization with bypass anastomosis ', ['362958002', '128927009'])}}

151461
patient has sufficient stored t cell product to manufacture appropriate doses of t-apcs
patient has sufficient stored t cell product to manufacture appropriate doses of t-apcs
['patient', 'sufficient stored t cell product to manufacture appropriate doses of t apcs']
{'patient': {'116154003': 'Patient '}, 'sufficient stored t cell product to manufacture appropriate doses of t apcs': {'51117008': 'Sufficient ', '440276004': 'Storage ', '57184004': 'T lymphocyte ', '260911001': 'dosage', '277406006': 'Dosages ', '284470004': 'Premature atrial contraction ', '287057009': 'Atrial premature complex ', '406461004': 'Ectopic atrial beats ', '63593006': 'Supraventricular premature beats '}}
{'sufficient stored t cell product to manufacture appropriate doses of t apcs': {'51117008': ('qualifier value', 'Sufficient ', ['272099008']), '277406006': ('qualifier value', 'Dosages ', ['272099008']), '284470004': ('clinical finding', 'Premature atrial contraction ', ['64572001', '287057009', '118234003']), '287057009': ('clinical finding', 'Atrial premature complex ', ['64572001', '118234003']), '406461004': ('clinical finding', 'Ectopic atrial beats ', ['64572001', '118234003']), '63593006': ('clinical finding', 'Supraventricular premature beats ', ['64572001', '118234003'])}}

156444
currently not involved in any other weight loss program,
currently not involved in any other weight loss program,
['currently', 'involved in any', 'other weight loss program,']
{'currently': {'15240007': 'Current '}, 'involved in any': {'248448006': 'Involved ', '278112009': 'involvement with'}, 'other weight loss program,': {'161832001': 'Weight decreasing ', '262285001': 'Weight decreased ', '89362005': 'Weight loss '}}
{'involved in any': {'248448006': ('qualifier value', 'Involved ', ['272099008'])}, 'other weight loss program,': {'161832001': ('clinical finding', 'Weight decreasing ', ['250171008', '89362005']), '262285001': ('clinical finding', 'Weight decreased ', ['250171008', '89362005']), '89362005': ('clinical finding', 'Weight loss ', ['250171008'])}}

162671
currently live within the united states
currently live within the united states
['currently', 'live within the united states']
{'currently': {'15240007': 'Current '}, 'live within the united states': {'419749002': '% live ', '223688001': 'United States of America '}}
{'live within the united states': {'419749002': ('unit', '% live ', ['767524001'])}}

173334
patient who is 20 years old or over
patient who is 20 years old or over
['patient', '20 years', 'old', 'over']
{'patient': {'116154003': 'Patient '}, '20 years': {'258707000': 'year '}, 'old': {'70753007': 'Old '}, 'over': {'21481007': 'Over ', '371881003': 'during'}}
{'20 years': {'258707000': ('unit', 'year ', ['767524001'])}, 'old': {'70753007': ('qualifier value', 'Old ', ['272099008'])}, 'over': {'21481007': ('qualifier value', 'Over ', ['272099008'])}}

176409
clinically normal baseline haematology, clinical chemistry, and urinalysis values
clinically normal baseline haematology, clinical chemistry, and urinalysis values
['clinically normal baseline haematology,', 'clinical chemistry,', 'urinalysis values']
{'clinically normal baseline haematology,': {'17621005': 'Normal ', '33468001': 'Hematology procedure ', '8117002': 'Gait normal ', '258744000': '% normal '}, 'clinical chemistry,': {'58147004': 'Clinical '}, 'urinalysis values': {'167217005': 'Urine examination ', '27171005': 'Urinalysis '}}
{'clinically normal baseline haematology,': {'17621005': ('qualifier value', 'Normal ', ['272099008']), '33468001': ('procedure', 'Hematology procedure ', ['128927009']), '8117002': ('clinical finding', 'Gait normal ', ['250171008']), '258744000': ('unit', '% normal ', ['767524001'])}, 'clinical chemistry,': {'58147004': ('qualifier value', 'Clinical ', ['272099008'])}, 'urinalysis values': {'167217005': ('procedure', 'Urine examination ', ['128927009']), '27171005': ('procedure', 'Urinalysis ', ['128927009'])}}

178510
written informed consent to participate in the study
written informed consent to participate in the study
['written informed consent', 'to', 'participate in the study']
{'written informed consent': {'12261009': 'Writing ', '108968006': 'Oprelvekin ', '410938009': 'Oprelvekin ', '223458004': 'Informing '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'participate in the study': {'224699009': 'Study '}}
{'written informed consent': {'12261009': ('observable entity', 'Writing ', ['246464006']), '108968006': ('product', 'Oprelvekin ', ['406455002', '312413002', '115668003']), '410938009': ('product', 'Oprelvekin ', ['763158003'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}}

179747
agrees to return for follow-up visit and willing to provide an address and/or telephone number for purposes of follow-up.
agrees to return for follow-up visit and willing to provide an address and/or telephone number for purposes of follow-up.
['to', 'return for follow up visit', 'willing', 'an address', 'telephone number for purposes of follow up']
{'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'return for follow up visit': {'7528007': 'Return to ', '308273005': 'Follow-up status ', '103324002': 'Patient visit for '}, 'willing': {'225466006': 'Willing '}, 'an address': {'397635003': 'Address ', '734004005': 'address '}, 'telephone number for purposes of follow up': {'386473003': 'Telephone follow-up ', '260299005': 'Number ', '410680006': 'numbers', '246099003': 'purpose', '363675004': 'Intents ', '410681005': 'Count of entities '}}
{'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'willing': {'225466006': ('clinical finding', 'Willing ', ['250171008'])}, 'an address': {'397635003': ('observable entity', 'Address ', ['160476009'])}, 'telephone number for purposes of follow up': {'363675004': ('qualifier value', 'Intents ', ['272099008'])}}

183972
serum creatinine below 1.7 mg/dl in woman and 1.8 mg/dl in males;
serum creatinine below 1.7 mg/dl in woman and 1.8 mg/dl in males;
['serum creatinine below 1 7 mg/dl', 'in woman', '1 8 mg/dl in males']
{'serum creatinine below 1 7 mg/dl': {'113075003': 'Creatinine measurement, serum ', '258797006': 'Milligram/deciliter ', '365757006': 'Finding of serum creatinine level '}, 'in woman': {'224526002': 'Woman '}, '1 8 mg/dl in males': {'732435009': '1.8', '258797006': 'Milligram/deciliter ', '10052007': 'Male structure ', '248153007': 'Male '}}
{'serum creatinine below 1 7 mg/dl': {'113075003': ('procedure', 'Creatinine measurement, serum ', ['128927009']), '258797006': ('unit', 'Milligram/deciliter ', ['767524001']), '365757006': ('clinical finding', 'Finding of serum creatinine level ', ['441742003'])}, 'in woman': {'224526002': ('person', 'Woman ', ['133936004'])}, '1 8 mg/dl in males': {'258797006': ('unit', 'Milligram/deciliter ', ['767524001']), '248153007': ('clinical finding', 'Male ', ['365860008'])}}

193668
at the mtd expansion phase of the protocol, all patients must have fine needle aspirate biopsiable disease
at the mtd expansion phase of the protocol, all patients must have fine needle aspirate biopsiable disease
['at the mtd expansion phase of the protocol,', 'all patients', 'fine needle aspirate biopsiable disease']
{'at the mtd expansion phase of the protocol,': {'21191007': 'phase', '258049002': 'Protocols '}, 'all patients': {'116154003': 'Patient '}, 'fine needle aspirate biopsiable disease': {'122550002': 'Specimen obtained by fine needle aspiration procedure ', '64572001': 'Disease ', '257759008': 'Fine needle aspiration biopsy - action ', '48635004': 'Fine needle biopsy '}}
{'fine needle aspirate biopsiable disease': {'48635004': ('procedure', 'Fine needle biopsy ', ['363691001', '128927009'])}}

196375
luteinizing hormone releasing hormone analogues
luteinizing hormone releasing hormone analogues
['luteinizing hormone releasing hormone analogues']
{'luteinizing hormone releasing hormone analogues': {'325995009': 'Gonadorelin ', '397197007': 'Gonadorelin agent ', '49869009': 'Gonadotropin releasing factor ', '75969007': 'Gonadotropin releasing factor preparation '}}
{'luteinizing hormone releasing hormone analogues': {'325995009': ('product', 'Gonadorelin ', ['75969007', '763158003']), '397197007': ('product', 'Gonadorelin agent ', ['406455002', '49869009', '312413002']), '49869009': ('product', 'Gonadotropin releasing factor ', ['406455002', '312413002']), '75969007': ('product', 'Gonadotropin releasing factor preparation ', ['763158003'])}}

196955
her2-negative patients (her2 1+ or negative, or her2 2+ and fish negative)
her2-negative patients (her2 1+ or negative, or her2 2+ and fish negative)
['her2 negative patients', '(her2 1', 'negative,', 'her2 2', 'fish negative']
{'her2 negative patients': {'44368005': 'Oncogene protein HER-2/neu ', '260385009': 'Negative ', '116154003': 'Patient '}, '(her2 1': {'44368005': 'Oncogene protein HER-2/neu '}, 'negative,': {'260385009': 'Negative '}, 'her2 2': {'44368005': 'Oncogene protein HER-2/neu '}, 'fish negative': {'90580008': 'Fish ', '260385009': 'Negative ', '227037002': 'Fish - dietary '}}
{'her2 negative patients': {'44368005': ('product', 'Oncogene protein HER-2/neu ', ['312413002', '115668003'])}, '(her2 1': {'44368005': ('product', 'Oncogene protein HER-2/neu ', ['312413002', '115668003'])}, 'her2 2': {'44368005': ('product', 'Oncogene protein HER-2/neu ', ['312413002', '115668003'])}}

201212
documented reversibility of ≥15% in fev1 in the screening phase.
documented reversibility of ≥15% in fev1 in the screening phase.
['documented reversibility of 15%', 'in fev1 in the screening phase']
{'documented reversibility of 15%': {'397934002': 'Documented ', '263508009': 'reversibility'}, 'in fev1 in the screening phase': {'59328004': 'Forced expired volume in 1 second ', '20135006': 'Screening procedure ', '21191007': 'phase'}}
{'in fev1 in the screening phase': {'59328004': ('observable entity', 'Forced expired volume in 1 second ', ['363788007']), '20135006': ('procedure', 'Screening procedure ', ['128927009'])}}

203650-1
ii.
ii.
[]
{}
{}

203650-2
or possession of 2 or more of the following minor criteria:
or possession of 2 or more of the following minor criteria:
['more of the following minor criteria']
{'more of the following minor criteria': {'242762006': 'More ', '367409002': 'followed by', '410599005': 'Minor ', '255606000': 'Minor ', '421939007': 'Follow - dosing instruction imperative '}}
{'more of the following minor criteria': {'242762006': ('qualifier value', 'More ', ['272099008']), '255606000': ('qualifier value', 'Minor ', ['272396007'])}}

212334
willing and able to provide written informed consent.
willing and provide written informed consent.
['willing', 'written informed consent']
{'willing': {'225466006': 'Willing '}, 'written informed consent': {'12261009': 'Writing ', '108968006': 'Oprelvekin ', '410938009': 'Oprelvekin ', '223458004': 'Informing '}}
{'willing': {'225466006': ('clinical finding', 'Willing ', ['250171008'])}, 'written informed consent': {'12261009': ('observable entity', 'Writing ', ['246464006']), '108968006': ('product', 'Oprelvekin ', ['406455002', '312413002', '115668003']), '410938009': ('product', 'Oprelvekin ', ['763158003'])}}

218026
planned primary unilateral tha or tka
planned primary unilateral tha or tka
['planned primary unilateral tha']
{'planned primary unilateral tha': {'397943006': 'Planned ', '63161005': 'Principal ', '66459002': 'Unilateral ', '263909009': 'True primary ', '261424001': 'Primary operation '}}
{'planned primary unilateral tha': {'63161005': ('qualifier value', 'Principal ', ['272099008']), '263909009': ('qualifier value', 'True primary ', ['272099008']), '261424001': ('qualifier value', 'Primary operation ', ['272099008'])}}

218515
no clinically significant deviation outside the normal ranges for blood pressure and pulse measurements
clinically significant deviation outside the normal ranges for blood pressure and pulse measurements
['clinically significant deviation', 'outside', 'the normal ranges for blood pressure', 'pulse measurements']
{'clinically significant deviation': {'386134007': 'Significant ', '112638000': 'Displacement ', '263739008': 'Displaced ', '40885006': 'Variant '}, 'outside': {'261074009': 'External '}, 'the normal ranges for blood pressure': {'609432006': 'concept model range ', '2004005': 'Normal blood pressure '}, 'pulse measurements': {'78564009': 'Heart rate measured at systemic artery ', '122869004': 'Measurement procedure ', '129266000': 'Measurement - action ', '272391002': 'Measurement technique ', '8499008': 'Pulse, function '}}
{'clinically significant deviation': {'263739008': ('qualifier value', 'Displaced ', ['272099008']), '40885006': ('qualifier value', 'Variant ', ['272099008'])}, 'the normal ranges for blood pressure': {'2004005': ('clinical finding', 'Normal blood pressure ', ['250171008', '118234003'])}, 'pulse measurements': {'78564009': ('observable entity', 'Heart rate measured at systemic artery ', ['363788007', '414237002']), '122869004': ('procedure', 'Measurement procedure ', ['128927009']), '8499008': ('observable entity', 'Pulse, function ', ['246464006'])}}

238081-1
age 18-70 years.
, .
[]
{}
{}

238081-2
kellgren-lawrence grade 1 - 4 evaluated on x-ray or icrs grade 2-4 evaluated on mri.
kellgren-lawrence grade 1 - 4 evaluated on x-ray or icrs grade 2-4 evaluated on mri.
['kellgren lawrence grade 1   4', 'on x ray', 'icrs grade 2 4', 'evaluated on mri']
{'kellgren lawrence grade 1   4': {'446441000124102': 'life threatening or disabling adverse event'}, 'on x ray': {'420771004': 'Upon - dosing instruction fragment ', '363680008': 'Radiographic imaging procedure ', '52250000': 'X-ray electromagnetic radiation ', '168537006': 'Plain radiography ', '420862001': 'On '}, 'icrs grade 2 4': {'446441000124102': 'life threatening or disabling adverse event'}, 'evaluated on mri': {'113091000': 'Magnetic resonance imaging ', '312250003': 'Magnetic resonance imaging - action '}}
{'on x ray': {'363680008': ('procedure', 'Radiographic imaging procedure ', ['128927009']), '168537006': ('procedure', 'Plain radiography ', ['363680008', '128927009']), '420862001': ('qualifier value', 'On ', ['272099008'])}, 'evaluated on mri': {'113091000': ('procedure', 'Magnetic resonance imaging ', ['128927009'])}}

247438
subjects must be in good general health as assessed by the investigator
subjects must be in good general health as assessed by the investigator
['be in good general health']
{'be in good general health': {'135815002': 'General health good '}}
{'be in good general health': {'135815002': ('clinical finding', 'General health good ', ['250171008'])}}

255115
transplant biopsy showing interstitial fibrosis and tubular atrophy of grade ii or greater, with some evidence of lymphocytic infiltration
transplant biopsy showing interstitial fibrosis and tubular atrophy of grade ii or greater, with some evidence of lymphocytic infiltration
['transplant biopsy', 'tubular atrophy of grade ii', 'greater,', 'with some evidence of lymphocytic infiltration']
{'transplant biopsy': {'129406001': 'Transplantation - action ', '263903005': 'Transplant ', '77465005': 'Transplantation ', '129314006': 'Biopsy - action ', '86273004': 'Biopsy ', '24486003': 'Transplant '}, 'tubular atrophy of grade ii': {'13336003': 'Tubular ', '13331008': 'Atrophy ', '1663004': 'G2 grade '}, 'greater,': {'263768009': 'Greater '}, 'with some evidence of lymphocytic infiltration': {'18669006': 'Evidence of ', '56972008': 'Lymphocyte ', '47351003': 'Infiltration ', '231287002': 'Infiltration ', '698082000': 'Spread by direct extension ', '255429003': 'Lymphocytic '}}
{'transplant biopsy': {'263903005': ('qualifier value', 'Transplant ', ['272099008']), '77465005': ('procedure', 'Transplantation ', ['128927009']), '86273004': ('procedure', 'Biopsy ', ['128927009'])}, 'tubular atrophy of grade ii': {'13336003': ('qualifier value', 'Tubular ', ['272099008']), '1663004': ('clinical finding', 'G2 grade ', ['250171008', '441742003'])}, 'greater,': {'263768009': ('qualifier value', 'Greater ', ['272099008'])}, 'with some evidence of lymphocytic infiltration': {'231287002': ('procedure', 'Infiltration ', ['128927009']), '255429003': ('qualifier value', 'Lymphocytic ', ['272099008'])}}

261026
documented history of nonvalvular atrial fibrillation
documented , nonvalvular atrial fibrillation
['documented', 'nonvalvular atrial fibrillation']
{'documented': {'397934002': 'Documented '}, 'nonvalvular atrial fibrillation': {'49436004': 'Atrial fibrillation ', '164889003': 'Electrocardiographic atrial fibrillation '}}
{'nonvalvular atrial fibrillation': {'49436004': ('clinical finding', 'Atrial fibrillation ', ['64572001', '118234003']), '164889003': ('clinical finding', 'Electrocardiographic atrial fibrillation ', ['441742003', '118234003'])}}

265750-1
subject has voluntarily agreed to participate by giving written informed consent.
subject has voluntarily agreed to participate by giving written informed consent.
['to', 'giving', 'written informed consent']
{'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'giving': {'419582001': 'Give - dosing instruction imperative '}, 'written informed consent': {'12261009': 'Writing ', '108968006': 'Oprelvekin ', '410938009': 'Oprelvekin ', '223458004': 'Informing '}}
{'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'written informed consent': {'12261009': ('observable entity', 'Writing ', ['246464006']), '108968006': ('product', 'Oprelvekin ', ['406455002', '312413002', '115668003']), '410938009': ('product', 'Oprelvekin ', ['763158003'])}}

265750-2
if subject has agreed to a newly obtained biopsy of tumor .
if subject has agreed to a newly obtained biopsy of tumor .
['agreed to a newly obtained biopsy of tumor']
{'agreed to a newly obtained biopsy of tumor': {'398092000': 'obtain', '129314006': 'Biopsy - action ', '86273004': 'Biopsy ', '108369006': 'Neoplasm '}}
{'agreed to a newly obtained biopsy of tumor': {'86273004': ('procedure', 'Biopsy ', ['128927009'])}}

265750-3
tissue obtained for the biopsy must not be previously irradiated.
tissue obtained for the biopsy , ly irradiated.
['tissue', 'obtained for the biopsy', 'ly', 'irradiated']
{'tissue': {'85756007': 'Body tissue structure '}, 'obtained for the biopsy': {'398092000': 'obtain', '129314006': 'Biopsy - action ', '86273004': 'Biopsy '}, 'ly': {'223512002': 'Libya '}, 'irradiated': {'126241000': 'Irradiated blood product ', '108290001': 'Radiation oncology AND/OR radiotherapy ', '53438000': 'Radiation therapy procedure or service '}}
{'obtained for the biopsy': {'86273004': ('procedure', 'Biopsy ', ['128927009'])}}

265750-4
no systemic antineoplastic therapy may be received by the subject between the time of the biopsy and the first administration of kn035.
systemic antineoplastic therapy may be received by the subject between the time of the biopsy and the first administration of kn035.
['systemic antineoplastic therapy', 'between the time of the biopsy', 'the first administration of kn035']
{'systemic antineoplastic therapy': {'31099001': 'Systemic ', '27867009': 'Antineoplastic agent ', '372688009': 'Antineoplastic agent ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure '}, 'between the time of the biopsy': {'410669006': 'Time ', '410670007': 'time', '129314006': 'Biopsy - action ', '86273004': 'Biopsy ', '900000000000475002': 'time '}, 'the first administration of kn035': {'255216001': 'First ', '413454004': 'Administration ', '416118004': 'Administration ', '232714002': 'Firstly '}}
{'systemic antineoplastic therapy': {'31099001': ('qualifier value', 'Systemic ', ['272099008']), '27867009': ('product', 'Antineoplastic agent ', ['763158003']), '276239002': ('procedure', 'Therapy ', ['277132007', '243120004'])}, 'between the time of the biopsy': {'86273004': ('procedure', 'Biopsy ', ['128927009'])}, 'the first administration of kn035': {'416118004': ('procedure', 'Administration ', ['128927009']), '232714002': ('qualifier value', 'Firstly ', ['272099008'])}}

271698
not at risk for general anesthesia
not at risk for general anesthesia
['not at risk for general anesthesia']
{'not at risk for general anesthesia': {'30207005': 'Risk of ', '50697003': 'General anesthesia '}}
{'not at risk for general anesthesia': {'50697003': ('procedure', 'General anesthesia ', ['128927009'])}}

271973
willing to discontinue medications with bowel altering side effects
willing to discontinue medications with bowel altering side effects
['willing to', 'discontinue', 'medications with bowel altering side effects']
{'willing to': {'225466006': 'Willing '}, 'discontinue': {'410546004': 'Discontinued ', '421286000': 'Discontinue - dosing instruction imperative '}, 'medications with bowel altering side effects': {'264519003': 'Drug reaction ', '62014003': 'Adverse reaction caused by drug ', '113276009': 'Intestinal structure ', '261093006': 'Intestinal ', '18307000': 'Altered ', '243326001': 'Changing '}}
{'willing to': {'225466006': ('clinical finding', 'Willing ', ['250171008'])}, 'medications with bowel altering side effects': {'264519003': ('qualifier value', 'Drug reaction ', ['272099008']), '62014003': ('clinical finding', 'Adverse reaction caused by drug ', ['64572001']), '18307000': ('qualifier value', 'Altered ', ['272099008']), '243326001': ('qualifier value', 'Changing ', ['272099008'])}}

277365-1
men undergoing a prostate cancer biopsy at ann arbor, durham, san francisco, or pittsburgh vas.
men undergoing a prostate cancer biopsy at ann arbor, durham, san francisco, or pittsburgh vas.
['men', 'a prostate cancer biopsy at ann arbor,', 'durham,', 'pittsburgh vas']
{'men': {'339947000': 'Man '}, 'a prostate cancer biopsy at ann arbor,': {'399068003': 'Malignant tumor of prostate ', '129314006': 'Biopsy - action ', '86273004': 'Biopsy ', '254900004': 'Carcinoma of prostate ', '363346000': 'Malignant neoplastic disease ', '65575008': 'Biopsy of prostate ', '372087000': 'Primary malignant neoplasm ', '86049000': 'Malignant neoplasm, primary '}, 'durham,': {'223876001': 'Durham '}, 'pittsburgh vas': {'273904000': 'Visual analog pain scale ', '273903006': 'Visual analog scale '}}
{'men': {'339947000': ('person', 'Man ', ['133936004'])}, 'a prostate cancer biopsy at ann arbor,': {'399068003': ('clinical finding', 'Malignant tumor of prostate ', ['64572001', '363346000', '118234003']), '86273004': ('procedure', 'Biopsy ', ['128927009']), '254900004': ('clinical finding', 'Carcinoma of prostate ', ['118234003', '64572001', '372087000', '363346000', '399068003']), '363346000': ('clinical finding', 'Malignant neoplastic disease ', ['64572001']), '65575008': ('procedure', 'Biopsy of prostate ', ['86273004', '362958002', '128927009']), '372087000': ('clinical finding', 'Primary malignant neoplasm ', ['64572001', '363346000'])}}

277365-2
additional inclusion criteria includes ability to speak english, provide informed consent, and have a psa < 20.
additional inclusion criteria includes speak english, provide informed consent, and have a psa < 20.
['additional inclusion criteria', 'includes', 'speak', 'english,', 'informed consent,']
{'additional inclusion criteria': {'20401003': 'in addition to', '55919000': 'Including '}, 'includes': {'55919000': 'Including '}, 'speak': {'285835004': 'Use of language ', '87335007': 'Speaking ', '286370002': 'Does speak '}, 'english,': {'297487008': 'English language ', '25804004': 'English ', '900000000000507009': 'english [international organization for standardization 639-1 code en] language reference set'}, 'informed consent,': {'108968006': 'Oprelvekin ', '410938009': 'Oprelvekin ', '223458004': 'Informing '}}
{'additional inclusion criteria': {'55919000': ('qualifier value', 'Including ', ['272099008'])}, 'includes': {'55919000': ('qualifier value', 'Including ', ['272099008'])}, 'speak': {'285835004': ('observable entity', 'Use of language ', ['246464006']), '87335007': ('observable entity', 'Speaking ', ['285835004', '246464006']), '286370002': ('clinical finding', 'Does speak ', ['250171008'])}, 'informed consent,': {'108968006': ('product', 'Oprelvekin ', ['406455002', '312413002', '115668003']), '410938009': ('product', 'Oprelvekin ', ['763158003'])}}

310445
must have a normal or clinically acceptable physical examination .
must have a normal or clinically acceptable physical examination .
['a normal', 'clinically acceptable physical examination']
{'a normal': {'17621005': 'Normal ', '8117002': 'Gait normal ', '258744000': '% normal '}, 'clinically acceptable physical examination': {'900000000000549004': 'acceptable ', '302199004': 'Examination - action ', '5880005': 'Physical examination procedure ', '81375008': 'Physical assessment '}}
{'a normal': {'17621005': ('qualifier value', 'Normal ', ['272099008']), '8117002': ('clinical finding', 'Gait normal ', ['250171008']), '258744000': ('unit', '% normal ', ['767524001'])}, 'clinically acceptable physical examination': {'5880005': ('procedure', 'Physical examination procedure ', ['362958002', '128927009']), '81375008': ('procedure', 'Physical assessment ', ['128927009'])}}

336256
documented bilateral oophorectomy;
documented bilateral oophorectomy;
['documented bilateral oophorectomy']
{'documented bilateral oophorectomy': {'397934002': 'Documented ', '76876009': 'Bilateral oophorectomy '}}
{'documented bilateral oophorectomy': {'76876009': ('procedure', 'Bilateral oophorectomy ', ['362958002', '128927009'])}}

338446
able to provide written informed consent
able to provide written informed consent
['able', 'to', 'written informed consent']
{'able': {'371150009': 'Able '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'written informed consent': {'12261009': 'Writing ', '108968006': 'Oprelvekin ', '410938009': 'Oprelvekin ', '223458004': 'Informing '}}
{'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'written informed consent': {'12261009': ('observable entity', 'Writing ', ['246464006']), '108968006': ('product', 'Oprelvekin ', ['406455002', '312413002', '115668003']), '410938009': ('product', 'Oprelvekin ', ['763158003'])}}

358019
for all participants:
for all participants:
[]
{}
{}

366627
paresthesia or numbness of the small finger and/or ring finger
paresthesia or numbness of the small finger and/or ring finger
['paresthesia', 'numbness of the small finger', 'ring finger']
{'paresthesia': {'91019004': 'Paresthesia '}, 'numbness of the small finger': {'309536001': 'Numbness of finger ', '255507004': 'Small '}, 'ring finger': {'82002001': 'Ring finger structure '}}
{'paresthesia': {'91019004': ('clinical finding', 'Paresthesia ', ['102957003', '118234003'])}, 'numbness of the small finger': {'309536001': ('clinical finding', 'Numbness of finger ', ['102957003', '118234003']), '255507004': ('qualifier value', 'Small ', ['272099008'])}}

375102
age ≥18 years
,
[]
{}
{}

375170
≥19 years of age
≥19 years of age
['19 years of age']
{'19 years of age': {'258707000': 'year ', '397669002': 'Age ', '424144002': 'Current chronological age '}}
{'19 years of age': {'258707000': ('unit', 'year ', ['767524001']), '397669002': ('qualifier value', 'Age ', ['272099008']), '424144002': ('observable entity', 'Current chronological age ', ['105727008'])}}

396255
patient is, in the opinion of the investigator, willing and able to comply with the study medication regimen and all other study requirements.
patient is, in the opinion of the investigator, willing and comply with the study medication regimen and all other study requirements.
['patient', 'willing', 'comply with the study medication regimen', 'all other study requirements']
{'patient': {'116154003': 'Patient '}, 'willing': {'225466006': 'Willing '}, 'comply with the study medication regimen': {'185922005': 'Clinical drug trial '}, 'all other study requirements': {'224699009': 'Study '}}
{'willing': {'225466006': ('clinical finding', 'Willing ', ['250171008'])}}

402647-1
patients must have a primary lesion or metastatic lesion measurable in >= 1 dimension by recist criteria within 4 weeks prior to entry of study 4.
patients must have a primary lesion or metastatic lesion measurable in >= 1 dimension by recist criteria , prior to entry of study 4.
['patients', 'a primary lesion', 'metastatic lesion measurable in >', '= 1 dimension by recist criteria', 'prior to entry of study 4']
{'patients': {'116154003': 'Patient '}, 'a primary lesion': {'63161005': 'Principal ', '52988006': 'Lesion ', '263909009': 'True primary ', '261424001': 'Primary operation '}, 'metastatic lesion measurable in >': {'77879006': 'metastatic to', '52988006': 'Lesion '}, '= 1 dimension by recist criteria': {'451231000124103': 'greater than one', '255506008': 'Dimensions '}, 'prior to entry of study 4': {'236874000': 'Status pre- ', '288556008': 'before', '224699009': 'Study '}}
{'a primary lesion': {'63161005': ('qualifier value', 'Principal ', ['272099008']), '263909009': ('qualifier value', 'True primary ', ['272099008']), '261424001': ('qualifier value', 'Primary operation ', ['272099008'])}, '= 1 dimension by recist criteria': {'255506008': ('qualifier value', 'Dimensions ', ['272099008'])}}

402647-2
> 4 weeks must have elapsed from the time of major surgery or completion of the last dose of chemotherapy, radiation therapy, investigational therapy and patients must adequately recover from these effects.
> 4 weeks must have elapsed from the time of major surgery or completion of the last dose of chemotherapy, radiation therapy, investigational therapy and patients must adequately recover from these effects.
['> 4 weeks', 'elapsed from the time of major surgery', 'completion of the last dose of chemotherapy,', 'radiation therapy,', 'investigational therapy', 'patients', 'recover from these effects']
{'> 4 weeks': {'260300002': '-4 ', '258705008': 'week '}, 'elapsed from the time of major surgery': {'410669006': 'Time ', '410670007': 'time', '24484000': 'Severe ', '257556004': 'Surgery ', '387713003': 'Surgical procedure ', '83578000': 'Surgical ', '394609007': 'General surgery ', '255603008': 'Major ', '900000000000475002': 'time '}, 'completion of the last dose of chemotherapy,': {'255594003': 'Complete ', '260911001': 'dosage', '277406006': 'Dosages ', '416608005': 'Drug therapy ', '716872004': 'Antineoplastic chemotherapy regimen ', '363688001': 'Administration of antineoplastic agent ', '367336001': 'Chemotherapy ', '408102007': 'Unit dose '}, 'radiation therapy,': {'108290001': 'Radiation oncology AND/OR radiotherapy ', '53438000': 'Radiation therapy procedure or service '}, 'investigational therapy': {'129265001': 'Evaluation - action ', '386053000': 'Evaluation procedure ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure '}, 'patients': {'116154003': 'Patient '}, 'recover from these effects': {'74822006': 'Recovering from ', '253861007': 'Effect '}}
{'> 4 weeks': {'258705008': ('unit', 'week ', ['767524001'])}, 'elapsed from the time of major surgery': {'24484000': ('qualifier value', 'Severe ', ['272396007']), '387713003': ('procedure', 'Surgical procedure ', ['128927009']), '83578000': ('qualifier value', 'Surgical ', ['272099008']), '255603008': ('qualifier value', 'Major ', ['272396007'])}, 'completion of the last dose of chemotherapy,': {'255594003': ('qualifier value', 'Complete ', ['272099008']), '277406006': ('qualifier value', 'Dosages ', ['272099008']), '416608005': ('procedure', 'Drug therapy ', ['277132007', '128927009']), '716872004': ('procedure', 'Antineoplastic chemotherapy regimen ', ['243120004', '128927009']), '363688001': ('procedure', 'Administration of antineoplastic agent ', ['416608005', '367336001', '128927009', '277132007']), '367336001': ('procedure', 'Chemotherapy ', ['416608005', '128927009', '277132007']), '408102007': ('unit', 'Unit dose ', ['767524001'])}, 'investigational therapy': {'386053000': ('procedure', 'Evaluation procedure ', ['128927009']), '276239002': ('procedure', 'Therapy ', ['277132007', '243120004'])}, 'recover from these effects': {'253861007': ('qualifier value', 'Effect ', ['272099008'])}}

403386
patients must not have received any prior systemic chemotherapy, thoracic radiotherapy or surgical resection for treatment of nsclc
patients must received any prior systemic chemotherapy, thoracic radiotherapy or surgical resection for treatment of nsclc
['patients', 'any prior systemic chemotherapy,', 'thoracic radiotherapy', 'surgical resection for treatment of nsclc']
{'patients': {'116154003': 'Patient '}, 'any prior systemic chemotherapy,': {'236874000': 'Status pre- ', '288556008': 'before', '31099001': 'Systemic ', '416608005': 'Drug therapy ', '716872004': 'Antineoplastic chemotherapy regimen ', '363688001': 'Administration of antineoplastic agent ', '367336001': 'Chemotherapy '}, 'thoracic radiotherapy': {'419815003': 'Radiation oncology ', '108290001': 'Radiation oncology AND/OR radiotherapy ', '53438000': 'Radiation therapy procedure or service '}, 'surgical resection for treatment of nsclc': {'118292001': 'Removal ', '129303008': 'Removal - action ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '254637007': 'Non-small cell lung cancer ', '416118004': 'Administration ', '128303001': 'Surgical removal ', '129304002': 'Excision - action ', '129306000': 'Surgical removal - action ', '65801008': 'Excision ', '257556004': 'Surgery ', '387713003': 'Surgical procedure ', '83578000': 'Surgical '}}
{'any prior systemic chemotherapy,': {'31099001': ('qualifier value', 'Systemic ', ['272099008']), '416608005': ('procedure', 'Drug therapy ', ['277132007', '128927009']), '716872004': ('procedure', 'Antineoplastic chemotherapy regimen ', ['243120004', '128927009']), '363688001': ('procedure', 'Administration of antineoplastic agent ', ['416608005', '367336001', '128927009', '277132007']), '367336001': ('procedure', 'Chemotherapy ', ['416608005', '128927009', '277132007'])}, 'surgical resection for treatment of nsclc': {'118292001': ('procedure', 'Removal ', ['128927009']), '276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '254637007': ('clinical finding', 'Non-small cell lung cancer ', ['64572001', '118234003']), '416118004': ('procedure', 'Administration ', ['128927009']), '128303001': ('procedure', 'Surgical removal ', ['128927009', '387713003', '118292001']), '65801008': ('procedure', 'Excision ', ['128303001', '387713003', '128927009', '118292001']), '387713003': ('procedure', 'Surgical procedure ', ['128927009']), '83578000': ('qualifier value', 'Surgical ', ['272099008'])}}

405918
meets criteria for metabolic syndrome or insulin resistance
meets criteria for metabolic syndrome or insulin resistance
['meets criteria for metabolic syndrome', 'insulin resistance']
{'meets criteria for metabolic syndrome': {'237602007': 'Metabolic syndrome X '}, 'insulin resistance': {'48606007': 'Drug resistance to insulin '}}
{'meets criteria for metabolic syndrome': {'237602007': ('clinical finding', 'Metabolic syndrome X ', ['64572001'])}, 'insulin resistance': {'48606007': ('clinical finding', 'Drug resistance to insulin ', ['64572001'])}}

410971-1
patients must be presenting in first, second relapse or third relapse.
patients must be presenting in first, second relapse or third relapse.
['patients', 'presenting in first,', 'second relapse', 'third', 'relapse']
{'patients': {'116154003': 'Patient '}, 'presenting in first,': {'18720000': 'within', '255216001': 'First ', '232714002': 'Firstly '}, 'second relapse': {'81170007': 'Second ', '263855007': 'Relapse phase ', '255318003': 'Relapsing course ', '58184002': 'Recurrent disease ', '257997001': 'seconds ', '288495006': 'per second '}, 'third': {'70905002': 'Third '}, 'relapse': {'263855007': 'Relapse phase ', '255318003': 'Relapsing course ', '58184002': 'Recurrent disease '}}
{'presenting in first,': {'232714002': ('qualifier value', 'Firstly ', ['272099008'])}, 'second relapse': {'81170007': ('qualifier value', 'Second ', ['272099008']), '263855007': ('qualifier value', 'Relapse phase ', ['272099008']), '255318003': ('qualifier value', 'Relapsing course ', ['272099008']), '58184002': ('clinical finding', 'Recurrent disease ', ['64572001']), '257997001': ('unit', 'seconds ', ['767524001']), '288495006': ('unit', 'per second ', ['767524001'])}, 'third': {'70905002': ('qualifier value', 'Third ', ['272099008'])}, 'relapse': {'263855007': ('qualifier value', 'Relapse phase ', ['272099008']), '255318003': ('qualifier value', 'Relapsing course ', ['272099008']), '58184002': ('clinical finding', 'Recurrent disease ', ['64572001'])}}

410971-2
relapse is defined as progression following anti-cancer therapy other than surgery, including non-surgical therapies that are considered standard treatment for high-grade glioma if administered to patients with prior low-grade glioma.
relapse is defined as progression following anti-cancer therapy other than surgery, including non-surgical therapies that are considered standard treatment for high-grade glioma if administered to patients with prior low-grade glioma.
['relapse', 'defined as progression', 'following', 'anti cancer therapy other than surgery', 'including', 'non surgical therapies', 'standard treatment for high grade glioma', 'administered to patients', 'with prior low grade glioma']
{'relapse': {'263855007': 'Relapse phase ', '255318003': 'Relapsing course ', '58184002': 'Recurrent disease '}, 'defined as progression': {'900000000000073002': 'sufficiently defined concept definition status ', '246453008': 'disease progression', '246450006': 'progression'}, 'following': {'237679004': 'Status post ', '255234002': 'status post', '255260001': 'following'}, 'anti cancer therapy other than surgery': {'363346000': 'Malignant neoplastic disease ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '257556004': 'Surgery ', '387713003': 'Surgical procedure ', '83578000': 'Surgical ', '394609007': 'General surgery ', '372087000': 'Primary malignant neoplasm ', '86049000': 'Malignant neoplasm, primary '}, 'including': {'55919000': 'Including '}, 'non surgical therapies': {'257556004': 'Surgery ', '387713003': 'Surgical procedure ', '83578000': 'Surgical ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '310138009': 'Surgical service '}, 'standard treatment for high grade glioma': {'276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '416500007': 'Malignant glioma - category ', '74532006': 'Glioma, malignant ', '416118004': 'Administration '}, 'administered to patients': {'418283001': 'Administer - dosing instruction imperative ', '116154003': 'Patient '}, 'with prior low grade glioma': {'236874000': 'Status pre- ', '288556008': 'before', '428954009': 'Low grade glioma '}}
{'relapse': {'263855007': ('qualifier value', 'Relapse phase ', ['272099008']), '255318003': ('qualifier value', 'Relapsing course ', ['272099008']), '58184002': ('clinical finding', 'Recurrent disease ', ['64572001'])}, 'anti cancer therapy other than surgery': {'363346000': ('clinical finding', 'Malignant neoplastic disease ', ['64572001']), '276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '387713003': ('procedure', 'Surgical procedure ', ['128927009']), '83578000': ('qualifier value', 'Surgical ', ['272099008']), '372087000': ('clinical finding', 'Primary malignant neoplasm ', ['64572001', '363346000'])}, 'including': {'55919000': ('qualifier value', 'Including ', ['272099008'])}, 'non surgical therapies': {'387713003': ('procedure', 'Surgical procedure ', ['128927009']), '83578000': ('qualifier value', 'Surgical ', ['272099008']), '276239002': ('procedure', 'Therapy ', ['277132007', '243120004'])}, 'standard treatment for high grade glioma': {'276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '416118004': ('procedure', 'Administration ', ['128927009'])}}

410971-3
prior therapy must have included external beam radiotherapy.
prior therapy must have included external beam radiotherapy.
['prior therapy', 'included', 'external beam radiotherapy']
{'prior therapy': {'236874000': 'Status pre- ', '288556008': 'before', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure '}, 'included': {'55919000': 'Including '}, 'external beam radiotherapy': {'33195004': 'Teleradiotherapy procedure '}}
{'prior therapy': {'276239002': ('procedure', 'Therapy ', ['277132007', '243120004'])}, 'included': {'55919000': ('qualifier value', 'Including ', ['272099008'])}}

428195
inclusion criteria of patient:
inclusion criteria of patient:
['inclusion criteria of patient']
{'inclusion criteria of patient': {'55919000': 'Including ', '116154003': 'Patient '}}
{'inclusion criteria of patient': {'55919000': ('qualifier value', 'Including ', ['272099008'])}}

436441
no contraindication to assessment protocol and training
contraindication to assessment protocol and training
['contraindication to assessment protocol', 'training']
{'contraindication to assessment protocol': {'103306004': 'Contraindication to ', '129265001': 'Evaluation - action ', '386053000': 'Evaluation procedure ', '258049002': 'Protocols '}, 'training': {'118629009': 'Functional training '}}
{'contraindication to assessment protocol': {'386053000': ('procedure', 'Evaluation procedure ', ['128927009'])}, 'training': {'118629009': ('procedure', 'Functional training ', ['128927009'])}}

436635
seeking outpatient physical therapy for a unilateral tkr
seeking outpatient physical therapy for a unilateral tkr
['outpatient physical therapy for a unilateral tkr']
{'outpatient physical therapy for a unilateral tkr': {'373864002': 'Outpatient ', '722138006': 'Physiotherapy ', '66459002': 'Unilateral ', '91251008': 'Physical therapy procedure '}}
{'outpatient physical therapy for a unilateral tkr': {'91251008': ('procedure', 'Physical therapy procedure ', ['243120004'])}}

438062
ability to understand and willing to sign a written informed consent document
understand and willing to sign a written informed consent document
['understand', 'willing', 'to', 'sign', 'a written informed consent document']
{'understand': {'66216009': 'Understanding, function '}, 'willing': {'225466006': 'Willing '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'sign': {'72670004': 'Sign '}, 'a written informed consent document': {'12261009': 'Writing ', '108968006': 'Oprelvekin ', '410938009': 'Oprelvekin ', '397966007': 'Documents ', '229059009': 'Report ', '223458004': 'Informing '}}
{'understand': {'66216009': ('observable entity', 'Understanding, function ', ['246464006'])}, 'willing': {'225466006': ('clinical finding', 'Willing ', ['250171008'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'sign': {'72670004': ('clinical finding', 'Sign ', ['250171008'])}, 'a written informed consent document': {'12261009': ('observable entity', 'Writing ', ['246464006']), '108968006': ('product', 'Oprelvekin ', ['406455002', '312413002', '115668003']), '410938009': ('product', 'Oprelvekin ', ['763158003'])}}

444954-1
woman subjects of childbearing potential must use maximally effective birth control during the period of therapy, must be willing to use contraception for the duration of the study .
woman subjects of childbearing potential must use maximally effective birth control during the period of therapy, must be willing to use contraception for the duration of the study .
['woman', 'use', 'maximally effective birth control during the period of therapy,', 'willing', 'to', 'contraception for the duration of the study']
{'woman': {'224526002': 'Woman '}, 'use': {'277889008': 'usage', '419385000': 'Use - dosing instruction imperative '}, 'maximally effective birth control during the period of therapy,': {'255403003': 'Effectiveness ', '13197004': 'Contraception ', '259037005': 'per period ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '272117007': 'Time periods ', '254648000': 'Effective '}, 'willing': {'225466006': 'Willing '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'contraception for the duration of the study': {'13197004': 'Contraception ', '103335007': 'duration ', '272116003': 'Durations ', '224699009': 'Study '}}
{'woman': {'224526002': ('person', 'Woman ', ['133936004'])}, 'maximally effective birth control during the period of therapy,': {'255403003': ('qualifier value', 'Effectiveness ', ['272099008']), '13197004': ('clinical finding', 'Contraception ', ['250171008']), '259037005': ('unit', 'per period ', ['767524001']), '276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '272117007': ('qualifier value', 'Time periods ', ['272099008', '272116003']), '254648000': ('qualifier value', 'Effective ', ['272099008'])}, 'willing': {'225466006': ('clinical finding', 'Willing ', ['250171008'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'contraception for the duration of the study': {'13197004': ('clinical finding', 'Contraception ', ['250171008']), '272116003': ('qualifier value', 'Durations ', ['272099008'])}}

444954-2
they also must have a negative pregnancy test upon entry into the study.
they also must have a negative pregnancy test upon entry into the study.
['a negative pregnancy test upon entry', 'into the study']
{'a negative pregnancy test upon entry': {'250425007': 'Pregnancy test negative '}, 'into the study': {'224699009': 'Study '}}
{'a negative pregnancy test upon entry': {'250425007': ('clinical finding', 'Pregnancy test negative ', ['441742003'])}}

444954-3
otherwise, woman subjects must be postmenopausal or surgically sterile.
otherwise, woman subjects must be postmenopausal or surgically sterile.
['woman subjects', 'postmenopausal', 'surgically sterile']
{'woman subjects': {'224526002': 'Woman '}, 'postmenopausal': {'76498008': 'Postmenopausal state '}, 'surgically sterile': {'257556004': 'Surgery ', '387713003': 'Surgical procedure ', '83578000': 'Surgical ', '15296000': 'Sterility ', '8619003': 'Infertile ', '260984003': 'Aseptic ', '261029002': 'Sterile '}}
{'woman subjects': {'224526002': ('person', 'Woman ', ['133936004'])}, 'postmenopausal': {'76498008': ('clinical finding', 'Postmenopausal state ', ['118234003'])}, 'surgically sterile': {'387713003': ('procedure', 'Surgical procedure ', ['128927009']), '83578000': ('qualifier value', 'Surgical ', ['272099008']), '15296000': ('clinical finding', 'Sterility ', ['118234003']), '8619003': ('clinical finding', 'Infertile ', ['118234003']), '260984003': ('qualifier value', 'Aseptic ', ['272099008'])}}

450889
prior exposure to taxane in the adjuvant, neoadjuvant setting or metastatic setting
prior exposure to taxane in the adjuvant, neoadjuvant setting or metastatic setting
['prior exposure to taxane', 'in the adjuvant,', 'metastatic setting']
{'prior exposure to taxane': {'236874000': 'Status pre- ', '288556008': 'before', '71677004': 'Injury due to exposure to external cause ', '24932003': 'Exposure to '}, 'in the adjuvant,': {'372861001': 'Immune enhancement agent ', '427067006': 'Immunologic adjuvant ', '81759008': 'Immune enhancement agent '}, 'metastatic setting': {'77879006': 'metastatic to'}}
{'prior exposure to taxane': {'71677004': ('clinical finding', 'Injury due to exposure to external cause ', ['64572001'])}, 'in the adjuvant,': {'427067006': ('product', 'Immunologic adjuvant ', ['115668003']), '81759008': ('product', 'Immune enhancement agent ', ['763158003'])}}

454211
serum total bilirubin level ≤ 3.0 mg/dl in the absence of biliary obstruction
serum total bilirubin level ≤ 3.0 mg/dl in the absence of biliary obstruction
['serum total bilirubin level  3 0 mg/dl in the absence of biliary obstruction']
{'serum total bilirubin level  3 0 mg/dl in the absence of biliary obstruction': {'313840000': 'Serum total bilirubin measurement ', '732360008': '0.3', '258797006': 'Milligram/deciliter ', '2667000': 'Absent ', '235918000': 'Obstruction of biliary tree '}}
{'serum total bilirubin level  3 0 mg/dl in the absence of biliary obstruction': {'313840000': ('procedure', 'Serum total bilirubin measurement ', ['128927009']), '258797006': ('unit', 'Milligram/deciliter ', ['767524001']), '235918000': ('clinical finding', 'Obstruction of biliary tree ', ['64572001', '118234003'])}}

481502
skin intact on bilateral lower extremities
skin intact on bilateral lower extremities
['skin', 'intact on bilateral lower extremities']
{'skin': {'119325001': 'Skin ', '608969007': 'Specimen from skin ', '39937001': 'Skin structure '}, 'intact on bilateral lower extremities': {'11163003': 'Intact ', '4180000': 'Both lower extremities '}}
{'intact on bilateral lower extremities': {'11163003': ('qualifier value', 'Intact ', ['272099008'])}}

483120
patient must have normal hepatic function and renal function defined as: 1) ast /alt </=3 x institutional upper limit of normal and 2) serum creatinine </= 2x institutional upper limit of normal.
patient must have normal hepatic function and renal function defined as: 1) ast /alt </=3 x institutional upper limit of normal and 2) serum creatinine </= 2x institutional upper limit of normal.
['patient', 'normal hepatic function', 'renal function', 'defined', '1', 'ast /alt </', '=3 x institutional upper limit of normal', '2', 'serum creatinine', '= 2x institutional upper limit of normal']
{'patient': {'116154003': 'Patient '}, 'normal hepatic function': {'17621005': 'Normal ', '79036002': 'Liver function ', '8117002': 'Gait normal ', '258744000': '% normal '}, 'renal function': {'11953005': 'Renal function '}, 'defined': {'900000000000073002': 'sufficiently defined concept definition status '}, '1': {'451231000124103': 'greater than one'}, 'ast /alt </': {'116063003': 'Atypical lipoma ', '28655007': 'Liposarcoma, well differentiated '}, '=3 x institutional upper limit of normal': {'260313008': '<3 ', '257622000': 'Healthcare facility ', '261183002': 'Upper ', '264217000': 'Superior ', '352730000': 'Supra- ', '260394003': 'Normal limits ', '385437003': 'Institution '}, '2': {'260306008': 'Integer +2 '}, 'serum creatinine': {'113075003': 'Creatinine measurement, serum ', '365757006': 'Finding of serum creatinine level '}, '= 2x institutional upper limit of normal': {'257622000': 'Healthcare facility ', '261183002': 'Upper ', '264217000': 'Superior ', '352730000': 'Supra- ', '260394003': 'Normal limits ', '385437003': 'Institution '}}
{'normal hepatic function': {'17621005': ('qualifier value', 'Normal ', ['272099008']), '79036002': ('observable entity', 'Liver function ', ['246464006']), '8117002': ('clinical finding', 'Gait normal ', ['250171008']), '258744000': ('unit', '% normal ', ['767524001'])}, 'renal function': {'11953005': ('observable entity', 'Renal function ', ['246464006'])}, '=3 x institutional upper limit of normal': {'352730000': ('qualifier value', 'Supra- ', ['272099008'])}, 'serum creatinine': {'113075003': ('procedure', 'Creatinine measurement, serum ', ['128927009']), '365757006': ('clinical finding', 'Finding of serum creatinine level ', ['441742003'])}, '= 2x institutional upper limit of normal': {'352730000': ('qualifier value', 'Supra- ', ['272099008'])}}

483414
each subject will have his medical history taken and will receive a complete medical examination as well as a 12-lead electrocardiogram within 14 days before the first administration of the test substance
each subject will have his medical history taken and will receive a complete medical examination as well as a 12-lead electrocardiogram , before the first administration of the test substance
['his medical history', 'taken', 'a complete medical examination', 'a 12 lead electrocardiogram', 'the first administration of the test substance']
{'his medical history': {'392521001': 'History of '}, 'taken': {'419652001': 'Take - dosing instruction imperative '}, 'a complete medical examination': {'255594003': 'Complete ', '225886003': 'Medical assessment '}, 'a 12 lead electrocardiogram': {'268400002': '12 lead electrocardiogram '}, 'the first administration of the test substance': {'255216001': 'First ', '432102000': 'Administration of substance ', '108252007': 'Laboratory procedure ', '15220000': 'Laboratory test ', '269814003': 'Laboratory procedures -general ', '272393004': 'Tests ', '277775005': 'Test finding ', '232714002': 'Firstly '}}
{'a complete medical examination': {'255594003': ('qualifier value', 'Complete ', ['272099008']), '225886003': ('procedure', 'Medical assessment ', ['128927009'])}, 'a 12 lead electrocardiogram': {'268400002': ('procedure', '12 lead electrocardiogram ', ['363691001', '362958002', '128927009'])}, 'the first administration of the test substance': {'432102000': ('procedure', 'Administration of substance ', ['128927009']), '15220000': ('procedure', 'Laboratory test ', ['128927009', '108252007']), '269814003': ('situation with explicit context', 'Laboratory procedures -general ', ['129125009']), '232714002': ('qualifier value', 'Firstly ', ['272099008'])}}

489472
injectable
injectable
['injectable']
{'injectable': {'385218009': 'Injection '}}
{}

501055
patient has a relative or caregiver who is willing and capable to support the clinical trial; his/her written informed consent is optional
patient has a relative or caregiver who is willing and capable to support the clinical trial; his/her written informed consent is optional
['patient', 'a relative', 'caregiver', 'willing', 'to', 'support', 'the clinical trial']
{'patient': {'116154003': 'Patient '}, 'a relative': {'125677006': 'Relative ', '29920004': 'Relative '}, 'caregiver': {'133932002': 'Caregiver '}, 'willing': {'225466006': 'Willing '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'support': {'9096001': 'Support, device '}, 'the clinical trial': {'110465008': 'Clinical trial '}}
{'a relative': {'29920004': ('qualifier value', 'Relative ', ['272099008'])}, 'willing': {'225466006': ('clinical finding', 'Willing ', ['250171008'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}}

501214
seeking or receiving services at the canandaigua va medical center or rochester outpatient clinic;
seeking or receiving services at the canandaigua va medical center or rochester outpatient clinic;
['receiving services at the canandaigua va medical center', 'rochester outpatient clinic']
{'receiving services at the canandaigua va medical center': {'118661008': 'Physician service ', '26216008': 'Central ', '224930009': 'Services ', '288565001': 'Medical center '}, 'rochester outpatient clinic': {'35971002': 'Ambulatory care site '}}
{'receiving services at the canandaigua va medical center': {'26216008': ('qualifier value', 'Central ', ['272099008'])}}

519075
age 18 or older at the time of consent
, at the time of consent
['at the time of consent']
{'at the time of consent': {'410669006': 'Time ', '410670007': 'time', '900000000000475002': 'time '}}
{}

529877
no history of variceal bleeding.
variceal bleeding.
['variceal bleeding']
{'variceal bleeding': {'57052009': 'Bleeding varices '}}
{}

533256
history/physical examination within 2 weeks prior to registration
history/physical examination , prior to registration
['history/physical examination']
{'history/physical examination': {'63332003': 'History AND physical examination '}}
{'history/physical examination': {'63332003': ('procedure', 'History AND physical examination ', ['362958002', '128927009'])}}

543353-1
all patients will be questioned about prior exposure to antibody therapy without affect to eligibility.
all patients will be questioned about prior exposure to antibody therapy without affect to eligibility.
['all patients', 'questioned about prior exposure', 'to antibody therapy without', 'affect to eligibility']
{'all patients': {'116154003': 'Patient '}, 'questioned about prior exposure': {'236874000': 'Status pre- ', '288556008': 'before', '71677004': 'Injury due to exposure to external cause ', '24932003': 'Exposure to '}, 'to antibody therapy without': {'68498002': 'Antibody ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '112133008': 'Immunoglobulin ', '333710000': 'Immunoglobulin products ', '399771004': 'Immunoglobulin structure '}, 'affect to eligibility': {'4065008': 'Affect, function '}}
{'questioned about prior exposure': {'71677004': ('clinical finding', 'Injury due to exposure to external cause ', ['64572001'])}, 'to antibody therapy without': {'68498002': ('product', 'Antibody ', ['312413002', '115668003']), '276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '112133008': ('product', 'Immunoglobulin ', ['312413002', '115668003']), '333710000': ('product', 'Immunoglobulin products ', ['763158003']), '399771004': ('product', 'Immunoglobulin structure ', ['312413002', '115668003', '112133008'])}, 'affect to eligibility': {'4065008': ('observable entity', 'Affect, function ', ['246464006'])}}

543353-2
patients with prior exposure will have a blood sample collected for human antimouse antibody .
patients with prior exposure will have a blood sample collected for human antimouse antibody .
['patients with prior exposure', 'a blood sample', 'collected for human antimouse antibody']
{'patients with prior exposure': {'116154003': 'Patient ', '236874000': 'Status pre- ', '288556008': 'before', '71677004': 'Injury due to exposure to external cause ', '24932003': 'Exposure to '}, 'a blood sample': {'119297000': 'Blood specimen '}, 'collected for human antimouse antibody': {'115628002': 'Human anti-mouse antibody ', '122155001': 'Measurement of human anti-mouse antibody '}}
{'patients with prior exposure': {'71677004': ('clinical finding', 'Injury due to exposure to external cause ', ['64572001'])}, 'collected for human antimouse antibody': {'115628002': ('product', 'Human anti-mouse antibody ', ['312413002', '115668003']), '122155001': ('procedure', 'Measurement of human anti-mouse antibody ', ['128927009'])}}

543353-3
for patients with no prior antibody therapy exposure, no further action will be taken.
for patients with prior antibody therapy exposure, further action will be taken.
['for patients with prior antibody therapy exposure', 'further action', 'taken']
{'for patients with prior antibody therapy exposure': {'116154003': 'Patient ', '236874000': 'Status pre- ', '288556008': 'before', '68498002': 'Antibody ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '71677004': 'Injury due to exposure to external cause ', '24932003': 'Exposure to ', '112133008': 'Immunoglobulin ', '333710000': 'Immunoglobulin products ', '399771004': 'Immunoglobulin structure '}, 'further action': {'46053002': 'Distal ', '129264002': 'Action ', '273248003': 'action'}, 'taken': {'419652001': 'Take - dosing instruction imperative '}}
{'for patients with prior antibody therapy exposure': {'68498002': ('product', 'Antibody ', ['312413002', '115668003']), '276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '71677004': ('clinical finding', 'Injury due to exposure to external cause ', ['64572001']), '112133008': ('product', 'Immunoglobulin ', ['312413002', '115668003']), '333710000': ('product', 'Immunoglobulin products ', ['763158003']), '399771004': ('product', 'Immunoglobulin structure ', ['312413002', '115668003', '112133008'])}, 'further action': {'46053002': ('qualifier value', 'Distal ', ['272099008'])}}

547005
man patient agrees to use an acceptable method for contraception during study drug therapy and for 4 weeks after discontinuation of bortezomib therapy.
man patient agrees to use an acceptable method for contraception during study drug therapy and for 4 weeks after discontinuation of bortezomib therapy.
['man patient', 'to', 'use', 'an acceptable method for contraception', 'during study drug therapy', 'and for 4 weeks', 'after discontinuation of bortezomib therapy']
{'man patient': {'339947000': 'Man ', '116154003': 'Patient ', '278412004': 'Human - origin ', '337915000': 'Homo sapiens ', '10052007': 'Male structure ', '248153007': 'Male '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'use': {'277889008': 'usage', '419385000': 'Use - dosing instruction imperative '}, 'an acceptable method for contraception': {'900000000000549004': 'acceptable ', '13197004': 'Contraception '}, 'during study drug therapy': {'185922005': 'Clinical drug trial ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '224699009': 'Study ', '416608005': 'Drug therapy '}, 'and for 4 weeks': {'260300002': '-4 ', '258705008': 'week '}, 'after discontinuation of bortezomib therapy': {'398907002': 'Bortezomib ', '407097007': 'Bortezomib ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '410546004': 'Discontinued '}}
{'man patient': {'339947000': ('person', 'Man ', ['133936004']), '278412004': ('qualifier value', 'Human - origin ', ['272099008']), '248153007': ('clinical finding', 'Male ', ['365860008'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'an acceptable method for contraception': {'13197004': ('clinical finding', 'Contraception ', ['250171008'])}, 'during study drug therapy': {'276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '416608005': ('procedure', 'Drug therapy ', ['277132007', '128927009'])}, 'and for 4 weeks': {'258705008': ('unit', 'week ', ['767524001'])}, 'after discontinuation of bortezomib therapy': {'398907002': ('product', 'Bortezomib ', ['763158003']), '276239002': ('procedure', 'Therapy ', ['277132007', '243120004'])}}

580062
a who performance status of 0 or 1. radiotherapy alone is allowed if given pre protocol or post protocol treatment.
a who performance status of 0 or 1. radiotherapy alone is allowed if given pre protocol or post protocol treatment.
['who performance status of 0', '1  radiotherapy', 'alone', 'given pre protocol', 'post protocol treatment']
{'who performance status of 0': {'263490005': 'status'}, '1  radiotherapy': {'451231000124103': 'greater than one', '419815003': 'Radiation oncology ', '108290001': 'Radiation oncology AND/OR radiotherapy ', '53438000': 'Radiation therapy procedure or service '}, 'alone': {'50607009': 'Singular ', '105529008': 'Lives alone '}, 'given pre protocol': {'419582001': 'Give - dosing instruction imperative ', '236874000': 'Status pre- ', '288556008': 'before', '258049002': 'Protocols ', '272113006': 'Before values '}, 'post protocol treatment': {'288563008': 'After values ', '258049002': 'Protocols ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '416118004': 'Administration '}}
{'alone': {'50607009': ('qualifier value', 'Singular ', ['272099008']), '105529008': ('clinical finding', 'Lives alone ', ['118240005'])}, 'given pre protocol': {'272113006': ('qualifier value', 'Before values ', ['272099008'])}, 'post protocol treatment': {'288563008': ('qualifier value', 'After values ', ['272099008']), '276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '416118004': ('procedure', 'Administration ', ['128927009'])}}

586230
body mass index maximum 40 kg/m^2
body mass index maximum 40 kg/m^2
['body mass index maximum 40 kg/m^2']
{'body mass index maximum 40 kg/m^2': {'301331008': 'Finding of body mass index ', '398303009': 'Max ', '259031006': 'per forty ', '414557004': 'Kilogram-meter ', '60621009': 'Body mass index '}}
{'body mass index maximum 40 kg/m^2': {'301331008': ('clinical finding', 'Finding of body mass index ', ['250171008']), '259031006': ('unit', 'per forty ', ['767524001']), '414557004': ('unit', 'Kilogram-meter ', ['767524001']), '60621009': ('observable entity', 'Body mass index ', ['363788007'])}}

593027
vital signs should be within normal ranges as deemed by the investigator.
vital signs should be within normal ranges as deemed by the investigator.
['vital signs', 'be within normal ranges']
{'vital signs': {'61746007': 'Taking patient vital signs '}, 'be within normal ranges': {'260395002': 'Normal range '}}
{'vital signs': {'61746007': ('procedure', 'Taking patient vital signs ', ['362958002', '128927009'])}}

595059
age 18 or above, or of legal age to give informed consent specific to national law
age 18 or above, or of legal age to give informed consent specific to national law
['age 18', 'above,', 'or of legal age', 'to', 'give', 'informed consent', 'specific to national law']
{'age 18': {'397669002': 'Age ', '424144002': 'Current chronological age '}, 'above,': {'261183002': 'Upper ', '264217000': 'Superior ', '352730000': 'Supra- '}, 'or of legal age': {'398165009': 'Legal ', '397669002': 'Age ', '424144002': 'Current chronological age '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'give': {'419582001': 'Give - dosing instruction imperative '}, 'informed consent': {'108968006': 'Oprelvekin ', '410938009': 'Oprelvekin ', '223458004': 'Informing '}, 'specific to national law': {'69658003': 'Specific '}}
{'age 18': {'397669002': ('qualifier value', 'Age ', ['272099008']), '424144002': ('observable entity', 'Current chronological age ', ['105727008'])}, 'above,': {'352730000': ('qualifier value', 'Supra- ', ['272099008'])}, 'or of legal age': {'398165009': ('qualifier value', 'Legal ', ['272099008']), '397669002': ('qualifier value', 'Age ', ['272099008']), '424144002': ('observable entity', 'Current chronological age ', ['105727008'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'informed consent': {'108968006': ('product', 'Oprelvekin ', ['406455002', '312413002', '115668003']), '410938009': ('product', 'Oprelvekin ', ['763158003'])}, 'specific to national law': {'69658003': ('qualifier value', 'Specific ', ['272099008'])}}

602716-1
fertile women of ≥ 16 years of age must use >= one of the following contraceptives for >= one month prior to initiation of trial participance: oral contraceptive, contraceptive diaphragm, intrauterine contraceptive device , tube ligation.
fertile women of , must use >= one of the following contraceptives for >= one month prior to initiation of trial participance: oral contraceptive, contraceptive diaphragm, intrauterine contraceptive device , tube ligation.
['fertile women of', 'use', '= one of the following contraceptives', '= one month prior to initiation of trial participance', 'oral contraceptive,', 'contraceptive diaphragm,', 'intrauterine contraceptive device ,', 'tube ligation']
{'fertile women of': {'397594008': 'Fertility, function ', '397647009': 'Ability to conceive ', '224526002': 'Woman '}, 'use': {'277889008': 'usage', '419385000': 'Use - dosing instruction imperative '}, '= one of the following contraceptives': {'38112003': 'One ', '367409002': 'followed by', '108899006': 'Contraceptives ', '421939007': 'Follow - dosing instruction imperative '}, '= one month prior to initiation of trial participance': {'4781000175106': 'one month', '236874000': 'Status pre- ', '288556008': 'before', '312009002': 'Cognitive function: initiation ', '110465008': 'Clinical trial '}, 'oral contraceptive,': {'59261009': 'Oral contraceptive preparation ', '5935008': 'Oral contraception '}, 'contraceptive diaphragm,': {'20359006': 'Contraceptive diaphragm, device ', '336704008': 'Vaginal contraceptive diaphragm ', '469119008': 'Diaphragm pessary '}, 'intrauterine contraceptive device ,': {'268460000': 'Intrauterine contraceptive device '}, 'tube ligation': {'77543007': 'Ligation of fallopian tube '}}
{'fertile women of': {'397594008': ('observable entity', 'Fertility, function ', ['246464006']), '397647009': ('observable entity', 'Ability to conceive ', ['363788007']), '224526002': ('person', 'Woman ', ['133936004'])}, '= one of the following contraceptives': {'108899006': ('product', 'Contraceptives ', ['763158003'])}, '= one month prior to initiation of trial participance': {'4781000175106': ('qualifier value', 'one month', ['272099008']), '312009002': ('observable entity', 'Cognitive function: initiation ', ['246464006'])}, 'oral contraceptive,': {'5935008': ('clinical finding', 'Oral contraception ', ['250171008'])}, 'tube ligation': {'77543007': ('procedure', 'Ligation of fallopian tube ', ['362958002', '128927009'])}}

602716-2
for girls between 12 and 15 years of age a written confirmation of sexual abstinence, given by a person having the care and custody of the child, is sufficient.
for girls between 12 and 15 years of age a written confirmation of sexual abstinence, given by a person having the care and custody of the child, is sufficient.
['for girls between 12', '15 years of age', 'a written confirmation of sexual abstinence,', 'given by a person', 'custody of the child,', 'sufficient']
{'for girls between 12': {'224526002': 'Woman ', '431549007': 'Female child '}, '15 years of age': {'258707000': 'year ', '397669002': 'Age ', '424144002': 'Current chronological age '}, 'a written confirmation of sexual abstinence,': {'12261009': 'Writing ', '74996004': 'Confirmation of '}, 'given by a person': {'419582001': 'Give - dosing instruction imperative ', '125676002': 'Person '}, 'custody of the child,': {'160499008': 'Child of '}, 'sufficient': {'51117008': 'Sufficient '}}
{'for girls between 12': {'224526002': ('person', 'Woman ', ['133936004', '125676002'])}, '15 years of age': {'258707000': ('unit', 'year ', ['767524001']), '397669002': ('qualifier value', 'Age ', ['272099008']), '424144002': ('observable entity', 'Current chronological age ', ['105727008'])}, 'a written confirmation of sexual abstinence,': {'12261009': ('observable entity', 'Writing ', ['246464006'])}, 'custody of the child,': {'160499008': ('clinical finding', 'Child of ', ['118240005'])}, 'sufficient': {'51117008': ('qualifier value', 'Sufficient ', ['272099008'])}}

636426
medically appropriate candidate for radical cystectomy, as per nyu attending urologic oncologist
medically appropriate candidate for radical cystectomy, as per nyu attending urologic oncologist
['medically appropriate candidate for radical cystectomy,', 'urologic oncologist']
{'medically appropriate candidate for radical cystectomy,': {'63016009': 'Total resection of urinary bladder ', '64063003': 'Radical cystectomy '}, 'urologic oncologist': {'394612005': 'Urology ', '77926000': 'Urologic '}}
{'medically appropriate candidate for radical cystectomy,': {'63016009': ('procedure', 'Total resection of urinary bladder ', ['362958002', '128927009']), '64063003': ('procedure', 'Radical cystectomy ', ['362958002', '63016009', '128927009'])}, 'urologic oncologist': {'77926000': ('qualifier value', 'Urologic ', ['272099008'])}}

639423
estimated glomerular filtration rate 20-45 mls/min/1.73m2; or
estimated glomerular filtration rate 20-45 mls/min/1.73m2; or
['estimated glomerular filtration rate 20 45 mls/min/1 73m2']
{'estimated glomerular filtration rate 20 45 mls/min/1 73m2': {'414135002': 'Estimated ', '80274001': 'Glomerular filtration rate ', '721879006': 'Microphthalmia with linear skin defect syndrome ', '398169003': 'Min 1 '}}
{'estimated glomerular filtration rate 20 45 mls/min/1 73m2': {'414135002': ('qualifier value', 'Estimated ', ['272099008']), '80274001': ('observable entity', 'Glomerular filtration rate ', ['363788007']), '721879006': ('clinical finding', 'Microphthalmia with linear skin defect syndrome ', ['64572001', '118234003']), '398169003': ('unit', 'Min 1 ', ['767524001'])}}

641347
subject treated by radiotherapy for a skin hemangioma in childhood at gustave roussy between 1941 and 1973 and who have received < 1 gy of radiation doses in the brain
subject treated by radiotherapy for a skin hemangioma in childhood at gustave roussy between 1941 and 1973 and who have received < 1 gy of radiation doses in the brain
['treated by radiotherapy', 'for a skin hemangioma in childhood', '< 1 gy of radiation doses', 'in the brain']
{'treated by radiotherapy': {'28995006': 'treated with', '419815003': 'Radiation oncology ', '108290001': 'Radiation oncology AND/OR radiotherapy ', '53438000': 'Radiation therapy procedure or service '}, 'for a skin hemangioma in childhood': {'93471006': 'Hemangioma of skin ', '255398004': 'Childhood ', '68433009': 'Childhood '}, '< 1 gy of radiation doses': {'451231000124103': 'greater than one', '223719008': 'Guyana ', '30821001': 'Electromagnetic radiation ', '260911001': 'dosage', '277406006': 'Dosages ', '282717008': 'Unit of radiation dose ', '82107009': 'Radiation ', '108290001': 'Radiation oncology AND/OR radiotherapy ', '53438000': 'Radiation therapy procedure or service ', '229029004': 'Gray '}, 'in the brain': {'12738006': 'Brain structure '}}
{'for a skin hemangioma in childhood': {'93471006': ('clinical finding', 'Hemangioma of skin ', ['64572001', '118234003']), '255398004': ('qualifier value', 'Childhood ', ['272099008']), '68433009': ('clinical finding', 'Childhood ', ['250171008'])}, '< 1 gy of radiation doses': {'277406006': ('qualifier value', 'Dosages ', ['272099008']), '282717008': ('unit', 'Unit of radiation dose ', ['767524001']), '229029004': ('unit', 'Gray ', ['282717008', '767524001'])}}

641918
subjects must be treated with a stable opioid regimen at a total daily dose on average of ≥ 30 mg equivalents of oral morphine sulfate
subjects must be treated with a stable opioid regimen at a total daily dose on average of ≥ 30 mg equivalents of oral morphine sulfate
['treated with a stable opioid regimen', 'at a total daily dose on average of  30 mg equivalents of oral morphine sulfate']
{'treated with a stable opioid regimen': {'28995006': 'treated with', '58158008': 'Stable ', '360204007': 'Opiate ', '404642006': 'Opiate agonist '}, 'at a total daily dose on average of  30 mg equivalents of oral morphine sulfate': {'258755000': '% of total ', '69620002': 'Daily ', '260911001': 'dosage', '277406006': 'Dosages ', '71651007': 'Mammography ', '258726008': 'equivalent - unit ', '9726003': 'Equal ', '350301004': 'Oral form morphine ', '95975008': 'Inorganic sulfate ', '104948005': 'Sulfate measurement ', '223575007': 'Mongolia ', '258797006': 'Milligram/deciliter ', '427264006': 'Milligram percent ', '408102007': 'Unit dose ', '255619001': 'Total '}}
{'treated with a stable opioid regimen': {'58158008': ('qualifier value', 'Stable ', ['272099008']), '360204007': ('product', 'Opiate ', ['763158003'])}, 'at a total daily dose on average of  30 mg equivalents of oral morphine sulfate': {'258755000': ('unit', '% of total ', ['767524001']), '69620002': ('qualifier value', 'Daily ', ['272099008']), '277406006': ('qualifier value', 'Dosages ', ['272099008']), '71651007': ('procedure', 'Mammography ', ['362958002', '128927009']), '258726008': ('unit', 'equivalent - unit ', ['767524001']), '9726003': ('qualifier value', 'Equal ', ['272099008']), '350301004': ('product', 'Oral form morphine ', ['360204007', '763158003']), '95975008': ('product', 'Inorganic sulfate ', ['406455002', '312413002', '312412007']), '104948005': ('procedure', 'Sulfate measurement ', ['128927009']), '258797006': ('unit', 'Milligram/deciliter ', ['767524001']), '427264006': ('unit', 'Milligram percent ', ['767524001']), '408102007': ('unit', 'Unit dose ', ['767524001']), '255619001': ('qualifier value', 'Total ', ['272099008'])}}

660575
women with previous lsil history may be included.
women with , lsil history may be included.
['women with', 'lsil history', 'included']
{'women with': {'224526002': 'Woman '}, 'lsil history': {'112662005': 'Low-grade squamous intraepithelial lesion ', '400002005': 'Squamous intraepithelial neoplasia grade 1 ', '450595003': 'Squamous intraepithelial neoplasia, low grade ', '392521001': 'History of '}, 'included': {'55919000': 'Including '}}
{'women with': {'224526002': ('person', 'Woman ', ['133936004'])}, 'included': {'55919000': ('qualifier value', 'Including ', ['272099008'])}}

665983
adequate bone marrow function, defined as follows:
adequate bone marrow function, defined as follows:
['adequate bone marrow function,', 'defined', 'follows']
{'adequate bone marrow function,': {'51117008': 'Sufficient ', '23435004': 'Bone function ', '227250008': 'Marrow ', '14016003': 'Bone marrow structure ', '279729006': 'All bone marrow ', '246464006': 'Function ', '277064003': 'function', '88323005': 'Adequate '}, 'defined': {'900000000000073002': 'sufficiently defined concept definition status '}, 'follows': {'367409002': 'followed by', '421939007': 'Follow - dosing instruction imperative '}}
{'adequate bone marrow function,': {'51117008': ('qualifier value', 'Sufficient ', ['272099008']), '23435004': ('observable entity', 'Bone function ', ['246464006'])}}

713518-1
women must not be breastfeeding.
women breastfeeding.
['women', 'breastfeeding']
{'women': {'224526002': 'Woman '}, 'breastfeeding': {'169741004': 'Breast fed '}}
{'women': {'224526002': ('person', 'Woman ', ['133936004'])}, 'breastfeeding': {'169741004': ('clinical finding', 'Breast fed ', ['250171008'])}}

713518-2
d) wocbp must agree to follow instructions for method of contraception for the duration of treatment with study drugs saxagliptin and dapagliflozin plus 5 half lives of study drug dapagliflozin for a total of 3 days following treatment completion.
d) wocbp must agree to follow instructions for method of contraception for the duration of treatment with study drugs saxagliptin and dapagliflozin plus 5 half lives of study drug dapagliflozin for a total of 3 days following treatment completion.
['to', 'follow', 'instructions for method of contraception', 'for the duration of treatment', 'with study drugs saxagliptin', 'dapagliflozin plus 5 half lives of study drug dapagliflozin', 'for a total of 3 days', 'following', 'treatment completion']
{'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'follow': {'367409002': 'followed by', '421939007': 'Follow - dosing instruction imperative '}, 'instructions for method of contraception': {'409073007': 'Education ', '13197004': 'Contraception '}, 'for the duration of treatment': {'261774000': 'Duration of treatment '}, 'with study drugs saxagliptin': {'185922005': 'Clinical drug trial ', '443066009': 'Saxagliptin ', '443087004': 'Saxagliptin '}, 'dapagliflozin plus 5 half lives of study drug dapagliflozin': {'703674001': 'Dapagliflozin ', '703678003': 'Dapagliflozin ', '20401003': 'in addition to', '224130005': 'Household composition ', '185922005': 'Clinical drug trial ', '419749002': '% live '}, 'for a total of 3 days': {'258755000': '% of total ', '258703001': 'day ', '255619001': 'Total '}, 'following': {'237679004': 'Status post ', '255234002': 'status post', '255260001': 'following'}, 'treatment completion': {'182992009': 'Treatment completed '}}
{'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'instructions for method of contraception': {'409073007': ('procedure', 'Education ', ['128927009']), '13197004': ('clinical finding', 'Contraception ', ['250171008'])}, 'for the duration of treatment': {'261774000': ('qualifier value', 'Duration of treatment ', ['272099008'])}, 'with study drugs saxagliptin': {'443066009': ('product', 'Saxagliptin ', ['763158003']), '443087004': ('product', 'Saxagliptin ', ['406455002', '312413002'])}, 'dapagliflozin plus 5 half lives of study drug dapagliflozin': {'703678003': ('product', 'Dapagliflozin ', ['763158003']), '224130005': ('observable entity', 'Household composition ', ['160476009']), '419749002': ('unit', '% live ', ['767524001'])}, 'for a total of 3 days': {'258755000': ('unit', '% of total ', ['767524001']), '258703001': ('unit', 'day ', ['767524001']), '255619001': ('qualifier value', 'Total ', ['272099008'])}, 'treatment completion': {'182992009': ('situation with explicit context', 'Treatment completed ', ['129125009'])}}

714028
sufficiently fluent in english to ensure valid understanding and completion of the tasks.
sufficiently fluent in english to ensure valid understanding and completion of the tasks.
['sufficiently fluent in english', 'to', 'valid understanding', 'completion of the tasks']
{'sufficiently fluent in english': {'297487008': 'English language ', '25804004': 'English ', '900000000000507009': 'english [international organization for standardization 639-1 code en] language reference set'}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'valid understanding': {'66216009': 'Understanding, function '}, 'completion of the tasks': {'255594003': 'Complete '}}
{'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'valid understanding': {'66216009': ('observable entity', 'Understanding, function ', ['246464006'])}, 'completion of the tasks': {'255594003': ('qualifier value', 'Complete ', ['272099008'])}}

714103
body mass index between 18 kg/m2 and 42 kg/m2, inclusive, based upon the height and weight at screening
body mass index between 18 kg/m2 and 42 kg/m2, inclusive, based upon the height and weight at screening
['body mass index between 18 kg/m2', '42 kg/m2,', 'inclusive,', 'based upon the height', 'weight at screening']
{'body mass index between 18 kg/m2': {'301331008': 'Finding of body mass index ', '258896009': 'Kilogram/square meter ', '60621009': 'Body mass index '}, '42 kg/m2,': {'258896009': 'Kilogram/square meter '}, 'inclusive,': {'55919000': 'Including '}, 'based upon the height': {'63813000': 'Alkali ', '75540009': 'High ', '371879000': 'Abnormally high '}, 'weight at screening': {'27113001': 'Body weight ', '20135006': 'Screening procedure ', '272102008': 'Weights ', '39857003': 'Weighing patient ', '726527001': 'importance weight'}}
{'body mass index between 18 kg/m2': {'301331008': ('clinical finding', 'Finding of body mass index ', ['250171008']), '258896009': ('unit', 'Kilogram/square meter ', ['767524001']), '60621009': ('observable entity', 'Body mass index ', ['363788007'])}, '42 kg/m2,': {'258896009': ('unit', 'Kilogram/square meter ', ['767524001'])}, 'inclusive,': {'55919000': ('qualifier value', 'Including ', ['272099008'])}, 'based upon the height': {'63813000': ('product', 'Alkali ', ['312413002']), '75540009': ('qualifier value', 'High ', ['272099008']), '371879000': ('qualifier value', 'Abnormally high ', ['75540009', '272099008'])}, 'weight at screening': {'27113001': ('observable entity', 'Body weight ', ['363788007']), '20135006': ('procedure', 'Screening procedure ', ['128927009']), '272102008': ('qualifier value', 'Weights ', ['272099008']), '39857003': ('procedure', 'Weighing patient ', ['128927009'])}}

736824
facilitators
facilitators
[]
{}
{}

738669
>= 2 consecutive previous treatment cycles of bont-a for current diagnosis
>= 2 consecutive , treatment cycles of bont-a for current diagnosis
['= 2 consecutive , treatment', 'cycles of bont a', 'for current diagnosis']
{'= 2 consecutive , treatment': {'260306008': 'Integer +2 ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '416118004': 'Administration '}, 'cycles of bont a': {'108890005': 'Botulinum toxin type A ', '427412002': 'Clostridium botulinum A toxin ', '703368006': 'IncobotulinumtoxinA '}, 'for current diagnosis': {'15240007': 'Current ', '439401001': 'Diagnosis '}}
{'= 2 consecutive , treatment': {'276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '416118004': ('procedure', 'Administration ', ['128927009'])}, 'cycles of bont a': {'108890005': ('product', 'Botulinum toxin type A ', ['406455002']), '427412002': ('product', 'Clostridium botulinum A toxin ', ['763158003']), '703368006': ('product', 'IncobotulinumtoxinA ', ['108890005', '406455002'])}}

740073
adequate haematological laboratory parameters:
adequate haematological laboratory parameters:
['adequate haematological laboratory parameters']
{'adequate haematological laboratory parameters': {'51117008': 'Sufficient ', '261904005': 'Laboratory ', '252116004': 'Observation parameter ', '33468001': 'Hematology procedure ', '88323005': 'Adequate '}}
{'adequate haematological laboratory parameters': {'51117008': ('qualifier value', 'Sufficient ', ['272099008']), '252116004': ('observable entity', 'Observation parameter ', ['363788007']), '33468001': ('procedure', 'Hematology procedure ', ['128927009'])}}

743254-1
4. all patients must have thorough tumor staging and meet >= 1 of the following criteria: a. either lymph node biopsy or lymph node dissection demonstrating lymph node metastasis by prostate cancer; b. non-bulky regional pelvic lymphadenopathy or distant lymphadenopathy visualized on ct/mri scan.
4. all patients must have thorough tumor staging and meet >= 1 of the following criteria: a. either lymph node biopsy or lymph node dissection demonstrating lymph node metastasis by prostate cancer; b. non-bulky regional pelvic lymphadenopathy or distant lymphadenopathy visualized on ct/mri scan.
['all patients', 'thorough tumor staging', '= 1 of the following criteria', 'a  either lymph node biopsy', 'lymph node dissection', 'lymph node metastasis by prostate cancer']
{'all patients': {'116154003': 'Patient '}, 'thorough tumor staging': {'254292007': 'Tumor staging '}, '= 1 of the following criteria': {'451231000124103': 'greater than one', '367409002': 'followed by', '421939007': 'Follow - dosing instruction imperative '}, 'a  either lymph node biopsy': {'21911005': 'Biopsy of lymph node '}, 'lymph node dissection': {'234253006': 'Excision of group of lymph nodes ', '58347006': 'Excision of lymph node '}, 'lymph node metastasis by prostate cancer': {'94392001': 'Secondary malignant neoplasm of lymph node ', '263847000': 'Prostatic ', '279689003': 'Prostatic gland structure ', '41216001': 'Prostatic structure '}}
{'a  either lymph node biopsy': {'21911005': ('procedure', 'Biopsy of lymph node ', ['362958002', '128927009'])}, 'lymph node dissection': {'234253006': ('procedure', 'Excision of group of lymph nodes ', ['362958002', '58347006', '128927009']), '58347006': ('procedure', 'Excision of lymph node ', ['362958002', '128927009'])}, 'lymph node metastasis by prostate cancer': {'94392001': ('clinical finding', 'Secondary malignant neoplasm of lymph node ', ['64572001', '250171008', '118234003'])}}

743254-2
lymph node biopsy is required if < 2.0 cm or in atypical distribution.
lymph node biopsy is required if < 2.0 cm or in atypical distribution.
['lymph node biopsy', 'or in atypical distribution']
{'lymph node biopsy': {'21911005': 'Biopsy of lymph node '}, 'or in atypical distribution': {'112231000': 'Atypical '}}
{'lymph node biopsy': {'21911005': ('procedure', 'Biopsy of lymph node ', ['362958002', '128927009'])}, 'or in atypical distribution': {'112231000': ('qualifier value', 'Atypical ', ['272099008'])}}

743254-3
c. primary tumor gleason score >/= 8 and serum psa concentration >/=25 ng/ml, indicating high risk of occult lymph node metastases.
c. primary tumor gleason score >/= 8 and serum psa concentration >/=25 ng/ml, indicating high risk of occult lymph node metastases.
['c  primary tumor gleason score', 'serum psa concentration', '=25 ng/ml,', 'high risk of occult lymph node metastases']
{'c  primary tumor gleason score': {'63161005': 'Principal ', '108369006': 'Neoplasm ', '106241006': 'Gleason grading system for prostatic cancer ', '372278000': 'Gleason score ', '263909009': 'True primary ', '261424001': 'Primary operation '}, 'serum psa concentration': {'67922002': 'Serum ', '702942001': 'Concentration ', '82742001': 'Concentration, function ', '119364003': 'Serum specimen '}, '=25 ng/ml,': {'258799009': 'Microgram/liter ', '258806002': 'Nanogram/milliliter '}, 'high risk of occult lymph node metastases': {'15508007': 'High risk of ', '81674002': 'Occultism ', '94392001': 'Secondary malignant neoplasm of lymph node ', '6080000': 'Occult '}}
{'c  primary tumor gleason score': {'63161005': ('qualifier value', 'Principal ', ['272099008']), '372278000': ('observable entity', 'Gleason score ', ['395531003']), '263909009': ('qualifier value', 'True primary ', ['272099008']), '261424001': ('qualifier value', 'Primary operation ', ['272099008'])}, 'serum psa concentration': {'67922002': ('product', 'Serum ', ['115669006', '115668003']), '82742001': ('observable entity', 'Concentration, function ', ['246464006'])}, '=25 ng/ml,': {'258799009': ('unit', 'Microgram/liter ', ['767524001']), '258806002': ('unit', 'Nanogram/milliliter ', ['767524001'])}, 'high risk of occult lymph node metastases': {'81674002': ('religion', 'Occultism ', ['108334009']), '94392001': ('clinical finding', 'Secondary malignant neoplasm of lymph node ', ['64572001', '250171008', '118234003']), '6080000': ('qualifier value', 'Occult ', ['272099008'])}}

743254-4
d. primary clinical tumor stage of t3 and gleason score >/= 7, indicating high risk of occult lymph node metastases.
d. primary clinical tumor stage of t3 and gleason score >/= 7, indicating high risk of occult lymph node metastases.
['d  primary clinical tumor stage of t3', 'gleason score', 'high risk of occult lymph node metastases']
{'d  primary clinical tumor stage of t3': {'876000': 'Blood group antigen D ', '63161005': 'Principal ', '58147004': 'Clinical ', '14410001': 'T3 category ', '263909009': 'True primary ', '261424001': 'Primary operation ', '69620002': 'Daily ', '258260000': 'd) '}, 'gleason score': {'106241006': 'Gleason grading system for prostatic cancer ', '372278000': 'Gleason score '}, 'high risk of occult lymph node metastases': {'15508007': 'High risk of ', '81674002': 'Occultism ', '94392001': 'Secondary malignant neoplasm of lymph node ', '6080000': 'Occult '}}
{'d  primary clinical tumor stage of t3': {'876000': ('product', 'Blood group antigen D ', ['115668003']), '63161005': ('qualifier value', 'Principal ', ['272099008']), '58147004': ('qualifier value', 'Clinical ', ['272099008']), '14410001': ('clinical finding', 'T3 category ', ['250171008']), '263909009': ('qualifier value', 'True primary ', ['272099008']), '261424001': ('qualifier value', 'Primary operation ', ['272099008']), '69620002': ('qualifier value', 'Daily ', ['272099008']), '258260000': ('staging and scales', 'd) ', ['254292007'])}, 'gleason score': {'372278000': ('observable entity', 'Gleason score ', ['395531003'])}, 'high risk of occult lymph node metastases': {'81674002': ('religion', 'Occultism ', ['108334009']), '94392001': ('clinical finding', 'Secondary malignant neoplasm of lymph node ', ['64572001', '250171008', '118234003']), '6080000': ('qualifier value', 'Occult ', ['272099008'])}}

743254-5
e. primary tumor stage t4, indicating high risk of occult lymph node metastases.
e. primary tumor stage t4, indicating high risk of occult lymph node metastases.
['e  primary tumor stage t4', 'high risk of occult lymph node metastases']
{'e  primary tumor stage t4': {'63161005': 'Principal ', '65565005': 'T4 category ', '263909009': 'True primary ', '261424001': 'Primary operation '}, 'high risk of occult lymph node metastases': {'15508007': 'High risk of ', '81674002': 'Occultism ', '94392001': 'Secondary malignant neoplasm of lymph node ', '6080000': 'Occult '}}
{'e  primary tumor stage t4': {'63161005': ('qualifier value', 'Principal ', ['272099008']), '65565005': ('clinical finding', 'T4 category ', ['250171008']), '263909009': ('qualifier value', 'True primary ', ['272099008']), '261424001': ('qualifier value', 'Primary operation ', ['272099008'])}, 'high risk of occult lymph node metastases': {'81674002': ('religion', 'Occultism ', ['108334009']), '94392001': ('clinical finding', 'Secondary malignant neoplasm of lymph node ', ['64572001', '250171008', '118234003']), '6080000': ('qualifier value', 'Occult ', ['272099008'])}}

743254-6
patients in any of these groups and < 3 sites of non-predominantly lytic b1 metastasis will be still considered eligible for the trial.
patients in any of these groups and < 3 sites of non-predominantly lytic b1 metastasis will be still considered eligible for the trial.
['patients in any of these groups', '< 3 sites of non predominantly lytic b1 metastasis', 'eligible for the trial']
{'patients in any of these groups': {'116154003': 'Patient ', '246261001': 'groups', '261586004': 'Groups ', '160481000': 'Social group ', '389109008': 'Group '}, '< 3 sites of non predominantly lytic b1 metastasis': {'260313008': '<3 ', '272737002': 'site of', '371757000': 'Lysis ', '128462008': 'Secondary malignant neoplastic disease ', '14799000': 'Neoplasm, metastatic ', '79282002': 'Carcinoma, metastatic ', '255308008': 'Lytic '}, 'eligible for the trial': {'110465008': 'Clinical trial '}}
{'patients in any of these groups': {'261586004': ('qualifier value', 'Groups ', ['272396007']), '160481000': ('observable entity', 'Social group ', ['160476009'])}, '< 3 sites of non predominantly lytic b1 metastasis': {'128462008': ('clinical finding', 'Secondary malignant neoplastic disease ', ['64572001']), '255308008': ('qualifier value', 'Lytic ', ['272099008'])}}

743254-7
the 2010 ajcc staging system will be followed.
the 2010 ajcc staging system will be followed.
['the 2010 ajcc staging system', 'followed']
{'the 2010 ajcc staging system': {'258236004': 'American Joint Committee on Cancer ', '246231009': 'staging system'}, 'followed': {'367409002': 'followed by'}}
{'the 2010 ajcc staging system': {'258236004': ('staging and scales', 'American Joint Committee on Cancer ', ['254292007'])}}

761076
subject is >18 years of age
subject is >18 years of age
['>18 years of age']
{'>18 years of age': {'258707000': 'year ', '397669002': 'Age ', '424144002': 'Current chronological age '}}
{'>18 years of age': {'258707000': ('unit', 'year ', ['767524001']), '397669002': ('qualifier value', 'Age ', ['272099008']), '424144002': ('observable entity', 'Current chronological age ', ['105727008'])}}

780757-1
hormonal contraception plus a barrier method.
hormonal contraception plus a barrier method.
['hormonal contraception plus a barrier method']
{'hormonal contraception plus a barrier method': {'278994005': 'Hormonal ', '225370004': 'Barrier contraception method '}}
{'hormonal contraception plus a barrier method': {'278994005': ('qualifier value', 'Hormonal ', ['272099008']), '225370004': ('clinical finding', 'Barrier contraception method ', ['250171008'])}}

780757-2
hormonal contraception al1 will not be considered adequate for inclusion into or participation in this study due to 1 of the study drugs being rifampicin.
hormonal contraception al1 will not be considered adequate for inclusion into or participation in this study due to 1 of the study drugs being rifampicin.
['hormonal contraception al1', 'adequate for inclusion', 'participation in this study', 'due to 1 of the study drugs', 'rifampicin']
{'hormonal contraception al1': {'278994005': 'Hormonal ', '13197004': 'Contraception '}, 'adequate for inclusion': {'51117008': 'Sufficient ', '55919000': 'Including ', '88323005': 'Adequate '}, 'participation in this study': {'224699009': 'Study '}, 'due to 1 of the study drugs': {'42752001': 'due to', '185922005': 'Clinical drug trial '}, 'rifampicin': {'29175007': 'Rifampin ', '387159009': 'Rifampin '}}
{'hormonal contraception al1': {'278994005': ('qualifier value', 'Hormonal ', ['272099008']), '13197004': ('clinical finding', 'Contraception ', ['250171008'])}, 'adequate for inclusion': {'51117008': ('qualifier value', 'Sufficient ', ['272099008']), '55919000': ('qualifier value', 'Including ', ['272099008'])}, 'rifampicin': {'29175007': ('product', 'Rifampin ', ['763158003']), '387159009': ('product', 'Rifampin ', ['312413002'])}}

803338
subjects must have a body mass index between 18 and 30 kg/m2, with a bodyweight of >50 kg
subjects must have a body mass index between 18 and 30 kg/m2, with a bodyweight of >50 kg
['a body mass index between 18', '30 kg/m2,', 'with a bodyweight of', '>50 kg']
{'a body mass index between 18': {'301331008': 'Finding of body mass index ', '60621009': 'Body mass index '}, '30 kg/m2,': {'258896009': 'Kilogram/square meter '}, 'with a bodyweight of': {'27113001': 'Body weight ', '39857003': 'Weighing patient '}, '>50 kg': {'223574006': 'Kyrgyzstan ', '258683005': 'kilogram '}}
{'a body mass index between 18': {'301331008': ('clinical finding', 'Finding of body mass index ', ['250171008']), '60621009': ('observable entity', 'Body mass index ', ['363788007'])}, '30 kg/m2,': {'258896009': ('unit', 'Kilogram/square meter ', ['767524001'])}, 'with a bodyweight of': {'27113001': ('observable entity', 'Body weight ', ['363788007']), '39857003': ('procedure', 'Weighing patient ', ['128927009'])}, '>50 kg': {'258683005': ('unit', 'kilogram ', ['767524001'])}}

806564
systolic bp ≥140 mmhg, or diastolic bp ≥90 mmhg on >= 2 occasions and
systolic bp ≥140 mmhg, or diastolic bp ≥90 mmhg on >= 2 occasions and
['systolic bp 140 mmhg', 'diastolic bp 90 mmhg', 'on >', '= 2 occasions']
{'systolic bp 140 mmhg': {'271649006': 'Systolic blood pressure ', '72313002': 'Systolic arterial pressure ', '732503007': '140', '259018001': 'Millimeter of mercury ', '304621005': 'torr '}, 'diastolic bp 90 mmhg': {'271650006': 'Diastolic blood pressure ', '264705001': '>90 ', '259018001': 'Millimeter of mercury ', '304621005': 'torr ', '264703008': '<90 '}, 'on >': {'420771004': 'Upon - dosing instruction fragment ', '420862001': 'On '}, '= 2 occasions': {'260306008': 'Integer +2 ', '27789000': 'Infrequent ', '84638005': 'Occasional '}}
{'systolic bp 140 mmhg': {'271649006': ('observable entity', 'Systolic blood pressure ', ['363788007']), '72313002': ('observable entity', 'Systolic arterial pressure ', ['363788007', '271649006']), '259018001': ('unit', 'Millimeter of mercury ', ['767524001']), '304621005': ('unit', 'torr ', ['767524001'])}, 'diastolic bp 90 mmhg': {'271650006': ('observable entity', 'Diastolic blood pressure ', ['363788007']), '259018001': ('unit', 'Millimeter of mercury ', ['767524001']), '304621005': ('unit', 'torr ', ['767524001'])}, 'on >': {'420862001': ('qualifier value', 'On ', ['272099008'])}, '= 2 occasions': {'27789000': ('qualifier value', 'Infrequent ', ['272099008']), '84638005': ('qualifier value', 'Occasional ', ['272099008'])}}

808646
age 18-70;
, ;
[]
{}
{}

833945
eastern cooperative oncology group performance status =< 2
eastern cooperative oncology group performance status =< 2
['eastern cooperative oncology group performance status', '< 2']
{'eastern cooperative oncology group performance status': {'423740007': 'Eastern Cooperative Oncology Group performance status '}, '< 2': {'260306008': 'Integer +2 '}}
{'eastern cooperative oncology group performance status': {'423740007': ('observable entity', 'Eastern Cooperative Oncology Group performance status ', ['278844005'])}}

834897
subject must have measurable disease and must be a candidate for intralesional therapy with >= 1 injectable cutaneous, subcutaneous, or nodal melanoma lesion or with multiple injectable lesions that in aggregate have a longest diameter of ≥ 10 mm.
subject must have measurable disease and must be a candidate for intralesional therapy with >= 1 injectable cutaneous, subcutaneous, or nodal melanoma lesion or with multiple injectable lesions 10 mm.
['measurable disease', 'a candidate for intralesional therapy', '= 1 injectable cutaneous, subcutaneous,', 'nodal melanoma lesion', 'or with multiple injectable lesions 10 mm']
{'measurable disease': {'64572001': 'Disease '}, 'a candidate for intralesional therapy': {'276239002': 'Therapy ', '277132007': 'Therapeutic procedure '}, '= 1 injectable cutaneous, subcutaneous,': {'451231000124103': 'greater than one', '385218009': 'Injection ', '448598008': 'Cutaneous route ', '263887005': 'Subcutaneous '}, 'nodal melanoma lesion': {'2142002': 'Nodular melanoma ', '254731001': 'Nodular malignant melanoma of skin ', '52988006': 'Lesion '}, 'or with multiple injectable lesions 10 mm': {'300582001': 'Multiple lesions ', '385218009': 'Injection '}}
{'a candidate for intralesional therapy': {'276239002': ('procedure', 'Therapy ', ['277132007', '243120004'])}, 'nodal melanoma lesion': {'254731001': ('clinical finding', 'Nodular malignant melanoma of skin ', ['64572001', '118234003'])}, 'or with multiple injectable lesions 10 mm': {'300582001': ('clinical finding', 'Multiple lesions ', ['118240005', '250171008'])}}

835315
acute lymphoblastic leukemia or lymphoblastic lymphoma
acute lymphoblastic leukemia or lymphoblastic lymphoma
['acute lymphoblastic leukemia', 'lymphoblastic lymphoma']
{'acute lymphoblastic leukemia': {'128822004': 'Precursor cell lymphoblastic leukemia ', '91857003': 'Acute lymphoid leukemia, disease '}, 'lymphoblastic lymphoma': {'109965004': 'Diffuse non-Hodgkins lymphoma, lymphoblastic ', '128806000': 'Precursor cell lymphoblastic lymphoma ', '188675007': 'Malignant lymphoma - small cleaved cell ', '128822004': 'Precursor cell lymphoblastic leukemia '}}
{'acute lymphoblastic leukemia': {'91857003': ('clinical finding', 'Acute lymphoid leukemia, disease ', ['64572001', '118234003'])}, 'lymphoblastic lymphoma': {'109965004': ('clinical finding', 'Diffuse non-Hodgkins lymphoma, lymphoblastic ', ['64572001']), '188675007': ('clinical finding', 'Malignant lymphoma - small cleaved cell ', ['64572001'])}}

842896-1
present to the emergency department with a migraine headache as defined by the modified irma criteria.
present to the emergency department with a migraine headache as defined by the modified irma criteria.
['present to the emergency department', 'with a migraine headache', 'defined by the modified irma criteria']
{'present to the emergency department': {'52101004': 'Present ', '225728007': 'Accident and Emergency department ', '246105001': 'presentation'}, 'with a migraine headache': {'37796009': 'Migraine '}, 'defined by the modified irma criteria': {'900000000000073002': 'sufficiently defined concept definition status ', '18307000': 'Altered ', '243326001': 'Changing ', '66238006': 'Radioreceptor assay '}}
{'with a migraine headache': {'37796009': ('clinical finding', 'Migraine ', ['64572001', '102957003', '118234003'])}, 'defined by the modified irma criteria': {'18307000': ('qualifier value', 'Altered ', ['272099008']), '243326001': ('qualifier value', 'Changing ', ['272099008']), '66238006': ('procedure', 'Radioreceptor assay ', ['128927009'])}}

842896-2
the modified irma criteria are as follows: headache episodes of 1-72 hours presenting with >= 3 of the following 6 criteria: moderate to severe episode of impaired daily activities; focal localization of headache; pulsatile description; nausea or vomiting or abdominal pain; photophobia or phonophobia or avoidance of light and noise; symptoms increasing with activity or resolving by rest.
the modified irma criteria are as follows: headache episodes of 1-72 hours presenting with >= 3 of the following 6 criteria: moderate to severe episode of impaired daily activities; focal localization of headache; pulsatile description; nausea or vomiting or abdominal pain; photophobia or phonophobia or avoidance of light and noise; symptoms increasing with activity or resolving by rest.
['the modified irma criteria', 'follows', 'headache episodes of 1 72 hours', 'presenting with', '= 3 of the following 6 criteria', 'moderate to severe episode of impaired daily activities']
{'the modified irma criteria': {'18307000': 'Altered ', '243326001': 'Changing ', '66238006': 'Radioreceptor assay '}, 'follows': {'367409002': 'followed by', '421939007': 'Follow - dosing instruction imperative '}, 'headache episodes of 1 72 hours': {'25064002': 'Headache ', '263503000': 'episode of', '272128006': 'Episodes ', '123028004': '72 hours '}, 'presenting with': {'246105001': 'presentation'}, '= 3 of the following 6 criteria': {'260281002': 'Distance vision 3/6 ', '367409002': 'followed by', '421939007': 'Follow - dosing instruction imperative ', '732653005': '3.6'}, 'moderate to severe episode of impaired daily activities': {'371924009': 'Moderate to severe ', '263503000': 'episode of', '272128006': 'Episodes ', '260379002': 'Impaired ', '129025006': 'Activity of daily living '}}
{'the modified irma criteria': {'18307000': ('qualifier value', 'Altered ', ['272099008']), '243326001': ('qualifier value', 'Changing ', ['272099008']), '66238006': ('procedure', 'Radioreceptor assay ', ['128927009'])}, 'headache episodes of 1 72 hours': {'25064002': ('clinical finding', 'Headache ', ['102957003', '118234003']), '272128006': ('qualifier value', 'Episodes ', ['272099008']), '123028004': ('qualifier value', '72 hours ', ['272099008'])}, '= 3 of the following 6 criteria': {'260281002': ('clinical finding', 'Distance vision 3/6 ', ['118234003'])}, 'moderate to severe episode of impaired daily activities': {'371924009': ('qualifier value', 'Moderate to severe ', ['272396007']), '272128006': ('qualifier value', 'Episodes ', ['272099008']), '129025006': ('observable entity', 'Activity of daily living ', ['246464006'])}}

848544
ability to understand the protocol and provide informed consent.
understand the protocol and provide informed consent.
['understand', 'the protocol', 'informed consent']
{'understand': {'66216009': 'Understanding, function '}, 'the protocol': {'258049002': 'Protocols '}, 'informed consent': {'108968006': 'Oprelvekin ', '410938009': 'Oprelvekin ', '223458004': 'Informing '}}
{'understand': {'66216009': ('observable entity', 'Understanding, function ', ['246464006'])}, 'informed consent': {'108968006': ('product', 'Oprelvekin ', ['406455002', '312413002', '115668003']), '410938009': ('product', 'Oprelvekin ', ['763158003'])}}

858057
have received previous treatment for ovarian cancer that included a platinum based chemotherapy regimen
have received , treatment for ovarian cancer
['treatment for ovarian cancer']
{'treatment for ovarian cancer': {'276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '363443007': 'Malignant tumor of ovary ', '416118004': 'Administration '}}
{'treatment for ovarian cancer': {'276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '363443007': ('clinical finding', 'Malignant tumor of ovary ', ['64572001', '118234003']), '416118004': ('procedure', 'Administration ', ['128927009'])}}

858414
hemoglobin values in 4 screening visits and the mean hb must be between 9.0 and 12.0 g/dl , and the difference between them must be ≤1.5 g/dl.
hemoglobin values in 4 screening visits and the mean hb must be between 9.0 and 12.0 g/dl , and the difference between them must be ≤1.5 g/dl.
['hemoglobin values in 4 screening visits', 'the mean hb', 'be between 9 0', '12 0 g/dl', 'the difference between them', '1 5 g/dl']
{'hemoglobin values in 4 screening visits': {'38082009': 'Hemoglobin ', '20135006': 'Screening procedure '}, 'the mean hb': {'255586005': 'Mean ', '38082009': 'Hemoglobin '}, 'be between 9 0': {'732402004': '0.9'}, '12 0 g/dl': {'258795003': 'Gram/deciliter '}, 'the difference between them': {'263735002': 'Differential '}, '1 5 g/dl': {'732425003': '1.5', '258795003': 'Gram/deciliter '}}
{'hemoglobin values in 4 screening visits': {'38082009': ('product', 'Hemoglobin ', ['312413002', '115668003']), '20135006': ('procedure', 'Screening procedure ', ['128927009'])}, 'the mean hb': {'255586005': ('qualifier value', 'Mean ', ['272099008']), '38082009': ('product', 'Hemoglobin ', ['312413002', '115668003'])}, '12 0 g/dl': {'258795003': ('unit', 'Gram/deciliter ', ['767524001'])}, 'the difference between them': {'263735002': ('qualifier value', 'Differential ', ['272099008'])}, '1 5 g/dl': {'258795003': ('unit', 'Gram/deciliter ', ['767524001'])}}

859795
age ≥ 18 years,
, ,
[]
{}
{}

874528
females of childbearing potential must have a negative pregnancy test result and must agree to use a medically acceptable method of contraception throughout the entire study period and for 30 days after the last dose of study drug.
females of childbearing potential must have a negative pregnancy test result and must agree to use a medically acceptable method of contraception throughout the entire study period and for 30 days after the last dose of study drug.
['females of childbearing potential', 'a negative pregnancy test result', 'to', 'use', 'a medically acceptable method of contraception', 'throughout the entire study period', 'and for 30 days', 'after the last dose of study drug']
{'females of childbearing potential': {'1086007': 'Female structure ', '248152002': 'Female '}, 'a negative pregnancy test result': {'250425007': 'Pregnancy test negative ', '394617004': 'Result ', '260385009': 'Negative ', '250421003': 'Pregnancy test finding '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'use': {'277889008': 'usage', '419385000': 'Use - dosing instruction imperative '}, 'a medically acceptable method of contraception': {'900000000000549004': 'acceptable ', '260686004': 'methods', '13197004': 'Contraception ', '246501002': 'techniques', '272394005': 'Technique '}, 'throughout the entire study period': {'255503000': 'Entire ', '224699009': 'Study ', '259037005': 'per period ', '272117007': 'Time periods ', '260232004': 'Whole '}, 'and for 30 days': {'258703001': 'day '}, 'after the last dose of study drug': {'398232005': 'Drug dose ', '224699009': 'Study ', '260911001': 'dosage', '277406006': 'Dosages ', '185922005': 'Clinical drug trial ', '408102007': 'Unit dose '}}
{'females of childbearing potential': {'248152002': ('clinical finding', 'Female ', ['365860008'])}, 'a negative pregnancy test result': {'250425007': ('clinical finding', 'Pregnancy test negative ', ['441742003', '250421003']), '250421003': ('clinical finding', 'Pregnancy test finding ', ['441742003'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'a medically acceptable method of contraception': {'13197004': ('clinical finding', 'Contraception ', ['250171008'])}, 'throughout the entire study period': {'255503000': ('qualifier value', 'Entire ', ['272099008']), '259037005': ('unit', 'per period ', ['767524001']), '272117007': ('qualifier value', 'Time periods ', ['272099008']), '260232004': ('qualifier value', 'Whole ', ['272099008'])}, 'and for 30 days': {'258703001': ('unit', 'day ', ['767524001'])}, 'after the last dose of study drug': {'398232005': ('clinical finding', 'Drug dose ', ['250171008']), '277406006': ('qualifier value', 'Dosages ', ['272099008']), '408102007': ('unit', 'Unit dose ', ['767524001'])}}

877687
patient must be able to give written informed consent
patient must give written informed consent
['patient', 'give', 'written informed consent']
{'patient': {'116154003': 'Patient '}, 'give': {'419582001': 'Give - dosing instruction imperative '}, 'written informed consent': {'12261009': 'Writing ', '108968006': 'Oprelvekin ', '410938009': 'Oprelvekin ', '223458004': 'Informing '}}
{'written informed consent': {'12261009': ('observable entity', 'Writing ', ['246464006']), '108968006': ('product', 'Oprelvekin ', ['406455002', '312413002', '115668003']), '410938009': ('product', 'Oprelvekin ', ['763158003'])}}

888217
patients with chronic disease between 18 -89 years old.
patients with chronic disease between 18 -89 years old.
['patients with chronic disease', 'between 18  89 years', 'old']
{'patients with chronic disease': {'116154003': 'Patient ', '27624003': 'Chronic disease '}, 'between 18  89 years': {'258707000': 'year '}, 'old': {'70753007': 'Old '}}
{'patients with chronic disease': {'27624003': ('clinical finding', 'Chronic disease ', ['64572001'])}, 'between 18  89 years': {'258707000': ('unit', 'year ', ['767524001'])}, 'old': {'70753007': ('qualifier value', 'Old ', ['272099008'])}}

889175
viral load and cd4+ cell count history
viral load and cd4+ cell count history
['viral load', 'cd4  cell count history']
{'viral load': {'395058002': 'Viral load '}, 'cd4  cell count history': {'118218001': 'Cell count ', '392521001': 'History of ', '115412003': 'T lymphocyte positive for CD4 antigen ', '116745007': 'Cell positive for CD4 antigen '}}
{'viral load': {'395058002': ('procedure', 'Viral load ', ['128927009'])}, 'cd4  cell count history': {'118218001': ('procedure', 'Cell count ', ['128927009'])}}

889671
fasting for 8-6 hours prior to surgery
fasting for 8-6 hours prior to surgery
['fasting for 8 6 hours', 'prior to surgery']
{'fasting for 8 6 hours': {'16985007': 'Fasting ', '258702006': 'hour '}, 'prior to surgery': {'257556004': 'Surgery ', '387713003': 'Surgical procedure ', '83578000': 'Surgical ', '394609007': 'General surgery '}}
{'fasting for 8 6 hours': {'16985007': ('clinical finding', 'Fasting ', ['250171008']), '258702006': ('unit', 'hour ', ['767524001'])}, 'prior to surgery': {'387713003': ('procedure', 'Surgical procedure ', ['128927009']), '83578000': ('qualifier value', 'Surgical ', ['272099008'])}}

893331
the total score of hamd-17 is ≥18 and ≤30, and item 1 ≥2 in both screening visit and baseline visit.
the total score of hamd-17 is ≥18 and ≤30, and item 1 ≥2 in both screening visit and baseline visit.
['the total score of hamd 17', 'item 1 2 in both screening visit']
{'the total score of hamd 17': {'258755000': '% of total ', '246262008': 'score', '278061009': 'Scores ', '255619001': 'Total '}, 'item 1 2 in both screening visit': {'20135006': 'Screening procedure '}}
{'the total score of hamd 17': {'258755000': ('unit', '% of total ', ['767524001']), '278061009': ('qualifier value', 'Scores ', ['272396007']), '255619001': ('qualifier value', 'Total ', ['272099008'])}, 'item 1 2 in both screening visit': {'20135006': ('procedure', 'Screening procedure ', ['128927009'])}}

901325
no cardiac disease that would preclude study participation
cardiac disease
['cardiac disease']
{'cardiac disease': {'56265001': 'Heart disease '}}
{'cardiac disease': {'56265001': ('clinical finding', 'Heart disease ', ['64572001', '118234003'])}}

927124
have received between 1 and 4 prior systemic treatments for metastatic triple negative breast cancer.
have received between 1 and 4 prior systemic treatments for metastatic triple negative breast cancer.
['4 prior systemic treatments for metastatic triple negative breast cancer']
{'4 prior systemic treatments for metastatic triple negative breast cancer': {'260300002': '-4 ', '236874000': 'Status pre- ', '288556008': 'before', '31099001': 'Systemic ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '77879006': 'metastatic to', '76070002': 'Triple ', '260385009': 'Negative ', '254837009': 'Malignant tumor of breast ', '254838004': 'Carcinoma of breast '}}
{'4 prior systemic treatments for metastatic triple negative breast cancer': {'31099001': ('qualifier value', 'Systemic ', ['272099008']), '276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '76070002': ('qualifier value', 'Triple ', ['272099008']), '254837009': ('clinical finding', 'Malignant tumor of breast ', ['64572001', '118234003']), '254838004': ('clinical finding', 'Carcinoma of breast ', ['254837009', '64572001', '118234003'])}}

943833
episode duration ≥ 3 months
episode duration ≥ 3 months
['episode duration  3 months']
{'episode duration  3 months': {'263503000': 'episode of', '272128006': 'Episodes ', '103335007': 'duration ', '272116003': 'Durations ', '258706009': 'month '}}
{'episode duration  3 months': {'272128006': ('qualifier value', 'Episodes ', ['272099008']), '272116003': ('qualifier value', 'Durations ', ['272099008']), '258706009': ('unit', 'month ', ['767524001'])}}

946582
platelet count ≥ 100 x 109/l
platelet count ≥ 100 x 109/l
['platelet count  100 x 109/l']
{'platelet count  100 x 109/l': {'277200003': 'Platelets/liter '}}
{'platelet count  100 x 109/l': {'277200003': ('unit', 'Platelets/liter ', ['767524001'])}}

956347
adequate hematological function
adequate hematological function
['adequate hematological function']
{'adequate hematological function': {'51117008': 'Sufficient ', '86084001': 'Hematologic function ', '88323005': 'Adequate '}}
{'adequate hematological function': {'51117008': ('qualifier value', 'Sufficient ', ['272099008']), '86084001': ('observable entity', 'Hematologic function ', ['246464006'])}}

961545
subjects who have a history of cancer to an affected limb that results in a surgical amputation maybe eligible.
subjects who have , cancer to an affected limb .
['cancer to an affected limb']
{'cancer to an affected limb': {'363346000': 'Malignant neoplastic disease ', '247591002': 'Affecting ', '66019005': 'Limb structure ', '248448006': 'Involved ', '278112009': 'involvement with', '372087000': 'Primary malignant neoplasm ', '86049000': 'Malignant neoplasm, primary '}}
{'cancer to an affected limb': {'363346000': ('clinical finding', 'Malignant neoplastic disease ', ['64572001']), '247591002': ('qualifier value', 'Affecting ', ['272099008']), '248448006': ('qualifier value', 'Involved ', ['272099008']), '372087000': ('clinical finding', 'Primary malignant neoplasm ', ['64572001', '363346000'])}}

970448
with a negative pregnancy test
with a negative pregnancy test
['with a negative pregnancy test']
{'with a negative pregnancy test': {'250425007': 'Pregnancy test negative '}}
{'with a negative pregnancy test': {'250425007': ('clinical finding', 'Pregnancy test negative ', ['441742003'])}}

973029
dpp-4 inhibitors
dpp-4 inhibitors
[]
{}
{}

980573
women not of childbearing potential due to surgical sterilization or menopause
women not of childbearing potential due to surgical sterilization or menopause
['women', 'due to surgical sterilization', 'menopause']
{'women': {'224526002': 'Woman '}, 'due to surgical sterilization': {'257556004': 'Surgery ', '387713003': 'Surgical procedure ', '83578000': 'Surgical ', '310138009': 'Surgical service '}, 'menopause': {'161712005': 'Menopause, function ', '198435007': 'Female climacteric state, function ', '289903006': 'Menopause present '}}
{'women': {'224526002': ('person', 'Woman ', ['133936004'])}, 'due to surgical sterilization': {'387713003': ('procedure', 'Surgical procedure ', ['128927009']), '83578000': ('qualifier value', 'Surgical ', ['272099008'])}, 'menopause': {'161712005': ('observable entity', 'Menopause, function ', ['246464006']), '198435007': ('observable entity', 'Female climacteric state, function ', ['246464006']), '289903006': ('clinical finding', 'Menopause present ', ['118234003'])}}

994517
patients must be greater than or = 18 years of age.
patients must be greater than or = 18 years of age.
['patients', 'greater than', '= 18 years of age']
{'patients': {'116154003': 'Patient '}, 'greater than': {'276140008': 'Greater-than symbol > '}, '= 18 years of age': {'258707000': 'year ', '397669002': 'Age ', '424144002': 'Current chronological age '}}
{'= 18 years of age': {'258707000': ('unit', 'year ', ['767524001']), '397669002': ('qualifier value', 'Age ', ['272099008']), '424144002': ('observable entity', 'Current chronological age ', ['105727008'])}}

995967-1
subjects who have had confirmation of a pro250arg mutation in fgfr3 by a clia-certified laboratory.
subjects who have had confirmation of a pro250arg mutation in fgfr3 by a clia-certified laboratory.
['confirmation of a pro250arg mutation', 'in fgfr3 by a clia certified laboratory']
{'confirmation of a pro250arg mutation': {'74996004': 'Confirmation of ', '55446002': 'Genetic mutation '}, 'in fgfr3 by a clia certified laboratory': {'261904005': 'Laboratory '}}
{'confirmation of a pro250arg mutation': {'55446002': ('clinical finding', 'Genetic mutation ', ['441742003'])}}

995967-2
our research team must receive a photocopy of the positive test result in order to enroll a patient in the study.
our research team must receive a photocopy of the positive test result in order to enroll a patient in the study.
['a photocopy of the positive test result', 'in order', 'to', 'a patient in the study']
{'a photocopy of the positive test result': {'258758003': '% positive cells ', '277775005': 'Test finding ', '118246004': 'Laboratory test finding ', '10828004': 'Positive '}, 'in order': {'721963009': 'Order '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'a patient in the study': {'116154003': 'Patient ', '224699009': 'Study '}}
{'a photocopy of the positive test result': {'258758003': ('unit', '% positive cells ', ['767524001']), '10828004': ('qualifier value', 'Positive ', ['272099008'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}}

995967-3
all races and genders are known to be at risk for muenke syndrome.
all races and genders are known to be at risk for muenke syndrome.
['all races', 'genders', 'known', 'to', 'at risk for muenke syndrome']
{'all races': {'103579009': 'Race ', '415229000': 'Racial group '}, 'genders': {'263495000': 'Gender ', '57312000': 'Sex structure '}, 'known': {'36692007': 'Known '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'at risk for muenke syndrome': {'410519009': 'At risk context ', '440350001': 'Fibroblast growth factor receptor 3-related craniosynostosis '}}
{'all races': {'103579009': ('observable entity', 'Race ', ['160476009'])}, 'genders': {'263495000': ('observable entity', 'Gender ', ['278844005'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'at risk for muenke syndrome': {'440350001': ('clinical finding', 'Fibroblast growth factor receptor 3-related craniosynostosis ', ['64572001', '118234003'])}}

995967-4
nationality or place of origin is not a specific barrier to participation.
nationality or place of origin is not a specific barrier to participation.
['place of origin', 'a specific barrier to participation']
{'place of origin': {'307117005': 'Place of origin '}, 'a specific barrier to participation': {'69658003': 'Specific '}}
{'place of origin': {'307117005': ('observable entity', 'Place of origin ', ['160476009'])}, 'a specific barrier to participation': {'69658003': ('qualifier value', 'Specific ', ['272099008'])}}

999333
received no previous chemotherapy for b-cll.
received previous chemotherapy for b-cll.
['received previous chemotherapy for b cll']
{'received previous chemotherapy for b cll': {'9130008': 'Previous ', '416608005': 'Drug therapy ', '277473004': 'B-cell chronic lymphocytic leukemia ', '51092000': 'B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma ', '92814006': 'Chronic lymphoid leukemia, disease ', '716872004': 'Antineoplastic chemotherapy regimen ', '363688001': 'Administration of antineoplastic agent ', '367336001': 'Chemotherapy '}}
{'received previous chemotherapy for b cll': {'9130008': ('qualifier value', 'Previous ', ['272099008']), '416608005': ('procedure', 'Drug therapy ', ['128927009']), '277473004': ('clinical finding', 'B-cell chronic lymphocytic leukemia ', ['64572001', '118234003', '92814006']), '92814006': ('clinical finding', 'Chronic lymphoid leukemia, disease ', ['64572001', '118234003']), '716872004': ('procedure', 'Antineoplastic chemotherapy regimen ', ['243120004', '128927009']), '363688001': ('procedure', 'Administration of antineoplastic agent ', ['416608005', '367336001', '128927009']), '367336001': ('procedure', 'Chemotherapy ', ['416608005', '128927009'])}}

1002946
hbeag positive and anti-hbe negative or hbeag negative and anti-hbe positive with positive hbsag for the previous 6 months
hbeag positive and anti-hbe negative or hbeag negative and anti-hbe positive with positive hbsag for the , 6 months
['hbeag positive', 'anti hbe negative', 'hbeag negative', 'anti hbe positive with positive hbsag', '6 months']
{'hbeag positive': {'165807006': 'Hepatitis Be antigen present '}, 'anti hbe negative': {'17627009': 'Antibody to hepatitis Be antigen ', '260385009': 'Negative '}, 'hbeag negative': {'60605004': 'Hepatitis B e antigen ', '260385009': 'Negative '}, 'anti hbe positive with positive hbsag': {'17627009': 'Antibody to hepatitis Be antigen ', '165806002': 'Hepatitis B surface antigen positive '}, '6 months': {'258706009': 'month '}}
{'hbeag positive': {'165807006': ('clinical finding', 'Hepatitis Be antigen present ', ['441742003'])}, 'anti hbe negative': {'17627009': ('product', 'Antibody to hepatitis Be antigen ', ['406455002', '312413002', '115668003'])}, 'hbeag negative': {'60605004': ('product', 'Hepatitis B e antigen ', ['406455002', '115668003', '312412007'])}, 'anti hbe positive with positive hbsag': {'17627009': ('product', 'Antibody to hepatitis Be antigen ', ['406455002', '312413002', '115668003']), '165806002': ('clinical finding', 'Hepatitis B surface antigen positive ', ['441742003'])}, '6 months': {'258706009': ('unit', 'month ', ['767524001'])}}

1028097
respiratory symptoms/signs
respiratory symptoms/signs
['respiratory symptoms/signs']
{'respiratory symptoms/signs': {'161920001': 'Respiratory symptom ', '72670004': 'Sign '}}
{'respiratory symptoms/signs': {'161920001': ('clinical finding', 'Respiratory symptom ', ['418799008', '118234003']), '72670004': ('clinical finding', 'Sign ', ['250171008'])}}

1045443
participants for whom no standard therapy exists
participants for whom standard therapy exists
['participants for whom standard therapy']
{'participants for whom standard therapy': {'276239002': 'Therapy ', '277132007': 'Therapeutic procedure '}}
{'participants for whom standard therapy': {'276239002': ('procedure', 'Therapy ', ['277132007', '243120004'])}}

1049008
body mass index = 40 kg/m^2 or below
body mass index = 40 kg/m^2 or below
['body mass index', '= 40 kg/m^2']
{'body mass index': {'301331008': 'Finding of body mass index ', '60621009': 'Body mass index '}, '= 40 kg/m^2': {'259031006': 'per forty ', '414557004': 'Kilogram-meter '}}
{'body mass index': {'301331008': ('clinical finding', 'Finding of body mass index ', ['250171008']), '60621009': ('observable entity', 'Body mass index ', ['363788007'])}, '= 40 kg/m^2': {'259031006': ('unit', 'per forty ', ['767524001']), '414557004': ('unit', 'Kilogram-meter ', ['767524001'])}}

1055084
diagnosis of active plaque psoriasis or nail changes consistent with psoriasis or documented history of plaque psoriasis
diagnosis of active plaque psoriasis or nail changes consistent with psoriasis or documented , plaque psoriasis
['diagnosis of active plaque psoriasis', 'nail', 'changes', 'consistent with psoriasis', 'documented , plaque psoriasis']
{'diagnosis of active plaque psoriasis': {'439401001': 'Diagnosis ', '55561003': 'Active ', '200965009': 'Plaque psoriasis ', '402308005': 'Chronic small plaque psoriasis '}, 'nail': {'314410003': 'Nail plate structure ', '72651009': 'Nail structure '}, 'changes': {'18307000': 'Altered ', '243326001': 'Changing ', '263703002': 'Changed status '}, 'consistent with psoriasis': {'385433004': 'Consistent with ', '9014002': 'Psoriasis ', '7883008': 'compatible'}, 'documented , plaque psoriasis': {'397934002': 'Documented ', '200965009': 'Plaque psoriasis ', '402308005': 'Chronic small plaque psoriasis '}}
{'diagnosis of active plaque psoriasis': {'55561003': ('qualifier value', 'Active ', ['272099008']), '200965009': ('clinical finding', 'Plaque psoriasis ', ['64572001', '9014002', '118234003']), '402308005': ('clinical finding', 'Chronic small plaque psoriasis ', ['64572001', '200965009', '9014002', '118234003'])}, 'changes': {'18307000': ('qualifier value', 'Altered ', ['272099008']), '243326001': ('qualifier value', 'Changing ', ['272099008'])}, 'consistent with psoriasis': {'9014002': ('clinical finding', 'Psoriasis ', ['64572001', '118234003'])}, 'documented , plaque psoriasis': {'200965009': ('clinical finding', 'Plaque psoriasis ', ['64572001', '9014002', '118234003']), '402308005': ('clinical finding', 'Chronic small plaque psoriasis ', ['64572001', '200965009', '9014002', '118234003'])}}

1059889
age 24-65
,
[]
{}
{}

1065714
with contrast medium injection
with contrast medium injection
['with contrast medium injection']
{'with contrast medium injection': {'385420005': 'Contrast media ', '407935004': 'Contrast media ', '28289002': 'Injection of therapeutic agent ', '385218009': 'Injection ', '129326001': 'Injection - action ', '59108006': 'Injection '}}
{'with contrast medium injection': {'407935004': ('product', 'Contrast media ', ['763158003']), '28289002': ('procedure', 'Injection of therapeutic agent ', ['59108006', '128927009']), '59108006': ('procedure', 'Injection ', ['128927009'])}}

1072682
patient is capable of meeting requirements and be present at the follow-up clinic visits at 30 days.
patient is capable of meeting requirements and be present at the follow-up clinic visits at 30 days.
['patient', 'capable of meeting requirements', 'present at the follow up clinic', 'visits at 30 days']
{'patient': {'116154003': 'Patient '}, 'capable of meeting requirements': {'229057006': 'Meetings '}, 'present at the follow up clinic': {'52101004': 'Present ', '308273005': 'Follow-up status ', '35971002': 'Ambulatory care site ', '257585005': 'Clinic ', '246105001': 'presentation'}, 'visits at 30 days': {'258703001': 'day '}}
{'visits at 30 days': {'258703001': ('unit', 'day ', ['767524001'])}}

1076396
no history of psychiatric disorder or neurological illness
psychiatric disorder or neurological illness
['psychiatric disorder', 'neurological illness']
{'psychiatric disorder': {'74732009': 'Mental disorder '}, 'neurological illness': {'1199008': 'Neurologic ', '39104002': 'Illness '}}
{'psychiatric disorder': {'74732009': ('clinical finding', 'Mental disorder ', ['64572001'])}, 'neurological illness': {'1199008': ('qualifier value', 'Neurologic ', ['272099008']), '39104002': ('clinical finding', 'Illness ', ['250171008'])}}

1083275
discontinuation of growth factors >= 2 weeks prior to study entry
discontinuation of growth factors >= 2 weeks prior to study entry
['discontinuation of growth factors', '= 2 weeks prior to study entry']
{'discontinuation of growth factors': {'81286007': 'Growth factor ', '410546004': 'Discontinued '}, '= 2 weeks prior to study entry': {'260306008': 'Integer +2 ', '258705008': 'week ', '236874000': 'Status pre- ', '288556008': 'before', '224699009': 'Study '}}
{'discontinuation of growth factors': {'81286007': ('product', 'Growth factor ', ['115668003'])}, '= 2 weeks prior to study entry': {'258705008': ('unit', 'week ', ['767524001'])}}

1085532
is capable of giving written informed consent
is capable of giving written informed consent
['giving', 'written informed consent']
{'giving': {'419582001': 'Give - dosing instruction imperative '}, 'written informed consent': {'12261009': 'Writing ', '108968006': 'Oprelvekin ', '410938009': 'Oprelvekin ', '223458004': 'Informing '}}
{'written informed consent': {'12261009': ('observable entity', 'Writing ', ['246464006']), '108968006': ('product', 'Oprelvekin ', ['406455002', '312413002', '115668003']), '410938009': ('product', 'Oprelvekin ', ['763158003'])}}

1093240
transfusions are permitted to meet both the platelet and hemoglobin criteria; patients must not be known to be refractory to red blood cell or platelet transfusions
transfusions are permitted to meet both the platelet and hemoglobin criteria; patients known to be refractory to red blood cell or platelet transfusions
['transfusions', 'permitted', 'to', 'both the platelet', 'hemoglobin criteria']
{'transfusions': {'116859006': 'Transfusion of blood product ', '303955003': 'Transfusion - action ', '5447007': 'Transfusion '}, 'permitted': {'958006': 'Trachinotus falcatus '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'both the platelet': {'16378004': 'Platelet '}, 'hemoglobin criteria': {'38082009': 'Hemoglobin '}}
{'transfusions': {'116859006': ('procedure', 'Transfusion of blood product ', ['128927009', '5447007']), '5447007': ('procedure', 'Transfusion ', ['128927009'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'hemoglobin criteria': {'38082009': ('product', 'Hemoglobin ', ['312413002', '115668003'])}}

1100215
physically and mentally healthy subjects
physically and mentally healthy subjects
['mentally healthy subjects']
{'mentally healthy subjects': {'263775005': 'Health '}}
{}

1113941
ecog performance status of 0, 1 or 2.
ecog performance status of 0, 1 or 2.
['ecog performance status of 0,', '1', '2']
{'ecog performance status of 0,': {'423740007': 'Eastern Cooperative Oncology Group performance status '}, '1': {'451231000124103': 'greater than one'}, '2': {'260306008': 'Integer +2 '}}
{'ecog performance status of 0,': {'423740007': ('observable entity', 'Eastern Cooperative Oncology Group performance status ', ['278844005'])}}

1115412
presence of copd with chronic respiratory global insufficiency
presence of copd with chronic respiratory global insufficiency
[]
{}
{}

1134708
in good health as determined by medical history and physical examination .
in good health as determined by medical history and physical examination .
['in good health', 'determined by medical history', 'physical examination']
{'in good health': {'20572008': 'Good ', '263775005': 'Health '}, 'determined by medical history': {'436000': 'Determined by ', '392521001': 'History of '}, 'physical examination': {'302199004': 'Examination - action ', '5880005': 'Physical examination procedure ', '81375008': 'Physical assessment '}}
{'in good health': {'20572008': ('qualifier value', 'Good ', ['272099008'])}, 'physical examination': {'5880005': ('procedure', 'Physical examination procedure ', ['362958002', '128927009']), '81375008': ('procedure', 'Physical assessment ', ['128927009'])}}

1136649
older than 18 years and younger than 60 years; without regard to cd4 count;
older than 18 years and younger than 60 years; without regard to cd4 count;
['older than 18 years', 'younger than 60 years']
{'older than 18 years': {'70753007': 'Old ', '258707000': 'year '}, 'younger than 60 years': {'84422007': 'Young ', '258707000': 'year '}}
{'older than 18 years': {'70753007': ('qualifier value', 'Old ', ['272099008']), '258707000': ('unit', 'year ', ['767524001'])}, 'younger than 60 years': {'84422007': ('qualifier value', 'Young ', ['272099008']), '258707000': ('unit', 'year ', ['767524001'])}}

1140082
non-smoker
non-smoker
['non smoker']
{'non smoker': {'8392000': 'Non-smoker ', '266919005': 'Never smoked tobacco '}}
{'non smoker': {'8392000': ('clinical finding', 'Non-smoker ', ['250171008']), '266919005': ('clinical finding', 'Never smoked tobacco ', ['250171008', '8392000'])}}

1150499
patients must have 1 of the following: elevated b2-microglobulin levels , carry a jak2 mutation, or presence of phosphorylated p65 nf-kb comp1nt in >= 5% of b1 marrow cells.
patients must have 1 of the following: elevated b2-microglobulin levels , carry a jak2 mutation, or presence of phosphorylated p65 nf-kb comp1nt in >= 5% of b1 marrow cells.
['patients', '1 of the following', 'elevated b2 microglobulin levels', 'carry', 'a jak2 mutation,', 'presence of phosphorylated p65 nf kb comp1nt', 'in >', '= 5% of b1 marrow cells']
{'patients': {'116154003': 'Patient '}, '1 of the following': {'451231000124103': 'greater than one', '367409002': 'followed by', '421939007': 'Follow - dosing instruction imperative '}, 'elevated b2 microglobulin levels': {'75540009': 'High ', '258395000': 'Levels '}, 'carry': {'288345009': 'Does carry '}, 'a jak2 mutation,': {'55446002': 'Genetic mutation '}, 'presence of phosphorylated p65 nf kb comp1nt': {'52101004': 'Present '}, 'in >': {'52101004': 'Present ', '18720000': 'within'}, '= 5% of b1 marrow cells': {'264606005': '-5 ', '227250008': 'Marrow ', '118218001': 'Cell count ', '4421005': 'Cell structure ', '264706000': '>5 ', '264605009': 'Integer +5 '}}
{'elevated b2 microglobulin levels': {'75540009': ('qualifier value', 'High ', ['272099008']), '258395000': ('qualifier value', 'Levels ', ['272396007'])}, 'carry': {'288345009': ('clinical finding', 'Does carry ', ['250171008'])}, 'a jak2 mutation,': {'55446002': ('clinical finding', 'Genetic mutation ', ['441742003'])}, '= 5% of b1 marrow cells': {'118218001': ('procedure', 'Cell count ', ['128927009'])}}

1154241
age 18-years or older
, years or older
['years', 'older']
{'years': {'258707000': 'year '}, 'older': {'70753007': 'Old '}}
{'years': {'258707000': ('unit', 'year ', ['767524001'])}, 'older': {'70753007': ('qualifier value', 'Old ', ['272099008'])}}

1161330
normal renal function at screening, as defined by
normal renal function at screening, as defined by
['normal renal function at screening,', 'defined by']
{'normal renal function at screening,': {'81141003': 'Normal renal function ', '20135006': 'Screening procedure '}, 'defined by': {'900000000000073002': 'sufficiently defined concept definition status '}}
{'normal renal function at screening,': {'81141003': ('clinical finding', 'Normal renal function ', ['118234003']), '20135006': ('procedure', 'Screening procedure ', ['128927009'])}}

1183688
does the patient have an absolute neutrophil count of ≥ 1500/mm3, and platelets ≥ 100,000/mm3
does the patient have an absolute neutrophil count of ≥ 1500/mm3, and platelets ≥ 100,000/mm3
['the patient', 'an absolute neutrophil count of  1500/mm3', 'platelets  100,000/mm3']
{'the patient': {'116154003': 'Patient '}, 'an absolute neutrophil count of  1500/mm3': {'56136002': 'Absolute ', '30630007': 'Neutrophil count ', '732516007': '1500', '258774008': 'microliter ', '396162003': 'cubic millimeter ', '396160006': 'per cubic millimeter ', '420167005': 'per microliter ', '116708001': 'Polymorphonuclear leukocyte count '}, 'platelets  100,000/mm3': {'16378004': 'Platelet ', '258774008': 'microliter ', '396162003': 'cubic millimeter ', '396160006': 'per cubic millimeter ', '420167005': 'per microliter ', '256395009': 'Platelet product '}}
{'an absolute neutrophil count of  1500/mm3': {'56136002': ('qualifier value', 'Absolute ', ['272099008']), '30630007': ('procedure', 'Neutrophil count ', ['128927009']), '258774008': ('unit', 'microliter ', ['767524001']), '396160006': ('unit', 'per cubic millimeter ', ['767524001']), '420167005': ('unit', 'per microliter ', ['767524001']), '116708001': ('procedure', 'Polymorphonuclear leukocyte count ', ['128927009'])}, 'platelets  100,000/mm3': {'258774008': ('unit', 'microliter ', ['767524001']), '396160006': ('unit', 'per cubic millimeter ', ['767524001']), '420167005': ('unit', 'per microliter ', ['767524001'])}}

1186232
failure to response to voice training or other non-surgical treatments
failure to response to voice training or other non-surgical treatments
['failure to response', 'to', 'training', 'other non surgical treatments']
{'failure to response': {'76797004': 'Failure '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'training': {'118629009': 'Functional training '}, 'other non surgical treatments': {'257556004': 'Surgery ', '387713003': 'Surgical procedure ', '83578000': 'Surgical '}}
{'failure to response': {'76797004': ('clinical finding', 'Failure ', ['250171008', '365860008'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'training': {'118629009': ('procedure', 'Functional training ', ['128927009'])}, 'other non surgical treatments': {'387713003': ('procedure', 'Surgical procedure ', ['128927009']), '83578000': ('qualifier value', 'Surgical ', ['272099008'])}}

1186311
man and woman subjects who are receiving skin testing or allergen immunotherapy from 1 allergy practice.
man and woman subjects who are receiving skin testing or allergen immunotherapy from 1 allergy practice.
['man', 'woman subjects', 'receiving skin testing', 'allergen immunotherapy from 1 allergy practice']
{'man': {'339947000': 'Man ', '278412004': 'Human - origin ', '337915000': 'Homo sapiens ', '10052007': 'Male structure ', '248153007': 'Male '}, 'woman subjects': {'224526002': 'Woman '}, 'receiving skin testing': {'164838003': 'Special dermatological testing ', '252515007': 'Type 1 hypersensitivity skin test ', '268377001': 'Hypersensitivity skin testing ', '53309004': 'Skin test '}, 'allergen immunotherapy from 1 allergy practice': {'182678001': 'Hyposensitization to allergens ', '408439002': 'Allergy - specialty ', '418634005': 'Allergic reaction caused by substance ', '421961002': 'Hypersensitivity reaction ', '419076005': 'Allergic reaction ', '609328004': 'Allergic disposition '}}
{'man': {'339947000': ('person', 'Man ', ['133936004']), '278412004': ('qualifier value', 'Human - origin ', ['272099008']), '248153007': ('clinical finding', 'Male ', ['365860008'])}, 'woman subjects': {'224526002': ('person', 'Woman ', ['133936004'])}, 'receiving skin testing': {'164838003': ('procedure', 'Special dermatological testing ', ['362958002', '53309004', '128927009']), '252515007': ('procedure', 'Type 1 hypersensitivity skin test ', ['128927009']), '268377001': ('procedure', 'Hypersensitivity skin testing ', ['128927009']), '53309004': ('procedure', 'Skin test ', ['362958002', '128927009'])}, 'allergen immunotherapy from 1 allergy practice': {'182678001': ('procedure', 'Hyposensitization to allergens ', ['128927009']), '418634005': ('clinical finding', 'Allergic reaction caused by substance ', ['64572001', '419076005', '421961002']), '421961002': ('clinical finding', 'Hypersensitivity reaction ', ['64572001']), '419076005': ('clinical finding', 'Allergic reaction ', ['64572001', '421961002'])}}

1203955
ankle-brachial index ( 50-90% and/or toe pressure 50-70% and where ankle pressure > 60 mmhg or toe pressure > 40 mmhg
ankle-brachial index ( 50-90% and/or toe pressure 50-70% and where ankle pressure > 60 mmhg or toe pressure > 40 mmhg
['ankle brachial index', '( 50 90%', 'toe pressure 50 70%', 'where ankle pressure', '> 60 mmhg', 'toe pressure', '> 40 mmhg']
{'ankle brachial index': {'446841001': 'Ankle brachial pressure index '}, '( 50 90%': {'264705001': '>90 ', '264703008': '<90 '}, 'toe pressure 50 70%': {'29707007': 'Toe structure ', '279046003': 'Pressure - physical agent ', '13543005': 'Pressure ', '257893003': 'Pressure - action ', '722243006': 'Pressure '}, 'where ankle pressure': {'344001': 'Ankle region structure ', '279046003': 'Pressure - physical agent ', '13543005': 'Pressure ', '257893003': 'Pressure - action ', '722243006': 'Pressure ', '70258002': 'Ankle joint structure '}, '> 60 mmhg': {'259018001': 'Millimeter of mercury ', '304621005': 'torr '}, 'toe pressure': {'29707007': 'Toe structure ', '279046003': 'Pressure - physical agent ', '13543005': 'Pressure ', '257893003': 'Pressure - action ', '722243006': 'Pressure '}, '> 40 mmhg': {'259031006': 'per forty ', '259018001': 'Millimeter of mercury ', '304621005': 'torr '}}
{'ankle brachial index': {'446841001': ('observable entity', 'Ankle brachial pressure index ', ['363788007'])}, 'toe pressure 50 70%': {'13543005': ('clinical finding', 'Pressure ', ['250171008', '365860008'])}, 'where ankle pressure': {'13543005': ('clinical finding', 'Pressure ', ['250171008', '365860008'])}, '> 60 mmhg': {'259018001': ('unit', 'Millimeter of mercury ', ['767524001']), '304621005': ('unit', 'torr ', ['767524001'])}, 'toe pressure': {'13543005': ('clinical finding', 'Pressure ', ['250171008', '365860008'])}, '> 40 mmhg': {'259031006': ('unit', 'per forty ', ['767524001']), '259018001': ('unit', 'Millimeter of mercury ', ['767524001']), '304621005': ('unit', 'torr ', ['767524001'])}}

1204987
bone marrow reserve consistent with: absolute neutrophil count ≥ 1.5 x 109/l, platelet count ≥ 100 x 109/l, and hemoglobin ≥ 9 g/dl within 1 week preceding the administration of the study drugs;
bone marrow reserve consistent with: absolute neutrophil count ≥ 1.5 x 109/l, platelet count ≥ 100 x 109/l, and hemoglobin ≥ 9 g/dl , preceding the administration of the study drugs;
['bone marrow', 'consistent with', 'absolute neutrophil count  1 5 x 109/l', 'platelet count  100 x 109/l', 'hemoglobin  9 g/dl', 'preceding', 'the administration of the study drugs']
{'bone marrow': {'14016003': 'Bone marrow structure ', '279729006': 'All bone marrow '}, 'consistent with': {'385433004': 'Consistent with ', '7883008': 'compatible'}, 'absolute neutrophil count  1 5 x 109/l': {'56136002': 'Absolute ', '30630007': 'Neutrophil count ', '116708001': 'Polymorphonuclear leukocyte count '}, 'platelet count  100 x 109/l': {'277200003': 'Platelets/liter '}, 'hemoglobin  9 g/dl': {'38082009': 'Hemoglobin ', '258795003': 'Gram/deciliter '}, 'preceding': {'236874000': 'Status pre- ', '288556008': 'before'}, 'the administration of the study drugs': {'18629005': 'Administration of drug or medicament ', '224699009': 'Study ', '413454004': 'Administration ', '185922005': 'Clinical drug trial ', '416118004': 'Administration '}}
{'absolute neutrophil count  1 5 x 109/l': {'56136002': ('qualifier value', 'Absolute ', ['272099008']), '30630007': ('procedure', 'Neutrophil count ', ['128927009']), '116708001': ('procedure', 'Polymorphonuclear leukocyte count ', ['128927009'])}, 'platelet count  100 x 109/l': {'277200003': ('unit', 'Platelets/liter ', ['767524001'])}, 'hemoglobin  9 g/dl': {'38082009': ('product', 'Hemoglobin ', ['312413002', '115668003']), '258795003': ('unit', 'Gram/deciliter ', ['767524001'])}, 'the administration of the study drugs': {'18629005': ('procedure', 'Administration of drug or medicament ', ['128927009']), '416118004': ('procedure', 'Administration ', ['128927009'])}}

1211392
diagnosis of end-stage renal disease
diagnosis of end-stage renal disease
['diagnosis of end stage renal disease']
{'diagnosis of end stage renal disease': {'439401001': 'Diagnosis ', '46177005': 'End stage renal disease ', '90688005': 'Chronic renal failure syndrome ', '433146000': 'Chronic kidney disease stage 5 '}}
{'diagnosis of end stage renal disease': {'46177005': ('clinical finding', 'End stage renal disease ', ['64572001', '441742003', '118234003']), '90688005': ('clinical finding', 'Chronic renal failure syndrome ', ['64572001', '441742003', '118234003']), '433146000': ('clinical finding', 'Chronic kidney disease stage 5 ', ['64572001', '441742003', '118234003'])}}

1213845
willing to complete evaluation forms
willing to complete evaluation forms
['willing', 'to', 'complete', 'evaluation', 'forms']
{'willing': {'225466006': 'Willing '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'complete': {'255594003': 'Complete '}, 'evaluation': {'129265001': 'Evaluation - action ', '386053000': 'Evaluation procedure '}, 'forms': {'246176004': 'qualitative form'}}
{'willing': {'225466006': ('clinical finding', 'Willing ', ['250171008'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'complete': {'255594003': ('qualifier value', 'Complete ', ['272099008'])}, 'evaluation': {'386053000': ('procedure', 'Evaluation procedure ', ['128927009'])}}

1216841
able to take in oral fluids.
able to take in oral fluids.
['able', 'to', 'take in oral fluids']
{'able': {'371150009': 'Able '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'take in oral fluids': {'419652001': 'Take - dosing instruction imperative ', '385022006': 'Oral liquid '}}
{'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}}

1225305
woman who participated in a phase 1, 2 or 3 clinical study with ad26.zebov and/or mva-bn-filo and became pregnant with estimated conception within 28 days after vaccination with mva-bn-filo or within 3 months after vaccination with ad26.zebov
woman who participated in a phase 1, 2 or 3 clinical study with ad26.zebov and/or mva-bn-filo and became pregnant with estimated conception , after vaccination with mva-bn-filo or , after vaccination with ad26.zebov
['woman', 'participated in a phase 1,', '2', '3 clinical study with ad26 zebov', 'mva bn filo', 'pregnant with estimated conception', 'vaccination with mva bn filo', 'vaccination with ad26 zebov']
{'woman': {'224526002': 'Woman '}, 'participated in a phase 1,': {'272109004': 'Phase 1 ', '261618000': 'Stage A '}, '2': {'260306008': 'Integer +2 '}, '3 clinical study with ad26 zebov': {'260313008': '<3 ', '58147004': 'Clinical ', '224699009': 'Study '}, 'mva bn filo': {'127348004': 'Motor vehicle accident victim ', '214031005': 'Motor vehicle traffic accident ', '418399005': 'Motor vehicle accident ', '223553005': 'Benin ', '44265005': 'Brown Norway rat '}, 'pregnant with estimated conception': {'77386006': 'Patient currently pregnant ', '414135002': 'Estimated ', '13693004': 'Conception, function ', '127362006': 'Previous pregnancies ', '161732006': 'Gravida ', '364323006': 'Quantity of pregnancy ', '366321006': 'Finding of gravida '}, 'vaccination with mva bn filo': {'33879002': 'Administration of vaccine to produce active immunity ', '127348004': 'Motor vehicle accident victim ', '214031005': 'Motor vehicle traffic accident ', '418399005': 'Motor vehicle accident ', '223553005': 'Benin ', '44265005': 'Brown Norway rat '}, 'vaccination with ad26 zebov': {'33879002': 'Administration of vaccine to produce active immunity '}}
{'woman': {'224526002': ('person', 'Woman ', ['133936004'])}, 'participated in a phase 1,': {'272109004': ('qualifier value', 'Phase 1 ', ['272099008']), '261618000': ('qualifier value', 'Stage A ', ['272396007'])}, '3 clinical study with ad26 zebov': {'58147004': ('qualifier value', 'Clinical ', ['272099008'])}, 'mva bn filo': {'127348004': ('clinical finding', 'Motor vehicle accident victim ', ['250171008', '365860008']), '214031005': ('event', 'Motor vehicle traffic accident ', ['418399005', '418019003']), '418399005': ('event', 'Motor vehicle accident ', ['418019003'])}, 'pregnant with estimated conception': {'77386006': ('clinical finding', 'Patient currently pregnant ', ['250171008']), '414135002': ('qualifier value', 'Estimated ', ['272099008']), '13693004': ('observable entity', 'Conception, function ', ['246464006']), '127362006': ('clinical finding', 'Previous pregnancies ', ['250171008']), '161732006': ('observable entity', 'Gravida ', ['363788007']), '364323006': ('observable entity', 'Quantity of pregnancy ', ['363788007']), '366321006': ('clinical finding', 'Finding of gravida ', ['250171008'])}, 'vaccination with mva bn filo': {'33879002': ('procedure', 'Administration of vaccine to produce active immunity ', ['128927009']), '127348004': ('clinical finding', 'Motor vehicle accident victim ', ['250171008', '365860008']), '214031005': ('event', 'Motor vehicle traffic accident ', ['418399005', '418019003']), '418399005': ('event', 'Motor vehicle accident ', ['418019003'])}, 'vaccination with ad26 zebov': {'33879002': ('procedure', 'Administration of vaccine to produce active immunity ', ['128927009'])}}

1225312
patients must receive their primary oncology care in the participating hospital
patients must receive their primary oncology care in the participating hospital
['patients', 'their primary oncology care in the participating hospital']
{'patients': {'116154003': 'Patient '}, 'their primary oncology care in the participating hospital': {'45131006': 'Primary care hospital ', '108369006': 'Neoplasm '}}
{}

1228373
no genomic alteration of tp53
genomic alteration of tp53
['genomic alteration of tp53']
{'genomic alteration of tp53': {'18470003': 'Genome ', '18307000': 'Altered ', '243326001': 'Changing '}}
{'genomic alteration of tp53': {'18470003': ('product', 'Genome ', ['115668003']), '18307000': ('qualifier value', 'Altered ', ['272099008']), '243326001': ('qualifier value', 'Changing ', ['272099008'])}}

1228485
serum creatinine ≤ 1.5 x upper limit of normal
serum creatinine ≤ 1.5 x upper limit of normal
['serum creatinine  1 5 x upper limit of normal']
{'serum creatinine  1 5 x upper limit of normal': {'166716007': 'Serum creatinine normal ', '261183002': 'Upper ', '264217000': 'Superior ', '352730000': 'Supra- ', '255469002': 'Limited '}}
{'serum creatinine  1 5 x upper limit of normal': {'166716007': ('clinical finding', 'Serum creatinine normal ', ['441742003']), '352730000': ('qualifier value', 'Supra- ', ['272099008']), '255469002': ('qualifier value', 'Limited ', ['272099008'])}}

1230090
man subject and their woman spouse/partners who are of childbearing potential must be using highly effective contraception consisting of 2 forms of birth control starting at screening and continuing throughout the study period and for 90 days after the final study drug administration.
man subject and their woman spouse/partners who are of childbearing potential must be using highly effective contraception consisting of 2 forms of birth control starting at screening and continuing throughout the study period and for 90 days after the final study drug administration.
['man subject', 'their woman spouse/partners', 'using', 'highly effective contraception', 'consisting of 2 forms of birth control starting', 'at screening', 'continuing throughout the study period', 'and for 90 days', 'after the final study drug administration']
{'man subject': {'339947000': 'Man ', '278412004': 'Human - origin ', '337915000': 'Homo sapiens ', '10052007': 'Male structure ', '248153007': 'Male '}, 'their woman spouse/partners': {'224526002': 'Woman ', '127848009': 'Spouse ', '262043009': 'Partner in relationship '}, 'using': {'260676000': 'use of'}, 'highly effective contraception': {'75540009': 'High ', '255403003': 'Effectiveness ', '13197004': 'Contraception ', '254648000': 'Effective '}, 'consisting of 2 forms of birth control starting': {'107646001': 'Consistency finding ', '246191002': 'consistency', '246176004': 'qualitative form', '13197004': 'Contraception ', '246062003': 'beginning', '255395001': 'Origins '}, 'at screening': {'20135006': 'Screening procedure '}, 'continuing throughout the study period': {'255238004': 'Continuous ', '224699009': 'Study ', '259037005': 'per period ', '272117007': 'Time periods '}, 'and for 90 days': {'264705001': '>90 ', '258703001': 'day ', '264703008': '<90 '}, 'after the final study drug administration': {'42796001': 'End-stage ', '185922005': 'Clinical drug trial ', '413454004': 'Administration ', '416118004': 'Administration ', '224699009': 'Study ', '182832007': 'Procedure related to management of drug administration ', '18629005': 'Administration of drug or medicament '}}
{'man subject': {'339947000': ('person', 'Man ', ['133936004']), '278412004': ('qualifier value', 'Human - origin ', ['272099008', '255395001']), '248153007': ('clinical finding', 'Male ', ['365860008'])}, 'their woman spouse/partners': {'224526002': ('person', 'Woman ', ['133936004'])}, 'highly effective contraception': {'75540009': ('qualifier value', 'High ', ['272099008']), '255403003': ('qualifier value', 'Effectiveness ', ['272099008']), '13197004': ('clinical finding', 'Contraception ', ['250171008']), '254648000': ('qualifier value', 'Effective ', ['272099008'])}, 'consisting of 2 forms of birth control starting': {'107646001': ('clinical finding', 'Consistency finding ', ['441742003']), '13197004': ('clinical finding', 'Contraception ', ['250171008']), '255395001': ('qualifier value', 'Origins ', ['272099008'])}, 'at screening': {'20135006': ('procedure', 'Screening procedure ', ['128927009'])}, 'continuing throughout the study period': {'255238004': ('qualifier value', 'Continuous ', ['272099008']), '259037005': ('unit', 'per period ', ['767524001']), '272117007': ('qualifier value', 'Time periods ', ['272099008'])}, 'and for 90 days': {'258703001': ('unit', 'day ', ['767524001'])}, 'after the final study drug administration': {'416118004': ('procedure', 'Administration ', ['128927009']), '182832007': ('procedure', 'Procedure related to management of drug administration ', ['128927009', '408766003']), '18629005': ('procedure', 'Administration of drug or medicament ', ['128927009'])}}

1241025-1
hemoglobin ≥ 9.0 g/dl.
hemoglobin ≥ 9.0 g/dl.
['hemoglobin  9 0 g/dl']
{'hemoglobin  9 0 g/dl': {'38082009': 'Hemoglobin ', '258795003': 'Gram/deciliter '}}
{'hemoglobin  9 0 g/dl': {'38082009': ('product', 'Hemoglobin ', ['312413002', '115668003']), '258795003': ('unit', 'Gram/deciliter ', ['767524001'])}}

1241025-2
patients may be transfused to meet this criterion.
patients may be transfused to meet this criterion.
['patients', 'to']
{'patients': {'116154003': 'Patient '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}}
{'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}}

1255200
right-handedness assessed by the edinburg handedness inventory
right-handedness assessed by the edinburg handedness inventory
['right handedness', 'assessed by the edinburg handedness inventory']
{'right handedness': {'46669005': 'Right handed '}, 'assessed by the edinburg handedness inventory': {'57427004': 'Handedness '}}
{'right handedness': {'46669005': ('clinical finding', 'Right handed ', ['118234003'])}, 'assessed by the edinburg handedness inventory': {'57427004': ('observable entity', 'Handedness ', ['363788007', '414237002'])}}

1264652
normal renal function
normal renal function
['normal renal function']
{'normal renal function': {'81141003': 'Normal renal function '}}
{'normal renal function': {'81141003': ('clinical finding', 'Normal renal function ', ['118234003'])}}

1272003
participants who are able to give written informed consent and willing to comply with all study-related procedures.
participants who give written informed consent and willing to comply with all study-related procedures.
['give', 'written informed consent', 'willing to', 'study', 'related procedures']
{'give': {'419582001': 'Give - dosing instruction imperative '}, 'written informed consent': {'12261009': 'Writing ', '108968006': 'Oprelvekin ', '410938009': 'Oprelvekin ', '223458004': 'Informing '}, 'willing to': {'225466006': 'Willing '}, 'study': {'224699009': 'Study '}, 'related procedures': {'263498003': 'relationships', '272151006': 'Relationships ', '71388002': 'Procedure ', '262094002': 'Related '}}
{'written informed consent': {'12261009': ('observable entity', 'Writing ', ['246464006']), '108968006': ('product', 'Oprelvekin ', ['406455002', '312413002', '115668003']), '410938009': ('product', 'Oprelvekin ', ['763158003'])}, 'willing to': {'225466006': ('clinical finding', 'Willing ', ['250171008'])}, 'related procedures': {'272151006': ('qualifier value', 'Relationships ', ['272099008']), '262094002': ('clinical finding', 'Related ', ['118240005'])}}

1279105
gestational age ≥ 37 weeks;
gestational , weeks;
[]
{}
{}

1287785
had >= 1 prenatal visit during which pregnancy was confirmed.
had >= 1 prenatal visit during .
['= 1 prenatal visit during']
{'= 1 prenatal visit during': {'451231000124103': 'greater than one', '424619006': 'Prenatal visit '}}
{'= 1 prenatal visit during': {'424619006': ('procedure', 'Prenatal visit ', ['243120004'])}}

1296688
patients must have histologically or cytologically confirmed indolent non-hodgkin's lymphoma; included in this category are newly diagnosed or relapsed/refractory follicular center lymphomas grade i, ii, iii, relapsed/refractory marginal zone b-cell lymphoma , relapsed/refractory mantle cell lymphoma
patients must have histologically or cytologically confirmed indolent non-hodgkin's lymphoma; included in this category are newly diagnosed or relapsed/refractory follicular center lymphomas grade i, ii, iii, relapsed/refractory marginal zone b-cell lymphoma , relapsed/refractory mantle cell lymphoma
['patients', 'histologically', 'confirmed', "indolent non hodgkin's lymphoma"]
{'patients': {'116154003': 'Patient '}, 'histologically': {'67151002': 'Histologic '}, 'confirmed': {'59156000': 'Confirmed by '}, "indolent non hodgkin's lymphoma": {'118601006': 'Non-Hodgkins lymphoma ', '128929007': 'Non-Hodgkin lymphoma - category ', '188675007': 'Malignant lymphoma - small cleaved cell ', '1929004': 'Non-Hodgkin lymphoma, no International Classification of Diseases for Oncology subtype '}}
{'histologically': {'67151002': ('qualifier value', 'Histologic ', ['272099008'])}, "indolent non hodgkin's lymphoma": {'118601006': ('clinical finding', 'Non-Hodgkins lymphoma ', ['64572001']), '188675007': ('clinical finding', 'Malignant lymphoma - small cleaved cell ', ['64572001', '118601006'])}}

1299134
obese family history of diabetes
obese family history of diabetes
['obese family history of diabetes']
{'obese family history of diabetes': {'414915002': 'Obese ', '414916001': 'Obesity ', '416471007': 'Family history of clinical finding ', '57177007': 'Family history with explicit context ', '73211009': 'Diabetes mellitus '}}
{'obese family history of diabetes': {'414915002': ('clinical finding', 'Obese ', ['250171008']), '414916001': ('clinical finding', 'Obesity ', ['64572001', '250171008', '414915002']), '416471007': ('situation with explicit context', 'Family history of clinical finding ', ['413350009', '57177007']), '73211009': ('clinical finding', 'Diabetes mellitus ', ['64572001', '118234003'])}}

1301792
willing to provide proof of identity by photographic id at screen and any subsequent visit
willing to provide proof of identity by photographic id at screen and any subsequent visit
['willing', 'to', 'proof of identity', 'by photographic id at screen', 'any subsequent visit']
{'willing': {'225466006': 'Willing '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'proof of identity': {'229796008': '% proof ', '247889000': 'Sense of identity '}, 'by photographic id at screen': {'257444003': 'Photograph ', '189822004': 'Contagious disease ', '191415002': 'Communicable disease ', '40733004': 'Infectious disease ', '20135006': 'Screening procedure ', '360156006': 'Screening - procedure intent ', '118522005': 'Identifier ', '257445002': 'Picture '}, 'any subsequent visit': {'255260001': 'following'}}
{'willing': {'225466006': ('clinical finding', 'Willing ', ['250171008'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'proof of identity': {'229796008': ('unit', '% proof ', ['767524001']), '247889000': ('observable entity', 'Sense of identity ', ['363788007'])}, 'by photographic id at screen': {'40733004': ('clinical finding', 'Infectious disease ', ['64572001']), '20135006': ('procedure', 'Screening procedure ', ['128927009']), '360156006': ('qualifier value', 'Screening - procedure intent ', ['272099008'])}}

1307397
patients must be suitable for and willing to undergo a radical prostatectomy at the completion of study therapy.
patients must be and willing to undergo a radical prostatectomy at the completion of study therapy.
['patients', 'willing', 'to', 'a radical prostatectomy at the completion of study therapy']
{'patients': {'116154003': 'Patient '}, 'willing': {'225466006': 'Willing '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'a radical prostatectomy at the completion of study therapy': {'26294005': 'Radical prostatectomy ', '255594003': 'Complete ', '224699009': 'Study ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure '}}
{'willing': {'225466006': ('clinical finding', 'Willing ', ['250171008'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'a radical prostatectomy at the completion of study therapy': {'26294005': ('procedure', 'Radical prostatectomy ', ['362958002', '128927009']), '255594003': ('qualifier value', 'Complete ', ['272099008']), '276239002': ('procedure', 'Therapy ', ['277132007', '243120004'])}}

1310229
man or woman subjects >= 18 to 75 years at the time of screening;
man or woman subjects >= 18 to 75 years at the time of screening;
['man', 'woman', '= 18 to 75 years', 'at the time of screening']
{'man': {'339947000': 'Man ', '278412004': 'Human - origin ', '337915000': 'Homo sapiens ', '10052007': 'Male structure ', '248153007': 'Male '}, 'woman': {'224526002': 'Woman '}, '= 18 to 75 years': {'732553001': '18.75', '258707000': 'year '}, 'at the time of screening': {'410669006': 'Time ', '410670007': 'time', '20135006': 'Screening procedure ', '900000000000475002': 'time '}}
{'man': {'339947000': ('person', 'Man ', ['133936004']), '278412004': ('qualifier value', 'Human - origin ', ['272099008']), '248153007': ('clinical finding', 'Male ', ['365860008'])}, 'woman': {'224526002': ('person', 'Woman ', ['133936004'])}, '= 18 to 75 years': {'258707000': ('unit', 'year ', ['767524001'])}, 'at the time of screening': {'20135006': ('procedure', 'Screening procedure ', ['128927009'])}}

1312072-1
any person who replies "yes" when asked "do you smoke?
any person who replies "yes" when asked "do you smoke?
['any person', 'smoke?']
{'any person': {'125676002': 'Person '}, 'smoke?': {'64197008': 'Smoke ', '102407002': 'Tobacco smoke '}}
{'smoke?': {'64197008': ('product', 'Smoke ', ['115669006']), '102407002': ('product', 'Tobacco smoke ', ['115669006', '64197008'])}}

1312072-2
".
".
[]
{}
{}

1328169
for patients with hormone receptor-positive disease: disease progression or recurrence in any setting on prior hormonal therapy, given with or without her2 directed therapy.
for patients with hormone receptor-positive disease: disease progression or recurrence in any setting on prior hormonal therapy, given with or without her2 directed therapy.
['for patients with hormone receptor positive disease', 'disease progression', 'recurrence in any', 'setting on prior hormonal therapy,', 'given with', 'or without her2', 'directed', 'therapy']
{'for patients with hormone receptor positive disease': {'116154003': 'Patient ', '87568004': 'Hormone ', '116647005': 'Receptor ', '10828004': 'Positive ', '64572001': 'Disease '}, 'disease progression': {'246453008': 'disease progression'}, 'recurrence in any': {'246455001': 'Recurrence '}, 'setting on prior hormonal therapy,': {'236874000': 'Status pre- ', '288556008': 'before', '169413002': 'Hormone therapy ', '309542002': 'Endocrine therapy '}, 'given with': {'419582001': 'Give - dosing instruction imperative '}, 'or without her2': {'44368005': 'Oncogene protein HER-2/neu '}, 'directed': {'255589003': 'Direct '}, 'therapy': {'276239002': 'Therapy ', '277132007': 'Therapeutic procedure '}}
{'for patients with hormone receptor positive disease': {'116647005': ('product', 'Receptor ', ['115668003']), '10828004': ('qualifier value', 'Positive ', ['272099008'])}, 'recurrence in any': {'246455001': ('qualifier value', 'Recurrence ', ['272099008'])}, 'setting on prior hormonal therapy,': {'169413002': ('procedure', 'Hormone therapy ', ['277132007', '128927009'])}, 'or without her2': {'44368005': ('product', 'Oncogene protein HER-2/neu ', ['312413002', '115668003'])}, 'directed': {'255589003': ('qualifier value', 'Direct ', ['272099008'])}, 'therapy': {'276239002': ('procedure', 'Therapy ', ['277132007', '243120004'])}}

1338841
undergoing an autologous intensity or reduced intensity conditioning allogeneic hsct
undergoing an autologous intensity or reduced intensity conditioning allogeneic hsct
['an autologous intensity', 'reduced intensity conditioning allogeneic hsct']
{'an autologous intensity': {'255379001': 'Autologous ', '103370009': 'with intensity'}, 'reduced intensity conditioning allogeneic hsct': {'260400001': 'Reduced ', '103370009': 'with intensity', '78326006': 'Conditioning, function ', '234336002': 'Hemopoietic stem cell transplant '}}
{'an autologous intensity': {'255379001': ('qualifier value', 'Autologous ', ['272099008'])}, 'reduced intensity conditioning allogeneic hsct': {'78326006': ('observable entity', 'Conditioning, function ', ['246464006']), '234336002': ('procedure', 'Hemopoietic stem cell transplant ', ['362958002', '128927009'])}}

1340730
post-menopausal or surgically sterile, or
post-menopausal or surgically sterile, or
['post menopausal', 'surgically sterile,']
{'post menopausal': {'76498008': 'Postmenopausal state '}, 'surgically sterile,': {'257556004': 'Surgery ', '387713003': 'Surgical procedure ', '83578000': 'Surgical ', '15296000': 'Sterility ', '8619003': 'Infertile ', '260984003': 'Aseptic ', '261029002': 'Sterile '}}
{'post menopausal': {'76498008': ('clinical finding', 'Postmenopausal state ', ['118234003'])}, 'surgically sterile,': {'387713003': ('procedure', 'Surgical procedure ', ['128927009']), '83578000': ('qualifier value', 'Surgical ', ['272099008']), '15296000': ('clinical finding', 'Sterility ', ['118234003']), '8619003': ('clinical finding', 'Infertile ', ['118234003']), '260984003': ('qualifier value', 'Aseptic ', ['272099008'])}}

1341311
oral maintenance treatment with azathioprine or 6-mercaptopurine is permitted.
oral maintenance treatment with azathioprine or 6-mercaptopurine is permitted.
['oral maintenance treatment with azathioprine', '6 mercaptopurine', 'permitted']
{'oral maintenance treatment with azathioprine': {'386359008': 'Administration of drug or medicament via oral route ', '111165009': 'Azathioprine ', '372574004': 'Azathioprine '}, '6 mercaptopurine': {'1039008': 'Mercaptopurine ', '386835005': 'Mercaptopurine '}, 'permitted': {'958006': 'Trachinotus falcatus '}}
{'oral maintenance treatment with azathioprine': {'386359008': ('procedure', 'Administration of drug or medicament via oral route ', ['128927009']), '111165009': ('product', 'Azathioprine ', ['763158003']), '372574004': ('product', 'Azathioprine ', ['312413002'])}, '6 mercaptopurine': {'1039008': ('product', 'Mercaptopurine ', ['763158003']), '386835005': ('product', 'Mercaptopurine ', ['312413002'])}}

1344982
hbeag positive or hbeag negative
hbeag positive or hbeag negative
['hbeag positive', 'hbeag negative']
{'hbeag positive': {'165807006': 'Hepatitis Be antigen present '}, 'hbeag negative': {'60605004': 'Hepatitis B e antigen ', '260385009': 'Negative '}}
{'hbeag positive': {'165807006': ('clinical finding', 'Hepatitis Be antigen present ', ['441742003'])}, 'hbeag negative': {'60605004': ('product', 'Hepatitis B e antigen ', ['406455002', '115668003', '312412007'])}}

1345098
migraine with aura; >= 2 attacks with 3 of following:
migraine with aura; >= 2 attacks with 3 of following:
['migraine with aura']
{'migraine with aura': {'4473006': 'Migraine with aura '}}
{'migraine with aura': {'4473006': ('clinical finding', 'Migraine with aura ', ['64572001', '102957003', '118234003'])}}

1358350
the patient has a resectable tumor or cyst arising from the pancreatic exocrine gland and is undergoing surgical resection of the neoplasm.
the patient has a resectable tumor or cyst arising from the pancreatic exocrine gland and is undergoing surgical resection of the neoplasm.
['the patient', 'a resectable tumor', 'cyst arising from the pancreatic exocrine gland', 'surgical resection of the neoplasm']
{'the patient': {'116154003': 'Patient '}, 'a resectable tumor': {'108369006': 'Neoplasm '}, 'cyst arising from the pancreatic exocrine gland': {'31258000': 'Cyst of pancreas ', '18720000': 'within', '362938003': 'Exocrine gland structure '}, 'surgical resection of the neoplasm': {'118292001': 'Removal ', '129303008': 'Removal - action ', '108369006': 'Neoplasm ', '55342001': 'Neoplastic disease ', '128303001': 'Surgical removal ', '129304002': 'Excision - action ', '129306000': 'Surgical removal - action ', '65801008': 'Excision '}}
{'cyst arising from the pancreatic exocrine gland': {'31258000': ('clinical finding', 'Cyst of pancreas ', ['64572001', '118234003'])}, 'surgical resection of the neoplasm': {'118292001': ('procedure', 'Removal ', ['128927009']), '55342001': ('clinical finding', 'Neoplastic disease ', ['64572001']), '128303001': ('procedure', 'Surgical removal ', ['128927009', '118292001']), '65801008': ('procedure', 'Excision ', ['128303001', '128927009', '118292001'])}}

1362711
schizophrenia
schizophrenia
['schizophrenia']
{'schizophrenia': {'191526005': 'Schizophrenic disorders ', '58214004': 'Schizophrenia '}}
{'schizophrenia': {'191526005': ('clinical finding', 'Schizophrenic disorders ', ['64572001', '58214004']), '58214004': ('clinical finding', 'Schizophrenia ', ['64572001'])}}

1374903
since each subject is receiving a gadolinium based contrast agent intravenously:
since each subject is receiving a gadolinium based contrast agent intravenously:
['a gadolinium based contrast agent intravenously']
{'a gadolinium based contrast agent intravenously': {'58281002': 'Gadolinium ', '63813000': 'Alkali ', '385420005': 'Contrast media ', '407935004': 'Contrast media ', '418836005': 'Base - unit of product usage '}}
{'a gadolinium based contrast agent intravenously': {'58281002': ('product', 'Gadolinium ', ['406455002', '312413002']), '63813000': ('product', 'Alkali ', ['312413002']), '407935004': ('product', 'Contrast media ', ['763158003']), '418836005': ('unit', 'Base - unit of product usage ', ['767524001'])}}

1387049
creatinine clearance > 30 ml/min, measured or calculated according to cockcroft and gault's formula.
creatinine clearance > 30 ml/min, measured or calculated according to cockcroft and gault's formula.
['creatinine clearance', '> 30 ml/min,', 'measured', 'calculated according to cockcroft']
{'creatinine clearance': {'15373003': 'Creatinine ', '260695007': 'clearance'}, '> 30 ml/min,': {'259030007': 'per 30 minutes ', '259035002': 'per milliliter ', '1071000175108': '30 minutes', '258859000': 'Milliliter/minute '}, 'measured': {'258104002': 'Measured '}, 'calculated according to cockcroft': {'258090004': 'Calculated ', '702873001': 'Calculation technique '}}
{'creatinine clearance': {'15373003': ('product', 'Creatinine ', ['312413002', '312412007'])}, '> 30 ml/min,': {'259030007': ('unit', 'per 30 minutes ', ['767524001']), '259035002': ('unit', 'per milliliter ', ['767524001']), '1071000175108': ('qualifier value', '30 minutes', ['272099008']), '258859000': ('unit', 'Milliliter/minute ', ['767524001'])}, 'measured': {'258104002': ('qualifier value', 'Measured ', ['272099008'])}, 'calculated according to cockcroft': {'258090004': ('qualifier value', 'Calculated ', ['272099008'])}}

1391505
ability to comply with the protocol.
comply with the protocol.
['comply with the protocol']
{'comply with the protocol': {'258049002': 'Protocols '}}
{}

1404685
continuing or restarting their first-line antiretroviral therapy or planned to be switched to a second line art regimen with >= 2 active agents at enrollment
continuing or restarting their first-line antiretroviral therapy or planned to be switched to a second line art regimen with >= 2 active agents at enrollment
['continuing', 'their first line antiretroviral therapy', 'planned', 'to', 'switched to a second line art regimen', '= 2 active agents at enrollment']
{'continuing': {'255238004': 'Continuous '}, 'their first line antiretroviral therapy': {'708255002': 'First line treatment '}, 'planned': {'397943006': 'Planned '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'switched to a second line art regimen': {'2603003': 'Secondary ', '50009006': 'Linear ', '278422005': 'Vascular line '}, '= 2 active agents at enrollment': {'260306008': 'Integer +2 ', '55561003': 'Active ', '260872001': 'agent'}}
{'continuing': {'255238004': ('qualifier value', 'Continuous ', ['272099008'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'switched to a second line art regimen': {'2603003': ('qualifier value', 'Secondary ', ['272099008']), '50009006': ('qualifier value', 'Linear ', ['272099008'])}, '= 2 active agents at enrollment': {'55561003': ('qualifier value', 'Active ', ['272099008'])}}

1406032
written informed consent
written informed consent
['written informed consent']
{'written informed consent': {'12261009': 'Writing ', '108968006': 'Oprelvekin ', '410938009': 'Oprelvekin ', '223458004': 'Informing '}}
{'written informed consent': {'12261009': ('observable entity', 'Writing ', ['246464006']), '108968006': ('product', 'Oprelvekin ', ['406455002', '312413002', '115668003']), '410938009': ('product', 'Oprelvekin ', ['763158003'])}}

1406247-1
mothers of children aged 0-12 mo.
mothers of children , mo.
['mothers of children', 'mo']
{'mothers of children': {'72705000': 'Mother ', '160499008': 'Child of '}, 'mo': {'223513007': 'Morocco ', '89185003': 'Monthly '}}
{'mothers of children': {'160499008': ('clinical finding', 'Child of ', ['118240005'])}, 'mo': {'89185003': ('qualifier value', 'Monthly ', ['272099008'])}}

1406247-2
or pregnant at time of enrollment
or pregnant at time of enrollment
['pregnant at time of enrollment']
{'pregnant at time of enrollment': {'77386006': 'Patient currently pregnant ', '410669006': 'Time ', '410670007': 'time', '900000000000475002': 'time ', '127362006': 'Previous pregnancies ', '161732006': 'Gravida ', '364323006': 'Quantity of pregnancy ', '366321006': 'Finding of gravida '}}
{'pregnant at time of enrollment': {'77386006': ('clinical finding', 'Patient currently pregnant ', ['250171008']), '127362006': ('clinical finding', 'Previous pregnancies ', ['250171008']), '161732006': ('observable entity', 'Gravida ', ['363788007']), '364323006': ('observable entity', 'Quantity of pregnancy ', ['363788007']), '366321006': ('clinical finding', 'Finding of gravida ', ['250171008'])}}

1416384-1
women seen at the gynecologic oncology clinic at the lyndon baines johnson general hospital.
women seen at the gynecologic oncology clinic at the lyndon baines johnson general hospital.
['women', 'seen at the gynecologic oncology clinic', 'at the lyndon baines johnson general hospital']
{'women': {'224526002': 'Woman '}, 'seen at the gynecologic oncology clinic': {'408446006': 'Gynecological oncology ', '35971002': 'Ambulatory care site ', '257585005': 'Clinic ', '74570005': 'Gynecologic ', '702931005': 'Oncology clinic '}, 'at the lyndon baines johnson general hospital': {'60132005': 'Generalized ', '22232009': 'Hospital ', '285201006': 'Hospital environment ', '700232004': 'General medical service '}}
{'women': {'224526002': ('person', 'Woman ', ['133936004'])}, 'seen at the gynecologic oncology clinic': {'74570005': ('qualifier value', 'Gynecologic ', ['272099008'])}, 'at the lyndon baines johnson general hospital': {'60132005': ('qualifier value', 'Generalized ', ['272099008'])}}

1416384-2
the women must be able to read and write either english or spanish.
the women must read and write either english or spanish.
['the women', 'read', 'write', 'either english', 'spanish']
{'the women': {'224526002': 'Woman '}, 'read': {'50360004': 'Reading '}, 'write': {'12261009': 'Writing '}, 'either english': {'297487008': 'English language ', '25804004': 'English ', '900000000000507009': 'english [international organization for standardization 639-1 code en] language reference set'}, 'spanish': {'414408004': 'Hispanic ', '28409002': 'Spaniards '}}
{'the women': {'224526002': ('person', 'Woman ', ['133936004'])}, 'read': {'50360004': ('observable entity', 'Reading ', ['246464006'])}, 'write': {'12261009': ('observable entity', 'Writing ', ['246464006'])}}

1419234
patient characteristics:
patient characteristics:
['patient characteristics']
{'patient characteristics': {'116154003': 'Patient '}}
{}

1420312
willingness to provide written informed consent to participate in the study.
willingness to provide written informed consent to participate in the study.
['willingness', 'to', 'written informed consent', 'participate in the study']
{'willingness': {'225466006': 'Willing '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'written informed consent': {'12261009': 'Writing ', '108968006': 'Oprelvekin ', '410938009': 'Oprelvekin ', '223458004': 'Informing '}, 'participate in the study': {'224699009': 'Study '}}
{'willingness': {'225466006': ('clinical finding', 'Willing ', ['250171008'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'written informed consent': {'12261009': ('observable entity', 'Writing ', ['246464006']), '108968006': ('product', 'Oprelvekin ', ['406455002', '312413002', '115668003']), '410938009': ('product', 'Oprelvekin ', ['763158003'])}}

1425619-1
patients must not have received: cytochrome p450 3a4 inhibitors within 7 days prior to registration on protocol and for the duration of the study.
patients must received: cytochrome p450 3a4 inhibitors , prior to registration on protocol and for the duration of the study.
['patients', 'prior to registration on protocol', 'and for the duration of the study']
{'patients': {'116154003': 'Patient '}, 'prior to registration on protocol': {'236874000': 'Status pre- ', '288556008': 'before', '258049002': 'Protocols '}, 'and for the duration of the study': {'103335007': 'duration ', '272116003': 'Durations ', '224699009': 'Study '}}
{'and for the duration of the study': {'272116003': ('qualifier value', 'Durations ', ['272099008'])}}

1425619-2
however, amiodarone, another cyp3a4 inhibitor, should have been discontinued 6 months prior to registration and for the duration of the study.
however, amiodarone, another cyp3a4 inhibitor, should have been discontinued 6 months prior to registration and for the duration of the study.
['amiodarone,', 'another cyp3a4 inhibitor,', 'discontinued', '6 months prior to registration', 'and for the duration of the study']
{'amiodarone,': {'372821002': 'Amiodarone ', '69236009': 'Amiodarone '}, 'another cyp3a4 inhibitor,': {'422741004': 'Cytochrome p450 CYP3A4 enzyme '}, 'discontinued': {'410546004': 'Discontinued '}, '6 months prior to registration': {'258706009': 'month ', '236874000': 'Status pre- ', '288556008': 'before'}, 'and for the duration of the study': {'103335007': 'duration ', '272116003': 'Durations ', '224699009': 'Study '}}
{'amiodarone,': {'372821002': ('product', 'Amiodarone ', ['406455002', '312413002']), '69236009': ('product', 'Amiodarone ', ['763158003'])}, 'another cyp3a4 inhibitor,': {'422741004': ('product', 'Cytochrome p450 CYP3A4 enzyme ', ['312413002', '115668003'])}, '6 months prior to registration': {'258706009': ('unit', 'month ', ['767524001'])}, 'and for the duration of the study': {'272116003': ('qualifier value', 'Durations ', ['272099008'])}}

1441709
absence of contraindication to iodinated contrast medium injection
absence of contraindication to iodinated contrast medium injection
['absence of contraindication', 'to iodinated contrast medium injection']
{'absence of contraindication': {'2667000': 'Absent ', '103306004': 'Contraindication to ', '397745006': 'Medical contraindication '}, 'to iodinated contrast medium injection': {'426722004': 'Iodinated contrast media ', '255508009': 'Medium ', '28289002': 'Injection of therapeutic agent ', '385218009': 'Injection ', '129326001': 'Injection - action ', '59108006': 'Injection '}}
{'absence of contraindication': {'397745006': ('clinical finding', 'Medical contraindication ', ['250171008'])}, 'to iodinated contrast medium injection': {'426722004': ('product', 'Iodinated contrast media ', ['406455002', '312413002', '115668003']), '255508009': ('qualifier value', 'Medium ', ['272099008']), '28289002': ('procedure', 'Injection of therapeutic agent ', ['59108006', '128927009']), '59108006': ('procedure', 'Injection ', ['128927009'])}}

1443380
age 18-65 years old;
, old;
['old']
{'old': {'70753007': 'Old '}}
{'old': {'70753007': ('qualifier value', 'Old ', ['272099008'])}}

1449875
patients with acceptable oral hygiene level,
patients with acceptable oral hygiene level,
['patients with acceptable oral hygiene level,']
{'patients with acceptable oral hygiene level,': {'116154003': 'Patient ', '900000000000549004': 'acceptable ', '385937007': 'Mouth care management ', '258395000': 'Levels ', '276625007': 'disease classification level'}}
{'patients with acceptable oral hygiene level,': {'385937007': ('procedure', 'Mouth care management ', ['128927009', '408766003']), '258395000': ('qualifier value', 'Levels ', ['272396007'])}}

1452571
ct measurable disease with >= 1 lesion having short axis ≥ 1.5cm or splenomegaly ≥ 14cm in cranio-caudal length attributable to relapsed lymphoma
ct measurable disease with >= 1 lesion having short axis ≥ 1.5cm or splenomegaly ≥ 14cm in cranio-caudal length attributable to relapsed lymphoma
['ct measurable disease with', '= 1 lesion', 'short axis  1 5cm', 'splenomegaly  14cm in cranio caudal length', 'attributable to relapsed lymphoma']
{'ct measurable disease with': {'223522008': 'Central African Republic ', '64572001': 'Disease '}, '= 1 lesion': {'451231000124103': 'greater than one', '52988006': 'Lesion '}, 'short axis  1 5cm': {'103340004': 'Short axis '}, 'splenomegaly  14cm in cranio caudal length': {'16294009': 'Splenomegaly ', '3583002': 'Caudal ', '272101001': 'Lengths ', '410667008': 'length', '410668003': 'Length property '}, 'attributable to relapsed lymphoma': {'255318003': 'Relapsing course ', '115244002': 'Malignant lymphoma - category ', '118600007': 'Malignant lymphoma ', '188676008': 'Malignant lymphoma - mixed small and large cell ', '21964009': 'Malignant lymphoma, no International Classification of Diseases for Oncology subtype '}}
{'short axis  1 5cm': {'103340004': ('qualifier value', 'Short axis ', ['272099008'])}, 'splenomegaly  14cm in cranio caudal length': {'16294009': ('clinical finding', 'Splenomegaly ', ['64572001', '118234003']), '272101001': ('qualifier value', 'Lengths ', ['272099008'])}, 'attributable to relapsed lymphoma': {'255318003': ('qualifier value', 'Relapsing course ', ['272099008']), '118600007': ('clinical finding', 'Malignant lymphoma ', ['64572001']), '188676008': ('clinical finding', 'Malignant lymphoma - mixed small and large cell ', ['64572001', '118600007'])}}

1460390
mds:
mds:
[]
{}
{}

1461924
patient must not have received immune suppressants: corticosteroids , cyclosporine or tacrolimus within 7 days of enrollment
patient must received immune suppressants: corticosteroids , cyclosporine or tacrolimus , of enrollment
['patient', 'received immune suppressants', 'corticosteroids ,', 'cyclosporine', 'tacrolimus']
{'patient': {'116154003': 'Patient '}, 'received immune suppressants': {'372823004': 'Immunosuppressant ', '69431002': 'Immunosuppressant '}, 'corticosteroids ,': {'21568003': 'Adrenal cortical hormone ', '79440004': 'Corticoid preparation '}, 'cyclosporine': {'387467008': 'Cyclosporine ', '80906007': 'Cyclosporine '}, 'tacrolimus': {'109129008': 'Tacrolimus ', '386975001': 'Tacrolimus '}}
{'received immune suppressants': {'69431002': ('product', 'Immunosuppressant ', ['763158003'])}, 'corticosteroids ,': {'79440004': ('product', 'Corticoid preparation ', ['763158003'])}, 'cyclosporine': {'387467008': ('product', 'Cyclosporine ', ['406455002', '372823004', '312413002', '312412007']), '80906007': ('product', 'Cyclosporine ', ['763158003'])}, 'tacrolimus': {'109129008': ('product', 'Tacrolimus ', ['763158003']), '386975001': ('product', 'Tacrolimus ', ['406455002', '372823004', '312413002'])}}

1529612
type 2 diabetes
type 2 diabetes
['type 2 diabetes']
{'type 2 diabetes': {'44054006': 'Diabetes mellitus type 2 '}}
{'type 2 diabetes': {'44054006': ('clinical finding', 'Diabetes mellitus type 2 ', ['64572001', '118234003'])}}

1539137
age 30-70 years old
, old
['old']
{'old': {'70753007': 'Old '}}
{'old': {'70753007': ('qualifier value', 'Old ', ['272099008'])}}

1544239
relapse or failure of 1 first line prior platinum-based chemotherapy
relapse or failure of 1 first line prior platinum-based chemotherapy
['relapse', 'failure of 1 first line prior platinum', 'based', 'chemotherapy']
{'relapse': {'263855007': 'Relapse phase ', '255318003': 'Relapsing course ', '58184002': 'Recurrent disease '}, 'failure of 1 first line prior platinum': {'76797004': 'Failure ', '255216001': 'First ', '50009006': 'Linear ', '236874000': 'Status pre- ', '288556008': 'before', '84847000': 'Platinum ', '278422005': 'Vascular line ', '232714002': 'Firstly '}, 'based': {'63813000': 'Alkali '}, 'chemotherapy': {'416608005': 'Drug therapy ', '716872004': 'Antineoplastic chemotherapy regimen ', '363688001': 'Administration of antineoplastic agent ', '367336001': 'Chemotherapy '}}
{'relapse': {'263855007': ('qualifier value', 'Relapse phase ', ['272099008']), '255318003': ('qualifier value', 'Relapsing course ', ['272099008']), '58184002': ('clinical finding', 'Recurrent disease ', ['64572001'])}, 'failure of 1 first line prior platinum': {'76797004': ('clinical finding', 'Failure ', ['250171008', '365860008']), '50009006': ('qualifier value', 'Linear ', ['272099008']), '84847000': ('product', 'Platinum ', ['406455002', '312413002']), '232714002': ('qualifier value', 'Firstly ', ['272099008'])}, 'based': {'63813000': ('product', 'Alkali ', ['312413002'])}, 'chemotherapy': {'416608005': ('procedure', 'Drug therapy ', ['128927009']), '716872004': ('procedure', 'Antineoplastic chemotherapy regimen ', ['243120004', '128927009']), '363688001': ('procedure', 'Administration of antineoplastic agent ', ['416608005', '367336001', '128927009']), '367336001': ('procedure', 'Chemotherapy ', ['416608005', '128927009'])}}

1552531-1
active gpa in the ent domain within 1 month prior to screening, where the active disease is defined as a score of ≥2 on a gpa ent disease activity score performed by direct endoscopic visualization of the upper airway and audiometric evaluation by a single expert otolaryngologist.
active gpa in the ent domain , prior to screening, where the active disease is defined as a score of ≥2 on a gpa ent disease activity score performed by direct endoscopic visualization of the upper airway and audiometric evaluation by a single expert otolaryngologist.
['active gpa in the ent domain', 'prior to screening,', 'the active disease', 'defined as a score of 2', 'on a gpa ent disease activity score', 'performed by direct endoscopic visualization of the upper airway', 'audiometric evaluation by a single expert otolaryngologist']
{'active gpa in the ent domain': {'55561003': 'Active ', '195353004': 'Granulomatosis with polyangiitis ', '609431004': 'concept model domain'}, 'prior to screening,': {'20135006': 'Screening procedure '}, 'the active disease': {'55561003': 'Active ', '64572001': 'Disease '}, 'defined as a score of 2': {'900000000000073002': 'sufficiently defined concept definition status ', '246262008': 'score', '278061009': 'Scores '}, 'on a gpa ent disease activity score': {'195353004': 'Granulomatosis with polyangiitis ', '116692003': 'condition activity', '246262008': 'score', '278061009': 'Scores '}, 'performed by direct endoscopic visualization of the upper airway': {'398166005': 'Performed ', '255589003': 'Direct ', '423827005': 'Endoscopy ', '255374006': 'Visual ', '47005005': 'Structure of upper respiratory tract cavity '}, 'audiometric evaluation by a single expert otolaryngologist': {'21727005': 'Audiometric test ', '129265001': 'Evaluation - action ', '386053000': 'Evaluation procedure ', '125681006': 'Single person ', '50607009': 'Singular '}}
{'active gpa in the ent domain': {'55561003': ('qualifier value', 'Active ', ['272099008']), '195353004': ('clinical finding', 'Granulomatosis with polyangiitis ', ['64572001', '441742003', '118234003'])}, 'prior to screening,': {'20135006': ('procedure', 'Screening procedure ', ['386053000', '128927009'])}, 'the active disease': {'55561003': ('qualifier value', 'Active ', ['272099008'])}, 'defined as a score of 2': {'278061009': ('qualifier value', 'Scores ', ['272396007'])}, 'on a gpa ent disease activity score': {'195353004': ('clinical finding', 'Granulomatosis with polyangiitis ', ['64572001', '441742003', '118234003']), '278061009': ('qualifier value', 'Scores ', ['272396007'])}, 'performed by direct endoscopic visualization of the upper airway': {'255589003': ('qualifier value', 'Direct ', ['272099008']), '423827005': ('procedure', 'Endoscopy ', ['363691001', '386053000', '128927009']), '255374006': ('qualifier value', 'Visual ', ['272099008'])}, 'audiometric evaluation by a single expert otolaryngologist': {'21727005': ('procedure', 'Audiometric test ', ['362958002', '386053000', '128927009']), '386053000': ('procedure', 'Evaluation procedure ', ['128927009']), '125681006': ('clinical finding', 'Single person ', ['118240005']), '50607009': ('qualifier value', 'Singular ', ['272099008'])}}

1552531-2
items included in the gpa ent disease activity score are:
items included in the gpa ent disease activity score are:
['included in the gpa ent disease activity score']
{'included in the gpa ent disease activity score': {'55919000': 'Including ', '195353004': 'Granulomatosis with polyangiitis ', '116692003': 'condition activity', '246262008': 'score', '278061009': 'Scores '}}
{'included in the gpa ent disease activity score': {'55919000': ('qualifier value', 'Including ', ['272099008']), '195353004': ('clinical finding', 'Granulomatosis with polyangiitis ', ['64572001', '441742003', '118234003']), '278061009': ('qualifier value', 'Scores ', ['272396007'])}}

1555791
adult cancer patients
adult cancer patients
['adult cancer patients']
{'adult cancer patients': {'133936004': 'Adult ', '363346000': 'Malignant neoplastic disease ', '116154003': 'Patient ', '372087000': 'Primary malignant neoplasm ', '86049000': 'Malignant neoplasm, primary '}}
{'adult cancer patients': {'363346000': ('clinical finding', 'Malignant neoplastic disease ', ['64572001']), '372087000': ('clinical finding', 'Primary malignant neoplasm ', ['64572001', '363346000'])}}

1565558
age 45 years or older
age 45 years or older
['age 45 years', 'older']
{'age 45 years': {'397669002': 'Age ', '424144002': 'Current chronological age ', '258707000': 'year '}, 'older': {'70753007': 'Old '}}
{'age 45 years': {'397669002': ('qualifier value', 'Age ', ['272099008']), '424144002': ('observable entity', 'Current chronological age ', ['105727008']), '258707000': ('unit', 'year ', ['767524001'])}, 'older': {'70753007': ('qualifier value', 'Old ', ['272099008'])}}

1568482
21 years of age or older
21 years of age or older
['21 years of age', 'older']
{'21 years of age': {'258707000': 'year ', '397669002': 'Age ', '424144002': 'Current chronological age '}, 'older': {'70753007': 'Old '}}
{'21 years of age': {'258707000': ('unit', 'year ', ['767524001']), '397669002': ('qualifier value', 'Age ', ['272099008']), '424144002': ('observable entity', 'Current chronological age ', ['105727008'])}, 'older': {'70753007': ('qualifier value', 'Old ', ['272099008'])}}

1574939
chronic hepatitis b defined by the presence of hbsag for >= 6 months prior to screening period.
chronic hepatitis b defined by the presence of hbsag , prior to screening period.
['chronic hepatitis b', 'defined by the presence of hbsag', 'prior to screening period']
{'chronic hepatitis b': {'61977001': 'Chronic type B viral hepatitis '}, 'defined by the presence of hbsag': {'900000000000073002': 'sufficiently defined concept definition status ', '52101004': 'Present ', '22290004': 'Hepatitis B surface antigen '}, 'prior to screening period': {'20135006': 'Screening procedure ', '259037005': 'per period ', '272117007': 'Time periods '}}
{'chronic hepatitis b': {'61977001': ('clinical finding', 'Chronic type B viral hepatitis ', ['64572001', '118234003'])}, 'defined by the presence of hbsag': {'22290004': ('product', 'Hepatitis B surface antigen ', ['406455002', '115668003', '312412007'])}, 'prior to screening period': {'20135006': ('procedure', 'Screening procedure ', ['128927009']), '259037005': ('unit', 'per period ', ['767524001']), '272117007': ('qualifier value', 'Time periods ', ['272099008'])}}

1579264
no prior radiation therapy to the head and neck sites.
prior radiation therapy to the head and neck sites.
['prior radiation therapy to the head and neck sites']
{'prior radiation therapy to the head and neck sites': {'236874000': 'Status pre- ', '288556008': 'before', '108290001': 'Radiation oncology AND/OR radiotherapy ', '53438000': 'Radiation therapy procedure or service ', '774007': 'Head and neck structure ', '10546003': 'site'}}
{}

1583845
a participant must have a diagnosis of histologically confirmed osteosarcoma or ewing sarcoma;
a participant must have a diagnosis of histologically confirmed osteosarcoma or ewing sarcoma;
['a diagnosis of histologically confirmed osteosarcoma', 'ewing sarcoma']
{'a diagnosis of histologically confirmed osteosarcoma': {'439401001': 'Diagnosis ', '67151002': 'Histologic ', '59156000': 'Confirmed by ', '21708004': 'Osteosarcoma, no International Classification of Diseases for Oncology subtype ', '307576001': 'Osteosarcoma of bone '}, 'ewing sarcoma': {'76909002': 'Ewings sarcoma '}}
{'a diagnosis of histologically confirmed osteosarcoma': {'67151002': ('qualifier value', 'Histologic ', ['272099008']), '307576001': ('clinical finding', 'Osteosarcoma of bone ', ['64572001', '118234003'])}}

1588318
men and women, who are >= 18 years of age
men and women, who are ,
['men', 'women,']
{'men': {'339947000': 'Man '}, 'women,': {'224526002': 'Woman '}}
{'men': {'339947000': ('person', 'Man ', ['133936004'])}, 'women,': {'224526002': ('person', 'Woman ', ['133936004'])}}

1594663
has an hcc diagnosis by histology or by the following non-invasive criteria observed either within 14 days prior to first tace or in the past.
has an hcc diagnosis by histology or by the following non-invasive criteria observed either , prior to first tace or in the past.
['an hcc diagnosis by histology', 'or by the following non invasive criteria', 'prior to first tace', 'or in the past']
{'an hcc diagnosis by histology': {'109841003': 'Liver cell carcinoma ', '187769009': 'Primary carcinoma of liver ', '25370001': 'Hepatocellular carcinoma ', '439401001': 'Diagnosis ', '714797009': 'Histologic test '}, 'or by the following non invasive criteria': {'237679004': 'Status post ', '255234002': 'status post', '22762002': 'Non-invasive ', '255260001': 'following'}, 'prior to first tace': {'255216001': 'First ', '400864005': 'Chlorotrianisene ', '420464005': 'Chlorotrianisene ', '232714002': 'Firstly '}, 'or in the past': {'410513005': 'In the past '}}
{'an hcc diagnosis by histology': {'109841003': ('clinical finding', 'Liver cell carcinoma ', ['64572001', '118234003']), '187769009': ('clinical finding', 'Primary carcinoma of liver ', ['64572001', '118234003']), '714797009': ('procedure', 'Histologic test ', ['128927009'])}, 'or by the following non invasive criteria': {'22762002': ('qualifier value', 'Non-invasive ', ['272099008'])}, 'prior to first tace': {'400864005': ('product', 'Chlorotrianisene ', ['763158003']), '420464005': ('product', 'Chlorotrianisene ', ['406455002', '312413002']), '232714002': ('qualifier value', 'Firstly ', ['272099008'])}}

1595329
healthy, non-smoking , adult males and females between 18 and 55 years of age, inclusive
healthy, non-smoking , adult males and females between 18 and 55 years of age, inclusive
['healthy, non smoking , adult males', 'females between 18', '55 years of age,', 'inclusive']
{'healthy, non smoking , adult males': {'102512003': 'Well adult ', '365981007': 'Finding of tobacco smoking behavior ', '10052007': 'Male structure ', '248153007': 'Male '}, 'females between 18': {'1086007': 'Female structure ', '248152002': 'Female '}, '55 years of age,': {'264691008': 'Arabic numeral 55 ', '258707000': 'year ', '397669002': 'Age ', '424144002': 'Current chronological age '}, 'inclusive': {'55919000': 'Including '}}
{'healthy, non smoking , adult males': {'102512003': ('clinical finding', 'Well adult ', ['250171008']), '365981007': ('clinical finding', 'Finding of tobacco smoking behavior ', ['250171008']), '248153007': ('clinical finding', 'Male ', ['365860008'])}, 'females between 18': {'248152002': ('clinical finding', 'Female ', ['365860008'])}, '55 years of age,': {'258707000': ('unit', 'year ', ['767524001']), '397669002': ('qualifier value', 'Age ', ['272099008']), '424144002': ('observable entity', 'Current chronological age ', ['105727008'])}, 'inclusive': {'55919000': ('qualifier value', 'Including ', ['272099008'])}}

1598594
the patient underwent coronary angiography and subsequent angioplasty with deployment of a bare metal stent within de novo stenotic lesion.
the patient underwent coronary angiography and subsequent angioplasty with deployment of a bare metal stent within de novo stenotic lesion.
['the patient', 'coronary angiography', 'subsequent angioplasty with deployment of a bare metal stent', 'within de novo stenotic lesion']
{'the patient': {'116154003': 'Patient '}, 'coronary angiography': {'33367005': 'Coronary angiography '}, 'subsequent angioplasty with deployment of a bare metal stent': {'255260001': 'following', '418285008': 'Angioplasty of blood vessel ', '698003007': 'Bare metal stent '}, 'within de novo stenotic lesion': {'224046004': 'Delaware ', '263879009': 'Stenosed ', '52988006': 'Lesion ', '223637004': 'Germany '}}
{'coronary angiography': {'33367005': ('procedure', 'Coronary angiography ', ['362958002', '128927009'])}, 'subsequent angioplasty with deployment of a bare metal stent': {'418285008': ('procedure', 'Angioplasty of blood vessel ', ['362958002', '128927009'])}, 'within de novo stenotic lesion': {'263879009': ('qualifier value', 'Stenosed ', ['272099008'])}}

1608605
adult patients, 18-65 years of age
adult patients, ,
['adult patients,']
{'adult patients,': {'133936004': 'Adult ', '116154003': 'Patient '}}
{}

1610733
patient is greater than 18 years of age
patient is greater than 18 years of age
['patient', 'greater than 18 years of age']
{'patient': {'116154003': 'Patient '}, 'greater than 18 years of age': {'276140008': 'Greater-than symbol > ', '258707000': 'year ', '397669002': 'Age ', '424144002': 'Current chronological age '}}
{'greater than 18 years of age': {'258707000': ('unit', 'year ', ['767524001']), '397669002': ('qualifier value', 'Age ', ['272099008']), '424144002': ('observable entity', 'Current chronological age ', ['105727008'])}}

1620636
ast and alt ≤ 1.5 x uln .
ast and alt ≤ 1.5 x uln .
['alt  1 5 x uln']
{'alt  1 5 x uln': {'116063003': 'Atypical lipoma ', '28655007': 'Liposarcoma, well differentiated '}}
{}

1627218
children and adolescent subjects 2-21 years of age at the time of the procedure, inclusive
children and adolescent subjects , at the time of the procedure, inclusive
['children', 'adolescent subjects', 'at the time of the procedure,', 'inclusive']
{'children': {'410601007': 'Childhood age person ', '67822003': 'Child ', '160499008': 'Child of '}, 'adolescent subjects': {'133937008': 'Adolescent '}, 'at the time of the procedure,': {'410669006': 'Time ', '410670007': 'time', '71388002': 'Procedure ', '900000000000475002': 'time '}, 'inclusive': {'55919000': 'Including '}}
{'children': {'160499008': ('clinical finding', 'Child of ', ['118240005'])}, 'inclusive': {'55919000': ('qualifier value', 'Including ', ['272099008'])}}

1635533
the patient will provide written informed consent.
the patient will provide written informed consent.
['the patient', 'written informed consent']
{'the patient': {'116154003': 'Patient '}, 'written informed consent': {'12261009': 'Writing ', '108968006': 'Oprelvekin ', '410938009': 'Oprelvekin ', '223458004': 'Informing '}}
{'written informed consent': {'12261009': ('observable entity', 'Writing ', ['246464006']), '108968006': ('product', 'Oprelvekin ', ['406455002', '312413002', '115668003']), '410938009': ('product', 'Oprelvekin ', ['763158003'])}}

1639287
fasting blood sugar > 110 mg/dl
fasting blood sugar > 110 mg/dl
['> 110 mg/dl']
{'> 110 mg/dl': {'732461008': '110', '258797006': 'Milligram/deciliter '}}
{'> 110 mg/dl': {'258797006': ('unit', 'Milligram/deciliter ', ['767524001'])}}

1645569
adequate liver function: bilirubin ≤ 1.5 x upper limit of normal range, alat and/or asat ≤ 2.5 x unl, alkaline phosphatase ≤5 x unl
adequate liver function: bilirubin ≤ 1.5 x upper limit of normal range, alat and/or asat ≤ 2.5 x unl, alkaline phosphatase ≤5 x unl
['adequate liver function', 'bilirubin  1 5 x upper limit of normal range', 'alkaline phosphatase 5 x unl']
{'adequate liver function': {'51117008': 'Sufficient ', '79036002': 'Liver function ', '88323005': 'Adequate '}, 'bilirubin  1 5 x upper limit of normal range': {'79706000': 'Bilirubin ', '261183002': 'Upper ', '264217000': 'Superior ', '352730000': 'Supra- ', '260394003': 'Normal limits ', '609432006': 'concept model range ', '255469002': 'Limited ', '260395002': 'Normal range '}, 'alkaline phosphatase 5 x unl': {'57056007': 'Alkaline phosphatase ', '406971006': 'Alkaline phosphatase stain '}}
{'adequate liver function': {'51117008': ('qualifier value', 'Sufficient ', ['272099008']), '79036002': ('observable entity', 'Liver function ', ['246464006'])}, 'bilirubin  1 5 x upper limit of normal range': {'79706000': ('product', 'Bilirubin ', ['312413002', '312412007']), '352730000': ('qualifier value', 'Supra- ', ['272099008']), '255469002': ('qualifier value', 'Limited ', ['272099008'])}, 'alkaline phosphatase 5 x unl': {'57056007': ('product', 'Alkaline phosphatase ', ['312413002', '115668003', '312412007']), '406971006': ('product', 'Alkaline phosphatase stain ', ['312412007'])}}

1652785
patients must have bi-dimensionally measurable disease with a least 1 lesion greater than or = 2 cm x 2 cm by ct scan
patients must have bi-dimensionally measurable disease with a least 1 lesion greater than or = 2 cm x 2 cm by ct scan
['patients', 'bi dimensionally measurable disease with a least 1 lesion', 'greater than', '= 2 cm x 2 cm by ct scan']
{'patients': {'116154003': 'Patient '}, 'bi dimensionally measurable disease with a least 1 lesion': {'64572001': 'Disease ', '52988006': 'Lesion '}, 'greater than': {'276140008': 'Greater-than symbol > '}, '= 2 cm x 2 cm by ct scan': {'732572001': '2.2', '77477000': 'Computerized axial tomography '}}
{'= 2 cm x 2 cm by ct scan': {'77477000': ('procedure', 'Computerized axial tomography ', ['128927009'])}}

1671861
sterilization of man partner; or,
sterilization of man partner; or,
['sterilization of man partner']
{'sterilization of man partner': {'339947000': 'Man ', '262043009': 'Partner in relationship ', '278412004': 'Human - origin ', '337915000': 'Homo sapiens ', '10052007': 'Male structure ', '248153007': 'Male '}}
{'sterilization of man partner': {'339947000': ('person', 'Man ', ['133936004']), '278412004': ('qualifier value', 'Human - origin ', ['272099008']), '248153007': ('clinical finding', 'Male ', ['365860008'])}}

1672408
prior adjuvant chemotherapy/radiotherapy or neo-adjuvant chemotherapy/radiotherapy allowed
prior adjuvant chemotherapy/radiotherapy or neo-adjuvant chemotherapy/radiotherapy allowed
['prior adjuvant chemotherapy/radiotherapy', 'neo adjuvant chemotherapy/radiotherapy']
{'prior adjuvant chemotherapy/radiotherapy': {'236874000': 'Status pre- ', '288556008': 'before', '372861001': 'Immune enhancement agent ', '427067006': 'Immunologic adjuvant ', '81759008': 'Immune enhancement agent ', '416608005': 'Drug therapy ', '419815003': 'Radiation oncology ', '108290001': 'Radiation oncology AND/OR radiotherapy ', '53438000': 'Radiation therapy procedure or service ', '716872004': 'Antineoplastic chemotherapy regimen ', '363688001': 'Administration of antineoplastic agent ', '367336001': 'Chemotherapy '}, 'neo adjuvant chemotherapy/radiotherapy': {'372861001': 'Immune enhancement agent ', '427067006': 'Immunologic adjuvant ', '81759008': 'Immune enhancement agent ', '416608005': 'Drug therapy ', '419815003': 'Radiation oncology ', '108290001': 'Radiation oncology AND/OR radiotherapy ', '53438000': 'Radiation therapy procedure or service ', '716872004': 'Antineoplastic chemotherapy regimen ', '363688001': 'Administration of antineoplastic agent ', '367336001': 'Chemotherapy '}}
{'prior adjuvant chemotherapy/radiotherapy': {'427067006': ('product', 'Immunologic adjuvant ', ['115668003']), '81759008': ('product', 'Immune enhancement agent ', ['763158003']), '416608005': ('procedure', 'Drug therapy ', ['128927009']), '716872004': ('procedure', 'Antineoplastic chemotherapy regimen ', ['243120004', '128927009']), '363688001': ('procedure', 'Administration of antineoplastic agent ', ['416608005', '367336001', '128927009']), '367336001': ('procedure', 'Chemotherapy ', ['416608005', '128927009'])}, 'neo adjuvant chemotherapy/radiotherapy': {'427067006': ('product', 'Immunologic adjuvant ', ['115668003']), '81759008': ('product', 'Immune enhancement agent ', ['763158003']), '416608005': ('procedure', 'Drug therapy ', ['128927009']), '716872004': ('procedure', 'Antineoplastic chemotherapy regimen ', ['243120004', '128927009']), '363688001': ('procedure', 'Administration of antineoplastic agent ', ['416608005', '367336001', '128927009']), '367336001': ('procedure', 'Chemotherapy ', ['416608005', '128927009'])}}

1688146
able to attend 3 clinical visits during the study period
able to attend 3 clinical visits during the study period
['able', 'to', '3 clinical visits during the study period']
{'able': {'371150009': 'Able '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, '3 clinical visits during the study period': {'260313008': '<3 ', '58147004': 'Clinical ', '224699009': 'Study ', '259037005': 'per period ', '272117007': 'Time periods '}}
{'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, '3 clinical visits during the study period': {'58147004': ('qualifier value', 'Clinical ', ['272099008']), '259037005': ('unit', 'per period ', ['767524001']), '272117007': ('qualifier value', 'Time periods ', ['272099008'])}}

1720537
relapsed acute lymphoblastic leukemia
relapsed acute lymphoblastic leukemia
['relapsed acute lymphoblastic leukemia']
{'relapsed acute lymphoblastic leukemia': {'255318003': 'Relapsing course ', '128822004': 'Precursor cell lymphoblastic leukemia ', '91857003': 'Acute lymphoid leukemia, disease '}}
{'relapsed acute lymphoblastic leukemia': {'255318003': ('qualifier value', 'Relapsing course ', ['272099008']), '91857003': ('clinical finding', 'Acute lymphoid leukemia, disease ', ['64572001', '118234003'])}}

1727915
surgery:
surgery:
['surgery']
{'surgery': {'257556004': 'Surgery ', '387713003': 'Surgical procedure ', '83578000': 'Surgical ', '394609007': 'General surgery '}}
{'surgery': {'387713003': ('procedure', 'Surgical procedure ', ['128927009']), '83578000': ('qualifier value', 'Surgical ', ['272099008'])}}

1736022
allowed:
allowed:
[]
{}
{}

1738973
prior medication:
prior medication:
['prior medication']
{'prior medication': {'236874000': 'Status pre- ', '288556008': 'before', '105903003': 'General drug type ', '373873005': 'Pharmaceutical / biologic product ', '410942007': 'Drug or medicament '}}
{}

1763655-1
histologically proven malignancy , advanced non-hematologic malignancy that is not curable by standard surgery, radiation therapy, or chemotherapy.
histologically proven malignancy , advanced non-hematologic malignancy that is not curable by standard surgery, radiation therapy, or chemotherapy.
['histologically proven malignancy ,', 'advanced', 'non hematologic malignancy', 'not curable by standard surgery,', 'radiation therapy,', 'chemotherapy']
{'histologically proven malignancy ,': {'67151002': 'Histologic ', '277025001': 'Proven ', '363346000': 'Malignant neoplastic disease ', '372087000': 'Primary malignant neoplasm ', '86049000': 'Malignant neoplasm, primary '}, 'advanced': {'86005002': 'Advanced '}, 'non hematologic malignancy': {'129154003': 'Hematologic neoplasm ', '269475001': 'Malignant tumor of lymphoid, hemopoietic AND/OR related tissue '}, 'not curable by standard surgery,': {'257556004': 'Surgery ', '387713003': 'Surgical procedure ', '83578000': 'Surgical ', '394609007': 'General surgery '}, 'radiation therapy,': {'108290001': 'Radiation oncology AND/OR radiotherapy ', '53438000': 'Radiation therapy procedure or service '}, 'chemotherapy': {'416608005': 'Drug therapy ', '716872004': 'Antineoplastic chemotherapy regimen ', '363688001': 'Administration of antineoplastic agent ', '367336001': 'Chemotherapy '}}
{'histologically proven malignancy ,': {'67151002': ('qualifier value', 'Histologic ', ['272099008']), '363346000': ('clinical finding', 'Malignant neoplastic disease ', ['64572001']), '372087000': ('clinical finding', 'Primary malignant neoplasm ', ['64572001', '363346000'])}, 'advanced': {'86005002': ('qualifier value', 'Advanced ', ['272099008'])}, 'non hematologic malignancy': {'129154003': ('clinical finding', 'Hematologic neoplasm ', ['64572001', '118234003']), '269475001': ('clinical finding', 'Malignant tumor of lymphoid, hemopoietic AND/OR related tissue ', ['64572001', '363346000'])}, 'not curable by standard surgery,': {'387713003': ('procedure', 'Surgical procedure ', ['128927009']), '83578000': ('qualifier value', 'Surgical ', ['272099008'])}, 'chemotherapy': {'416608005': ('procedure', 'Drug therapy ', ['128927009']), '716872004': ('procedure', 'Antineoplastic chemotherapy regimen ', ['243120004', '128927009']), '363688001': ('procedure', 'Administration of antineoplastic agent ', ['416608005', '367336001', '128927009']), '367336001': ('procedure', 'Chemotherapy ', ['416608005', '128927009'])}}

1763655-2
patients with melanoma, especially those with accessible tumors will be sought for this trial, but this part of the trial will not be limited to only melanoma patients
patients with melanoma, especially those with accessible tumors will be sought for this trial, but this part of the trial will not be limited to only melanoma patients
['patients with melanoma,', 'those with accessible tumors', 'sought for this trial,', 'this part of the trial', 'limited', 'to only melanoma patients']
{'patients with melanoma,': {'116154003': 'Patient ', '2092003': 'Malignant melanoma, no International Classification of Diseases for Oncology subtype ', '372244006': 'Malignant melanoma '}, 'those with accessible tumors': {'108369006': 'Neoplasm '}, 'sought for this trial,': {'110465008': 'Clinical trial '}, 'this part of the trial': {'123005000': 'part of', '110465008': 'Clinical trial '}, 'limited': {'255469002': 'Limited ', '900000000000486000': 'limited component '}, 'to only melanoma patients': {'223570002': 'Togo ', '50607009': 'Singular ', '2092003': 'Malignant melanoma, no International Classification of Diseases for Oncology subtype ', '372244006': 'Malignant melanoma ', '116154003': 'Patient ', '420295001': 'Only - dosing instruction fragment ', '9986007': 'Tryptophanase '}}
{'patients with melanoma,': {'372244006': ('clinical finding', 'Malignant melanoma ', ['64572001'])}, 'limited': {'255469002': ('qualifier value', 'Limited ', ['272099008'])}, 'to only melanoma patients': {'50607009': ('qualifier value', 'Singular ', ['272099008']), '372244006': ('clinical finding', 'Malignant melanoma ', ['64572001']), '9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}}

1763827
has had a documented hysterectomy or double oophorectomy or
has had a documented hysterectomy or double oophorectomy or
['a documented hysterectomy', 'double oophorectomy']
{'a documented hysterectomy': {'397934002': 'Documented ', '236886002': 'Hysterectomy '}, 'double oophorectomy': {'1305003': 'Double ', '83152002': 'Oophorectomy '}}
{'a documented hysterectomy': {'236886002': ('procedure', 'Hysterectomy ', ['362958002', '128927009'])}, 'double oophorectomy': {'1305003': ('qualifier value', 'Double ', ['272099008']), '83152002': ('procedure', 'Oophorectomy ', ['362958002', '128927009'])}}

1777950
currently using ocular lubricating drops >= once per day for, >=, the past 3 months;
currently using ocular lubricating drops >= once per day for, >=, the past 3 months;
['currently', 'using', 'ocular lubricating drops', 'once per day', 'the past 3 months']
{'currently': {'15240007': 'Current '}, 'using': {'260676000': 'use of'}, 'ocular lubricating drops': {'371398005': 'Eye region structure ', '81745001': 'Structure of eye proper ', '426684005': 'Drops dose form ', '404218003': 'Drop - unit of product usage ', '281004000': 'Visual function ', '714483002': 'Structure of orbital region '}, 'once per day': {'69620002': 'Daily ', '258703001': 'day ', '259032004': 'per day '}, 'the past 3 months': {'410513005': 'In the past ', '258706009': 'month '}}
{'ocular lubricating drops': {'404218003': ('unit', 'Drop - unit of product usage ', ['767524001']), '281004000': ('observable entity', 'Visual function ', ['246464006'])}, 'once per day': {'69620002': ('qualifier value', 'Daily ', ['272099008']), '258703001': ('unit', 'day ', ['767524001']), '259032004': ('unit', 'per day ', ['767524001'])}, 'the past 3 months': {'258706009': ('unit', 'month ', ['767524001'])}}

1781226
egfr > 75 ml/min/1.73 m² at inclusion
egfr > 75 ml/min/1.73 m² at inclusion
['> 75 ml/min/1 73 m at inclusion']
{'> 75 ml/min/1 73 m at inclusion': {'732861002': '75', '259035002': 'per milliliter ', '398169003': 'Min 1 ', '258311008': 'M+ ', '55919000': 'Including ', '277318003': 'm) '}}
{'> 75 ml/min/1 73 m at inclusion': {'259035002': ('unit', 'per milliliter ', ['767524001']), '398169003': ('unit', 'Min 1 ', ['767524001']), '258311008': ('staging and scales', 'M+ ', ['254292007']), '55919000': ('qualifier value', 'Including ', ['272099008']), '277318003': ('staging and scales', 'm) ', ['254292007'])}}

1781497
woman between, and including, 18 and 55 years of age at the time of enrolment;
woman between, and including, 18 and 55 years of age at the time of enrolment;
['woman between,', 'including', '55 years of age', 'at the time of enrolment']
{'woman between,': {'224526002': 'Woman '}, 'including': {'55919000': 'Including '}, '55 years of age': {'264691008': 'Arabic numeral 55 ', '258707000': 'year ', '397669002': 'Age ', '424144002': 'Current chronological age '}, 'at the time of enrolment': {'410669006': 'Time ', '410670007': 'time', '900000000000475002': 'time '}}
{'woman between,': {'224526002': ('person', 'Woman ', ['133936004'])}, 'including': {'55919000': ('qualifier value', 'Including ', ['272099008'])}, '55 years of age': {'258707000': ('unit', 'year ', ['767524001']), '397669002': ('qualifier value', 'Age ', ['272099008']), '424144002': ('observable entity', 'Current chronological age ', ['105727008'])}}

1784768
uncontrolled type 2 diabetes mellitus
uncontrolled type 2 diabetes mellitus
['uncontrolled type 2 diabetes mellitus']
{'uncontrolled type 2 diabetes mellitus': {'19032002': 'Uncontrolled ', '44054006': 'Diabetes mellitus type 2 '}}
{'uncontrolled type 2 diabetes mellitus': {'19032002': ('qualifier value', 'Uncontrolled ', ['272099008']), '44054006': ('clinical finding', 'Diabetes mellitus type 2 ', ['64572001', '118234003'])}}

1792570
fully recovered from prior surgical procedures and recovered to ≤ grade 1 from adverse events due to previous treatments
fully recovered from prior surgical procedures and recovered to ≤ grade 1 from adverse events due to , treatments
['recovered from prior surgical procedures', 'recovered', 'to  grade 1 from adverse events', 'treatments']
{'recovered from prior surgical procedures': {'74822006': 'Recovering from ', '161615003': 'History of surgery '}, 'recovered': {'74822006': 'Recovering from '}, 'to  grade 1 from adverse events': {'223570002': 'Togo ', '54102005': 'G1 grade ', '272379006': 'Event ', '9986007': 'Tryptophanase '}, 'treatments': {'276239002': 'Therapy ', '277132007': 'Therapeutic procedure '}}
{'recovered from prior surgical procedures': {'161615003': ('situation with explicit context', 'History of surgery ', ['129125009'])}, 'to  grade 1 from adverse events': {'54102005': ('clinical finding', 'G1 grade ', ['250171008', '441742003']), '9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'treatments': {'276239002': ('procedure', 'Therapy ', ['277132007', '243120004'])}}

1795674
ecog performance status 0-2
ecog performance status 0-2
['ecog performance status 0 2']
{'ecog performance status 0 2': {'423740007': 'Eastern Cooperative Oncology Group performance status ', '732349004': '0.2'}}
{'ecog performance status 0 2': {'423740007': ('observable entity', 'Eastern Cooperative Oncology Group performance status ', ['278844005'])}}

1798620
>18yr
>18yr
[]
{}
{}

1819920-1
never smokers, i.e.
never smokers, i.e.
['never smokers,', 'i e']
{'never smokers,': {'266919005': 'Never smoked tobacco '}, 'i e': {'42146005': 'Iodide salt ', '22971001': 'Blood group antibody I '}}
{'never smokers,': {'266919005': ('clinical finding', 'Never smoked tobacco ', ['250171008'])}, 'i e': {'42146005': ('product', 'Iodide salt ', ['406455002', '312413002', '115668003']), '22971001': ('product', 'Blood group antibody I ', ['312413002', '115668003'])}}

1819920-2
no cigarettes last year, and maximal 5 pack years
cigarettes last year, and maximal 5 pack years
['cigarettes', 'year,', 'maximal 5 pack years']
{'cigarettes': {'722496004': 'Cigarette '}, 'year,': {'258707000': 'year ', '259039008': 'per year '}, 'maximal 5 pack years': {'56851009': 'Maximal ', '315609007': 'Pack years ', '398303009': 'Max '}}
{'year,': {'258707000': ('unit', 'year ', ['767524001']), '259039008': ('unit', 'per year ', ['767524001'])}, 'maximal 5 pack years': {'56851009': ('qualifier value', 'Maximal ', ['272099008'])}}

1829177
woman or man patients
woman or man patients
['woman', 'man patients']
{'woman': {'224526002': 'Woman '}, 'man patients': {'339947000': 'Man ', '116154003': 'Patient ', '278412004': 'Human - origin ', '337915000': 'Homo sapiens ', '10052007': 'Male structure ', '248153007': 'Male '}}
{'woman': {'224526002': ('person', 'Woman ', ['133936004'])}, 'man patients': {'339947000': ('person', 'Man ', ['133936004']), '278412004': ('qualifier value', 'Human - origin ', ['272099008']), '248153007': ('clinical finding', 'Male ', ['365860008'])}}

1831065
has no symptoms of dry eye
has symptoms of dry eye
['symptoms of dry eye']
{'symptoms of dry eye': {'162290004': 'Dry eyes '}}
{'symptoms of dry eye': {'162290004': ('clinical finding', 'Dry eyes ', ['118234003'])}}

1849815
histological confirmation of non-small cell lung cancer
histological confirmation of non-small cell lung cancer
['histological confirmation of non small cell lung cancer']
{'histological confirmation of non small cell lung cancer': {'67151002': 'Histologic ', '74996004': 'Confirmation of ', '254637007': 'Non-small cell lung cancer '}}
{'histological confirmation of non small cell lung cancer': {'67151002': ('qualifier value', 'Histologic ', ['272099008']), '254637007': ('clinical finding', 'Non-small cell lung cancer ', ['64572001', '118234003'])}}

1868573
between 50 to 74 years old
between 50 to 74 years old
['between 50 to 74 years', 'old']
{'between 50 to 74 years': {'732860001': '74', '258707000': 'year '}, 'old': {'70753007': 'Old '}}
{'between 50 to 74 years': {'258707000': ('unit', 'year ', ['767524001'])}, 'old': {'70753007': ('qualifier value', 'Old ', ['272099008'])}}

1874038
qualifying c-peptide value in a mixed meal test at visit 1
qualifying c-peptide value in a mixed meal test at visit 1
['qualifying c peptide value in a mixed meal test']
{'qualifying c peptide value in a mixed meal test': {'39973008': 'C peptide ', '26242008': 'Mixed ', '108252007': 'Laboratory procedure ', '15220000': 'Laboratory test ', '269814003': 'Laboratory procedures -general ', '272393004': 'Tests ', '277775005': 'Test finding '}}
{'qualifying c peptide value in a mixed meal test': {'39973008': ('product', 'C peptide ', ['312413002']), '26242008': ('qualifier value', 'Mixed ', ['272099008']), '15220000': ('procedure', 'Laboratory test ', ['128927009', '108252007']), '269814003': ('situation with explicit context', 'Laboratory procedures -general ', ['129125009'])}}

1877444
patient requiring surgical management for the cancer of the esophagus or stomach.
patient requiring surgical management for the cancer of the esophagus or stomach.
['patient', 'surgical management for the cancer of the esophagus', 'stomach']
{'patient': {'116154003': 'Patient '}, 'surgical management for the cancer of the esophagus': {'257556004': 'Surgery ', '387713003': 'Surgical procedure ', '83578000': 'Surgical ', '413454004': 'Administration ', '372138000': 'Carcinoma of esophagus ', '363402007': 'Malignant tumor of esophagus ', '119270007': 'Management procedure ', '310138009': 'Surgical service '}, 'stomach': {'69695003': 'Stomach structure '}}
{'surgical management for the cancer of the esophagus': {'387713003': ('procedure', 'Surgical procedure ', ['128927009']), '83578000': ('qualifier value', 'Surgical ', ['272099008']), '372138000': ('clinical finding', 'Carcinoma of esophagus ', ['363402007', '64572001', '118234003']), '363402007': ('clinical finding', 'Malignant tumor of esophagus ', ['64572001', '118234003']), '119270007': ('procedure', 'Management procedure ', ['128927009'])}}

1892423
on insulin for > 5 years
on insulin for > 5 years
['on insulin for', '> 5 years']
{'on insulin for': {'39487003': 'Insulin product ', '412222002': 'Regular insulin ', '67866001': 'Insulin '}, '> 5 years': {'264606005': '-5 ', '258707000': 'year ', '264706000': '>5 ', '264605009': 'Integer +5 '}}
{'on insulin for': {'39487003': ('product', 'Insulin product ', ['763158003']), '412222002': ('product', 'Regular insulin ', ['115668003', '67866001', '312413002']), '67866001': ('product', 'Insulin ', ['115668003', '312413002'])}, '> 5 years': {'258707000': ('unit', 'year ', ['767524001'])}}

1896712
plasma nt-probnp
plasma nt-probnp
['plasma nt probnp']
{'plasma nt probnp': {'419185008': 'Blood plasma ', '50863008': 'Plasma ', '407060002': 'Pro-brain natriuretic peptide ', '414798009': 'N-terminal pro-B-type natriuretic peptide '}}
{'plasma nt probnp': {'50863008': ('product', 'Plasma ', ['115669006', '115668003']), '407060002': ('product', 'Pro-brain natriuretic peptide ', ['312413002']), '414798009': ('product', 'N-terminal pro-B-type natriuretic peptide ', ['312413002'])}}

1899935
the subject must be ≥ 18 years of age on day of signing informed consent.
the subject must be , on day of signing informed consent.
['on day of signing informed consent']
{'on day of signing informed consent': {'69620002': 'Daily ', '72670004': 'Sign ', '108968006': 'Oprelvekin ', '410938009': 'Oprelvekin ', '223458004': 'Informing ', '258703001': 'day ', '259032004': 'per day '}}
{'on day of signing informed consent': {'69620002': ('qualifier value', 'Daily ', ['272099008']), '72670004': ('clinical finding', 'Sign ', ['250171008']), '108968006': ('product', 'Oprelvekin ', ['406455002', '312413002', '115668003']), '410938009': ('product', 'Oprelvekin ', ['763158003']), '258703001': ('unit', 'day ', ['767524001']), '259032004': ('unit', 'per day ', ['767524001'])}}

1912358
participants must have relapsed disease despite standard therapy.
participants must have relapsed disease despite standard therapy.
['relapsed disease despite standard therapy']
{'relapsed disease despite standard therapy': {'58184002': 'Recurrent disease ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure '}}
{'relapsed disease despite standard therapy': {'58184002': ('clinical finding', 'Recurrent disease ', ['64572001']), '276239002': ('procedure', 'Therapy ', ['277132007', '243120004'])}}

1923862
age at the time of inclusion: 55 -79y,
age at the time of inclusion: 55 -79y,
['age at the time of inclusion', '55  79y']
{'age at the time of inclusion': {'397669002': 'Age ', '424144002': 'Current chronological age ', '410669006': 'Time ', '410670007': 'time', '55919000': 'Including ', '900000000000475002': 'time '}, '55  79y': {'264691008': 'Arabic numeral 55 '}}
{'age at the time of inclusion': {'397669002': ('qualifier value', 'Age ', ['272099008']), '424144002': ('observable entity', 'Current chronological age ', ['105727008']), '55919000': ('qualifier value', 'Including ', ['272099008'])}}

1932237
only adults will be included in this study.
only adults will be included in this study.
['only adults', 'included in this study']
{'only adults': {'50607009': 'Singular ', '133936004': 'Adult ', '420295001': 'Only - dosing instruction fragment '}, 'included in this study': {'55919000': 'Including ', '224699009': 'Study '}}
{'only adults': {'50607009': ('qualifier value', 'Singular ', ['272099008'])}, 'included in this study': {'55919000': ('qualifier value', 'Including ', ['272099008'])}}

1940094
subjects must meet all of the following criteria to be included in the study.
subjects must meet all of the following criteria to be included in the study.
['all of the following criteria', 'to', 'included in the study']
{'all of the following criteria': {'237679004': 'Status post ', '255234002': 'status post', '255260001': 'following'}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'included in the study': {'55919000': 'Including ', '224699009': 'Study '}}
{'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'included in the study': {'55919000': ('qualifier value', 'Including ', ['272099008'])}}

1952488
presence of >= 1 measurable central nervous system target lesion
presence of >= 1 measurable central nervous system target lesion
['presence of >', '= 1 measurable central nervous system target lesion']
{'presence of >': {'52101004': 'Present '}, '= 1 measurable central nervous system target lesion': {'451231000124103': 'greater than one', '21483005': 'Structure of central nervous system ', '36715001': 'Erythema multiforme '}}
{'= 1 measurable central nervous system target lesion': {'36715001': ('clinical finding', 'Erythema multiforme ', ['64572001', '247441003', '118234003'])}}

1980188
patients must sign a study-specific informed consent form prior to study entry.
patients must sign a study-specific informed consent form prior to study entry.
['patients', 'sign', 'a study specific informed consent form prior to study entry']
{'patients': {'116154003': 'Patient '}, 'sign': {'72670004': 'Sign '}, 'a study specific informed consent form prior to study entry': {'224699009': 'Study ', '69658003': 'Specific ', '108968006': 'Oprelvekin ', '410938009': 'Oprelvekin ', '246176004': 'qualitative form', '236874000': 'Status pre- ', '288556008': 'before', '223458004': 'Informing '}}
{'sign': {'72670004': ('clinical finding', 'Sign ', ['250171008'])}, 'a study specific informed consent form prior to study entry': {'69658003': ('qualifier value', 'Specific ', ['272099008']), '108968006': ('product', 'Oprelvekin ', ['406455002', '312413002', '115668003']), '410938009': ('product', 'Oprelvekin ', ['763158003'])}}

1998146
age>18 years of age;
, of age;
['of age']
{'of age': {'397669002': 'Age ', '424144002': 'Current chronological age '}}
{'of age': {'397669002': ('qualifier value', 'Age ', ['272099008']), '424144002': ('observable entity', 'Current chronological age ', ['105727008'])}}

1999423
woman members of the couple may report that they have engaged in low level aggression during the past 6 months in their current relationship on the revised conflict tactics scale
woman members of the couple may report
['woman members of the couple', 'report']
{'woman members of the couple': {'224526002': 'Woman ', '394852005': 'member'}, 'report': {'229059009': 'Report ', '223458004': 'Informing '}}
{'woman members of the couple': {'224526002': ('person', 'Woman ', ['133936004'])}}

1999566
histologically confirmed aggressive b cell non-hodgkin lymphoma including the following types defined by world health organization 2008:
histologically confirmed aggressive b cell non-hodgkin lymphoma including the following types defined by world health organization 2008:
['histologically', 'confirmed', 'aggressive b cell non hodgkin lymphoma', 'including', 'the following types', 'defined by world health organization 2008']
{'histologically': {'67151002': 'Histologic '}, 'confirmed': {'59156000': 'Confirmed by '}, 'aggressive b cell non hodgkin lymphoma': {'61372001': 'Aggressive behavior ', '109979007': 'B-cell lymphoma ', '1929004': 'Non-Hodgkin lymphoma, no International Classification of Diseases for Oncology subtype ', '413616009': 'B-cell neoplasm '}, 'including': {'55919000': 'Including '}, 'the following types': {'237679004': 'Status post ', '255234002': 'status post', '261664005': 'Types ', '35362001': 'type - attribute', '410656007': 'Type ', '410657003': 'type - attribute', '704318007': 'type - attribute', '255260001': 'following'}, 'defined by world health organization 2008': {'900000000000073002': 'sufficiently defined concept definition status ', '263775005': 'Health ', '21139007': 'Organization ', '385650005': 'Organized '}}
{'histologically': {'67151002': ('qualifier value', 'Histologic ', ['272099008'])}, 'aggressive b cell non hodgkin lymphoma': {'61372001': ('clinical finding', 'Aggressive behavior ', ['250171008']), '109979007': ('clinical finding', 'B-cell lymphoma ', ['64572001'])}, 'including': {'55919000': ('qualifier value', 'Including ', ['272099008'])}, 'the following types': {'261664005': ('qualifier value', 'Types ', ['272396007'])}}

2020740
telephone contact available
telephone contact available
['telephone', 'contact', 'available']
{'telephone': {'359993007': 'Telephone ', '734005006': 'telephone number'}, 'contact': {'11723008': 'Contact with ', '70862002': 'Contact person '}, 'available': {'103328004': 'Availability of '}}
{}

2034041
subjects who agree to undergo the any of the following 4 treatments, including radical prostatectomy, definitive prostate radiotherapy, systemic chemotherapy, and androgen deprivation therapy for prostate cancer.
subjects who agree to undergo the any of the following 4 treatments, including radical prostatectomy, definitive prostate radiotherapy, systemic chemotherapy, and androgen deprivation therapy for prostate cancer.
['to', 'the any of the following 4 treatments,', 'including', 'radical prostatectomy,', 'definitive prostate radiotherapy,', 'systemic chemotherapy,', 'androgen deprivation therapy for prostate cancer']
{'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'the any of the following 4 treatments,': {'237679004': 'Status post ', '255234002': 'status post', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '255260001': 'following'}, 'including': {'55919000': 'Including '}, 'radical prostatectomy,': {'26294005': 'Radical prostatectomy '}, 'definitive prostate radiotherapy,': {'261002007': 'Definitive ', '263847000': 'Prostatic ', '279689003': 'Prostatic gland structure ', '41216001': 'Prostatic structure ', '419815003': 'Radiation oncology ', '108290001': 'Radiation oncology AND/OR radiotherapy ', '53438000': 'Radiation therapy procedure or service '}, 'systemic chemotherapy,': {'31099001': 'Systemic ', '416608005': 'Drug therapy ', '716872004': 'Antineoplastic chemotherapy regimen ', '363688001': 'Administration of antineoplastic agent ', '367336001': 'Chemotherapy '}, 'androgen deprivation therapy for prostate cancer': {'707266006': 'Androgen deprivation therapy ', '399068003': 'Malignant tumor of prostate ', '254900004': 'Carcinoma of prostate '}}
{'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'the any of the following 4 treatments,': {'276239002': ('procedure', 'Therapy ', ['277132007', '243120004'])}, 'including': {'55919000': ('qualifier value', 'Including ', ['272099008'])}, 'radical prostatectomy,': {'26294005': ('procedure', 'Radical prostatectomy ', ['362958002', '128927009'])}, 'definitive prostate radiotherapy,': {'261002007': ('qualifier value', 'Definitive ', ['272099008'])}, 'systemic chemotherapy,': {'31099001': ('qualifier value', 'Systemic ', ['272099008']), '416608005': ('procedure', 'Drug therapy ', ['277132007', '128927009']), '716872004': ('procedure', 'Antineoplastic chemotherapy regimen ', ['243120004', '128927009']), '363688001': ('procedure', 'Administration of antineoplastic agent ', ['416608005', '367336001', '128927009', '277132007']), '367336001': ('procedure', 'Chemotherapy ', ['416608005', '128927009', '277132007'])}, 'androgen deprivation therapy for prostate cancer': {'707266006': ('procedure', 'Androgen deprivation therapy ', ['416608005', '128927009', '277132007']), '399068003': ('clinical finding', 'Malignant tumor of prostate ', ['64572001', '118234003']), '254900004': ('clinical finding', 'Carcinoma of prostate ', ['64572001', '399068003', '118234003'])}}

2036555
having a score of greater than or = 26 on the mini-mental state exam
having a score of greater than or = 26 on the mini-mental state exam
['a score of greater', '= 26 on the mini mental state exam']
{'a score of greater': {'246262008': 'score', '278061009': 'Scores ', '263768009': 'Greater '}, '= 26 on the mini mental state exam': {'262445005': 'Mini ', '363871006': 'Mental state ', '36456004': 'Mental state finding ', '225886003': 'Medical assessment '}}
{'a score of greater': {'278061009': ('qualifier value', 'Scores ', ['272396007']), '263768009': ('qualifier value', 'Greater ', ['272099008'])}, '= 26 on the mini mental state exam': {'262445005': ('qualifier value', 'Mini ', ['272396007']), '363871006': ('observable entity', 'Mental state ', ['363788007']), '36456004': ('clinical finding', 'Mental state finding ', ['250171008']), '225886003': ('procedure', 'Medical assessment ', ['128927009'])}}

2037806-1
presence of 4-8 ak lesions total in a 25 cm2 area identified on the face through transparency mapping and photographs.
presence of 4-8 ak lesions total in a 25 cm2 area identified on the face through transparency mapping and photographs.
['presence of 4 8 ak', 'lesions', 'total in a 25 cm2 area', 'identified on the face', 'through transparency mapping', 'photographs']
{'presence of 4 8 ak': {'52101004': 'Present ', '224040005': 'Alaska '}, 'lesions': {'52988006': 'Lesion '}, 'total in a 25 cm2 area': {'258755000': '% of total ', '259022006': 'square centimeter ', '42798000': 'Area ', '373587001': 'Chiari malformation type II ', '255619001': 'Total '}, 'identified on the face': {'7882003': 'Identified ', '89545001': 'Face structure '}, 'through transparency mapping': {'300828005': 'Translucent ', '360220002': 'Mapping - action '}, 'photographs': {'257444003': 'Photograph ', '257445002': 'Picture '}}
{'total in a 25 cm2 area': {'258755000': ('unit', '% of total ', ['767524001']), '259022006': ('unit', 'square centimeter ', ['767524001']), '42798000': ('qualifier value', 'Area ', ['272099008']), '373587001': ('clinical finding', 'Chiari malformation type II ', ['64572001', '118234003']), '255619001': ('qualifier value', 'Total ', ['272099008'])}, 'identified on the face': {'7882003': ('qualifier value', 'Identified ', ['272099008'])}, 'through transparency mapping': {'300828005': ('qualifier value', 'Translucent ', ['272099008'])}}

2037806-2
the face area will be defined from hair line to jaw line.
the face area will be defined from hair line to jaw line.
['the face area', 'defined from hair line', 'to jaw line']
{'the face area': {'89545001': 'Face structure ', '42798000': 'Area '}, 'defined from hair line': {'900000000000073002': 'sufficiently defined concept definition status ', '386045008': 'Hair structure ', '50009006': 'Linear ', '278422005': 'Vascular line ', '119326000': 'Hair specimen '}, 'to jaw line': {'661005': 'Jaw region structure ', '50009006': 'Linear ', '278422005': 'Vascular line '}}
{'the face area': {'42798000': ('qualifier value', 'Area ', ['272099008'])}, 'defined from hair line': {'50009006': ('qualifier value', 'Linear ', ['272099008'])}, 'to jaw line': {'50009006': ('qualifier value', 'Linear ', ['272099008'])}}

2037806-3
the scalp will not be included.
the scalp will not be included.
['the scalp', 'included']
{'the scalp': {'41695006': 'Scalp structure '}, 'included': {'55919000': 'Including '}}
{'included': {'55919000': ('qualifier value', 'Including ', ['272099008'])}}

2037806-4
an imaginary normal hair line will be the upper boundary for bald men.
an imaginary normal hair line will be the upper boundary for bald men.
['an imaginary normal hair line', 'the upper boundary for bald men']
{'an imaginary normal hair line': {'17621005': 'Normal ', '386045008': 'Hair structure ', '50009006': 'Linear ', '278422005': 'Vascular line ', '119326000': 'Hair specimen ', '8117002': 'Gait normal ', '258744000': '% normal '}, 'the upper boundary for bald men': {'261183002': 'Upper ', '264217000': 'Superior ', '352730000': 'Supra- ', '278040002': 'Loss of hair ', '56317004': 'Alopecia ', '339947000': 'Man '}}
{'an imaginary normal hair line': {'17621005': ('qualifier value', 'Normal ', ['272099008']), '50009006': ('qualifier value', 'Linear ', ['272099008']), '8117002': ('clinical finding', 'Gait normal ', ['250171008']), '258744000': ('unit', '% normal ', ['767524001'])}, 'the upper boundary for bald men': {'352730000': ('qualifier value', 'Supra- ', ['272099008']), '278040002': ('clinical finding', 'Loss of hair ', ['118234003']), '56317004': ('clinical finding', 'Alopecia ', ['64572001', '118234003']), '339947000': ('person', 'Man ', ['133936004'])}}

2047090
cc resistant pcos
cc resistant pcos
['cc resistant pcos']
{'cc resistant pcos': {'108943009': 'Cholecalciferol preparation ', '18414002': 'Vitamin D>3< ', '30714006': 'Resistant ', '69878008': 'Polycystic ovaries '}}
{'cc resistant pcos': {'108943009': ('product', 'Cholecalciferol preparation ', ['763158003']), '18414002': ('product', 'Vitamin D>3< ', ['406455002', '115668003', '312413002'])}}

2050206
healthy participants
healthy participants
['healthy participants']
{'healthy participants': {'263775005': 'Health '}}
{}

2052028
number of retrieved oocytes was ≥20
number of retrieved oocytes was ≥20
['number of retrieved oocytes']
{'number of retrieved oocytes': {'246440005': 'Number of oocytes '}}
{'number of retrieved oocytes': {'246440005': ('qualifier value', 'Number of oocytes ', ['272099008'])}}

2056785
written informed consent must be obtained.
written informed consent must be obtained.
['written informed consent', 'obtained']
{'written informed consent': {'12261009': 'Writing ', '108968006': 'Oprelvekin ', '410938009': 'Oprelvekin ', '223458004': 'Informing '}, 'obtained': {'398092000': 'obtain'}}
{'written informed consent': {'12261009': ('observable entity', 'Writing ', ['246464006']), '108968006': ('product', 'Oprelvekin ', ['406455002', '312413002', '115668003']), '410938009': ('product', 'Oprelvekin ', ['763158003'])}}

2059249
>= 1 of the regimens must have included high-dose dexamethasone or medium-dose dexamethasone of a 28-day course
>= 1 of the regimens must have included high-dose dexamethasone or medium-dose dexamethasone of a 28-day course
['= 1 of the regimens', 'included', 'high dose dexamethasone', 'medium dose dexamethasone of a 28 day course']
{'= 1 of the regimens': {'451231000124103': 'greater than one'}, 'included': {'55919000': 'Including '}, 'high dose dexamethasone': {'261829003': 'High dose ', '372584003': 'Dexamethasone ', '7561000': 'Dexamethasone preparation '}, 'medium dose dexamethasone of a 28 day course': {'255508009': 'Medium ', '260911001': 'dosage', '277406006': 'Dosages ', '372584003': 'Dexamethasone ', '7561000': 'Dexamethasone preparation ', '69620002': 'Daily ', '288524001': 'Courses ', '258703001': 'day ', '259032004': 'per day ', '408102007': 'Unit dose '}}
{'included': {'55919000': ('qualifier value', 'Including ', ['272099008'])}, 'high dose dexamethasone': {'261829003': ('qualifier value', 'High dose ', ['277406006', '272099008']), '372584003': ('product', 'Dexamethasone ', ['406455002', '312413002']), '7561000': ('product', 'Dexamethasone preparation ', ['763158003'])}, 'medium dose dexamethasone of a 28 day course': {'255508009': ('qualifier value', 'Medium ', ['272099008']), '277406006': ('qualifier value', 'Dosages ', ['272099008']), '372584003': ('product', 'Dexamethasone ', ['406455002', '312413002']), '7561000': ('product', 'Dexamethasone preparation ', ['763158003']), '69620002': ('qualifier value', 'Daily ', ['272099008']), '288524001': ('qualifier value', 'Courses ', ['272099008']), '258703001': ('unit', 'day ', ['767524001']), '259032004': ('unit', 'per day ', ['767524001']), '408102007': ('unit', 'Unit dose ', ['767524001'])}}

2061066
wocbp had to abstain from sex or they and their partners had to use adequate contraceptive precautions for the duration of the study.
wocbp had to abstain from sex or they and their partners had to use adequate contraceptive precautions for the duration of the study.
['to', 'abstain from sex', 'their partners', 'use', 'adequate contraceptive precautions for the duration of the study']
{'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'abstain from sex': {'258139002': 'Intercourse ', '363903009': 'Sexual behavior ', '473013003': 'Finding relating to sexual behavior or practice ', '263495000': 'Gender ', '70256003': 'Finding of sexual intercourse ', '734000001': 'sexual intercourse - finding', '57312000': 'Sex structure '}, 'their partners': {'262043009': 'Partner in relationship '}, 'use': {'277889008': 'usage', '419385000': 'Use - dosing instruction imperative '}, 'adequate contraceptive precautions for the duration of the study': {'51117008': 'Sufficient ', '108899006': 'Contraceptives ', '103335007': 'duration ', '272116003': 'Durations ', '224699009': 'Study ', '348649005': 'Contraceptive device ', '88323005': 'Adequate '}}
{'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'abstain from sex': {'363903009': ('observable entity', 'Sexual behavior ', ['363788007']), '473013003': ('clinical finding', 'Finding relating to sexual behavior or practice ', ['250171008']), '263495000': ('observable entity', 'Gender ', ['278844005']), '70256003': ('clinical finding', 'Finding of sexual intercourse ', ['250171008'])}, 'adequate contraceptive precautions for the duration of the study': {'51117008': ('qualifier value', 'Sufficient ', ['272099008']), '108899006': ('product', 'Contraceptives ', ['763158003']), '272116003': ('qualifier value', 'Durations ', ['272099008'])}}

2090882
able and willing to attend scheduled follow-up visits and study related exams.
able and willing to attend scheduled follow-up visits and study related exams.
['able', 'willing', 'to', 'scheduled follow up visits', 'study', 'related exams']
{'able': {'371150009': 'Able '}, 'willing': {'225466006': 'Willing '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'scheduled follow up visits': {'416151008': 'Scheduled - procedure status ', '185389009': 'Follow-up visit ', '416774000': 'Scheduled - priority '}, 'study': {'224699009': 'Study '}, 'related exams': {'263498003': 'relationships', '272151006': 'Relationships ', '225886003': 'Medical assessment ', '262094002': 'Related '}}
{'willing': {'225466006': ('clinical finding', 'Willing ', ['250171008'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'scheduled follow up visits': {'416774000': ('qualifier value', 'Scheduled - priority ', ['272099008'])}, 'related exams': {'272151006': ('qualifier value', 'Relationships ', ['272099008']), '225886003': ('procedure', 'Medical assessment ', ['128927009']), '262094002': ('clinical finding', 'Related ', ['118240005'])}}

2102590
eastern cooperative oncology group performance status score of 0 or 1
eastern cooperative oncology group performance status score of 0 or 1
['eastern cooperative oncology group performance status score of 0', '1']
{'eastern cooperative oncology group performance status score of 0': {'423740007': 'Eastern Cooperative Oncology Group performance status ', '246262008': 'score', '278061009': 'Scores '}, '1': {'451231000124103': 'greater than one'}}
{'eastern cooperative oncology group performance status score of 0': {'423740007': ('observable entity', 'Eastern Cooperative Oncology Group performance status ', ['278844005']), '278061009': ('qualifier value', 'Scores ', ['272396007'])}}

2103258
ability to send and receive emails
send and receive emails
[]
{}
{}

2105312
sight and hearing are sufficiently good to allow the undertaking of study-related procedures and psychometric tests.
sight and hearing are sufficiently good to allow the undertaking of study-related procedures and psychometric tests.
['sight', 'hearing', 'sufficiently good', 'to', 'the undertaking of study related procedures', 'psychometric tests']
{'sight': {'281004000': 'Visual function '}, 'hearing': {'47078008': 'Hearing, function ', '118230007': 'Hearing finding '}, 'sufficiently good': {'20572008': 'Good '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'the undertaking of study related procedures': {'224699009': 'Study ', '263498003': 'relationships', '272151006': 'Relationships ', '71388002': 'Procedure ', '262094002': 'Related '}, 'psychometric tests': {'307809000': 'Psychometric testing '}}
{'sight': {'281004000': ('observable entity', 'Visual function ', ['246464006'])}, 'hearing': {'47078008': ('observable entity', 'Hearing, function ', ['246464006']), '118230007': ('clinical finding', 'Hearing finding ', ['250171008', '118234003'])}, 'sufficiently good': {'20572008': ('qualifier value', 'Good ', ['272099008'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'the undertaking of study related procedures': {'272151006': ('qualifier value', 'Relationships ', ['272099008']), '262094002': ('clinical finding', 'Related ', ['118240005'])}}

2106583
no history of other malignancy within the last 3 years, except for carcinoma in situ of the cervix or basal cell or spinocellular carcinoma of the skin.
other malignancy within the last 3 years, except for carcinoma in situ of the cervix or basal cell or spinocellular carcinoma of the skin.
['other malignancy within the last 3 years,', 'except for carcinoma in situ of the cervix', 'basal cell', 'spinocellular carcinoma of the skin']
{'other malignancy within the last 3 years,': {'363346000': 'Malignant neoplastic disease ', '258707000': 'year ', '372087000': 'Primary malignant neoplasm ', '86049000': 'Malignant neoplasm, primary '}, 'except for carcinoma in situ of the cervix': {'5185003': 'except for', '285432005': 'Carcinoma of cervix ', '264031007': 'In situ '}, 'basal cell': {'57195005': 'Basal ', '4421005': 'Cell structure '}, 'spinocellular carcinoma of the skin': {'372130007': 'Malignant neoplasm of skin '}}
{'other malignancy within the last 3 years,': {'363346000': ('clinical finding', 'Malignant neoplastic disease ', ['64572001']), '258707000': ('unit', 'year ', ['767524001']), '372087000': ('clinical finding', 'Primary malignant neoplasm ', ['64572001', '363346000'])}, 'except for carcinoma in situ of the cervix': {'285432005': ('clinical finding', 'Carcinoma of cervix ', ['64572001', '372087000', '363346000', '118234003'])}, 'basal cell': {'57195005': ('qualifier value', 'Basal ', ['272099008'])}, 'spinocellular carcinoma of the skin': {'372130007': ('clinical finding', 'Malignant neoplasm of skin ', ['64572001', '363346000', '118234003'])}}

2122540
any individual with features of autism who has had genetic testing and a known genetic diagnosis may be eligible to participate; contact the study team for more information.
any individual with features of autism who has had genetic testing and a known genetic diagnosis may be eligible to participate; contact the study team for more information.
['any individual with features of autism', 'genetic testing', 'a known genetic diagnosis', 'to']
{'any individual with features of autism': {'125676002': 'Person ', '408856003': 'Autistic disorder ', '408857007': 'Infantile autism ', '43614003': 'Autistic disorder of childhood onset ', '385435006': 'Individual '}, 'genetic testing': {'405824009': 'Genetic test '}, 'a known genetic diagnosis': {'36692007': 'Known ', '394613000': 'Gene therapy ', '439401001': 'Diagnosis '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}}
{'any individual with features of autism': {'408856003': ('clinical finding', 'Autistic disorder ', ['64572001']), '408857007': ('clinical finding', 'Infantile autism ', ['64572001', '408856003']), '43614003': ('clinical finding', 'Autistic disorder of childhood onset ', ['64572001', '408856003'])}, 'genetic testing': {'405824009': ('procedure', 'Genetic test ', ['128927009'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}}

2124769
18 years or older
18 years or older
['18 years', 'older']
{'18 years': {'258707000': 'year '}, 'older': {'70753007': 'Old '}}
{'18 years': {'258707000': ('unit', 'year ', ['767524001'])}, 'older': {'70753007': ('qualifier value', 'Old ', ['272099008'])}}

2128081
signature of the written consent
signature of the written consent
['signature of the written consent']
{'signature of the written consent': {'12261009': 'Writing '}}
{'signature of the written consent': {'12261009': ('observable entity', 'Writing ', ['246464006'])}}

2144028
patients with newly diagnosed multiple myeloma, secretory, or oligosecretor or not secretor if it has soft tissue plasmacytomas.
patients with newly diagnosed multiple myeloma, secretory, or oligosecretor or not secretor if it has soft tissue plasmacytomas.
['patients with', 'diagnosed', 'multiple myeloma,', 'soft tissue plasmacytomas']
{'patients with': {'116154003': 'Patient '}, 'diagnosed': {'439401001': 'Diagnosis '}, 'multiple myeloma,': {'109989006': 'Multiple myeloma ', '55921005': 'Multiple myeloma, no International Classification of Diseases for Oncology subtype '}, 'soft tissue plasmacytomas': {'181607009': 'Soft tissue ', '87784001': 'Soft tissues ', '10639003': 'Solitary plasmacytoma of bone ', '415112005': 'Plasmacytoma '}}
{'multiple myeloma,': {'109989006': ('clinical finding', 'Multiple myeloma ', ['64572001'])}, 'soft tissue plasmacytomas': {'415112005': ('clinical finding', 'Plasmacytoma ', ['64572001'])}}

2150276
apgar score < 5 at 10 minutes, or
apgar score < 5 at 10 minutes, or
['apgar score', '< 5 at 10 minutes,']
{'apgar score': {'302083008': 'Finding of Apgar score '}, '< 5 at 10 minutes,': {'732442009': '10.5', '258701004': 'min ', '255507004': 'Small ', '286549009': 'per minute ', '356624006': 'Minute ', '264606005': '-5 ', '259027000': 'per 10 minutes ', '264706000': '>5 ', '264605009': 'Integer +5 '}}
{'apgar score': {'302083008': ('clinical finding', 'Finding of Apgar score ', ['250171008'])}, '< 5 at 10 minutes,': {'258701004': ('unit', 'min ', ['767524001']), '255507004': ('qualifier value', 'Small ', ['272099008']), '286549009': ('unit', 'per minute ', ['767524001']), '356624006': ('qualifier value', 'Minute ', ['272099008']), '259027000': ('unit', 'per 10 minutes ', ['767524001'])}}

2150718
patient who do not declined to have his medical records reviewed for research
patient who do not declined to have his medical records reviewed for research
['patient', 'to', 'his medical records']
{'patient': {'116154003': 'Patient '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'his medical records': {'129465004': 'Medical record, device '}}
{'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}}

2152081
no period of good functioning in previous 2 years; or,
period of good functioning in , 2 years; or,
['period of good functioning', '2 years']
{'period of good functioning': {'259037005': 'per period ', '20572008': 'Good ', '40143009': 'Functional ', '246464006': 'Function ', '277064003': 'function', '272117007': 'Time periods '}, '2 years': {'260306008': 'Integer +2 ', '258707000': 'year '}}
{'period of good functioning': {'259037005': ('unit', 'per period ', ['767524001']), '20572008': ('qualifier value', 'Good ', ['272099008']), '40143009': ('qualifier value', 'Functional ', ['272099008']), '272117007': ('qualifier value', 'Time periods ', ['272099008'])}, '2 years': {'258707000': ('unit', 'year ', ['767524001'])}}

2159122
are postmenopausal for >= 1 year before the screening visit, or
are postmenopausal for >= 1 year before the screening visit, or
['postmenopausal for', '= 1 year before the screening visit,']
{'postmenopausal for': {'76498008': 'Postmenopausal state '}, '= 1 year before the screening visit,': {'451231000124103': 'greater than one', '258707000': 'year ', '20135006': 'Screening procedure ', '259039008': 'per year '}}
{'postmenopausal for': {'76498008': ('clinical finding', 'Postmenopausal state ', ['118234003'])}, '= 1 year before the screening visit,': {'258707000': ('unit', 'year ', ['767524001']), '20135006': ('procedure', 'Screening procedure ', ['128927009']), '259039008': ('unit', 'per year ', ['767524001'])}}

2176221
uncontrolled glucose levels
uncontrolled glucose levels
['uncontrolled glucose levels']
{'uncontrolled glucose levels': {'19032002': 'Uncontrolled ', '365811003': 'Finding of glucose level '}}
{'uncontrolled glucose levels': {'19032002': ('qualifier value', 'Uncontrolled ', ['272099008']), '365811003': ('clinical finding', 'Finding of glucose level ', ['441742003'])}}

2185683
overtly healthy males or females
overtly healthy males or females
['overtly healthy males', 'females']
{'overtly healthy males': {'263775005': 'Health ', '10052007': 'Male structure ', '248153007': 'Male '}, 'females': {'1086007': 'Female structure ', '248152002': 'Female '}}
{'overtly healthy males': {'248153007': ('clinical finding', 'Male ', ['365860008'])}, 'females': {'248152002': ('clinical finding', 'Female ', ['365860008'])}}

2192186
not pregnant
not pregnant
['not pregnant']
{'not pregnant': {'60001007': 'Not pregnant '}}
{'not pregnant': {'60001007': ('clinical finding', 'Not pregnant ', ['250171008'])}}

2193027
willing and able to wear a fitbit wrist-based activity tracker device and an actigraph device.
willing and wear a fitbit wrist-based activity tracker device and an actigraph device.
['willing', 'a fitbit wrist', 'based', 'activity tracker device', 'an actigraph device']
{'willing': {'225466006': 'Willing '}, 'a fitbit wrist': {'8205005': 'Wrist region structure ', '699026005': 'Joint structure of wrist region ', '74670003': 'Wrist joint structure '}, 'based': {'63813000': 'Alkali '}, 'activity tracker device': {'55561003': 'Active ', '303607000': 'Biomedical equipment ', '63653004': 'Biomedical device ', '49062001': 'Device ', '258745004': '% activity ', '257733005': 'Activity '}, 'an actigraph device': {'303607000': 'Biomedical equipment ', '63653004': 'Biomedical device ', '49062001': 'Device '}}
{'willing': {'225466006': ('clinical finding', 'Willing ', ['250171008'])}, 'based': {'63813000': ('product', 'Alkali ', ['312413002'])}, 'activity tracker device': {'55561003': ('qualifier value', 'Active ', ['272099008']), '258745004': ('unit', '% activity ', ['767524001'])}}

2199345
a man with no congenital disease or chronic disease in 3 years, no history of symptoms in internal treatment, or no knowledge in the area
a man with congenital disease or chronic disease in 3 years, symptoms in internal treatment, or knowledge in the area
['a man with congenital disease', 'chronic disease in 3 years,', 'symptoms in internal treatment,', 'knowledge in the area']
{'a man with congenital disease': {'339947000': 'Man ', '66091009': 'Congenital disease ', '278412004': 'Human - origin ', '337915000': 'Homo sapiens ', '10052007': 'Male structure ', '248153007': 'Male '}, 'chronic disease in 3 years,': {'27624003': 'Chronic disease ', '258707000': 'year '}, 'symptoms in internal treatment,': {'260521003': 'Internal ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '416118004': 'Administration '}, 'knowledge in the area': {'42798000': 'Area '}}
{'a man with congenital disease': {'339947000': ('person', 'Man ', ['133936004']), '66091009': ('clinical finding', 'Congenital disease ', ['64572001']), '278412004': ('qualifier value', 'Human - origin ', ['272099008']), '248153007': ('clinical finding', 'Male ', ['365860008'])}, 'chronic disease in 3 years,': {'27624003': ('clinical finding', 'Chronic disease ', ['64572001']), '258707000': ('unit', 'year ', ['767524001'])}, 'symptoms in internal treatment,': {'276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '416118004': ('procedure', 'Administration ', ['128927009'])}, 'knowledge in the area': {'42798000': ('qualifier value', 'Area ', ['272099008'])}}

2207927
expected lifetime>1 year
expected lifetime>1 year
['expected lifetime', '>1 year']
{'expected lifetime': {'385635001': 'Expectations ', '410517006': 'Expectation context '}, '>1 year': {'451231000124103': 'greater than one', '258707000': 'year ', '259039008': 'per year '}}
{'>1 year': {'258707000': ('unit', 'year ', ['767524001']), '259039008': ('unit', 'per year ', ['767524001'])}}

2212242
history of percutaneous coronary intervention or coronary artery bypass graft
, percutaneous coronary intervention or coronary artery bypass graft
['percutaneous coronary intervention', 'coronary artery bypass graft']
{'percutaneous coronary intervention': {'415070008': 'Percutaneous coronary intervention '}, 'coronary artery bypass graft': {'232717009': 'Coronary artery bypass grafting ', '67166004': 'Aortocoronary artery bypass graft ', '90205004': 'Cardiac revascularization with bypass anastomosis '}}
{'percutaneous coronary intervention': {'415070008': ('procedure', 'Percutaneous coronary intervention ', ['362958002'])}, 'coronary artery bypass graft': {'232717009': ('procedure', 'Coronary artery bypass grafting ', ['362958002', '128927009']), '67166004': ('procedure', 'Aortocoronary artery bypass graft ', ['362958002', '128927009']), '90205004': ('procedure', 'Cardiac revascularization with bypass anastomosis ', ['362958002', '128927009'])}}

2243818
apache ii score ≥ 10 and
apache ii score ≥ 10 and
['apache ii score  10']
{'apache ii score  10': {'273258004': 'Acute physiology and chronic health evaluation II ', '246262008': 'score', '278061009': 'Scores '}}
{'apache ii score  10': {'278061009': ('qualifier value', 'Scores ', ['272396007'])}}

2252606
life expectancy >= 12 weeks
life expectancy >= 12 weeks
['life expectancy', '= 12 weeks']
{'life expectancy': {'224130005': 'Household composition ', '385635001': 'Expectations ', '410517006': 'Expectation context '}, '= 12 weeks': {'258705008': 'week '}}
{'life expectancy': {'224130005': ('observable entity', 'Household composition ', ['160476009'])}, '= 12 weeks': {'258705008': ('unit', 'week ', ['767524001'])}}

2262006
singleton pregnancy.
singleton pregnancy.
['singleton pregnancy']
{'singleton pregnancy': {'289908002': 'Pregnancy, function ', '77386006': 'Patient currently pregnant '}}
{'singleton pregnancy': {'289908002': ('observable entity', 'Pregnancy, function ', ['246464006']), '77386006': ('clinical finding', 'Patient currently pregnant ', ['250171008'])}}

2266669
all patients were ventilated and sedated during an 8-hour period of measurement
all patients were ventilated and sedated during an 8-hour period of measurement
['all patients', 'sedated during an 8 hour period of measurement']
{'all patients': {'116154003': 'Patient '}, 'sedated during an 8 hour period of measurement': {'17971005': 'Sedated ', '258702006': 'hour ', '252132001': 'Measurement period ', '286551008': 'per hour '}}
{'sedated during an 8 hour period of measurement': {'17971005': ('clinical finding', 'Sedated ', ['250171008']), '258702006': ('unit', 'hour ', ['767524001']), '252132001': ('observable entity', 'Measurement period ', ['363788007']), '286551008': ('unit', 'per hour ', ['767524001'])}}

2266828
age >= 18 years
,
[]
{}
{}

2266961
copd patients with ahrf requiring niv
copd patients with ahrf requiring niv
['copd patients with ahrf requiring niv']
{'copd patients with ahrf requiring niv': {'13645005': 'Chronic obstructive lung disease ', '116154003': 'Patient ', '115511007': 'Nipah virus '}}
{'copd patients with ahrf requiring niv': {'13645005': ('clinical finding', 'Chronic obstructive lung disease ', ['64572001', '118234003']), '115511007': ('clinical finding', 'Nipah virus ', ['49872002'])}}

2286265
healthy man and/or woman subjects of non childbearing potential.
healthy man and/or woman subjects of non childbearing potential.
['healthy man', 'woman']
{'healthy man': {'263775005': 'Health ', '339947000': 'Man ', '278412004': 'Human - origin ', '337915000': 'Homo sapiens ', '10052007': 'Male structure ', '248153007': 'Male '}, 'woman': {'224526002': 'Woman '}}
{'healthy man': {'339947000': ('person', 'Man ', ['133936004']), '278412004': ('qualifier value', 'Human - origin ', ['272099008']), '248153007': ('clinical finding', 'Male ', ['365860008'])}, 'woman': {'224526002': ('person', 'Woman ', ['133936004'])}}

2287684
patients aged between 7 and 15 years
patients ,
['patients']
{'patients': {'116154003': 'Patient '}}
{}

2301851
no previous diagnosis of familial polyposis syndromes
previous diagnosis of familial polyposis syndromes
['previous diagnosis of familial polyposis syndromes']
{'previous diagnosis of familial polyposis syndromes': {'48318009': 'Prior diagnosis ', '423471004': 'MYH-associated polyposis ', '70921007': 'Adenomatous polyposis coli ', '72900001': 'Familial multiple polyposis syndrome '}}
{'previous diagnosis of familial polyposis syndromes': {'423471004': ('clinical finding', 'MYH-associated polyposis ', ['64572001', '118234003']), '72900001': ('clinical finding', 'Familial multiple polyposis syndrome ', ['64572001', '118234003'])}}

2307623
japanese
japanese
['japanese']
{'japanese': {'297460009': 'Japanese language ', '414551003': 'Japanese '}}
{}

2319573
relapsed after prior autologous sct
relapsed after prior autologous sct
['relapsed after prior autologous sct']
{'relapsed after prior autologous sct': {'255318003': 'Relapsing course ', '236874000': 'Status pre- ', '288556008': 'before', '255379001': 'Autologous ', '116152004': 'Spiral computed tomography scan ', '702351004': 'Spondylocarpotarsal synostosis syndrome '}}
{'relapsed after prior autologous sct': {'255318003': ('qualifier value', 'Relapsing course ', ['272099008']), '255379001': ('qualifier value', 'Autologous ', ['272099008']), '116152004': ('procedure', 'Spiral computed tomography scan ', ['128927009']), '702351004': ('clinical finding', 'Spondylocarpotarsal synostosis syndrome ', ['64572001'])}}

2323394
infants born prematurely, as defined by birth at < 37 weeks gestational age, referred for a videofluoroscopic swallow study due to suspected pharyngeal phase dysphagia.
infants born prematurely, as defined by birth at < 37 weeks gestational age, referred for a videofluoroscopic swallow study due to suspected pharyngeal phase dysphagia.
['infants', 'born', 'defined by birth', '< 37 weeks gestational age,', 'referred for a videofluoroscopic swallow study', 'due to suspected pharyngeal phase dysphagia']
{'infants': {'133931009': 'Infant '}, 'born': {'3950001': 'Birth '}, 'defined by birth': {'900000000000073002': 'sufficiently defined concept definition status ', '3950001': 'Birth '}, '< 37 weeks gestational age,': {'258705008': 'week ', '57036006': 'Fetal gestational age '}, 'referred for a videofluoroscopic swallow study': {'439980006': 'Referral placed ', '241149003': 'Videofluoroscopy swallow ', '224699009': 'Study '}, 'due to suspected pharyngeal phase dysphagia': {'71457002': 'Oropharyngeal dysphagia ', '21191007': 'phase', '21101000119105': 'Pharyngeal dysphagia ', '415684004': 'Suspected '}}
{'born': {'3950001': ('clinical finding', 'Birth ', ['250171008'])}, 'defined by birth': {'3950001': ('clinical finding', 'Birth ', ['250171008'])}, '< 37 weeks gestational age,': {'258705008': ('unit', 'week ', ['767524001']), '57036006': ('observable entity', 'Fetal gestational age ', ['363788007'])}, 'referred for a videofluoroscopic swallow study': {'439980006': ('situation with explicit context', 'Referral placed ', ['129125009']), '241149003': ('procedure', 'Videofluoroscopy swallow ', ['362958002', '128927009'])}, 'due to suspected pharyngeal phase dysphagia': {'71457002': ('clinical finding', 'Oropharyngeal dysphagia ', ['64572001', '250171008', '118234003']), '21101000119105': ('clinical finding', 'Pharyngeal dysphagia ', ['64572001', '250171008', '118234003', '71457002'])}}

2332002
patients must give written consent.
patients must give written consent.
['patients', 'give', 'written consent']
{'patients': {'116154003': 'Patient '}, 'give': {'419582001': 'Give - dosing instruction imperative '}, 'written consent': {'12261009': 'Writing '}}
{'written consent': {'12261009': ('observable entity', 'Writing ', ['246464006'])}}

2335735-1
patients who identified their predominant symptom as heartburn and were classifiend as grande m or n according to hoshihara's modofied version of los angeles classification at esophagogastroduodenoscopy.
patients who identified their predominant symptom as heartburn and were classifiend as grande m or n according to hoshihara's modofied version of los angeles classification at esophagogastroduodenoscopy.
['patients', 'identified', 'their predominant symptom as heartburn', 'classifiend as grande m', "n according to hoshihara's modofied version of los angeles classification", 'at esophagogastroduodenoscopy']
{'patients': {'116154003': 'Patient '}, 'identified': {'7882003': 'Identified '}, 'their predominant symptom as heartburn': {'16331000': 'Heartburn '}, 'classifiend as grande m': {'258311008': 'M+ ', '277318003': 'm) '}, "n according to hoshihara's modofied version of los angeles classification": {'258310009': 'N+ ', '22303008': 'Version ', '115670007': 'Classification system ', '278201002': 'classification', '73504009': 'Classified '}, 'at esophagogastroduodenoscopy': {'387596007': 'Fiberoptic esophagogastroduodenoscopy ', '76009000': 'Esophagogastroduodenoscopy '}}
{'identified': {'7882003': ('qualifier value', 'Identified ', ['272099008'])}, 'their predominant symptom as heartburn': {'16331000': ('clinical finding', 'Heartburn ', ['102957003', '118234003'])}, 'classifiend as grande m': {'258311008': ('staging and scales', 'M+ ', ['254292007']), '277318003': ('staging and scales', 'm) ', ['254292007'])}, "n according to hoshihara's modofied version of los angeles classification": {'258310009': ('staging and scales', 'N+ ', ['254292007']), '73504009': ('qualifier value', 'Classified ', ['272099008'])}, 'at esophagogastroduodenoscopy': {'387596007': ('procedure', 'Fiberoptic esophagogastroduodenoscopy ', ['76009000', '362958002', '363691001', '128927009']), '76009000': ('procedure', 'Esophagogastroduodenoscopy ', ['363691001', '362958002', '128927009'])}}

2335735-2
written informed consent, ability to comply with study instructions
written informed consent, comply with study instructions
['written informed consent,', 'comply with study instructions']
{'written informed consent,': {'12261009': 'Writing ', '108968006': 'Oprelvekin ', '410938009': 'Oprelvekin ', '223458004': 'Informing '}, 'comply with study instructions': {'224699009': 'Study ', '409073007': 'Education '}}
{'written informed consent,': {'12261009': ('observable entity', 'Writing ', ['246464006']), '108968006': ('product', 'Oprelvekin ', ['406455002', '312413002', '115668003']), '410938009': ('product', 'Oprelvekin ', ['763158003'])}, 'comply with study instructions': {'409073007': ('procedure', 'Education ', ['128927009'])}}

2344025
before patient registration, written informed consent must be given according to ich/gcp, and national regulations.
before patient registration, written informed consent must be given according to ich/gcp, and national regulations.
['before patient registration,', 'written informed consent', 'given according to ich/gcp,']
{'before patient registration,': {'184047000': 'Patient registration '}, 'written informed consent': {'12261009': 'Writing ', '108968006': 'Oprelvekin ', '410938009': 'Oprelvekin ', '223458004': 'Informing '}, 'given according to ich/gcp,': {'419582001': 'Give - dosing instruction imperative '}}
{'written informed consent': {'12261009': ('observable entity', 'Writing ', ['246464006']), '108968006': ('product', 'Oprelvekin ', ['406455002', '312413002', '115668003']), '410938009': ('product', 'Oprelvekin ', ['763158003'])}}

2374575
phakic study eye
phakic study eye
['phakic study eye']
{'phakic study eye': {'224699009': 'Study ', '371398005': 'Eye region structure ', '81745001': 'Structure of eye proper '}}
{}

2381864
french participants: in france, a subject will be eligible for inclusion in this study only if either affiliated to or a beneficiary of a social security category.
french participants: in france, a subject will be eligible for inclusion in this study only if either affiliated to or a beneficiary of a social security category.
['french participants', 'in france,', 'eligible for inclusion', 'in this study only']
{'french participants': {'297499001': 'French language ', '19434008': 'French '}, 'in france,': {'223666001': 'France '}, 'eligible for inclusion': {'55919000': 'Including '}, 'in this study only': {'224699009': 'Study ', '50607009': 'Singular ', '420295001': 'Only - dosing instruction fragment '}}
{'eligible for inclusion': {'55919000': ('qualifier value', 'Including ', ['272099008'])}, 'in this study only': {'50607009': ('qualifier value', 'Singular ', ['272099008'])}}

2401121
rheumatoid arthritis diagnostic according to the american college rheumatology 1987 criteria [38]
rheumatoid arthritis diagnostic according to the american college rheumatology 1987 criteria [38]
['rheumatoid arthritis', 'diagnostic according to the american college rheumatology 1987 criteria']
{'rheumatoid arthritis': {'69896004': 'Rheumatoid arthritis '}, 'diagnostic according to the american college rheumatology 1987 criteria': {'439401001': 'Diagnosis ', '224864007': 'College ', '394810000': 'Rheumatology ', '277272007': '1987 ', '261004008': 'Diagnostic intent ', '53115007': 'Diagnostic dental procedure '}}
{'rheumatoid arthritis': {'69896004': ('clinical finding', 'Rheumatoid arthritis ', ['64572001', '118234003'])}, 'diagnostic according to the american college rheumatology 1987 criteria': {'277272007': ('qualifier value', '1987 ', ['272099008']), '261004008': ('qualifier value', 'Diagnostic intent ', ['272099008']), '53115007': ('procedure', 'Diagnostic dental procedure ', ['362958002', '128927009'])}}

2404155
fluent in reading and speaking english and have a reliable study partner .
fluent in reading and speaking english and have a reliable study partner .
['fluent in reading', 'speaking english', 'a reliable study partner']
{'fluent in reading': {'50360004': 'Reading '}, 'speaking english': {'285835004': 'Use of language ', '87335007': 'Speaking ', '297487008': 'English language ', '25804004': 'English ', '900000000000507009': 'english [international organization for standardization 639-1 code en] language reference set'}, 'a reliable study partner': {'224699009': 'Study ', '262043009': 'Partner in relationship '}}
{'fluent in reading': {'50360004': ('observable entity', 'Reading ', ['285835004', '246464006'])}, 'speaking english': {'285835004': ('observable entity', 'Use of language ', ['246464006']), '87335007': ('observable entity', 'Speaking ', ['285835004', '246464006'])}}

2404766
a stable sleep/wake pattern with a normal phase relationship to the environment and no history of sleep disorders
a stable sleep/wake pattern with a normal phase relationship to the environment and sleep disorders
['a stable sleep/wake pattern with a normal phase relationship', 'to the environment', 'sleep disorders']
{'a stable sleep/wake pattern with a normal phase relationship': {'58158008': 'Stable ', '255377004': 'Waking ', '247950007': 'Sleep behavior finding ', '401175000': 'Sleep pattern finding ', '404950004': 'Sleep behavior ', '17621005': 'Normal ', '261618000': 'Stage A ', '263498003': 'relationships', '272151006': 'Relationships ', '8117002': 'Gait normal ', '258744000': '% normal ', '307156004': 'On waking '}, 'to the environment': {'276339004': 'Environment '}, 'sleep disorders': {'53888004': 'Disturbance in sleep behavior ', '39898005': 'Sleep disorder '}}
{'a stable sleep/wake pattern with a normal phase relationship': {'58158008': ('qualifier value', 'Stable ', ['272099008']), '247950007': ('clinical finding', 'Sleep behavior finding ', ['250171008']), '401175000': ('clinical finding', 'Sleep pattern finding ', ['250171008']), '404950004': ('observable entity', 'Sleep behavior ', ['363788007']), '17621005': ('qualifier value', 'Normal ', ['272099008']), '261618000': ('qualifier value', 'Stage A ', ['272396007']), '272151006': ('qualifier value', 'Relationships ', ['272099008']), '8117002': ('clinical finding', 'Gait normal ', ['250171008']), '258744000': ('unit', '% normal ', ['767524001']), '307156004': ('qualifier value', 'On waking ', ['272099008'])}, 'sleep disorders': {'53888004': ('clinical finding', 'Disturbance in sleep behavior ', ['250171008']), '39898005': ('clinical finding', 'Sleep disorder ', ['64572001', '250171008'])}}

2414344
age: < 80 years
,
[]
{}
{}

2427523
human leukocyte antigen b27 positivity
human leukocyte antigen b27 positivity
['human leukocyte antigen b27 positivity']
{'human leukocyte antigen b27 positivity': {'34453005': 'Human leukocyte antigen B27 ', '258758003': '% positive cells ', '10828004': 'Positive '}}
{'human leukocyte antigen b27 positivity': {'34453005': ('product', 'Human leukocyte antigen B27 ', ['115668003', '312412007']), '258758003': ('unit', '% positive cells ', ['767524001']), '10828004': ('qualifier value', 'Positive ', ['272099008'])}}

2429058
able to take and retain oral medications
able to take and retain oral medications
['able', 'to', 'take', 'retain', 'oral medications']
{'able': {'371150009': 'Able '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'take': {'419652001': 'Take - dosing instruction imperative '}, 'retain': {'397909002': 'Retained '}, 'oral medications': {'40461009': 'Oral drug preparation '}}
{'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'retain': {'397909002': ('qualifier value', 'Retained ', ['272099008'])}}

2442010-1
he[systolic ] and diastolic ]lthy as determined by a responsible physician and experienced physician, based on a medical evaluation including medical history, physical examination, laboratory tests and cardiac monitoring.
he[systolic ] and diastolic ]lthy , based on a medical evaluation including medical history, physical examination, laboratory tests and cardiac monitoring.
['[systolic', 'diastolic', 'based on a medical evaluation', 'including', 'medical history,', 'physical examination,', 'laboratory tests', 'cardiac monitoring']
{'[systolic': {'111973004': 'Systole, function '}, 'diastolic': {'90892000': 'Diastole, function '}, 'based on a medical evaluation': {'63813000': 'Alkali ', '225886003': 'Medical assessment '}, 'including': {'55919000': 'Including '}, 'medical history,': {'392521001': 'History of '}, 'physical examination,': {'302199004': 'Examination - action ', '5880005': 'Physical examination procedure ', '81375008': 'Physical assessment '}, 'laboratory tests': {'108252007': 'Laboratory procedure ', '15220000': 'Laboratory test ', '269814003': 'Laboratory procedures -general '}, 'cardiac monitoring': {'23852006': 'Cardiac monitoring '}}
{'[systolic': {'111973004': ('observable entity', 'Systole, function ', ['246464006'])}, 'diastolic': {'90892000': ('observable entity', 'Diastole, function ', ['246464006'])}, 'based on a medical evaluation': {'63813000': ('product', 'Alkali ', ['312413002']), '225886003': ('procedure', 'Medical assessment ', ['128927009'])}, 'including': {'55919000': ('qualifier value', 'Including ', ['272099008'])}, 'physical examination,': {'5880005': ('procedure', 'Physical examination procedure ', ['362958002', '128927009']), '81375008': ('procedure', 'Physical assessment ', ['128927009'])}, 'laboratory tests': {'15220000': ('procedure', 'Laboratory test ', ['128927009', '108252007']), '269814003': ('situation with explicit context', 'Laboratory procedures -general ', ['129125009'])}, 'cardiac monitoring': {'23852006': ('procedure', 'Cardiac monitoring ', ['362958002', '243120004', '128927009'])}}

2442010-2
a subject with a clinical abnormality or laboratory parameters outside the reference range for the population being studied may be included only if the investigator and the gsk medical monitor agree that the finding is unlikely to introduce additional risk factors and will not interfere with the study procedures.
a subject with a clinical abnormality or laboratory parameters outside the reference range for the population being studied may be included only if the investigator and the gsk medical monitor agree and will not interfere with the study procedures.
['a subject with a clinical abnormality', 'laboratory parameters', 'outside', 'the reference range for the population', 'studied', 'included', 'only', 'the gsk medical monitor', 'interfere with the study procedures']
{'a subject with a clinical abnormality': {'428024001': 'Clinical trial participant ', '263654008': 'Abnormal '}, 'laboratory parameters': {'261904005': 'Laboratory ', '252116004': 'Observation parameter '}, 'outside': {'261074009': 'External '}, 'the reference range for the population': {'260395002': 'Normal range ', '385436007': 'Population ', '389109008': 'Group '}, 'studied': {'224699009': 'Study '}, 'included': {'55919000': 'Including '}, 'only': {'50607009': 'Singular ', '420295001': 'Only - dosing instruction fragment '}, 'the gsk medical monitor': {'373655009': 'Medical service ', '182777000': 'Monitoring of patient ', '302805002': 'Preventive monitoring ', '13288007': 'Monitor, device ', '74188005': 'Medical '}, 'interfere with the study procedures': {'78235001': 'Interferes with ', '224699009': 'Study ', '71388002': 'Procedure '}}
{'laboratory parameters': {'252116004': ('observable entity', 'Observation parameter ', ['363788007'])}, 'included': {'55919000': ('qualifier value', 'Including ', ['272099008'])}, 'only': {'50607009': ('qualifier value', 'Singular ', ['272099008'])}, 'the gsk medical monitor': {'182777000': ('procedure', 'Monitoring of patient ', ['71388002', '243120004', '128927009']), '302805002': ('procedure', 'Preventive monitoring ', ['182777000', '71388002', '243120004', '128927009']), '74188005': ('qualifier value', 'Medical ', ['272099008'])}}

2442010-3
subjects with blood pressure values outside the normal range [systolic and diastolic ] and subjects with ecg findings suggestive of a previous mi should always be excluded from enrollment.
subjects with blood pressure values outside the normal range [systolic and diastolic ] and subjects with ecg findings suggestive of a , mi should always be excluded from enrollment.
['subjects with blood pressure values', 'outside', 'the normal range', '[systolic', 'diastolic', 'subjects with ecg findings', 'suggestive of a', 'excluded from enrollment']
{'subjects with blood pressure values': {'75367002': 'Blood pressure ', '392570002': 'Blood pressure finding ', '364090009': 'Systemic arterial pressure ', '386534000': 'Arterial blood pressure ', '386536003': 'Systemic blood pressure '}, 'outside': {'261074009': 'External '}, 'the normal range': {'260395002': 'Normal range '}, '[systolic': {'111973004': 'Systole, function '}, 'diastolic': {'90892000': 'Diastole, function '}, 'subjects with ecg findings': {'271921002': 'Electrocardiogram finding '}, 'suggestive of a': {'7196007': 'suggestive of'}, 'excluded from enrollment': {'77765009': 'Exclude '}}
{'subjects with blood pressure values': {'75367002': ('observable entity', 'Blood pressure ', ['363788007']), '392570002': ('clinical finding', 'Blood pressure finding ', ['250171008', '118234003']), '364090009': ('observable entity', 'Systemic arterial pressure ', ['75367002', '363788007', '386536003', '386534000']), '386534000': ('observable entity', 'Arterial blood pressure ', ['75367002', '363788007']), '386536003': ('observable entity', 'Systemic blood pressure ', ['75367002', '363788007'])}, '[systolic': {'111973004': ('observable entity', 'Systole, function ', ['246464006'])}, 'diastolic': {'90892000': ('observable entity', 'Diastole, function ', ['246464006'])}, 'excluded from enrollment': {'77765009': ('qualifier value', 'Exclude ', ['272099008'])}}

2444857
willingness to track medications, relaxation techniques and number of case manager visit
willingness to track medications, relaxation techniques and number of case manager visit
['willingness', 'to', 'track', 'medications,', 'relaxation techniques', 'number of case manager']
{'willingness': {'225466006': 'Willing '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'track': {'257719005': 'Track '}, 'medications,': {'105903003': 'General drug type ', '373873005': 'Pharmaceutical / biologic product ', '410942007': 'Drug or medicament '}, 'relaxation techniques': {'284467003': 'Relaxation technique '}, 'number of case manager': {'260299005': 'Number ', '410680006': 'numbers', '184154008': 'Care manager ', '410681005': 'Count of entities '}}
{'willingness': {'225466006': ('clinical finding', 'Willing ', ['250171008'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}}

2450258
alt over n and hcv rna+ at screening
alt over n and hcv rna+ at screening
['alt over n', 'hcv rna  at screening']
{'alt over n': {'116063003': 'Atypical lipoma ', '28655007': 'Liposarcoma, well differentiated '}, 'hcv rna  at screening': {'62944002': 'Hepatitis C virus ', '27888000': 'Ribonucleic acid ', '20135006': 'Screening procedure '}}
{'hcv rna  at screening': {'62944002': ('clinical finding', 'Hepatitis C virus ', ['49872002']), '27888000': ('product', 'Ribonucleic acid ', ['312413002']), '20135006': ('procedure', 'Screening procedure ', ['128927009'])}}

2450771
reported >= a 1-year history of regularly experiencing pmdd.
reported >= a 1-year , regularly experiencing pmdd.
['reported', '= a 1 year', 'pmdd']
{'reported': {'229059009': 'Report ', '223458004': 'Informing ', '733985002': 'reported'}, '= a 1 year': {'259039008': 'per year ', '258707000': 'year '}, 'pmdd': {'596004': 'Premenstrual dysphoric disorder '}}
{'= a 1 year': {'259039008': ('unit', 'per year ', ['767524001']), '258707000': ('unit', 'year ', ['767524001'])}, 'pmdd': {'596004': ('clinical finding', 'Premenstrual dysphoric disorder ', ['64572001'])}}

2452952
males or females between 18 and 45 years, inclusive.
males or females between 18 and 45 years, inclusive.
['males', 'females between 18', '45 years,', 'inclusive']
{'males': {'10052007': 'Male structure ', '248153007': 'Male '}, 'females between 18': {'1086007': 'Female structure ', '248152002': 'Female '}, '45 years,': {'258707000': 'year '}, 'inclusive': {'55919000': 'Including '}}
{'males': {'248153007': ('clinical finding', 'Male ', ['365860008'])}, 'females between 18': {'248152002': ('clinical finding', 'Female ', ['365860008'])}, '45 years,': {'258707000': ('unit', 'year ', ['767524001'])}, 'inclusive': {'55919000': ('qualifier value', 'Including ', ['272099008'])}}

2458412
patient has fibroids confirmed by mri
patient has fibroids confirmed by mri
['patient', 'fibroids', 'confirmed by mri']
{'patient': {'116154003': 'Patient '}, 'fibroids': {'702978006': 'Leiomyofibroma ', '146801000119103': 'Leiomyoma ', '44598004': 'Leiomyoma, no International Classification of Diseases for Oncology subtype ', '95315005': 'Uterine leiomyoma '}, 'confirmed by mri': {'59156000': 'Confirmed by ', '113091000': 'Magnetic resonance imaging ', '312250003': 'Magnetic resonance imaging - action '}}
{'fibroids': {'146801000119103': ('clinical finding', 'Leiomyoma ', ['64572001']), '95315005': ('clinical finding', 'Uterine leiomyoma ', ['64572001', '118234003', '146801000119103'])}, 'confirmed by mri': {'113091000': ('procedure', 'Magnetic resonance imaging ', ['128927009'])}}

2462504
cataract
cataract
['cataract']
{'cataract': {'128306009': 'Cataract ', '193570009': 'Cataract ', '247053007': 'Cataract form '}}
{'cataract': {'193570009': ('clinical finding', 'Cataract ', ['64572001', '118234003']), '247053007': ('observable entity', 'Cataract form ', ['363788007', '414237002'])}}

2463540
partial seizures with or without secondary generalization
partial seizures with or without secondary generalization
['partial seizures with', 'or without secondary generalization']
{'partial seizures with': {'29753000': 'Partial seizure '}, 'or without secondary generalization': {'2603003': 'Secondary ', '81170007': 'Second '}}
{'partial seizures with': {'29753000': ('clinical finding', 'Partial seizure ', ['64572001', '102957003', '118234003'])}, 'or without secondary generalization': {'2603003': ('qualifier value', 'Secondary ', ['272099008']), '81170007': ('qualifier value', 'Second ', ['272099008'])}}

2471411
national institutes of health stroke scale score greater than 4
national institutes of health stroke scale score greater than 4
['national institutes of health stroke scale', 'score', 'greater than 4']
{'national institutes of health stroke scale': {'450741005': 'National Institutes of Health stroke scale '}, 'score': {'246262008': 'score', '278061009': 'Scores '}, 'greater than 4': {'276140008': 'Greater-than symbol > '}}
{'score': {'278061009': ('qualifier value', 'Scores ', ['272396007'])}}

2474451
must have a history of mild to moderate hypertension .
must have , mild to moderate hypertension .
['mild to moderate hypertension']
{'mild to moderate hypertension': {'371923003': 'Mild to moderate ', '38341003': 'Hypertensive disorder, systemic arterial '}}
{'mild to moderate hypertension': {'371923003': ('qualifier value', 'Mild to moderate ', ['272396007']), '38341003': ('clinical finding', 'Hypertensive disorder, systemic arterial ', ['64572001', '118234003'])}}

2499164
age >= 18
,
[]
{}
{}

2519710
presence of >= moderate symptom severity measured according to the panss
presence of >= moderate symptom severity measured according to the panss
['presence of >', '= moderate symptom severity', 'measured according to the panss']
{'presence of >': {'52101004': 'Present '}, '= moderate symptom severity': {'6736007': 'Moderate ', '162465004': 'Symptom severity ', '405162009': 'Symptom severity level '}, 'measured according to the panss': {'263572006': 'measured to '}}
{'= moderate symptom severity': {'6736007': ('qualifier value', 'Moderate ', ['272396007']), '162465004': ('clinical finding', 'Symptom severity ', ['418799008']), '405162009': ('observable entity', 'Symptom severity level ', ['278844005'])}}

2520136
signed informed consent,
signed informed consent,
['signed', 'informed consent,']
{'signed': {'72670004': 'Sign '}, 'informed consent,': {'108968006': 'Oprelvekin ', '410938009': 'Oprelvekin ', '223458004': 'Informing '}}
{'signed': {'72670004': ('clinical finding', 'Sign ', ['250171008'])}, 'informed consent,': {'108968006': ('product', 'Oprelvekin ', ['406455002', '312413002', '115668003']), '410938009': ('product', 'Oprelvekin ', ['763158003'])}}

2523494
body weight:55-90kg, bmi:18.0-27.0
body weight:55-90kg, bmi:18.0-27.0
['body weight', '55 90kg', 'bmi', '18 0 27 0']
{'body weight': {'27113001': 'Body weight ', '39857003': 'Weighing patient '}, '55 90kg': {'264691008': 'Arabic numeral 55 '}, 'bmi': {'301331008': 'Finding of body mass index '}, '18 0 27 0': {'732629004': '27'}}
{'body weight': {'27113001': ('observable entity', 'Body weight ', ['363788007']), '39857003': ('procedure', 'Weighing patient ', ['128927009'])}, 'bmi': {'301331008': ('clinical finding', 'Finding of body mass index ', ['250171008'])}}

2547812
inclusion criteria for obese subjects:
inclusion criteria for obese subjects:
['inclusion criteria for obese subjects']
{'inclusion criteria for obese subjects': {'55919000': 'Including ', '414915002': 'Obese ', '414916001': 'Obesity '}}
{'inclusion criteria for obese subjects': {'55919000': ('qualifier value', 'Including ', ['272099008']), '414915002': ('clinical finding', 'Obese ', ['250171008']), '414916001': ('clinical finding', 'Obesity ', ['64572001', '250171008', '414915002'])}}

2551701
men and women, ages ≥ 18 years of age
men and women, , of age
['men', 'women,', 'of age']
{'men': {'339947000': 'Man '}, 'women,': {'224526002': 'Woman '}, 'of age': {'397669002': 'Age ', '424144002': 'Current chronological age '}}
{'men': {'339947000': ('person', 'Man ', ['133936004'])}, 'women,': {'224526002': ('person', 'Woman ', ['133936004'])}, 'of age': {'397669002': ('qualifier value', 'Age ', ['272099008']), '424144002': ('observable entity', 'Current chronological age ', ['105727008'])}}

2557838
permanent, refractory atrial fibrillation treated with atrio-ventricular node ablation and biventricular pacing
permanent, refractory atrial fibrillation treated with atrio-ventricular node ablation and biventricular pacing
['permanent, refractory atrial fibrillation', 'treated with atrio ventricular node ablation', 'biventricular pacing']
{'permanent, refractory atrial fibrillation': {'440028005': 'Permanent atrial fibrillation ', '20646008': 'Intractable '}, 'treated with atrio ventricular node ablation': {'28995006': 'treated with', '25943004': 'Structure of atrioventricular node ', '257729003': 'Ablation - action ', '64597002': 'Destructive procedure ', '129382001': 'Destruction - action '}, 'biventricular pacing': {'74691006': 'Pacing up and down '}}
{'permanent, refractory atrial fibrillation': {'440028005': ('clinical finding', 'Permanent atrial fibrillation ', ['64572001', '118234003']), '20646008': ('qualifier value', 'Intractable ', ['272099008'])}, 'treated with atrio ventricular node ablation': {'64597002': ('procedure', 'Destructive procedure ', ['128927009'])}, 'biventricular pacing': {'74691006': ('clinical finding', 'Pacing up and down ', ['250171008'])}}

2568089
patient has a prostate size of >= 25 ml and not > 80 ml, measured by ultrasound
patient has a prostate size of >= 25 ml and not > 80 ml, measured by ultrasound
['patient', 'a prostate size of >', '= 25 ml', '> 80 ml,', 'measured by ultrasound']
{'patient': {'116154003': 'Patient '}, 'a prostate size of >': {'249606000': 'Prostate size '}, '= 25 ml': {'259035002': 'per milliliter '}, '> 80 ml,': {'259035002': 'per milliliter '}, 'measured by ultrasound': {'258104002': 'Measured ', '16310003': 'Diagnostic ultrasonography ', '278292003': 'Ultrasound imaging - action '}}
{'a prostate size of >': {'249606000': ('observable entity', 'Prostate size ', ['363788007'])}, '= 25 ml': {'259035002': ('unit', 'per milliliter ', ['767524001'])}, '> 80 ml,': {'259035002': ('unit', 'per milliliter ', ['767524001'])}, 'measured by ultrasound': {'258104002': ('qualifier value', 'Measured ', ['272099008']), '16310003': ('procedure', 'Diagnostic ultrasonography ', ['128927009'])}}

2568402
ad
ad
[]
{}
{}

2576942
patients with the ability to understand and give written informed consent for participation in this trial, including all evaluations and procedures as specified by this protocol.
patients with the understand and give written informed consent for participation in this trial, including all evaluations and procedures as specified by this protocol.
['patients with the', 'understand', 'give', 'written informed consent for participation', 'in this trial,', 'including', 'all evaluations', 'procedures', 'specified by this protocol']
{'patients with the': {'116154003': 'Patient '}, 'understand': {'66216009': 'Understanding, function '}, 'give': {'419582001': 'Give - dosing instruction imperative '}, 'written informed consent for participation': {'12261009': 'Writing ', '108968006': 'Oprelvekin ', '410938009': 'Oprelvekin ', '223458004': 'Informing '}, 'in this trial,': {'110465008': 'Clinical trial '}, 'including': {'55919000': 'Including '}, 'all evaluations': {'129265001': 'Evaluation - action ', '386053000': 'Evaluation procedure '}, 'procedures': {'71388002': 'Procedure '}, 'specified by this protocol': {'704346009': 'specified by', '258049002': 'Protocols '}}
{'understand': {'66216009': ('observable entity', 'Understanding, function ', ['246464006'])}, 'written informed consent for participation': {'12261009': ('observable entity', 'Writing ', ['246464006']), '108968006': ('product', 'Oprelvekin ', ['406455002', '312413002', '115668003']), '410938009': ('product', 'Oprelvekin ', ['763158003'])}, 'including': {'55919000': ('qualifier value', 'Including ', ['272099008'])}, 'all evaluations': {'386053000': ('procedure', 'Evaluation procedure ', ['71388002', '128927009'])}}

2578682
patient is ≥ 18 years old at the time of the drug administration
patient is ≥ 18 years old at the time of the drug administration
['patient', '18 years old at the time of the drug administration']
{'patient': {'116154003': 'Patient '}, '18 years old at the time of the drug administration': {'70753007': 'Old ', '229783007': 'times/year ', '182832007': 'Procedure related to management of drug administration ', '18629005': 'Administration of drug or medicament '}}
{'18 years old at the time of the drug administration': {'70753007': ('qualifier value', 'Old ', ['272099008']), '229783007': ('unit', 'times/year ', ['767524001']), '182832007': ('procedure', 'Procedure related to management of drug administration ', ['128927009', '408766003']), '18629005': ('procedure', 'Administration of drug or medicament ', ['128927009'])}}

2579306
subject is scheduled to undergo 1 of the surgical procedures described above
subject is scheduled to undergo 1 of the surgical procedures described above
['scheduled', 'to', '1 of the surgical procedures']
{'scheduled': {'416151008': 'Scheduled - procedure status ', '416774000': 'Scheduled - priority '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, '1 of the surgical procedures': {'451231000124103': 'greater than one', '257556004': 'Surgery ', '387713003': 'Surgical procedure ', '83578000': 'Surgical '}}
{'scheduled': {'416774000': ('qualifier value', 'Scheduled - priority ', ['272099008'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, '1 of the surgical procedures': {'387713003': ('procedure', 'Surgical procedure ', ['128927009']), '83578000': ('qualifier value', 'Surgical ', ['272099008'])}}

2591183
stable diet and exercise routine
stable diet and exercise routine
['stable diet', 'exercise', 'routine']
{'stable diet': {'58158008': 'Stable ', '41829006': 'Dietary finding '}, 'exercise': {'183301007': 'Physical exercises ', '256235009': 'Exercise ', '61686008': 'Physical exercise '}, 'routine': {'50811001': 'Routine '}}
{'stable diet': {'58158008': ('qualifier value', 'Stable ', ['272099008']), '41829006': ('clinical finding', 'Dietary finding ', ['250171008'])}, 'exercise': {'183301007': ('procedure', 'Physical exercises ', ['243120004'])}, 'routine': {'50811001': ('qualifier value', 'Routine ', ['272099008'])}}

2602964
ability and willingness of volunteer to provide written informed consent
ability and willingness of volunteer to provide written informed consent
['ability', 'willingness of volunteer', 'to', 'written informed consent']
{'ability': {'371150009': 'Able '}, 'willingness of volunteer': {'225466006': 'Willing ', '160772005': 'Voluntary worker ', '276035002': 'Voluntary helper ', '276037005': 'Volunteer helper ', '428024001': 'Clinical trial participant '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'written informed consent': {'12261009': 'Writing ', '108968006': 'Oprelvekin ', '410938009': 'Oprelvekin ', '223458004': 'Informing '}}
{'willingness of volunteer': {'225466006': ('clinical finding', 'Willing ', ['250171008'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'written informed consent': {'12261009': ('observable entity', 'Writing ', ['246464006']), '108968006': ('product', 'Oprelvekin ', ['406455002', '312413002', '115668003']), '410938009': ('product', 'Oprelvekin ', ['763158003'])}}

2606844
recipients and donors willing to be recruited as a pair to this study
recipients and donors willing to be recruited as a pair to this study
['willing', 'to', 'to this study']
{'willing': {'225466006': 'Willing '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'to this study': {'224699009': 'Study '}}
{'willing': {'225466006': ('clinical finding', 'Willing ', ['250171008'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}}

2607416
histologic confirmation of intrinsic brain stem tumors not required
histologic confirmation of intrinsic brain stem tumors not required
['histologic confirmation of intrinsic brain stem tumors']
{'histologic confirmation of intrinsic brain stem tumors': {'67151002': 'Histologic ', '74996004': 'Confirmation of ', '260521003': 'Internal ', '126961004': 'Neoplasm of brain stem ', '255406006': 'Intrinsic '}}
{'histologic confirmation of intrinsic brain stem tumors': {'67151002': ('qualifier value', 'Histologic ', ['272099008']), '126961004': ('clinical finding', 'Neoplasm of brain stem ', ['64572001', '118234003']), '255406006': ('qualifier value', 'Intrinsic ', ['272099008'])}}

2654798
patients with controlled systemic disease for >6 weeks
patients with controlled systemic disease for >6 weeks
['patients with controlled systemic disease', '>6 weeks']
{'patients with controlled systemic disease': {'116154003': 'Patient ', '246106000': 'control function', '31509003': 'Controlled ', '264578000': 'Systemic illness ', '56019007': 'Systemic disease '}, '>6 weeks': {'258705008': 'week '}}
{'patients with controlled systemic disease': {'31509003': ('qualifier value', 'Controlled ', ['272099008']), '264578000': ('qualifier value', 'Systemic illness ', ['272099008']), '56019007': ('clinical finding', 'Systemic disease ', ['250171008'])}, '>6 weeks': {'258705008': ('unit', 'week ', ['767524001'])}}

2659220
any patient who has undergone prior excisional biopsy of their primary breast tumor must have had margins positive for disease, or must have either mammographic evidence or ultrasonographic evidence of probable residual disease in the breast.
any patient who has undergone prior excisional biopsy of their primary breast tumor must have had margins positive for disease, or must have either mammographic evidence or ultrasonographic evidence of probable residual disease in the breast.
['any patient', 'undergone prior excisional biopsy of their primary breast tumor', 'margins positive for disease,', 'either mammographic evidence', 'ultrasonographic evidence of probable residual disease', 'in the breast']
{'any patient': {'116154003': 'Patient '}, 'undergone prior excisional biopsy of their primary breast tumor': {'236874000': 'Status pre- ', '288556008': 'before', '237372000': 'Excisional biopsy of breast ', '63161005': 'Principal ', '108369006': 'Neoplasm ', '263909009': 'True primary ', '261424001': 'Primary operation '}, 'margins positive for disease,': {'112233002': 'Marginal ', '10828004': 'Positive ', '64572001': 'Disease ', '82868003': 'Surgical margins ', '372249001': 'Tumor margin status '}, 'either mammographic evidence': {'71651007': 'Mammography '}, 'ultrasonographic evidence of probable residual disease': {'18669006': 'Evidence of ', '2931005': 'Probable diagnosis ', '452201000124102': 'probable diagnosis', '17964000': 'Residual tumor stage '}, 'in the breast': {'76752008': 'Breast structure '}}
{'undergone prior excisional biopsy of their primary breast tumor': {'237372000': ('procedure', 'Excisional biopsy of breast ', ['362958002', '128927009']), '63161005': ('qualifier value', 'Principal ', ['272099008']), '263909009': ('qualifier value', 'True primary ', ['272099008']), '261424001': ('qualifier value', 'Primary operation ', ['272099008'])}, 'margins positive for disease,': {'112233002': ('qualifier value', 'Marginal ', ['272099008']), '10828004': ('qualifier value', 'Positive ', ['272099008']), '372249001': ('observable entity', 'Tumor margin status ', ['395531003'])}, 'either mammographic evidence': {'71651007': ('procedure', 'Mammography ', ['362958002', '128927009'])}, 'ultrasonographic evidence of probable residual disease': {'17964000': ('observable entity', 'Residual tumor stage ', ['395531003'])}}

2664445
patient is on a stable medication regimen for >= 4 weeks prior to enrollment
patient is on a stable medication regimen for >= 4 weeks prior to enrollment
['patient', 'is on a stable medication regimen', '= 4 weeks prior to enrollment']
{'patient': {'116154003': 'Patient '}, 'is on a stable medication regimen': {'58158008': 'Stable ', '105903003': 'General drug type ', '373873005': 'Pharmaceutical / biologic product ', '410942007': 'Drug or medicament '}, '= 4 weeks prior to enrollment': {'260300002': '-4 ', '258705008': 'week ', '236874000': 'Status pre- ', '288556008': 'before'}}
{'is on a stable medication regimen': {'58158008': ('qualifier value', 'Stable ', ['272099008'])}, '= 4 weeks prior to enrollment': {'258705008': ('unit', 'week ', ['767524001'])}}

2665214
symptomatic urinary tract infection at inclusion
symptomatic urinary tract infection at inclusion
['symptomatic urinary tract infection at inclusion']
{'symptomatic urinary tract infection at inclusion': {'264931009': 'Symptomatic ', '68566005': 'Urinary tract infectious disease ', '55919000': 'Including ', '197927001': 'Recurrent urinary tract infection '}}
{'symptomatic urinary tract infection at inclusion': {'264931009': ('qualifier value', 'Symptomatic ', ['272099008']), '68566005': ('clinical finding', 'Urinary tract infectious disease ', ['64572001', '118234003']), '55919000': ('qualifier value', 'Including ', ['272099008']), '197927001': ('clinical finding', 'Recurrent urinary tract infection ', ['64572001', '118234003', '68566005'])}}

2670242
creatinine =< 2.0 x uln
creatinine =< 2.0 x uln
['creatinine', '< 2 0 x uln']
{'creatinine': {'15373003': 'Creatinine '}, '< 2 0 x uln': {'260306008': 'Integer +2 '}}
{'creatinine': {'15373003': ('product', 'Creatinine ', ['312413002', '312412007'])}}

2673089
child-pugh class a or b
child-pugh class a or b
['child pugh class']
{'child pugh class': {'410601007': 'Childhood age person ', '67822003': 'Child ', '258391009': 'Classes ', '277046005': 'class', '160499008': 'Child of '}}
{'child pugh class': {'258391009': ('qualifier value', 'Classes ', ['272396007']), '160499008': ('clinical finding', 'Child of ', ['118240005'])}}

2675371
large foci or clusters of blasts in bone marrow biopsy
large foci or clusters of blasts in bone marrow biopsy
['large foci', 'clusters of blasts', 'in bone marrow biopsy']
{'large foci': {'255509001': 'Large ', '87017008': 'Focal '}, 'clusters of blasts': {'90391002': 'Blast ', '312256009': 'Blast cell ', '104102000': 'Blast count, blood '}, 'in bone marrow biopsy': {'234326005': 'Bone marrow sampling '}}
{'large foci': {'255509001': ('qualifier value', 'Large ', ['272099008']), '87017008': ('qualifier value', 'Focal ', ['272099008'])}, 'clusters of blasts': {'104102000': ('procedure', 'Blast count, blood ', ['128927009'])}, 'in bone marrow biopsy': {'234326005': ('procedure', 'Bone marrow sampling ', ['362958002', '128927009'])}}

2677733
women who have completed 12 months of active treatment in study m01-391 and month 12 visit procedures or completed 18 months of active treatment in study c03-062 and month 18 visit procedures or could not continue in a previous asoprisnil study, but are now eligible for retreatment
women who have completed 12 months of active treatment in study m01-391 and month 12 visit procedures or completed 18 months of active treatment in study c03-062 and month 18 visit procedures or could not continue in a , asoprisnil study, but are now eligible for retreatment
['women', 'completed', '12 months of active treatment in study m01 391', 'month 12 visit procedures', '18 months of active treatment in study c03 062', 'month 18 visit procedures', 'continue in a', 'asoprisnil study,']
{'women': {'224526002': 'Woman '}, 'completed': {'255594003': 'Complete '}, '12 months of active treatment in study m01 391': {'258706009': 'month ', '55561003': 'Active ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '224699009': 'Study ', '416118004': 'Administration '}, 'month 12 visit procedures': {'89185003': 'Monthly ', '308335008': 'Patient encounter procedure ', '258706009': 'month ', '259036001': 'per month '}, '18 months of active treatment in study c03 062': {'258706009': 'month ', '55561003': 'Active ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '224699009': 'Study ', '416118004': 'Administration '}, 'month 18 visit procedures': {'89185003': 'Monthly ', '308335008': 'Patient encounter procedure ', '258706009': 'month ', '259036001': 'per month '}, 'continue in a': {'255238004': 'Continuous '}, 'asoprisnil study,': {'224699009': 'Study '}}
{'women': {'224526002': ('person', 'Woman ', ['133936004'])}, 'completed': {'255594003': ('qualifier value', 'Complete ', ['272099008'])}, '12 months of active treatment in study m01 391': {'258706009': ('unit', 'month ', ['767524001']), '55561003': ('qualifier value', 'Active ', ['272099008']), '276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '416118004': ('procedure', 'Administration ', ['128927009'])}, 'month 12 visit procedures': {'89185003': ('qualifier value', 'Monthly ', ['272099008']), '258706009': ('unit', 'month ', ['767524001']), '259036001': ('unit', 'per month ', ['767524001'])}, '18 months of active treatment in study c03 062': {'258706009': ('unit', 'month ', ['767524001']), '55561003': ('qualifier value', 'Active ', ['272099008']), '276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '416118004': ('procedure', 'Administration ', ['128927009'])}, 'month 18 visit procedures': {'89185003': ('qualifier value', 'Monthly ', ['272099008']), '258706009': ('unit', 'month ', ['767524001']), '259036001': ('unit', 'per month ', ['767524001'])}, 'continue in a': {'255238004': ('qualifier value', 'Continuous ', ['272099008'])}}

2680510
no evidence of metabolic disease (hypothyroidism, uncontrolled diabetes [hemoglobin a1c >10% within the past 6 months], electrolyte imbalance).
evidence of metabolic disease (hypothyroidism, uncontrolled diabetes [hemoglobin a1c >10% , ], electrolyte imbalance).
['evidence of metabolic disease', '(hypothyroidism,', 'uncontrolled diabetes', 'electrolyte imbalance']
{'evidence of metabolic disease': {'18669006': 'Evidence of ', '30390004': 'Generalized metabolic disorder ', '75934005': 'Metabolic disease '}, '(hypothyroidism,': {'40930008': 'Hypothyroidism '}, 'uncontrolled diabetes': {'19032002': 'Uncontrolled ', '73211009': 'Diabetes mellitus '}, 'electrolyte imbalance': {'105593004': 'Electrolyte imbalance '}}
{'evidence of metabolic disease': {'30390004': ('clinical finding', 'Generalized metabolic disorder ', ['64572001', '75934005']), '75934005': ('clinical finding', 'Metabolic disease ', ['64572001'])}, '(hypothyroidism,': {'40930008': ('clinical finding', 'Hypothyroidism ', ['64572001', '118234003'])}, 'uncontrolled diabetes': {'19032002': ('qualifier value', 'Uncontrolled ', ['272099008']), '73211009': ('clinical finding', 'Diabetes mellitus ', ['64572001', '75934005', '118234003'])}, 'electrolyte imbalance': {'105593004': ('clinical finding', 'Electrolyte imbalance ', ['64572001', '75934005'])}}

2683561
clinical spinal cord compression
clinical spinal cord compression
['clinical spinal cord compression']
{'clinical spinal cord compression': {'58147004': 'Clinical ', '71286001': 'Spinal cord compression '}}
{'clinical spinal cord compression': {'58147004': ('qualifier value', 'Clinical ', ['272099008']), '71286001': ('clinical finding', 'Spinal cord compression ', ['64572001', '118234003'])}}

2684168
age greater than 18 years
age greater than 18 years
['age', 'greater than 18 years']
{'age': {'397669002': 'Age ', '424144002': 'Current chronological age '}, 'greater than 18 years': {'276140008': 'Greater-than symbol > ', '258707000': 'year '}}
{'age': {'397669002': ('qualifier value', 'Age ', ['272099008']), '424144002': ('observable entity', 'Current chronological age ', ['105727008'])}, 'greater than 18 years': {'258707000': ('unit', 'year ', ['767524001'])}}

2688167
≥1 poorly-controlled cvd risk factor , irrespective of medications used
≥1 poorly-controlled cvd risk factor , irrespective of medications used
['1 poorly controlled cvd risk factor', 'irrespective of medications', 'used']
{'1 poorly controlled cvd risk factor': {'451231000124103': 'greater than one', '444931000124107': 'poorly controlled', '49601007': 'Disorder of cardiovascular system ', '80943009': 'Risk factor '}, 'irrespective of medications': {'105903003': 'General drug type ', '373873005': 'Pharmaceutical / biologic product ', '410942007': 'Drug or medicament '}, 'used': {'394850002': 'used by'}}
{'1 poorly controlled cvd risk factor': {'444931000124107': ('qualifier value', 'poorly controlled', ['272099008']), '49601007': ('clinical finding', 'Disorder of cardiovascular system ', ['64572001', '118234003']), '80943009': ('observable entity', 'Risk factor ', ['363788007'])}}

2705366
with a cartilage lesion identified during mri and either >= 1 out of 4 mri severity criteria:
with a cartilage lesion identified during mri and either >= 1 out of 4 mri severity criteria:
['with a cartilage lesion', 'identified during mri', '= 1 out of 4 mri severity criteria']
{'with a cartilage lesion': {'309312004': 'Cartilage tissue ', '61496007': 'Cartilaginous tissue structure ', '52988006': 'Lesion '}, 'identified during mri': {'7882003': 'Identified ', '113091000': 'Magnetic resonance imaging ', '312250003': 'Magnetic resonance imaging - action '}, '= 1 out of 4 mri severity criteria': {'732422000': '1.4', '255529000': 'Out ', '113091000': 'Magnetic resonance imaging ', '312250003': 'Magnetic resonance imaging - action ', '246112005': 'severities', '272141005': 'Severities ', '103370009': 'with intensity'}}
{'identified during mri': {'7882003': ('qualifier value', 'Identified ', ['272099008']), '113091000': ('procedure', 'Magnetic resonance imaging ', ['128927009'])}, '= 1 out of 4 mri severity criteria': {'255529000': ('qualifier value', 'Out ', ['272099008']), '113091000': ('procedure', 'Magnetic resonance imaging ', ['128927009']), '272141005': ('qualifier value', 'Severities ', ['272396007'])}}

2707854
nhl previously untreated with cytotoxic chemotherapy; however, patients may be entered if they have had prior cyclophosphamide for an urgent problem at diagnosis and/or a single dose of intrathecal methotrexte at the time of the pre-treatment diagnostic lumbar puncture
nhl , ly untreated with cytotoxic chemotherapy; however, patients may be entered if they have had prior cyclophosphamide for an urgent problem at diagnosis and/or a single dose of intrathecal methotrexte at the time of the pre-treatment diagnostic lumbar puncture
['nhl', 'ly', 'untreated with cytotoxic chemotherapy']
{'nhl': {'118601006': 'Non-Hodgkins lymphoma ', '128929007': 'Non-Hodgkin lymphoma - category ', '188675007': 'Malignant lymphoma - small cleaved cell ', '1929004': 'Non-Hodgkin lymphoma, no International Classification of Diseases for Oncology subtype '}, 'ly': {'223512002': 'Libya '}, 'untreated with cytotoxic chemotherapy': {'25265005': 'Did not receive therapy or drug for ', '373526007': 'Cytotoxic agent ', '71837009': 'Cytotoxic agent ', '416608005': 'Drug therapy ', '716872004': 'Antineoplastic chemotherapy regimen ', '363688001': 'Administration of antineoplastic agent ', '367336001': 'Chemotherapy '}}
{'nhl': {'118601006': ('clinical finding', 'Non-Hodgkins lymphoma ', ['64572001']), '188675007': ('clinical finding', 'Malignant lymphoma - small cleaved cell ', ['64572001', '118601006'])}, 'untreated with cytotoxic chemotherapy': {'71837009': ('product', 'Cytotoxic agent ', ['763158003']), '416608005': ('procedure', 'Drug therapy ', ['128927009']), '716872004': ('procedure', 'Antineoplastic chemotherapy regimen ', ['243120004', '128927009']), '363688001': ('procedure', 'Administration of antineoplastic agent ', ['416608005', '367336001', '128927009']), '367336001': ('procedure', 'Chemotherapy ', ['416608005', '128927009'])}}

2710629
measurable disease or evaluable disease
measurable disease or evaluable disease
['measurable disease', 'evaluable disease']
{'measurable disease': {'64572001': 'Disease '}, 'evaluable disease': {'64572001': 'Disease '}}
{}

2721805
pulmonary function: dlco corrected for hemoglobin and alveolar volume greater than or = 50% of predicted.
pulmonary function: dlco corrected for hemoglobin and alveolar volume greater than or = 50% of predicted.
['pulmonary function', 'corrected for hemoglobin', 'alveolar volume', 'greater than']
{'pulmonary function': {'106053004': 'Pulmonary function '}, 'corrected for hemoglobin': {'33714007': 'Corrected ', '370975003': 'Remediated ', '38082009': 'Hemoglobin '}, 'alveolar volume': {'251953007': 'Alveolar volume '}, 'greater than': {'276140008': 'Greater-than symbol > '}}
{'pulmonary function': {'106053004': ('observable entity', 'Pulmonary function ', ['246464006'])}, 'corrected for hemoglobin': {'33714007': ('qualifier value', 'Corrected ', ['272099008']), '370975003': ('clinical finding', 'Remediated ', ['118240005']), '38082009': ('product', 'Hemoglobin ', ['312413002', '115668003'])}, 'alveolar volume': {'251953007': ('observable entity', 'Alveolar volume ', ['363788007'])}}

2729340
preterm neonates.
preterm neonates.
['preterm neonates']
{'preterm neonates': {'282020008': 'Premature delivery ', '49550006': 'Premature pregnancy delivered ', '133933007': 'Newborn '}}
{'preterm neonates': {'282020008': ('clinical finding', 'Premature delivery ', ['250171008']), '49550006': ('clinical finding', 'Premature pregnancy delivered ', ['250171008'])}}

2741594
ability to write and read properly in hebrew
write and read properly in hebrew
['write', 'read']
{'write': {'12261009': 'Writing '}, 'read': {'50360004': 'Reading '}}
{'write': {'12261009': ('observable entity', 'Writing ', ['246464006'])}, 'read': {'50360004': ('observable entity', 'Reading ', ['246464006'])}}

2745721
not receiving bp-lowering medication.
not receiving bp-lowering medication.
['bp lowering medication']
{'bp lowering medication': {'45007003': 'Low blood pressure ', '105903003': 'General drug type ', '373873005': 'Pharmaceutical / biologic product ', '410942007': 'Drug or medicament '}}
{'bp lowering medication': {'45007003': ('clinical finding', 'Low blood pressure ', ['64572001', '118234003'])}}

2760708
good general health
good general health
['good general health']
{'good general health': {'20572008': 'Good ', '82832008': 'General body state finding '}}
{'good general health': {'20572008': ('qualifier value', 'Good ', ['272099008']), '82832008': ('clinical finding', 'General body state finding ', ['250171008'])}}

2763001
all subjects/patients must sign an informed consent form prior to participation in the trial in accordance with ich-gcp and the local legislation, i.e., the copd patients must give written informed consent prior to pre-study washout of their usual pulmonary medications.
all subjects/patients must sign an informed consent form prior to participation in the trial in accordance with ich-gcp and the local legislation, i.e., the copd patients must give written informed consent prior to pre-study washout of their usual pulmonary medications.
['/patients', 'sign', 'an informed consent form prior to participation', 'in the trial in accordance with ich gcp', 'the local legislation,', 'i e', 'the copd patients', 'give', 'written informed consent prior to pre study washout of their usual pulmonary medications']
{'/patients': {'116154003': 'Patient '}, 'sign': {'72670004': 'Sign '}, 'an informed consent form prior to participation': {'108968006': 'Oprelvekin ', '410938009': 'Oprelvekin ', '246176004': 'qualitative form', '236874000': 'Status pre- ', '288556008': 'before', '223458004': 'Informing '}, 'in the trial in accordance with ich gcp': {'110465008': 'Clinical trial '}, 'the local legislation,': {'255470001': 'Local '}, 'i e': {'42146005': 'Iodide salt ', '22971001': 'Blood group antibody I '}, 'the copd patients': {'13645005': 'Chronic obstructive lung disease ', '116154003': 'Patient '}, 'give': {'419582001': 'Give - dosing instruction imperative '}, 'written informed consent prior to pre study washout of their usual pulmonary medications': {'12261009': 'Writing ', '108968006': 'Oprelvekin ', '410938009': 'Oprelvekin ', '236874000': 'Status pre- ', '288556008': 'before', '39607008': 'Lung structure ', '185922005': 'Clinical drug trial ', '264164005': 'Pulmonary ', '272113006': 'Before values ', '223458004': 'Informing '}}
{'sign': {'72670004': ('clinical finding', 'Sign ', ['250171008'])}, 'an informed consent form prior to participation': {'108968006': ('product', 'Oprelvekin ', ['406455002', '312413002', '115668003']), '410938009': ('product', 'Oprelvekin ', ['763158003'])}, 'the local legislation,': {'255470001': ('qualifier value', 'Local ', ['272099008'])}, 'i e': {'42146005': ('product', 'Iodide salt ', ['406455002', '312413002', '115668003']), '22971001': ('product', 'Blood group antibody I ', ['312413002', '115668003'])}, 'the copd patients': {'13645005': ('clinical finding', 'Chronic obstructive lung disease ', ['64572001', '118234003'])}, 'written informed consent prior to pre study washout of their usual pulmonary medications': {'12261009': ('observable entity', 'Writing ', ['246464006']), '108968006': ('product', 'Oprelvekin ', ['406455002', '312413002', '115668003']), '410938009': ('product', 'Oprelvekin ', ['763158003']), '272113006': ('qualifier value', 'Before values ', ['272099008'])}}

2769953
refused chemotherapy
refused chemotherapy
['refused chemotherapy']
{'refused chemotherapy': {'443390004': 'Refused ', '416608005': 'Drug therapy ', '716872004': 'Antineoplastic chemotherapy regimen ', '363688001': 'Administration of antineoplastic agent ', '367336001': 'Chemotherapy '}}
{'refused chemotherapy': {'416608005': ('procedure', 'Drug therapy ', ['128927009']), '716872004': ('procedure', 'Antineoplastic chemotherapy regimen ', ['243120004', '128927009']), '363688001': ('procedure', 'Administration of antineoplastic agent ', ['416608005', '367336001', '128927009']), '367336001': ('procedure', 'Chemotherapy ', ['416608005', '128927009'])}}

2779028
eastern cooperative oncology group performance status 0-1
eastern cooperative oncology group performance status 0-1
['eastern cooperative oncology group performance status 0 1']
{'eastern cooperative oncology group performance status 0 1': {'423740007': 'Eastern Cooperative Oncology Group performance status ', '732332006': '0.1'}}
{'eastern cooperative oncology group performance status 0 1': {'423740007': ('observable entity', 'Eastern Cooperative Oncology Group performance status ', ['278844005'])}}

2782296
subject has an hba1c value between 7.5 and 10.0% at visit 2 and the difference of hba1c value within ± 1.0% between visit 1 and visit 2
subject has an hba1c value between 7.5 and 10.0% at visit 2 and the difference of hba1c value within ± 1.0% between visit 1 and visit 2
['10 0% at visit 2', 'the difference of hba1c value', 'within  1 0% between visit 1']
{'10 0% at visit 2': {'732349004': '0.2'}, 'the difference of hba1c value': {'263735002': 'Differential '}, 'within  1 0% between visit 1': {'732332006': '0.1'}}
{'the difference of hba1c value': {'263735002': ('qualifier value', 'Differential ', ['272099008'])}}

2797456
triglycerides ≥ 150 mg/d.l
triglycerides ≥ 150 mg/d.l
['triglycerides  150 mg/d l']
{'triglycerides  150 mg/d l': {'85600001': 'Triacylglycerol ', '258796002': 'Milligram/liter ', '258801007': 'Microgram/milliliter ', '258895008': 'g/kL ', '272082007': 'Nanogram/microliter '}}
{'triglycerides  150 mg/d l': {'85600001': ('product', 'Triacylglycerol ', ['312413002', '312412007']), '258796002': ('unit', 'Milligram/liter ', ['767524001']), '258801007': ('unit', 'Microgram/milliliter ', ['767524001']), '258895008': ('unit', 'g/kL ', ['767524001']), '272082007': ('unit', 'Nanogram/microliter ', ['767524001'])}}

2805379
free of acute diseases and chronic diseases as determined by medical history, physical examination and laboratory tests.
free of acute diseases and chronic diseases as determined by medical history, physical examination and laboratory tests.
['free of acute diseases', 'chronic diseases', 'determined by medical history,', 'physical examination', 'laboratory tests']
{'free of acute diseases': {'37837009': 'free of ', '2704003': 'Acute disease '}, 'chronic diseases': {'27624003': 'Chronic disease '}, 'determined by medical history,': {'436000': 'Determined by ', '392521001': 'History of '}, 'physical examination': {'302199004': 'Examination - action ', '5880005': 'Physical examination procedure ', '81375008': 'Physical assessment '}, 'laboratory tests': {'108252007': 'Laboratory procedure ', '15220000': 'Laboratory test ', '269814003': 'Laboratory procedures -general '}}
{'free of acute diseases': {'2704003': ('clinical finding', 'Acute disease ', ['64572001'])}, 'chronic diseases': {'27624003': ('clinical finding', 'Chronic disease ', ['64572001'])}, 'physical examination': {'5880005': ('procedure', 'Physical examination procedure ', ['362958002', '128927009']), '81375008': ('procedure', 'Physical assessment ', ['128927009'])}, 'laboratory tests': {'15220000': ('procedure', 'Laboratory test ', ['128927009', '108252007']), '269814003': ('situation with explicit context', 'Laboratory procedures -general ', ['129125009'])}}

2816782
be currently taking 1 to 3 aeds.
be currently taking 1 to 3 aeds.
['currently', 'taking', '1 to 3 aeds']
{'currently': {'15240007': 'Current '}, 'taking': {'419652001': 'Take - dosing instruction imperative '}, '1 to 3 aeds': {'732418005': '1.3'}}
{}

2829437
current alcohol dependence
current alcohol dependence
['current alcohol dependence']
{'current alcohol dependence': {'15240007': 'Current ', '284591009': 'Persistent alcohol abuse ', '66590003': 'Alcohol dependence ', '7200002': 'Alcoholism '}}
{'current alcohol dependence': {'284591009': ('clinical finding', 'Persistent alcohol abuse ', ['64572001', '7200002']), '66590003': ('clinical finding', 'Alcohol dependence ', ['64572001', '7200002']), '7200002': ('clinical finding', 'Alcoholism ', ['64572001'])}}

2838965
healthy volunteers will be eligible for the study if they are:
healthy volunteers will be eligible for the study if they are:
['healthy volunteers', 'eligible for the study']
{'healthy volunteers': {'263775005': 'Health ', '160772005': 'Voluntary worker ', '276035002': 'Voluntary helper ', '276037005': 'Volunteer helper '}, 'eligible for the study': {'224699009': 'Study '}}
{}

2849393
women of childbearing potential must have a negative serum or urine pregnancy test within 24 hours prior to the start of study drug.
women of childbearing potential must have a negative serum or urine pregnancy test within 24 hours prior to the start of study drug.
['women of childbearing potential', 'a negative serum', 'urine pregnancy test within 24 hours', 'prior to the start of study drug']
{'women of childbearing potential': {'224526002': 'Woman '}, 'a negative serum': {'260385009': 'Negative ', '67922002': 'Serum ', '119364003': 'Serum specimen '}, 'urine pregnancy test within 24 hours': {'167252002': 'Urine pregnancy test ', '123027009': '24 hours ', '259029002': 'per 24 hours '}, 'prior to the start of study drug': {'236874000': 'Status pre- ', '288556008': 'before', '246062003': 'beginning', '255395001': 'Origins ', '185922005': 'Clinical drug trial '}}
{'women of childbearing potential': {'224526002': ('person', 'Woman ', ['133936004'])}, 'a negative serum': {'67922002': ('product', 'Serum ', ['115669006', '115668003'])}, 'urine pregnancy test within 24 hours': {'167252002': ('procedure', 'Urine pregnancy test ', ['128927009']), '123027009': ('qualifier value', '24 hours ', ['272099008']), '259029002': ('unit', 'per 24 hours ', ['767524001'])}, 'prior to the start of study drug': {'255395001': ('qualifier value', 'Origins ', ['272099008'])}}

2855265
admitted for respiratory failure primarily due to copd exacerbation
admitted for respiratory failure primarily due to copd exacerbation
['admitted for respiratory failure primarily', 'due to copd exacerbation']
{'admitted for respiratory failure primarily': {'32485007': 'Hospital admission ', '409622000': 'Respiratory failure '}, 'due to copd exacerbation': {'13645005': 'Chronic obstructive lung disease '}}
{'admitted for respiratory failure primarily': {'409622000': ('clinical finding', 'Respiratory failure ', ['64572001', '118234003'])}, 'due to copd exacerbation': {'13645005': ('clinical finding', 'Chronic obstructive lung disease ', ['64572001', '118234003'])}}

2855605
≥ 50 years of age
,
[]
{}
{}

2859460
group a: art naïve or if art-exposed, has not received haart for >= the six months prior to study entry group b: has been receiving haart for >= six months at the time of study entry, with two hiv-1 rna plasma viral loads < 400 copies/ml on two previous clinical visits within the 6 months prior to study entry
group a: art naïve or if art-exposed, has not received haart for >= the six months prior to study entry group b: has been receiving haart for >= six months at the time of study entry, with two hiv-1 rna plasma viral loads < 400 copies/ml on two , clinical visits , prior to study entry
['group a', 'exposed', 'not received haart for', 'the six months prior to study entry group b', 'receiving haart for', '= six months at the time of study entry,', 'with two hiv 1 rna plasma viral loads', '< 400 copies/ml on two', 'clinical visits', 'prior to study entry']
{'group a': {'272414007': 'Group A '}, 'exposed': {'24932003': 'Exposure to '}, 'not received haart for': {'416234007': 'Highly active anti-retroviral therapy '}, 'the six months prior to study entry group b': {'4841000175107': 'six months', '236874000': 'Status pre- ', '288556008': 'before', '224699009': 'Study ', '246261001': 'groups', '261586004': 'Groups ', '160481000': 'Social group ', '389109008': 'Group '}, 'receiving haart for': {'416234007': 'Highly active anti-retroviral therapy '}, '= six months at the time of study entry,': {'4841000175107': 'six months', '410669006': 'Time ', '410670007': 'time', '224699009': 'Study ', '900000000000475002': 'time ', '68244004': 'Six ', '229782002': 'times/month '}, 'with two hiv 1 rna plasma viral loads': {'19338005': 'Two ', '121202003': 'Human immunodeficiency virus 1 ribonucleic acid ', '419185008': 'Blood plasma ', '50863008': 'Plasma ', '395058002': 'Viral load '}, '< 400 copies/ml on two': {'732733003': '400', '413913003': 'Copies/milliliter ', '19338005': 'Two '}, 'clinical visits': {'58147004': 'Clinical '}, 'prior to study entry': {'224699009': 'Study '}}
{'group a': {'272414007': ('qualifier value', 'Group A ', ['272396007', '261586004'])}, 'not received haart for': {'416234007': ('procedure', 'Highly active anti-retroviral therapy ', ['128927009'])}, 'the six months prior to study entry group b': {'4841000175107': ('qualifier value', 'six months', ['272099008']), '261586004': ('qualifier value', 'Groups ', ['272396007']), '160481000': ('observable entity', 'Social group ', ['160476009'])}, 'receiving haart for': {'416234007': ('procedure', 'Highly active anti-retroviral therapy ', ['128927009'])}, '= six months at the time of study entry,': {'4841000175107': ('qualifier value', 'six months', ['272099008']), '229782002': ('unit', 'times/month ', ['767524001'])}, 'with two hiv 1 rna plasma viral loads': {'121202003': ('product', 'Human immunodeficiency virus 1 ribonucleic acid ', ['312413002']), '50863008': ('product', 'Plasma ', ['115669006', '115668003']), '395058002': ('procedure', 'Viral load ', ['128927009'])}, '< 400 copies/ml on two': {'413913003': ('unit', 'Copies/milliliter ', ['767524001'])}, 'clinical visits': {'58147004': ('qualifier value', 'Clinical ', ['272099008'])}}

2861148
patients undergoing elective repair, willing/able to undertake a period of prehabilitation, and those able to comprehend and retain instructions regarding self-training.
patients undergoing elective repair, willing/able to undertake a period of prehabilitation, and those comprehend and retain instructions regarding self-training.
['patients', 'elective repair,', 'willing', '/able', 'to', 'a period of prehabilitation,', 'retain', 'instructions', 'self training']
{'patients': {'116154003': 'Patient '}, 'elective repair,': {'274075007': 'Optional surgery ', '18867006': 'Structure resulting from tissue repair process ', '298005009': 'Finding of wound healing ', '257903006': 'Repair - action ', '4365001': 'Surgical repair ', '103390000': 'Elective '}, 'willing': {'225466006': 'Willing '}, '/able': {'371150009': 'Able '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'a period of prehabilitation,': {'259037005': 'per period ', '272117007': 'Time periods '}, 'retain': {'397909002': 'Retained '}, 'instructions': {'409073007': 'Education '}, 'self training': {'118629009': 'Functional training '}}
{'elective repair,': {'274075007': ('procedure', 'Optional surgery ', ['128927009']), '298005009': ('clinical finding', 'Finding of wound healing ', ['225552003']), '4365001': ('procedure', 'Surgical repair ', ['128927009']), '103390000': ('qualifier value', 'Elective ', ['272099008'])}, 'willing': {'225466006': ('clinical finding', 'Willing ', ['250171008'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'a period of prehabilitation,': {'259037005': ('unit', 'per period ', ['767524001']), '272117007': ('qualifier value', 'Time periods ', ['272099008'])}, 'retain': {'397909002': ('qualifier value', 'Retained ', ['272099008'])}, 'instructions': {'409073007': ('procedure', 'Education ', ['128927009'])}, 'self training': {'118629009': ('procedure', 'Functional training ', ['409073007', '128927009'])}}

2870636
man and woman patients with a diagnosis of short bowel syndrome between the ages of 1-17
man and woman patients with a diagnosis of short bowel syndrome between the ages of 1-17
['man', 'woman patients with a diagnosis of short bowel syndrome', 'between the ages of 1 17']
{'man': {'339947000': 'Man ', '278412004': 'Human - origin ', '337915000': 'Homo sapiens ', '10052007': 'Male structure ', '248153007': 'Male '}, 'woman patients with a diagnosis of short bowel syndrome': {'224526002': 'Woman ', '116154003': 'Patient ', '439401001': 'Diagnosis ', '26629001': 'Short bowel syndrome '}, 'between the ages of 1 17': {'397669002': 'Age ', '424144002': 'Current chronological age '}}
{'man': {'339947000': ('person', 'Man ', ['133936004']), '278412004': ('qualifier value', 'Human - origin ', ['272099008']), '248153007': ('clinical finding', 'Male ', ['365860008'])}, 'woman patients with a diagnosis of short bowel syndrome': {'224526002': ('person', 'Woman ', ['133936004']), '26629001': ('clinical finding', 'Short bowel syndrome ', ['64572001', '118234003'])}, 'between the ages of 1 17': {'397669002': ('qualifier value', 'Age ', ['272099008']), '424144002': ('observable entity', 'Current chronological age ', ['105727008'])}}

2873596
the evaluator must be:
the evaluator must be:
[]
{}
{}

2885467-1
males or females aged ≥18 years, < 75 years.
males or females , , < 75 years.
['males', 'females', '< 75 years']
{'males': {'10052007': 'Male structure ', '248153007': 'Male '}, 'females': {'1086007': 'Female structure ', '248152002': 'Female '}, '< 75 years': {'732861002': '75', '258707000': 'year '}}
{'males': {'248153007': ('clinical finding', 'Male ', ['365860008'])}, 'females': {'248152002': ('clinical finding', 'Female ', ['365860008'])}, '< 75 years': {'258707000': ('unit', 'year ', ['767524001'])}}

2885467-2
eastern cooperative oncology group performance status 0-3. life expectancy ≥12 weeks.
eastern cooperative oncology group performance status 0-3. life expectancy ≥12 weeks.
['eastern cooperative oncology group performance status 0 3  life expectancy 12 weeks']
{'eastern cooperative oncology group performance status 0 3  life expectancy 12 weeks': {'423740007': 'Eastern Cooperative Oncology Group performance status ', '732360008': '0.3', '224130005': 'Household composition ', '385635001': 'Expectations ', '410517006': 'Expectation context ', '258705008': 'week '}}
{'eastern cooperative oncology group performance status 0 3  life expectancy 12 weeks': {'423740007': ('observable entity', 'Eastern Cooperative Oncology Group performance status ', ['278844005']), '224130005': ('observable entity', 'Household composition ', ['160476009']), '258705008': ('unit', 'week ', ['767524001'])}}

2885467-3
ability to maintain a drainage catheter.
maintain a drainage catheter.
['a drainage catheter']
{'a drainage catheter': {'307488001': 'Discharge - substance ', '75823008': 'Discharge ', '19923001': 'Catheter, device ', '122462000': 'Drainage procedure ', '129289008': 'Drainage - action '}}
{'a drainage catheter': {'307488001': ('product', 'Discharge - substance ', ['115669006']), '122462000': ('procedure', 'Drainage procedure ', ['128927009'])}}

2885467-4
previous intrapleural administration of chemotherapeutic drugs males and females should be contraceptive during the period of the trial until 8 weeks after the last administration of the drug.
, intrapleural administration of chemotherapeutic drugs males and females should be contraceptive during the period of the trial until 8 weeks after the last administration of the drug.
['intrapleural administration of chemotherapeutic drugs males', 'females', 'contraceptive during the period of the trial', 'until 8 weeks after the last administration of the drug']
{'intrapleural administration of chemotherapeutic drugs males': {'372469009': 'Intrapleural route ', '18629005': 'Administration of drug or medicament ', '416608005': 'Drug therapy ', '10052007': 'Male structure ', '248153007': 'Male ', '716872004': 'Antineoplastic chemotherapy regimen ', '363688001': 'Administration of antineoplastic agent ', '367336001': 'Chemotherapy '}, 'females': {'1086007': 'Female structure ', '248152002': 'Female '}, 'contraceptive during the period of the trial': {'108899006': 'Contraceptives ', '259037005': 'per period ', '110465008': 'Clinical trial ', '272117007': 'Time periods ', '348649005': 'Contraceptive device '}, 'until 8 weeks after the last administration of the drug': {'258705008': 'week ', '182832007': 'Procedure related to management of drug administration ', '18629005': 'Administration of drug or medicament '}}
{'intrapleural administration of chemotherapeutic drugs males': {'18629005': ('procedure', 'Administration of drug or medicament ', ['128927009']), '416608005': ('procedure', 'Drug therapy ', ['128927009', '18629005']), '248153007': ('clinical finding', 'Male ', ['365860008']), '716872004': ('procedure', 'Antineoplastic chemotherapy regimen ', ['243120004', '128927009', '18629005']), '363688001': ('procedure', 'Administration of antineoplastic agent ', ['416608005', '367336001', '128927009', '18629005']), '367336001': ('procedure', 'Chemotherapy ', ['416608005', '128927009', '18629005'])}, 'females': {'248152002': ('clinical finding', 'Female ', ['365860008'])}, 'contraceptive during the period of the trial': {'108899006': ('product', 'Contraceptives ', ['763158003']), '259037005': ('unit', 'per period ', ['767524001']), '272117007': ('qualifier value', 'Time periods ', ['272099008'])}, 'until 8 weeks after the last administration of the drug': {'258705008': ('unit', 'week ', ['767524001']), '182832007': ('procedure', 'Procedure related to management of drug administration ', ['128927009', '408766003']), '18629005': ('procedure', 'Administration of drug or medicament ', ['128927009'])}}

2899672
er+ve or er-ve
er+ve or er-ve
['er ve']
{'er ve': {'223724006': 'Venezuela '}}
{}

2916264
no unstable angina pectoris within the past 6 months
unstable angina pectoris ,
['unstable angina pectoris']
{'unstable angina pectoris': {'25106000': 'Impending infarction ', '4557003': 'Preinfarction syndrome '}}
{'unstable angina pectoris': {'25106000': ('clinical finding', 'Impending infarction ', ['64572001', '118234003']), '4557003': ('clinical finding', 'Preinfarction syndrome ', ['64572001', '102957003', '118234003'])}}

2934601
no distant metastases
distant metastases
['distant metastases']
{'distant metastases': {'371497001': 'pM category '}}
{'distant metastases': {'371497001': ('observable entity', 'pM category ', ['395531003'])}}

2952727
patient age at surgery is 12-35.
patient age at surgery is 12-35.
['patient age at surgery', '12 35']
{'patient age at surgery': {'116154003': 'Patient ', '397669002': 'Age ', '424144002': 'Current chronological age ', '257556004': 'Surgery ', '387713003': 'Surgical procedure ', '83578000': 'Surgical ', '394609007': 'General surgery '}, '12 35': {'732694002': '35'}}
{'patient age at surgery': {'397669002': ('qualifier value', 'Age ', ['272099008']), '424144002': ('observable entity', 'Current chronological age ', ['105727008']), '387713003': ('procedure', 'Surgical procedure ', ['128927009']), '83578000': ('qualifier value', 'Surgical ', ['272099008'])}}

2959596
subject does not have a history of any bleeding disorder
subject does , any bleeding disorder
['any bleeding disorder']
{'any bleeding disorder': {'362970003': 'Disorder of hemostatic system ', '64779008': 'Blood coagulation disorder ', '248250000': 'Tendency to bleed '}}
{'any bleeding disorder': {'362970003': ('clinical finding', 'Disorder of hemostatic system ', ['64572001']), '64779008': ('clinical finding', 'Blood coagulation disorder ', ['64572001', '362970003']), '248250000': ('observable entity', 'Tendency to bleed ', ['363788007'])}}

2965813
able and willing to provide informed consent
able and willing to provide informed consent
['able', 'willing', 'to', 'informed consent']
{'able': {'371150009': 'Able '}, 'willing': {'225466006': 'Willing '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'informed consent': {'108968006': 'Oprelvekin ', '410938009': 'Oprelvekin ', '223458004': 'Informing '}}
{'willing': {'225466006': ('clinical finding', 'Willing ', ['250171008'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'informed consent': {'108968006': ('product', 'Oprelvekin ', ['406455002', '312413002', '115668003']), '410938009': ('product', 'Oprelvekin ', ['763158003'])}}

2970223
completion of basic education .
completion of basic education .
['completion of basic education']
{'completion of basic education': {'255594003': 'Complete ', '63813000': 'Alkali ', '105421008': 'Educational achievement ', '266981003': 'Schooling ', '409073007': 'Education ', '418836005': 'Base - unit of product usage '}}
{'completion of basic education': {'255594003': ('qualifier value', 'Complete ', ['272099008']), '63813000': ('product', 'Alkali ', ['312413002']), '105421008': ('observable entity', 'Educational achievement ', ['160476009']), '266981003': ('observable entity', 'Schooling ', ['160476009']), '409073007': ('procedure', 'Education ', ['128927009']), '418836005': ('unit', 'Base - unit of product usage ', ['767524001'])}}

2984052
nuclear sclerosis: upto grade 3
nuclear sclerosis: upto grade 3
['nuclear sclerosis', 'upto grade 3']
{'nuclear sclerosis': {'53889007': 'Nuclear cataract ', '373414000': 'Nuclear sclerosis '}, 'upto grade 3': {'263843001': 'Poorly differentiated ', '61026006': 'G3 grade '}}
{'nuclear sclerosis': {'53889007': ('clinical finding', 'Nuclear cataract ', ['64572001', '118234003']), '373414000': ('clinical finding', 'Nuclear sclerosis ', ['118234003'])}, 'upto grade 3': {'263843001': ('qualifier value', 'Poorly differentiated ', ['272396007']), '61026006': ('clinical finding', 'G3 grade ', ['250171008', '441742003'])}}

2984079
subject has left ventricular ejection fraction ≥50%.
subject has left ventricular ejection fraction ≥50%.
['left ventricular ejection fraction 50%']
{'left ventricular ejection fraction 50%': {'250908004': 'Left ventricular ejection fraction '}}
{'left ventricular ejection fraction 50%': {'250908004': ('observable entity', 'Left ventricular ejection fraction ', ['363788007', '246464006', '414237002'])}}

2994552
8.0 g/dl
8.0 g/dl
['8 0 g/dl']
{'8 0 g/dl': {'258795003': 'Gram/deciliter '}}
{'8 0 g/dl': {'258795003': ('unit', 'Gram/deciliter ', ['767524001'])}}

3033298
meet standard nih eligibility criteria for bariatric surgery
meet standard nih eligibility criteria for bariatric surgery
['standard nih eligibility criteria for bariatric surgery']
{'standard nih eligibility criteria for bariatric surgery': {'257556004': 'Surgery ', '387713003': 'Surgical procedure ', '83578000': 'Surgical ', '394609007': 'General surgery '}}
{'standard nih eligibility criteria for bariatric surgery': {'387713003': ('procedure', 'Surgical procedure ', ['128927009']), '83578000': ('qualifier value', 'Surgical ', ['272099008'])}}

3040215
man and woman participants 15 years of age and above.
man and woman participants 15 years of age and above.
['man', 'woman participants 15 years of age', 'above']
{'man': {'339947000': 'Man ', '278412004': 'Human - origin ', '337915000': 'Homo sapiens ', '10052007': 'Male structure ', '248153007': 'Male '}, 'woman participants 15 years of age': {'224526002': 'Woman ', '258707000': 'year ', '397669002': 'Age ', '424144002': 'Current chronological age '}, 'above': {'261183002': 'Upper ', '264217000': 'Superior ', '352730000': 'Supra- '}}
{'man': {'339947000': ('person', 'Man ', ['133936004']), '278412004': ('qualifier value', 'Human - origin ', ['272099008']), '248153007': ('clinical finding', 'Male ', ['365860008'])}, 'woman participants 15 years of age': {'224526002': ('person', 'Woman ', ['133936004']), '258707000': ('unit', 'year ', ['767524001']), '397669002': ('qualifier value', 'Age ', ['272099008']), '424144002': ('observable entity', 'Current chronological age ', ['105727008'])}, 'above': {'352730000': ('qualifier value', 'Supra- ', ['272099008'])}}

3041779
fifteen patients who are 1 month to-12 months of natalizumab therapy, fifteen patients who are 24 months and over of natalizumab therapy will be asked to participate in the tnf alpha subset.
fifteen patients who are 1 month to-12 months of natalizumab therapy, fifteen patients who are 24 months and over of natalizumab therapy will be asked to participate in the tnf alpha subset.
['fifteen patients', '1 month to 12 months of natalizumab therapy', '24 months', 'over of natalizumab therapy', 'to', 'participate in the tnf alpha subset']
{'fifteen patients': {'732510001': 'fifteen', '116154003': 'Patient '}, '1 month to 12 months of natalizumab therapy': {'451231000124103': 'greater than one', '89185003': 'Monthly ', '258706009': 'month ', '414804006': 'Natalizumab ', '414805007': 'Natalizumab ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '259036001': 'per month '}, '24 months': {'258706009': 'month '}, 'over of natalizumab therapy': {'21481007': 'Over ', '414804006': 'Natalizumab ', '414805007': 'Natalizumab ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '371881003': 'during'}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'participate in the tnf alpha subset': {'413858005': 'Class Alphaproteobacteria ', '39525005': 'Tumor necrosis factor alpha ', '8612007': 'Tumor necrosis factor '}}
{'1 month to 12 months of natalizumab therapy': {'89185003': ('qualifier value', 'Monthly ', ['272099008']), '258706009': ('unit', 'month ', ['767524001']), '414804006': ('product', 'Natalizumab ', ['763158003']), '414805007': ('product', 'Natalizumab ', ['312413002', '115668003']), '276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '259036001': ('unit', 'per month ', ['767524001'])}, '24 months': {'258706009': ('unit', 'month ', ['767524001'])}, 'over of natalizumab therapy': {'21481007': ('qualifier value', 'Over ', ['272099008']), '414804006': ('product', 'Natalizumab ', ['763158003']), '414805007': ('product', 'Natalizumab ', ['312413002', '115668003']), '276239002': ('procedure', 'Therapy ', ['277132007', '243120004'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'participate in the tnf alpha subset': {'39525005': ('product', 'Tumor necrosis factor alpha ', ['8612007', '312413002', '115668003']), '8612007': ('product', 'Tumor necrosis factor ', ['312413002', '115668003'])}}

3046474
bmi 20 to 27 kg/m2
bmi 20 to 27 kg/m2
['bmi 20 to 27 kg/m2']
{'bmi 20 to 27 kg/m2': {'301331008': 'Finding of body mass index ', '732629004': '27', '258896009': 'Kilogram/square meter '}}
{'bmi 20 to 27 kg/m2': {'301331008': ('clinical finding', 'Finding of body mass index ', ['250171008']), '258896009': ('unit', 'Kilogram/square meter ', ['767524001'])}}

3057612
grade 3 histology
grade 3 histology
['grade 3 histology']
{'grade 3 histology': {'263843001': 'Poorly differentiated ', '714797009': 'Histologic test ', '61026006': 'G3 grade '}}
{'grade 3 histology': {'263843001': ('qualifier value', 'Poorly differentiated ', ['272396007']), '714797009': ('procedure', 'Histologic test ', ['128927009']), '61026006': ('clinical finding', 'G3 grade ', ['250171008', '441742003'])}}

3058013
high ldl cholesterol , on statin therapy or not
high ldl cholesterol , on statin therapy or not
['high ldl cholesterol ,', 'on statin therapy']
{'high ldl cholesterol ,': {'13644009': 'Hypercholesterolemia '}, 'on statin therapy': {'315053001': 'Statin prophylaxis '}}
{'high ldl cholesterol ,': {'13644009': ('clinical finding', 'Hypercholesterolemia ', ['64572001', '441742003'])}, 'on statin therapy': {'315053001': ('procedure', 'Statin prophylaxis ', ['128927009'])}}

3070260
nodule must be discovered at the time of diagnosis of the primary malignancy or after the completion of therapy
nodule must be discovered at the time of diagnosis of the primary malignancy or after the completion of therapy
['nodule', 'discovered at the time of diagnosis of the primary malignancy', 'or after the completion of therapy']
{'nodule': {'27925004': 'Nodule '}, 'discovered at the time of diagnosis of the primary malignancy': {'410669006': 'Time ', '410670007': 'time', '8319008': 'Principal diagnosis ', '363346000': 'Malignant neoplastic disease ', '372087000': 'Primary malignant neoplasm ', '86049000': 'Malignant neoplasm, primary ', '439401001': 'Diagnosis ', '900000000000475002': 'time '}, 'or after the completion of therapy': {'255594003': 'Complete ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure '}}
{'discovered at the time of diagnosis of the primary malignancy': {'363346000': ('clinical finding', 'Malignant neoplastic disease ', ['64572001']), '372087000': ('clinical finding', 'Primary malignant neoplasm ', ['64572001', '363346000'])}, 'or after the completion of therapy': {'255594003': ('qualifier value', 'Complete ', ['272099008']), '276239002': ('procedure', 'Therapy ', ['277132007', '243120004'])}}

3072966
response must be confirmed to be stable between the end of the previous therapy and the initiation of the trial .
response must be confirmed to be stable between the end of the , therapy and the initiation of the trial .
['confirmed', 'to', 'stable between the end of the', 'therapy', 'the initiation of the trial']
{'confirmed': {'59156000': 'Confirmed by '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'stable between the end of the': {'58158008': 'Stable ', '261782000': 'End ', '422117008': 'Stop '}, 'therapy': {'276239002': 'Therapy ', '277132007': 'Therapeutic procedure '}, 'the initiation of the trial': {'312009002': 'Cognitive function: initiation ', '110465008': 'Clinical trial '}}
{'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'stable between the end of the': {'58158008': ('qualifier value', 'Stable ', ['272099008']), '261782000': ('qualifier value', 'End ', ['272099008']), '422117008': ('qualifier value', 'Stop ', ['272099008'])}, 'therapy': {'276239002': ('procedure', 'Therapy ', ['277132007', '243120004'])}, 'the initiation of the trial': {'312009002': ('observable entity', 'Cognitive function: initiation ', ['246464006'])}}

3075082
onset of ms symptoms occurring within 90 days of randomization
onset of ms symptoms occurring , of randomization
['onset of ms symptoms', 'occurring']
{'onset of ms symptoms': {'77374008': 'Onset of '}, 'occurring': {'246454002': 'occurrence', '272120004': 'Occurrences '}}
{'occurring': {'272120004': ('qualifier value', 'Occurrences ', ['272099008'])}}

3078909
patients should not be on antibiotics for any infection but post operative antibiotics are allowed if used prophylactically but should be completed prior to starting rt.
patients should not be on antibiotics for any infection but post operative antibiotics are allowed if used prophylactically but should be completed prior to starting rt.
['patients', 'be on antibiotics', 'for any infection', 'post operative antibiotics', 'used', 'completed prior to starting rt']
{'patients': {'116154003': 'Patient '}, 'be on antibiotics': {'255631004': 'Antibiotic ', '417927007': 'Antibiotic antituberculosis agent '}, 'for any infection': {'189822004': 'Contagious disease ', '191415002': 'Communicable disease ', '40733004': 'Infectious disease '}, 'post operative antibiotics': {'262061000': 'Postoperative period ', '255631004': 'Antibiotic ', '417927007': 'Antibiotic antituberculosis agent '}, 'used': {'394850002': 'used by'}, 'completed prior to starting rt': {'255594003': 'Complete ', '236874000': 'Status pre- ', '288556008': 'before', '246062003': 'beginning', '255395001': 'Origins ', '11207009': 'Structure of right thigh '}}
{'be on antibiotics': {'255631004': ('product', 'Antibiotic ', ['763158003'])}, 'for any infection': {'40733004': ('clinical finding', 'Infectious disease ', ['64572001'])}, 'post operative antibiotics': {'262061000': ('qualifier value', 'Postoperative period ', ['272099008']), '255631004': ('product', 'Antibiotic ', ['763158003'])}, 'completed prior to starting rt': {'255594003': ('qualifier value', 'Complete ', ['272099008']), '255395001': ('qualifier value', 'Origins ', ['272099008'])}}

3107646
sign an informed consent agreement.
sign an informed consent agreement.
['sign', 'an informed consent agreement']
{'sign': {'72670004': 'Sign '}, 'an informed consent agreement': {'108968006': 'Oprelvekin ', '410938009': 'Oprelvekin ', '223458004': 'Informing '}}
{'sign': {'72670004': ('clinical finding', 'Sign ', ['250171008'])}, 'an informed consent agreement': {'108968006': ('product', 'Oprelvekin ', ['406455002', '312413002', '115668003']), '410938009': ('product', 'Oprelvekin ', ['763158003'])}}

3133800
ecog performance status < or = 2 .
ecog performance status < or = 2 .
['ecog performance status', '= 2']
{'ecog performance status': {'423740007': 'Eastern Cooperative Oncology Group performance status '}, '= 2': {'260306008': 'Integer +2 '}}
{'ecog performance status': {'423740007': ('observable entity', 'Eastern Cooperative Oncology Group performance status ', ['278844005'])}}

3142931
without physical complications that prevent the execution of physical exercises
without physical complications
['without physical complications']
{'without physical complications': {'302199004': 'Examination - action ', '5880005': 'Physical examination procedure ', '81375008': 'Physical assessment ', '116223007': 'Complication ', '19388002': 'Physical '}}
{'without physical complications': {'5880005': ('procedure', 'Physical examination procedure ', ['362958002', '128927009']), '81375008': ('procedure', 'Physical assessment ', ['128927009']), '116223007': ('clinical finding', 'Complication ', ['64572001']), '19388002': ('qualifier value', 'Physical ', ['272099008'])}}

3144224
patients >= 18 years of age at the time of informed consent
patients , at the time of informed consent
['patients', 'at the time of informed consent']
{'patients': {'116154003': 'Patient '}, 'at the time of informed consent': {'410669006': 'Time ', '410670007': 'time', '108968006': 'Oprelvekin ', '410938009': 'Oprelvekin ', '223458004': 'Informing ', '900000000000475002': 'time '}}
{'at the time of informed consent': {'108968006': ('product', 'Oprelvekin ', ['406455002', '312413002', '115668003']), '410938009': ('product', 'Oprelvekin ', ['763158003'])}}

3147482
ability to walk independently or assisted or move unassisted in a wheelchair
walk independently or assisted or move unassisted in a wheelchair
['walk', 'assisted', 'move', 'unassisted in a wheelchair']
{'walk': {'129006008': 'Walking '}, 'assisted': {'116697009': 'assisted ', '371152001': 'Assisted '}, 'move': {'302000008': 'Does move ', '384598002': 'moved from', '370125004': 'moved to'}, 'unassisted in a wheelchair': {'58938008': 'Wheelchair device '}}
{'walk': {'129006008': ('observable entity', 'Walking ', ['246464006'])}, 'move': {'302000008': ('clinical finding', 'Does move ', ['250171008'])}}

3154383
infertile females with preserved gonadal function
infertile females with preserved gonadal function
['infertile females with preserved gonadal function']
{'infertile females with preserved gonadal function': {'10114008': 'Female sterility ', '43174007': 'Gonadal structure ', '246464006': 'Function ', '277064003': 'function'}}
{'infertile females with preserved gonadal function': {'10114008': ('clinical finding', 'Female sterility ', ['118234003'])}}

3174561
occupation as a flight attendant for >= 5 years prior to the smoking ban on commercial aircraft.
occupation as a flight attendant for >= 5 years prior to the smoking ban on commercial aircraft.
['occupation as a flight attendant', '= 5 years prior to the smoking ban', 'on commercial aircraft']
{'occupation as a flight attendant': {'14679004': 'Occupation '}, '= 5 years prior to the smoking ban': {'264606005': '-5 ', '258707000': 'year ', '236874000': 'Status pre- ', '288556008': 'before', '365981007': 'Finding of tobacco smoking behavior ', '264706000': '>5 ', '264605009': 'Integer +5 '}, 'on commercial aircraft': {'21753002': 'Aircraft, device '}}
{'= 5 years prior to the smoking ban': {'258707000': ('unit', 'year ', ['767524001']), '365981007': ('clinical finding', 'Finding of tobacco smoking behavior ', ['250171008'])}}

3175892
iii) has had a bilateral tubal ligation, or
iii) has had a bilateral tubal ligation, or
['iii', 'a bilateral tubal ligation,']
{'iii': {'257471003': 'Roman numeral III '}, 'a bilateral tubal ligation,': {'287664005': 'Bilateral tubal ligation '}}
{'a bilateral tubal ligation,': {'287664005': ('procedure', 'Bilateral tubal ligation ', ['362958002', '128927009'])}}

3183098
patients 18-70 years old having a planned laparoscopic surgery with an umbilical first trocar at chus were included.
patients 18-70 years old having a planned laparoscopic surgery with an umbilical first trocar at chus were included.
['patients 18 70 years', 'old', 'a planned laparoscopic surgery with an umbilical first trocar', 'included']
{'patients 18 70 years': {'116154003': 'Patient ', '258707000': 'year '}, 'old': {'70753007': 'Old '}, 'a planned laparoscopic surgery with an umbilical first trocar': {'397943006': 'Planned ', '470582007': 'Laparoscopic trocar ', '257556004': 'Surgery ', '387713003': 'Surgical procedure ', '83578000': 'Surgical ', '78220002': 'Umbilical structure ', '255216001': 'First ', '232714002': 'Firstly ', '394609007': 'General surgery '}, 'included': {'55919000': 'Including '}}
{'patients 18 70 years': {'258707000': ('unit', 'year ', ['767524001'])}, 'old': {'70753007': ('qualifier value', 'Old ', ['272099008'])}, 'a planned laparoscopic surgery with an umbilical first trocar': {'387713003': ('procedure', 'Surgical procedure ', ['128927009']), '83578000': ('qualifier value', 'Surgical ', ['272099008']), '232714002': ('qualifier value', 'Firstly ', ['272099008'])}, 'included': {'55919000': ('qualifier value', 'Including ', ['272099008'])}}

3187381
age 18 years or older
age 18 years or older
['age 18 years', 'older']
{'age 18 years': {'397669002': 'Age ', '424144002': 'Current chronological age ', '258707000': 'year '}, 'older': {'70753007': 'Old '}}
{'age 18 years': {'397669002': ('qualifier value', 'Age ', ['272099008']), '424144002': ('observable entity', 'Current chronological age ', ['105727008']), '258707000': ('unit', 'year ', ['767524001'])}, 'older': {'70753007': ('qualifier value', 'Old ', ['272099008'])}}

3197413
patients who are older than 20 years at the time of consent
patients who are older than 20 years at the time of consent
['patients', 'older than 20 years', 'at the time of consent']
{'patients': {'116154003': 'Patient '}, 'older than 20 years': {'70753007': 'Old ', '258707000': 'year '}, 'at the time of consent': {'410669006': 'Time ', '410670007': 'time', '900000000000475002': 'time '}}
{'older than 20 years': {'70753007': ('qualifier value', 'Old ', ['272099008']), '258707000': ('unit', 'year ', ['767524001'])}}

3208808
man partner with normal semen analysis according to world health organization 2010.
man partner with normal semen analysis according to world health organization 2010.
['man partner with normal semen analysis', 'according to world health organization 2010']
{'man partner with normal semen analysis': {'339947000': 'Man ', '262043009': 'Partner in relationship ', '17621005': 'Normal ', '11900001': 'Semen analysis ', '8117002': 'Gait normal ', '258744000': '% normal ', '278412004': 'Human - origin ', '337915000': 'Homo sapiens ', '10052007': 'Male structure ', '248153007': 'Male '}, 'according to world health organization 2010': {'263775005': 'Health ', '21139007': 'Organization ', '385650005': 'Organized '}}
{'man partner with normal semen analysis': {'339947000': ('person', 'Man ', ['133936004']), '17621005': ('qualifier value', 'Normal ', ['272099008']), '11900001': ('procedure', 'Semen analysis ', ['128927009']), '8117002': ('clinical finding', 'Gait normal ', ['250171008']), '258744000': ('unit', '% normal ', ['767524001']), '278412004': ('qualifier value', 'Human - origin ', ['272099008']), '248153007': ('clinical finding', 'Male ', ['365860008'])}}

3209272
if woman, must be neither pregnant nor breast-feeding and must lack childbearing potential for the duration of the study.
if woman, must be neither pregnant nor breast-feeding and must lack childbearing potential for the duration of the study.
['woman,', 'neither pregnant', 'breast feeding', 'lack', 'childbearing potential for the duration of the study']
{'woman,': {'224526002': 'Woman '}, 'neither pregnant': {'77386006': 'Patient currently pregnant ', '127362006': 'Previous pregnancies ', '161732006': 'Gravida ', '364323006': 'Quantity of pregnancy ', '366321006': 'Finding of gravida '}, 'breast feeding': {'169741004': 'Breast fed ', '413712001': 'Breastfeeding '}, 'lack': {'41277001': 'Lacking '}, 'childbearing potential for the duration of the study': {'103335007': 'duration ', '272116003': 'Durations ', '224699009': 'Study '}}
{'woman,': {'224526002': ('person', 'Woman ', ['133936004'])}, 'neither pregnant': {'77386006': ('clinical finding', 'Patient currently pregnant ', ['250171008']), '127362006': ('clinical finding', 'Previous pregnancies ', ['250171008']), '161732006': ('observable entity', 'Gravida ', ['363788007']), '364323006': ('observable entity', 'Quantity of pregnancy ', ['363788007']), '366321006': ('clinical finding', 'Finding of gravida ', ['250171008'])}, 'breast feeding': {'169741004': ('clinical finding', 'Breast fed ', ['250171008']), '413712001': ('observable entity', 'Breastfeeding ', ['246464006'])}, 'childbearing potential for the duration of the study': {'272116003': ('qualifier value', 'Durations ', ['272099008'])}}

3227237
bmi <30 kg/m2
bmi <30 kg/m2
['bmi', '<30 kg/m2']
{'bmi': {'301331008': 'Finding of body mass index '}, '<30 kg/m2': {'258896009': 'Kilogram/square meter '}}
{'bmi': {'301331008': ('clinical finding', 'Finding of body mass index ', ['250171008'])}, '<30 kg/m2': {'258896009': ('unit', 'Kilogram/square meter ', ['767524001'])}}

3230726-1
participants must meet all inclusion criteria, verified by medical evaluation, psychological evaluation, and review of medical history.
participants must meet all inclusion criteria, verified by medical evaluation, psychological evaluation, and review of medical history.
['all inclusion criteria,', 'verified by medical evaluation,', 'psychological evaluation,', 'review of medical history']
{'all inclusion criteria,': {'55919000': 'Including '}, 'verified by medical evaluation,': {'225886003': 'Medical assessment '}, 'psychological evaluation,': {'60224009': 'Psychologic ', '129265001': 'Evaluation - action ', '386053000': 'Evaluation procedure '}, 'review of medical history': {'55210009': 'Review of ', '392521001': 'History of '}}
{'all inclusion criteria,': {'55919000': ('qualifier value', 'Including ', ['272099008'])}, 'verified by medical evaluation,': {'225886003': ('procedure', 'Medical assessment ', ['386053000', '128927009'])}, 'psychological evaluation,': {'60224009': ('qualifier value', 'Psychologic ', ['272099008']), '386053000': ('procedure', 'Evaluation procedure ', ['128927009'])}}

3230726-2
inclusion criteria include:
inclusion criteria include:
['inclusion criteria', 'include']
{'inclusion criteria': {'55919000': 'Including '}, 'include': {'55919000': 'Including '}}
{'inclusion criteria': {'55919000': ('qualifier value', 'Including ', ['272099008'])}, 'include': {'55919000': ('qualifier value', 'Including ', ['272099008'])}}

3234335
informed consent signed by the patient
informed consent signed by the patient
['informed consent', 'signed by the patient']
{'informed consent': {'108968006': 'Oprelvekin ', '410938009': 'Oprelvekin ', '223458004': 'Informing '}, 'signed by the patient': {'72670004': 'Sign ', '116154003': 'Patient '}}
{'informed consent': {'108968006': ('product', 'Oprelvekin ', ['406455002', '312413002', '115668003']), '410938009': ('product', 'Oprelvekin ', ['763158003'])}, 'signed by the patient': {'72670004': ('clinical finding', 'Sign ', ['250171008'])}}

3237608
at the discretion of the pi, concomitant medications will be permitted if the following conditions are met prior to baseline assessment :
at the discretion of the pi, concomitant medications will be permitted if the following conditions are met prior to baseline assessment :
['at the discretion of the pi,', 'concomitant medications', 'permitted', 'the following conditions', 'met prior to baseline assessment']
{'at the discretion of the pi,': {'252068008': 'Pulsatility index, arterial velocity waveform '}, 'concomitant medications': {'79970003': 'Simultaneous ', '105903003': 'General drug type ', '373873005': 'Pharmaceutical / biologic product ', '410942007': 'Drug or medicament '}, 'permitted': {'958006': 'Trachinotus falcatus '}, 'the following conditions': {'237679004': 'Status post ', '255234002': 'status post', '64572001': 'Disease ', '260905004': 'condition', '255260001': 'following'}, 'met prior to baseline assessment': {'104811002': 'Methionine measurement ', '236874000': 'Status pre- ', '288556008': 'before', '129265001': 'Evaluation - action ', '386053000': 'Evaluation procedure '}}
{'at the discretion of the pi,': {'252068008': ('observable entity', 'Pulsatility index, arterial velocity waveform ', ['363788007'])}, 'concomitant medications': {'79970003': ('qualifier value', 'Simultaneous ', ['272099008'])}, 'met prior to baseline assessment': {'104811002': ('procedure', 'Methionine measurement ', ['386053000', '128927009']), '386053000': ('procedure', 'Evaluation procedure ', ['128927009'])}}

3240747
must be able to understand and give written informed consent and comply with study procedures
must understand and give written informed consent and comply with study procedures
['understand', 'give', 'written informed consent', 'comply with study procedures']
{'understand': {'66216009': 'Understanding, function '}, 'give': {'419582001': 'Give - dosing instruction imperative '}, 'written informed consent': {'12261009': 'Writing ', '108968006': 'Oprelvekin ', '410938009': 'Oprelvekin ', '223458004': 'Informing '}, 'comply with study procedures': {'224699009': 'Study ', '71388002': 'Procedure '}}
{'understand': {'66216009': ('observable entity', 'Understanding, function ', ['246464006'])}, 'written informed consent': {'12261009': ('observable entity', 'Writing ', ['246464006']), '108968006': ('product', 'Oprelvekin ', ['406455002', '312413002', '115668003']), '410938009': ('product', 'Oprelvekin ', ['763158003'])}}

3259677
patients with her2/neu overexpression or amplification will be allowed but will be informed about other available treatment options such as lapatinib plus capecitabine.
patients with her2/neu overexpression or amplification will be allowed but will be informed about other available treatment options such as lapatinib plus capecitabine.
['patients with her2/neu overexpression', 'informed about other available treatment options', 'such as lapatinib plus capecitabine']
{'patients with her2/neu overexpression': {'116154003': 'Patient ', '44368005': 'Oncogene protein HER-2/neu '}, 'informed about other available treatment options': {'108968006': 'Oprelvekin ', '410938009': 'Oprelvekin ', '103328004': 'Availability of ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '416118004': 'Administration ', '223458004': 'Informing '}, 'such as lapatinib plus capecitabine': {'425466009': 'Lapatinib ', '425820005': 'Lapatinib ', '20401003': 'in addition to', '108761006': 'Capecitabine ', '386906001': 'Capecitabine '}}
{'patients with her2/neu overexpression': {'44368005': ('product', 'Oncogene protein HER-2/neu ', ['312413002', '115668003'])}, 'informed about other available treatment options': {'108968006': ('product', 'Oprelvekin ', ['406455002', '312413002', '115668003']), '410938009': ('product', 'Oprelvekin ', ['763158003']), '276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '416118004': ('procedure', 'Administration ', ['128927009'])}, 'such as lapatinib plus capecitabine': {'425466009': ('product', 'Lapatinib ', ['763158003']), '425820005': ('product', 'Lapatinib ', ['312413002', '312412007']), '108761006': ('product', 'Capecitabine ', ['763158003']), '386906001': ('product', 'Capecitabine ', ['406455002', '312413002'])}}

3260143
clinical stage ≥t3 disease, as determined by standard digital rectal examination
clinical stage ≥t3 disease, as determined by standard digital rectal examination
['clinical stage t3 disease', 'determined by standard digital rectal examination']
{'clinical stage t3 disease': {'58147004': 'Clinical ', '14410001': 'T3 category ', '64572001': 'Disease '}, 'determined by standard digital rectal examination': {'436000': 'Determined by ', '410006001': 'Digital examination of rectum ', '410007005': 'Rectal examination '}}
{'clinical stage t3 disease': {'58147004': ('qualifier value', 'Clinical ', ['272099008']), '14410001': ('clinical finding', 'T3 category ', ['250171008'])}, 'determined by standard digital rectal examination': {'410006001': ('procedure', 'Digital examination of rectum ', ['410007005', '362958002', '128927009']), '410007005': ('procedure', 'Rectal examination ', ['362958002', '128927009'])}}

3264414
planned sit against wasp venom or finished 5 years sit against wsp venom
planned sit against wasp venom or finished 5 years sit against wsp venom
['planned sit against wasp venom', 'finished', '5 years', 'sit against wsp venom']
{'planned sit against wasp venom': {'397943006': 'Planned ', '33586001': 'Sitting position ', '256440004': 'Wasp venom ', '421627001': 'Wasp venom ', '282967005': 'Does sit '}, 'finished': {'420604000': 'Finish - dosing instruction imperative '}, '5 years': {'264606005': '-5 ', '258707000': 'year ', '264706000': '>5 ', '264605009': 'Integer +5 '}, 'sit against wsp venom': {'33586001': 'Sitting position ', '37663002': 'Venom ', '282967005': 'Does sit '}}
{'planned sit against wasp venom': {'33586001': ('clinical finding', 'Sitting position ', ['250171008']), '256440004': ('product', 'Wasp venom ', ['406455002', '115668003']), '421627001': ('product', 'Wasp venom ', ['763158003']), '282967005': ('clinical finding', 'Does sit ', ['250171008'])}, '5 years': {'258707000': ('unit', 'year ', ['767524001'])}, 'sit against wsp venom': {'33586001': ('clinical finding', 'Sitting position ', ['250171008']), '37663002': ('product', 'Venom ', ['115668003']), '282967005': ('clinical finding', 'Does sit ', ['250171008'])}}

3268582
men or women aged 18 - 50 years or greater than 55 years old
men or women , or greater than 55 years old
['men', 'women', 'greater than 55 years', 'old']
{'men': {'339947000': 'Man '}, 'women': {'224526002': 'Woman '}, 'greater than 55 years': {'276140008': 'Greater-than symbol > ', '264691008': 'Arabic numeral 55 ', '258707000': 'year '}, 'old': {'70753007': 'Old '}}
{'men': {'339947000': ('person', 'Man ', ['133936004'])}, 'women': {'224526002': ('person', 'Woman ', ['133936004'])}, 'greater than 55 years': {'258707000': ('unit', 'year ', ['767524001'])}, 'old': {'70753007': ('qualifier value', 'Old ', ['272099008'])}}

3271512
additional inclusion criteria apply
additional inclusion criteria apply
['additional inclusion criteria', 'apply']
{'additional inclusion criteria': {'20401003': 'in addition to', '55919000': 'Including '}, 'apply': {'417924000': 'Apply - dosing instruction imperative '}}
{'additional inclusion criteria': {'55919000': ('qualifier value', 'Including ', ['272099008'])}}

3271755
histological confirmation of adenocarcinoma of the prostate with the gleason score reported .
histological confirmation of adenocarcinoma of the prostate with the gleason score reported .
['histological confirmation of adenocarcinoma of the prostate', 'with the gleason score', 'reported']
{'histological confirmation of adenocarcinoma of the prostate': {'67151002': 'Histologic ', '74996004': 'Confirmation of ', '399490008': 'Adenocarcinoma of prostate '}, 'with the gleason score': {'106241006': 'Gleason grading system for prostatic cancer ', '372278000': 'Gleason score '}, 'reported': {'229059009': 'Report ', '223458004': 'Informing ', '733985002': 'reported'}}
{'histological confirmation of adenocarcinoma of the prostate': {'67151002': ('qualifier value', 'Histologic ', ['272099008']), '399490008': ('clinical finding', 'Adenocarcinoma of prostate ', ['64572001', '118234003'])}, 'with the gleason score': {'372278000': ('observable entity', 'Gleason score ', ['395531003'])}}

3273316
b.uacr between 100 and 3000 mg/g as determined at the initial screening visit or by the mean of the 2 morning void urine specimens obtained prior to the second screening visit.
b.uacr between 100 and 3000 mg/g as determined at the initial screening visit or by the mean of the 2 morning void urine specimens obtained prior to the second screening visit.
['3000 mg/g', 'determined at the initial screening visit', 'or by the mean of the 2 morning void urine specimens', 'obtained prior to the second screening visit']
{'3000 mg/g': {'732659009': '3000', '396167009': 'Gram/kilogram ', '408168009': 'Milligram/gram ', '414718005': 'Microgram/milligram '}, 'determined at the initial screening visit': {'436000': 'Determined by ', '884001': 'Initial ', '20135006': 'Screening procedure ', '232714002': 'Firstly '}, 'or by the mean of the 2 morning void urine specimens': {'255586005': 'Mean ', '73775008': 'Morning ', '50741009': 'Urinary tract function ', '123038009': 'Specimen '}, 'obtained prior to the second screening visit': {'398092000': 'obtain', '236874000': 'Status pre- ', '288556008': 'before', '81170007': 'Second ', '20135006': 'Screening procedure ', '257997001': 'seconds ', '288495006': 'per second '}}
{'3000 mg/g': {'396167009': ('unit', 'Gram/kilogram ', ['767524001']), '408168009': ('unit', 'Milligram/gram ', ['767524001']), '414718005': ('unit', 'Microgram/milligram ', ['767524001'])}, 'determined at the initial screening visit': {'884001': ('qualifier value', 'Initial ', ['272099008']), '20135006': ('procedure', 'Screening procedure ', ['128927009']), '232714002': ('qualifier value', 'Firstly ', ['272099008'])}, 'or by the mean of the 2 morning void urine specimens': {'255586005': ('qualifier value', 'Mean ', ['272099008']), '73775008': ('qualifier value', 'Morning ', ['272099008']), '50741009': ('observable entity', 'Urinary tract function ', ['246464006'])}, 'obtained prior to the second screening visit': {'81170007': ('qualifier value', 'Second ', ['272099008']), '20135006': ('procedure', 'Screening procedure ', ['128927009']), '257997001': ('unit', 'seconds ', ['767524001']), '288495006': ('unit', 'per second ', ['767524001'])}}

3420
cardiac arrhythmias requiring anti-arrhythmic therapy other than beta blockers or digoxin.
cardiac arrhythmias requiring anti-arrhythmic therapy other than beta blockers or digoxin.
['cardiac arrhythmias', 'anti arrhythmic therapy other than beta blockers', 'digoxin']
{'cardiac arrhythmias': {'698247007': 'Cardiac arrhythmia '}, 'anti arrhythmic therapy other than beta blockers': {'372813008': 'Antiarrhythmic agent ', '67507000': 'Antiarrhythmic drug ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '33252009': 'beta-Blocking agent ', '373254001': 'beta-Blocking agent '}, 'digoxin': {'387461009': 'Digoxin ', '796001': 'Digoxin '}}
{'cardiac arrhythmias': {'698247007': ('clinical finding', 'Cardiac arrhythmia ', ['64572001', '118234003'])}, 'anti arrhythmic therapy other than beta blockers': {'67507000': ('product', 'Antiarrhythmic drug ', ['763158003']), '276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '33252009': ('product', 'beta-Blocking agent ', ['763158003']), '373254001': ('product', 'beta-Blocking agent ', ['406455002'])}, 'digoxin': {'387461009': ('product', 'Digoxin ', ['406455002', '312413002', '372813008']), '796001': ('product', 'Digoxin ', ['763158003'])}}

6941
diabetes mellitus
diabetes mellitus
['diabetes mellitus']
{'diabetes mellitus': {'73211009': 'Diabetes mellitus '}}
{'diabetes mellitus': {'73211009': ('clinical finding', 'Diabetes mellitus ', ['64572001', '118234003'])}}

13702
a primary active mental illness diagnosis other than schizoaffective disorder
a primary active mental illness diagnosis other than schizoaffective disorder
['a primary active mental illness diagnosis other than schizoaffective disorder']
{'a primary active mental illness diagnosis other than schizoaffective disorder': {'8319008': 'Principal diagnosis ', '55561003': 'Active ', '74732009': 'Mental disorder ', '191567000': 'Schizoaffective schizophrenia ', '68890003': 'Schizoaffective disorder '}}
{'a primary active mental illness diagnosis other than schizoaffective disorder': {'55561003': ('qualifier value', 'Active ', ['272099008']), '74732009': ('clinical finding', 'Mental disorder ', ['64572001']), '191567000': ('clinical finding', 'Schizoaffective schizophrenia ', ['64572001', '68890003', '74732009']), '68890003': ('clinical finding', 'Schizoaffective disorder ', ['64572001', '74732009'])}}

22403
too large to fit in the magnet
too large to fit in the magnet
['too large', 'to', 'fit in the magnet']
{'too large': {'255509001': 'Large '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'fit in the magnet': {'91175000': 'Seizure ', '44396004': 'Magnet, device '}}
{'too large': {'255509001': ('qualifier value', 'Large ', ['272099008'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'fit in the magnet': {'91175000': ('clinical finding', 'Seizure ', ['102957003', '118234003'])}}

24263
has known hypersensitivity to pembrolizumab and/or epacadostat or any of their excipients
has known hypersensitivity to pembrolizumab and/or epacadostat or any of their excipients
['known hypersensitivity to pembrolizumab', 'any of their excipients']
{'known hypersensitivity to pembrolizumab': {'36692007': 'Known ', '418634005': 'Allergic reaction caused by substance ', '421961002': 'Hypersensitivity reaction ', '716125002': 'Pembrolizumab ', '421369008': 'Emotional hypersensitivity '}, 'any of their excipients': {'360215002': 'Pharmaceutical excipient ', '43747001': 'Drug excipient '}}
{'known hypersensitivity to pembrolizumab': {'418634005': ('clinical finding', 'Allergic reaction caused by substance ', ['64572001', '421961002']), '421961002': ('clinical finding', 'Hypersensitivity reaction ', ['64572001']), '716125002': ('product', 'Pembrolizumab ', ['312413002', '115668003']), '421369008': ('clinical finding', 'Emotional hypersensitivity ', ['250171008'])}, 'any of their excipients': {'360215002': ('product', 'Pharmaceutical excipient ', ['312412007'])}}

29709
history of solid organ transplantation or collagen vascular disease
, solid organ transplantation or collagen vascular disease
['solid organ transplantation', 'collagen vascular disease']
{'solid organ transplantation': {'256885008': 'Solid organ ', '129406001': 'Transplantation - action ', '263903005': 'Transplant ', '77465005': 'Transplantation '}, 'collagen vascular disease': {'81573002': 'Collagen disease '}}
{'solid organ transplantation': {'256885008': ('qualifier value', 'Solid organ ', ['272099008']), '263903005': ('qualifier value', 'Transplant ', ['272099008']), '77465005': ('procedure', 'Transplantation ', ['128927009'])}, 'collagen vascular disease': {'81573002': ('clinical finding', 'Collagen disease ', ['64572001', '118234003'])}}

39217
facial trauma or burns that might interfere with the esophageal catheter placement
facial trauma or burns
['facial trauma', 'burns']
{'facial trauma': {'125593007': 'Injury of face '}, 'burns': {'125666000': 'Burn ', '48333001': 'Burn injury '}}
{'facial trauma': {'125593007': ('clinical finding', 'Injury of face ', ['64572001', '118234003'])}, 'burns': {'125666000': ('clinical finding', 'Burn ', ['64572001'])}}

44094
sub-retinal fibrosis in the study eye
sub-retinal fibrosis in the study eye
['sub retinal fibrosis in the study eye']
{'sub retinal fibrosis in the study eye': {'261089000': 'Inferior ', '351726001': 'Below ', '5665001': 'Retinal structure ', '112674009': 'Fibrosis ', '263756000': 'Fibrosis ', '224699009': 'Study ', '371398005': 'Eye region structure ', '81745001': 'Structure of eye proper ', '118555000': 'Substance amount '}}
{'sub retinal fibrosis in the study eye': {'351726001': ('qualifier value', 'Below ', ['272099008']), '263756000': ('qualifier value', 'Fibrosis ', ['272099008'])}}

47631
evidence of bleeding diathesis or coagulopathy
evidence of bleeding diathesis or coagulopathy
['evidence of bleeding diathesis', 'coagulopathy']
{'evidence of bleeding diathesis': {'18669006': 'Evidence of ', '362970003': 'Disorder of hemostatic system ', '64779008': 'Blood coagulation disorder ', '248250000': 'Tendency to bleed '}, 'coagulopathy': {'362970003': 'Disorder of hemostatic system ', '64779008': 'Blood coagulation disorder '}}
{'evidence of bleeding diathesis': {'362970003': ('clinical finding', 'Disorder of hemostatic system ', ['64572001']), '64779008': ('clinical finding', 'Blood coagulation disorder ', ['64572001', '362970003']), '248250000': ('observable entity', 'Tendency to bleed ', ['363788007'])}, 'coagulopathy': {'362970003': ('clinical finding', 'Disorder of hemostatic system ', ['64572001']), '64779008': ('clinical finding', 'Blood coagulation disorder ', ['64572001', '362970003'])}}

57907
any current serious disorders determined to be clinically significant to the study.
any current serious disorders determined to be clinically significant to the study.
['any current serious disorders', 'to', 'clinically significant to the study']
{'any current serious disorders': {'15240007': 'Current ', '42745003': 'Serious ', '64572001': 'Disease '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'clinically significant to the study': {'386134007': 'Significant ', '224699009': 'Study '}}
{'any current serious disorders': {'42745003': ('qualifier value', 'Serious ', ['272099008'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}}

60279
previous adjuvant therapy with capecitabine+platinum
, adjuvant therapy with capecitabine+platinum
['adjuvant therapy with capecitabine platinum']
{'adjuvant therapy with capecitabine platinum': {'372861001': 'Immune enhancement agent ', '427067006': 'Immunologic adjuvant ', '81759008': 'Immune enhancement agent ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '108761006': 'Capecitabine ', '386906001': 'Capecitabine ', '84847000': 'Platinum '}}
{'adjuvant therapy with capecitabine platinum': {'427067006': ('product', 'Immunologic adjuvant ', ['115668003']), '81759008': ('product', 'Immune enhancement agent ', ['763158003']), '276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '108761006': ('product', 'Capecitabine ', ['763158003']), '386906001': ('product', 'Capecitabine ', ['406455002', '312413002']), '84847000': ('product', 'Platinum ', ['406455002', '312413002'])}}

62543
malarial hepatopathy, enteric hepatitis, alcoholic hepatitis, or ischemic hepatitis.
malarial hepatopathy, enteric hepatitis, alcoholic hepatitis, or ischemic hepatitis.
['malarial hepatopathy,', 'enteric hepatitis,', 'alcoholic hepatitis,', 'ischemic hepatitis']
{'malarial hepatopathy,': {'105649009': 'Disease caused by Plasmodiidae ', '248437004': 'Malarial fever ', '61462000': 'Malaria ', '235856003': 'Disorder of liver '}, 'enteric hepatitis,': {'225770002': 'Enteral ', '128241005': 'Inflammatory disease of liver ', '40468003': 'Viral hepatitis, type A '}, 'alcoholic hepatitis,': {'235875008': 'Alcoholic hepatitis '}, 'ischemic hepatitis': {'235877000': 'Ischemic hepatitis '}}
{'malarial hepatopathy,': {'105649009': ('clinical finding', 'Disease caused by Plasmodiidae ', ['64572001']), '248437004': ('clinical finding', 'Malarial fever ', ['250171008']), '61462000': ('clinical finding', 'Malaria ', ['64572001', '105649009']), '235856003': ('clinical finding', 'Disorder of liver ', ['64572001', '118234003'])}, 'enteric hepatitis,': {'128241005': ('clinical finding', 'Inflammatory disease of liver ', ['64572001', '235856003', '118234003']), '40468003': ('clinical finding', 'Viral hepatitis, type A ', ['64572001', '235856003', '118234003', '128241005'])}, 'alcoholic hepatitis,': {'235875008': ('clinical finding', 'Alcoholic hepatitis ', ['64572001', '235856003', '118234003', '128241005'])}, 'ischemic hepatitis': {'235877000': ('clinical finding', 'Ischemic hepatitis ', ['64572001', '235856003', '118234003', '128241005'])}}

70643
an expected survival, in the opinion of the investigator that would not permit a sufficient observation period for evaluating on 01910.na.
an expected survival, in the opinion of the investigator .na.
['an expected survival,', 'in the opinion of the investigator  na']
{'an expected survival,': {'385635001': 'Expectations ', '410517006': 'Expectation context '}, 'in the opinion of the investigator  na': {'385432009': 'Not applicable '}}
{'in the opinion of the investigator  na': {'385432009': ('qualifier value', 'Not applicable ', ['272099008'])}}

82311
the subject has had a blood transfusion during the current pregnancy
the subject has had a blood transfusion during the current pregnancy
['a blood transfusion during the current pregnancy']
{'a blood transfusion during the current pregnancy': {'116859006': 'Transfusion of blood product ', '15240007': 'Current ', '289908002': 'Pregnancy, function ', '77386006': 'Patient currently pregnant ', '161664006': 'History of blood transfusion '}}
{'a blood transfusion during the current pregnancy': {'116859006': ('procedure', 'Transfusion of blood product ', ['128927009']), '289908002': ('observable entity', 'Pregnancy, function ', ['246464006']), '77386006': ('clinical finding', 'Patient currently pregnant ', ['250171008']), '161664006': ('situation with explicit context', 'History of blood transfusion ', ['129125009'])}}

92281
subject at an immediate need of transfusion or with a hb <8 g/dl or with a hb >15 g/dl.
subject at an immediate need of transfusion or with a hb <8 g/dl or with a hb >15 g/dl.
['subject at an immediate need of transfusion', 'or with a hb <8 g/dl', 'or with a hb >15 g/dl']
{'subject at an immediate need of transfusion': {'88694003': 'Immediate ', '410525008': 'Needed ', '116859006': 'Transfusion of blood product ', '303955003': 'Transfusion - action ', '5447007': 'Transfusion ', '103325001': 'Patient need for ', '49499008': 'Stat '}, 'or with a hb <8 g/dl': {'31299006': 'Hemoglobin A ', '258795003': 'Gram/deciliter '}, 'or with a hb >15 g/dl': {'31299006': 'Hemoglobin A ', '258795003': 'Gram/deciliter '}}
{'subject at an immediate need of transfusion': {'88694003': ('qualifier value', 'Immediate ', ['272099008']), '116859006': ('procedure', 'Transfusion of blood product ', ['128927009', '5447007']), '5447007': ('procedure', 'Transfusion ', ['128927009']), '49499008': ('qualifier value', 'Stat ', ['272099008'])}, 'or with a hb <8 g/dl': {'31299006': ('product', 'Hemoglobin A ', ['312413002', '115668003']), '258795003': ('unit', 'Gram/deciliter ', ['767524001'])}, 'or with a hb >15 g/dl': {'31299006': ('product', 'Hemoglobin A ', ['312413002', '115668003']), '258795003': ('unit', 'Gram/deciliter ', ['767524001'])}}

92362
participation in another clinical study with a non-biologic investigational product or new formulation of a marketed non-biologic drug within 3 months prior to the screening visit.
participation in another clinical study with a non-biologic investigational product or new formulation of a marketed non-biologic drug , prior to the screening visit.
['participation in another clinical study', 'with a non biologic investigational product', 'new formulation of a marketed non biologic drug', 'prior to the screening visit']
{'participation in another clinical study': {'58147004': 'Clinical ', '224699009': 'Study '}, 'with a non biologic investigational product': {'436621000124106': 'biologic product origin', '129265001': 'Evaluation - action ', '386053000': 'Evaluation procedure '}, 'new formulation of a marketed non biologic drug': {'7147002': 'New ', '284440009': 'Market ', '115668003': 'Biological substance ', '418980009': 'Biological agent ', '69509008': 'Biological agent ', '421967003': 'Drug dose form ', '12893009': 'Biologic '}, 'prior to the screening visit': {'20135006': 'Screening procedure '}}
{'participation in another clinical study': {'58147004': ('qualifier value', 'Clinical ', ['272099008'])}, 'with a non biologic investigational product': {'436621000124106': ('qualifier value', 'biologic product origin', ['272099008', '12893009']), '386053000': ('procedure', 'Evaluation procedure ', ['128927009'])}, 'new formulation of a marketed non biologic drug': {'7147002': ('qualifier value', 'New ', ['272099008']), '12893009': ('qualifier value', 'Biologic ', ['272099008'])}, 'prior to the screening visit': {'20135006': ('procedure', 'Screening procedure ', ['386053000', '128927009'])}}

98571
> two moderate/severe ipf exacerbations within the past year exacerbation is defined as worsening of two or more of the following major symptoms: dyspnea, sputum volume, sputum purulence or worsening of any one major symptom together with >= one of the following additional symptoms: sore throat, colds , fever > 37.5 ° c without any explained cause, increased cough, increase wheeze.
> two moderate/severe ipf exacerbations with , exacerbation is defined as worsening of two or more of the following major symptoms: dyspnea, sputum volume, sputum purulence or worsening of any one major symptom together with >= one of the following additional symptoms: sore throat, colds , fever > 37.5 ° c without any explained cause, increased cough, increase wheeze.
['> two', 'moderate', '/severe ipf exacerbations with', 'defined as worsening of two', 'more of the following major symptoms', 'dyspnea,', 'sputum volume,', 'sputum purulence', 'worsening of any one major symptom', '= one of the following additional symptoms', 'sore throat,', 'colds ,', 'fever', '> 37 5  c without any explained cause', 'increased cough,', 'increase wheeze']
{'> two': {'19338005': 'Two '}, 'moderate': {'6736007': 'Moderate '}, '/severe ipf exacerbations with': {'24484000': 'Severe ', '51615001': 'Fibrosis of lung ', '196125002': 'Diffuse interstitial pulmonary fibrosis ', '426437004': 'Familial idiopathic pulmonary fibrosis '}, 'defined as worsening of two': {'900000000000073002': 'sufficiently defined concept definition status ', '230993007': 'Worsening ', '19338005': 'Two ', '231877006': 'Worse '}, 'more of the following major symptoms': {'242762006': 'More ', '367409002': 'followed by', '24484000': 'Severe ', '255603008': 'Major ', '421939007': 'Follow - dosing instruction imperative '}, 'dyspnea,': {'230145002': 'Difficulty breathing ', '267036007': 'Dyspnea '}, 'sputum volume,': {'248598005': 'Sputum volume '}, 'sputum purulence': {'42192008': 'Purulent sputum '}, 'worsening of any one major symptom': {'230993007': 'Worsening ', '38112003': 'One ', '24484000': 'Severe ', '255603008': 'Major ', '231877006': 'Worse '}, '= one of the following additional symptoms': {'38112003': 'One ', '367409002': 'followed by', '20401003': 'in addition to', '421939007': 'Follow - dosing instruction imperative '}, 'sore throat,': {'405737000': 'Pharyngitis ', '162397003': 'Pain in throat ', '267102003': 'Sore throat symptom '}, 'colds ,': {'82272006': 'Common cold '}, 'fever': {'386661006': 'Fever ', '50177009': 'Body temperature above reference range ', '248427009': 'Fever symptoms '}, '> 37 5  c without any explained cause': {'732706002': '37.5'}, 'increased cough,': {'35105006': 'Increased ', '263731006': 'Coughing ', '272039006': 'Complaining of cough ', '49727002': 'Cough ', '260366006': 'Increase '}, 'increase wheeze': {'260366006': 'Increase ', '56018004': 'Wheezing '}}
{'moderate': {'6736007': ('qualifier value', 'Moderate ', ['272396007'])}, '/severe ipf exacerbations with': {'24484000': ('qualifier value', 'Severe ', ['272396007']), '51615001': ('clinical finding', 'Fibrosis of lung ', ['64572001', '118234003']), '196125002': ('clinical finding', 'Diffuse interstitial pulmonary fibrosis ', ['64572001', '51615001', '118234003']), '426437004': ('clinical finding', 'Familial idiopathic pulmonary fibrosis ', ['64572001', '51615001', '118234003'])}, 'defined as worsening of two': {'230993007': ('qualifier value', 'Worsening ', ['272099008'])}, 'more of the following major symptoms': {'242762006': ('qualifier value', 'More ', ['272099008']), '24484000': ('qualifier value', 'Severe ', ['272396007']), '255603008': ('qualifier value', 'Major ', ['272396007'])}, 'dyspnea,': {'230145002': ('clinical finding', 'Difficulty breathing ', ['118234003']), '267036007': ('clinical finding', 'Dyspnea ', ['118234003', '230145002'])}, 'sputum volume,': {'248598005': ('observable entity', 'Sputum volume ', ['364684009', '414237002'])}, 'sputum purulence': {'42192008': ('clinical finding', 'Purulent sputum ', ['248595008'])}, 'worsening of any one major symptom': {'230993007': ('qualifier value', 'Worsening ', ['272099008']), '24484000': ('qualifier value', 'Severe ', ['272396007']), '255603008': ('qualifier value', 'Major ', ['272396007'])}, 'sore throat,': {'405737000': ('clinical finding', 'Pharyngitis ', ['64572001', '118234003']), '162397003': ('clinical finding', 'Pain in throat ', ['102957003', '118234003']), '267102003': ('clinical finding', 'Sore throat symptom ', ['418799008', '162397003', '102957003', '118234003'])}, 'colds ,': {'82272006': ('clinical finding', 'Common cold ', ['64572001', '118234003'])}, 'fever': {'386661006': ('clinical finding', 'Fever ', ['250171008', '50177009']), '50177009': ('clinical finding', 'Body temperature above reference range ', ['250171008']), '248427009': ('clinical finding', 'Fever symptoms ', ['418799008', '250171008'])}, 'increased cough,': {'35105006': ('qualifier value', 'Increased ', ['272099008']), '272039006': ('clinical finding', 'Complaining of cough ', ['418799008', '118234003', '49727002']), '49727002': ('clinical finding', 'Cough ', ['118234003'])}, 'increase wheeze': {'56018004': ('clinical finding', 'Wheezing ', ['118234003'])}}

142364
active iritis
active iritis
['active iritis']
{'active iritis': {'55561003': 'Active ', '65074000': 'Iritis '}}
{'active iritis': {'55561003': ('qualifier value', 'Active ', ['272099008']), '65074000': ('clinical finding', 'Iritis ', ['64572001', '118234003'])}}

143462
any biopsy-proven hsil partially outside of the etz
any biopsy-proven hsil partially outside of the etz
['any biopsy proven hsil partially outside of the etz']
{'any biopsy proven hsil partially outside of the etz': {'129314006': 'Biopsy - action ', '86273004': 'Biopsy ', '277025001': 'Proven ', '22725004': 'High-grade squamous intraepithelial lesion ', '261074009': 'External '}}
{'any biopsy proven hsil partially outside of the etz': {'86273004': ('procedure', 'Biopsy ', ['128927009'])}}

147214
life expectancy < 12 months
life expectancy < 12 months
['life expectancy', '< 12 months']
{'life expectancy': {'224130005': 'Household composition ', '385635001': 'Expectations ', '410517006': 'Expectation context '}, '< 12 months': {'258706009': 'month '}}
{'life expectancy': {'224130005': ('observable entity', 'Household composition ', ['160476009'])}, '< 12 months': {'258706009': ('unit', 'month ', ['767524001'])}}

153547
keratolytic-containing therapeutic products or medicated or irritant topical salves within 2 weeks of visit 1/baseline, including, but not limited to, alpha hydroxy acids , beta hydroxy acid , and urea >5%;
keratolytic-containing therapeutic products or medicated or irritant topical salves , of visit 1/baseline, including, but not limited to, alpha hydroxy acids , beta hydroxy acid , and urea >5%;
['keratolytic containing therapeutic products', 'irritant topical salves', 'including', 'limited to,', 'alpha hydroxy acids ,', 'beta hydroxy acid ,', 'urea', '>5%']
{'keratolytic containing therapeutic products': {'280906005': 'Keratolytic ', '42504009': 'Containing ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '262202000': 'Therapeutic intent '}, 'irritant topical salves': {'255756000': 'Chemical irritant ', '406429003': 'Irritant ', '412453003': 'Irritant ', '359540000': 'Topical ', '385101003': 'Ointment ', '417519007': 'Ointment ', '263789000': 'Irritant '}, 'including': {'55919000': 'Including '}, 'limited to,': {'255469002': 'Limited ', '900000000000486000': 'limited component '}, 'alpha hydroxy acids ,': {'263660008': 'Greek letter alpha ', '34957004': 'Acid '}, 'beta hydroxy acid ,': {'52095000': 'Beta ', '34957004': 'Acid ', '5022001': 'Lysergic acid diethylamide measurement ', '260989008': 'Greek letter beta '}, 'urea': {'16858004': 'Urea ', '387092000': 'Urea '}, '>5%': {'264606005': '-5 ', '264706000': '>5 ', '264605009': 'Integer +5 '}}
{'keratolytic containing therapeutic products': {'280906005': ('product', 'Keratolytic ', ['763158003']), '42504009': ('qualifier value', 'Containing ', ['272099008']), '276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '262202000': ('qualifier value', 'Therapeutic intent ', ['272099008'])}, 'irritant topical salves': {'255756000': ('product', 'Chemical irritant ', ['406429003', '312413002', '312412007']), '412453003': ('product', 'Irritant ', ['763158003']), '359540000': ('qualifier value', 'Topical ', ['272099008']), '263789000': ('qualifier value', 'Irritant ', ['272099008'])}, 'including': {'55919000': ('qualifier value', 'Including ', ['272099008'])}, 'limited to,': {'255469002': ('qualifier value', 'Limited ', ['272099008'])}, 'alpha hydroxy acids ,': {'34957004': ('product', 'Acid ', ['312413002'])}, 'beta hydroxy acid ,': {'34957004': ('product', 'Acid ', ['312413002']), '5022001': ('procedure', 'Lysergic acid diethylamide measurement ', ['128927009'])}, 'urea': {'16858004': ('product', 'Urea ', ['763158003']), '387092000': ('product', 'Urea ', ['406455002', '312413002'])}}

160624
patients with hiatal hernia and full stomach patients.
patients with hiatal hernia and full stomach patients.
['patients with hiatal hernia', 'full stomach patients']
{'patients with hiatal hernia': {'116154003': 'Patient ', '84089009': 'Hiatal hernia '}, 'full stomach patients': {'261015003': 'Full ', '69695003': 'Stomach structure ', '116154003': 'Patient '}}
{'patients with hiatal hernia': {'84089009': ('clinical finding', 'Hiatal hernia ', ['64572001', '118234003'])}, 'full stomach patients': {'261015003': ('qualifier value', 'Full ', ['272099008'])}}

162458
the subject is known to be positive for hepbsag, or hcv rna.
the subject is known to be positive for hepbsag, or hcv rna.
['known', 'to', 'positive for hepbsag,', 'hcv rna']
{'known': {'36692007': 'Known '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'positive for hepbsag,': {'10828004': 'Positive '}, 'hcv rna': {'62944002': 'Hepatitis C virus ', '27888000': 'Ribonucleic acid '}}
{'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'positive for hepbsag,': {'10828004': ('qualifier value', 'Positive ', ['272099008'])}, 'hcv rna': {'62944002': ('clinical finding', 'Hepatitis C virus ', ['49872002']), '27888000': ('product', 'Ribonucleic acid ', ['312413002'])}}

185577
psychologically incapable of undergoing bmt with associated strict isolation or documented history of medical non-compliance.
psychologically incapable of undergoing bmt with associated strict isolation or documented , medical non-compliance.
['psychologically incapable of undergoing bmt', 'with associated strict isolation', 'documented , medical non compliance']
{'psychologically incapable of undergoing bmt': {'23719005': 'Transplantation of bone marrow '}, 'with associated strict isolation': {'47429007': 'associated with', '40174006': 'Isolation procedure ', '46651001': 'Isolated '}, 'documented , medical non compliance': {'397934002': 'Documented ', '7058009': 'Noncompliance with treatment '}}
{'psychologically incapable of undergoing bmt': {'23719005': ('procedure', 'Transplantation of bone marrow ', ['362958002', '128927009'])}, 'with associated strict isolation': {'40174006': ('procedure', 'Isolation procedure ', ['408767007']), '46651001': ('qualifier value', 'Isolated ', ['272099008'])}, 'documented , medical non compliance': {'7058009': ('clinical finding', 'Noncompliance with treatment ', ['250171008'])}}

188522
have a medical condition that would, in the opinion of the study physician, make participation medically hazardous.
have a medical condition that would, in the opinion of the study physician, make participation medically hazardous.
['a medical condition', 'in the opinion of the study physician,']
{'a medical condition': {'373655009': 'Medical service ', '64572001': 'Disease ', '260905004': 'condition', '74188005': 'Medical '}, 'in the opinion of the study physician,': {'224699009': 'Study ', '112247003': 'Medical doctor ', '158965000': 'Medical practitioner ', '309343006': 'Physician '}}
{'a medical condition': {'74188005': ('qualifier value', 'Medical ', ['272099008'])}}

196061
current alcoholism, and/or any known current addiction to pain medications
current alcoholism, and/or any known current addiction to pain medications
['current alcoholism,', 'any known current addiction to pain medications']
{'current alcoholism,': {'15240007': 'Current ', '284591009': 'Persistent alcohol abuse ', '66590003': 'Alcohol dependence ', '7200002': 'Alcoholism '}, 'any known current addiction to pain medications': {'36692007': 'Known ', '15240007': 'Current ', '22253000': 'Pain ', '2403008': 'Psychoactive substance dependence '}}
{'current alcoholism,': {'284591009': ('clinical finding', 'Persistent alcohol abuse ', ['64572001', '2403008', '7200002']), '66590003': ('clinical finding', 'Alcohol dependence ', ['64572001', '2403008', '7200002']), '7200002': ('clinical finding', 'Alcoholism ', ['64572001', '2403008'])}, 'any known current addiction to pain medications': {'22253000': ('clinical finding', 'Pain ', ['102957003']), '2403008': ('clinical finding', 'Psychoactive substance dependence ', ['64572001'])}}

196388
any condition that impairs patient's ability to swallow whole pills.
any condition that impairs patient's swallow whole pills.
['any condition', "patient's swallow whole pills"]
{'any condition': {'64572001': 'Disease ', '260905004': 'condition'}, "patient's swallow whole pills": {'116154003': 'Patient ', '107160003': 'Family Hirundinidae ', '260232004': 'Whole ', '46992007': 'Pill ', '421521009': 'Swallow - dosing instruction imperative '}}
{"patient's swallow whole pills": {'260232004': ('qualifier value', 'Whole ', ['272099008'])}}

200237
prior concurrent therapy:
prior concurrent therapy:
['prior concurrent therapy']
{'prior concurrent therapy': {'236874000': 'Status pre- ', '288556008': 'before', '68405009': 'Concurrent ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure '}}
{'prior concurrent therapy': {'68405009': ('qualifier value', 'Concurrent ', ['272099008']), '276239002': ('procedure', 'Therapy ', ['277132007', '243120004'])}}

202292
history of seizures, strokes, degenerative neurological disease, fibromyalgia, diabetic neuropathy, thyroid dysfunction, hypotension, clinically significant arthritis or musculoskeletal disorder.
, seizures, strokes, degenerative neurological disease, fibromyalgia, diabetic neuropathy, thyroid dysfunction, hypotension, clinically significant arthritis or musculoskeletal disorder.
['seizures,', 'strokes,', 'degenerative neurological disease,', 'fibromyalgia,', 'diabetic neuropathy,', 'thyroid dysfunction,', 'hypotension,', 'clinically significant arthritis', 'musculoskeletal disorder']
{'seizures,': {'91175000': 'Seizure '}, 'strokes,': {'230690007': 'Cerebrovascular accident '}, 'degenerative neurological disease,': {'362975008': 'Degenerative disorder ', '1199008': 'Neurologic ', '107669003': 'Degenerative abnormality ', '33359002': 'Degeneration ', '118940003': 'Disorder of nervous system '}, 'fibromyalgia,': {'203082005': 'Fibromyalgia ', '203102006': 'Muscular rheumatism ', '24693007': 'Fibromyositis ', '56557000': 'Fibrositis ', '726531007': 'fibromyalgia'}, 'diabetic neuropathy,': {'230572002': 'Diabetic neuropathy '}, 'thyroid dysfunction,': {'264580006': 'Thyroid dysfunction '}, 'hypotension,': {'45007003': 'Low blood pressure '}, 'clinically significant arthritis': {'386134007': 'Significant ', '3723001': 'Arthritis '}, 'musculoskeletal disorder': {'928000': 'Disorder of musculoskeletal system '}}
{'seizures,': {'91175000': ('clinical finding', 'Seizure ', ['102957003', '118234003'])}, 'strokes,': {'230690007': ('clinical finding', 'Cerebrovascular accident ', ['64572001', '118940003', '118234003'])}, 'degenerative neurological disease,': {'362975008': ('clinical finding', 'Degenerative disorder ', ['64572001']), '1199008': ('qualifier value', 'Neurologic ', ['272099008']), '118940003': ('clinical finding', 'Disorder of nervous system ', ['64572001', '118234003'])}, 'fibromyalgia,': {'203082005': ('clinical finding', 'Fibromyalgia ', ['64572001', '102957003', '118234003']), '203102006': ('clinical finding', 'Muscular rheumatism ', ['64572001', '928000', '118234003']), '24693007': ('clinical finding', 'Fibromyositis ', ['64572001', '928000', '118234003']), '56557000': ('clinical finding', 'Fibrositis ', ['64572001', '928000', '102957003', '118234003']), '726531007': ('clinical finding', 'fibromyalgia', ['64572001', '928000', '102957003', '118234003'])}, 'diabetic neuropathy,': {'230572002': ('clinical finding', 'Diabetic neuropathy ', ['64572001', '118940003', '118234003'])}, 'thyroid dysfunction,': {'264580006': ('clinical finding', 'Thyroid dysfunction ', ['64572001', '118234003'])}, 'hypotension,': {'45007003': ('clinical finding', 'Low blood pressure ', ['64572001', '118234003'])}, 'clinically significant arthritis': {'3723001': ('clinical finding', 'Arthritis ', ['64572001', '928000', '118234003'])}, 'musculoskeletal disorder': {'928000': ('clinical finding', 'Disorder of musculoskeletal system ', ['64572001', '118234003'])}}

204607
subjects will be ineligible to participate in the study if they meet any of the following criteria:
subjects will be ineligible to participate in the study if they meet any of the following criteria:
['to', 'participate in the study', 'any of the following criteria']
{'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'participate in the study': {'224699009': 'Study '}, 'any of the following criteria': {'237679004': 'Status post ', '255234002': 'status post', '255260001': 'following'}}
{'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}}

213238
cardiogenic shock
cardiogenic shock
['cardiogenic shock']
{'cardiogenic shock': {'89138009': 'Cardiogenic shock '}}
{'cardiogenic shock': {'89138009': ('clinical finding', 'Cardiogenic shock ', ['64572001', '118234003'])}}

215122
prior therapy with sunitinib or anti-pd-1 antibodies or anti-pdl-1 antibodies prior therapy with other kit inhibitors allowed but results from these patients will be analyzed separately.
prior therapy with sunitinib or anti-pd-1 antibodies or anti-pdl-1 antibodies prior therapy with other kit inhibitors allowed but results from these patients will be analyzed separately.
['prior therapy with sunitinib', 'anti pd 1 antibodies', 'anti pdl 1 antibodies prior therapy with other kit inhibitors', 'results from these patients']
{'prior therapy with sunitinib': {'236874000': 'Status pre- ', '288556008': 'before', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '421192001': 'Sunitinib ', '421448007': 'Sunitinib '}, 'anti pd 1 antibodies': {'68498002': 'Antibody '}, 'anti pdl 1 antibodies prior therapy with other kit inhibitors': {'68498002': 'Antibody ', '236874000': 'Status pre- ', '288556008': 'before', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '707725007': 'Device kit ', '419179001': 'Kit - unit of product usage '}, 'results from these patients': {'394617004': 'Result ', '116154003': 'Patient '}}
{'prior therapy with sunitinib': {'276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '421192001': ('product', 'Sunitinib ', ['312413002', '312412007']), '421448007': ('product', 'Sunitinib ', ['763158003'])}, 'anti pd 1 antibodies': {'68498002': ('product', 'Antibody ', ['312413002', '115668003'])}, 'anti pdl 1 antibodies prior therapy with other kit inhibitors': {'68498002': ('product', 'Antibody ', ['312413002', '115668003']), '276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '419179001': ('unit', 'Kit - unit of product usage ', ['767524001'])}}

225297
same as exclusion criteria for hiv negative subjects with known subclinical atherosclerosis
same as exclusion criteria for hiv negative subjects with known subclinical atherosclerosis
['same as exclusion criteria', 'for hiv negative subjects with known subclinical atherosclerosis']
{'same as exclusion criteria': {'168666000': 'same as'}, 'for hiv negative subjects with known subclinical atherosclerosis': {'19030005': 'Human immunodeficiency virus ', '260385009': 'Negative ', '36692007': 'Known ', '74314007': 'Subclinical ', '107671003': 'Vascular sclerosis ', '28960008': 'Arteriosclerosis ', '72092001': 'Arteriosclerotic vascular disease ', '38716007': 'Atherosclerosis ', '165816005': 'Human immunodeficiency virus positive '}}
{'for hiv negative subjects with known subclinical atherosclerosis': {'19030005': ('clinical finding', 'Human immunodeficiency virus ', ['49872002']), '74314007': ('qualifier value', 'Subclinical ', ['272099008']), '72092001': ('clinical finding', 'Arteriosclerotic vascular disease ', ['64572001', '118234003']), '165816005': ('clinical finding', 'Human immunodeficiency virus positive ', ['441742003'])}}

231719
category ii or iii fetal heart rate
category ii or iii fetal heart rate
['iii fetal heart rate']
{'iii fetal heart rate': {'257471003': 'Roman numeral III ', '249043002': 'Fetal heart rate '}}
{'iii fetal heart rate': {'249043002': ('observable entity', 'Fetal heart rate ', ['363788007', '414237002'])}}

244895
abnormal liver function at screening:
abnormal liver function at screening:
['abnormal liver function at screening']
{'abnormal liver function at screening': {'75183008': 'Abnormal liver function ', '20135006': 'Screening procedure '}}
{'abnormal liver function at screening': {'75183008': ('clinical finding', 'Abnormal liver function ', ['118234003']), '20135006': ('procedure', 'Screening procedure ', ['128927009'])}}

250327
major surgery in the previous month
major surgery in the , month
['major surgery in the', 'month']
{'major surgery in the': {'24484000': 'Severe ', '257556004': 'Surgery ', '387713003': 'Surgical procedure ', '83578000': 'Surgical ', '394609007': 'General surgery ', '255603008': 'Major '}, 'month': {'89185003': 'Monthly ', '258706009': 'month ', '259036001': 'per month '}}
{'major surgery in the': {'24484000': ('qualifier value', 'Severe ', ['272396007']), '387713003': ('procedure', 'Surgical procedure ', ['128927009']), '83578000': ('qualifier value', 'Surgical ', ['272099008']), '255603008': ('qualifier value', 'Major ', ['272396007'])}, 'month': {'89185003': ('qualifier value', 'Monthly ', ['272099008']), '258706009': ('unit', 'month ', ['767524001']), '259036001': ('unit', 'per month ', ['767524001'])}}

253987
systemic infections, psychiatric disorders or metabolic disorders, known food allergies or intolerances related to the products used in the study , ongoing drug or former drug abuse, high intake of alcohol , pregnancy or ongoing planning of pregnancy, vegetarianism or veganism, participation in other scientific studies during the study period, and blood donation during - or in the month leading up to - the study period
systemic infections, psychiatric disorders or metabolic disorders, known food allergies or intolerances related to the products used in the study , ongoing drug or former drug abuse, high intake of alcohol , pregnancy or ongoing planning of pregnancy, vegetarianism or veganism, participation in other scientific studies during the study period, and blood donation during - or in the month leading up to - the study period
['systemic infections,', 'psychiatric disorders', 'metabolic disorders,', 'known food allergies', 'intolerances', 'related to the products', 'used in the study ,', 'ongoing drug', 'former drug abuse,', 'high intake of alcohol ,', 'pregnancy', 'ongoing planning of pregnancy,', 'vegetarianism', 'participation in other scientific studies', 'during the study period,', 'blood donation during', 'or in the month', 'leading up to   the study period']
{'systemic infections,': {'91302008': 'Sepsis '}, 'psychiatric disorders': {'74732009': 'Mental disorder ', '25786006': 'Abnormal behavior ', '277843001': 'Problem behavior '}, 'metabolic disorders,': {'30390004': 'Generalized metabolic disorder ', '75934005': 'Metabolic disease '}, 'known food allergies': {'228010002': 'Familiar food ', '418634005': 'Allergic reaction caused by substance ', '421961002': 'Hypersensitivity reaction ', '36692007': 'Known ', '414285001': 'Food allergy '}, 'intolerances': {'29544009': 'Intolerance, function '}, 'related to the products': {'263498003': 'relationships', '272151006': 'Relationships ', '262094002': 'Related '}, 'used in the study ,': {'394850002': 'used by', '224699009': 'Study '}, 'ongoing drug': {'255238004': 'Continuous ', '105903003': 'General drug type ', '373873005': 'Pharmaceutical / biologic product ', '410942007': 'Drug or medicament '}, 'former drug abuse,': {'9130008': 'Previous ', '26416006': 'Drug abuse '}, 'high intake of alcohol ,': {'75540009': 'High ', '160573003': 'Alcohol intake ', '371879000': 'Abnormally high '}, 'pregnancy': {'289908002': 'Pregnancy, function ', '77386006': 'Patient currently pregnant '}, 'ongoing planning of pregnancy,': {'255238004': 'Continuous ', '169565003': 'Pregnant - planned '}, 'vegetarianism': {'5940000': 'Vegetarian diet '}, 'participation in other scientific studies': {'224699009': 'Study '}, 'during the study period,': {'224699009': 'Study ', '259037005': 'per period ', '272117007': 'Time periods '}, 'blood donation during': {'25179006': 'Blood unit collection '}, 'or in the month': {'89185003': 'Monthly ', '258706009': 'month ', '259036001': 'per month '}, 'leading up to   the study period': {'236874000': 'Status pre- ', '288556008': 'before', '224699009': 'Study ', '259037005': 'per period ', '272117007': 'Time periods '}}
{'systemic infections,': {'91302008': ('clinical finding', 'Sepsis ', ['64572001'])}, 'psychiatric disorders': {'74732009': ('clinical finding', 'Mental disorder ', ['64572001']), '25786006': ('clinical finding', 'Abnormal behavior ', ['250171008']), '277843001': ('clinical finding', 'Problem behavior ', ['250171008'])}, 'metabolic disorders,': {'30390004': ('clinical finding', 'Generalized metabolic disorder ', ['64572001', '75934005']), '75934005': ('clinical finding', 'Metabolic disease ', ['64572001'])}, 'known food allergies': {'418634005': ('clinical finding', 'Allergic reaction caused by substance ', ['64572001', '421961002']), '421961002': ('clinical finding', 'Hypersensitivity reaction ', ['64572001'])}, 'intolerances': {'29544009': ('observable entity', 'Intolerance, function ', ['246464006'])}, 'related to the products': {'272151006': ('qualifier value', 'Relationships ', ['272099008']), '262094002': ('clinical finding', 'Related ', ['118240005'])}, 'ongoing drug': {'255238004': ('qualifier value', 'Continuous ', ['272099008'])}, 'former drug abuse,': {'9130008': ('qualifier value', 'Previous ', ['272099008']), '26416006': ('clinical finding', 'Drug abuse ', ['64572001'])}, 'high intake of alcohol ,': {'75540009': ('qualifier value', 'High ', ['272099008']), '160573003': ('observable entity', 'Alcohol intake ', ['363788007']), '371879000': ('qualifier value', 'Abnormally high ', ['75540009', '272099008'])}, 'pregnancy': {'289908002': ('observable entity', 'Pregnancy, function ', ['246464006']), '77386006': ('clinical finding', 'Patient currently pregnant ', ['250171008'])}, 'ongoing planning of pregnancy,': {'255238004': ('qualifier value', 'Continuous ', ['272099008']), '169565003': ('clinical finding', 'Pregnant - planned ', ['250171008'])}, 'during the study period,': {'259037005': ('unit', 'per period ', ['767524001']), '272117007': ('qualifier value', 'Time periods ', ['272099008'])}, 'or in the month': {'89185003': ('qualifier value', 'Monthly ', ['272099008']), '258706009': ('unit', 'month ', ['767524001']), '259036001': ('unit', 'per month ', ['767524001'])}, 'leading up to   the study period': {'259037005': ('unit', 'per period ', ['767524001']), '272117007': ('qualifier value', 'Time periods ', ['272099008'])}}

261876
history of
,
[]
{}
{}

280364
prior adjuvant taxane or neoadjuvant taxane chemotherapy within 12 months prior to day 1
prior adjuvant taxane or neoadjuvant taxane chemotherapy , prior to day 1
['prior adjuvant taxane', 'neoadjuvant taxane chemotherapy', 'prior to day 1']
{'prior adjuvant taxane': {'236874000': 'Status pre- ', '288556008': 'before', '372861001': 'Immune enhancement agent ', '427067006': 'Immunologic adjuvant ', '81759008': 'Immune enhancement agent '}, 'neoadjuvant taxane chemotherapy': {'416608005': 'Drug therapy ', '716872004': 'Antineoplastic chemotherapy regimen ', '363688001': 'Administration of antineoplastic agent ', '367336001': 'Chemotherapy '}, 'prior to day 1': {'69620002': 'Daily ', '258703001': 'day ', '259032004': 'per day '}}
{'prior adjuvant taxane': {'427067006': ('product', 'Immunologic adjuvant ', ['115668003']), '81759008': ('product', 'Immune enhancement agent ', ['763158003'])}, 'neoadjuvant taxane chemotherapy': {'416608005': ('procedure', 'Drug therapy ', ['128927009']), '716872004': ('procedure', 'Antineoplastic chemotherapy regimen ', ['243120004', '128927009']), '363688001': ('procedure', 'Administration of antineoplastic agent ', ['416608005', '367336001', '128927009']), '367336001': ('procedure', 'Chemotherapy ', ['416608005', '128927009'])}, 'prior to day 1': {'69620002': ('qualifier value', 'Daily ', ['272099008']), '258703001': ('unit', 'day ', ['767524001']), '259032004': ('unit', 'per day ', ['767524001'])}}

287480
active substance abuse
active substance abuse
['active substance abuse']
{'active substance abuse': {'55561003': 'Active ', '66214007': 'Substance abuse '}}
{'active substance abuse': {'55561003': ('qualifier value', 'Active ', ['272099008']), '66214007': ('clinical finding', 'Substance abuse ', ['64572001'])}}

292384
any contraindication to magnetic resonance scanning, including claustrophobia
any contraindication to magnetic resonance scanning, including claustrophobia
['any contraindication to magnetic resonance scanning,', 'including', 'claustrophobia']
{'any contraindication to magnetic resonance scanning,': {'103306004': 'Contraindication to ', '285650006': 'Magnetism ', '39527002': 'Resonance, function ', '373205008': 'Nuclear medicine imaging procedure ', '33679000': 'Vibration ', '300594005': 'resonance lesion attribute'}, 'including': {'55919000': 'Including '}, 'claustrophobia': {'19887002': 'Claustrophobia ', '247850006': 'Fear of enclosed spaces '}}
{'any contraindication to magnetic resonance scanning,': {'39527002': ('observable entity', 'Resonance, function ', ['246464006']), '373205008': ('procedure', 'Nuclear medicine imaging procedure ', ['128927009'])}, 'including': {'55919000': ('qualifier value', 'Including ', ['272099008'])}, 'claustrophobia': {'19887002': ('clinical finding', 'Claustrophobia ', ['250171008']), '247850006': ('clinical finding', 'Fear of enclosed spaces ', ['19887002', '250171008'])}}

301955
patients with concurrent serious infections.
patients with concurrent serious infections.
['patients with concurrent serious infections']
{'patients with concurrent serious infections': {'116154003': 'Patient ', '68405009': 'Concurrent ', '42745003': 'Serious '}}
{'patients with concurrent serious infections': {'68405009': ('qualifier value', 'Concurrent ', ['272099008']), '42745003': ('qualifier value', 'Serious ', ['272099008'])}}

305511
participant is receiving physical therapy, heat therapy, ultrasound, spinal manipulation, cognitive-behavioral therapy, biofeedback or anticonvulsants for his/her lbp.
participant is receiving physical therapy, heat therapy, ultrasound, spinal manipulation, cognitive-behavioral therapy, biofeedback or anticonvulsants for his/her lbp.
['physical therapy,', 'heat therapy,', 'ultrasound,', 'spinal manipulation,', 'cognitive behavioral therapy', 'biofeedback', 'anticonvulsants for his/']
{'physical therapy,': {'722138006': 'Physiotherapy ', '91251008': 'Physical therapy procedure '}, 'heat therapy,': {'261570006': 'Thermotherapy ', '266694003': 'Heat therapy '}, 'ultrasound,': {'16310003': 'Diagnostic ultrasonography ', '278292003': 'Ultrasound imaging - action '}, 'spinal manipulation,': {'225511007': 'Manipulation of the vertebrae - non-surgical ', '44275008': 'Manipulation of spine '}, 'cognitive behavioral therapy': {'183383008': 'Psychotherapy - cognitive ', '228553007': 'Cognitive therapy ', '228557008': 'Cognitive and behavioral therapy ', '304891004': 'Cognitive - behavior therapy '}, 'biofeedback': {'28150003': 'Biofeedback procedure ', '61334006': 'Biofeedback, function '}, 'anticonvulsants for his/': {'255632006': 'Anticonvulsant ', '63094006': 'Anticonvulsant '}}
{'physical therapy,': {'91251008': ('procedure', 'Physical therapy procedure ', ['243120004'])}, 'heat therapy,': {'261570006': ('procedure', 'Thermotherapy ', ['243120004']), '266694003': ('procedure', 'Heat therapy ', ['128927009'])}, 'ultrasound,': {'16310003': ('procedure', 'Diagnostic ultrasonography ', ['128927009'])}, 'spinal manipulation,': {'225511007': ('procedure', 'Manipulation of the vertebrae - non-surgical ', ['362958002']), '44275008': ('procedure', 'Manipulation of spine ', ['362958002', '128927009'])}, 'cognitive behavioral therapy': {'183383008': ('procedure', 'Psychotherapy - cognitive ', ['243120004']), '228553007': ('procedure', 'Cognitive therapy ', ['228557008', '243120004']), '228557008': ('procedure', 'Cognitive and behavioral therapy ', ['243120004']), '304891004': ('procedure', 'Cognitive - behavior therapy ', ['228557008', '243120004'])}, 'biofeedback': {'28150003': ('procedure', 'Biofeedback procedure ', ['243120004', '128927009']), '61334006': ('observable entity', 'Biofeedback, function ', ['246464006'])}, 'anticonvulsants for his/': {'63094006': ('product', 'Anticonvulsant ', ['763158003'])}}

323477
other severe diseases
other severe diseases
['other severe diseases']
{'other severe diseases': {'24484000': 'Severe ', '64572001': 'Disease '}}
{'other severe diseases': {'24484000': ('qualifier value', 'Severe ', ['272396007'])}}

327977
history of risk factors for ventricular tachycardia or torsades de pointes or history of fainting, unexplained loss of consciousness, or convulsions
, risk factors for ventricular tachycardia or torsades de pointes or , fainting, unexplained loss of consciousness, or convulsions
['risk factors for ventricular tachycardia', 'torsades de pointes', 'fainting', 'unexplained loss of consciousness,', 'convulsions']
{'risk factors for ventricular tachycardia': {'80943009': 'Risk factor ', '25569003': 'Ventricular tachycardia ', '6624005': 'Ventricular tachyarrhythmia ', '164895002': 'Electrocardiographic ventricular tachycardia '}, 'torsades de pointes': {'31722008': 'Torsades de pointes '}, 'fainting': {'271594007': 'Syncope ', '272030005': 'Syncope symptom ', '309585006': 'Syncope and collapse '}, 'unexplained loss of consciousness,': {'418107008': 'Unconscious ', '419045004': 'Loss of consciousness '}, 'convulsions': {'91175000': 'Seizure '}}
{'risk factors for ventricular tachycardia': {'80943009': ('observable entity', 'Risk factor ', ['363788007']), '25569003': ('clinical finding', 'Ventricular tachycardia ', ['64572001', '118234003']), '6624005': ('clinical finding', 'Ventricular tachyarrhythmia ', ['64572001', '118234003', '25569003']), '164895002': ('clinical finding', 'Electrocardiographic ventricular tachycardia ', ['441742003', '118234003'])}, 'torsades de pointes': {'31722008': ('clinical finding', 'Torsades de pointes ', ['64572001', '118234003', '25569003'])}, 'fainting': {'271594007': ('clinical finding', 'Syncope ', ['64572001', '250171008', '118234003', '419045004']), '272030005': ('clinical finding', 'Syncope symptom ', ['418799008', '118234003']), '309585006': ('clinical finding', 'Syncope and collapse ', ['271594007', '118234003', '419045004', '64572001', '250171008'])}, 'unexplained loss of consciousness,': {'418107008': ('clinical finding', 'Unconscious ', ['250171008']), '419045004': ('clinical finding', 'Loss of consciousness ', ['250171008'])}, 'convulsions': {'91175000': ('clinical finding', 'Seizure ', ['102957003', '118234003'])}}

329275
having received a second dose of measles vaccine
having received a second dose of measles vaccine
['a second dose of measles vaccine']
{'a second dose of measles vaccine': {'81170007': 'Second ', '260911001': 'dosage', '277406006': 'Dosages ', '386012008': 'Measles vaccine ', '396427003': 'Measles vaccine ', '408102007': 'Unit dose ', '257997001': 'seconds ', '288495006': 'per second '}}
{'a second dose of measles vaccine': {'81170007': ('qualifier value', 'Second ', ['272099008']), '277406006': ('qualifier value', 'Dosages ', ['272099008']), '386012008': ('product', 'Measles vaccine ', ['763158003']), '396427003': ('product', 'Measles vaccine ', ['406455002', '115668003']), '408102007': ('unit', 'Unit dose ', ['767524001']), '257997001': ('unit', 'seconds ', ['767524001']), '288495006': ('unit', 'per second ', ['767524001'])}}

335997
permanently immobile patient
permanently immobile patient
['permanently immobile patient']
{'permanently immobile patient': {'102491009': 'Immobile ', '116154003': 'Patient '}}
{'permanently immobile patient': {'102491009': ('clinical finding', 'Immobile ', ['250171008'])}}

347880
known congenital viral infection
known congenital viral infection
['known congenital viral infection']
{'known congenital viral infection': {'36692007': 'Known ', '276660001': 'Congenital viral disease '}}
{'known congenital viral infection': {'276660001': ('clinical finding', 'Congenital viral disease ', ['64572001'])}}

355897
the presence of uncontrolled hypertension, uncontrolled diabetes, clinically significant cardiovascular disease, asthma or reduced pulmonary capacity, or a history of seizure or other neurologic disorder;
the presence of uncontrolled hypertension, uncontrolled diabetes, clinically significant cardiovascular disease, asthma or reduced pulmonary capacity, or , seizure or other neurologic disorder;
['the presence of uncontrolled hypertension,', 'uncontrolled diabetes,', 'clinically significant cardiovascular disease,', 'asthma', 'reduced pulmonary capacity,', 'seizure', 'other neurologic disorder']
{'the presence of uncontrolled hypertension,': {'52101004': 'Present ', '19032002': 'Uncontrolled ', '38341003': 'Hypertensive disorder, systemic arterial '}, 'uncontrolled diabetes,': {'19032002': 'Uncontrolled ', '73211009': 'Diabetes mellitus '}, 'clinically significant cardiovascular disease,': {'386134007': 'Significant ', '49601007': 'Disorder of cardiovascular system '}, 'asthma': {'195967001': 'Asthma '}, 'reduced pulmonary capacity,': {'260400001': 'Reduced ', '39607008': 'Lung structure ', '264164005': 'Pulmonary '}, 'seizure': {'91175000': 'Seizure '}, 'other neurologic disorder': {'118940003': 'Disorder of nervous system '}}
{'the presence of uncontrolled hypertension,': {'19032002': ('qualifier value', 'Uncontrolled ', ['272099008']), '38341003': ('clinical finding', 'Hypertensive disorder, systemic arterial ', ['64572001', '118234003', '49601007'])}, 'uncontrolled diabetes,': {'19032002': ('qualifier value', 'Uncontrolled ', ['272099008']), '73211009': ('clinical finding', 'Diabetes mellitus ', ['64572001', '118234003'])}, 'clinically significant cardiovascular disease,': {'49601007': ('clinical finding', 'Disorder of cardiovascular system ', ['64572001', '118234003'])}, 'asthma': {'195967001': ('clinical finding', 'Asthma ', ['64572001', '118234003'])}, 'seizure': {'91175000': ('clinical finding', 'Seizure ', ['102957003', '118234003'])}, 'other neurologic disorder': {'118940003': ('clinical finding', 'Disorder of nervous system ', ['64572001', '118234003'])}}

360186
participation in other biomedical research in the last 1 month or planned during the study
participation in other biomedical research in the , or planned during the study
['planned during the study']
{'planned during the study': {'397943006': 'Planned ', '224699009': 'Study '}}
{}

365907
a positive test for drugs of abuse at the screening visit
a positive test for drugs of abuse at the screening visit
['a positive test for drugs of abuse', 'at the screening visit']
{'a positive test for drugs of abuse': {'10828004': 'Positive ', '108252007': 'Laboratory procedure ', '15220000': 'Laboratory test ', '269814003': 'Laboratory procedures -general ', '26416006': 'Drug abuse ', '77657003': 'Illegal drug ', '272393004': 'Tests ', '277775005': 'Test finding '}, 'at the screening visit': {'20135006': 'Screening procedure '}}
{'a positive test for drugs of abuse': {'10828004': ('qualifier value', 'Positive ', ['272099008']), '15220000': ('procedure', 'Laboratory test ', ['128927009', '108252007']), '269814003': ('situation with explicit context', 'Laboratory procedures -general ', ['129125009']), '26416006': ('clinical finding', 'Drug abuse ', ['64572001'])}, 'at the screening visit': {'20135006': ('procedure', 'Screening procedure ', ['128927009'])}}

379096
subjects with diagnosed malignancy, psychiatric disorders, or thyroid disorders
subjects with diagnosed malignancy, psychiatric disorders, or thyroid disorders
['subjects with diagnosed malignancy,', 'psychiatric disorders,', 'thyroid disorders']
{'subjects with diagnosed malignancy,': {'439401001': 'Diagnosis ', '363346000': 'Malignant neoplastic disease ', '372087000': 'Primary malignant neoplasm ', '86049000': 'Malignant neoplasm, primary '}, 'psychiatric disorders,': {'74732009': 'Mental disorder ', '25786006': 'Abnormal behavior ', '277843001': 'Problem behavior '}, 'thyroid disorders': {'14304000': 'Disorder of thyroid gland '}}
{'subjects with diagnosed malignancy,': {'363346000': ('clinical finding', 'Malignant neoplastic disease ', ['64572001']), '372087000': ('clinical finding', 'Primary malignant neoplasm ', ['64572001', '363346000'])}, 'psychiatric disorders,': {'74732009': ('clinical finding', 'Mental disorder ', ['64572001']), '25786006': ('clinical finding', 'Abnormal behavior ', ['250171008']), '277843001': ('clinical finding', 'Problem behavior ', ['250171008'])}, 'thyroid disorders': {'14304000': ('clinical finding', 'Disorder of thyroid gland ', ['64572001', '118234003'])}}

386911
no evidence of current schizophrenia or past schizophrenia, bipolar disorder, or organic mental disorder
evidence of current schizophrenia or past schizophrenia, bipolar disorder, or organic mental disorder
['evidence of current schizophrenia', 'past schizophrenia,', 'bipolar disorder,', 'organic mental disorder']
{'evidence of current schizophrenia': {'18669006': 'Evidence of ', '15240007': 'Current ', '191526005': 'Schizophrenic disorders ', '58214004': 'Schizophrenia '}, 'past schizophrenia,': {'410513005': 'In the past ', '191526005': 'Schizophrenic disorders ', '58214004': 'Schizophrenia '}, 'bipolar disorder,': {'13746004': 'Bipolar disorder '}, 'organic mental disorder': {'106014008': 'Organic mental disorder of unknown etiology ', '111479008': 'Organic mental disorder '}}
{'evidence of current schizophrenia': {'191526005': ('clinical finding', 'Schizophrenic disorders ', ['64572001', '58214004']), '58214004': ('clinical finding', 'Schizophrenia ', ['64572001'])}, 'past schizophrenia,': {'191526005': ('clinical finding', 'Schizophrenic disorders ', ['64572001', '58214004']), '58214004': ('clinical finding', 'Schizophrenia ', ['64572001'])}, 'bipolar disorder,': {'13746004': ('clinical finding', 'Bipolar disorder ', ['64572001'])}, 'organic mental disorder': {'106014008': ('clinical finding', 'Organic mental disorder of unknown etiology ', ['64572001', '111479008', '118234003']), '111479008': ('clinical finding', 'Organic mental disorder ', ['64572001', '118234003'])}}

390572
prior chemotherapy other than hydroxyurea.
prior chemotherapy other than hydroxyurea.
['prior chemotherapy other than hydroxyurea']
{'prior chemotherapy other than hydroxyurea': {'236874000': 'Status pre- ', '288556008': 'before', '416608005': 'Drug therapy ', '387314007': 'Hydroxyurea ', '56602009': 'Hydroxyurea ', '716872004': 'Antineoplastic chemotherapy regimen ', '363688001': 'Administration of antineoplastic agent ', '367336001': 'Chemotherapy '}}
{'prior chemotherapy other than hydroxyurea': {'416608005': ('procedure', 'Drug therapy ', ['128927009']), '387314007': ('product', 'Hydroxyurea ', ['406455002', '312413002']), '56602009': ('product', 'Hydroxyurea ', ['763158003']), '716872004': ('procedure', 'Antineoplastic chemotherapy regimen ', ['243120004', '128927009']), '363688001': ('procedure', 'Administration of antineoplastic agent ', ['416608005', '367336001', '128927009']), '367336001': ('procedure', 'Chemotherapy ', ['416608005', '128927009'])}}

391106
pleural/pericardial effusion or ascites estimated to be >1l.
pleural/pericardial effusion or ascites estimated to be >1l.
['pleural/pericardial effusion', 'ascites', 'estimated', 'to']
{'pleural/pericardial effusion': {'60046008': 'Pleural effusion ', '24949005': 'Pericardial sac structure ', '76848001': 'Pericardial structure ', '264135001': 'Pericardial ', '3120008': 'Pleural membrane structure ', '373945007': 'Pericardial effusion ', '264148002': 'Pleural '}, 'ascites': {'389026000': 'Ascites '}, 'estimated': {'414135002': 'Estimated '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}}
{'pleural/pericardial effusion': {'60046008': ('clinical finding', 'Pleural effusion ', ['64572001', '118234003']), '373945007': ('clinical finding', 'Pericardial effusion ', ['64572001', '118234003'])}, 'ascites': {'389026000': ('clinical finding', 'Ascites ', ['64572001', '118234003'])}, 'estimated': {'414135002': ('qualifier value', 'Estimated ', ['272099008'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}}

394796
previous surgical procedures for weight loss;
, surgical procedures for weight loss;
['surgical procedures for weight loss']
{'surgical procedures for weight loss': {'257556004': 'Surgery ', '387713003': 'Surgical procedure ', '83578000': 'Surgical ', '161832001': 'Weight decreasing ', '262285001': 'Weight decreased ', '89362005': 'Weight loss '}}
{'surgical procedures for weight loss': {'387713003': ('procedure', 'Surgical procedure ', ['128927009']), '83578000': ('qualifier value', 'Surgical ', ['272099008']), '161832001': ('clinical finding', 'Weight decreasing ', ['250171008', '89362005']), '262285001': ('clinical finding', 'Weight decreased ', ['250171008', '89362005']), '89362005': ('clinical finding', 'Weight loss ', ['250171008'])}}

400794
end stage renal disease
end stage renal disease
['end stage renal disease']
{'end stage renal disease': {'46177005': 'End stage renal disease ', '90688005': 'Chronic renal failure syndrome ', '433146000': 'Chronic kidney disease stage 5 '}}
{'end stage renal disease': {'46177005': ('clinical finding', 'End stage renal disease ', ['64572001', '441742003', '118234003']), '90688005': ('clinical finding', 'Chronic renal failure syndrome ', ['64572001', '441742003', '118234003']), '433146000': ('clinical finding', 'Chronic kidney disease stage 5 ', ['64572001', '441742003', '118234003'])}}

413960
history of liver disease such as cirrhosis, chronic active hepatitis, chronic persistent hepatitis or hepatitis b, hepatitis c
, liver disease such as cirrhosis, chronic active hepatitis, chronic persistent hepatitis or hepatitis b, hepatitis c
['liver disease such as cirrhosis,', 'chronic active hepatitis,', 'chronic persistent hepatitis', 'hepatitis b,', 'hepatitis c']
{'liver disease such as cirrhosis,': {'235856003': 'Disorder of liver ', '19943007': 'Cirrhosis of liver ', '64572001': 'Disease '}, 'chronic active hepatitis,': {'197284004': 'Chronic active hepatitis '}, 'chronic persistent hepatitis': {'41889008': 'Chronic persistent hepatitis '}, 'hepatitis b,': {'66071002': 'Viral hepatitis type B '}, 'hepatitis c': {'186634008': 'Hepatitis non-A non-B ', '50711007': 'Viral hepatitis type C ', '62944002': 'Hepatitis C virus '}}
{'liver disease such as cirrhosis,': {'235856003': ('clinical finding', 'Disorder of liver ', ['64572001', '118234003']), '19943007': ('clinical finding', 'Cirrhosis of liver ', ['64572001', '235856003', '118234003'])}, 'chronic active hepatitis,': {'197284004': ('clinical finding', 'Chronic active hepatitis ', ['64572001', '235856003', '118234003'])}, 'chronic persistent hepatitis': {'41889008': ('clinical finding', 'Chronic persistent hepatitis ', ['64572001', '235856003', '118234003'])}, 'hepatitis b,': {'66071002': ('clinical finding', 'Viral hepatitis type B ', ['64572001', '235856003', '118234003'])}, 'hepatitis c': {'50711007': ('clinical finding', 'Viral hepatitis type C ', ['64572001', '235856003', '118234003']), '62944002': ('clinical finding', 'Hepatitis C virus ', ['49872002'])}}

414001
nonstable doses of 1 or more of the following medications within 28 days before entry into the study: hydroxychloroquine, mycophenolate mofetil, methotrexate, azathioprine
nonstable doses of 1 or more of the following medications , before entry into the study: hydroxychloroquine, mycophenolate mofetil, methotrexate, azathioprine
['nonstable doses of 1', 'more of the following medications', 'entry into the study', 'hydroxychloroquine,', 'mycophenolate mofetil,', 'methotrexate,', 'azathioprine']
{'nonstable doses of 1': {'260911001': 'dosage', '277406006': 'Dosages '}, 'more of the following medications': {'242762006': 'More ', '367409002': 'followed by', '105903003': 'General drug type ', '373873005': 'Pharmaceutical / biologic product ', '410942007': 'Drug or medicament ', '421939007': 'Follow - dosing instruction imperative '}, 'entry into the study': {'224699009': 'Study '}, 'hydroxychloroquine,': {'373540008': 'Hydroxychloroquine ', '83490000': 'Hydroxychloroquine '}, 'mycophenolate mofetil,': {'109131004': 'Mycophenolate mofetil ', '386976000': 'Mycophenolate mofetil '}, 'methotrexate,': {'387381009': 'Methotrexate ', '68887009': 'Methotrexate '}, 'azathioprine': {'111165009': 'Azathioprine ', '372574004': 'Azathioprine '}}
{'nonstable doses of 1': {'277406006': ('qualifier value', 'Dosages ', ['272099008'])}, 'more of the following medications': {'242762006': ('qualifier value', 'More ', ['272099008'])}, 'hydroxychloroquine,': {'373540008': ('product', 'Hydroxychloroquine ', ['410942007', '312413002']), '83490000': ('product', 'Hydroxychloroquine ', ['373873005', '763158003'])}, 'mycophenolate mofetil,': {'109131004': ('product', 'Mycophenolate mofetil ', ['373873005', '763158003']), '386976000': ('product', 'Mycophenolate mofetil ', ['406455002', '410942007', '312413002'])}, 'methotrexate,': {'387381009': ('product', 'Methotrexate ', ['406455002', '410942007', '312413002']), '68887009': ('product', 'Methotrexate ', ['373873005', '763158003'])}, 'azathioprine': {'111165009': ('product', 'Azathioprine ', ['373873005', '763158003']), '372574004': ('product', 'Azathioprine ', ['410942007', '312413002'])}}

414276
current or past psychiatric disorder
current or past psychiatric disorder
['current', 'past psychiatric disorder']
{'current': {'15240007': 'Current '}, 'past psychiatric disorder': {'410513005': 'In the past ', '74732009': 'Mental disorder '}}
{'past psychiatric disorder': {'74732009': ('clinical finding', 'Mental disorder ', ['64572001'])}}

421440-1
having experienced a medical event, which may confound study outcomes [e.g.
having experienced a medical event, which may confound study outcomes [e.g.
['a medical event,', 'study', 'outcomes']
{'a medical event,': {'373655009': 'Medical service ', '272379006': 'Event ', '74188005': 'Medical '}, 'study': {'224699009': 'Study '}, 'outcomes': {'394617004': 'Result '}}
{'a medical event,': {'74188005': ('qualifier value', 'Medical ', ['272099008'])}}

421440-2
heart attack, stroke, cancer , lupus, rheumatoid arthritis, chronic inflammatory disease]
heart attack, stroke, cancer , lupus, rheumatoid arthritis, chronic inflammatory disease]
['heart attack,', 'stroke,', 'cancer ,', 'lupus,', 'rheumatoid arthritis,', 'chronic inflammatory disease']
{'heart attack,': {'22298006': 'Myocardial infarction '}, 'stroke,': {'230690007': 'Cerebrovascular accident '}, 'cancer ,': {'363346000': 'Malignant neoplastic disease ', '372087000': 'Primary malignant neoplasm ', '86049000': 'Malignant neoplasm, primary '}, 'lupus,': {'10528009': 'Lupus vulgaris ', '200938002': 'Discoid lupus erythematosus ', '238927000': 'Chronic discoid lupus erythematosus ', '200936003': 'Lupus erythematosus '}, 'rheumatoid arthritis,': {'69896004': 'Rheumatoid arthritis '}, 'chronic inflammatory disease': {'128294001': 'Chronic inflammatory disorder '}}
{'heart attack,': {'22298006': ('clinical finding', 'Myocardial infarction ', ['64572001', '118234003'])}, 'stroke,': {'230690007': ('clinical finding', 'Cerebrovascular accident ', ['64572001', '118234003'])}, 'cancer ,': {'363346000': ('clinical finding', 'Malignant neoplastic disease ', ['64572001']), '372087000': ('clinical finding', 'Primary malignant neoplasm ', ['64572001', '363346000'])}, 'lupus,': {'10528009': ('clinical finding', 'Lupus vulgaris ', ['64572001', '118234003']), '200938002': ('clinical finding', 'Discoid lupus erythematosus ', ['64572001', '118234003']), '238927000': ('clinical finding', 'Chronic discoid lupus erythematosus ', ['64572001', '118234003', '200938002']), '200936003': ('clinical finding', 'Lupus erythematosus ', ['64572001', '118234003'])}, 'rheumatoid arthritis,': {'69896004': ('clinical finding', 'Rheumatoid arthritis ', ['64572001', '118234003'])}, 'chronic inflammatory disease': {'128294001': ('clinical finding', 'Chronic inflammatory disorder ', ['64572001'])}}

423895
symptomatic bipolar disorder
symptomatic bipolar disorder
['symptomatic bipolar disorder']
{'symptomatic bipolar disorder': {'264931009': 'Symptomatic ', '13746004': 'Bipolar disorder '}}
{'symptomatic bipolar disorder': {'264931009': ('qualifier value', 'Symptomatic ', ['272099008']), '13746004': ('clinical finding', 'Bipolar disorder ', ['64572001'])}}

449343
active airway disease
active airway disease
['active airway disease']
{'active airway disease': {'55561003': 'Active ', '43725001': 'Airway device ', '64572001': 'Disease ', '89187006': 'Airway structure '}}
{'active airway disease': {'55561003': ('qualifier value', 'Active ', ['272099008'])}}

478689
body weight < 50 kg.
body weight < 50 kg.
['body weight', '< 50 kg']
{'body weight': {'27113001': 'Body weight ', '39857003': 'Weighing patient '}, '< 50 kg': {'223574006': 'Kyrgyzstan ', '258683005': 'kilogram '}}
{'body weight': {'27113001': ('observable entity', 'Body weight ', ['363788007']), '39857003': ('procedure', 'Weighing patient ', ['128927009'])}, '< 50 kg': {'258683005': ('unit', 'kilogram ', ['767524001'])}}

482860
excessive physical activities
excessive physical activities
['excessive physical activities']
{'excessive physical activities': {'260378005': 'Excessive ', '183301007': 'Physical exercises ', '256235009': 'Exercise ', '61686008': 'Physical exercise ', '48761009': 'Motor behavior ', '68130003': 'Physical activity '}}
{'excessive physical activities': {'183301007': ('procedure', 'Physical exercises ', ['243120004'])}}

491104
males and females over the age of 18 without ipf.
males and females over the age of 18 without ipf.
['males', 'females over the age of 18', 'without ipf']
{'males': {'10052007': 'Male structure ', '248153007': 'Male '}, 'females over the age of 18': {'1086007': 'Female structure ', '248152002': 'Female ', '397669002': 'Age ', '424144002': 'Current chronological age '}, 'without ipf': {'51615001': 'Fibrosis of lung ', '196125002': 'Diffuse interstitial pulmonary fibrosis ', '426437004': 'Familial idiopathic pulmonary fibrosis '}}
{'males': {'248153007': ('clinical finding', 'Male ', ['365860008'])}, 'females over the age of 18': {'248152002': ('clinical finding', 'Female ', ['365860008']), '397669002': ('qualifier value', 'Age ', ['272099008']), '424144002': ('observable entity', 'Current chronological age ', ['105727008'])}, 'without ipf': {'51615001': ('clinical finding', 'Fibrosis of lung ', ['64572001', '118234003']), '196125002': ('clinical finding', 'Diffuse interstitial pulmonary fibrosis ', ['64572001', '51615001', '118234003']), '426437004': ('clinical finding', 'Familial idiopathic pulmonary fibrosis ', ['64572001', '51615001', '118234003'])}}

505407
are currently receiving or have previously received endocrine therapy for locoregionally recurrent breast or metastatic breast cancer
are currently receiving or have , ly received endocrine therapy for locoregionally recurrent breast or metastatic breast cancer
['currently', 'ly', 'endocrine therapy for locoregionally recurrent breast', 'metastatic breast cancer']
{'currently': {'15240007': 'Current '}, 'ly': {'223512002': 'Libya '}, 'endocrine therapy for locoregionally recurrent breast': {'169413002': 'Hormone therapy ', '309542002': 'Endocrine therapy ', '278499009': 'Episodic ', '76752008': 'Breast structure ', '255227004': 'Recurrent '}, 'metastatic breast cancer': {'405843009': 'Widespread metastatic malignant neoplastic disease ', '76752008': 'Breast structure ', '128462008': 'Secondary malignant neoplastic disease ', '14799000': 'Neoplasm, metastatic ', '79282002': 'Carcinoma, metastatic ', '77879006': 'metastatic to', '254837009': 'Malignant tumor of breast ', '254838004': 'Carcinoma of breast '}}
{'endocrine therapy for locoregionally recurrent breast': {'169413002': ('procedure', 'Hormone therapy ', ['128927009']), '278499009': ('qualifier value', 'Episodic ', ['272099008']), '255227004': ('qualifier value', 'Recurrent ', ['272099008'])}, 'metastatic breast cancer': {'405843009': ('clinical finding', 'Widespread metastatic malignant neoplastic disease ', ['64572001', '128462008']), '128462008': ('clinical finding', 'Secondary malignant neoplastic disease ', ['64572001']), '254837009': ('clinical finding', 'Malignant tumor of breast ', ['64572001', '118234003']), '254838004': ('clinical finding', 'Carcinoma of breast ', ['254837009', '64572001', '118234003'])}}

511984
have any history or evidence suggestive of seizure disorder or brain injury
have any history or evidence suggestive of seizure disorder or brain injury
['any history', 'suggestive of seizure disorder', 'brain injury']
{'any history': {'392521001': 'History of '}, 'suggestive of seizure disorder': {'7196007': 'suggestive of', '128613002': 'Seizure disorder ', '84757009': 'Epilepsy '}, 'brain injury': {'127294003': 'Traumatic AND/OR non-traumatic brain injury ', '2470005': 'Brain damage ', '702632000': 'Acquired brain injury '}}
{'suggestive of seizure disorder': {'128613002': ('clinical finding', 'Seizure disorder ', ['64572001', '102957003', '118234003']), '84757009': ('clinical finding', 'Epilepsy ', ['64572001', '102957003', '128613002', '118234003'])}, 'brain injury': {'127294003': ('clinical finding', 'Traumatic AND/OR non-traumatic brain injury ', ['64572001', '118234003'])}}

513878
>= common terminology criteria for adverse events grade 3 anxiety
>= common terminology criteria for adverse events grade 3 anxiety
['= common terminology criteria for adverse events grade 3 anxiety']
{'= common terminology criteria for adverse events grade 3 anxiety': {'446431000124107': 'grade 3 severe adverse event', '48694002': 'Anxiety ', '197480006': 'Anxiety disorder '}}
{'= common terminology criteria for adverse events grade 3 anxiety': {'48694002': ('clinical finding', 'Anxiety ', ['250171008']), '197480006': ('clinical finding', 'Anxiety disorder ', ['64572001', '250171008', '48694002'])}}

518215
inability to communicate verbally in the appropriate language in a group setting
communicate verbally in the appropriate language in a group setting
['communicate', 'verbally in the appropriate language', 'in a group setting']
{'communicate': {'288577006': 'Does communicate '}, 'verbally in the appropriate language': {'61909002': 'Language, function '}, 'in a group setting': {'246261001': 'groups', '261586004': 'Groups ', '160481000': 'Social group ', '389109008': 'Group '}}
{'communicate': {'288577006': ('clinical finding', 'Does communicate ', ['250171008'])}, 'verbally in the appropriate language': {'61909002': ('observable entity', 'Language, function ', ['246464006'])}, 'in a group setting': {'261586004': ('qualifier value', 'Groups ', ['272396007']), '160481000': ('observable entity', 'Social group ', ['160476009'])}}

526969
allergy to nicardipine hypersensitivity or known hypersensitivity to nicardipine.
allergy to nicardipine hypersensitivity or known hypersensitivity to nicardipine.
['allergy to nicardipine hypersensitivity', 'known hypersensitivity to nicardipine']
{'allergy to nicardipine hypersensitivity': {'294004002': 'Nicardipine allergy ', '418634005': 'Allergic reaction caused by substance ', '421961002': 'Hypersensitivity reaction ', '421369008': 'Emotional hypersensitivity '}, 'known hypersensitivity to nicardipine': {'36692007': 'Known ', '418634005': 'Allergic reaction caused by substance ', '421961002': 'Hypersensitivity reaction ', '108526002': 'Nicardipine ', '372502001': 'Nicardipine ', '421369008': 'Emotional hypersensitivity '}}
{'allergy to nicardipine hypersensitivity': {'418634005': ('clinical finding', 'Allergic reaction caused by substance ', ['64572001', '421961002']), '421961002': ('clinical finding', 'Hypersensitivity reaction ', ['64572001']), '421369008': ('clinical finding', 'Emotional hypersensitivity ', ['250171008'])}, 'known hypersensitivity to nicardipine': {'418634005': ('clinical finding', 'Allergic reaction caused by substance ', ['64572001', '421961002']), '421961002': ('clinical finding', 'Hypersensitivity reaction ', ['64572001']), '108526002': ('product', 'Nicardipine ', ['763158003']), '372502001': ('product', 'Nicardipine ', ['406455002', '312413002']), '421369008': ('clinical finding', 'Emotional hypersensitivity ', ['250171008'])}}

537908
known hiv carrier
known hiv carrier
['known hiv carrier']
{'known hiv carrier': {'36692007': 'Known ', '19030005': 'Human immunodeficiency virus ', '47461006': 'Genetic disorder carrier ', '29679002': 'Carrier of disorder ', '165816005': 'Human immunodeficiency virus positive '}}
{'known hiv carrier': {'19030005': ('clinical finding', 'Human immunodeficiency virus ', ['49872002']), '47461006': ('clinical finding', 'Genetic disorder carrier ', ['250171008', '29679002', '365860008']), '29679002': ('clinical finding', 'Carrier of disorder ', ['250171008', '365860008']), '165816005': ('clinical finding', 'Human immunodeficiency virus positive ', ['441742003'])}}

541397
subject received oral concomitant analgesics for hs-related pain within 14 days prior to baseline visit.
subject received oral concomitant analgesics for hs-related pain , prior to baseline visit.
['received oral concomitant analgesics for hs', 'related', 'pain']
{'received oral concomitant analgesics for hs': {'260548002': 'Oral ', '79970003': 'Simultaneous ', '373265006': 'Analgesic ', '53009005': 'Analgesic '}, 'related': {'263498003': 'relationships', '272151006': 'Relationships ', '262094002': 'Related '}, 'pain': {'22253000': 'Pain '}}
{'received oral concomitant analgesics for hs': {'79970003': ('qualifier value', 'Simultaneous ', ['272099008']), '53009005': ('product', 'Analgesic ', ['763158003'])}, 'related': {'272151006': ('qualifier value', 'Relationships ', ['272099008']), '262094002': ('clinical finding', 'Related ', ['118240005'])}, 'pain': {'22253000': ('clinical finding', 'Pain ', ['102957003'])}}

541841
subjects where the carer's english is not fluent services and translational services are not available
subjects where the carer's english is not fluent services and translational services are not available
["the carer's english", 'not fluent services', 'translational services', 'not available']
{"the carer's english": {'133932002': 'Caregiver ', '297487008': 'English language ', '25804004': 'English ', '900000000000507009': 'english [international organization for standardization 639-1 code en] language reference set', '229774002': 'Carer '}, 'not fluent services': {'224930009': 'Services '}, 'translational services': {'112211004': 'Genetic translation ', '224930009': 'Services '}, 'not available': {'103329007': 'Unavailability of ', '397854000': 'Unavailability '}}
{'translational services': {'112211004': ('clinical finding', 'Genetic translation ', ['441742003'])}}

549610
any serious chronic disease or progressive disease according to judgment of the investigator ;
any serious chronic disease or progressive disease according to judgment of the investigator ;
['any serious chronic disease', 'progressive disease according to judgment of the investigator']
{'any serious chronic disease': {'42745003': 'Serious ', '27624003': 'Chronic disease '}, 'progressive disease according to judgment of the investigator': {'252157006': 'Progressing to ', '255314001': 'Progressive ', '64572001': 'Disease ', '61254005': 'Judgement '}}
{'any serious chronic disease': {'42745003': ('qualifier value', 'Serious ', ['272099008']), '27624003': ('clinical finding', 'Chronic disease ', ['64572001'])}, 'progressive disease according to judgment of the investigator': {'252157006': ('qualifier value', 'Progressing to ', ['272099008']), '255314001': ('qualifier value', 'Progressive ', ['272099008']), '61254005': ('observable entity', 'Judgement ', ['363788007'])}}

553791
for part 3, subject has ovarian cancer that was previously treated with platinum based chemotherapy resulting in progression free survival for < 6 months from the completion of treatment.
for part 3, subject has ovarian cancer that was , ly treated with platinum based chemotherapy resulting in progression free survival , from the completion of treatment.
['for part 3,', 'ovarian cancer', 'ly', 'treated with platinum', 'based', 'chemotherapy', 'resulting in progression free survival', 'from the completion of treatment']
{'for part 3,': {'260726005': 'part'}, 'ovarian cancer': {'363443007': 'Malignant tumor of ovary '}, 'ly': {'223512002': 'Libya '}, 'treated with platinum': {'28995006': 'treated with', '84847000': 'Platinum '}, 'based': {'63813000': 'Alkali '}, 'chemotherapy': {'416608005': 'Drug therapy ', '716872004': 'Antineoplastic chemotherapy regimen ', '363688001': 'Administration of antineoplastic agent ', '367336001': 'Chemotherapy '}, 'resulting in progression free survival': {'79409006': 'resulting in', '246453008': 'disease progression', '37837009': 'free of ', '246450006': 'progression'}, 'from the completion of treatment': {'182992009': 'Treatment completed '}}
{'ovarian cancer': {'363443007': ('clinical finding', 'Malignant tumor of ovary ', ['64572001', '118234003'])}, 'treated with platinum': {'84847000': ('product', 'Platinum ', ['406455002', '312413002'])}, 'based': {'63813000': ('product', 'Alkali ', ['312413002'])}, 'chemotherapy': {'416608005': ('procedure', 'Drug therapy ', ['128927009']), '716872004': ('procedure', 'Antineoplastic chemotherapy regimen ', ['243120004', '128927009']), '363688001': ('procedure', 'Administration of antineoplastic agent ', ['416608005', '367336001', '128927009']), '367336001': ('procedure', 'Chemotherapy ', ['416608005', '128927009'])}, 'from the completion of treatment': {'182992009': ('situation with explicit context', 'Treatment completed ', ['129125009'])}}

556353
previous thromboembolism/arrhythmias
, thromboembolism/arrhythmias
['thromboembolism/arrhythmias']
{'thromboembolism/arrhythmias': {'13713005': 'Thromboembolus ', '371039008': 'Thromboembolic disorder ', '698247007': 'Cardiac arrhythmia '}}
{'thromboembolism/arrhythmias': {'371039008': ('clinical finding', 'Thromboembolic disorder ', ['64572001', '118234003']), '698247007': ('clinical finding', 'Cardiac arrhythmia ', ['64572001', '118234003'])}}

560035
a positive test result for urine toxicology.
a positive test result for urine toxicology.
['a positive test result for urine toxicology']
{'a positive test result for urine toxicology': {'10828004': 'Positive ', '277775005': 'Test finding ', '78014005': 'Urine ', '409967009': 'Toxicology ', '118246004': 'Laboratory test finding '}}
{'a positive test result for urine toxicology': {'10828004': ('qualifier value', 'Positive ', ['272099008']), '78014005': ('product', 'Urine ', ['115669006'])}}

582853-1
contraindication to any of the components of the polypill .
contraindication to any of the components of the polypill .
['contraindication to any of the components of the polypill']
{'contraindication to any of the components of the polypill': {'103306004': 'Contraindication to ', '246093002': 'component object'}}
{}

582853-2
such contraindications are fully listed in the investigator brochures.
such contraindications are fully listed in the investigator brochures.
['such contraindications']
{'such contraindications': {'397745006': 'Medical contraindication '}}
{'such contraindications': {'397745006': ('clinical finding', 'Medical contraindication ', ['250171008'])}}

588218
inability to provide informed consent
provide informed consent
['informed consent']
{'informed consent': {'108968006': 'Oprelvekin ', '410938009': 'Oprelvekin ', '223458004': 'Informing '}}
{'informed consent': {'108968006': ('product', 'Oprelvekin ', ['406455002', '312413002', '115668003']), '410938009': ('product', 'Oprelvekin ', ['763158003'])}}

617383
pregnant women or lactating women, and pregnancy may not take effective contraceptive measures;
pregnant women or lactating women, and pregnancy may not take effective contraceptive measures;
['pregnant women', 'lactating women,', 'pregnancy', 'take', 'effective contraceptive measures']
{'pregnant women': {'255409004': 'Pregnant woman '}, 'lactating women,': {'83036002': 'Lactate ', '224526002': 'Woman '}, 'pregnancy': {'289908002': 'Pregnancy, function ', '77386006': 'Patient currently pregnant '}, 'take': {'419652001': 'Take - dosing instruction imperative '}, 'effective contraceptive measures': {'255403003': 'Effectiveness ', '108899006': 'Contraceptives ', '246445000': 'measures', '367346004': 'measures ', '348649005': 'Contraceptive device ', '254648000': 'Effective '}}
{'pregnant women': {'255409004': ('person', 'Pregnant woman ', ['133936004', '224526002'])}, 'lactating women,': {'83036002': ('product', 'Lactate ', ['312413002']), '224526002': ('person', 'Woman ', ['133936004'])}, 'pregnancy': {'289908002': ('observable entity', 'Pregnancy, function ', ['246464006']), '77386006': ('clinical finding', 'Patient currently pregnant ', ['250171008'])}, 'effective contraceptive measures': {'255403003': ('qualifier value', 'Effectiveness ', ['272099008']), '108899006': ('product', 'Contraceptives ', ['763158003']), '254648000': ('qualifier value', 'Effective ', ['272099008'])}}

623783
hypersensibility to ursolic acid o calcined magnesia
hypersensibility to ursolic acid o calcined magnesia
['hypersensibility to ursolic acid o', 'magnesia']
{'hypersensibility to ursolic acid o': {'34957004': 'Acid ', '5022001': 'Lysergic acid diethylamide measurement '}, 'magnesia': {'419521006': 'Magnesium oxide ', '66389008': 'Magnesium oxide '}}
{'hypersensibility to ursolic acid o': {'34957004': ('product', 'Acid ', ['312413002']), '5022001': ('procedure', 'Lysergic acid diethylamide measurement ', ['128927009'])}, 'magnesia': {'419521006': ('product', 'Magnesium oxide ', ['763158003']), '66389008': ('product', 'Magnesium oxide ', ['406455002', '312413002'])}}

625306
subjects with a critical illness or who are immunocompromised
subjects with a critical illness or who are immunocompromised
['subjects with a critical illness', 'immunocompromised']
{'subjects with a critical illness': {'39104002': 'Illness '}, 'immunocompromised': {'370388006': 'Patient immunocompromised ', '370391006': 'Patient immunosuppressed '}}
{'subjects with a critical illness': {'39104002': ('clinical finding', 'Illness ', ['250171008'])}, 'immunocompromised': {'370388006': ('clinical finding', 'Patient immunocompromised ', ['441742003']), '370391006': ('clinical finding', 'Patient immunosuppressed ', ['441742003'])}}

632623
has concurrent intracranial tumors, intracranial aneurysm or arteriovenous malformation.
has concurrent intracranial tumors, intracranial aneurysm or arteriovenous malformation.
['concurrent intracranial tumors,', 'intracranial aneurysm', 'arteriovenous malformation']
{'concurrent intracranial tumors,': {'68405009': 'Concurrent ', '254935002': 'Intracranial tumor '}, 'intracranial aneurysm': {'128609009': 'Intracranial aneurysm '}, 'arteriovenous malformation': {'234141001': 'Congenital arteriovenous malformation ', '24551003': 'Arteriovenous malformation ', '11071001': 'Racemose hemangioma ', '14156004': 'Racemose aneurysm ', '233982006': 'Cirsoid aneurysm ', '403966009': 'Arteriovenous hemangioma '}}
{'concurrent intracranial tumors,': {'68405009': ('qualifier value', 'Concurrent ', ['272099008']), '254935002': ('clinical finding', 'Intracranial tumor ', ['64572001', '118234003'])}, 'intracranial aneurysm': {'128609009': ('clinical finding', 'Intracranial aneurysm ', ['64572001', '118234003'])}, 'arteriovenous malformation': {'234141001': ('clinical finding', 'Congenital arteriovenous malformation ', ['64572001', '118234003']), '233982006': ('clinical finding', 'Cirsoid aneurysm ', ['64572001', '118234003']), '403966009': ('clinical finding', 'Arteriovenous hemangioma ', ['64572001'])}}

632744
multiple myeloma of igm subtype.
multiple myeloma of igm subtype.
['multiple myeloma of igm subtype']
{'multiple myeloma of igm subtype': {'109989006': 'Multiple myeloma ', '55921005': 'Multiple myeloma, no International Classification of Diseases for Oncology subtype ', '260837004': 'subtype '}}
{'multiple myeloma of igm subtype': {'109989006': ('clinical finding', 'Multiple myeloma ', ['64572001'])}}

636777
clinical laboratory test values are outside the accepted normal range
clinical laboratory test values are outside the accepted normal range
['clinical laboratory test values', 'outside', 'the accepted normal range']
{'clinical laboratory test values': {'58147004': 'Clinical ', '108252007': 'Laboratory procedure ', '15220000': 'Laboratory test ', '269814003': 'Laboratory procedures -general '}, 'outside': {'261074009': 'External '}, 'the accepted normal range': {'385645004': 'Accepted ', '260395002': 'Normal range '}}
{'clinical laboratory test values': {'58147004': ('qualifier value', 'Clinical ', ['272099008']), '15220000': ('procedure', 'Laboratory test ', ['128927009', '108252007']), '269814003': ('situation with explicit context', 'Laboratory procedures -general ', ['129125009'])}}

644695
inability to take or absorb oral medicine
take or absorb oral medicine
['take', 'oral medicine']
{'take': {'419652001': 'Take - dosing instruction imperative '}, 'oral medicine': {'260548002': 'Oral ', '105903003': 'General drug type ', '373873005': 'Pharmaceutical / biologic product ', '410942007': 'Drug or medicament '}}
{}

648129
the inclusion of patients with prior malignancy or concurrent malignancy must be discussed
the inclusion of patients with prior malignancy or concurrent malignancy must be discussed
['the inclusion of patients', 'with prior malignancy', 'concurrent malignancy']
{'the inclusion of patients': {'55919000': 'Including ', '116154003': 'Patient '}, 'with prior malignancy': {'236874000': 'Status pre- ', '288556008': 'before', '363346000': 'Malignant neoplastic disease ', '372087000': 'Primary malignant neoplasm ', '86049000': 'Malignant neoplasm, primary '}, 'concurrent malignancy': {'68405009': 'Concurrent ', '363346000': 'Malignant neoplastic disease ', '372087000': 'Primary malignant neoplasm ', '86049000': 'Malignant neoplasm, primary '}}
{'the inclusion of patients': {'55919000': ('qualifier value', 'Including ', ['272099008'])}, 'with prior malignancy': {'363346000': ('clinical finding', 'Malignant neoplastic disease ', ['64572001']), '372087000': ('clinical finding', 'Primary malignant neoplasm ', ['64572001', '363346000'])}, 'concurrent malignancy': {'68405009': ('qualifier value', 'Concurrent ', ['272099008']), '363346000': ('clinical finding', 'Malignant neoplastic disease ', ['64572001']), '372087000': ('clinical finding', 'Primary malignant neoplasm ', ['64572001', '363346000'])}}

651677
lesions in coronary artery bypass grafts
lesions in coronary artery bypass grafts
['lesions in coronary artery bypass grafts']
{'lesions in coronary artery bypass grafts': {'52988006': 'Lesion ', '232717009': 'Coronary artery bypass grafting ', '67166004': 'Aortocoronary artery bypass graft ', '90205004': 'Cardiac revascularization with bypass anastomosis '}}
{'lesions in coronary artery bypass grafts': {'232717009': ('procedure', 'Coronary artery bypass grafting ', ['362958002', '128927009']), '67166004': ('procedure', 'Aortocoronary artery bypass graft ', ['362958002', '128927009']), '90205004': ('procedure', 'Cardiac revascularization with bypass anastomosis ', ['362958002', '128927009'])}}

652678
any other condition or circumstance that the investigator considers should exclude the patients or that could interfere with the interpretation of the study results
any other condition or circumstance results
['other condition', 'results']
{'other condition': {'64572001': 'Disease ', '260905004': 'condition'}, 'results': {'394617004': 'Result '}}
{}

652952
participants who are unable to understand the study protocol or unable to give informed consent, and have no legal representative.
participants who understand the study protocol or give informed consent, and have legal representative.
['understand', 'the study protocol', 'give', 'informed consent,', 'legal representative']
{'understand': {'66216009': 'Understanding, function '}, 'the study protocol': {'224699009': 'Study ', '258049002': 'Protocols '}, 'give': {'419582001': 'Give - dosing instruction imperative '}, 'informed consent,': {'108968006': 'Oprelvekin ', '410938009': 'Oprelvekin ', '223458004': 'Informing '}, 'legal representative': {'398165009': 'Legal '}}
{'understand': {'66216009': ('observable entity', 'Understanding, function ', ['246464006'])}, 'informed consent,': {'108968006': ('product', 'Oprelvekin ', ['406455002', '312413002', '115668003']), '410938009': ('product', 'Oprelvekin ', ['763158003'])}, 'legal representative': {'398165009': ('qualifier value', 'Legal ', ['272099008'])}}

653769
dialysis or continuous venovenous hemofiltration before recruitment
dialysis or continuous venovenous hemofiltration before recruitment
['dialysis', 'continuous venovenous hemofiltration before recruitment']
{'dialysis': {'108241001': 'Dialysis procedure ', '265764009': 'Renal dialysis '}, 'continuous venovenous hemofiltration before recruitment': {'233585000': 'Continuous venovenous hemofiltration '}}
{'dialysis': {'108241001': ('procedure', 'Dialysis procedure ', ['128927009']), '265764009': ('procedure', 'Renal dialysis ', ['108241001', '128927009'])}, 'continuous venovenous hemofiltration before recruitment': {'233585000': ('procedure', 'Continuous venovenous hemofiltration ', ['265764009', '108241001', '362958002', '128927009'])}}

661244
tricuspidal- and or artificial aortic valve
tricuspidal- and or artificial aortic valve
['tricuspidal', 'artificial aortic valve']
{'tricuspidal': {'263911000': 'Tricuspid '}, 'artificial aortic valve': {'71967004': 'Artificial ', '34202007': 'Aortic valve structure '}}
{'tricuspidal': {'263911000': ('qualifier value', 'Tricuspid ', ['272099008'])}, 'artificial aortic valve': {'71967004': ('qualifier value', 'Artificial ', ['272099008'])}}

661835
breast feeding
breast feeding
['breast feeding']
{'breast feeding': {'169741004': 'Breast fed ', '413712001': 'Breastfeeding '}}
{'breast feeding': {'169741004': ('clinical finding', 'Breast fed ', ['250171008']), '413712001': ('observable entity', 'Breastfeeding ', ['246464006'])}}

662494
patients who have a recent history of drug substance or alcohol abuse.
patients who have a recent , drug substance or alcohol abuse.
['patients', 'a recent , drug substance', 'alcohol abuse']
{'patients': {'116154003': 'Patient '}, 'a recent , drug substance': {'263852005': 'Recent episode ', '6493001': 'Recent ', '105903003': 'General drug type ', '373873005': 'Pharmaceutical / biologic product ', '410942007': 'Drug or medicament ', '105590001': 'Substance ', '261217004': 'substance'}, 'alcohol abuse': {'15167005': 'Alcohol abuse '}}
{'a recent , drug substance': {'263852005': ('qualifier value', 'Recent episode ', ['272099008'])}, 'alcohol abuse': {'15167005': ('clinical finding', 'Alcohol abuse ', ['64572001'])}}

664118
active psychosis
active psychosis
['active psychosis']
{'active psychosis': {'55561003': 'Active ', '69322001': 'Psychotic disorder ', '191525009': 'Non-organic psychosis '}}
{'active psychosis': {'55561003': ('qualifier value', 'Active ', ['272099008']), '69322001': ('clinical finding', 'Psychotic disorder ', ['64572001']), '191525009': ('clinical finding', 'Non-organic psychosis ', ['64572001', '69322001'])}}

667235
no signed informed consent by both parents
signed informed consent by both parents
['signed', 'informed consent by both parents']
{'signed': {'72670004': 'Sign '}, 'informed consent by both parents': {'108968006': 'Oprelvekin ', '410938009': 'Oprelvekin ', '160503002': 'Parent of ', '40683002': 'Parent ', '223458004': 'Informing '}}
{'signed': {'72670004': ('clinical finding', 'Sign ', ['250171008'])}, 'informed consent by both parents': {'108968006': ('product', 'Oprelvekin ', ['406455002', '312413002', '115668003']), '410938009': ('product', 'Oprelvekin ', ['763158003']), '160503002': ('observable entity', 'Parent of ', ['160476009'])}}

680558
chronic medically refractory atrial tachyarrhythmias
chronic medically refractory atrial tachyarrhythmias
['chronic medically refractory atrial tachyarrhythmias']
{'chronic medically refractory atrial tachyarrhythmias': {'90734009': 'Chronic ', '20646008': 'Intractable ', '59652004': 'Atrial structure ', '6285003': 'Tachyarrhythmia '}}
{'chronic medically refractory atrial tachyarrhythmias': {'90734009': ('qualifier value', 'Chronic ', ['272099008']), '20646008': ('qualifier value', 'Intractable ', ['272099008']), '6285003': ('clinical finding', 'Tachyarrhythmia ', ['64572001', '118234003'])}}

681913
patients reporting prior use of "ecstasy" > 5 times or at any time within the previous 6 months.
patients reporting prior use of "ecstasy" > 5 times or at any time , .
['patients', 'reporting', 'prior use of "ecstasy"', '> 5 times', 'or at any time']
{'patients': {'116154003': 'Patient '}, 'reporting': {'223458004': 'Informing '}, 'prior use of "ecstasy"': {'236874000': 'Status pre- ', '288556008': 'before', '260676000': 'use of', '115539008': 'Methylene-dioxymethamphetamine ', '288459003': 'Methylenedioxymethamphetamine ', '67877007': 'Ecstasy ', '121373009': 'Methylenedioxymethamphetamine measurement '}, '> 5 times': {'264606005': '-5 ', '410669006': 'Time ', '410670007': 'time', '417929005': 'Times ', '264706000': '>5 ', '264605009': 'Integer +5 '}, 'or at any time': {'410669006': 'Time ', '410670007': 'time', '900000000000475002': 'time '}}
{'prior use of "ecstasy"': {'288459003': ('product', 'Methylenedioxymethamphetamine ', ['406455002', '312413002']), '67877007': ('clinical finding', 'Ecstasy ', ['250171008']), '121373009': ('procedure', 'Methylenedioxymethamphetamine measurement ', ['128927009'])}}

683893
typical angina pectoris symptoms at rest or during exercise
typical angina pectoris symptoms at rest or during exercise
['typical angina pectoris symptoms at rest', 'or during exercise']
{'typical angina pectoris symptoms at rest': {'25106000': 'Impending infarction ', '4557003': 'Preinfarction syndrome ', '59021001': 'Angina decubitus '}, 'or during exercise': {'183301007': 'Physical exercises ', '256235009': 'Exercise ', '61686008': 'Physical exercise '}}
{'typical angina pectoris symptoms at rest': {'25106000': ('clinical finding', 'Impending infarction ', ['64572001', '118234003']), '4557003': ('clinical finding', 'Preinfarction syndrome ', ['64572001', '102957003', '118234003']), '59021001': ('clinical finding', 'Angina decubitus ', ['64572001', '102957003', '118234003'])}, 'or during exercise': {'183301007': ('procedure', 'Physical exercises ', ['243120004'])}}

686723
medical conditions or psychiatric conditions which, in the opinion of the investigator, make participation in an investigational trial of this nature a poor risk.
medical conditions or psychiatric conditions which, in the opinion of the investigator, make participation in an investigational trial of this nature a poor risk.
['medical conditions', 'psychiatric conditions', 'participation in an investigational trial of this nature', 'a poor risk']
{'medical conditions': {'373655009': 'Medical service ', '64572001': 'Disease ', '260905004': 'condition', '74188005': 'Medical '}, 'psychiatric conditions': {'74732009': 'Mental disorder '}, 'participation in an investigational trial of this nature': {'129265001': 'Evaluation - action ', '386053000': 'Evaluation procedure ', '110465008': 'Clinical trial ', '246425008': 'natures', '277302009': 'Natures '}, 'a poor risk': {'11403006': 'Financially poor ', '30207005': 'Risk of ', '255351007': 'Poor - grade '}}
{'medical conditions': {'74188005': ('qualifier value', 'Medical ', ['272099008'])}, 'psychiatric conditions': {'74732009': ('clinical finding', 'Mental disorder ', ['64572001'])}, 'participation in an investigational trial of this nature': {'386053000': ('procedure', 'Evaluation procedure ', ['128927009']), '277302009': ('qualifier value', 'Natures ', ['272099008'])}, 'a poor risk': {'11403006': ('clinical finding', 'Financially poor ', ['118240005', '250171008']), '255351007': ('qualifier value', 'Poor - grade ', ['272396007'])}}

687258
pulmonary lymphangitic involvement that results in pulmonary dysfunction requiring active treatment, including the use of oxygen
pulmonary lymphangitic involvement in pulmonary dysfunction requiring active treatment, including the use of oxygen
['pulmonary lymphangitic involvement in pulmonary dysfunction', 'active treatment,', 'including', 'the use of oxygen']
{'pulmonary lymphangitic involvement in pulmonary dysfunction': {'39607008': 'Lung structure ', '1415005': 'Lymphangitis ', '248448006': 'Involved ', '278112009': 'involvement with', '386585008': 'Functional disorder ', '264164005': 'Pulmonary '}, 'active treatment,': {'55561003': 'Active ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '416118004': 'Administration '}, 'including': {'55919000': 'Including '}, 'the use of oxygen': {'260676000': 'use of', '24099007': 'Oxygen '}}
{'pulmonary lymphangitic involvement in pulmonary dysfunction': {'1415005': ('clinical finding', 'Lymphangitis ', ['64572001', '118234003']), '248448006': ('qualifier value', 'Involved ', ['272099008']), '386585008': ('clinical finding', 'Functional disorder ', ['250171008'])}, 'active treatment,': {'55561003': ('qualifier value', 'Active ', ['272099008']), '276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '416118004': ('procedure', 'Administration ', ['128927009'])}, 'including': {'55919000': ('qualifier value', 'Including ', ['272099008'])}, 'the use of oxygen': {'24099007': ('product', 'Oxygen ', ['115669006', '312413002', '312412007'])}}

687945
use of any alpha-adrenoreceptor agonists or anticholinergics or cholinergics within 48 hours prior to all uroflowmetry assessments.
use of any alpha-adrenoreceptor agonists or anticholinergics or cholinergics within 48 hours prior to all uroflowmetry assessments.
['use of any alpha adrenoreceptor agonists', 'anticholinergics', 'cholinergics within 48 hours', 'prior to all uroflowmetry assessments']
{'use of any alpha adrenoreceptor agonists': {'260676000': 'use of', '349917000': 'Alpha-adrenoceptor agonist ', '372622007': 'Alpha-adrenoceptor agonist '}, 'anticholinergics': {'14601000': 'Anticholinergic agent ', '373246003': 'Anticholinergic agent '}, 'cholinergics within 48 hours': {'19581007': 'Parasympathomimetic agent ', '255249005': '48 hours '}, 'prior to all uroflowmetry assessments': {'44856007': 'Uroflowmetry ', '129265001': 'Evaluation - action ', '386053000': 'Evaluation procedure '}}
{'use of any alpha adrenoreceptor agonists': {'349917000': ('product', 'Alpha-adrenoceptor agonist ', ['763158003'])}, 'anticholinergics': {'14601000': ('product', 'Anticholinergic agent ', ['763158003']), '373246003': ('product', 'Anticholinergic agent ', ['406455002'])}, 'cholinergics within 48 hours': {'19581007': ('product', 'Parasympathomimetic agent ', ['763158003']), '255249005': ('qualifier value', '48 hours ', ['272099008'])}, 'prior to all uroflowmetry assessments': {'44856007': ('procedure', 'Uroflowmetry ', ['386053000', '362958002', '128927009']), '386053000': ('procedure', 'Evaluation procedure ', ['128927009'])}}

695885
subject has any condition which makes the subject unsuitable for study participation .
subject has any condition which makes the subject un study participation .
['any condition', 'the subject un study participation']
{'any condition': {'64572001': 'Disease ', '260905004': 'condition'}, 'the subject un study participation': {'224699009': 'Study '}}
{}

704149
patients who are prisoners
patients who are prisoners
['patients']
{'patients': {'116154003': 'Patient '}}
{}

704173
active infection
active infection
['active infection']
{'active infection': {'55561003': 'Active ', '189822004': 'Contagious disease ', '191415002': 'Communicable disease ', '40733004': 'Infectious disease '}}
{'active infection': {'55561003': ('qualifier value', 'Active ', ['272099008']), '40733004': ('clinical finding', 'Infectious disease ', ['64572001'])}}

705358
patient participating to a biomedical research with drug
patient participating to a biomedical research with drug
['patient participating to a biomedical research', 'with drug']
{'patient participating to a biomedical research': {'116154003': 'Patient '}, 'with drug': {'105903003': 'General drug type ', '373873005': 'Pharmaceutical / biologic product ', '410942007': 'Drug or medicament '}}
{}

713786
patient has evidence of active viral illness .
patient has evidence of active viral illness .
['patient', 'evidence of active viral illness']
{'patient': {'116154003': 'Patient '}, 'evidence of active viral illness': {'18669006': 'Evidence of ', '55561003': 'Active ', '34014006': 'Viral disease '}}
{'evidence of active viral illness': {'55561003': ('qualifier value', 'Active ', ['272099008']), '34014006': ('clinical finding', 'Viral disease ', ['64572001'])}}

726449
history of cryptorchidism.
, cryptorchidism.
['cryptorchidism']
{'cryptorchidism': {'204878001': 'Undescended testicle '}}
{'cryptorchidism': {'204878001': ('clinical finding', 'Undescended testicle ', ['64572001', '118234003'])}}

726612
current abuse of alcohol or drug addiction that may interfere with the subject's ability to comply with trial procedures
current abuse of alcohol or drug addiction that may interfere with the subject's comply with trial procedures
['current abuse of alcohol', 'drug addiction', "interfere with the subject's", 'comply with trial procedures']
{'current abuse of alcohol': {'15240007': 'Current ', '15167005': 'Alcohol abuse '}, 'drug addiction': {'191816009': 'Drug dependence ', '2403008': 'Psychoactive substance dependence ', '6525002': 'Dependent drug abuse '}, "interfere with the subject's": {'78235001': 'Interferes with '}, 'comply with trial procedures': {'110465008': 'Clinical trial ', '71388002': 'Procedure '}}
{'current abuse of alcohol': {'15167005': ('clinical finding', 'Alcohol abuse ', ['64572001', '2403008', '191816009'])}, 'drug addiction': {'191816009': ('clinical finding', 'Drug dependence ', ['64572001']), '2403008': ('clinical finding', 'Psychoactive substance dependence ', ['64572001', '191816009']), '6525002': ('clinical finding', 'Dependent drug abuse ', ['64572001'])}}

736058
subjects who started hormonal treatment within < 3 months.
subjects who started hormonal treatment , .
['started', 'hormonal treatment']
{'started': {'385652002': 'Started '}, 'hormonal treatment': {'278994005': 'Hormonal ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '416118004': 'Administration '}}
{'hormonal treatment': {'278994005': ('qualifier value', 'Hormonal ', ['272099008']), '276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '416118004': ('procedure', 'Administration ', ['128927009'])}}

738261
prisoners or subjects who are compulsorily detained for treatment of either a psychiatric illness or physical illness must not be enrolled into this study;
prisoners or subjects who are compulsorily detained for treatment of either a psychiatric illness or physical illness enrolled into this study;
['detained for treatment of either', 'a psychiatric illness', 'physical illness', 'enrolled into this study']
{'detained for treatment of either': {'276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '416118004': 'Administration '}, 'a psychiatric illness': {'74732009': 'Mental disorder '}, 'physical illness': {'302199004': 'Examination - action ', '5880005': 'Physical examination procedure ', '81375008': 'Physical assessment ', '39104002': 'Illness ', '19388002': 'Physical '}, 'enrolled into this study': {'224699009': 'Study '}}
{'detained for treatment of either': {'276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '416118004': ('procedure', 'Administration ', ['128927009'])}, 'a psychiatric illness': {'74732009': ('clinical finding', 'Mental disorder ', ['64572001'])}, 'physical illness': {'5880005': ('procedure', 'Physical examination procedure ', ['362958002', '128927009']), '81375008': ('procedure', 'Physical assessment ', ['128927009']), '39104002': ('clinical finding', 'Illness ', ['250171008']), '19388002': ('qualifier value', 'Physical ', ['272099008'])}}

741944
recent cerebrovascular accident or transient ischemic attack
recent cerebrovascular accident or transient ischemic attack
['recent cerebrovascular accident', 'transient ischemic attack']
{'recent cerebrovascular accident': {'263852005': 'Recent episode ', '6493001': 'Recent ', '230690007': 'Cerebrovascular accident '}, 'transient ischemic attack': {'266257000': 'Transient ischemic attack '}}
{'recent cerebrovascular accident': {'263852005': ('qualifier value', 'Recent episode ', ['272099008']), '230690007': ('clinical finding', 'Cerebrovascular accident ', ['64572001', '118234003'])}, 'transient ischemic attack': {'266257000': ('clinical finding', 'Transient ischemic attack ', ['64572001', '118234003'])}}

750906
subject has a history of pressure ulcer / dti in same location.
subject has , pressure ulcer / dti in same location.
['pressure ulcer / dti in same location']
{'pressure ulcer / dti in same location': {'399912005': 'Pressure ulcer ', '420226006': 'Pressure ulcer ', '262126009': 'Same ', '246267002': 'location'}}
{'pressure ulcer / dti in same location': {'399912005': ('clinical finding', 'Pressure ulcer ', ['64572001', '118234003']), '262126009': ('qualifier value', 'Same ', ['272099008'])}}

751401-1
type 1 diabetes or type 2 diabetes with medication known to induce hypoglycemia (f.e.
type 1 diabetes or type 2 diabetes with medication known to induce hypoglycemia (f.e.
['type 1 diabetes', 'type 2 diabetes with medication', 'known', 'to', 'induce', 'hypoglycemia', '(f e']
{'type 1 diabetes': {'46635009': 'Diabetes mellitus type 1 '}, 'type 2 diabetes with medication': {'44054006': 'Diabetes mellitus type 2 ', '105903003': 'General drug type ', '373873005': 'Pharmaceutical / biologic product ', '410942007': 'Drug or medicament '}, 'known': {'36692007': 'Known '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'induce': {'16404004': 'Induced '}, 'hypoglycemia': {'237630007': 'Hypoglycemic disorder ', '271327008': 'Hypoglycemic syndrome ', '302866003': 'Hypoglycemia '}, '(f e': {'350594000': 'Fluoride product ', '372639009': 'Fluoride ', '387415009': 'Fluoride salt ', '258258002': 'f) '}}
{'type 1 diabetes': {'46635009': ('clinical finding', 'Diabetes mellitus type 1 ', ['64572001', '118234003'])}, 'type 2 diabetes with medication': {'44054006': ('clinical finding', 'Diabetes mellitus type 2 ', ['64572001', '118234003'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'induce': {'16404004': ('qualifier value', 'Induced ', ['272099008'])}, 'hypoglycemia': {'237630007': ('clinical finding', 'Hypoglycemic disorder ', ['64572001', '118234003']), '271327008': ('clinical finding', 'Hypoglycemic syndrome ', ['64572001']), '302866003': ('clinical finding', 'Hypoglycemia ', ['64572001', '237630007', '118234003'])}, '(f e': {'350594000': ('product', 'Fluoride product ', ['373873005', '763158003']), '372639009': ('product', 'Fluoride ', ['406455002', '312413002', '410942007', '115668003']), '258258002': ('staging and scales', 'f) ', ['254292007'])}}

751401-2
sulfonylurea derivatives
sulfonylurea derivatives
['sulfonylurea derivatives']
{'sulfonylurea derivatives': {'259552008': 'Sulfonylurea and its derivatives ', '34012005': 'Sulfonylurea ', '372711004': 'Sulfonylurea '}}
{'sulfonylurea derivatives': {'259552008': ('product', 'Sulfonylurea and its derivatives ', ['406455002', '312413002']), '34012005': ('product', 'Sulfonylurea ', ['763158003']), '372711004': ('product', 'Sulfonylurea ', ['406455002', '259552008', '312413002'])}}

759414
donation or loss of 500 ml or more of blood within 8 weeks prior to the first dose of investigational drug.
donation or loss of 500 ml or more of blood , prior to the first dose of investigational drug.
['donation', 'loss of 500 ml', 'more of blood', 'prior to the first dose of investigational drug']
{'donation': {'449951000124101': 'patient status determination, deceased and body donated'}, 'loss of 500 ml': {'732775002': '500', '259035002': 'per milliliter '}, 'more of blood': {'242762006': 'More ', '87612001': 'Blood ', '119273009': 'Peripheral blood '}, 'prior to the first dose of investigational drug': {'236874000': 'Status pre- ', '288556008': 'before', '255216001': 'First ', '398232005': 'Drug dose ', '129265001': 'Evaluation - action ', '386053000': 'Evaluation procedure ', '260911001': 'dosage', '277406006': 'Dosages ', '185922005': 'Clinical drug trial ', '408102007': 'Unit dose ', '232714002': 'Firstly '}}
{'donation': {'449951000124101': ('clinical finding', 'patient status determination, deceased and body donated', ['250171008'])}, 'loss of 500 ml': {'259035002': ('unit', 'per milliliter ', ['767524001'])}, 'more of blood': {'242762006': ('qualifier value', 'More ', ['272099008']), '87612001': ('product', 'Blood ', ['115669006', '115668003']), '119273009': ('product', 'Peripheral blood ', ['115669006', '87612001', '115668003'])}, 'prior to the first dose of investigational drug': {'398232005': ('clinical finding', 'Drug dose ', ['250171008']), '386053000': ('procedure', 'Evaluation procedure ', ['128927009']), '277406006': ('qualifier value', 'Dosages ', ['272099008']), '408102007': ('unit', 'Unit dose ', ['767524001']), '232714002': ('qualifier value', 'Firstly ', ['272099008'])}}

760191
immunodepressed patients
immunodepressed patients
['immunodepressed patients']
{'immunodepressed patients': {'86553008': 'Immunosuppressive therapy ', '116154003': 'Patient ', '38013005': 'Immunosuppression '}}
{'immunodepressed patients': {'38013005': ('clinical finding', 'Immunosuppression ', ['250171008'])}}

760445
administration of a depot antipsychotic injection within 1 dosing interval before randomization
administration of a depot antipsychotic injection within 1 dosing interval before randomization
['administration of a depot antipsychotic injection', 'within 1 dosing interval before randomization']
{'administration of a depot antipsychotic injection': {'28289002': 'Injection of therapeutic agent ', '10784006': 'Anti-psychotic agent ', '372482001': 'Anti-psychotic agent ', '129326001': 'Injection - action ', '59108006': 'Injection '}, 'within 1 dosing interval before randomization': {'451231000124103': 'greater than one', '260911001': 'dosage', '277406006': 'Dosages ', '385673002': 'Interval ', '408102007': 'Unit dose '}}
{'administration of a depot antipsychotic injection': {'28289002': ('procedure', 'Injection of therapeutic agent ', ['59108006', '128927009']), '10784006': ('product', 'Anti-psychotic agent ', ['763158003']), '59108006': ('procedure', 'Injection ', ['128927009'])}, 'within 1 dosing interval before randomization': {'277406006': ('qualifier value', 'Dosages ', ['272099008']), '408102007': ('unit', 'Unit dose ', ['767524001'])}}

762457
the travellers not visiting areas with chloroquine resistant malaria
the travellers not visiting areas with chloroquine resistant malaria
['not visiting areas with chloroquine resistant malaria']
{'not visiting areas with chloroquine resistant malaria': {'42798000': 'Area ', '14728000': 'Chloroquine ', '373468005': 'Chloroquine ', '30714006': 'Resistant ', '105649009': 'Disease caused by Plasmodiidae ', '248437004': 'Malarial fever ', '61462000': 'Malaria '}}
{'not visiting areas with chloroquine resistant malaria': {'42798000': ('qualifier value', 'Area ', ['272099008']), '14728000': ('product', 'Chloroquine ', ['763158003']), '373468005': ('product', 'Chloroquine ', ['312413002']), '105649009': ('clinical finding', 'Disease caused by Plasmodiidae ', ['64572001']), '248437004': ('clinical finding', 'Malarial fever ', ['250171008']), '61462000': ('clinical finding', 'Malaria ', ['64572001', '105649009'])}}

763916
asa score of > 4
asa score of > 4
['asa score of', '> 4']
{'asa score of': {'387458008': 'Aspirin ', '7947003': 'Aspirin ', '246262008': 'score', '278061009': 'Scores '}, '> 4': {'260300002': '-4 '}}
{'asa score of': {'387458008': ('product', 'Aspirin ', ['406455002', '312413002']), '7947003': ('product', 'Aspirin ', ['763158003']), '278061009': ('qualifier value', 'Scores ', ['272396007'])}}

766679
calcium serum values below 7.0 mg/dl or above 10.0 mg/dl
calcium serum values below 7.0 mg/dl or above 10.0 mg/dl
['calcium serum values below 7 0 mg/dl', 'or above 10 0 mg/dl']
{'calcium serum values below 7 0 mg/dl': {'271240001': 'Serum calcium measurement ', '732391002': '0.7', '258797006': 'Milligram/deciliter '}, 'or above 10 0 mg/dl': {'258797006': 'Milligram/deciliter '}}
{'calcium serum values below 7 0 mg/dl': {'271240001': ('procedure', 'Serum calcium measurement ', ['128927009']), '258797006': ('unit', 'Milligram/deciliter ', ['767524001'])}, 'or above 10 0 mg/dl': {'258797006': ('unit', 'Milligram/deciliter ', ['767524001'])}}

769851
history of chronic pancreatitis or idiopathic acute pancreatitis
, chronic pancreatitis or idiopathic acute pancreatitis
['chronic pancreatitis', 'idiopathic acute pancreatitis']
{'chronic pancreatitis': {'233870001': 'Recurrent pancreatitis ', '234689009': 'Relapsing pancreatitis ', '235494005': 'Chronic pancreatitis ', '235956004': 'Familial chronic pancreatitis ', '68072000': 'Hereditary pancreatitis '}, 'idiopathic acute pancreatitis': {'235943006': 'Idiopathic acute pancreatitis '}}
{'chronic pancreatitis': {'233870001': ('clinical finding', 'Recurrent pancreatitis ', ['64572001', '118234003']), '234689009': ('clinical finding', 'Relapsing pancreatitis ', ['64572001', '118234003', '235494005']), '235494005': ('clinical finding', 'Chronic pancreatitis ', ['64572001', '118234003']), '235956004': ('clinical finding', 'Familial chronic pancreatitis ', ['64572001', '68072000', '118234003', '235494005']), '68072000': ('clinical finding', 'Hereditary pancreatitis ', ['64572001', '118234003'])}, 'idiopathic acute pancreatitis': {'235943006': ('clinical finding', 'Idiopathic acute pancreatitis ', ['64572001', '118234003'])}}

771993
> 14 grams of fiber per 1000 kcal per day
> 14 grams of fiber per 1000 kcal per day
['> 14 grams of fiber', 'per 1000 kcal per day']
{'> 14 grams of fiber': {'258682000': 'gram ', '116272000': 'Dietary fiber ', '400293002': 'Fiber ', '400556009': 'Fiber ', '37202001': 'Plant fiber '}, 'per 1000 kcal per day': {'259057009': 'Kilocalorie/day '}}
{'> 14 grams of fiber': {'258682000': ('unit', 'gram ', ['767524001']), '116272000': ('product', 'Dietary fiber ', ['115668003', '37202001']), '400293002': ('product', 'Fiber ', ['406455002']), '400556009': ('product', 'Fiber ', ['763158003']), '37202001': ('product', 'Plant fiber ', ['115668003'])}, 'per 1000 kcal per day': {'259057009': ('unit', 'Kilocalorie/day ', ['767524001'])}}

775149
history of a hypersensitivity reaction to > 3 drugs
, a hypersensitivity reaction to > 3 drugs
['a hypersensitivity reaction to', '> 3 drugs']
{'a hypersensitivity reaction to': {'418634005': 'Allergic reaction caused by substance ', '421961002': 'Hypersensitivity reaction '}, '> 3 drugs': {'260313008': '<3 ', '105903003': 'General drug type ', '373873005': 'Pharmaceutical / biologic product ', '410942007': 'Drug or medicament '}}
{'a hypersensitivity reaction to': {'418634005': ('clinical finding', 'Allergic reaction caused by substance ', ['64572001', '421961002']), '421961002': ('clinical finding', 'Hypersensitivity reaction ', ['64572001'])}}

780892
has the patient ever had facial radiotherapy or is the patient scheduled to facial radiotherapy?
has the patient ever had facial radiotherapy or is the patient scheduled to facial radiotherapy?
['the patient', 'facial radiotherapy', 'scheduled to facial radiotherapy?']
{'the patient': {'116154003': 'Patient '}, 'facial radiotherapy': {'89545001': 'Face structure ', '419815003': 'Radiation oncology ', '108290001': 'Radiation oncology AND/OR radiotherapy ', '53438000': 'Radiation therapy procedure or service '}, 'scheduled to facial radiotherapy?': {'416151008': 'Scheduled - procedure status ', '89545001': 'Face structure ', '419815003': 'Radiation oncology ', '108290001': 'Radiation oncology AND/OR radiotherapy ', '53438000': 'Radiation therapy procedure or service ', '416774000': 'Scheduled - priority '}}
{'scheduled to facial radiotherapy?': {'416774000': ('qualifier value', 'Scheduled - priority ', ['272099008'])}}

780915
drug abuse including alcoholism or addiction to cocaine, heroin or amphetamines
drug abuse including alcoholism or addiction to cocaine, heroin or amphetamines
['drug abuse', 'including', 'alcoholism', 'addiction to cocaine,', 'heroin', 'amphetamines']
{'drug abuse': {'26416006': 'Drug abuse '}, 'including': {'55919000': 'Including '}, 'alcoholism': {'284591009': 'Persistent alcohol abuse ', '66590003': 'Alcohol dependence ', '7200002': 'Alcoholism '}, 'addiction to cocaine,': {'191829009': 'Cocaine type drug dependence ', '31956009': 'Cocaine dependence '}, 'heroin': {'387341002': 'Heroin ', '60881009': 'Heroin '}, 'amphetamines': {'22672005': 'Amphetamine '}}
{'drug abuse': {'26416006': ('clinical finding', 'Drug abuse ', ['64572001'])}, 'including': {'55919000': ('qualifier value', 'Including ', ['272099008'])}, 'alcoholism': {'284591009': ('clinical finding', 'Persistent alcohol abuse ', ['64572001', '7200002']), '66590003': ('clinical finding', 'Alcohol dependence ', ['64572001', '7200002']), '7200002': ('clinical finding', 'Alcoholism ', ['64572001'])}, 'addiction to cocaine,': {'31956009': ('clinical finding', 'Cocaine dependence ', ['64572001'])}, 'heroin': {'387341002': ('product', 'Heroin ', ['115668003', '312413002', '312412007']), '60881009': ('product', 'Heroin ', ['763158003'])}, 'amphetamines': {'22672005': ('product', 'Amphetamine ', ['763158003'])}}

781374
other protocol-defined inclusion/exclusion criteria may apply
other protocol-defined inclusion/exclusion criteria may apply
['other protocol defined inclusion/exclusion criteria', 'apply']
{'other protocol defined inclusion/exclusion criteria': {'258049002': 'Protocols ', '900000000000073002': 'sufficiently defined concept definition status ', '55919000': 'Including '}, 'apply': {'417924000': 'Apply - dosing instruction imperative '}}
{'other protocol defined inclusion/exclusion criteria': {'55919000': ('qualifier value', 'Including ', ['272099008'])}}

798604
hearing loss
hearing loss
['hearing loss']
{'hearing loss': {'343087000': 'Partial deafness ', '103276001': 'Decreased hearing ', '15188001': 'Hearing loss '}}
{'hearing loss': {'343087000': ('clinical finding', 'Partial deafness ', ['64572001', '250171008', '15188001', '118234003']), '103276001': ('clinical finding', 'Decreased hearing ', ['250171008', '118234003']), '15188001': ('clinical finding', 'Hearing loss ', ['64572001', '250171008', '118234003'])}}

801882
history of myocardial infarction, unstable angina pectoris, percutaneous coronary intervention, congestive heart failure, hypertensive encephalopathy, stroke or tia within the last 6 months.
, myocardial infarction, unstable angina pectoris, percutaneous coronary intervention, congestive heart failure, hypertensive encephalopathy, stroke or tia , .
['myocardial infarction,', 'unstable angina pectoris,', 'percutaneous coronary intervention,', 'congestive heart failure,', 'hypertensive encephalopathy,', 'stroke', 'tia']
{'myocardial infarction,': {'22298006': 'Myocardial infarction ', '164865005': 'Electrocardiographic myocardial infarction '}, 'unstable angina pectoris,': {'25106000': 'Impending infarction ', '4557003': 'Preinfarction syndrome '}, 'percutaneous coronary intervention,': {'415070008': 'Percutaneous coronary intervention '}, 'congestive heart failure,': {'42343007': 'Congestive heart failure '}, 'hypertensive encephalopathy,': {'50490005': 'Hypertensive encephalopathy '}, 'stroke': {'230690007': 'Cerebrovascular accident '}, 'tia': {'266257000': 'Transient ischemic attack '}}
{'myocardial infarction,': {'22298006': ('clinical finding', 'Myocardial infarction ', ['64572001', '118234003']), '164865005': ('clinical finding', 'Electrocardiographic myocardial infarction ', ['441742003'])}, 'unstable angina pectoris,': {'25106000': ('clinical finding', 'Impending infarction ', ['64572001', '118234003']), '4557003': ('clinical finding', 'Preinfarction syndrome ', ['64572001', '102957003', '118234003'])}, 'percutaneous coronary intervention,': {'415070008': ('procedure', 'Percutaneous coronary intervention ', ['362958002'])}, 'congestive heart failure,': {'42343007': ('clinical finding', 'Congestive heart failure ', ['64572001', '118234003'])}, 'hypertensive encephalopathy,': {'50490005': ('clinical finding', 'Hypertensive encephalopathy ', ['64572001', '118234003'])}, 'stroke': {'230690007': ('clinical finding', 'Cerebrovascular accident ', ['64572001', '118234003'])}, 'tia': {'266257000': ('clinical finding', 'Transient ischemic attack ', ['64572001', '118234003'])}}

814401
pregnancy or lactation.
pregnancy or lactation.
['pregnancy', 'lactation']
{'pregnancy': {'289908002': 'Pregnancy, function ', '77386006': 'Patient currently pregnant '}, 'lactation': {'169741004': 'Breast fed ', '63158009': 'Lactation, function '}}
{'pregnancy': {'289908002': ('observable entity', 'Pregnancy, function ', ['246464006']), '77386006': ('clinical finding', 'Patient currently pregnant ', ['250171008'])}, 'lactation': {'169741004': ('clinical finding', 'Breast fed ', ['250171008']), '63158009': ('observable entity', 'Lactation, function ', ['246464006'])}}

821260
patient participating in another clinical study that investigates a drug or device
patient participating in another clinical study
['patient participating in another clinical study']
{'patient participating in another clinical study': {'116154003': 'Patient ', '58147004': 'Clinical ', '224699009': 'Study '}}
{'patient participating in another clinical study': {'58147004': ('qualifier value', 'Clinical ', ['272099008'])}}

822417
infants known to be at risk of anemia due to isoimmunization (mother has red blood cell antibodies
infants known to be at risk of anemia due to isoimmunization (mother has red blood cell antibodies
['infants', 'known', 'to', 'be at risk of anemia', 'due to isoimmunization', '(mother', 'red blood cell antibodies']
{'infants': {'133931009': 'Infant '}, 'known': {'36692007': 'Known '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'be at risk of anemia': {'30207005': 'Risk of ', '271737000': 'Anemia '}, 'due to isoimmunization': {'57325008': 'Isoimmunization '}, '(mother': {'72705000': 'Mother '}, 'red blood cell antibodies': {'120930001': 'Erythrocyte antibody '}}
{'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'be at risk of anemia': {'271737000': ('clinical finding', 'Anemia ', ['64572001', '441742003'])}, 'due to isoimmunization': {'57325008': ('clinical finding', 'Isoimmunization ', ['250171008'])}, 'red blood cell antibodies': {'120930001': ('product', 'Erythrocyte antibody ', ['312413002', '115668003'])}}

824941
patients with pulmonary diseases
patients with pulmonary diseases
['patients with pulmonary diseases']
{'patients with pulmonary diseases': {'116154003': 'Patient ', '19829001': 'Disorder of lung '}}
{'patients with pulmonary diseases': {'19829001': ('clinical finding', 'Disorder of lung ', ['64572001', '118234003'])}}

828151
serious cognitive problems or psychiatric problems .
serious cognitive problems or psychiatric problems .
['serious cognitive problems', 'psychiatric problems']
{'serious cognitive problems': {'42745003': 'Serious ', '55607006': 'Problem '}, 'psychiatric problems': {'27296002': 'Psychiatric ', '55607006': 'Problem '}}
{'serious cognitive problems': {'42745003': ('qualifier value', 'Serious ', ['272099008']), '55607006': ('clinical finding', 'Problem ', ['250171008'])}, 'psychiatric problems': {'27296002': ('qualifier value', 'Psychiatric ', ['272099008']), '55607006': ('clinical finding', 'Problem ', ['250171008'])}}

830104
subjects with infected burn wounds
subjects with infected burn wounds
['subjects with infected burn wounds']
{'subjects with infected burn wounds': {'76844004': 'Local infection of wound ', '125666000': 'Burn ', '48333001': 'Burn injury '}}
{'subjects with infected burn wounds': {'76844004': ('clinical finding', 'Local infection of wound ', ['64572001', '225552003']), '125666000': ('clinical finding', 'Burn ', ['64572001'])}}

836827
any indication of compromised liver function that would otherwise contraindicate use of itraconazole
any indication of compromised liver function
['any indication of compromised liver function']
{'any indication of compromised liver function': {'230165009': 'Indication of ', '410665000': 'indication of ', '410666004': 'indication of ', '79036002': 'Liver function '}}
{'any indication of compromised liver function': {'79036002': ('observable entity', 'Liver function ', ['246464006'])}}

840316
active infection
active infection
['active infection']
{'active infection': {'55561003': 'Active ', '189822004': 'Contagious disease ', '191415002': 'Communicable disease ', '40733004': 'Infectious disease '}}
{'active infection': {'55561003': ('qualifier value', 'Active ', ['272099008']), '40733004': ('clinical finding', 'Infectious disease ', ['64572001'])}}

845175
alpha-1 antitrypsin deficiency
alpha-1 antitrypsin deficiency
['alpha 1 antitrypsin deficiency']
{'alpha 1 antitrypsin deficiency': {'30188007': 'Alpha-1-antitrypsin deficiency '}}
{'alpha 1 antitrypsin deficiency': {'30188007': ('clinical finding', 'Alpha-1-antitrypsin deficiency ', ['64572001', '118234003'])}}

847025
presence of hepatic encephalopathy
presence of hepatic encephalopathy
['presence of hepatic encephalopathy']
{'presence of hepatic encephalopathy': {'52101004': 'Present ', '13920009': 'Hepatic encephalopathy ', '449902003': 'Portal systemic encephalopathy '}}
{'presence of hepatic encephalopathy': {'13920009': ('clinical finding', 'Hepatic encephalopathy ', ['64572001', '118234003']), '449902003': ('clinical finding', 'Portal systemic encephalopathy ', ['64572001', '13920009', '118234003'])}}

861395
subject has a significant cardiovascular disease
subject has a significant cardiovascular disease
['a significant cardiovascular disease']
{'a significant cardiovascular disease': {'386134007': 'Significant ', '49601007': 'Disorder of cardiovascular system '}}
{'a significant cardiovascular disease': {'49601007': ('clinical finding', 'Disorder of cardiovascular system ', ['64572001', '118234003'])}}

863674
clinically significant immune-related diseases or significant recent co-morbidities
clinically significant immune-related diseases or significant recent co-morbidities
['clinically significant immune related diseases', 'significant recent co morbidities']
{'clinically significant immune related diseases': {'386134007': 'Significant ', '41266007': 'Disorder of immune system ', '263498003': 'relationships', '272151006': 'Relationships ', '262094002': 'Related '}, 'significant recent co morbidities': {'386134007': 'Significant ', '263852005': 'Recent episode ', '6493001': 'Recent ', '223717005': 'Colombia '}}
{'clinically significant immune related diseases': {'272151006': ('qualifier value', 'Relationships ', ['272099008']), '262094002': ('clinical finding', 'Related ', ['118240005'])}, 'significant recent co morbidities': {'263852005': ('qualifier value', 'Recent episode ', ['272099008'])}}

878787
received experimental drug or device within 3 months prior to start of study
received experimental drug or device , prior to start of study
['received experimental drug', 'device', 'prior to start of study']
{'received experimental drug': {'902003': 'Experimental drug '}, 'device': {'303607000': 'Biomedical equipment ', '63653004': 'Biomedical device ', '49062001': 'Device '}, 'prior to start of study': {'236874000': 'Status pre- ', '288556008': 'before', '246062003': 'beginning', '255395001': 'Origins ', '224699009': 'Study '}}
{'prior to start of study': {'255395001': ('qualifier value', 'Origins ', ['272099008'])}}

882716
presence of adrenal gland diseases,
presence of adrenal gland diseases,
['presence of adrenal gland diseases,']
{'presence of adrenal gland diseases,': {'52101004': 'Present ', '30171000': 'Disorder of adrenal gland '}}
{'presence of adrenal gland diseases,': {'30171000': ('clinical finding', 'Disorder of adrenal gland ', ['64572001', '118234003'])}}

885876
youth scheduled to move from oregon within the next year.
youth scheduled to move from oregon within the next year.
['youth', 'scheduled', 'to', 'move from oregon', 'within the next year']
{'youth': {'22396007': 'Adolescence ', '263659003': 'Adolescence '}, 'scheduled': {'416151008': 'Scheduled - procedure status ', '416774000': 'Scheduled - priority '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'move from oregon': {'422239001': 'Oregon ', '302000008': 'Does move ', '384598002': 'moved from', '370125004': 'moved to'}, 'within the next year': {'18769003': 'Juxta-posed ', '258707000': 'year ', '259039008': 'per year ', '255260001': 'following'}}
{'youth': {'22396007': ('clinical finding', 'Adolescence ', ['250171008']), '263659003': ('qualifier value', 'Adolescence ', ['272099008'])}, 'scheduled': {'416774000': ('qualifier value', 'Scheduled - priority ', ['272099008'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'move from oregon': {'302000008': ('clinical finding', 'Does move ', ['250171008'])}, 'within the next year': {'18769003': ('qualifier value', 'Juxta-posed ', ['272099008']), '258707000': ('unit', 'year ', ['767524001']), '259039008': ('unit', 'per year ', ['767524001'])}}

905533
prior exposure of > 360 mg/m2 doxorubicin or liposomal doxorubicin, > 120 mg/m2 mitoxantrone, > 90 mg/m2 idarubicin, or > 720 mg/m2 epirubicin
prior exposure of > 360 mg/m2 doxorubicin or liposomal doxorubicin, > 120 mg/m2 mitoxantrone, > 90 mg/m2 idarubicin, or > 720 mg/m2 epirubicin
['prior exposure of', '> 360 mg/m2 doxorubicin', 'liposomal doxorubicin,', '> 120 mg/m2 mitoxantrone,', '> 90 mg/m2 idarubicin,', '> 720 mg/m2 epirubicin']
{'prior exposure of': {'236874000': 'Status pre- ', '288556008': 'before', '71677004': 'Injury due to exposure to external cause ', '24932003': 'Exposure to '}, '> 360 mg/m2 doxorubicin': {'732700008': '360', '396174004': 'mg/m2 ', '404216004': 'Milligram/square meter ', '372817009': 'Doxorubicin ', '68444001': 'Doxorubicin '}, 'liposomal doxorubicin,': {'418792004': 'Doxorubicin liposomal ', '428681007': 'Doxorubicin liposome '}, '> 120 mg/m2 mitoxantrone,': {'732474002': '120', '396174004': 'mg/m2 ', '404216004': 'Milligram/square meter ', '108791001': 'Mitoxantrone ', '386913001': 'Mitoxantrone '}, '> 90 mg/m2 idarubicin,': {'264705001': '>90 ', '396174004': 'mg/m2 ', '404216004': 'Milligram/square meter ', '108786002': 'Idarubicin ', '372539000': 'Idarubicin ', '264703008': '<90 '}, '> 720 mg/m2 epirubicin': {'732858003': '720', '396174004': 'mg/m2 ', '404216004': 'Milligram/square meter ', '349848009': 'Epirubicin ', '417916005': 'Epirubicin '}}
{'prior exposure of': {'71677004': ('clinical finding', 'Injury due to exposure to external cause ', ['64572001'])}, '> 360 mg/m2 doxorubicin': {'396174004': ('unit', 'mg/m2 ', ['767524001']), '404216004': ('unit', 'Milligram/square meter ', ['767524001']), '372817009': ('product', 'Doxorubicin ', ['312413002']), '68444001': ('product', 'Doxorubicin ', ['763158003'])}, 'liposomal doxorubicin,': {'428681007': ('product', 'Doxorubicin liposome ', ['312413002'])}, '> 120 mg/m2 mitoxantrone,': {'396174004': ('unit', 'mg/m2 ', ['767524001']), '404216004': ('unit', 'Milligram/square meter ', ['767524001']), '108791001': ('product', 'Mitoxantrone ', ['763158003']), '386913001': ('product', 'Mitoxantrone ', ['406455002', '312413002'])}, '> 90 mg/m2 idarubicin,': {'396174004': ('unit', 'mg/m2 ', ['767524001']), '404216004': ('unit', 'Milligram/square meter ', ['767524001']), '108786002': ('product', 'Idarubicin ', ['763158003']), '372539000': ('product', 'Idarubicin ', ['312413002'])}, '> 720 mg/m2 epirubicin': {'396174004': ('unit', 'mg/m2 ', ['767524001']), '404216004': ('unit', 'Milligram/square meter ', ['767524001']), '349848009': ('product', 'Epirubicin ', ['763158003']), '417916005': ('product', 'Epirubicin ', ['312413002'])}}

910406
woman currently pregnant, planning a pregnancy or lactating
woman currently pregnant, planning a pregnancy or lactating
['woman', 'currently pregnant', 'planning', 'a pregnancy', 'lactating']
{'woman': {'224526002': 'Woman '}, 'currently pregnant': {'77386006': 'Patient currently pregnant '}, 'planning': {'312011006': 'Cognitive function: planning ', '397943006': 'Planned '}, 'a pregnancy': {'289908002': 'Pregnancy, function ', '77386006': 'Patient currently pregnant '}, 'lactating': {'83036002': 'Lactate '}}
{'woman': {'224526002': ('person', 'Woman ', ['133936004'])}, 'currently pregnant': {'77386006': ('clinical finding', 'Patient currently pregnant ', ['250171008'])}, 'planning': {'312011006': ('observable entity', 'Cognitive function: planning ', ['246464006'])}, 'a pregnancy': {'289908002': ('observable entity', 'Pregnancy, function ', ['246464006']), '77386006': ('clinical finding', 'Patient currently pregnant ', ['250171008'])}, 'lactating': {'83036002': ('product', 'Lactate ', ['312413002'])}}

919904
gastrointestinal tract disease resulting in an inability to take oral medication or a requirement for iv alimentation, prior surgical procedures affecting absorption, or active peptic ulcer disease
gastrointestinal tract disease resulting in an take oral medication or a requirement for iv alimentation, prior surgical procedures affecting absorption, or active peptic ulcer disease
['gastrointestinal tract disease', 'resulting in an', 'take', 'oral medication', 'a requirement for iv alimentation,', 'prior surgical procedures', 'affecting', 'active peptic ulcer disease']
{'gastrointestinal tract disease': {'119292006': 'Disorder of gastrointestinal tract ', '25374005': 'Gastroenteritis ', '53619000': 'Disorder of digestive system '}, 'resulting in an': {'79409006': 'resulting in'}, 'take': {'419652001': 'Take - dosing instruction imperative '}, 'oral medication': {'260548002': 'Oral ', '105903003': 'General drug type ', '373873005': 'Pharmaceutical / biologic product ', '410942007': 'Drug or medicament '}, 'a requirement for iv alimentation,': {'223561000': 'Ivory Coast '}, 'prior surgical procedures': {'161615003': 'History of surgery '}, 'affecting': {'247591002': 'Affecting ', '248448006': 'Involved ', '278112009': 'involvement with'}, 'active peptic ulcer disease': {'55561003': 'Active ', '13200003': 'Peptic ulcer '}}
{'gastrointestinal tract disease': {'119292006': ('clinical finding', 'Disorder of gastrointestinal tract ', ['53619000', '64572001', '118234003']), '25374005': ('clinical finding', 'Gastroenteritis ', ['53619000', '64572001', '119292006', '118234003']), '53619000': ('clinical finding', 'Disorder of digestive system ', ['64572001', '118234003'])}, 'prior surgical procedures': {'161615003': ('situation with explicit context', 'History of surgery ', ['129125009'])}, 'affecting': {'247591002': ('qualifier value', 'Affecting ', ['272099008']), '248448006': ('qualifier value', 'Involved ', ['272099008'])}, 'active peptic ulcer disease': {'55561003': ('qualifier value', 'Active ', ['272099008']), '13200003': ('clinical finding', 'Peptic ulcer ', ['53619000', '64572001', '119292006', '118234003'])}}

928997
women who are pregnant or breast-feeding.
women who are pregnant or breast-feeding.
['women', 'pregnant', 'breast feeding']
{'women': {'224526002': 'Woman '}, 'pregnant': {'77386006': 'Patient currently pregnant ', '127362006': 'Previous pregnancies ', '161732006': 'Gravida ', '364323006': 'Quantity of pregnancy ', '366321006': 'Finding of gravida '}, 'breast feeding': {'169741004': 'Breast fed ', '413712001': 'Breastfeeding '}}
{'women': {'224526002': ('person', 'Woman ', ['133936004'])}, 'pregnant': {'77386006': ('clinical finding', 'Patient currently pregnant ', ['250171008']), '127362006': ('clinical finding', 'Previous pregnancies ', ['250171008']), '161732006': ('observable entity', 'Gravida ', ['363788007']), '364323006': ('observable entity', 'Quantity of pregnancy ', ['363788007']), '366321006': ('clinical finding', 'Finding of gravida ', ['250171008'])}, 'breast feeding': {'169741004': ('clinical finding', 'Breast fed ', ['250171008']), '413712001': ('observable entity', 'Breastfeeding ', ['246464006'])}}

934672
traumatic cardiac arrest
traumatic cardiac arrest
['traumatic cardiac arrest']
{'traumatic cardiac arrest': {'263904004': 'Traumatic ', '397829000': 'Asystole ', '410429000': 'Cardiac arrest '}}
{'traumatic cardiac arrest': {'397829000': ('clinical finding', 'Asystole ', ['64572001', '410429000', '118234003']), '410429000': ('clinical finding', 'Cardiac arrest ', ['64572001', '118234003'])}}

939471
does not cycle 2-3 times/week
does not cycle 2-3 times/week
['not cycle 2 3 times/week']
{'not cycle 2 3 times/week': {'44180009': 'Cyclic ', '259086007': 'times/week '}}
{'not cycle 2 3 times/week': {'44180009': ('qualifier value', 'Cyclic ', ['272099008']), '259086007': ('unit', 'times/week ', ['767524001'])}}

940160
any history of cardiovascular disease/active cardiovascular treatment;
, cardiovascular disease/active cardiovascular treatment;
['cardiovascular disease/active cardiovascular treatment']
{'cardiovascular disease/active cardiovascular treatment': {'49601007': 'Disorder of cardiovascular system ', '55561003': 'Active ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '416118004': 'Administration '}}
{'cardiovascular disease/active cardiovascular treatment': {'49601007': ('clinical finding', 'Disorder of cardiovascular system ', ['64572001', '118234003']), '55561003': ('qualifier value', 'Active ', ['272099008']), '276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '416118004': ('procedure', 'Administration ', ['128927009'])}}

947044
participant has a transplanted organ, excluding corneal transplant, performed > 3 months prior to the first dose of trial medication
participant has a transplanted organ, excluding corneal transplant, performed > 3 months prior to the first dose of trial medication
['a transplanted organ,', 'excluding', 'corneal transplant,', 'performed', '> 3 months prior to the first dose of trial medication']
{'a transplanted organ,': {'24486003': 'Transplant '}, 'excluding': {'77765009': 'Exclude '}, 'corneal transplant,': {'293820001': 'Keratoplasty ', '60656008': 'Corneal transplant '}, 'performed': {'398166005': 'Performed '}, '> 3 months prior to the first dose of trial medication': {'260313008': '<3 ', '258706009': 'month ', '236874000': 'Status pre- ', '288556008': 'before', '255216001': 'First ', '398232005': 'Drug dose ', '110465008': 'Clinical trial ', '232714002': 'Firstly '}}
{'excluding': {'77765009': ('qualifier value', 'Exclude ', ['272099008'])}, 'corneal transplant,': {'293820001': ('procedure', 'Keratoplasty ', ['362958002', '128927009']), '60656008': ('procedure', 'Corneal transplant ', ['362958002', '128927009'])}, '> 3 months prior to the first dose of trial medication': {'258706009': ('unit', 'month ', ['767524001']), '398232005': ('clinical finding', 'Drug dose ', ['250171008']), '232714002': ('qualifier value', 'Firstly ', ['272099008'])}}

949362
leukemia or mds or pnh or fanconi's disease
leukemia or mds or pnh or fanconi's disease
['leukemia', 'pnh', "fanconi's disease"]
{'leukemia': {'87163000': 'Leukemia, no International Classification of Diseases for Oncology subtype ', '93143009': 'Leukemia, disease '}, 'pnh': {'1963002': 'Paroxysmal nocturnal hemoglobinuria '}, "fanconi's disease": {'64572001': 'Disease '}}
{'leukemia': {'93143009': ('clinical finding', 'Leukemia, disease ', ['64572001', '118234003'])}, 'pnh': {'1963002': ('clinical finding', 'Paroxysmal nocturnal hemoglobinuria ', ['64572001', '441742003'])}}

952568
hypertension
hypertension
['hypertension']
{'hypertension': {'38341003': 'Hypertensive disorder, systemic arterial '}}
{'hypertension': {'38341003': ('clinical finding', 'Hypertensive disorder, systemic arterial ', ['64572001', '118234003'])}}

957318
<= 2 prior chemotherapy regimens
<= 2 prior chemotherapy regimens
['= 2 prior chemotherapy regimens']
{'= 2 prior chemotherapy regimens': {'260306008': 'Integer +2 ', '236874000': 'Status pre- ', '288556008': 'before', '716872004': 'Antineoplastic chemotherapy regimen '}}
{'= 2 prior chemotherapy regimens': {'716872004': ('procedure', 'Antineoplastic chemotherapy regimen ', ['243120004', '128927009'])}}

960846
ecog performance status greater than 2
ecog performance status greater than 2
['ecog performance status', 'greater than 2']
{'ecog performance status': {'423740007': 'Eastern Cooperative Oncology Group performance status '}, 'greater than 2': {'276140008': 'Greater-than symbol > '}}
{'ecog performance status': {'423740007': ('observable entity', 'Eastern Cooperative Oncology Group performance status ', ['278844005'])}}

964891
preoperative intra-aortic balloon pump
preoperative intra-aortic balloon pump
['preoperative intra aortic balloon pump']
{'preoperative intra aortic balloon pump': {'262068006': 'Preoperative ', '399052009': 'Aortic balloon pump operation ', '399217008': 'Cardioassist by aortic balloon pump ', '129113006': 'Intra-aortic balloon pump, device ', '59833007': 'Collapsible balloon, device '}}
{'preoperative intra aortic balloon pump': {'262068006': ('qualifier value', 'Preoperative ', ['272099008']), '399052009': ('procedure', 'Aortic balloon pump operation ', ['363691001', '362958002', '128927009']), '399217008': ('procedure', 'Cardioassist by aortic balloon pump ', ['362958002'])}}

971870
cancer or other hematologic malignancy during treatment or in remission for < 5 years.
cancer or other hematologic malignancy during treatment or in remission for < 5 years.
['cancer', 'other hematologic malignancy during treatment', 'or in remission', '< 5 years']
{'cancer': {'363346000': 'Malignant neoplastic disease ', '372087000': 'Primary malignant neoplasm ', '86049000': 'Malignant neoplasm, primary '}, 'other hematologic malignancy during treatment': {'129154003': 'Hematologic neoplasm ', '269475001': 'Malignant tumor of lymphoid, hemopoietic AND/OR related tissue ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '416118004': 'Administration '}, 'or in remission': {'277022003': 'Remission phase '}, '< 5 years': {'264606005': '-5 ', '258707000': 'year ', '264706000': '>5 ', '264605009': 'Integer +5 '}}
{'cancer': {'363346000': ('clinical finding', 'Malignant neoplastic disease ', ['64572001']), '372087000': ('clinical finding', 'Primary malignant neoplasm ', ['64572001', '363346000'])}, 'other hematologic malignancy during treatment': {'129154003': ('clinical finding', 'Hematologic neoplasm ', ['64572001', '118234003']), '269475001': ('clinical finding', 'Malignant tumor of lymphoid, hemopoietic AND/OR related tissue ', ['64572001', '363346000']), '276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '416118004': ('procedure', 'Administration ', ['128927009'])}, 'or in remission': {'277022003': ('qualifier value', 'Remission phase ', ['272099008'])}, '< 5 years': {'258707000': ('unit', 'year ', ['767524001'])}}

977135
uncontrolled thyroid disease ; testing required within three months prior to admission for subjects with a goiter, positive antibodies, or who are on thyroid hormone replacement, and within one year otherwise
uncontrolled thyroid disease ; testing required within three months prior to admission for subjects with a goiter, positive antibodies, or who are on thyroid hormone replacement, and within one year otherwise
['uncontrolled thyroid disease']
{'uncontrolled thyroid disease': {'19032002': 'Uncontrolled ', '14304000': 'Disorder of thyroid gland '}}
{'uncontrolled thyroid disease': {'19032002': ('qualifier value', 'Uncontrolled ', ['272099008']), '14304000': ('clinical finding', 'Disorder of thyroid gland ', ['64572001', '118234003'])}}

978491
 ecog scores 3-4 combined with serious diseases of other organs.
ecog scores 3-4 combined with serious diseases of other organs.
['ecog', 'scores', '3 4', 'combined with serious diseases of other organs']
{'ecog': {'81906003': 'Electrocorticogram '}, 'scores': {'246262008': 'score', '278061009': 'Scores '}, '3 4': {'260279004': 'Distance vision 3/4 ', '732650008': '3.4'}, 'combined with serious diseases of other organs': {'89780004': 'Combined ', '42745003': 'Serious ', '64572001': 'Disease '}}
{'ecog': {'81906003': ('procedure', 'Electrocorticogram ', ['362958002', '128927009'])}, 'scores': {'278061009': ('qualifier value', 'Scores ', ['272396007'])}, '3 4': {'260279004': ('clinical finding', 'Distance vision 3/4 ', ['118234003'])}, 'combined with serious diseases of other organs': {'89780004': ('qualifier value', 'Combined ', ['272099008']), '42745003': ('qualifier value', 'Serious ', ['272099008'])}}

984545
patient has intolerable to dual anti-platelet therapy.
patient has intolerable to dual anti-platelet therapy.
['patient', 'intolerable to dual anti platelet therapy']
{'patient': {'116154003': 'Patient '}, 'intolerable to dual anti platelet therapy': {'16378004': 'Platelet ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure '}}
{'intolerable to dual anti platelet therapy': {'276239002': ('procedure', 'Therapy ', ['277132007', '243120004'])}}

994845
alcohol and/or any other drug abuse
alcohol and/or any other drug abuse
['alcohol', 'any other drug abuse']
{'alcohol': {'398624005': 'Ethyl alcohol ', '419442005': 'Ethyl alcohol ', '53041004': 'Alcohol '}, 'any other drug abuse': {'26416006': 'Drug abuse '}}
{'alcohol': {'398624005': ('product', 'Ethyl alcohol ', ['763158003']), '419442005': ('product', 'Ethyl alcohol ', ['406455002', '53041004', '312413002']), '53041004': ('product', 'Alcohol ', ['406455002', '312413002'])}, 'any other drug abuse': {'26416006': ('clinical finding', 'Drug abuse ', ['64572001'])}}

995333
unable to provide informed consent.
unable to provide informed consent.
['unable', 'to', 'informed consent']
{'unable': {'289001005': 'Unable to feed self ', '371151008': 'Unable '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'informed consent': {'108968006': 'Oprelvekin ', '410938009': 'Oprelvekin ', '223458004': 'Informing '}}
{'unable': {'289001005': ('clinical finding', 'Unable to feed self ', ['250171008'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'informed consent': {'108968006': ('product', 'Oprelvekin ', ['406455002', '312413002', '115668003']), '410938009': ('product', 'Oprelvekin ', ['763158003'])}}

1000841
patients with the following organ dysfunction symptomatic coronary artery disease or ejection fraction < 35% or other cardiac failure requiring therapy; ejection fraction is required if the patient is > 50 years of age, or history of cardiac disease or anthracycline exposure
patients with the following organ dysfunction symptomatic coronary artery disease or ejection fraction < 35% or other cardiac failure requiring therapy; ejection fraction is required if the patient is , or , cardiac disease or anthracycline exposure
['patients with the following organ dysfunction symptomatic coronary artery disease', 'ejection fraction', '< 35%', 'other cardiac failure requiring therapy']
{'patients with the following organ dysfunction symptomatic coronary artery disease': {'116154003': 'Patient ', '367409002': 'followed by', '251526004': 'Single organ dysfunction ', '264931009': 'Symptomatic ', '443502000': 'Atherosclerosis of coronary artery ', '53741008': 'Coronary arteriosclerosis ', '414024009': 'Disorder of coronary artery ', '421939007': 'Follow - dosing instruction imperative '}, 'ejection fraction': {'34205009': 'Ejection ', '103398007': 'Fractions of ', '115468007': 'Fraction of ', '278277004': 'Fractions '}, '< 35%': {'732694002': '35'}, 'other cardiac failure requiring therapy': {'308118002': 'Cardiac failure therapy '}}
{'patients with the following organ dysfunction symptomatic coronary artery disease': {'251526004': ('clinical finding', 'Single organ dysfunction ', ['64572001', '118234003']), '264931009': ('qualifier value', 'Symptomatic ', ['272099008']), '443502000': ('clinical finding', 'Atherosclerosis of coronary artery ', ['53741008', '64572001', '414024009', '118234003']), '53741008': ('clinical finding', 'Coronary arteriosclerosis ', ['64572001', '414024009', '118234003']), '414024009': ('clinical finding', 'Disorder of coronary artery ', ['64572001', '118234003'])}, 'ejection fraction': {'34205009': ('qualifier value', 'Ejection ', ['415577004'])}}

1002406
patient is known to be hepatitis b surface antigen-positive or has known active hepatitis c infection.
patient is known to be hepatitis b surface antigen-positive or has known active hepatitis c infection.
['patient', 'known', 'to', 'hepatitis b surface antigen positive', 'known active hepatitis c infection']
{'patient': {'116154003': 'Patient '}, 'known': {'36692007': 'Known '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'hepatitis b surface antigen positive': {'165806002': 'Hepatitis B surface antigen positive '}, 'known active hepatitis c infection': {'36692007': 'Known ', '55561003': 'Active ', '186634008': 'Hepatitis non-A non-B ', '50711007': 'Viral hepatitis type C '}}
{'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'hepatitis b surface antigen positive': {'165806002': ('clinical finding', 'Hepatitis B surface antigen positive ', ['441742003'])}, 'known active hepatitis c infection': {'55561003': ('qualifier value', 'Active ', ['272099008']), '50711007': ('clinical finding', 'Viral hepatitis type C ', ['64572001', '118234003'])}}

1017259
subject has active systemic infection
subject has active systemic infection
['active systemic infection']
{'active systemic infection': {'55561003': 'Active ', '91302008': 'Sepsis '}}
{'active systemic infection': {'55561003': ('qualifier value', 'Active ', ['272099008']), '91302008': ('clinical finding', 'Sepsis ', ['64572001'])}}

1020543
history of clinically significant gastrointestinal, renal, hepatic, neurologic, hematologic diseases, in the opinion of the principal investigator, would jeopardize the safety of the subject or impact the validity of the study results.
, clinically significant gastrointestinal, renal, hepatic, neurologic, hematologic diseases, in the opinion of the principal investigator, would jeopardize the safety of the subject or impact the validity of the study results.
['clinically significant gastrointestinal, renal, hepatic, neurologic, hematologic diseases,', 'in the opinion of the principal investigator,', 'the validity of the study results']
{'clinically significant gastrointestinal, renal, hepatic, neurologic, hematologic diseases,': {'386134007': 'Significant ', '119292006': 'Disorder of gastrointestinal tract ', '25374005': 'Gastroenteritis ', '53619000': 'Disorder of digestive system ', '64033007': 'Kidney structure ', '32381004': 'Portal ', '1199008': 'Neurologic ', '57407000': 'Hematologic '}, 'in the opinion of the principal investigator,': {'63161005': 'Principal ', '302311007': 'Teaching principal '}, 'the validity of the study results': {'224699009': 'Study ', '394617004': 'Result '}}
{'clinically significant gastrointestinal, renal, hepatic, neurologic, hematologic diseases,': {'119292006': ('clinical finding', 'Disorder of gastrointestinal tract ', ['53619000', '64572001', '118234003']), '25374005': ('clinical finding', 'Gastroenteritis ', ['53619000', '64572001', '119292006', '118234003']), '53619000': ('clinical finding', 'Disorder of digestive system ', ['64572001', '118234003']), '32381004': ('qualifier value', 'Portal ', ['272099008']), '1199008': ('qualifier value', 'Neurologic ', ['272099008']), '57407000': ('qualifier value', 'Hematologic ', ['272099008'])}, 'in the opinion of the principal investigator,': {'63161005': ('qualifier value', 'Principal ', ['272099008'])}}

1025011
known multi-fetal pregnancy at enrolment
known multi-fetal pregnancy at enrolment
['known multi fetal pregnancy at enrolment']
{'known multi fetal pregnancy at enrolment': {'36692007': 'Known ', '16356006': 'Multiple pregnancy ', '18114009': 'Prenatal examination and care of mother ', '424525001': 'Antenatal care '}}
{'known multi fetal pregnancy at enrolment': {'16356006': ('clinical finding', 'Multiple pregnancy ', ['64572001', '250171008']), '18114009': ('procedure', 'Prenatal examination and care of mother ', ['408767007', '362958002', '128927009']), '424525001': ('procedure', 'Antenatal care ', ['243120004'])}}

1026206
< 6 months of follow-up after surgery
< 6 months of follow-up after surgery
['< 6 months of follow up', 'surgery']
{'< 6 months of follow up': {'300042001': 'Follow-up 6 months '}, 'surgery': {'257556004': 'Surgery ', '387713003': 'Surgical procedure ', '83578000': 'Surgical ', '394609007': 'General surgery '}}
{'surgery': {'387713003': ('procedure', 'Surgical procedure ', ['128927009']), '83578000': ('qualifier value', 'Surgical ', ['272099008'])}}

1033088
pregnant state
pregnant state
['pregnant state']
{'pregnant state': {'77386006': 'Patient currently pregnant ', '398070004': 'State ', '127362006': 'Previous pregnancies ', '161732006': 'Gravida ', '364323006': 'Quantity of pregnancy ', '366321006': 'Finding of gravida '}}
{'pregnant state': {'77386006': ('clinical finding', 'Patient currently pregnant ', ['250171008']), '127362006': ('clinical finding', 'Previous pregnancies ', ['250171008']), '161732006': ('observable entity', 'Gravida ', ['363788007']), '364323006': ('observable entity', 'Quantity of pregnancy ', ['363788007']), '366321006': ('clinical finding', 'Finding of gravida ', ['250171008'])}}

1041986
may not be receiving other concurrent chemotherapy or radiation therapy
may not be receiving other concurrent chemotherapy or radiation therapy
['other concurrent chemotherapy', 'radiation therapy']
{'other concurrent chemotherapy': {'68405009': 'Concurrent ', '416608005': 'Drug therapy ', '716872004': 'Antineoplastic chemotherapy regimen ', '363688001': 'Administration of antineoplastic agent ', '367336001': 'Chemotherapy '}, 'radiation therapy': {'108290001': 'Radiation oncology AND/OR radiotherapy ', '53438000': 'Radiation therapy procedure or service '}}
{'other concurrent chemotherapy': {'68405009': ('qualifier value', 'Concurrent ', ['272099008']), '416608005': ('procedure', 'Drug therapy ', ['128927009']), '716872004': ('procedure', 'Antineoplastic chemotherapy regimen ', ['243120004', '128927009']), '363688001': ('procedure', 'Administration of antineoplastic agent ', ['416608005', '367336001', '128927009']), '367336001': ('procedure', 'Chemotherapy ', ['416608005', '128927009'])}}

1043429
disease and/or medical conditions accompanied by hypercalcaemia and/or hypercalciuria
disease and/or medical conditions accompanied by hypercalcaemia and/or hypercalciuria
['disease', 'medical conditions', 'accompanied by hypercalcaemia', 'hypercalciuria']
{'disease': {'64572001': 'Disease '}, 'medical conditions': {'373655009': 'Medical service ', '64572001': 'Disease ', '260905004': 'condition', '74188005': 'Medical '}, 'accompanied by hypercalcaemia': {'166702002': 'Raised serum calcium level ', '66931009': 'Hypercalcemia '}, 'hypercalciuria': {'71938000': 'Hypercalciuria '}}
{'medical conditions': {'74188005': ('qualifier value', 'Medical ', ['272099008'])}, 'accompanied by hypercalcaemia': {'166702002': ('clinical finding', 'Raised serum calcium level ', ['441742003']), '66931009': ('clinical finding', 'Hypercalcemia ', ['64572001', '441742003', '166702002'])}, 'hypercalciuria': {'71938000': ('clinical finding', 'Hypercalciuria ', ['64572001', '118234003'])}}

1050535
subjects requiring control medication against asthma
subjects requiring control medication against asthma
['control medication against asthma']
{'control medication against asthma': {'246106000': 'control function', '31509003': 'Controlled ', '105903003': 'General drug type ', '373873005': 'Pharmaceutical / biologic product ', '410942007': 'Drug or medicament ', '195967001': 'Asthma '}}
{'control medication against asthma': {'31509003': ('qualifier value', 'Controlled ', ['272099008']), '195967001': ('clinical finding', 'Asthma ', ['64572001', '118234003'])}}

1058940
history of hypersensitivity to any of the study drugs or to drugs with similar chemical class, or to any of the excipients
, hypersensitivity to any of the study drugs or to drugs with similar chemical class, or to any of the excipients
['hypersensitivity to any of the study drugs', 'or to drugs', 'with similar chemical class,', 'or to any of the excipients']
{'hypersensitivity to any of the study drugs': {'224699009': 'Study '}, 'or to drugs': {'105903003': 'General drug type ', '373873005': 'Pharmaceutical / biologic product ', '410942007': 'Drug or medicament '}, 'with similar chemical class,': {'441900009': 'Chemical ', '258391009': 'Classes ', '277046005': 'class'}, 'or to any of the excipients': {'360215002': 'Pharmaceutical excipient ', '43747001': 'Drug excipient '}}
{'with similar chemical class,': {'441900009': ('product', 'Chemical ', ['312413002']), '258391009': ('qualifier value', 'Classes ', ['272396007'])}, 'or to any of the excipients': {'360215002': ('product', 'Pharmaceutical excipient ', ['312412007'])}}

1060026
use of anticoagulant medications.
use of anticoagulant medications.
['use of anticoagulant medications']
{'use of anticoagulant medications': {'260676000': 'use of', '372862008': 'Anticoagulant ', '81839001': 'Anticoagulant '}}
{'use of anticoagulant medications': {'81839001': ('product', 'Anticoagulant ', ['763158003'])}}

1063916
target disease exceptions
target disease exceptions
['target disease exceptions']
{'target disease exceptions': {'64572001': 'Disease '}}
{}

1064500
pain originating from ear
pain originating from ear
['pain originating from ear']
{'pain originating from ear': {'16001004': 'Otalgia ', '162356005': 'Earache symptom '}}
{'pain originating from ear': {'16001004': ('clinical finding', 'Otalgia ', ['102957003', '118234003']), '162356005': ('clinical finding', 'Earache symptom ', ['102957003', '16001004', '118234003'])}}

1083193
pregnant women or lactating women.
pregnant women or lactating women.
['pregnant women', 'lactating women']
{'pregnant women': {'255409004': 'Pregnant woman '}, 'lactating women': {'83036002': 'Lactate ', '224526002': 'Woman '}}
{'pregnant women': {'255409004': ('person', 'Pregnant woman ', ['133936004', '224526002'])}, 'lactating women': {'83036002': ('product', 'Lactate ', ['312413002']), '224526002': ('person', 'Woman ', ['133936004'])}}

1086605
no reported participation in another nutritional trial or biomedical trial 3 months before screening;
reported participation in another nutritional trial or biomedical trial 3 months before screening;
['reported participation in another nutritional trial', 'biomedical trial 3 months before screening']
{'reported participation in another nutritional trial': {'229059009': 'Report ', '110465008': 'Clinical trial ', '223458004': 'Informing ', '733985002': 'reported'}, 'biomedical trial 3 months before screening': {'110465008': 'Clinical trial ', '258706009': 'month ', '20135006': 'Screening procedure '}}
{'biomedical trial 3 months before screening': {'258706009': ('unit', 'month ', ['767524001']), '20135006': ('procedure', 'Screening procedure ', ['128927009'])}}

1089852
pregnancy/lactation or man subjects whose woman partners are pregnant
pregnancy/lactation or man subjects whose woman partners are pregnant
['pregnancy/lactation', 'man subjects', 'whose woman partners', 'pregnant']
{'pregnancy/lactation': {'289908002': 'Pregnancy, function ', '77386006': 'Patient currently pregnant ', '169741004': 'Breast fed ', '63158009': 'Lactation, function '}, 'man subjects': {'339947000': 'Man ', '278412004': 'Human - origin ', '337915000': 'Homo sapiens ', '10052007': 'Male structure ', '248153007': 'Male '}, 'whose woman partners': {'224526002': 'Woman ', '262043009': 'Partner in relationship '}, 'pregnant': {'77386006': 'Patient currently pregnant ', '127362006': 'Previous pregnancies ', '161732006': 'Gravida ', '364323006': 'Quantity of pregnancy ', '366321006': 'Finding of gravida '}}
{'pregnancy/lactation': {'289908002': ('observable entity', 'Pregnancy, function ', ['246464006']), '77386006': ('clinical finding', 'Patient currently pregnant ', ['250171008']), '169741004': ('clinical finding', 'Breast fed ', ['250171008']), '63158009': ('observable entity', 'Lactation, function ', ['246464006'])}, 'man subjects': {'339947000': ('person', 'Man ', ['133936004']), '278412004': ('qualifier value', 'Human - origin ', ['272099008']), '248153007': ('clinical finding', 'Male ', ['365860008'])}, 'whose woman partners': {'224526002': ('person', 'Woman ', ['133936004'])}, 'pregnant': {'77386006': ('clinical finding', 'Patient currently pregnant ', ['250171008']), '127362006': ('clinical finding', 'Previous pregnancies ', ['250171008']), '161732006': ('observable entity', 'Gravida ', ['363788007']), '364323006': ('observable entity', 'Quantity of pregnancy ', ['363788007']), '366321006': ('clinical finding', 'Finding of gravida ', ['250171008'])}}

1100244
chronic back pain
chronic back pain
['chronic back pain']
{'chronic back pain': {'134407002': 'Chronic back pain '}}
{'chronic back pain': {'134407002': ('clinical finding', 'Chronic back pain ', ['102957003', '118234003'])}}

1117236
left ventricular ejection fraction < 30%;
left ventricular ejection fraction < 30%;
['left ventricular ejection fraction']
{'left ventricular ejection fraction': {'250908004': 'Left ventricular ejection fraction '}}
{'left ventricular ejection fraction': {'250908004': ('observable entity', 'Left ventricular ejection fraction ', ['363788007', '246464006', '414237002'])}}

1121287
presence of illicit drug and/or alcohol dependence.
presence of illicit drug and/or alcohol dependence.
['presence of illicit drug', 'alcohol dependence']
{'presence of illicit drug': {'365753005': 'Finding of presence of drug ', '66401009': 'Illicit '}, 'alcohol dependence': {'284591009': 'Persistent alcohol abuse ', '66590003': 'Alcohol dependence ', '7200002': 'Alcoholism '}}
{'presence of illicit drug': {'365753005': ('clinical finding', 'Finding of presence of drug ', ['441742003']), '66401009': ('qualifier value', 'Illicit ', ['272099008'])}, 'alcohol dependence': {'284591009': ('clinical finding', 'Persistent alcohol abuse ', ['64572001', '7200002']), '66590003': ('clinical finding', 'Alcohol dependence ', ['64572001', '7200002']), '7200002': ('clinical finding', 'Alcoholism ', ['64572001'])}}

1129175
worse than moderate ascites
worse than moderate ascites
['worse than moderate ascites']
{'worse than moderate ascites': {'230993007': 'Worsening ', '6736007': 'Moderate ', '389026000': 'Ascites ', '390772001': 'Deterioration of status ', '231877006': 'Worse '}}
{'worse than moderate ascites': {'230993007': ('qualifier value', 'Worsening ', ['272099008']), '6736007': ('qualifier value', 'Moderate ', ['272396007']), '389026000': ('clinical finding', 'Ascites ', ['64572001', '118234003'])}}

1135028
patients with pre-planned elective surgery that is likely to change or impact on the control of pd symptoms, or involve hospitalisation.
patients with pre-planned elective surgery that is likely to change or impact on the control of pd symptoms, or involve hospitalisation.
['patients with', 'pre planned', 'elective surgery', 'likely', 'to', 'change', 'impact on the control of pd symptoms,', 'hospitalisation']
{'patients with': {'116154003': 'Patient '}, 'pre planned': {'236874000': 'Status pre- ', '288556008': 'before', '397943006': 'Planned ', '272113006': 'Before values '}, 'elective surgery': {'274075007': 'Optional surgery '}, 'likely': {'2931005': 'Probable diagnosis ', '452201000124102': 'probable diagnosis'}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'change': {'18307000': 'Altered ', '243326001': 'Changing ', '263703002': 'Changed status '}, 'impact on the control of pd symptoms,': {'225353007': 'Symptom control '}, 'hospitalisation': {'394656005': 'Inpatient care '}}
{'pre planned': {'272113006': ('qualifier value', 'Before values ', ['272099008'])}, 'elective surgery': {'274075007': ('procedure', 'Optional surgery ', ['128927009'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'change': {'18307000': ('qualifier value', 'Altered ', ['272099008']), '243326001': ('qualifier value', 'Changing ', ['272099008'])}, 'impact on the control of pd symptoms,': {'225353007': ('procedure', 'Symptom control ', ['243120004'])}, 'hospitalisation': {'394656005': ('procedure', 'Inpatient care ', ['243120004'])}}

1137688
patients with known significant allergy to vancomycin
patients with known significant allergy to vancomycin
['patients with known significant allergy', 'to vancomycin']
{'patients with known significant allergy': {'116154003': 'Patient ', '36692007': 'Known ', '386134007': 'Significant ', '408439002': 'Allergy - specialty ', '418634005': 'Allergic reaction caused by substance ', '421961002': 'Hypersensitivity reaction ', '419076005': 'Allergic reaction ', '609328004': 'Allergic disposition '}, 'to vancomycin': {'372735009': 'Vancomycin ', '42082003': 'Vancomycin '}}
{'patients with known significant allergy': {'418634005': ('clinical finding', 'Allergic reaction caused by substance ', ['64572001', '419076005', '421961002']), '421961002': ('clinical finding', 'Hypersensitivity reaction ', ['64572001']), '419076005': ('clinical finding', 'Allergic reaction ', ['64572001', '421961002'])}, 'to vancomycin': {'372735009': ('product', 'Vancomycin ', ['312413002', '115668003']), '42082003': ('product', 'Vancomycin ', ['763158003'])}}

1138865
patients blood glucose > 11.1 mmol/l measured by glucometer immediately prior to scan.
patients blood glucose > 11.1 mmol/l measured by glucometer immediately prior to scan.
['patients blood glucose', '> 11 1 mmol/l', 'measured by glucometer immediately', 'prior to scan']
{'patients blood glucose': {'116154003': 'Patient ', '87612001': 'Blood ', '111138002': 'Glucose preparation ', '67079006': 'Glucose ', '119273009': 'Peripheral blood '}, '> 11 1 mmol/l': {'258813002': 'Millimole/liter ', '414719002': 'Micromole/milliliter '}, 'measured by glucometer immediately': {'258104002': 'Measured ', '337414009': 'Blood glucose meters ', '49499008': 'Stat '}, 'prior to scan': {'373205008': 'Nuclear medicine imaging procedure '}}
{'patients blood glucose': {'87612001': ('product', 'Blood ', ['115669006', '115668003']), '111138002': ('product', 'Glucose preparation ', ['763158003']), '67079006': ('product', 'Glucose ', ['115668003', '312413002']), '119273009': ('product', 'Peripheral blood ', ['115669006', '87612001', '115668003'])}, '> 11 1 mmol/l': {'258813002': ('unit', 'Millimole/liter ', ['767524001']), '414719002': ('unit', 'Micromole/milliliter ', ['767524001'])}, 'measured by glucometer immediately': {'258104002': ('qualifier value', 'Measured ', ['272099008']), '49499008': ('qualifier value', 'Stat ', ['272099008'])}, 'prior to scan': {'373205008': ('procedure', 'Nuclear medicine imaging procedure ', ['128927009'])}}

1139199
enrollment in another clinical trial
enrollment in another clinical trial
['enrollment in another clinical trial']
{'enrollment in another clinical trial': {'709491003': 'Enrollment in clinical trial '}}
{}

1146440
evidence of hepatic decompensation .
evidence of hepatic decompensation .
['evidence of hepatic decompensation']
{'evidence of hepatic decompensation': {'18669006': 'Evidence of ', '32381004': 'Portal ', '87228002': 'Decompensation '}}
{'evidence of hepatic decompensation': {'32381004': ('qualifier value', 'Portal ', ['272099008']), '87228002': ('clinical finding', 'Decompensation ', ['250171008', '365860008'])}}

1154191
active infection requiring systemic antibiotic therapy
active infection requiring systemic antibiotic therapy
['active infection', 'systemic antibiotic therapy']
{'active infection': {'55561003': 'Active ', '189822004': 'Contagious disease ', '191415002': 'Communicable disease ', '40733004': 'Infectious disease '}, 'systemic antibiotic therapy': {'31099001': 'Systemic ', '281789004': 'Antibiotic therapy '}}
{'active infection': {'55561003': ('qualifier value', 'Active ', ['272099008']), '40733004': ('clinical finding', 'Infectious disease ', ['64572001'])}, 'systemic antibiotic therapy': {'31099001': ('qualifier value', 'Systemic ', ['272099008']), '281789004': ('procedure', 'Antibiotic therapy ', ['128927009'])}}

1159280
patients with increased risk of regurgitation and aspiration
patients with increased risk of regurgitation and aspiration
['patients with increased risk of regurgitation', 'aspiration']
{'patients with increased risk of regurgitation': {'116154003': 'Patient ', '35105006': 'Increased ', '30207005': 'Risk of ', '302769004': 'Regurgitates after swallowing ', '263854006': 'Regurgitation - mechanism ', '78104003': 'Regurgitation of gastric content ', '260366006': 'Increase '}, 'aspiration': {'278847003': 'Endotracheal aspiration ', '129316008': 'Aspiration - action ', '14766002': 'Aspiration ', '68052005': 'Pulmonary aspiration ', '413585005': 'Aspiration into respiratory tract '}}
{'patients with increased risk of regurgitation': {'35105006': ('qualifier value', 'Increased ', ['272099008']), '302769004': ('clinical finding', 'Regurgitates after swallowing ', ['250171008', '78104003', '118234003']), '78104003': ('clinical finding', 'Regurgitation of gastric content ', ['250171008', '118234003'])}, 'aspiration': {'14766002': ('procedure', 'Aspiration ', ['128927009']), '68052005': ('clinical finding', 'Pulmonary aspiration ', ['413585005', '118234003']), '413585005': ('clinical finding', 'Aspiration into respiratory tract ', ['118234003'])}}

1161352
current, clinically significant malabsorption
current, clinically significant malabsorption
['current,', 'clinically significant malabsorption']
{'current,': {'15240007': 'Current '}, 'clinically significant malabsorption': {'386134007': 'Significant ', '197476001': 'Intestinal malabsorption ', '32230006': 'Malabsorption syndrome '}}
{'clinically significant malabsorption': {'197476001': ('clinical finding', 'Intestinal malabsorption ', ['64572001', '118234003', '32230006']), '32230006': ('clinical finding', 'Malabsorption syndrome ', ['64572001', '118234003'])}}

1163734
past medical history of: liver dysfunction , chronic alcohol abuse, gastrointestinal bleed or recent gastrointestinal bleed , renal dysfunction or disease, seizures , inflammatory bowel disease , hepatitis .
past medical , : liver dysfunction , chronic alcohol abuse, gastrointestinal bleed or recent gastrointestinal bleed , renal dysfunction or disease, seizures , inflammatory bowel disease , hepatitis .
['past medical', 'liver dysfunction ,', 'chronic alcohol abuse,', 'gastrointestinal bleed', 'recent gastrointestinal bleed ,', 'renal dysfunction', 'disease,', 'seizures ,', 'inflammatory bowel disease ,', 'hepatitis']
{'past medical': {'410513005': 'In the past ', '373655009': 'Medical service ', '74188005': 'Medical '}, 'liver dysfunction ,': {'75183008': 'Abnormal liver function '}, 'chronic alcohol abuse,': {'284591009': 'Persistent alcohol abuse ', '66590003': 'Alcohol dependence ', '7200002': 'Alcoholism '}, 'gastrointestinal bleed': {'74474003': 'Gastrointestinal hemorrhage '}, 'recent gastrointestinal bleed ,': {'263852005': 'Recent episode ', '6493001': 'Recent ', '74474003': 'Gastrointestinal hemorrhage '}, 'renal dysfunction': {'236423003': 'Renal impairment '}, 'disease,': {'64572001': 'Disease '}, 'seizures ,': {'91175000': 'Seizure '}, 'inflammatory bowel disease ,': {'24526004': 'Inflammatory bowel disease '}, 'hepatitis': {'128241005': 'Inflammatory disease of liver ', '40468003': 'Viral hepatitis, type A '}}
{'past medical': {'74188005': ('qualifier value', 'Medical ', ['272099008'])}, 'liver dysfunction ,': {'75183008': ('clinical finding', 'Abnormal liver function ', ['118234003'])}, 'chronic alcohol abuse,': {'284591009': ('clinical finding', 'Persistent alcohol abuse ', ['64572001', '7200002']), '66590003': ('clinical finding', 'Alcohol dependence ', ['64572001', '7200002']), '7200002': ('clinical finding', 'Alcoholism ', ['64572001'])}, 'gastrointestinal bleed': {'74474003': ('clinical finding', 'Gastrointestinal hemorrhage ', ['64572001', '118234003', '131148009'])}, 'recent gastrointestinal bleed ,': {'263852005': ('qualifier value', 'Recent episode ', ['272099008']), '74474003': ('clinical finding', 'Gastrointestinal hemorrhage ', ['64572001', '118234003', '131148009'])}, 'renal dysfunction': {'236423003': ('clinical finding', 'Renal impairment ', ['64572001', '441742003', '118234003'])}, 'seizures ,': {'91175000': ('clinical finding', 'Seizure ', ['102957003', '118234003'])}, 'inflammatory bowel disease ,': {'24526004': ('clinical finding', 'Inflammatory bowel disease ', ['64572001', '118234003'])}, 'hepatitis': {'128241005': ('clinical finding', 'Inflammatory disease of liver ', ['64572001', '118234003']), '40468003': ('clinical finding', 'Viral hepatitis, type A ', ['64572001', '118234003', '128241005'])}}

1164749
unable to consume test-dose of rutf in clinic
unable to consume test-dose of rutf in clinic
['unable', 'to', 'test dose of rutf', 'in clinic']
{'unable': {'289001005': 'Unable to feed self ', '371151008': 'Unable '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'test dose of rutf': {'108252007': 'Laboratory procedure ', '15220000': 'Laboratory test ', '269814003': 'Laboratory procedures -general ', '260911001': 'dosage', '277406006': 'Dosages ', '408102007': 'Unit dose ', '272393004': 'Tests ', '277775005': 'Test finding '}, 'in clinic': {'52101004': 'Present ', '35971002': 'Ambulatory care site ', '257585005': 'Clinic ', '18720000': 'within'}}
{'unable': {'289001005': ('clinical finding', 'Unable to feed self ', ['250171008'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'test dose of rutf': {'15220000': ('procedure', 'Laboratory test ', ['128927009', '108252007']), '269814003': ('situation with explicit context', 'Laboratory procedures -general ', ['129125009']), '277406006': ('qualifier value', 'Dosages ', ['272099008']), '408102007': ('unit', 'Unit dose ', ['767524001'])}}

1165203
history of mania or hypomania within the past 2 years
, mania or hypomania ,
['mania', 'hypomania']
{'mania': {'231494001': 'Mania ', '405273008': 'Manic mood '}, 'hypomania': {'231496004': 'Hypomania ', '281257007': 'Hypomanic mood '}}
{'mania': {'231494001': ('clinical finding', 'Mania ', ['64572001']), '405273008': ('clinical finding', 'Manic mood ', ['250171008'])}, 'hypomania': {'231496004': ('clinical finding', 'Hypomania ', ['64572001']), '281257007': ('clinical finding', 'Hypomanic mood ', ['250171008'])}}

1179435
interruption of thromboprophylaxis would pose an unacceptable health risk , as determined by physician
interruption of thromboprophylaxis would pose an unacceptable health risk ,
['interruption of thromboprophylaxis', 'an unacceptable health risk ,']
{'interruption of thromboprophylaxis': {'76555007': 'Disruption '}, 'an unacceptable health risk ,': {'263775005': 'Health ', '30207005': 'Risk of '}}
{}

1188465
medical instability
medical instability
['medical instability']
{'medical instability': {'373655009': 'Medical service ', '410728007': 'Instability ', '74188005': 'Medical '}}
{'medical instability': {'74188005': ('qualifier value', 'Medical ', ['272099008'])}}

1204686
phq-8 score of 15 or greater on the baseline interview
phq-8 score of 15 or greater on the baseline interview
['phq 8 score of 15', 'greater on the baseline interview']
{'phq 8 score of 15': {'720198001': 'SCORE Index of Family Function and Change 15 '}, 'greater on the baseline interview': {'263768009': 'Greater '}}
{'greater on the baseline interview': {'263768009': ('qualifier value', 'Greater ', ['272099008'])}}

1213530
inability to comply with treatment and follow-up schedule
comply with treatment and follow-up schedule
['comply with treatment', 'follow up schedule']
{'comply with treatment': {'276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '416118004': 'Administration '}, 'follow up schedule': {'308273005': 'Follow-up status '}}
{'comply with treatment': {'276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '416118004': ('procedure', 'Administration ', ['128927009'])}}

1213659
treatment with any enzyme replacement therapy for fabry disease within 3 months before study entry;
treatment with any enzyme replacement therapy for fabry disease , before study entry;
['treatment with any enzyme replacement therapy', 'for fabry disease', 'study entry']
{'treatment with any enzyme replacement therapy': {'276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '90668006': 'Enzyme ', '182819002': 'Replacement therapy ', '416118004': 'Administration '}, 'for fabry disease': {'124464003': 'Deficiency of alpha-galactosidase ', '16652001': 'Fabrys disease '}, 'study entry': {'224699009': 'Study '}}
{'treatment with any enzyme replacement therapy': {'276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '90668006': ('product', 'Enzyme ', ['312413002', '115668003']), '182819002': ('situation with explicit context', 'Replacement therapy ', ['129125009']), '416118004': ('procedure', 'Administration ', ['128927009'])}, 'for fabry disease': {'124464003': ('clinical finding', 'Deficiency of alpha-galactosidase ', ['64572001']), '16652001': ('clinical finding', 'Fabrys disease ', ['64572001', '118234003'])}}

1222652
visual impairments such as uncorrected vision or color blindness
visual impairments such as uncorrected vision or color blindness
['visual impairments such as uncorrected vision', 'color blindness']
{'visual impairments such as uncorrected vision': {'397540003': 'Visual impairment ', '7973008': 'Abnormal vision ', '281004000': 'Visual function '}, 'color blindness': {'193683001': 'Color blindness '}}
{'visual impairments such as uncorrected vision': {'397540003': ('clinical finding', 'Visual impairment ', ['64572001', '118234003']), '7973008': ('clinical finding', 'Abnormal vision ', ['118234003']), '281004000': ('observable entity', 'Visual function ', ['246464006'])}, 'color blindness': {'193683001': ('clinical finding', 'Color blindness ', ['64572001', '118234003'])}}

1223117
the patient is under judicial protection, or is an adult under guardianship
the patient is under judicial protection, or is an adult under guardianship
['the patient', 'is under judicial protection,', 'an adult under guardianship']
{'the patient': {'116154003': 'Patient '}, 'is under judicial protection,': {'65823007': 'Protective agent '}, 'an adult under guardianship': {'133936004': 'Adult '}}
{'is under judicial protection,': {'65823007': ('product', 'Protective agent ', ['763158003'])}}

1225451
patients with active or suspected ocular infections or periocular infections
patients with active or suspected ocular infections or periocular infections
['patients with active', 'suspected ocular infections']
{'patients with active': {'116154003': 'Patient ', '55561003': 'Active '}, 'suspected ocular infections': {'128351009': 'Eye infection ', '415684004': 'Suspected '}}
{'patients with active': {'55561003': ('qualifier value', 'Active ', ['272099008'])}, 'suspected ocular infections': {'128351009': ('clinical finding', 'Eye infection ', ['64572001', '118234003'])}}

1235371
donating blood 2 months within or during study period
donating blood 2 months within or during study period
['donating blood 2 months within', 'or during study period']
{'donating blood 2 months within': {'160655006': 'Willing to be donor of blood ', '258706009': 'month '}, 'or during study period': {'224699009': 'Study ', '259037005': 'per period ', '272117007': 'Time periods '}}
{'donating blood 2 months within': {'160655006': ('clinical finding', 'Willing to be donor of blood ', ['365860008']), '258706009': ('unit', 'month ', ['767524001'])}, 'or during study period': {'259037005': ('unit', 'per period ', ['767524001']), '272117007': ('qualifier value', 'Time periods ', ['272099008'])}}

1236296
smokers or use of any tobacco products in past 6 months
smokers or use of any tobacco products in past 6 months
['smokers', 'use of any tobacco products', 'in past 6 months']
{'smokers': {'77176002': 'Smoker '}, 'use of any tobacco products': {'89765005': 'Tobacco dependence syndrome ', '1221000119103': 'History of tobacco use '}, 'in past 6 months': {'410513005': 'In the past ', '258706009': 'month '}}
{'smokers': {'77176002': ('clinical finding', 'Smoker ', ['250171008'])}, 'use of any tobacco products': {'89765005': ('clinical finding', 'Tobacco dependence syndrome ', ['64572001'])}, 'in past 6 months': {'258706009': ('unit', 'month ', ['767524001'])}}

1236973
the use of inhaled corticosteroids and mineralocorticoids for patients with orthostatic hypotension or adrenocortical insufficiency is allowed
the use of inhaled corticosteroids and mineralocorticoids for patients with orthostatic hypotension or adrenocortical insufficiency is allowed
['the use of inhaled corticosteroids', 'mineralocorticoids for patients', 'with orthostatic hypotension', 'adrenocortical insufficiency']
{'the use of inhaled corticosteroids': {'260676000': 'use of', '14910006': 'Inspiration ', '258160008': 'Inhaling ', '21568003': 'Adrenal cortical hormone ', '79440004': 'Corticoid preparation '}, 'mineralocorticoids for patients': {'36887008': 'Mineralocorticoid hormone ', '83692001': 'Mineralocorticoid preparation ', '116154003': 'Patient '}, 'with orthostatic hypotension': {'28651003': 'Orthostatic hypotension '}, 'adrenocortical insufficiency': {'60086000': 'Aldosterone deficiency ', '386584007': 'Adrenal cortical hypofunction '}}
{'the use of inhaled corticosteroids': {'14910006': ('observable entity', 'Inspiration ', ['246464006']), '79440004': ('product', 'Corticoid preparation ', ['763158003'])}, 'mineralocorticoids for patients': {'36887008': ('product', 'Mineralocorticoid hormone ', ['406455002', '21568003', '312413002']), '83692001': ('product', 'Mineralocorticoid preparation ', ['79440004', '763158003'])}, 'with orthostatic hypotension': {'28651003': ('clinical finding', 'Orthostatic hypotension ', ['64572001', '118234003'])}, 'adrenocortical insufficiency': {'60086000': ('clinical finding', 'Aldosterone deficiency ', ['64572001', '386584007', '118234003']), '386584007': ('clinical finding', 'Adrenal cortical hypofunction ', ['64572001', '118234003'])}}

1240650
prisoners or patients in custody
prisoners or patients in custody
['patients in custody']
{'patients in custody': {'116154003': 'Patient '}}
{}

1245993
patients with medical conditions and/or taking concomitant medications that would have put them at risk, interfered with the study evaluations, or made them unable to complete the requirements of the study;
patients with medical conditions and/or taking concomitant medications , interfered with the study evaluations, or made them complete the requirements of the study;
['patients with medical conditions', 'taking concomitant medications', 'interfered with the study evaluations,', 'complete', 'the requirements of the study']
{'patients with medical conditions': {'116154003': 'Patient ', '373655009': 'Medical service ', '64572001': 'Disease ', '260905004': 'condition', '74188005': 'Medical '}, 'taking concomitant medications': {'129019007': 'Taking medication ', '79970003': 'Simultaneous '}, 'interfered with the study evaluations,': {'78235001': 'Interferes with ', '224699009': 'Study ', '129265001': 'Evaluation - action ', '386053000': 'Evaluation procedure '}, 'complete': {'255594003': 'Complete '}, 'the requirements of the study': {'224699009': 'Study '}}
{'patients with medical conditions': {'74188005': ('qualifier value', 'Medical ', ['272099008'])}, 'taking concomitant medications': {'129019007': ('observable entity', 'Taking medication ', ['246464006']), '79970003': ('qualifier value', 'Simultaneous ', ['272099008'])}, 'interfered with the study evaluations,': {'386053000': ('procedure', 'Evaluation procedure ', ['128927009'])}, 'complete': {'255594003': ('qualifier value', 'Complete ', ['272099008'])}}

1265510
subject requires long-term use of vitamin k antagonists
subject requires long-term use of vitamin k antagonists
['long term use of vitamin k antagonists']
{'long term use of vitamin k antagonists': {'260676000': 'use of', '65183007': 'Vitamin K ', '74226000': 'Vitamin K preparation ', '58516001': 'Antagonist muscle action, function '}}
{'long term use of vitamin k antagonists': {'65183007': ('product', 'Vitamin K ', ['406455002', '312413002', '115668003']), '74226000': ('product', 'Vitamin K preparation ', ['763158003']), '58516001': ('observable entity', 'Antagonist muscle action, function ', ['246464006'])}}

1268266
serious hearing or visual impairment
serious hearing or visual impairment
['serious hearing', 'visual impairment']
{'serious hearing': {'42745003': 'Serious ', '47078008': 'Hearing, function ', '118230007': 'Hearing finding '}, 'visual impairment': {'246635007': 'Dim vision ', '397540003': 'Visual impairment ', '7973008': 'Abnormal vision '}}
{'serious hearing': {'42745003': ('qualifier value', 'Serious ', ['272099008']), '47078008': ('observable entity', 'Hearing, function ', ['246464006']), '118230007': ('clinical finding', 'Hearing finding ', ['250171008', '118234003'])}, 'visual impairment': {'246635007': ('clinical finding', 'Dim vision ', ['64572001', '118234003']), '397540003': ('clinical finding', 'Visual impairment ', ['64572001', '118234003']), '7973008': ('clinical finding', 'Abnormal vision ', ['118234003'])}}

1287819
plan to travel outside of north america in the time between vaccination and 21 days following vaccination
plan to travel outside of north america in the time between vaccination and 21 days following vaccination
['plan', 'to', 'travel outside of north america', 'in the time between vaccination', '21 days', 'following', 'vaccination']
{'plan': {'52713000': 'Infantile neuroaxonal dystrophy ', '397943006': 'Planned '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'travel outside of north america': {'129018004': 'Traveling ', '420008001': 'Travel ', '261074009': 'External ', '223503004': 'North America '}, 'in the time between vaccination': {'410669006': 'Time ', '410670007': 'time', '33879002': 'Administration of vaccine to produce active immunity ', '900000000000475002': 'time '}, '21 days': {'258703001': 'day '}, 'following': {'237679004': 'Status post ', '255234002': 'status post', '255260001': 'following'}, 'vaccination': {'33879002': 'Administration of vaccine to produce active immunity '}}
{'plan': {'52713000': ('clinical finding', 'Infantile neuroaxonal dystrophy ', ['64572001', '118234003'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'travel outside of north america': {'129018004': ('observable entity', 'Traveling ', ['246464006'])}, 'in the time between vaccination': {'33879002': ('procedure', 'Administration of vaccine to produce active immunity ', ['128927009'])}, '21 days': {'258703001': ('unit', 'day ', ['767524001'])}, 'vaccination': {'33879002': ('procedure', 'Administration of vaccine to produce active immunity ', ['128927009'])}}

1290744
presence of a precursor lesion of cutaneous neoplasia, such as nevus melanocyte and keratoses actinium
presence of a precursor lesion of cutaneous neoplasia, such as nevus melanocyte and keratoses actinium
['presence of a precursor lesion of cutaneous neoplasia,', 'such as nevus melanocyte', 'keratoses actinium']
{'presence of a precursor lesion of cutaneous neoplasia,': {'52101004': 'Present ', '52988006': 'Lesion ', '126488004': 'Neoplasm of skin '}, 'such as nevus melanocyte': {'51697005': 'Cutaneous hamartoma ', '9683001': 'Melanocyte ', '21119008': 'Pigmented nevus, no International Classification of Diseases for Oncology subtype ', '400096001': 'Melanocytic nevus ', '400010006': 'Melanocytic nevus of skin '}, 'keratoses actinium': {'254666005': 'Keratosis ', '1396009': 'Actinium '}}
{'presence of a precursor lesion of cutaneous neoplasia,': {'126488004': ('clinical finding', 'Neoplasm of skin ', ['64572001', '118234003'])}, 'such as nevus melanocyte': {'400096001': ('clinical finding', 'Melanocytic nevus ', ['64572001']), '400010006': ('clinical finding', 'Melanocytic nevus of skin ', ['64572001', '126488004', '400096001', '118234003'])}, 'keratoses actinium': {'254666005': ('clinical finding', 'Keratosis ', ['64572001', '118234003']), '1396009': ('product', 'Actinium ', ['312413002'])}}

1293632
other exclusion criteria apply according to the us product information
other exclusion criteria apply according to the us product information
['apply according to the']
{'apply according to the': {'417924000': 'Apply - dosing instruction imperative '}}
{}

1293795
presence of any hypersensitivity to drugs similar to azelastine and to either sorbitol or sucralose
presence of any hypersensitivity to drugs similar to azelastine and to either sorbitol or sucralose
['presence of any hypersensitivity', 'to drugs similar to azelastine', 'and to either sorbitol', 'sucralose']
{'presence of any hypersensitivity': {'52101004': 'Present ', '418634005': 'Allergic reaction caused by substance ', '421961002': 'Hypersensitivity reaction ', '421369008': 'Emotional hypersensitivity '}, 'to drugs similar to azelastine': {'105903003': 'General drug type ', '373873005': 'Pharmaceutical / biologic product ', '410942007': 'Drug or medicament ', '108644000': 'Azelastine ', '372520005': 'Azelastine '}, 'and to either sorbitol': {'19839007': 'Sorbitol ', '412513004': 'Sorbitol '}, 'sucralose': {'418992009': 'Sucralose '}}
{'presence of any hypersensitivity': {'418634005': ('clinical finding', 'Allergic reaction caused by substance ', ['64572001', '421961002']), '421961002': ('clinical finding', 'Hypersensitivity reaction ', ['64572001']), '421369008': ('clinical finding', 'Emotional hypersensitivity ', ['250171008'])}, 'to drugs similar to azelastine': {'108644000': ('product', 'Azelastine ', ['373873005', '763158003']), '372520005': ('product', 'Azelastine ', ['410942007', '406455002'])}, 'and to either sorbitol': {'19839007': ('product', 'Sorbitol ', ['410942007', '115668003', '312413002', '406455002']), '412513004': ('product', 'Sorbitol ', ['373873005', '763158003'])}, 'sucralose': {'418992009': ('product', 'Sucralose ', ['312413002'])}}

1296744
infection with human immunodeficiency virus and/or chronic/active infection with hepatitis b virus or hepatitis c virus
infection with human immunodeficiency virus and/or chronic/active infection with hepatitis b virus or hepatitis c virus
['infection with human immunodeficiency virus', 'chronic/active infection with hepatitis b virus', 'hepatitis c virus']
{'infection with human immunodeficiency virus': {'86406008': 'Human immunodeficiency virus infection '}, 'chronic/active infection with hepatitis b virus': {'61977001': 'Chronic type B viral hepatitis ', '55561003': 'Active ', '50167007': 'Chronic active type B viral hepatitis ', '49872002': 'Virus '}, 'hepatitis c virus': {'62944002': 'Hepatitis C virus '}}
{'infection with human immunodeficiency virus': {'86406008': ('clinical finding', 'Human immunodeficiency virus infection ', ['64572001'])}, 'chronic/active infection with hepatitis b virus': {'61977001': ('clinical finding', 'Chronic type B viral hepatitis ', ['64572001', '118234003']), '55561003': ('qualifier value', 'Active ', ['272099008']), '50167007': ('clinical finding', 'Chronic active type B viral hepatitis ', ['64572001', '118234003', '61977001'])}, 'hepatitis c virus': {'62944002': ('clinical finding', 'Hepatitis C virus ', ['49872002'])}}

1301994
history of anaphylactic reaction attributed to any contrast agent or drugs containing polyethylene glycol .
, anaphylactic reaction attributed to any contrast agent or drugs containing polyethylene glycol .
['anaphylactic reaction', 'attributed to any contrast agent', 'drugs', 'containing', 'polyethylene glycol']
{'anaphylactic reaction': {'39579001': 'Anaphylaxis '}, 'attributed to any contrast agent': {'385420005': 'Contrast media ', '407935004': 'Contrast media ', '260872001': 'agent'}, 'drugs': {'105903003': 'General drug type ', '373873005': 'Pharmaceutical / biologic product ', '410942007': 'Drug or medicament '}, 'containing': {'42504009': 'Containing '}, 'polyethylene glycol': {'356076006': 'Polyethylene glycol product ', '8030004': 'Polyethylene glycol '}}
{'anaphylactic reaction': {'39579001': ('clinical finding', 'Anaphylaxis ', ['64572001'])}, 'attributed to any contrast agent': {'407935004': ('product', 'Contrast media ', ['373873005', '763158003'])}, 'containing': {'42504009': ('qualifier value', 'Containing ', ['272099008'])}, 'polyethylene glycol': {'356076006': ('product', 'Polyethylene glycol product ', ['373873005', '763158003']), '8030004': ('product', 'Polyethylene glycol ', ['410942007', '312413002', '406455002', '312412007'])}}

1307133
any uncontrolled infection
any uncontrolled infection
['any uncontrolled infection']
{'any uncontrolled infection': {'19032002': 'Uncontrolled ', '189822004': 'Contagious disease ', '191415002': 'Communicable disease ', '40733004': 'Infectious disease '}}
{'any uncontrolled infection': {'19032002': ('qualifier value', 'Uncontrolled ', ['272099008']), '40733004': ('clinical finding', 'Infectious disease ', ['64572001'])}}

1308128
spinal cord compression and/or brain metastases unless asymptomatic &amp or treated &amp; stable off steroids for >= 4 weeks
spinal cord compression and/or brain metastases unless asymptomatic &amp or treated &amp; stable off steroids for >= 4 weeks
['spinal cord compression', 'brain metastases', 'asymptomatic']
{'spinal cord compression': {'71286001': 'Spinal cord compression '}, 'brain metastases': {'94225005': 'Secondary malignant neoplasm of brain '}, 'asymptomatic': {'84387000': 'Asymptomatic '}}
{'spinal cord compression': {'71286001': ('clinical finding', 'Spinal cord compression ', ['64572001', '118234003'])}, 'brain metastases': {'94225005': ('clinical finding', 'Secondary malignant neoplasm of brain ', ['64572001', '118234003'])}, 'asymptomatic': {'84387000': ('clinical finding', 'Asymptomatic ', ['250171008'])}}

1319736
having or undergoing any form of treatment for active cancer, or having a history of skin cancer or any other cancer in the areas to be treated, including presence of malignant or pre‐malignant pigmented lesions
having or undergoing any form of treatment for active cancer, or having , skin cancer or any other cancer in the areas to be treated, including presence of malignant or pre‐malignant pigmented lesions
['any form of treatment', 'for active cancer,', 'skin cancer', 'any other cancer in the areas', 'to', 'treated', 'including', 'presence of malignant', 'premalignant pigmented lesions']
{'any form of treatment': {'246176004': 'qualitative form', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '416118004': 'Administration '}, 'for active cancer,': {'55561003': 'Active ', '363346000': 'Malignant neoplastic disease ', '372087000': 'Primary malignant neoplasm ', '86049000': 'Malignant neoplasm, primary '}, 'skin cancer': {'372130007': 'Malignant neoplasm of skin '}, 'any other cancer in the areas': {'363346000': 'Malignant neoplastic disease ', '42798000': 'Area ', '372087000': 'Primary malignant neoplasm ', '86049000': 'Malignant neoplasm, primary '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'treated': {'276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '116700008': 'treatment intent', '395077000': 'Treatment intent '}, 'including': {'55919000': 'Including '}, 'presence of malignant': {'52101004': 'Present ', '21594007': 'Malignant '}, 'premalignant pigmented lesions': {'300597003': 'Pigmented ', '52988006': 'Lesion '}}
{'any form of treatment': {'276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '416118004': ('procedure', 'Administration ', ['128927009'])}, 'for active cancer,': {'55561003': ('qualifier value', 'Active ', ['272099008']), '363346000': ('clinical finding', 'Malignant neoplastic disease ', ['64572001']), '372087000': ('clinical finding', 'Primary malignant neoplasm ', ['64572001', '363346000'])}, 'skin cancer': {'372130007': ('clinical finding', 'Malignant neoplasm of skin ', ['64572001', '363346000', '118234003'])}, 'any other cancer in the areas': {'363346000': ('clinical finding', 'Malignant neoplastic disease ', ['64572001']), '42798000': ('qualifier value', 'Area ', ['272099008']), '372087000': ('clinical finding', 'Primary malignant neoplasm ', ['64572001', '363346000'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'treated': {'276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '395077000': ('situation with explicit context', 'Treatment intent ', ['129125009'])}, 'including': {'55919000': ('qualifier value', 'Including ', ['272099008'])}, 'presence of malignant': {'21594007': ('qualifier value', 'Malignant ', ['272099008'])}, 'premalignant pigmented lesions': {'300597003': ('qualifier value', 'Pigmented ', ['272099008'])}}

1323003
serum potassium : greater than 5.5 mmol/l
serum potassium : greater than 5.5 mmol/l
['serum potassium', 'greater than 5 5 mmol/l']
{'serum potassium': {'271236005': 'Serum potassium measurement '}, 'greater than 5 5 mmol/l': {'276140008': 'Greater-than symbol > ', '258813002': 'Millimole/liter ', '414719002': 'Micromole/milliliter '}}
{'serum potassium': {'271236005': ('procedure', 'Serum potassium measurement ', ['128927009'])}, 'greater than 5 5 mmol/l': {'258813002': ('unit', 'Millimole/liter ', ['767524001']), '414719002': ('unit', 'Micromole/milliliter ', ['767524001'])}}

1323360
patient with acute hepatitis due to any cause or clinically significant chronic liver disease including but not limited to cirrhosis, ascites, encephalopathy, hypoalbuminemia, prolonged pt/ptt varices and/or esophageal varices.
patient with acute hepatitis due to any cause or clinically significant chronic liver disease including but not limited to cirrhosis, ascites, encephalopathy, hypoalbuminemia, prolonged pt/ptt varices and/or esophageal varices.
['patient with acute hepatitis', 'clinically significant chronic liver disease', 'including', 'limited to cirrhosis,', 'ascites,', 'encephalopathy,', 'hypoalbuminemia,', 'prolonged pt/ptt varices', 'esophageal varices']
{'patient with acute hepatitis': {'116154003': 'Patient ', '37871000': 'Acute hepatitis '}, 'clinically significant chronic liver disease': {'386134007': 'Significant ', '328383001': 'Chronic liver disease '}, 'including': {'55919000': 'Including '}, 'limited to cirrhosis,': {'255469002': 'Limited ', '19943007': 'Cirrhosis of liver ', '900000000000486000': 'limited component '}, 'ascites,': {'389026000': 'Ascites '}, 'encephalopathy,': {'81308009': 'Disorder of brain '}, 'hypoalbuminemia,': {'119247004': 'Hypoalbuminemia '}, 'prolonged pt/ptt varices': {'409675001': 'Partial thromboplastin time increased ', '363678002': 'Positron emission tomographic imaging - action ', '82918005': 'Positron emission tomography ', '128060009': 'Venous varices ', '12856003': 'Uneven venous ectasia ', '399989005': 'Venous ectasia ', '722138006': 'Physiotherapy ', '409674002': 'Prothrombin time increased ', '42525009': 'Partial thromboplastin time, activated '}, 'esophageal varices': {'28670008': 'Esophageal varices '}}
{'patient with acute hepatitis': {'37871000': ('clinical finding', 'Acute hepatitis ', ['64572001', '118234003'])}, 'clinically significant chronic liver disease': {'328383001': ('clinical finding', 'Chronic liver disease ', ['64572001', '118234003'])}, 'including': {'55919000': ('qualifier value', 'Including ', ['272099008'])}, 'limited to cirrhosis,': {'255469002': ('qualifier value', 'Limited ', ['272099008']), '19943007': ('clinical finding', 'Cirrhosis of liver ', ['64572001', '328383001', '118234003'])}, 'ascites,': {'389026000': ('clinical finding', 'Ascites ', ['64572001', '118234003'])}, 'encephalopathy,': {'81308009': ('clinical finding', 'Disorder of brain ', ['64572001', '118234003'])}, 'hypoalbuminemia,': {'119247004': ('clinical finding', 'Hypoalbuminemia ', ['64572001'])}, 'prolonged pt/ptt varices': {'409675001': ('clinical finding', 'Partial thromboplastin time increased ', ['250171008', '441742003']), '82918005': ('procedure', 'Positron emission tomography ', ['128927009']), '128060009': ('clinical finding', 'Venous varices ', ['64572001', '118234003']), '409674002': ('clinical finding', 'Prothrombin time increased ', ['441742003', '250171008']), '42525009': ('procedure', 'Partial thromboplastin time, activated ', ['128927009'])}, 'esophageal varices': {'28670008': ('clinical finding', 'Esophageal varices ', ['64572001', '128060009', '118234003'])}}

1324182
patients aged under 18 years
patients aged under 18 years
['patients', 'aged under 18 years']
{'patients': {'116154003': 'Patient '}, 'aged under 18 years': {'397669002': 'Age ', '424144002': 'Current chronological age ', '258707000': 'year ', '105436006': 'Elderly person ', '49808004': 'Old-age ', '271872005': 'Old age ', '32864002': 'Senility '}}
{'aged under 18 years': {'397669002': ('qualifier value', 'Age ', ['272099008']), '424144002': ('observable entity', 'Current chronological age ', ['105727008']), '258707000': ('unit', 'year ', ['767524001']), '105436006': ('person', 'Elderly person ', ['133936004']), '49808004': ('clinical finding', 'Old-age ', ['250171008']), '271872005': ('qualifier value', 'Old age ', ['272099008']), '32864002': ('observable entity', 'Senility ', ['105727008'])}}

1327793
dnar order in place
dnar order in place
['dnar order in place']
{'dnar order in place': {'721963009': 'Order ', '246297005': 'place', '257557008': 'Place ', '421066005': 'Place - dosing instruction imperative '}}
{}

1334845
patients with congenital spinal deformity
patients with congenital spinal deformity
['patients with congenital spinal deformity']
{'patients with congenital spinal deformity': {'116154003': 'Patient ', '255399007': 'Congenital ', '298380006': 'Deformity of spine '}}
{'patients with congenital spinal deformity': {'255399007': ('qualifier value', 'Congenital ', ['272099008']), '298380006': ('clinical finding', 'Deformity of spine ', ['118234003', '417893002'])}}

1337227
refuse to participate in the protocol
refuse to participate in the protocol
['refuse', 'to', 'participate in the protocol']
{'refuse': {'58377000': 'Trash ', '443390004': 'Refused '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'participate in the protocol': {'258049002': 'Protocols '}}
{'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}}

1338613
a positive β-hcg test at enrollment
a positive β-hcg test at enrollment
['a positive  hcg test at enrollment']
{'a positive  hcg test at enrollment': {'258758003': '% positive cells ', '108252007': 'Laboratory procedure ', '15220000': 'Laboratory test ', '269814003': 'Laboratory procedures -general ', '272393004': 'Tests ', '277775005': 'Test finding ', '10828004': 'Positive '}}
{'a positive  hcg test at enrollment': {'258758003': ('unit', '% positive cells ', ['767524001']), '15220000': ('procedure', 'Laboratory test ', ['128927009', '108252007']), '269814003': ('situation with explicit context', 'Laboratory procedures -general ', ['129125009']), '10828004': ('qualifier value', 'Positive ', ['272099008'])}}

1342789
body mass index > 35 mg/kg
body mass index > 35 mg/kg
['body mass index', '> 35 mg/kg']
{'body mass index': {'301331008': 'Finding of body mass index ', '60621009': 'Body mass index '}, '> 35 mg/kg': {'732694002': '35', '258802000': 'Microgram/gram ', '396163008': 'Milligram/kilogram '}}
{'body mass index': {'301331008': ('clinical finding', 'Finding of body mass index ', ['250171008']), '60621009': ('observable entity', 'Body mass index ', ['363788007'])}, '> 35 mg/kg': {'258802000': ('unit', 'Microgram/gram ', ['767524001']), '396163008': ('unit', 'Milligram/kilogram ', ['767524001'])}}

1347445
nephrosis
nephrosis
['nephrosis']
{'nephrosis': {'90708001': 'Kidney disease ', '52254009': 'Nephrotic syndrome '}}
{'nephrosis': {'90708001': ('clinical finding', 'Kidney disease ', ['64572001', '118234003']), '52254009': ('clinical finding', 'Nephrotic syndrome ', ['64572001', '441742003', '90708001', '118234003'])}}

1347572
acute or chronic severe renal insufficiency , as calculated by the mdrd equation, or
acute or chronic severe renal insufficiency , as calculated by the mdrd equation, or
['acute', 'chronic severe renal insufficiency ,', 'calculated by the mdrd equation,']
{'acute': {'272118002': 'Acuteness '}, 'chronic severe renal insufficiency ,': {'709044004': 'Chronic kidney disease ', '723190009': 'Chronic renal insufficiency ', '24484000': 'Severe '}, 'calculated by the mdrd equation,': {'258090004': 'Calculated ', '702873001': 'Calculation technique ', '702668005': 'Modification of diet in renal disease formula '}}
{'acute': {'272118002': ('qualifier value', 'Acuteness ', ['272099008'])}, 'chronic severe renal insufficiency ,': {'709044004': ('clinical finding', 'Chronic kidney disease ', ['64572001', '441742003', '118234003']), '723190009': ('clinical finding', 'Chronic renal insufficiency ', ['64572001', '441742003', '118234003', '709044004']), '24484000': ('qualifier value', 'Severe ', ['272396007'])}, 'calculated by the mdrd equation,': {'258090004': ('qualifier value', 'Calculated ', ['272099008'])}}

1356370
other exclusion criteria will be: tobacco use, habitual alcohol use of > 1 drink per day, excessive caffeine intake of > 300 mg per day
other exclusion criteria will be: tobacco use, habitual alcohol use of > 1 drink per day, excessive caffeine intake of > 300 mg per day
['tobacco use,', 'habitual alcohol use of', '> 1 drink per day,', 'excessive caffeine intake of', '> 300 mg per day']
{'tobacco use,': {'1221000119103': 'History of tobacco use ', '110483000': 'Tobacco user '}, 'habitual alcohol use of': {'40451002': 'Habitual ', '398624005': 'Ethyl alcohol ', '419442005': 'Ethyl alcohol ', '260676000': 'use of', '53041004': 'Alcohol '}, '> 1 drink per day,': {'451231000124103': 'greater than one', '228327003': 'Drinking day '}, 'excessive caffeine intake of': {'440491000124109': 'excessive caffeine intake'}, '> 300 mg per day': {'725125005': '300', '258835005': 'Milligram/day ', '258836006': 'Milligrams/24 hours '}}
{'tobacco use,': {'110483000': ('clinical finding', 'Tobacco user ', ['250171008'])}, 'habitual alcohol use of': {'40451002': ('qualifier value', 'Habitual ', ['272099008']), '398624005': ('product', 'Ethyl alcohol ', ['763158003']), '419442005': ('product', 'Ethyl alcohol ', ['406455002', '53041004', '312413002']), '53041004': ('product', 'Alcohol ', ['406455002', '312413002'])}, '> 1 drink per day,': {'228327003': ('clinical finding', 'Drinking day ', ['250171008'])}, 'excessive caffeine intake of': {'440491000124109': ('clinical finding', 'excessive caffeine intake', ['250171008'])}, '> 300 mg per day': {'258835005': ('unit', 'Milligram/day ', ['767524001']), '258836006': ('unit', 'Milligrams/24 hours ', ['767524001'])}}

1365947
patients with asthma who are primarily cared for by a respirologist/pulmonologist;
patients with asthma who are primarily cared for by a respirologist/pulmonologist;
['patients with asthma', 'by a respirologist/pulmonologist']
{'patients with asthma': {'116154003': 'Patient ', '195967001': 'Asthma '}, 'by a respirologist/pulmonologist': {'41672002': 'Respiratory disease specialist '}}
{'patients with asthma': {'195967001': ('clinical finding', 'Asthma ', ['64572001', '118234003'])}}

1377433
history of life-threatening respiratory distress that requires admission to an intensive care unit for treatment
, life-threatening respiratory distress
['life threatening respiratory distress']
{'life threatening respiratory distress': {'446441000124102': 'life threatening or disabling adverse event', '271825005': 'Respiratory distress '}}
{'life threatening respiratory distress': {'271825005': ('clinical finding', 'Respiratory distress ', ['365860008', '118234003'])}}

1379806
prior history of hyperglycemic crises.
, hyperglycemic crises.
['hyperglycemic crises']
{'hyperglycemic crises': {'32937002': 'Crisis '}}
{'hyperglycemic crises': {'32937002': ('clinical finding', 'Crisis ', ['250171008'])}}

1392258
diabetes, other significant medical problem or intercurrent acute illness that in the nurse practitioner's and/or principal investigator, would preclude provision of informed consent, make participation in the study unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objective.
diabetes, other significant medical problem or intercurrent acute illness that in the nurse practitioner's and/or principal investigator, would preclude provision of informed consent, make participation in the study unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objective.
['diabetes,', 'other significant medical problem', 'intercurrent acute illness', "that in the nurse practitioner's", 'principal investigator,', 'provision of informed consent,', 'participation in the study', 'complicate', 'interpretation of study outcome data,', 'interfere with achieving', 'the study objective']
{'diabetes,': {'73211009': 'Diabetes mellitus '}, 'other significant medical problem': {'386134007': 'Significant ', '373655009': 'Medical service ', '55607006': 'Problem ', '74188005': 'Medical '}, 'intercurrent acute illness': {'272118002': 'Acuteness ', '39104002': 'Illness '}, "that in the nurse practitioner's": {'224571005': 'Nurse practitioner '}, 'principal investigator,': {'63161005': 'Principal ', '302311007': 'Teaching principal '}, 'provision of informed consent,': {'108968006': 'Oprelvekin ', '410938009': 'Oprelvekin ', '223458004': 'Informing '}, 'participation in the study': {'224699009': 'Study '}, 'complicate': {'255302009': 'Complicated '}, 'interpretation of study outcome data,': {'118580000': 'Impression AND/OR interpretation of study ', '394617004': 'Result '}, 'interfere with achieving': {'78235001': 'Interferes with '}, 'the study objective': {'224699009': 'Study ', '410518001': 'Goal context ', '260224007': 'Objective observation '}}
{'diabetes,': {'73211009': ('clinical finding', 'Diabetes mellitus ', ['64572001', '118234003'])}, 'other significant medical problem': {'55607006': ('clinical finding', 'Problem ', ['250171008']), '74188005': ('qualifier value', 'Medical ', ['272099008'])}, 'intercurrent acute illness': {'272118002': ('qualifier value', 'Acuteness ', ['272099008']), '39104002': ('clinical finding', 'Illness ', ['250171008'])}, 'principal investigator,': {'63161005': ('qualifier value', 'Principal ', ['272099008'])}, 'provision of informed consent,': {'108968006': ('product', 'Oprelvekin ', ['406455002', '312413002', '115668003']), '410938009': ('product', 'Oprelvekin ', ['763158003'])}, 'complicate': {'255302009': ('qualifier value', 'Complicated ', ['272099008'])}, 'the study objective': {'260224007': ('qualifier value', 'Objective observation ', ['272099008'])}}

1396518
participant is hepatitis b surface antigen positive or hepatitis c virus antibody positive with hcv rna positive, or has another clinically active liver disease at screening
participant is hepatitis b surface antigen positive or hepatitis c virus antibody positive with hcv rna positive, or has another clinically active liver disease at screening
['hepatitis b surface antigen positive', 'hepatitis c virus antibody positive with hcv rna positive,', 'another clinically active liver disease at screening']
{'hepatitis b surface antigen positive': {'165806002': 'Hepatitis B surface antigen positive '}, 'hepatitis c virus antibody positive with hcv rna positive,': {'314706002': 'Hepatitis C antibody test positive ', '62944002': 'Hepatitis C virus ', '27888000': 'Ribonucleic acid ', '121204002': 'Hepatitis C virus ribonucleic acid ', '68498002': 'Antibody ', '258758003': '% positive cells ', '10828004': 'Positive ', '112133008': 'Immunoglobulin ', '333710000': 'Immunoglobulin products ', '399771004': 'Immunoglobulin structure '}, 'another clinically active liver disease at screening': {'55561003': 'Active ', '235856003': 'Disorder of liver ', '20135006': 'Screening procedure '}}
{'hepatitis b surface antigen positive': {'165806002': ('clinical finding', 'Hepatitis B surface antigen positive ', ['441742003'])}, 'hepatitis c virus antibody positive with hcv rna positive,': {'314706002': ('clinical finding', 'Hepatitis C antibody test positive ', ['441742003']), '62944002': ('clinical finding', 'Hepatitis C virus ', ['49872002']), '27888000': ('product', 'Ribonucleic acid ', ['312413002']), '121204002': ('product', 'Hepatitis C virus ribonucleic acid ', ['312413002', '27888000']), '68498002': ('product', 'Antibody ', ['312413002', '115668003']), '258758003': ('unit', '% positive cells ', ['767524001']), '10828004': ('qualifier value', 'Positive ', ['272099008']), '112133008': ('product', 'Immunoglobulin ', ['312413002', '115668003']), '333710000': ('product', 'Immunoglobulin products ', ['763158003']), '399771004': ('product', 'Immunoglobulin structure ', ['312413002', '115668003', '112133008'])}, 'another clinically active liver disease at screening': {'55561003': ('qualifier value', 'Active ', ['272099008']), '235856003': ('clinical finding', 'Disorder of liver ', ['64572001', '118234003']), '20135006': ('procedure', 'Screening procedure ', ['128927009'])}}

1399550
peritoneal fluid and/or pleural fluid drainage within 28 days prior to screening
peritoneal fluid and/or pleural fluid drainage , prior to screening
['peritoneal fluid', 'pleural fluid drainage', 'prior to screening']
{'peritoneal fluid': {'409614007': 'Peritoneal fluid ', '409615008': 'Ascitic fluid '}, 'pleural fluid drainage': {'2778004': 'Pleural fluid ', '307488001': 'Discharge - substance ', '75823008': 'Discharge ', '122462000': 'Drainage procedure ', '129289008': 'Drainage - action ', '3120008': 'Pleural membrane structure ', '264148002': 'Pleural '}, 'prior to screening': {'20135006': 'Screening procedure '}}
{'peritoneal fluid': {'409614007': ('product', 'Peritoneal fluid ', ['115669006']), '409615008': ('product', 'Ascitic fluid ', ['115669006', '409614007'])}, 'pleural fluid drainage': {'2778004': ('product', 'Pleural fluid ', ['115669006']), '307488001': ('product', 'Discharge - substance ', ['115669006']), '122462000': ('procedure', 'Drainage procedure ', ['128927009'])}, 'prior to screening': {'20135006': ('procedure', 'Screening procedure ', ['128927009'])}}

1401482
known psychiatric disorders
known psychiatric disorders
['known psychiatric disorders']
{'known psychiatric disorders': {'36692007': 'Known ', '74732009': 'Mental disorder ', '25786006': 'Abnormal behavior ', '277843001': 'Problem behavior '}}
{'known psychiatric disorders': {'74732009': ('clinical finding', 'Mental disorder ', ['64572001']), '25786006': ('clinical finding', 'Abnormal behavior ', ['250171008']), '277843001': ('clinical finding', 'Problem behavior ', ['250171008'])}}

1413350
exclusion criteria:
exclusion criteria:
[]
{}
{}

1413789
50% extrasystole
50% extrasystole
['50% extrasystole']
{'50% extrasystole': {'29717002': 'Premature beats ', '33413000': 'Ectopic beats '}}
{'50% extrasystole': {'29717002': ('clinical finding', 'Premature beats ', ['64572001', '118234003']), '33413000': ('clinical finding', 'Ectopic beats ', ['64572001', '118234003'])}}

1417170
inability to adhere to blood age randomization due to limitations of the blood bank inventory
adhere to blood age randomization due to limitations of the blood bank inventory
['adhere to blood age randomization', 'due to limitations of the blood bank inventory']
{'adhere to blood age randomization': {'87612001': 'Blood ', '397669002': 'Age ', '424144002': 'Current chronological age ', '119273009': 'Peripheral blood '}, 'due to limitations of the blood bank inventory': {'42752001': 'due to', '246175000': 'limitation', '87612001': 'Blood ', '257568008': 'Bank ', '119273009': 'Peripheral blood '}}
{'adhere to blood age randomization': {'87612001': ('product', 'Blood ', ['115669006', '115668003']), '397669002': ('qualifier value', 'Age ', ['272099008']), '424144002': ('observable entity', 'Current chronological age ', ['105727008']), '119273009': ('product', 'Peripheral blood ', ['115669006', '87612001', '115668003'])}, 'due to limitations of the blood bank inventory': {'87612001': ('product', 'Blood ', ['115669006', '115668003']), '119273009': ('product', 'Peripheral blood ', ['115669006', '87612001', '115668003'])}}

1419393
unable to comply with the study protocol.
unable to comply with the study protocol.
['unable', 'to', 'comply with the study protocol']
{'unable': {'289001005': 'Unable to feed self ', '371151008': 'Unable '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'comply with the study protocol': {'224699009': 'Study ', '258049002': 'Protocols '}}
{'unable': {'289001005': ('clinical finding', 'Unable to feed self ', ['250171008'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}}

1420450
other retinal vasculopathy in the study eye
other retinal vasculopathy in the study eye
['other retinal vasculopathy in the study eye']
{'other retinal vasculopathy in the study eye': {'5665001': 'Retinal structure ', '27550009': 'Disorder of blood vessel ', '224699009': 'Study ', '371398005': 'Eye region structure ', '81745001': 'Structure of eye proper '}}
{'other retinal vasculopathy in the study eye': {'27550009': ('clinical finding', 'Disorder of blood vessel ', ['64572001', '118234003'])}}

1433093
core biopsy or other minor surgical procedure, excluding placement of a vascular access device, within 7 days prior to study enrollment.
core biopsy or other minor surgical procedure, excluding placement of a vascular access device, , prior to study enrollment.
['core biopsy', 'excluding', 'placement of a vascular access device,', 'prior to study enrollment']
{'core biopsy': {'9911007': 'Core needle biopsy '}, 'excluding': {'77765009': 'Exclude '}, 'placement of a vascular access device,': {'257867005': 'Insertion - action ', '71861002': 'Implantation ', '59820001': 'Blood vessel structure ', '260507000': 'access'}, 'prior to study enrollment': {'224699009': 'Study '}}
{'core biopsy': {'9911007': ('procedure', 'Core needle biopsy ', ['363691001', '128927009'])}, 'excluding': {'77765009': ('qualifier value', 'Exclude ', ['272099008'])}, 'placement of a vascular access device,': {'71861002': ('procedure', 'Implantation ', ['128927009'])}}

1445485
systemic diseases
systemic diseases
['systemic diseases']
{'systemic diseases': {'264578000': 'Systemic illness ', '56019007': 'Systemic disease '}}
{'systemic diseases': {'264578000': ('qualifier value', 'Systemic illness ', ['272099008']), '56019007': ('clinical finding', 'Systemic disease ', ['250171008'])}}

1450112
pregnant
pregnant
['pregnant']
{'pregnant': {'77386006': 'Patient currently pregnant ', '127362006': 'Previous pregnancies ', '161732006': 'Gravida ', '364323006': 'Quantity of pregnancy ', '366321006': 'Finding of gravida '}}
{'pregnant': {'77386006': ('clinical finding', 'Patient currently pregnant ', ['250171008']), '127362006': ('clinical finding', 'Previous pregnancies ', ['250171008']), '161732006': ('observable entity', 'Gravida ', ['363788007']), '364323006': ('observable entity', 'Quantity of pregnancy ', ['363788007']), '366321006': ('clinical finding', 'Finding of gravida ', ['250171008'])}}

1451530
use of drugs: weight lowering agents, glucocorticoids, oral contraceptive pills.
use of drugs: weight lowering agents, glucocorticoids, oral contraceptive pills.
['use of drugs', 'weight lowering agents,', 'glucocorticoids,', 'oral contraceptive pills']
{'use of drugs': {'260676000': 'use of', '105903003': 'General drug type ', '373873005': 'Pharmaceutical / biologic product ', '410942007': 'Drug or medicament '}, 'weight lowering agents,': {'27113001': 'Body weight ', '261122009': 'Lower ', '260872001': 'agent', '272102008': 'Weights ', '39857003': 'Weighing patient ', '726527001': 'importance weight'}, 'glucocorticoids,': {'116596006': 'Glucocorticoid preparation ', '35150008': 'Glucocorticoid hormone ', '419933005': 'Glucocorticoid '}, 'oral contraceptive pills': {'59261009': 'Oral contraceptive preparation ', '346388008': 'Combined oral contraceptive ', '5935008': 'Oral contraception '}}
{'weight lowering agents,': {'27113001': ('observable entity', 'Body weight ', ['363788007']), '272102008': ('qualifier value', 'Weights ', ['272099008']), '39857003': ('procedure', 'Weighing patient ', ['128927009'])}, 'glucocorticoids,': {'116596006': ('product', 'Glucocorticoid preparation ', ['373873005', '763158003']), '35150008': ('product', 'Glucocorticoid hormone ', ['410942007', '406455002', '312413002', '419933005']), '419933005': ('product', 'Glucocorticoid ', ['406455002', '312413002'])}, 'oral contraceptive pills': {'5935008': ('clinical finding', 'Oral contraception ', ['250171008'])}}

1462240
severe lung disease: fev1/fvc <0.5 and total lung capacity < 70% of the normal value
severe lung disease: fev1/fvc <0.5 and total lung capacity < 70% of the normal value
['severe lung disease', 'fev1/fvc', '<0 5', 'total lung capacity', '< 70% of the normal value']
{'severe lung disease': {'24484000': 'Severe ', '19829001': 'Disorder of lung '}, 'fev1/fvc': {'59328004': 'Forced expired volume in 1 second ', '50834005': 'Forced vital capacity '}, '<0 5': {'260304006': '0.5 '}, 'total lung capacity': {'57566009': 'Total lung capacity '}, '< 70% of the normal value': {'260395002': 'Normal range '}}
{'severe lung disease': {'24484000': ('qualifier value', 'Severe ', ['272396007']), '19829001': ('clinical finding', 'Disorder of lung ', ['64572001', '118234003'])}, 'fev1/fvc': {'59328004': ('observable entity', 'Forced expired volume in 1 second ', ['363788007']), '50834005': ('observable entity', 'Forced vital capacity ', ['363788007'])}, 'total lung capacity': {'57566009': ('observable entity', 'Total lung capacity ', ['363788007'])}}

1463072
significant diminished mental capacity that is unable to understand the protocol, surveys and questionnaires; unable to read/write english or spanish.
significant diminished mental capacity that understand the protocol, surveys and questionnaires; read/write english or spanish.
['significant diminished mental capacity', 'understand', 'the protocol,']
{'significant diminished mental capacity': {'386134007': 'Significant ', '1250004': 'Decreased '}, 'understand': {'66216009': 'Understanding, function '}, 'the protocol,': {'258049002': 'Protocols '}}
{'understand': {'66216009': ('observable entity', 'Understanding, function ', ['246464006'])}}

1463579
previous bone marrow transplant.
, bone marrow transplant.
['bone marrow transplant']
{'bone marrow transplant': {'23719005': 'Transplantation of bone marrow '}}
{'bone marrow transplant': {'23719005': ('procedure', 'Transplantation of bone marrow ', ['362958002', '128927009'])}}

1464931
other serious medical illness likely to interfere with study participation or with the ability to complete the trial by the judgment of the investigator.
other serious medical illness likely to interfere with study participation or with the complete the trial by the judgment of the investigator.
['other serious medical illness', 'likely', 'to', 'interfere with study participation', 'complete', 'the trial by the judgment of the investigator']
{'other serious medical illness': {'42745003': 'Serious ', '373655009': 'Medical service ', '39104002': 'Illness ', '74188005': 'Medical '}, 'likely': {'2931005': 'Probable diagnosis ', '452201000124102': 'probable diagnosis'}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'interfere with study participation': {'78235001': 'Interferes with ', '224699009': 'Study '}, 'complete': {'255594003': 'Complete '}, 'the trial by the judgment of the investigator': {'110465008': 'Clinical trial ', '61254005': 'Judgement '}}
{'other serious medical illness': {'42745003': ('qualifier value', 'Serious ', ['272099008']), '39104002': ('clinical finding', 'Illness ', ['250171008']), '74188005': ('qualifier value', 'Medical ', ['272099008'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'complete': {'255594003': ('qualifier value', 'Complete ', ['272099008'])}, 'the trial by the judgment of the investigator': {'61254005': ('observable entity', 'Judgement ', ['363788007'])}}

1472957
subject has facial hair that could interfere with the study assessments in the opinion of the investigator.
subject has facial hair .
['facial hair']
{'facial hair': {'62961004': 'Structure of hair of face '}}
{}

1476708
pregnant females or lactating females.
pregnant females or lactating females.
['pregnant females', 'lactating females']
{'pregnant females': {'255409004': 'Pregnant woman '}, 'lactating females': {'83036002': 'Lactate ', '1086007': 'Female structure ', '248152002': 'Female '}}
{'pregnant females': {'255409004': ('person', 'Pregnant woman ', ['133936004'])}, 'lactating females': {'83036002': ('product', 'Lactate ', ['312413002']), '248152002': ('clinical finding', 'Female ', ['365860008'])}}

1490355
significant heart failure
significant heart failure
['significant heart failure']
{'significant heart failure': {'386134007': 'Significant ', '84114007': 'Heart failure ', '42343007': 'Congestive heart failure '}}
{'significant heart failure': {'84114007': ('clinical finding', 'Heart failure ', ['64572001', '118234003']), '42343007': ('clinical finding', 'Congestive heart failure ', ['64572001', '118234003', '84114007'])}}

1493631
inability of subject to understand and sign the icf;
inability of subject to understand and sign the icf;
['understand', 'sign']
{'understand': {'66216009': 'Understanding, function '}, 'sign': {'72670004': 'Sign '}}
{'understand': {'66216009': ('observable entity', 'Understanding, function ', ['246464006'])}, 'sign': {'72670004': ('clinical finding', 'Sign ', ['250171008'])}}

1493785
subject engaged in unprotected intercourse with > 2 persons in the previous 6 months
subject engaged in unprotected intercourse with > 2 persons in the , 6 months
['engaged in unprotected intercourse', '> 2 persons in the', '6 months']
{'engaged in unprotected intercourse': {'54986009': 'Engaged to be married ', '2314005': 'Unprotected sexual intercourse '}, '> 2 persons in the': {'260306008': 'Integer +2 ', '125676002': 'Person '}, '6 months': {'258706009': 'month '}}
{'engaged in unprotected intercourse': {'54986009': ('clinical finding', 'Engaged to be married ', ['118240005', '250171008']), '2314005': ('clinical finding', 'Unprotected sexual intercourse ', ['250171008'])}, '6 months': {'258706009': ('unit', 'month ', ['767524001'])}}

1496000
on therapy with a drug that would affect collagen synthesis
on therapy with a drug
['on therapy with a drug']
{'on therapy with a drug': {'420771004': 'Upon - dosing instruction fragment ', '416608005': 'Drug therapy ', '420862001': 'On '}}
{'on therapy with a drug': {'416608005': ('procedure', 'Drug therapy ', ['128927009']), '420862001': ('qualifier value', 'On ', ['272099008'])}}

1509456
concurrent participation in any another study for people with dementia/carers
concurrent participation in any another study for people with dementia/carers
['concurrent participation in any', 'study for people', 'with dementia/carers']
{'concurrent participation in any': {'68405009': 'Concurrent '}, 'study for people': {'224699009': 'Study ', '125676002': 'Person '}, 'with dementia/carers': {'12348006': 'Presenile dementia ', '133932002': 'Caregiver ', '229774002': 'Carer ', '52448006': 'Dementia '}}
{'concurrent participation in any': {'68405009': ('qualifier value', 'Concurrent ', ['272099008'])}, 'with dementia/carers': {'12348006': ('clinical finding', 'Presenile dementia ', ['64572001', '118234003', '52448006']), '52448006': ('clinical finding', 'Dementia ', ['64572001', '118234003'])}}

1514135
evidence or symptoms consistent with autonomic dysfunction as defined in the protocol
evidence or symptoms consistent with autonomic dysfunction as defined in the protocol
['consistent with autonomic dysfunction', 'defined in the protocol']
{'consistent with autonomic dysfunction': {'385433004': 'Consistent with ', '15241006': 'Disorder of autonomic nervous system ', '7883008': 'compatible'}, 'defined in the protocol': {'900000000000073002': 'sufficiently defined concept definition status ', '258049002': 'Protocols '}}
{'consistent with autonomic dysfunction': {'15241006': ('clinical finding', 'Disorder of autonomic nervous system ', ['64572001', '118234003'])}}

1515923
current participation in any clinical trial or any other non-interventional study of a drug or device
current participation in any clinical trial or any other non-interventional study of a drug or device
['current participation in any clinical trial', 'any other non interventional study of a drug', 'device']
{'current participation in any clinical trial': {'15240007': 'Current ', '110465008': 'Clinical trial '}, 'any other non interventional study of a drug': {'71388002': 'Procedure ', '185922005': 'Clinical drug trial '}, 'device': {'303607000': 'Biomedical equipment ', '63653004': 'Biomedical device ', '49062001': 'Device '}}
{}

1520037
rheumatoid arthritis, evidence/suspicion of infectious/septic arthritis, or other acute inflammatory arthritis
rheumatoid arthritis, evidence/suspicion of infectious/septic arthritis, or other acute inflammatory arthritis
['rheumatoid arthritis,', 'evidence/suspicion of infectious/septic arthritis,', 'other acute inflammatory arthritis']
{'rheumatoid arthritis,': {'69896004': 'Rheumatoid arthritis '}, 'evidence/suspicion of infectious/septic arthritis,': {'18669006': 'Evidence of ', '706876006': 'Suspicion ', '372939007': 'Suppurative arthritis ', '396234004': 'Infective arthritis ', '91302008': 'Sepsis '}, 'other acute inflammatory arthritis': {'11939005': 'Acute arthritis '}}
{'rheumatoid arthritis,': {'69896004': ('clinical finding', 'Rheumatoid arthritis ', ['64572001', '118234003'])}, 'evidence/suspicion of infectious/septic arthritis,': {'706876006': ('clinical finding', 'Suspicion ', ['250171008']), '372939007': ('clinical finding', 'Suppurative arthritis ', ['64572001', '118234003']), '396234004': ('clinical finding', 'Infective arthritis ', ['64572001', '118234003']), '91302008': ('clinical finding', 'Sepsis ', ['64572001'])}, 'other acute inflammatory arthritis': {'11939005': ('clinical finding', 'Acute arthritis ', ['64572001', '118234003'])}}

1528758
sexually active individuals capable of becoming pregnant or causing a pregnancy who are unable or unwilling to use appropriate contraceptives.
sexually active individuals capable of becoming pregnant or causing a pregnancy who are unable or unwilling to use appropriate contraceptives.
['sexually active individuals', 'pregnant', 'causing', 'a pregnancy', 'unable', 'unwilling', 'to', 'use', 'appropriate contraceptives']
{'sexually active individuals': {'228453005': 'Sexually active ', '125676002': 'Person ', '385435006': 'Individual '}, 'pregnant': {'77386006': 'Patient currently pregnant ', '127362006': 'Previous pregnancies ', '161732006': 'Gravida ', '364323006': 'Quantity of pregnancy ', '366321006': 'Finding of gravida '}, 'causing': {'23981006': 'causing'}, 'a pregnancy': {'289908002': 'Pregnancy, function ', '77386006': 'Patient currently pregnant '}, 'unable': {'289001005': 'Unable to feed self ', '371151008': 'Unable '}, 'unwilling': {'225465005': 'Unwilling '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'use': {'277889008': 'usage', '419385000': 'Use - dosing instruction imperative '}, 'appropriate contraceptives': {'108899006': 'Contraceptives '}}
{'sexually active individuals': {'228453005': ('clinical finding', 'Sexually active ', ['250171008'])}, 'pregnant': {'77386006': ('clinical finding', 'Patient currently pregnant ', ['250171008']), '127362006': ('clinical finding', 'Previous pregnancies ', ['250171008']), '161732006': ('observable entity', 'Gravida ', ['363788007']), '364323006': ('observable entity', 'Quantity of pregnancy ', ['363788007']), '366321006': ('clinical finding', 'Finding of gravida ', ['250171008'])}, 'a pregnancy': {'289908002': ('observable entity', 'Pregnancy, function ', ['246464006']), '77386006': ('clinical finding', 'Patient currently pregnant ', ['250171008'])}, 'unable': {'289001005': ('clinical finding', 'Unable to feed self ', ['250171008'])}, 'unwilling': {'225465005': ('clinical finding', 'Unwilling ', ['250171008'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'appropriate contraceptives': {'108899006': ('product', 'Contraceptives ', ['763158003'])}}

1537603
congenital long qt syndrome
congenital long qt syndrome
['congenital long qt syndrome']
{'congenital long qt syndrome': {'442917000': 'Congenital long QT syndrome '}}
{'congenital long qt syndrome': {'442917000': ('clinical finding', 'Congenital long QT syndrome ', ['64572001', '118234003'])}}

1539072
patient under guardianship or under judicial protection
patient under guardianship or under judicial protection
['patient under guardianship', 'or under judicial protection']
{'patient under guardianship': {'116154003': 'Patient '}, 'or under judicial protection': {'65823007': 'Protective agent '}}
{'or under judicial protection': {'65823007': ('product', 'Protective agent ', ['763158003'])}}

1539873
evidence of clinically significant immunosuppression
evidence of clinically significant immunosuppression
['evidence of clinically significant immunosuppression']
{'evidence of clinically significant immunosuppression': {'18669006': 'Evidence of ', '386134007': 'Significant ', '86553008': 'Immunosuppressive therapy ', '38013005': 'Immunosuppression '}}
{'evidence of clinically significant immunosuppression': {'38013005': ('clinical finding', 'Immunosuppression ', ['250171008'])}}

1540162
patient discomfort
patient discomfort
['patient discomfort']
{'patient discomfort': {'116154003': 'Patient ', '213257006': 'Generally unwell ', '248282002': 'Undifferentiated illness: Vague ill health ', '367391008': 'Malaise ', '247347003': 'Discomfort '}}
{'patient discomfort': {'213257006': ('clinical finding', 'Generally unwell ', ['250171008']), '248282002': ('clinical finding', 'Undifferentiated illness: Vague ill health ', ['250171008']), '367391008': ('clinical finding', 'Malaise ', ['250171008']), '247347003': ('clinical finding', 'Discomfort ', ['102957003'])}}

1553028
patients with respiratory failure, or stomach disease
patients with respiratory failure, or stomach disease
['patients with respiratory failure,', 'stomach disease']
{'patients with respiratory failure,': {'116154003': 'Patient ', '409622000': 'Respiratory failure '}, 'stomach disease': {'29384001': 'Disorder of stomach '}}
{'patients with respiratory failure,': {'409622000': ('clinical finding', 'Respiratory failure ', ['64572001', '118234003'])}, 'stomach disease': {'29384001': ('clinical finding', 'Disorder of stomach ', ['64572001', '118234003'])}}

1556213
any laboratory abnormality or condition that, in the investigator's opinion, could adversely affect the safety of the individual or impair the assessment of study results
any laboratory abnormality or condition that, in the investigator's opinion, could adversely affect the safety of the individual or impair the assessment of study results
['any laboratory abnormality', 'condition', 'affect', 'the safety of the individual', 'the assessment of study results']
{'any laboratory abnormality': {'261904005': 'Laboratory ', '263654008': 'Abnormal '}, 'condition': {'64572001': 'Disease ', '260905004': 'condition'}, 'affect': {'4065008': 'Affect, function '}, 'the safety of the individual': {'125676002': 'Person ', '385435006': 'Individual '}, 'the assessment of study results': {'129265001': 'Evaluation - action ', '386053000': 'Evaluation procedure ', '224699009': 'Study ', '394617004': 'Result '}}
{'affect': {'4065008': ('observable entity', 'Affect, function ', ['246464006'])}, 'the assessment of study results': {'386053000': ('procedure', 'Evaluation procedure ', ['128927009'])}}

1556868
absence of crt with class i indication criteria for biventricular pacing - subjects on high dose steroids or immunosuppressant therapy
absence of crt with class i indication criteria for biventricular pacing - subjects on high dose steroids or immunosuppressant therapy
['absence of crt', 'with class i indication criteria for biventricular pacing   subjects', 'on high dose steroids', 'immunosuppressant therapy']
{'absence of crt': {'2667000': 'Absent '}, 'with class i indication criteria for biventricular pacing   subjects': {'258392002': 'Class 1 ', '230165009': 'Indication of ', '410665000': 'indication of ', '410666004': 'indication of ', '74691006': 'Pacing up and down '}, 'on high dose steroids': {'261829003': 'High dose ', '112113009': 'Steroid hormone ', '116566001': 'Steroid '}, 'immunosuppressant therapy': {'86553008': 'Immunosuppressive therapy '}}
{'with class i indication criteria for biventricular pacing   subjects': {'258392002': ('qualifier value', 'Class 1 ', ['272396007']), '74691006': ('clinical finding', 'Pacing up and down ', ['250171008'])}, 'on high dose steroids': {'261829003': ('qualifier value', 'High dose ', ['272099008']), '112113009': ('product', 'Steroid hormone ', ['312413002', '116566001']), '116566001': ('product', 'Steroid ', ['312413002'])}}

1560128
history of blood coagulation pathology
, blood coagulation pathology
['blood coagulation pathology']
{'blood coagulation pathology': {'74848003': 'Hemostatic function ', '394595002': 'Pathology '}}
{'blood coagulation pathology': {'74848003': ('observable entity', 'Hemostatic function ', ['246464006'])}}

1566187
any agent for hypoglycemia, such as diazoxide or octreotide
any agent for hypoglycemia, such as diazoxide or octreotide
['any agent for hypoglycemia,', 'such as diazoxide', 'octreotide']
{'any agent for hypoglycemia,': {'312064005': 'Hypoglycemic agent '}, 'such as diazoxide': {'387328001': 'Diazoxide ', '58905004': 'Diazoxide '}, 'octreotide': {'109053000': 'Octreotide ', '126155003': 'Octreotide preparation '}}
{'any agent for hypoglycemia,': {'312064005': ('product', 'Hypoglycemic agent ', ['763158003'])}, 'such as diazoxide': {'387328001': ('product', 'Diazoxide ', ['406455002', '312413002']), '58905004': ('product', 'Diazoxide ', ['763158003'])}, 'octreotide': {'109053000': ('product', 'Octreotide ', ['406455002', '312413002']), '126155003': ('product', 'Octreotide preparation ', ['763158003'])}}

1580241
contraindication for pneumoperitoneum
contraindication for pneumoperitoneum
['contraindication for pneumoperitoneum']
{'contraindication for pneumoperitoneum': {'103306004': 'Contraindication to ', '17204006': 'Pneumoperitoneum ', '168819002': 'Pneumoperitoneum - abdomen ', '449182000': 'Injection of air into peritoneal cavity ', '64941009': 'Surgical pneumoperitoneum by injection ', '397745006': 'Medical contraindication '}}
{'contraindication for pneumoperitoneum': {'17204006': ('clinical finding', 'Pneumoperitoneum ', ['64572001', '118234003']), '168819002': ('procedure', 'Pneumoperitoneum - abdomen ', ['64941009', '362958002', '128927009']), '449182000': ('procedure', 'Injection of air into peritoneal cavity ', ['362958002', '128927009']), '64941009': ('procedure', 'Surgical pneumoperitoneum by injection ', ['362958002', '128927009']), '397745006': ('clinical finding', 'Medical contraindication ', ['250171008'])}}

1587376
ages 18-65, based on the usual ages of patients seen in the adult neurology services who are not likely to suffer from the exclusions , plus:
, , based on the usual ages of patients seen in the adult neurology services who are not likely to suffer from the exclusions , plus:
['based on the usual ages of patients', 'seen in the adult neurology services', 'not likely', 'to', 'suffer from the exclusions ,', 'plus']
{'based on the usual ages of patients': {'63813000': 'Alkali ', '397669002': 'Age ', '424144002': 'Current chronological age ', '116154003': 'Patient '}, 'seen in the adult neurology services': {'133936004': 'Adult ', '310057003': 'Neurology service ', '3591000175103': 'neurology service'}, 'not likely': {'2931005': 'Probable diagnosis ', '452201000124102': 'probable diagnosis'}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'suffer from the exclusions ,': {'706873003': 'Suffering '}, 'plus': {'20401003': 'in addition to'}}
{'based on the usual ages of patients': {'63813000': ('product', 'Alkali ', ['312413002']), '397669002': ('qualifier value', 'Age ', ['272099008']), '424144002': ('observable entity', 'Current chronological age ', ['105727008'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'suffer from the exclusions ,': {'706873003': ('clinical finding', 'Suffering ', ['365860008'])}}

1602392
current pregnancy or lactating or planning to get pregnant
current pregnancy or lactating or planning to get pregnant
['current pregnancy', 'lactating', 'planning', 'to', 'pregnant']
{'current pregnancy': {'15240007': 'Current ', '289908002': 'Pregnancy, function ', '77386006': 'Patient currently pregnant '}, 'lactating': {'83036002': 'Lactate '}, 'planning': {'312011006': 'Cognitive function: planning ', '397943006': 'Planned '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'pregnant': {'77386006': 'Patient currently pregnant ', '127362006': 'Previous pregnancies ', '161732006': 'Gravida ', '364323006': 'Quantity of pregnancy ', '366321006': 'Finding of gravida '}}
{'current pregnancy': {'289908002': ('observable entity', 'Pregnancy, function ', ['246464006']), '77386006': ('clinical finding', 'Patient currently pregnant ', ['250171008'])}, 'lactating': {'83036002': ('product', 'Lactate ', ['312413002'])}, 'planning': {'312011006': ('observable entity', 'Cognitive function: planning ', ['246464006'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'pregnant': {'77386006': ('clinical finding', 'Patient currently pregnant ', ['250171008']), '127362006': ('clinical finding', 'Previous pregnancies ', ['250171008']), '161732006': ('observable entity', 'Gravida ', ['363788007']), '364323006': ('observable entity', 'Quantity of pregnancy ', ['363788007']), '366321006': ('clinical finding', 'Finding of gravida ', ['250171008'])}}

1636740
uveitis limited to only the anterior segment of the study eye.
uveitis limited to only the anterior segment of the study eye.
['uveitis', 'limited', 'to only', 'the anterior segment of the study eye']
{'uveitis': {'128473001': 'Uveitis '}, 'limited': {'255469002': 'Limited ', '900000000000486000': 'limited component '}, 'to only': {'223570002': 'Togo ', '50607009': 'Singular ', '420295001': 'Only - dosing instruction fragment ', '9986007': 'Tryptophanase '}, 'the anterior segment of the study eye': {'32259006': 'Anterior eyeball segment structure ', '224699009': 'Study '}}
{'uveitis': {'128473001': ('clinical finding', 'Uveitis ', ['64572001', '118234003'])}, 'limited': {'255469002': ('qualifier value', 'Limited ', ['272099008'])}, 'to only': {'50607009': ('qualifier value', 'Singular ', ['272099008']), '9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}}

1639530
diseases requiring anticoagulant treatment
diseases requiring anticoagulant treatment
['diseases', 'anticoagulant treatment']
{'diseases': {'64572001': 'Disease '}, 'anticoagulant treatment': {'372862008': 'Anticoagulant ', '81839001': 'Anticoagulant ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '416118004': 'Administration '}}
{'anticoagulant treatment': {'81839001': ('product', 'Anticoagulant ', ['763158003']), '276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '416118004': ('procedure', 'Administration ', ['128927009'])}}

1641671
suspected contraindication or hypersensitivity to study medications tafluprost or timolol or to wash-out medication brinzolamide
suspected contraindication or hypersensitivity to study medications tafluprost or timolol or to wash-out medication brinzolamide
['suspected contraindication', 'hypersensitivity', 'to', 'study', 'medications tafluprost', 'timolol', 'or to wash out medication brinzolamide']
{'suspected contraindication': {'103306004': 'Contraindication to ', '397745006': 'Medical contraindication ', '415684004': 'Suspected '}, 'hypersensitivity': {'418634005': 'Allergic reaction caused by substance ', '421961002': 'Hypersensitivity reaction ', '421369008': 'Emotional hypersensitivity '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'study': {'224699009': 'Study '}, 'medications tafluprost': {'105903003': 'General drug type ', '373873005': 'Pharmaceutical / biologic product ', '410942007': 'Drug or medicament ', '699181001': 'Tafluprost ', '704470009': 'Tafluprost '}, 'timolol': {'372880004': 'Timolol ', '85591001': 'Timolol '}, 'or to wash out medication brinzolamide': {'255529000': 'Out ', '105903003': 'General drug type ', '373873005': 'Pharmaceutical / biologic product ', '410942007': 'Drug or medicament ', '108836002': 'Brinzolamide ', '386925003': 'Brinzolamide '}}
{'suspected contraindication': {'397745006': ('clinical finding', 'Medical contraindication ', ['250171008'])}, 'hypersensitivity': {'418634005': ('clinical finding', 'Allergic reaction caused by substance ', ['64572001', '421961002']), '421961002': ('clinical finding', 'Hypersensitivity reaction ', ['64572001']), '421369008': ('clinical finding', 'Emotional hypersensitivity ', ['250171008'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'medications tafluprost': {'699181001': ('product', 'Tafluprost ', ['406455002', '312413002', '410942007', '115668003']), '704470009': ('product', 'Tafluprost ', ['373873005', '763158003'])}, 'timolol': {'372880004': ('product', 'Timolol ', ['406455002', '410942007', '312413002']), '85591001': ('product', 'Timolol ', ['373873005', '763158003'])}, 'or to wash out medication brinzolamide': {'255529000': ('qualifier value', 'Out ', ['272099008']), '108836002': ('product', 'Brinzolamide ', ['373873005', '763158003']), '386925003': ('product', 'Brinzolamide ', ['406455002', '312413002'])}}

1657626
parent/s or guardian of subject unable to maintain diary card
parent/s or guardian of subject maintain diary card
['parent/s', 'guardian of subject', 'diary card']
{'parent/s': {'160503002': 'Parent of ', '40683002': 'Parent '}, 'guardian of subject': {'58626002': 'Legal guardian ', '394619001': 'Guardian '}, 'diary card': {'39179006': 'Disorder of sexual differentiation '}}
{'parent/s': {'160503002': ('observable entity', 'Parent of ', ['160476009'])}, 'diary card': {'39179006': ('clinical finding', 'Disorder of sexual differentiation ', ['64572001', '118234003'])}}

1661652
chronic pancreatitis
chronic pancreatitis
['chronic pancreatitis']
{'chronic pancreatitis': {'233870001': 'Recurrent pancreatitis ', '234689009': 'Relapsing pancreatitis ', '235494005': 'Chronic pancreatitis ', '235956004': 'Familial chronic pancreatitis ', '68072000': 'Hereditary pancreatitis '}}
{'chronic pancreatitis': {'233870001': ('clinical finding', 'Recurrent pancreatitis ', ['64572001', '118234003']), '234689009': ('clinical finding', 'Relapsing pancreatitis ', ['64572001', '118234003', '235494005']), '235494005': ('clinical finding', 'Chronic pancreatitis ', ['64572001', '118234003']), '235956004': ('clinical finding', 'Familial chronic pancreatitis ', ['64572001', '68072000', '118234003', '235494005']), '68072000': ('clinical finding', 'Hereditary pancreatitis ', ['64572001', '118234003'])}}

1668490
cardiac arrhythmia requiring medical therapy
cardiac arrhythmia requiring medical therapy
['cardiac arrhythmia', 'medical therapy']
{'cardiac arrhythmia': {'698247007': 'Cardiac arrhythmia ', '44808001': 'Conduction disorder of the heart '}, 'medical therapy': {'243121000': 'Medical therapy '}}
{'cardiac arrhythmia': {'698247007': ('clinical finding', 'Cardiac arrhythmia ', ['64572001', '118234003']), '44808001': ('clinical finding', 'Conduction disorder of the heart ', ['64572001', '698247007', '118234003'])}}

1685202
subject has an acute psychiatric disorder or is cognitively impaired.
subject has an acute psychiatric disorder or is cognitively impaired.
['an acute psychiatric disorder', 'impaired']
{'an acute psychiatric disorder': {'2704003': 'Acute disease ', '27296002': 'Psychiatric ', '272118002': 'Acuteness ', '74732009': 'Mental disorder '}, 'impaired': {'260379002': 'Impaired '}}
{'an acute psychiatric disorder': {'2704003': ('clinical finding', 'Acute disease ', ['64572001']), '27296002': ('qualifier value', 'Psychiatric ', ['272099008']), '272118002': ('qualifier value', 'Acuteness ', ['272099008']), '74732009': ('clinical finding', 'Mental disorder ', ['64572001'])}}

1690294
no diagnosis of gastroparesis.
gastroparesis.
['gastroparesis']
{'gastroparesis': {'196753007': 'Gastric atonia ', '235675006': 'Gastroparesis '}}
{'gastroparesis': {'196753007': ('clinical finding', 'Gastric atonia ', ['64572001', '118234003']), '235675006': ('clinical finding', 'Gastroparesis ', ['64572001', '118234003'])}}

1694914
triglycerides > 400 mg/dl
triglycerides > 400 mg/dl
['triglycerides', '> 400 mg/dl']
{'triglycerides': {'85600001': 'Triacylglycerol '}, '> 400 mg/dl': {'732733003': '400', '258797006': 'Milligram/deciliter '}}
{'triglycerides': {'85600001': ('product', 'Triacylglycerol ', ['312413002', '312412007'])}, '> 400 mg/dl': {'258797006': ('unit', 'Milligram/deciliter ', ['767524001'])}}

1695802
participants with peripheral sensory neuropathies with impaired functional activities
participants with peripheral sensory neuropathies with impaired functional activities
['participants with peripheral sensory neuropathies', 'with impaired functional activities']
{'participants with peripheral sensory neuropathies': {'95662005': 'Sensory neuropathy '}, 'with impaired functional activities': {'260379002': 'Impaired ', '40143009': 'Functional ', '257733005': 'Activity ', '246464006': 'Function ', '277064003': 'function'}}
{'participants with peripheral sensory neuropathies': {'95662005': ('clinical finding', 'Sensory neuropathy ', ['64572001', '118234003'])}, 'with impaired functional activities': {'40143009': ('qualifier value', 'Functional ', ['272099008'])}}

1706049-1
history of an ongoing, chronic or recurrent infectious disease including recurrent respiratory tract and/or urinary tract infections or evidence of tuberculosis infection as defined by a positive quantiferon tb-gold test at screening.
, an ongoing, chronic or recurrent infectious disease including recurrent respiratory tract and/or urinary tract infections or evidence of tuberculosis infection as defined by a positive quantiferon tb-gold test at screening.
['an ongoing, chronic', 'recurrent infectious disease', 'including', 'recurrent respiratory tract', 'urinary tract infections', 'evidence of tuberculosis infection', 'defined by a positive quantiferon tb gold test', 'at screening']
{'an ongoing, chronic': {'255238004': 'Continuous ', '90734009': 'Chronic '}, 'recurrent infectious disease': {'451991000124106': 'recurrent infections'}, 'including': {'55919000': 'Including '}, 'recurrent respiratory tract': {'278499009': 'Episodic ', '20139000': 'Structure of respiratory system ', '321667001': 'Respiratory tract structure ', '255227004': 'Recurrent '}, 'urinary tract infections': {'68566005': 'Urinary tract infectious disease ', '197927001': 'Recurrent urinary tract infection '}, 'evidence of tuberculosis infection': {'18669006': 'Evidence of ', '371569005': 'Tuberculous ', '373576009': 'Infection caused by Mycobacterium tuberculosis ', '56717001': 'Tuberculosis ', '11999007': 'Inactive tuberculosis '}, 'defined by a positive quantiferon tb gold test': {'900000000000073002': 'sufficiently defined concept definition status ', '258758003': '% positive cells ', '2309006': 'Gold ', '108252007': 'Laboratory procedure ', '15220000': 'Laboratory test ', '269814003': 'Laboratory procedures -general ', '272393004': 'Tests ', '277775005': 'Test finding ', '371256005': 'Gold color ', '10828004': 'Positive '}, 'at screening': {'20135006': 'Screening procedure '}}
{'an ongoing, chronic': {'255238004': ('qualifier value', 'Continuous ', ['272099008']), '90734009': ('qualifier value', 'Chronic ', ['272099008'])}, 'recurrent infectious disease': {'451991000124106': ('clinical finding', 'recurrent infections', ['64572001'])}, 'including': {'55919000': ('qualifier value', 'Including ', ['272099008'])}, 'recurrent respiratory tract': {'278499009': ('qualifier value', 'Episodic ', ['272099008', '90734009']), '255227004': ('qualifier value', 'Recurrent ', ['272099008', '90734009'])}, 'urinary tract infections': {'68566005': ('clinical finding', 'Urinary tract infectious disease ', ['64572001', '118234003']), '197927001': ('clinical finding', 'Recurrent urinary tract infection ', ['451991000124106', '64572001', '118234003', '68566005'])}, 'evidence of tuberculosis infection': {'371569005': ('qualifier value', 'Tuberculous ', ['272099008']), '373576009': ('clinical finding', 'Infection caused by Mycobacterium tuberculosis ', ['64572001', '56717001']), '56717001': ('clinical finding', 'Tuberculosis ', ['64572001']), '11999007': ('clinical finding', 'Inactive tuberculosis ', ['64572001', '56717001'])}, 'defined by a positive quantiferon tb gold test': {'258758003': ('unit', '% positive cells ', ['767524001']), '2309006': ('product', 'Gold ', ['406455002', '312413002']), '15220000': ('procedure', 'Laboratory test ', ['128927009', '108252007']), '269814003': ('situation with explicit context', 'Laboratory procedures -general ', ['129125009']), '371256005': ('qualifier value', 'Gold color ', ['272099008']), '10828004': ('qualifier value', 'Positive ', ['272099008'])}, 'at screening': {'20135006': ('procedure', 'Screening procedure ', ['128927009'])}}

1706049-2
subjects with a positive quantiferon or indeterminate quantiferon tb-gold test may participate in the study if further full tuberculosis work up completed >= 12 weeks prior to first study drug administration establishes conclusively that the subject has no evidence of active tuberculosis.
subjects with a positive quantiferon or indeterminate quantiferon tb-gold test may participate in the study if further full tuberculosis work up completed >= 12 weeks prior to first study drug administration establishes conclusively .
['subjects with a positive quantiferon', 'indeterminate quantiferon tb gold test', 'participate in the study', 'further full tuberculosis work up', 'completed', '= 12 weeks prior to first study drug administration', 'establishes']
{'subjects with a positive quantiferon': {'258758003': '% positive cells ', '10828004': 'Positive '}, 'indeterminate quantiferon tb gold test': {'82334004': 'Indeterminate ', '2309006': 'Gold ', '108252007': 'Laboratory procedure ', '15220000': 'Laboratory test ', '269814003': 'Laboratory procedures -general ', '272393004': 'Tests ', '277775005': 'Test finding ', '371256005': 'Gold color '}, 'participate in the study': {'224699009': 'Study '}, 'further full tuberculosis work up': {'46053002': 'Distal ', '261015003': 'Full ', '371569005': 'Tuberculous ', '373576009': 'Infection caused by Mycobacterium tuberculosis ', '56717001': 'Tuberculosis ', '261041009': 'Working, function '}, 'completed': {'255594003': 'Complete '}, '= 12 weeks prior to first study drug administration': {'258705008': 'week ', '236874000': 'Status pre- ', '288556008': 'before', '255216001': 'First ', '185922005': 'Clinical drug trial ', '413454004': 'Administration ', '416118004': 'Administration ', '224699009': 'Study ', '182832007': 'Procedure related to management of drug administration ', '18629005': 'Administration of drug or medicament ', '232714002': 'Firstly '}, 'establishes': {'263748003': 'Established '}}
{'subjects with a positive quantiferon': {'258758003': ('unit', '% positive cells ', ['767524001']), '10828004': ('qualifier value', 'Positive ', ['272099008'])}, 'indeterminate quantiferon tb gold test': {'82334004': ('qualifier value', 'Indeterminate ', ['272099008']), '2309006': ('product', 'Gold ', ['406455002', '312413002']), '15220000': ('procedure', 'Laboratory test ', ['128927009', '108252007']), '269814003': ('situation with explicit context', 'Laboratory procedures -general ', ['129125009']), '371256005': ('qualifier value', 'Gold color ', ['272099008'])}, 'further full tuberculosis work up': {'46053002': ('qualifier value', 'Distal ', ['272099008']), '261015003': ('qualifier value', 'Full ', ['272099008']), '371569005': ('qualifier value', 'Tuberculous ', ['272099008']), '373576009': ('clinical finding', 'Infection caused by Mycobacterium tuberculosis ', ['64572001', '56717001']), '56717001': ('clinical finding', 'Tuberculosis ', ['64572001']), '261041009': ('observable entity', 'Working, function ', ['246464006'])}, 'completed': {'255594003': ('qualifier value', 'Complete ', ['272099008'])}, '= 12 weeks prior to first study drug administration': {'258705008': ('unit', 'week ', ['767524001']), '416118004': ('procedure', 'Administration ', ['128927009']), '182832007': ('procedure', 'Procedure related to management of drug administration ', ['128927009', '408766003']), '18629005': ('procedure', 'Administration of drug or medicament ', ['128927009']), '232714002': ('qualifier value', 'Firstly ', ['272099008'])}, 'establishes': {'263748003': ('qualifier value', 'Established ', ['272099008'])}}

1706049-3
if presence of latent tuberculosis is established, then treatment must have been initiated and maintained according to local country guidelines for >= 4 weeks prior to screening.
if presence of latent tuberculosis is established, then treatment must have been initiated and maintained according to local country guidelines for >= 4 weeks prior to screening.
['presence of latent tuberculosis', 'established', 'then treatment', 'maintained according to local country guidelines', '= 4 weeks prior to screening']
{'presence of latent tuberculosis': {'52101004': 'Present ', '11999007': 'Inactive tuberculosis '}, 'established': {'263748003': 'Established ', '385645004': 'Accepted '}, 'then treatment': {'276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '416118004': 'Administration '}, 'maintained according to local country guidelines': {'385630006': 'Maintained ', '255470001': 'Local ', '223369002': 'Country '}, '= 4 weeks prior to screening': {'260300002': '-4 ', '258705008': 'week ', '236874000': 'Status pre- ', '288556008': 'before', '20135006': 'Screening procedure '}}
{'presence of latent tuberculosis': {'11999007': ('clinical finding', 'Inactive tuberculosis ', ['64572001'])}, 'established': {'263748003': ('qualifier value', 'Established ', ['272099008'])}, 'then treatment': {'276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '416118004': ('procedure', 'Administration ', ['128927009'])}, 'maintained according to local country guidelines': {'255470001': ('qualifier value', 'Local ', ['272099008'])}, '= 4 weeks prior to screening': {'258705008': ('unit', 'week ', ['767524001']), '20135006': ('procedure', 'Screening procedure ', ['128927009'])}}

1709201
clinically important active infections or infestations, chronic, recurrent infections or latent infections or infestations
clinically important active infections or infestations, chronic, recurrent infections or latent infections or infestations
['clinically important active infections', 'chronic,', 'recurrent infections', 'latent infections']
{'clinically important active infections': {'55561003': 'Active '}, 'chronic,': {'90734009': 'Chronic '}, 'recurrent infections': {'451991000124106': 'recurrent infections'}, 'latent infections': {'44104002': 'Latent '}}
{'clinically important active infections': {'55561003': ('qualifier value', 'Active ', ['272099008'])}, 'chronic,': {'90734009': ('qualifier value', 'Chronic ', ['272099008'])}, 'recurrent infections': {'451991000124106': ('clinical finding', 'recurrent infections', ['64572001'])}, 'latent infections': {'44104002': ('qualifier value', 'Latent ', ['272099008'])}}

1713074
prior use or current use of systemic anti-vascular endothelial growth factor inhibitors, cytokines or mechanistic target of rapamycin inhibitors .
prior use or current use of systemic anti-vascular endothelial growth factor inhibitors, cytokines or mechanistic target of rapamycin inhibitors .
['prior use', 'current use of systemic anti vascular endothelial growth factor inhibitors', 'cytokines', 'mechanistic target of rapamycin inhibitors']
{'prior use': {'236874000': 'Status pre- ', '288556008': 'before', '277889008': 'usage', '419385000': 'Use - dosing instruction imperative '}, 'current use of systemic anti vascular endothelial growth factor inhibitors': {'15240007': 'Current ', '260676000': 'use of', '31099001': 'Systemic ', '59820001': 'Blood vessel structure ', '27168002': 'Endothelium ', '81286007': 'Growth factor '}, 'cytokines': {'75777003': 'Cytokine '}, 'mechanistic target of rapamycin inhibitors': {'257544000': 'Mechanisms ', '278109006': 'mechanism ', '116109004': 'Sirolimus ', '387014003': 'Sirolimus '}}
{'current use of systemic anti vascular endothelial growth factor inhibitors': {'31099001': ('qualifier value', 'Systemic ', ['272099008']), '81286007': ('product', 'Growth factor ', ['115668003'])}, 'cytokines': {'75777003': ('product', 'Cytokine ', ['312413002', '115668003'])}, 'mechanistic target of rapamycin inhibitors': {'116109004': ('product', 'Sirolimus ', ['763158003']), '387014003': ('product', 'Sirolimus ', ['406455002', '312413002', '312412007'])}}

1716293
currently receiving any other investigational agents or having participated in an investigational therapy trial within 30 days.
currently receiving any other investigational agents or having participated in an investigational therapy trial , .
['currently', 'any other investigational agents', 'participated in an investigational therapy trial']
{'currently': {'15240007': 'Current '}, 'any other investigational agents': {'129265001': 'Evaluation - action ', '386053000': 'Evaluation procedure ', '260872001': 'agent'}, 'participated in an investigational therapy trial': {'129265001': 'Evaluation - action ', '386053000': 'Evaluation procedure ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '110465008': 'Clinical trial '}}
{'any other investigational agents': {'386053000': ('procedure', 'Evaluation procedure ', ['128927009'])}, 'participated in an investigational therapy trial': {'386053000': ('procedure', 'Evaluation procedure ', ['128927009']), '276239002': ('procedure', 'Therapy ', ['277132007', '243120004'])}}

1719166
other malignancy within the last 3 years
other malignancy ,
['other malignancy']
{'other malignancy': {'363346000': 'Malignant neoplastic disease ', '372087000': 'Primary malignant neoplasm ', '86049000': 'Malignant neoplasm, primary '}}
{'other malignancy': {'363346000': ('clinical finding', 'Malignant neoplastic disease ', ['64572001']), '372087000': ('clinical finding', 'Primary malignant neoplasm ', ['64572001', '363346000'])}}

1722000
refusal by a patient to do the pca
refusal by a patient to do the pca
['refusal by a patient to do']
{'refusal by a patient to do': {'116154003': 'Patient '}}
{}

1722204
immunosuppressants or biphosphonates
immunosuppressants or biphosphonates
['immunosuppressants', 'biphosphonates']
{'immunosuppressants': {'372823004': 'Immunosuppressant ', '69431002': 'Immunosuppressant '}, 'biphosphonates': {'372907000': 'Diphosphonate ', '96281001': 'Diphosphonate '}}
{'immunosuppressants': {'69431002': ('product', 'Immunosuppressant ', ['763158003'])}, 'biphosphonates': {'372907000': ('product', 'Diphosphonate ', ['406455002', '312413002']), '96281001': ('product', 'Diphosphonate ', ['763158003'])}}

1732294
investigational biologics
investigational biologics
['investigational biologics']
{'investigational biologics': {'129265001': 'Evaluation - action ', '386053000': 'Evaluation procedure ', '115668003': 'Biological substance ', '418980009': 'Biological agent ', '69509008': 'Biological agent '}}
{'investigational biologics': {'386053000': ('procedure', 'Evaluation procedure ', ['128927009'])}}

1735915
excluded:
excluded:
['excluded']
{'excluded': {'77765009': 'Exclude '}}
{'excluded': {'77765009': ('qualifier value', 'Exclude ', ['272099008'])}}

1739291
oral magnesium or parenteral magnesium and calcium supplementation.
oral magnesium or parenteral magnesium and calcium supplementation.
['oral magnesium', 'parenteral magnesium', 'calcium supplementation']
{'oral magnesium': {'260548002': 'Oral ', '72717003': 'Magnesium '}, 'parenteral magnesium': {'25156005': 'Intravenous feeding of patient ', '72717003': 'Magnesium '}, 'calcium supplementation': {'438841000124104': 'calcium supplement therapy'}}
{'oral magnesium': {'72717003': ('product', 'Magnesium ', ['115668003', '312413002'])}, 'parenteral magnesium': {'25156005': ('procedure', 'Intravenous feeding of patient ', ['243120004']), '72717003': ('product', 'Magnesium ', ['115668003', '312413002'])}, 'calcium supplementation': {'438841000124104': ('procedure', 'calcium supplement therapy', ['243120004'])}}

1739704
a mmse score < or = 20.
a mmse score < or = 20.
['a mmse score']
{'a mmse score': {'273617000': 'Mini-mental state examination ', '246262008': 'score', '278061009': 'Scores '}}
{'a mmse score': {'278061009': ('qualifier value', 'Scores ', ['272396007'])}}

1749333
patients will not be eligible for this study if they:
patients will not be eligible for this study if they:
['patients', 'eligible for this study']
{'patients': {'116154003': 'Patient '}, 'eligible for this study': {'224699009': 'Study '}}
{}

1751113
corneal, lens, or vitreous opacification which precludes examination of the fundi in patients with cmv retinitis.
corneal, lens, or vitreous opacification precludes examination of the fundi in patients with cmv retinitis.
['corneal, lens,', 'vitreous opacification', 'examination of the fundi', 'in patients with cmv retinitis']
{'corneal, lens,': {'28726007': 'Corneal structure ', '78076003': 'Structure of lens of eye '}, 'vitreous opacification': {'263506008': 'opacification'}, 'examination of the fundi': {'14347000': 'Structure of fundus of gallbladder '}, 'in patients with cmv retinitis': {'116154003': 'Patient ', '22455005': 'Cytomegaloviral retinitis '}}
{'in patients with cmv retinitis': {'22455005': ('clinical finding', 'Cytomegaloviral retinitis ', ['64572001', '118234003'])}}

1754560
al721.
al721.
[]
{}
{}

1757815
donation of > 500 ml of blood in the past 8 weeks prior to study drug dosing or difficulty in donating blood.
donation of > 500 ml of blood , prior to study drug dosing or difficulty in donating blood.
['donation of', '> 500 ml of blood', 'prior to study drug dosing', 'difficulty in donating blood']
{'donation of': {'449951000124101': 'patient status determination, deceased and body donated'}, '> 500 ml of blood': {'732775002': '500', '259035002': 'per milliliter ', '87612001': 'Blood ', '119273009': 'Peripheral blood '}, 'prior to study drug dosing': {'185922005': 'Clinical drug trial '}, 'difficulty in donating blood': {'371157007': 'Able with difficulty ', '160655006': 'Willing to be donor of blood '}}
{'donation of': {'449951000124101': ('clinical finding', 'patient status determination, deceased and body donated', ['250171008'])}, '> 500 ml of blood': {'259035002': ('unit', 'per milliliter ', ['767524001']), '87612001': ('product', 'Blood ', ['115669006', '115668003']), '119273009': ('product', 'Peripheral blood ', ['115669006', '87612001', '115668003'])}, 'difficulty in donating blood': {'160655006': ('clinical finding', 'Willing to be donor of blood ', ['365860008'])}}

1762945
other severe acute or chronic medical condition or psychiatric condition, or laboratory abnormality that may increase the risk associated with study participation or study drug administration or may interfere with the interpretation of study results and in the judgment of the investigator would make the patient inappropriate for entry into this study.
other severe acute or chronic medical condition or psychiatric condition, or laboratory abnormality would make the patient inappropriate for entry into this study.
['other severe acute', 'chronic medical condition', 'psychiatric condition,', 'laboratory abnormality', 'the patient', 'inappropriate for entry', 'into this study']
{'other severe acute': {'24484000': 'Severe ', '272118002': 'Acuteness '}, 'chronic medical condition': {'27624003': 'Chronic disease ', '373655009': 'Medical service ', '74188005': 'Medical '}, 'psychiatric condition,': {'74732009': 'Mental disorder '}, 'laboratory abnormality': {'261904005': 'Laboratory ', '263654008': 'Abnormal '}, 'the patient': {'116154003': 'Patient '}, 'inappropriate for entry': {'900000000000494007': 'inappropriate component '}, 'into this study': {'224699009': 'Study '}}
{'other severe acute': {'24484000': ('qualifier value', 'Severe ', ['272396007']), '272118002': ('qualifier value', 'Acuteness ', ['272099008'])}, 'chronic medical condition': {'27624003': ('clinical finding', 'Chronic disease ', ['64572001']), '74188005': ('qualifier value', 'Medical ', ['272099008'])}, 'psychiatric condition,': {'74732009': ('clinical finding', 'Mental disorder ', ['64572001'])}}

1769202
patients who need urgent shunt replacement and therefore cannot wait for the shuntcheck evaluation of shunt patency.
patients who need urgent shunt replacement and therefore cannot wait for the shuntcheck evaluation of shunt patency.
['patients', 'need', 'urgent shunt replacement', 'wait for the shuntcheck evaluation of shunt patency']
{'patients': {'116154003': 'Patient '}, 'need': {'410525008': 'Needed ', '103325001': 'Patient need for '}, 'urgent shunt replacement': {'103391001': 'Urgency ', '442119001': 'Cardiac shunt ', '129337000': 'Reimplantation - action ', '3137001': 'Reimplantation ', '373188003': 'Replacement procedure ', '282089006': 'Replacement - action ', '257351008': 'Shunt ', '125319009': 'Surgical fistula '}, 'wait for the shuntcheck evaluation of shunt patency': {'129265001': 'Evaluation - action ', '386053000': 'Evaluation procedure ', '442119001': 'Cardiac shunt ', '263505007': 'open', '434851000124108': 'open', '56116003': 'Patent ', '257351008': 'Shunt ', '125319009': 'Surgical fistula '}}
{'urgent shunt replacement': {'103391001': ('qualifier value', 'Urgency ', ['272099008']), '442119001': ('clinical finding', 'Cardiac shunt ', ['118234003']), '3137001': ('procedure', 'Reimplantation ', ['128927009']), '373188003': ('procedure', 'Replacement procedure ', ['128927009'])}, 'wait for the shuntcheck evaluation of shunt patency': {'386053000': ('procedure', 'Evaluation procedure ', ['128927009']), '442119001': ('clinical finding', 'Cardiac shunt ', ['118234003']), '434851000124108': ('qualifier value', 'open', ['272099008']), '56116003': ('qualifier value', 'Patent ', ['272099008'])}}

1770518
any patient with active cancer or a history of cancer with < 5 years disease-free survival time.
any patient with active cancer or , cancer with < 5 years disease-free survival time.
['any patient with active cancer', 'cancer with', '< 5 years disease free survival time']
{'any patient with active cancer': {'116154003': 'Patient ', '55561003': 'Active ', '363346000': 'Malignant neoplastic disease ', '372087000': 'Primary malignant neoplasm ', '86049000': 'Malignant neoplasm, primary '}, 'cancer with': {'363346000': 'Malignant neoplastic disease ', '372087000': 'Primary malignant neoplasm ', '86049000': 'Malignant neoplasm, primary '}, '< 5 years disease free survival time': {'264606005': '-5 ', '258707000': 'year ', '64572001': 'Disease ', '37837009': 'free of ', '445320007': 'Survival time ', '264706000': '>5 ', '264605009': 'Integer +5 '}}
{'any patient with active cancer': {'55561003': ('qualifier value', 'Active ', ['272099008']), '363346000': ('clinical finding', 'Malignant neoplastic disease ', ['64572001']), '372087000': ('clinical finding', 'Primary malignant neoplasm ', ['64572001', '363346000'])}, 'cancer with': {'363346000': ('clinical finding', 'Malignant neoplastic disease ', ['64572001']), '372087000': ('clinical finding', 'Primary malignant neoplasm ', ['64572001', '363346000'])}, '< 5 years disease free survival time': {'258707000': ('unit', 'year ', ['767524001']), '445320007': ('observable entity', 'Survival time ', ['363788007'])}}

1782977
diagnosis of, or receiving treatment for malignancy in the previous 5 years
diagnosis of, or receiving treatment for malignancy in the , 5 years
['diagnosis of,', 'receiving treatment for malignancy', '5 years']
{'diagnosis of,': {'439401001': 'Diagnosis '}, 'receiving treatment for malignancy': {'276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '363346000': 'Malignant neoplastic disease ', '372087000': 'Primary malignant neoplasm ', '86049000': 'Malignant neoplasm, primary ', '416118004': 'Administration '}, '5 years': {'264606005': '-5 ', '258707000': 'year ', '264706000': '>5 ', '264605009': 'Integer +5 '}}
{'receiving treatment for malignancy': {'276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '363346000': ('clinical finding', 'Malignant neoplastic disease ', ['64572001']), '372087000': ('clinical finding', 'Primary malignant neoplasm ', ['64572001', '363346000']), '416118004': ('procedure', 'Administration ', ['128927009'])}, '5 years': {'258707000': ('unit', 'year ', ['767524001'])}}

1794905
unstable medical condition;
unstable medical condition;
['unstable medical condition']
{'unstable medical condition': {'263922001': 'Unstable status ', '373655009': 'Medical service ', '64572001': 'Disease ', '260905004': 'condition', '74188005': 'Medical '}}
{'unstable medical condition': {'74188005': ('qualifier value', 'Medical ', ['272099008'])}}

1795981
pregnant women or lactating women
pregnant women or lactating women
['pregnant women', 'lactating women']
{'pregnant women': {'255409004': 'Pregnant woman '}, 'lactating women': {'83036002': 'Lactate ', '224526002': 'Woman '}}
{'pregnant women': {'255409004': ('person', 'Pregnant woman ', ['133936004', '224526002'])}, 'lactating women': {'83036002': ('product', 'Lactate ', ['312413002']), '224526002': ('person', 'Woman ', ['133936004'])}}

1801802
history of chronic narcotic use, defined as > 5mg of oxycodone q4 hours
, chronic narcotic use, defined as > 5mg of oxycodone q4 hours
['chronic narcotic use,', 'defined', '> 5mg of oxycodone q4 hours']
{'chronic narcotic use,': {'90734009': 'Chronic ', '277889008': 'usage', '419385000': 'Use - dosing instruction imperative '}, 'defined': {'900000000000073002': 'sufficiently defined concept definition status '}, '> 5mg of oxycodone q4 hours': {'414984009': 'Oxycodone ', '55452001': 'Oxycodone ', '258702006': 'hour '}}
{'chronic narcotic use,': {'90734009': ('qualifier value', 'Chronic ', ['272099008'])}, '> 5mg of oxycodone q4 hours': {'414984009': ('product', 'Oxycodone ', ['763158003']), '55452001': ('product', 'Oxycodone ', ['115668003', '312413002', '312412007']), '258702006': ('unit', 'hour ', ['767524001'])}}

1812944
subjects cannot have known heptic metastases or peritoneal metastases detected by ultrasound , ct scan, or laparotomy/laparoscopy prior to treatment.
subjects cannot have known heptic metastases or peritoneal metastases detected by ultrasound , ct scan, or laparotomy/laparoscopy prior to treatment.
['known', 'heptic metastases', 'peritoneal metastases', 'detected by ultrasound ,', 'ct scan,', 'laparotomy/laparoscopy prior to treatment']
{'known': {'36692007': 'Known '}, 'heptic metastases': {'128462008': 'Secondary malignant neoplastic disease ', '14799000': 'Neoplasm, metastatic ', '79282002': 'Carcinoma, metastatic '}, 'peritoneal metastases': {'15425007': 'Peritoneum ', '128462008': 'Secondary malignant neoplastic disease ', '14799000': 'Neoplasm, metastatic ', '79282002': 'Carcinoma, metastatic ', '264143006': 'Peritoneal '}, 'detected by ultrasound ,': {'260373001': 'Detected ', '16310003': 'Diagnostic ultrasonography ', '278292003': 'Ultrasound imaging - action '}, 'ct scan,': {'77477000': 'Computerized axial tomography '}, 'laparotomy/laparoscopy prior to treatment': {'86481000': 'Laparotomy ', '108191006': 'Abdomen endoscopy ', '73632009': 'Laparoscopy ', '236874000': 'Status pre- ', '288556008': 'before', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '416118004': 'Administration '}}
{'heptic metastases': {'128462008': ('clinical finding', 'Secondary malignant neoplastic disease ', ['64572001'])}, 'peritoneal metastases': {'128462008': ('clinical finding', 'Secondary malignant neoplastic disease ', ['64572001'])}, 'detected by ultrasound ,': {'16310003': ('procedure', 'Diagnostic ultrasonography ', ['128927009'])}, 'ct scan,': {'77477000': ('procedure', 'Computerized axial tomography ', ['128927009'])}, 'laparotomy/laparoscopy prior to treatment': {'86481000': ('procedure', 'Laparotomy ', ['362958002', '128927009']), '108191006': ('procedure', 'Abdomen endoscopy ', ['363691001', '362958002', '128927009']), '73632009': ('procedure', 'Laparoscopy ', ['108191006', '363691001', '362958002', '128927009']), '276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '416118004': ('procedure', 'Administration ', ['128927009'])}}

1816297
type 1 diabetes mellitus patients
type 1 diabetes mellitus patients
['type 1 diabetes mellitus patients']
{'type 1 diabetes mellitus patients': {'46635009': 'Diabetes mellitus type 1 ', '116154003': 'Patient '}}
{'type 1 diabetes mellitus patients': {'46635009': ('clinical finding', 'Diabetes mellitus type 1 ', ['64572001', '118234003'])}}

1816443-1
use of biologic response modifiers, such as g-csf, within 3 week of study entry.
use of biologic response modifiers, such as g-csf, , of study entry.
['use of biologic response modifiers,', 'such as g csf', 'of study entry']
{'use of biologic response modifiers,': {'260676000': 'use of', '115668003': 'Biological substance ', '418980009': 'Biological agent ', '69509008': 'Biological agent ', '900000000000450001': 'modifier ', '12893009': 'Biologic '}, 'such as g csf': {'80572003': 'Colony-stimulating factor, granulocytic '}, 'of study entry': {'224699009': 'Study '}}
{'use of biologic response modifiers,': {'12893009': ('qualifier value', 'Biologic ', ['272099008'])}, 'such as g csf': {'80572003': ('product', 'Colony-stimulating factor, granulocytic ', ['406455002'])}}

1816443-2
[g-csf and other hematopoietic growth factors may be used in the management of acute toxicity such as febrile neutropenia when clinically indicated or at the discretion of the investigator; however they may not be substituted for a required dose reduction.]
[g-csf and other hematopoietic growth factors may be used in the management of acute toxicity such as febrile neutropenia when clinically indicated or at the discretion of the investigator; however they may not be substituted for a required dose reduction.]
['[g csf', 'other hematopoietic growth factors', 'used in the management of acute toxicity', 'such as febrile neutropenia', 'indicated']
{'[g csf': {'80572003': 'Colony-stimulating factor, granulocytic '}, 'other hematopoietic growth factors': {'57171008': 'Hematopoietic system structure ', '81286007': 'Growth factor '}, 'used in the management of acute toxicity': {'260676000': 'use of', '413454004': 'Administration ', '272118002': 'Acuteness ', '75478009': 'Poisoning ', '119270007': 'Management procedure '}, 'such as febrile neutropenia': {'409089005': 'Febrile neutropenia '}, 'indicated': {'410535002': 'Indicated '}}
{'[g csf': {'80572003': ('product', 'Colony-stimulating factor, granulocytic ', ['406455002'])}, 'other hematopoietic growth factors': {'81286007': ('product', 'Growth factor ', ['115668003'])}, 'used in the management of acute toxicity': {'272118002': ('qualifier value', 'Acuteness ', ['272099008']), '75478009': ('clinical finding', 'Poisoning ', ['64572001']), '119270007': ('procedure', 'Management procedure ', ['128927009'])}, 'such as febrile neutropenia': {'409089005': ('clinical finding', 'Febrile neutropenia ', ['64572001', '441742003'])}}

1816443-3
[patients taking chronic erythropoietin are permitted provided no dose adjustment is undertaken within 2 months prior to the study or during the study]
[patients taking chronic erythropoietin are permitted provided dose adjustment is undertaken , prior to the study or during the study]
['[patients', 'taking', 'chronic erythropoietin', 'permitted', 'dose adjustment', 'prior to the study', 'or during the study']
{'[patients': {'116154003': 'Patient '}, 'taking': {'419652001': 'Take - dosing instruction imperative '}, 'chronic erythropoietin': {'90734009': 'Chronic ', '111167001': 'Erythropoietin preparation ', '83042003': 'Erythropoietin ', '108964008': 'Epoetin alfa ', '386947003': 'Epoetin alfa '}, 'permitted': {'958006': 'Trachinotus falcatus '}, 'dose adjustment': {'260911001': 'dosage', '277406006': 'Dosages ', '410616005': 'individual adjustment', '129426002': 'Adjustment - action ', '410617001': 'Adjustment ', '408102007': 'Unit dose '}, 'prior to the study': {'224699009': 'Study '}, 'or during the study': {'224699009': 'Study '}}
{'chronic erythropoietin': {'90734009': ('qualifier value', 'Chronic ', ['272099008']), '111167001': ('product', 'Erythropoietin preparation ', ['763158003']), '83042003': ('product', 'Erythropoietin ', ['406455002', '115668003']), '108964008': ('product', 'Epoetin alfa ', ['111167001', '763158003']), '386947003': ('product', 'Epoetin alfa ', ['406455002', '115668003', '83042003'])}, 'dose adjustment': {'277406006': ('qualifier value', 'Dosages ', ['272099008']), '410617001': ('procedure', 'Adjustment ', ['128927009']), '408102007': ('unit', 'Unit dose ', ['767524001'])}}

1817041
for the rpfna/adipose tissue substudy: bilateral breast cancer, bilateral mastectomy, unable or unwilling to stop aspirin or nsaids for 1 week before and after the procedure, allergy to anesthetics or local anesthetics.
for the rpfna/adipose tissue substudy: bilateral breast cancer, bilateral mastectomy, unable or unwilling to stop aspirin or nsaids for 1 week before and after the procedure, allergy to anesthetics or local anesthetics.
['for the rpfna/adipose tissue substudy', 'bilateral breast cancer,', 'bilateral mastectomy,', 'unable', 'unwilling', 'to', 'stop', 'aspirin', 'nsaids for 1 week', 'and after the procedure,', 'allergy to anesthetics', 'local anesthetics']
{'for the rpfna/adipose tissue substudy': {'38888009': 'Yellow fat ', '55603005': 'Adipose tissue '}, 'bilateral breast cancer,': {'63762007': 'Both breasts ', '363346000': 'Malignant neoplastic disease ', '372087000': 'Primary malignant neoplasm ', '86049000': 'Malignant neoplasm, primary ', '51440002': 'Right and left ', '254837009': 'Malignant tumor of breast ', '254838004': 'Carcinoma of breast '}, 'bilateral mastectomy,': {'27865001': 'Bilateral mastectomy '}, 'unable': {'289001005': 'Unable to feed self ', '371151008': 'Unable '}, 'unwilling': {'225465005': 'Unwilling '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'stop': {'422117008': 'Stop '}, 'aspirin': {'387458008': 'Aspirin ', '7947003': 'Aspirin '}, 'nsaids for 1 week': {'16403005': 'Non-steroidal anti-inflammatory agent ', '372665008': 'Non-steroidal anti-inflammatory agent ', '14497002': 'Weekly ', '259038000': 'per week ', '258705008': 'week '}, 'and after the procedure,': {'303110006': 'Postprocedural period '}, 'allergy to anesthetics': {'418434002': 'Anesthetic allergy '}, 'local anesthetics': {'27548001': 'Local anesthetic ', '373477003': 'Local anesthetic '}}
{'bilateral breast cancer,': {'363346000': ('clinical finding', 'Malignant neoplastic disease ', ['64572001']), '372087000': ('clinical finding', 'Primary malignant neoplasm ', ['64572001', '363346000']), '51440002': ('qualifier value', 'Right and left ', ['272099008']), '254837009': ('clinical finding', 'Malignant tumor of breast ', ['64572001', '363346000', '118234003']), '254838004': ('clinical finding', 'Carcinoma of breast ', ['254837009', '64572001', '363346000', '118234003'])}, 'bilateral mastectomy,': {'27865001': ('procedure', 'Bilateral mastectomy ', ['362958002', '128927009'])}, 'unable': {'289001005': ('clinical finding', 'Unable to feed self ', ['250171008'])}, 'unwilling': {'225465005': ('clinical finding', 'Unwilling ', ['250171008'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'stop': {'422117008': ('qualifier value', 'Stop ', ['272099008'])}, 'aspirin': {'387458008': ('product', 'Aspirin ', ['406455002', '312413002']), '7947003': ('product', 'Aspirin ', ['763158003'])}, 'nsaids for 1 week': {'16403005': ('product', 'Non-steroidal anti-inflammatory agent ', ['763158003']), '14497002': ('qualifier value', 'Weekly ', ['272099008']), '259038000': ('unit', 'per week ', ['767524001']), '258705008': ('unit', 'week ', ['767524001'])}, 'and after the procedure,': {'303110006': ('qualifier value', 'Postprocedural period ', ['272099008'])}}

1834525
treatment with prior donor lymphocyte infusion
treatment with prior donor lymphocyte infusion
['treatment with prior donor lymphocyte infusion']
{'treatment with prior donor lymphocyte infusion': {'276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '236874000': 'Status pre- ', '288556008': 'before', '416118004': 'Administration '}}
{'treatment with prior donor lymphocyte infusion': {'276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '416118004': ('procedure', 'Administration ', ['128927009'])}}

1837754-1
patients who are not capable of complying with the procedures established by the protocol and of signing the informed consent.
patients who are not capable of complying with the procedures established by the protocol and of signing the informed consent.
['patients', 'with the procedures', 'established by the protocol', 'and of signing', 'the informed consent']
{'patients': {'116154003': 'Patient '}, 'with the procedures': {'71388002': 'Procedure '}, 'established by the protocol': {'263748003': 'Established ', '258049002': 'Protocols ', '385645004': 'Accepted '}, 'and of signing': {'72670004': 'Sign '}, 'the informed consent': {'108968006': 'Oprelvekin ', '410938009': 'Oprelvekin ', '223458004': 'Informing '}}
{'established by the protocol': {'263748003': ('qualifier value', 'Established ', ['272099008'])}, 'and of signing': {'72670004': ('clinical finding', 'Sign ', ['250171008'])}, 'the informed consent': {'108968006': ('product', 'Oprelvekin ', ['406455002', '312413002', '115668003']), '410938009': ('product', 'Oprelvekin ', ['763158003'])}}

1837754-2
in case of minors or incapacitated patients unable to release their informed consent to take part in the study, the consent must be released and signed also by the parents/guardian or by the legal representative.
in case of minors or incapacitated patients release their informed consent to take part in the study, the consent must be released and signed also by the parents/guardian or by the legal representative.
['in case of minors', 'incapacitated patients', 'release', 'their informed consent', 'to', 'take', 'part in the study,', 'released', 'signed', 'also by the parents/guardian', 'or by the legal representative']
{'in case of minors': {'410599005': 'Minor ', '255606000': 'Minor '}, 'incapacitated patients': {'116154003': 'Patient '}, 'release': {'58000006': 'Patient discharge ', '68776005': 'Released ', '258760001': '% release ', '129299003': 'Release - action ', '115956009': 'Release '}, 'their informed consent': {'108968006': 'Oprelvekin ', '410938009': 'Oprelvekin ', '223458004': 'Informing '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'take': {'419652001': 'Take - dosing instruction imperative '}, 'part in the study,': {'260726005': 'part', '224699009': 'Study '}, 'released': {'68776005': 'Released ', '129299003': 'Release - action '}, 'signed': {'72670004': 'Sign '}, 'also by the parents/guardian': {'160503002': 'Parent of ', '40683002': 'Parent ', '58626002': 'Legal guardian ', '394619001': 'Guardian '}, 'or by the legal representative': {'398165009': 'Legal '}}
{'in case of minors': {'255606000': ('qualifier value', 'Minor ', ['272396007'])}, 'release': {'68776005': ('qualifier value', 'Released ', ['272099008']), '258760001': ('unit', '% release ', ['767524001']), '115956009': ('procedure', 'Release ', ['128927009'])}, 'their informed consent': {'108968006': ('product', 'Oprelvekin ', ['406455002', '312413002', '115668003']), '410938009': ('product', 'Oprelvekin ', ['763158003'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'released': {'68776005': ('qualifier value', 'Released ', ['272099008'])}, 'signed': {'72670004': ('clinical finding', 'Sign ', ['250171008'])}, 'also by the parents/guardian': {'160503002': ('observable entity', 'Parent of ', ['160476009'])}, 'or by the legal representative': {'398165009': ('qualifier value', 'Legal ', ['272099008'])}}

1837754-3
minors or incapacitated patients must as well sign the informed consent to the best of their ability.
minors or incapacitated patients must as well sign the informed consent to the best of their ability.
['minors', 'incapacitated patients', 'must as well', 'sign', 'the informed consent to the best of their ability']
{'minors': {'410599005': 'Minor ', '255606000': 'Minor '}, 'incapacitated patients': {'116154003': 'Patient '}, 'must as well': {'20572008': 'Good '}, 'sign': {'72670004': 'Sign '}, 'the informed consent to the best of their ability': {'108968006': 'Oprelvekin ', '410938009': 'Oprelvekin ', '371150009': 'Able ', '223458004': 'Informing '}}
{'minors': {'255606000': ('qualifier value', 'Minor ', ['272396007'])}, 'must as well': {'20572008': ('qualifier value', 'Good ', ['272099008'])}, 'sign': {'72670004': ('clinical finding', 'Sign ', ['250171008'])}, 'the informed consent to the best of their ability': {'108968006': ('product', 'Oprelvekin ', ['406455002', '312413002', '115668003']), '410938009': ('product', 'Oprelvekin ', ['763158003'])}}

1851216
concurrent use of other extracorporeal therapies such as extracorporeal membrane oxygenation, plasmapheresis or intermittent hemodialysis
concurrent use of other extracorporeal therapies such as extracorporeal membrane oxygenation, plasmapheresis or intermittent hemodialysis
['concurrent use of other extracorporeal therapies', 'such as extracorporeal membrane oxygenation,', 'plasmapheresis', 'intermittent hemodialysis']
{'concurrent use of other extracorporeal therapies': {'68405009': 'Concurrent ', '260676000': 'use of', '260520002': 'Extracorporeal ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure '}, 'such as extracorporeal membrane oxygenation,': {'233573008': 'Extracorporeal membrane oxygenation '}, 'plasmapheresis': {'20720000': 'Plasmapheresis '}, 'intermittent hemodialysis': {'233575001': 'Intermittent hemodialysis '}}
{'concurrent use of other extracorporeal therapies': {'68405009': ('qualifier value', 'Concurrent ', ['272099008']), '276239002': ('procedure', 'Therapy ', ['277132007', '243120004'])}, 'such as extracorporeal membrane oxygenation,': {'233573008': ('procedure', 'Extracorporeal membrane oxygenation ', ['128927009'])}, 'plasmapheresis': {'20720000': ('procedure', 'Plasmapheresis ', ['362958002', '128927009'])}, 'intermittent hemodialysis': {'233575001': ('procedure', 'Intermittent hemodialysis ', ['128927009'])}}

1852303
late onset congenital adrenal hyperplasia
late onset congenital adrenal hyperplasia
['late onset congenital adrenal hyperplasia']
{'late onset congenital adrenal hyperplasia': {'237754008': 'Late onset congenital adrenal hyperplasia '}}
{'late onset congenital adrenal hyperplasia': {'237754008': ('clinical finding', 'Late onset congenital adrenal hyperplasia ', ['64572001', '118234003'])}}

1861254
having with cognitive alterations
having with cognitive alterations
['having with cognitive alterations']
{'having with cognitive alterations': {'18307000': 'Altered ', '243326001': 'Changing '}}
{'having with cognitive alterations': {'18307000': ('qualifier value', 'Altered ', ['272099008']), '243326001': ('qualifier value', 'Changing ', ['272099008'])}}

1870531
radiotherapy to bone lesions, systemic surgery, orthopedic surgery , clinically significant unhealed wound, or unrecovered bone fracture
radiotherapy to bone lesions, systemic surgery, orthopedic surgery , clinically significant unhealed wound, or unrecovered bone fracture
['radiotherapy to bone lesions,', 'systemic surgery,', 'orthopedic surgery ,', 'clinically significant unhealed wound,', 'unrecovered bone fracture']
{'radiotherapy to bone lesions,': {'109301001': 'Radiation injury of bone ', '52988006': 'Lesion '}, 'systemic surgery,': {'31099001': 'Systemic ', '257556004': 'Surgery ', '387713003': 'Surgical procedure ', '83578000': 'Surgical ', '394609007': 'General surgery '}, 'orthopedic surgery ,': {'257556004': 'Surgery ', '387713003': 'Surgical procedure ', '83578000': 'Surgical ', '394609007': 'General surgery '}, 'clinically significant unhealed wound,': {'386134007': 'Significant ', '13924000': 'Wound ', '416462003': 'Wound ', '19130008': 'Traumatic abnormality ', '417746004': 'Traumatic injury '}, 'unrecovered bone fracture': {'125605004': 'Fracture of bone ', '72704001': 'Fracture '}}
{'radiotherapy to bone lesions,': {'109301001': ('clinical finding', 'Radiation injury of bone ', ['64572001', '417746004', '118234003', '419026008'])}, 'systemic surgery,': {'31099001': ('qualifier value', 'Systemic ', ['272099008']), '387713003': ('procedure', 'Surgical procedure ', ['128927009']), '83578000': ('qualifier value', 'Surgical ', ['272099008'])}, 'orthopedic surgery ,': {'387713003': ('procedure', 'Surgical procedure ', ['128927009']), '83578000': ('qualifier value', 'Surgical ', ['272099008'])}, 'clinically significant unhealed wound,': {'416462003': ('clinical finding', 'Wound ', ['64572001', '225552003', '417746004']), '417746004': ('clinical finding', 'Traumatic injury ', ['64572001'])}, 'unrecovered bone fracture': {'125605004': ('clinical finding', 'Fracture of bone ', ['64572001', '417746004', '118234003'])}}

1870943
lidocaine allergy,
lidocaine allergy,
['lidocaine allergy,']
{'lidocaine allergy,': {'293722000': 'Lignocaine allergy '}}
{}

1882334
subject is currently a heavy user of nicotine, ie, smoking > 20 cigarettes per day or equivalent .
subject is currently a heavy user of nicotine, ie, smoking > 20 cigarettes per day or equivalent .
['currently', 'a heavy user of nicotine,', 'ie,', 'smoking', '> 20 cigarettes per day', 'equivalent']
{'currently': {'15240007': 'Current '}, 'a heavy user of nicotine,': {'410712002': 'Heavy sensation quality ', '90845004': 'Heavy ', '722494001': 'Nicotine user '}, 'ie,': {'73774007': 'Subacute bacterial endocarditis ', '223676003': 'Republic of Ireland ', '258997004': 'international units '}, 'smoking': {'365981007': 'Finding of tobacco smoking behavior '}, '> 20 cigarettes per day': {'722496004': 'Cigarette ', '69620002': 'Daily ', '258703001': 'day ', '259032004': 'per day '}, 'equivalent': {'258726008': 'equivalent - unit ', '9726003': 'Equal '}}
{'a heavy user of nicotine,': {'410712002': ('qualifier value', 'Heavy sensation quality ', ['272099008']), '90845004': ('qualifier value', 'Heavy ', ['272099008']), '722494001': ('clinical finding', 'Nicotine user ', ['250171008'])}, 'ie,': {'73774007': ('clinical finding', 'Subacute bacterial endocarditis ', ['64572001', '118234003']), '258997004': ('unit', 'international units ', ['767524001'])}, 'smoking': {'365981007': ('clinical finding', 'Finding of tobacco smoking behavior ', ['250171008'])}, '> 20 cigarettes per day': {'69620002': ('qualifier value', 'Daily ', ['272099008']), '258703001': ('unit', 'day ', ['767524001']), '259032004': ('unit', 'per day ', ['767524001'])}, 'equivalent': {'258726008': ('unit', 'equivalent - unit ', ['767524001']), '9726003': ('qualifier value', 'Equal ', ['272099008'])}}

1883213
ocular disease other than glaucoma that may affect assessment of visual acuity and/or iop
ocular disease other than glaucoma
['ocular disease other than glaucoma']
{'ocular disease other than glaucoma': {'371398005': 'Eye region structure ', '81745001': 'Structure of eye proper ', '64572001': 'Disease ', '23986001': 'Glaucoma ', '281004000': 'Visual function ', '714483002': 'Structure of orbital region '}}
{'ocular disease other than glaucoma': {'23986001': ('clinical finding', 'Glaucoma ', ['64572001', '118234003']), '281004000': ('observable entity', 'Visual function ', ['246464006'])}}

1886218
unstable blood sugar control defined as 1 or more episodes of severe hypoglycemia within the last 30 days
unstable blood sugar control defined as 1 or more episodes of severe hypoglycemia ,
['unstable blood sugar control', 'defined', 'as 1', 'more episodes of severe hypoglycemia']
{'unstable blood sugar control': {'263922001': 'Unstable status ', '33747003': 'Glucose measurement, blood ', '246106000': 'control function', '31509003': 'Controlled '}, 'defined': {'900000000000073002': 'sufficiently defined concept definition status '}, 'as 1': {'223621005': 'Australia ', '432410005': 'Artesunate ', '432555000': 'Artesunate '}, 'more episodes of severe hypoglycemia': {'242762006': 'More ', '263503000': 'episode of', '272128006': 'Episodes ', '24484000': 'Severe ', '237630007': 'Hypoglycemic disorder ', '271327008': 'Hypoglycemic syndrome ', '302866003': 'Hypoglycemia '}}
{'unstable blood sugar control': {'33747003': ('procedure', 'Glucose measurement, blood ', ['128927009']), '31509003': ('qualifier value', 'Controlled ', ['272099008'])}, 'as 1': {'432410005': ('product', 'Artesunate ', ['115668003', '312413002']), '432555000': ('product', 'Artesunate ', ['763158003'])}, 'more episodes of severe hypoglycemia': {'242762006': ('qualifier value', 'More ', ['272099008']), '272128006': ('qualifier value', 'Episodes ', ['272099008']), '24484000': ('qualifier value', 'Severe ', ['272396007']), '237630007': ('clinical finding', 'Hypoglycemic disorder ', ['64572001', '118234003']), '271327008': ('clinical finding', 'Hypoglycemic syndrome ', ['64572001']), '302866003': ('clinical finding', 'Hypoglycemia ', ['64572001', '237630007', '118234003'])}}

1890217
women of child-bearing potential must have a negative pregnancy test, cannot be breastfeeding and must be willing to use contraception
women of child-bearing potential must have a negative pregnancy test, cannot be breastfeeding and must be willing to use contraception
['women of child bearing potential', 'a negative pregnancy test,', 'breastfeeding', 'willing', 'to', 'use', 'contraception']
{'women of child bearing potential': {'224526002': 'Woman ', '160499008': 'Child of ', '106970005': 'Family Ursidae '}, 'a negative pregnancy test,': {'250425007': 'Pregnancy test negative '}, 'breastfeeding': {'169741004': 'Breast fed ', '413712001': 'Breastfeeding '}, 'willing': {'225466006': 'Willing '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'use': {'277889008': 'usage', '419385000': 'Use - dosing instruction imperative '}, 'contraception': {'13197004': 'Contraception '}}
{'women of child bearing potential': {'224526002': ('person', 'Woman ', ['133936004']), '160499008': ('clinical finding', 'Child of ', ['118240005'])}, 'a negative pregnancy test,': {'250425007': ('clinical finding', 'Pregnancy test negative ', ['441742003'])}, 'breastfeeding': {'169741004': ('clinical finding', 'Breast fed ', ['250171008']), '413712001': ('observable entity', 'Breastfeeding ', ['246464006'])}, 'willing': {'225466006': ('clinical finding', 'Willing ', ['250171008'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'contraception': {'13197004': ('clinical finding', 'Contraception ', ['250171008'])}}

1914747
renal dysfunction <30 ml/min/1.73m2)
renal dysfunction <30 ml/min/1.73m2)
['renal dysfunction', '<30 ml/min/1 73m2']
{'renal dysfunction': {'236423003': 'Renal impairment '}, '<30 ml/min/1 73m2': {'258859000': 'Milliliter/minute '}}
{'renal dysfunction': {'236423003': ('clinical finding', 'Renal impairment ', ['64572001', '441742003', '118234003'])}, '<30 ml/min/1 73m2': {'258859000': ('unit', 'Milliliter/minute ', ['767524001'])}}

1915484
intellectual disability
intellectual disability
['intellectual disability']
{'intellectual disability': {'228156007': 'Intellectual functioning disability '}}
{'intellectual disability': {'228156007': ('clinical finding', 'Intellectual functioning disability ', ['250171008', '365860008'])}}

1920771
pregnancy or planning pregnancy during the duration of the study
pregnancy or planning pregnancy during the duration of the study
['pregnancy', 'planning pregnancy during the duration of the study']
{'pregnancy': {'289908002': 'Pregnancy, function ', '77386006': 'Patient currently pregnant '}, 'planning pregnancy during the duration of the study': {'312011006': 'Cognitive function: planning ', '366323009': 'Finding of length of gestation ', '224699009': 'Study ', '397943006': 'Planned '}}
{'pregnancy': {'289908002': ('observable entity', 'Pregnancy, function ', ['246464006']), '77386006': ('clinical finding', 'Patient currently pregnant ', ['250171008'])}, 'planning pregnancy during the duration of the study': {'312011006': ('observable entity', 'Cognitive function: planning ', ['246464006']), '366323009': ('clinical finding', 'Finding of length of gestation ', ['250171008'])}}

1923096
axis 2 diagnosis, chronic substance abuse, suicidality or disruptive to group dynamic
axis 2 diagnosis, chronic substance abuse, suicidality or disruptive to group dynamic
['axis 2 diagnosis,', 'chronic substance abuse,', 'suicidality', 'disruptive to group', 'dynamic']
{'axis 2 diagnosis,': {'39976000': 'Bone structure of axis ', '439401001': 'Diagnosis ', '388282002': 'Genus Axis '}, 'chronic substance abuse,': {'110281001': 'Chronic drug abuse ', '105590001': 'Substance ', '261217004': 'substance', '90734009': 'Chronic ', '66214007': 'Substance abuse '}, 'suicidality': {'267073005': 'Suicidal '}, 'disruptive to group': {'76555007': 'Disruption ', '246261001': 'groups', '261586004': 'Groups ', '160481000': 'Social group ', '389109008': 'Group '}, 'dynamic': {'229027002': 'Dynamic '}}
{'chronic substance abuse,': {'110281001': ('clinical finding', 'Chronic drug abuse ', ['64572001', '66214007']), '90734009': ('qualifier value', 'Chronic ', ['272099008']), '66214007': ('clinical finding', 'Substance abuse ', ['64572001'])}, 'suicidality': {'267073005': ('clinical finding', 'Suicidal ', ['250171008'])}, 'disruptive to group': {'261586004': ('qualifier value', 'Groups ', ['272396007']), '160481000': ('observable entity', 'Social group ', ['160476009'])}, 'dynamic': {'229027002': ('qualifier value', 'Dynamic ', ['272099008'])}}

1923438
① medications that are potent inhibitors of cyp3a4, including cyclosporine, systemic itraconazole or ketoconazole, erythromycin or clarithromycin, nefazodone, verapamil and human immunodeficiency virus protease inhibitors.
① medications that are potent inhibitors of cyp3a4, including cyclosporine, systemic itraconazole or ketoconazole, erythromycin or clarithromycin, nefazodone, verapamil and human immunodeficiency virus protease inhibitors.
['medications', 'potent inhibitors of cyp3a4,', 'including', 'cyclosporine,', 'systemic itraconazole', 'ketoconazole,', 'erythromycin', 'clarithromycin,', 'nefazodone,', 'verapamil', 'human immunodeficiency virus protease inhibitors']
{'medications': {'105903003': 'General drug type ', '373873005': 'Pharmaceutical / biologic product ', '410942007': 'Drug or medicament '}, 'potent inhibitors of cyp3a4,': {'422741004': 'Cytochrome p450 CYP3A4 enzyme '}, 'including': {'55919000': 'Including '}, 'cyclosporine,': {'387467008': 'Cyclosporine ', '80906007': 'Cyclosporine '}, 'systemic itraconazole': {'31099001': 'Systemic ', '387532006': 'Itraconazole ', '96038009': 'Itraconazole '}, 'ketoconazole,': {'387216007': 'Ketoconazole ', '40232005': 'Ketoconazole '}, 'erythromycin': {'30427009': 'Erythromycin ', '372694001': 'Erythromycin '}, 'clarithromycin,': {'387487009': 'Clarithromycin ', '83999008': 'Clarithromycin '}, 'nefazodone,': {'108435006': 'Nefazodone ', '372491002': 'Nefazodone '}, 'verapamil': {'372754009': 'Verapamil ', '47898004': 'Verapamil '}, 'human immunodeficiency virus protease inhibitors': {'19030005': 'Human immunodeficiency virus ', '412127001': 'Peptide hydrolase inhibitor ', '422745008': 'Peptide hydrolase inhibitor ', '72621000119104': 'Human immunodeficiency virus '}}
{'potent inhibitors of cyp3a4,': {'422741004': ('product', 'Cytochrome p450 CYP3A4 enzyme ', ['312413002', '115668003'])}, 'including': {'55919000': ('qualifier value', 'Including ', ['272099008'])}, 'cyclosporine,': {'387467008': ('product', 'Cyclosporine ', ['406455002', '410942007', '312413002', '312412007']), '80906007': ('product', 'Cyclosporine ', ['373873005', '763158003'])}, 'systemic itraconazole': {'31099001': ('qualifier value', 'Systemic ', ['272099008']), '387532006': ('product', 'Itraconazole ', ['410942007', '312413002']), '96038009': ('product', 'Itraconazole ', ['373873005', '763158003'])}, 'ketoconazole,': {'387216007': ('product', 'Ketoconazole ', ['410942007', '312413002']), '40232005': ('product', 'Ketoconazole ', ['373873005', '763158003'])}, 'erythromycin': {'30427009': ('product', 'Erythromycin ', ['373873005', '763158003']), '372694001': ('product', 'Erythromycin ', ['410942007', '312413002'])}, 'clarithromycin,': {'387487009': ('product', 'Clarithromycin ', ['410942007', '312413002']), '83999008': ('product', 'Clarithromycin ', ['373873005', '763158003'])}, 'nefazodone,': {'108435006': ('product', 'Nefazodone ', ['373873005', '763158003']), '372491002': ('product', 'Nefazodone ', ['410942007', '312413002', '406455002'])}, 'verapamil': {'372754009': ('product', 'Verapamil ', ['410942007', '406455002']), '47898004': ('product', 'Verapamil ', ['373873005', '763158003'])}, 'human immunodeficiency virus protease inhibitors': {'19030005': ('clinical finding', 'Human immunodeficiency virus ', ['49872002']), '422745008': ('product', 'Peptide hydrolase inhibitor ', ['373873005', '763158003']), '72621000119104': ('clinical finding', 'Human immunodeficiency virus ', ['64572001'])}}

1930822
patients received symptomatic treatment for bone marrow toxicity within 7 days prior to enrollment.
patients received symptomatic treatment for bone marrow toxicity , prior to enrollment.
['patients', 'symptomatic treatment for bone marrow toxicity']
{'patients': {'116154003': 'Patient '}, 'symptomatic treatment for bone marrow toxicity': {'264931009': 'Symptomatic ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '14016003': 'Bone marrow structure ', '279729006': 'All bone marrow ', '75478009': 'Poisoning ', '416118004': 'Administration '}}
{'symptomatic treatment for bone marrow toxicity': {'264931009': ('qualifier value', 'Symptomatic ', ['272099008']), '276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '75478009': ('clinical finding', 'Poisoning ', ['64572001']), '416118004': ('procedure', 'Administration ', ['128927009'])}}

1936817
a positive pre-study drug/alcohol screen.
a positive pre-study drug/alcohol screen.
['a positive pre study drug/alcohol screen']
{'a positive pre study drug/alcohol screen': {'258758003': '% positive cells ', '236874000': 'Status pre- ', '288556008': 'before', '185922005': 'Clinical drug trial ', '398624005': 'Ethyl alcohol ', '419442005': 'Ethyl alcohol ', '20135006': 'Screening procedure ', '360156006': 'Screening - procedure intent ', '53041004': 'Alcohol ', '224699009': 'Study ', '370854007': 'Screening for substance abuse ', '89732002': 'Drug of abuse screen ', '394642008': 'Drug screening test ', '272113006': 'Before values ', '10828004': 'Positive '}}
{'a positive pre study drug/alcohol screen': {'258758003': ('unit', '% positive cells ', ['767524001']), '398624005': ('product', 'Ethyl alcohol ', ['763158003']), '419442005': ('product', 'Ethyl alcohol ', ['406455002', '53041004', '312413002']), '20135006': ('procedure', 'Screening procedure ', ['128927009']), '360156006': ('qualifier value', 'Screening - procedure intent ', ['272099008']), '53041004': ('product', 'Alcohol ', ['406455002', '312413002']), '370854007': ('procedure', 'Screening for substance abuse ', ['20135006', '408767007', '128927009']), '89732002': ('procedure', 'Drug of abuse screen ', ['394642008', '128927009']), '394642008': ('procedure', 'Drug screening test ', ['128927009']), '272113006': ('qualifier value', 'Before values ', ['272099008']), '10828004': ('qualifier value', 'Positive ', ['272099008'])}}

1940594
hemodynamically unstable
hemodynamically unstable
['hemodynamically unstable']
{'hemodynamically unstable': {'263922001': 'Unstable status '}}
{}

1941313
profound sensory loss/absent touch sensation
profound sensory loss/absent touch sensation
['profound sensory loss/absent touch sensation']
{'profound sensory loss/absent touch sensation': {'795002': 'Deep ', '33653009': 'Absence of sensation ', '2667000': 'Absent ', '386475005': 'Therapeutic touch ', '386476006': 'Touch ', '52962008': 'Tactile ', '397624008': 'Touch sensation, function '}}
{'profound sensory loss/absent touch sensation': {'795002': ('qualifier value', 'Deep ', ['272099008']), '33653009': ('clinical finding', 'Absence of sensation ', ['102957003']), '386475005': ('procedure', 'Therapeutic touch ', ['243120004', '386476006']), '386476006': ('procedure', 'Touch ', ['243120004']), '52962008': ('qualifier value', 'Tactile ', ['272099008']), '397624008': ('observable entity', 'Touch sensation, function ', ['246464006'])}}

1951167
clinically unstable patients
clinically unstable patients
['clinically unstable patients']
{'clinically unstable patients': {'263922001': 'Unstable status ', '116154003': 'Patient '}}
{}

1956193
intake of antibiotics within past 6 weeks prior to inclusion
intake of antibiotics , prior to inclusion
['intake of antibiotics', 'prior to inclusion']
{'intake of antibiotics': {'255631004': 'Antibiotic ', '417927007': 'Antibiotic antituberculosis agent '}, 'prior to inclusion': {'55919000': 'Including '}}
{'intake of antibiotics': {'255631004': ('product', 'Antibiotic ', ['763158003'])}, 'prior to inclusion': {'55919000': ('qualifier value', 'Including ', ['272099008'])}}

1968408
endometrioma and/or endometriosis-stage iii or iv
endometrioma and/or endometriosis-stage iii or iv
['endometrioma', 'endometriosis stage iii', 'iv']
{'endometrioma': {'103678008': 'Endometriotic cyst ', '116342008': 'Endometrial cyst of ovary ', '237116001': 'Chocolate cyst of ovary '}, 'endometriosis stage iii': {'129103003': 'Endometriosis ', '396224008': 'Endometriosis ', '258224005': 'Stage 3 ', '83606005': 'Stage level 3 '}, 'iv': {'223561000': 'Ivory Coast '}}
{'endometrioma': {'237116001': ('clinical finding', 'Chocolate cyst of ovary ', ['64572001', '118234003', '129103003'])}, 'endometriosis stage iii': {'129103003': ('clinical finding', 'Endometriosis ', ['64572001']), '258224005': ('qualifier value', 'Stage 3 ', ['272396007'])}}

1974148
unable to follow post-operative exercise regimen or return for evaluations
unable to follow post-operative exercise regimen or return for evaluations
['unable', 'to', 'follow', 'post operative exercise regimen', 'return for evaluations']
{'unable': {'289001005': 'Unable to feed self ', '371151008': 'Unable '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'follow': {'367409002': 'followed by', '421939007': 'Follow - dosing instruction imperative '}, 'post operative exercise regimen': {'255214003': 'After exercise '}, 'return for evaluations': {'7528007': 'Return to ', '129265001': 'Evaluation - action ', '386053000': 'Evaluation procedure '}}
{'unable': {'289001005': ('clinical finding', 'Unable to feed self ', ['250171008'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'post operative exercise regimen': {'255214003': ('qualifier value', 'After exercise ', ['272099008'])}, 'return for evaluations': {'386053000': ('procedure', 'Evaluation procedure ', ['128927009'])}}

1981750
subjects with arterial or venous thrombotic events or embolic events such as cerebrovascular accident , deep vein thrombosis, or pulmonary embolism within the 6 months before start of study medication
subjects with arterial or venous thrombotic events or embolic events such as cerebrovascular accident , deep vein thrombosis, or pulmonary embolism , before start of study medication
['subjects with arterial', 'venous thrombotic events', 'embolic events such as cerebrovascular accident ,', 'deep vein thrombosis,', 'pulmonary embolism', 'start of study medication']
{'subjects with arterial': {'51114001': 'Arterial structure ', '263954005': 'Arterial '}, 'venous thrombotic events': {'29092000': 'Venous structure ', '396339007': 'Thrombus ', '272379006': 'Event ', '263925004': 'Venous '}, 'embolic events such as cerebrovascular accident ,': {'371041009': 'Embolic stroke ', '272379006': 'Event '}, 'deep vein thrombosis,': {'128053003': 'Deep venous thrombosis '}, 'pulmonary embolism': {'59282003': 'Pulmonary embolism '}, 'start of study medication': {'246062003': 'beginning', '255395001': 'Origins ', '185922005': 'Clinical drug trial ', '224699009': 'Study ', '266709005': 'Medication commenced '}}
{'embolic events such as cerebrovascular accident ,': {'371041009': ('clinical finding', 'Embolic stroke ', ['64572001', '118234003'])}, 'deep vein thrombosis,': {'128053003': ('clinical finding', 'Deep venous thrombosis ', ['64572001', '118234003'])}, 'pulmonary embolism': {'59282003': ('clinical finding', 'Pulmonary embolism ', ['64572001', '118234003'])}, 'start of study medication': {'255395001': ('qualifier value', 'Origins ', ['272099008']), '266709005': ('situation with explicit context', 'Medication commenced ', ['129125009'])}}

1982227
systemic infections.
systemic infections.
['systemic infections']
{'systemic infections': {'91302008': 'Sepsis '}}
{'systemic infections': {'91302008': ('clinical finding', 'Sepsis ', ['64572001'])}}

1991241
ocular surgery in the previous 6 months
ocular surgery in the , 6 months
['ocular surgery in the', '6 months']
{'ocular surgery in the': {'422191005': 'Ophthalmic surgery '}, '6 months': {'258706009': 'month '}}
{'6 months': {'258706009': ('unit', 'month ', ['767524001'])}}

1992187
preeclampsia
preeclampsia
['preeclampsia']
{'preeclampsia': {'15394000': 'Toxemia of pregnancy ', '398254007': 'Pre-eclampsia '}}
{'preeclampsia': {'15394000': ('clinical finding', 'Toxemia of pregnancy ', ['64572001', '118234003']), '398254007': ('clinical finding', 'Pre-eclampsia ', ['64572001', '118234003'])}}

1992873
concurrent treatment with non-permitted drugs and other interventions
concurrent treatment with non-permitted drugs and other interventions
['concurrent treatment with non permitted drugs', 'other interventions']
{'concurrent treatment with non permitted drugs': {'68405009': 'Concurrent ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '958006': 'Trachinotus falcatus ', '105903003': 'General drug type ', '373873005': 'Pharmaceutical / biologic product ', '410942007': 'Drug or medicament ', '416118004': 'Administration '}, 'other interventions': {'225334002': 'Intervention regime '}}
{'concurrent treatment with non permitted drugs': {'68405009': ('qualifier value', 'Concurrent ', ['272099008']), '276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '416118004': ('procedure', 'Administration ', ['128927009'])}, 'other interventions': {'225334002': ('procedure', 'Intervention regime ', ['243120004'])}}

1996428
evidence of biochemical failure
evidence of biochemical failure
['evidence of biochemical failure']
{'evidence of biochemical failure': {'18669006': 'Evidence of ', '80534008': 'Biochemical ', '76797004': 'Failure '}}
{'evidence of biochemical failure': {'76797004': ('clinical finding', 'Failure ', ['250171008', '365860008'])}}

1996677
acute confusional state.
acute confusional state.
['acute confusional state']
{'acute confusional state': {'130987000': 'Acute confusion ', '2776000': 'Delirium '}}
{'acute confusional state': {'130987000': ('clinical finding', 'Acute confusion ', ['250171008']), '2776000': ('clinical finding', 'Delirium ', ['64572001', '118234003'])}}

1998876
currently with lice or open wounds on scalp.
currently with lice or open wounds on scalp.
['currently with lice', 'open wounds on scalp']
{'currently with lice': {'15240007': 'Current ', '106775008': 'Order Anoplura ', '414966007': 'Order Phthiraptera ', '420973007': 'Family Pediculidae '}, 'open wounds on scalp': {'210323002': 'Open wound of scalp '}}
{'open wounds on scalp': {'210323002': ('clinical finding', 'Open wound of scalp ', ['64572001', '225552003', '118234003'])}}

2013626
lobectomy patients.
lobectomy patients.
['lobectomy patients']
{'lobectomy patients': {'125571002': 'Lobectomy ', '116154003': 'Patient '}}
{'lobectomy patients': {'125571002': ('procedure', 'Lobectomy ', ['128927009'])}}

2020754
patient refusal
patient refusal
['patient refusal']
{'patient refusal': {'116154003': 'Patient '}}
{}

2022064
have a history of alcohol abuse.
have , alcohol abuse.
['alcohol abuse']
{'alcohol abuse': {'15167005': 'Alcohol abuse '}}
{'alcohol abuse': {'15167005': ('clinical finding', 'Alcohol abuse ', ['64572001'])}}

2023003
smokers, alcoholic and drug abusers.
smokers, alcoholic and drug abusers.
['smokers,', 'alcoholic', 'drug abusers']
{'smokers,': {'77176002': 'Smoker '}, 'alcoholic': {'228281002': 'Problem drinker '}, 'drug abusers': {'361055000': 'Misuses drugs '}}
{'smokers,': {'77176002': ('clinical finding', 'Smoker ', ['250171008'])}, 'alcoholic': {'228281002': ('clinical finding', 'Problem drinker ', ['250171008'])}, 'drug abusers': {'361055000': ('clinical finding', 'Misuses drugs ', ['250171008'])}}

2037735
for both study populations:
for both study populations:
['for both study populations']
{'for both study populations': {'224699009': 'Study ', '385436007': 'Population ', '389109008': 'Group '}}
{}

2039832
inability, in the investigator's opinion, to comply with study procedures or assessments
inability, in the investigator's opinion, to comply with study procedures or assessments
['to', 'comply with study procedures', 'assessments']
{'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'comply with study procedures': {'224699009': 'Study ', '71388002': 'Procedure '}, 'assessments': {'129265001': 'Evaluation - action ', '386053000': 'Evaluation procedure '}}
{'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'assessments': {'386053000': ('procedure', 'Evaluation procedure ', ['71388002', '128927009'])}}

2040608
asthma that needed emergency treatment, hospitalization, oral corticosteroid or intravenous corticosteroid to keep stable in the past 2 years.
asthma that needed emergency treatment, hospitalization, oral corticosteroid or intravenous corticosteroid to keep stable , .
['asthma', 'that needed emergency treatment,', 'hospitalization,', 'oral corticosteroid', 'intravenous corticosteroid', 'to', 'keep', 'stable']
{'asthma': {'195967001': 'Asthma '}, 'that needed emergency treatment,': {'410525008': 'Needed ', '182813001': 'Emergency treatment ', '103325001': 'Patient need for '}, 'hospitalization,': {'394656005': 'Inpatient care '}, 'oral corticosteroid': {'260548002': 'Oral ', '21568003': 'Adrenal cortical hormone ', '79440004': 'Corticoid preparation '}, 'intravenous corticosteroid': {'255560000': 'Intravenous ', '21568003': 'Adrenal cortical hormone ', '79440004': 'Corticoid preparation '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'keep': {'397909002': 'Retained '}, 'stable': {'58158008': 'Stable '}}
{'asthma': {'195967001': ('clinical finding', 'Asthma ', ['64572001', '118234003'])}, 'that needed emergency treatment,': {'182813001': ('procedure', 'Emergency treatment ', ['410533009'])}, 'hospitalization,': {'394656005': ('procedure', 'Inpatient care ', ['243120004'])}, 'oral corticosteroid': {'79440004': ('product', 'Corticoid preparation ', ['763158003'])}, 'intravenous corticosteroid': {'79440004': ('product', 'Corticoid preparation ', ['763158003'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'keep': {'397909002': ('qualifier value', 'Retained ', ['272099008'])}, 'stable': {'58158008': ('qualifier value', 'Stable ', ['272099008'])}}

2041098
prior radiation therapy within the last 4 weeks; prior radiation therapy to indicator lesion .
prior radiation therapy , ; prior radiation therapy to indicator lesion .
['prior radiation therapy']
{'prior radiation therapy': {'236874000': 'Status pre- ', '288556008': 'before', '108290001': 'Radiation oncology AND/OR radiotherapy ', '53438000': 'Radiation therapy procedure or service '}}
{}

2043549
hepatic insufficiency or aspartate aminotransferase above 2 times the central laboratory's upper reference limit)
hepatic insufficiency or aspartate aminotransferase above 2 times the central laboratory's upper reference limit)
['hepatic insufficiency', 'aspartate aminotransferase above 2 times', "the central laboratory's upper reference limit"]
{'hepatic insufficiency': {'59927004': 'Hepatic failure '}, 'aspartate aminotransferase above 2 times': {'26091008': 'Aspartate aminotransferase ', '410669006': 'Time ', '410670007': 'time', '417929005': 'Times '}, "the central laboratory's upper reference limit": {'26216008': 'Central ', '261904005': 'Laboratory ', '261183002': 'Upper ', '264217000': 'Superior ', '352730000': 'Supra- ', '255469002': 'Limited '}}
{'hepatic insufficiency': {'59927004': ('clinical finding', 'Hepatic failure ', ['64572001', '118234003'])}, 'aspartate aminotransferase above 2 times': {'26091008': ('product', 'Aspartate aminotransferase ', ['312413002', '115668003', '312412007'])}, "the central laboratory's upper reference limit": {'26216008': ('qualifier value', 'Central ', ['272099008']), '352730000': ('qualifier value', 'Supra- ', ['272099008']), '255469002': ('qualifier value', 'Limited ', ['272099008'])}}

2049413
cognitive impairment
cognitive impairment
['cognitive impairment']
{'cognitive impairment': {'386806002': 'Impaired cognition '}}
{'cognitive impairment': {'386806002': ('clinical finding', 'Impaired cognition ', ['250171008'])}}

2052639
patients on concurrent anticancer therapy
patients on concurrent anticancer therapy
['patients on concurrent anticancer therapy']
{'patients on concurrent anticancer therapy': {'116154003': 'Patient ', '68405009': 'Concurrent ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure '}}
{'patients on concurrent anticancer therapy': {'68405009': ('qualifier value', 'Concurrent ', ['272099008']), '276239002': ('procedure', 'Therapy ', ['277132007', '243120004'])}}

2054922
participation to any investigational drug study < 4 weeks preceding study enrolment
participation to any investigational drug study < 4 weeks preceding study enrolment
['participation to any investigational drug study', '< 4 weeks', 'preceding', 'study enrolment']
{'participation to any investigational drug study': {'185922005': 'Clinical drug trial ', '224699009': 'Study ', '129265001': 'Evaluation - action ', '386053000': 'Evaluation procedure '}, '< 4 weeks': {'260300002': '-4 ', '258705008': 'week '}, 'preceding': {'236874000': 'Status pre- ', '288556008': 'before'}, 'study enrolment': {'224699009': 'Study '}}
{'participation to any investigational drug study': {'386053000': ('procedure', 'Evaluation procedure ', ['128927009'])}, '< 4 weeks': {'258705008': ('unit', 'week ', ['767524001'])}}

2056758
patients who are pregnant.
patients who are pregnant.
['patients', 'pregnant']
{'patients': {'116154003': 'Patient '}, 'pregnant': {'77386006': 'Patient currently pregnant ', '127362006': 'Previous pregnancies ', '161732006': 'Gravida ', '364323006': 'Quantity of pregnancy ', '366321006': 'Finding of gravida '}}
{'pregnant': {'77386006': ('clinical finding', 'Patient currently pregnant ', ['250171008']), '127362006': ('clinical finding', 'Previous pregnancies ', ['250171008']), '161732006': ('observable entity', 'Gravida ', ['363788007']), '364323006': ('observable entity', 'Quantity of pregnancy ', ['363788007']), '366321006': ('clinical finding', 'Finding of gravida ', ['250171008'])}}

2058350
change of immunomodulatory therapy < 30 days prior to inclusion
change of immunomodulatory therapy < 30 days prior to inclusion
['change of immunomodulatory therapy', '< 30 days prior to inclusion']
{'change of immunomodulatory therapy': {'18307000': 'Altered ', '243326001': 'Changing ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '263703002': 'Changed status '}, '< 30 days prior to inclusion': {'258703001': 'day ', '236874000': 'Status pre- ', '288556008': 'before', '55919000': 'Including '}}
{'change of immunomodulatory therapy': {'18307000': ('qualifier value', 'Altered ', ['272099008']), '243326001': ('qualifier value', 'Changing ', ['272099008']), '276239002': ('procedure', 'Therapy ', ['277132007', '243120004'])}, '< 30 days prior to inclusion': {'258703001': ('unit', 'day ', ['767524001']), '55919000': ('qualifier value', 'Including ', ['272099008'])}}

2062354
non- consenting
non- consenting
[]
{}
{}

2076601
chronic medication which could affect the results of the study.
chronic medication .
['chronic medication']
{'chronic medication': {'90734009': 'Chronic ', '105903003': 'General drug type ', '373873005': 'Pharmaceutical / biologic product ', '410942007': 'Drug or medicament '}}
{'chronic medication': {'90734009': ('qualifier value', 'Chronic ', ['272099008'])}}

2078271
sensitivity to any of the study medications or any of the ingredients or excipients of these medications
sensitivity to any of the study medications or any of the ingredients or excipients of these medications
['sensitivity to any of the study medications', 'excipients of these medications']
{'sensitivity to any of the study medications': {'418634005': 'Allergic reaction caused by substance ', '421961002': 'Hypersensitivity reaction ', '185922005': 'Clinical drug trial ', '35209006': 'Sensitivity ', '14788002': 'Antimicrobial susceptibility test ', '365705006': 'Finding of antimicrobial susceptibility ', '83185005': 'Sensitive '}, 'excipients of these medications': {'360215002': 'Pharmaceutical excipient ', '43747001': 'Drug excipient ', '105903003': 'General drug type ', '373873005': 'Pharmaceutical / biologic product ', '410942007': 'Drug or medicament '}}
{'sensitivity to any of the study medications': {'418634005': ('clinical finding', 'Allergic reaction caused by substance ', ['64572001', '421961002']), '421961002': ('clinical finding', 'Hypersensitivity reaction ', ['64572001']), '35209006': ('clinical finding', 'Sensitivity ', ['250171008']), '14788002': ('procedure', 'Antimicrobial susceptibility test ', ['128927009']), '365705006': ('clinical finding', 'Finding of antimicrobial susceptibility ', ['441742003'])}, 'excipients of these medications': {'360215002': ('product', 'Pharmaceutical excipient ', ['312412007'])}}

2079001
subjects with malnutrition, defined as a serum albumin < 3.0 mg/dl, in order to avoid worsening protein-malnutrition status during the restricted study period since phosphate restricted diets are also low in protein
subjects with malnutrition, defined as a serum albumin < 3.0 mg/dl, in order to avoid worsening protein-malnutrition status during the restricted study period since phosphate restricted diets are also low in protein
['subjects with malnutrition,', 'defined as a serum albumin', '< 3 0 mg/dl', 'in order', 'to', 'worsening protein malnutrition status during the restricted study period', 'phosphate restricted diets', 'also low in protein']
{'subjects with malnutrition,': {'248325000': 'Undernourished ', '2492009': 'Nutritional disorder ', '47563007': 'Nutritional deficiency ', '65404009': 'Undernutrition ', '70241007': 'Nutritional deficiency disorder '}, 'defined as a serum albumin': {'900000000000073002': 'sufficiently defined concept definition status ', '104485008': 'Albumin measurement, serum '}, '< 3 0 mg/dl': {'260313008': '<3 ', '258797006': 'Milligram/deciliter '}, 'in order': {'721963009': 'Order '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'worsening protein malnutrition status during the restricted study period': {'230993007': 'Worsening ', '58262005': 'Kwashiorkor ', '410664001': 'Status during ', '263856008': 'Restricted ', '224699009': 'Study ', '259037005': 'per period ', '272117007': 'Time periods ', '231877006': 'Worse '}, 'phosphate restricted diets': {'301785006': 'Phosphoric acid ester ', '50352000': 'Organic phosphorus compound ', '259296007': 'Phosphate '}, 'also low in protein': {'160673009': 'Low protein diet ', '437471000124106': 'diet, protein-restricted'}}
{'subjects with malnutrition,': {'248325000': ('clinical finding', 'Undernourished ', ['250171008']), '2492009': ('clinical finding', 'Nutritional disorder ', ['64572001']), '47563007': ('clinical finding', 'Nutritional deficiency ', ['250171008']), '65404009': ('clinical finding', 'Undernutrition ', ['64572001', '70241007', '2492009']), '70241007': ('clinical finding', 'Nutritional deficiency disorder ', ['64572001', '2492009'])}, 'defined as a serum albumin': {'104485008': ('procedure', 'Albumin measurement, serum ', ['128927009'])}, '< 3 0 mg/dl': {'258797006': ('unit', 'Milligram/deciliter ', ['767524001'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'worsening protein malnutrition status during the restricted study period': {'230993007': ('qualifier value', 'Worsening ', ['272099008']), '58262005': ('clinical finding', 'Kwashiorkor ', ['64572001', '70241007', '65404009', '2492009']), '263856008': ('qualifier value', 'Restricted ', ['272099008']), '259037005': ('unit', 'per period ', ['767524001']), '272117007': ('qualifier value', 'Time periods ', ['272099008'])}, 'phosphate restricted diets': {'301785006': ('product', 'Phosphoric acid ester ', ['312413002']), '50352000': ('product', 'Organic phosphorus compound ', ['312413002']), '259296007': ('product', 'Phosphate ', ['312413002'])}, 'also low in protein': {'160673009': ('clinical finding', 'Low protein diet ', ['250171008']), '437471000124106': ('procedure', 'diet, protein-restricted', ['243120004'])}}

2086935
head injury with > 5 minutes of unconsciousness
head injury with > 5 minutes of unconsciousness
['head injury with', '> 5 minutes of unconsciousness']
{'head injury with': {'82271004': 'Injury of head '}, '> 5 minutes of unconsciousness': {'264606005': '-5 ', '258701004': 'min ', '418107008': 'Unconscious ', '419045004': 'Loss of consciousness ', '255507004': 'Small ', '286549009': 'per minute ', '356624006': 'Minute ', '264706000': '>5 ', '264605009': 'Integer +5 '}}
{'head injury with': {'82271004': ('clinical finding', 'Injury of head ', ['64572001', '118234003'])}, '> 5 minutes of unconsciousness': {'258701004': ('unit', 'min ', ['767524001']), '418107008': ('clinical finding', 'Unconscious ', ['250171008']), '419045004': ('clinical finding', 'Loss of consciousness ', ['250171008']), '255507004': ('qualifier value', 'Small ', ['272099008']), '286549009': ('unit', 'per minute ', ['767524001']), '356624006': ('qualifier value', 'Minute ', ['272099008'])}}

2089941
stroke
stroke
['stroke']
{'stroke': {'230690007': 'Cerebrovascular accident '}}
{'stroke': {'230690007': ('clinical finding', 'Cerebrovascular accident ', ['64572001', '118234003'])}}

2092106
participant who have received intra-articular, intramuscular , or intravenous corticosteroids, including adrenocorticotropic hormone within 4 weeks before the first dose of the study medication
participant who have received intra-articular, intramuscular , or intravenous corticosteroids, including adrenocorticotropic hormone , before the first dose of the study medication
['intra articular intramuscular ,', 'intravenous corticosteroids,', 'including', 'adrenocorticotropic hormone', 'the first dose of the study medication']
{'intra articular intramuscular ,': {'131183008': 'Intra-articular ', '76601001': 'Intramuscular injection ', '255559005': 'Intramuscular '}, 'intravenous corticosteroids,': {'255560000': 'Intravenous ', '21568003': 'Adrenal cortical hormone ', '79440004': 'Corticoid preparation '}, 'including': {'55919000': 'Including '}, 'adrenocorticotropic hormone': {'111153005': 'Corticotropin preparation ', '40789008': 'Adrenocorticotropic hormone '}, 'the first dose of the study medication': {'255216001': 'First ', '398232005': 'Drug dose ', '224699009': 'Study ', '260911001': 'dosage', '277406006': 'Dosages ', '185922005': 'Clinical drug trial ', '408102007': 'Unit dose ', '232714002': 'Firstly '}}
{'intra articular intramuscular ,': {'131183008': ('qualifier value', 'Intra-articular ', ['272099008']), '76601001': ('procedure', 'Intramuscular injection ', ['362958002', '128927009'])}, 'intravenous corticosteroids,': {'79440004': ('product', 'Corticoid preparation ', ['763158003'])}, 'including': {'55919000': ('qualifier value', 'Including ', ['272099008'])}, 'adrenocorticotropic hormone': {'40789008': ('product', 'Adrenocorticotropic hormone ', ['406455002', '312413002', '115668003', '312412007'])}, 'the first dose of the study medication': {'398232005': ('clinical finding', 'Drug dose ', ['250171008']), '277406006': ('qualifier value', 'Dosages ', ['272099008']), '408102007': ('unit', 'Unit dose ', ['767524001']), '232714002': ('qualifier value', 'Firstly ', ['272099008'])}}

2095677
placement of an intrauterine device or intrauterine system ; or
placement of an intrauterine device or intrauterine system ; or
['placement of an intrauterine device', 'intrauterine system']
{'placement of an intrauterine device': {'257867005': 'Insertion - action ', '71861002': 'Implantation ', '398236008': 'Intrauterine '}, 'intrauterine system': {'398236008': 'Intrauterine ', '246333005': 'system', '733021006': 'system '}}
{'placement of an intrauterine device': {'71861002': ('procedure', 'Implantation ', ['128927009'])}, 'intrauterine system': {'733021006': ('unit', 'system ', ['767524001'])}}

2100956
no social security
social security
[]
{}
{}

2104494
retrolabyrinthine approach
retrolabyrinthine approach
['retrolabyrinthine approach']
{'retrolabyrinthine approach': {'260621007': 'Retrolabyrinthine approach '}}
{}

2104785
major surgery in the past 2 weeks
major surgery ,
['major surgery']
{'major surgery': {'24484000': 'Severe ', '257556004': 'Surgery ', '387713003': 'Surgical procedure ', '83578000': 'Surgical ', '394609007': 'General surgery ', '255603008': 'Major '}}
{'major surgery': {'24484000': ('qualifier value', 'Severe ', ['272396007']), '387713003': ('procedure', 'Surgical procedure ', ['128927009']), '83578000': ('qualifier value', 'Surgical ', ['272099008']), '255603008': ('qualifier value', 'Major ', ['272396007'])}}

2104878
subject has positive serology for hiv 1, hiv 2, hbsag or hcv.
subject has positive serology for hiv 1, hiv 2, hbsag or hcv.
['positive serology for hiv 1,', 'hiv 2,', 'hbsag', 'hcv']
{'positive serology for hiv 1,': {'165816005': 'Human immunodeficiency virus positive '}, 'hiv 2,': {'36115006': 'Human immunodeficiency virus type 2 '}, 'hbsag': {'22290004': 'Hepatitis B surface antigen '}, 'hcv': {'62944002': 'Hepatitis C virus '}}
{'positive serology for hiv 1,': {'165816005': ('clinical finding', 'Human immunodeficiency virus positive ', ['441742003'])}, 'hiv 2,': {'36115006': ('clinical finding', 'Human immunodeficiency virus type 2 ', ['49872002'])}, 'hbsag': {'22290004': ('product', 'Hepatitis B surface antigen ', ['406455002', '115668003', '312412007'])}, 'hcv': {'62944002': ('clinical finding', 'Hepatitis C virus ', ['49872002'])}}

2118396
necessity of planned treatment with other chemotherapeutics oder anti-hormone therapy
necessity of planned treatment with other chemotherapeutics oder anti-hormone therapy
['necessity of planned treatment', 'with other chemotherapeutics oder anti hormone therapy']
{'necessity of planned treatment': {'397943006': 'Planned ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '416118004': 'Administration '}, 'with other chemotherapeutics oder anti hormone therapy': {'169413002': 'Hormone therapy ', '309542002': 'Endocrine therapy '}}
{'necessity of planned treatment': {'276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '416118004': ('procedure', 'Administration ', ['128927009'])}, 'with other chemotherapeutics oder anti hormone therapy': {'169413002': ('procedure', 'Hormone therapy ', ['277132007', '128927009'])}}

2118868
prior/concomitant therapy with thienopyridine or daily treatment with nonsteroidal antiinflammatory drugs or cyclooxygenase-2 inhibitors
prior/concomitant therapy with thienopyridine or daily treatment with nonsteroidal antiinflammatory drugs or cyclooxygenase-2 inhibitors
['prior/concomitant therapy with thienopyridine', 'daily treatment with nonsteroidal antiinflammatory drugs', 'cyclooxygenase 2 inhibitors']
{'prior/concomitant therapy with thienopyridine': {'236874000': 'Status pre- ', '288556008': 'before', '79970003': 'Simultaneous ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure '}, 'daily treatment with nonsteroidal antiinflammatory drugs': {'69620002': 'Daily ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '16403005': 'Non-steroidal anti-inflammatory agent ', '372665008': 'Non-steroidal anti-inflammatory agent ', '416118004': 'Administration '}, 'cyclooxygenase 2 inhibitors': {'123954005': 'Cox-2 inhibitor ', '387050005': 'Cox-2 inhibitor '}}
{'prior/concomitant therapy with thienopyridine': {'79970003': ('qualifier value', 'Simultaneous ', ['272099008']), '276239002': ('procedure', 'Therapy ', ['277132007', '243120004'])}, 'daily treatment with nonsteroidal antiinflammatory drugs': {'69620002': ('qualifier value', 'Daily ', ['272099008']), '276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '16403005': ('product', 'Non-steroidal anti-inflammatory agent ', ['763158003']), '416118004': ('procedure', 'Administration ', ['128927009'])}, 'cyclooxygenase 2 inhibitors': {'123954005': ('product', 'Cox-2 inhibitor ', ['763158003'])}}

2120155
subject has a positive serology test for hepatitis b surface antigen , hepatitis a virus antibodies (immunoglobulin m [igm]), hepatitis c virus antibodies , or antibodies to human immunodeficiency virus type 1 and/or type 2 at screening.
subject has a positive serology test for hepatitis b surface antigen , hepatitis a virus antibodies (immunoglobulin m [igm]), hepatitis c virus antibodies , or antibodies to human immunodeficiency virus type 1 and/or type 2 at screening.
['a positive serology test for hepatitis b surface antigen ,', 'hepatitis a virus antibodies', '(immunoglobulin m', 'hepatitis c virus antibodies ,', 'antibodies to human immunodeficiency virus type 1', 'type 2 at screening']
{'a positive serology test for hepatitis b surface antigen ,': {'10828004': 'Positive ', '68793005': 'Serologic test ', '66071002': 'Viral hepatitis type B ', '410678000': 'surface', '410679008': 'Surface ', '7120007': 'Antigen '}, 'hepatitis a virus antibodies': {'32609007': 'Antibody to hepatitis A virus '}, '(immunoglobulin m': {'74889000': 'Immunoglobulin M '}, 'hepatitis c virus antibodies ,': {'72165005': 'Antibody to hepatitis C virus '}, 'antibodies to human immunodeficiency virus type 1': {'120841000': 'Human immunodeficiency virus type 1 antibody '}, 'type 2 at screening': {'258195006': 'Type 2 ', '20135006': 'Screening procedure '}}
{'a positive serology test for hepatitis b surface antigen ,': {'10828004': ('qualifier value', 'Positive ', ['272099008']), '68793005': ('procedure', 'Serologic test ', ['128927009']), '66071002': ('clinical finding', 'Viral hepatitis type B ', ['64572001', '118234003']), '410679008': ('qualifier value', 'Surface ', ['272099008']), '7120007': ('product', 'Antigen ', ['115668003'])}, 'hepatitis a virus antibodies': {'32609007': ('product', 'Antibody to hepatitis A virus ', ['312413002', '115668003'])}, '(immunoglobulin m': {'74889000': ('product', 'Immunoglobulin M ', ['312413002', '115668003'])}, 'hepatitis c virus antibodies ,': {'72165005': ('product', 'Antibody to hepatitis C virus ', ['312413002', '115668003'])}, 'antibodies to human immunodeficiency virus type 1': {'120841000': ('product', 'Human immunodeficiency virus type 1 antibody ', ['312413002', '115668003'])}, 'type 2 at screening': {'258195006': ('qualifier value', 'Type 2 ', ['272396007']), '20135006': ('procedure', 'Screening procedure ', ['128927009'])}}

2125797
hiv positive patients with advanced immune supression and evidence of hiv resistant to all combinations of antiretroviral therapy considered at high risk of non lymphoma related death within 12-months due to other aids complications should not be enrolled on the study.
hiv positive patients with advanced immune supression and evidence of hiv resistant to all combinations of antiretroviral therapy considered at high risk of non lymphoma related death within 12-months due to other aids complications should not be enrolled on the study.
['hiv positive patients with advanced immune supression', 'evidence of hiv', 'resistant to all combinations of antiretroviral therapy', 'considered at high risk of non lymphoma', 'related', 'death within 12 months', 'due to other aids complications', 'enrolled on the study']
{'hiv positive patients with advanced immune supression': {'165816005': 'Human immunodeficiency virus positive ', '116154003': 'Patient ', '86005002': 'Advanced ', '255386009': 'Immune '}, 'evidence of hiv': {'18669006': 'Evidence of ', '19030005': 'Human immunodeficiency virus ', '165816005': 'Human immunodeficiency virus positive '}, 'resistant to all combinations of antiretroviral therapy': {'30714006': 'Resistant ', '229554006': 'Combination therapy '}, 'considered at high risk of non lymphoma': {'15508007': 'High risk of ', '115244002': 'Malignant lymphoma - category ', '118600007': 'Malignant lymphoma ', '188676008': 'Malignant lymphoma - mixed small and large cell ', '21964009': 'Malignant lymphoma, no International Classification of Diseases for Oncology subtype '}, 'related': {'263498003': 'relationships', '272151006': 'Relationships ', '262094002': 'Related '}, 'death within 12 months': {'419620001': 'Death ', '258706009': 'month ', '268923008': 'On examination - dead ', '397709008': 'Patient died '}, 'due to other aids complications': {'420721002': 'Acquired immunodeficiency syndrome-associated disorder '}, 'enrolled on the study': {'224699009': 'Study '}}
{'hiv positive patients with advanced immune supression': {'165816005': ('clinical finding', 'Human immunodeficiency virus positive ', ['441742003']), '86005002': ('qualifier value', 'Advanced ', ['272099008']), '255386009': ('qualifier value', 'Immune ', ['272099008'])}, 'evidence of hiv': {'19030005': ('clinical finding', 'Human immunodeficiency virus ', ['49872002']), '165816005': ('clinical finding', 'Human immunodeficiency virus positive ', ['441742003'])}, 'resistant to all combinations of antiretroviral therapy': {'229554006': ('procedure', 'Combination therapy ', ['243120004'])}, 'considered at high risk of non lymphoma': {'118600007': ('clinical finding', 'Malignant lymphoma ', ['64572001']), '188676008': ('clinical finding', 'Malignant lymphoma - mixed small and large cell ', ['64572001', '118600007'])}, 'related': {'272151006': ('qualifier value', 'Relationships ', ['272099008']), '262094002': ('clinical finding', 'Related ', ['118240005'])}, 'death within 12 months': {'258706009': ('unit', 'month ', ['767524001']), '268923008': ('clinical finding', 'On examination - dead ', ['118240005', '365860008']), '397709008': ('clinical finding', 'Patient died ', ['365860008'])}, 'due to other aids complications': {'420721002': ('clinical finding', 'Acquired immunodeficiency syndrome-associated disorder ', ['64572001'])}}

2126100
plasma donation within 7 days prior to day -1 of period 1.
plasma donation , prior to day -1 of period 1.
['plasma donation', 'prior to day  1 of period 1']
{'plasma donation': {'419185008': 'Blood plasma ', '50863008': 'Plasma ', '449951000124101': 'patient status determination, deceased and body donated'}, 'prior to day  1 of period 1': {'236874000': 'Status pre- ', '288556008': 'before', '69620002': 'Daily ', '259037005': 'per period ', '272117007': 'Time periods ', '258703001': 'day ', '259032004': 'per day '}}
{'plasma donation': {'50863008': ('product', 'Plasma ', ['115669006', '115668003']), '449951000124101': ('clinical finding', 'patient status determination, deceased and body donated', ['250171008'])}, 'prior to day  1 of period 1': {'69620002': ('qualifier value', 'Daily ', ['272099008']), '259037005': ('unit', 'per period ', ['767524001']), '272117007': ('qualifier value', 'Time periods ', ['272099008']), '258703001': ('unit', 'day ', ['767524001']), '259032004': ('unit', 'per day ', ['767524001'])}}

2127984
any new serious opportunistic infection within the past 6 weeks
any new serious opportunistic infection ,
['any new serious opportunistic infection']
{'any new serious opportunistic infection': {'7147002': 'New ', '42745003': 'Serious ', '61274003': 'Opportunistic infectious disease '}}
{'any new serious opportunistic infection': {'7147002': ('qualifier value', 'New ', ['272099008']), '42745003': ('qualifier value', 'Serious ', ['272099008']), '61274003': ('clinical finding', 'Opportunistic infectious disease ', ['64572001'])}}

2133829
previous bypass operation
, bypass operation
['bypass operation']
{'bypass operation': {'88834003': 'Construction of shunt ', '257556004': 'Surgery ', '387713003': 'Surgical procedure ', '83578000': 'Surgical '}}
{'bypass operation': {'88834003': ('procedure', 'Construction of shunt ', ['387713003', '128927009']), '387713003': ('procedure', 'Surgical procedure ', ['128927009']), '83578000': ('qualifier value', 'Surgical ', ['272099008'])}}

2141627
subject has had prior abdominal surgery of the gastrointestinal tract in the last 6 months, other than uncomplicated procedures that would be unlikely to lead to bowel obstruction based on the clinical judgment of the investigator.
subject has had prior abdominal surgery of the gastrointestinal tract in the , , other than uncomplicated procedures .
['prior abdominal surgery of the gastrointestinal tract', 'other than uncomplicated procedures']
{'prior abdominal surgery of the gastrointestinal tract': {'236874000': 'Status pre- ', '288556008': 'before', '113345001': 'Abdominal structure ', '277112006': 'Abdominal ', '386621005': 'Operation on gastrointestinal tract '}, 'other than uncomplicated procedures': {'263914008': 'Uncomplicated ', '71388002': 'Procedure '}}
{'prior abdominal surgery of the gastrointestinal tract': {'386621005': ('procedure', 'Operation on gastrointestinal tract ', ['71388002', '362958002', '128927009'])}, 'other than uncomplicated procedures': {'263914008': ('qualifier value', 'Uncomplicated ', ['272099008'])}}

2151374
upper respiratory signs or symptoms or
upper respiratory signs or symptoms or
['upper respiratory signs']
{'upper respiratory signs': {'261183002': 'Upper ', '264217000': 'Superior ', '352730000': 'Supra- ', '72670004': 'Sign '}}
{'upper respiratory signs': {'352730000': ('qualifier value', 'Supra- ', ['272099008']), '72670004': ('clinical finding', 'Sign ', ['250171008'])}}

2160898
be unwilling to comply with the study requirements
be unwilling to comply with the study requirements
['unwilling to', 'comply with the study requirements']
{'unwilling to': {'225465005': 'Unwilling '}, 'comply with the study requirements': {'224699009': 'Study '}}
{'unwilling to': {'225465005': ('clinical finding', 'Unwilling ', ['250171008'])}}

2161936
presence of cervical lesion pre-invasive or invasive on the cervix *
presence of cervical lesion pre-invasive or invasive on the cervix *
['presence of cervical lesion', 'pre invasive', 'invasive on the cervix']
{'presence of cervical lesion': {'52101004': 'Present ', '289794001': 'Lesion of cervix '}, 'pre invasive': {'236874000': 'Status pre- ', '288556008': 'before', '10179008': 'Invasive ', '272113006': 'Before values '}, 'invasive on the cervix': {'10179008': 'Invasive ', '71252005': 'Cervix uteri structure '}}
{'presence of cervical lesion': {'289794001': ('clinical finding', 'Lesion of cervix ', ['118234003'])}, 'pre invasive': {'10179008': ('qualifier value', 'Invasive ', ['272099008']), '272113006': ('qualifier value', 'Before values ', ['272099008'])}, 'invasive on the cervix': {'10179008': ('qualifier value', 'Invasive ', ['272099008'])}}

2167457
patients diagnosed with clinical depression
patients diagnosed with clinical depression
['patients', 'diagnosed with clinical depression']
{'patients': {'116154003': 'Patient '}, 'diagnosed with clinical depression': {'439401001': 'Diagnosis ', '58147004': 'Clinical ', '35489007': 'Depressive disorder ', '78667006': 'Dysthymia ', '366979004': 'Depressed mood ', '255339005': 'Depression - motion '}}
{'diagnosed with clinical depression': {'58147004': ('qualifier value', 'Clinical ', ['272099008']), '35489007': ('clinical finding', 'Depressive disorder ', ['64572001']), '78667006': ('clinical finding', 'Dysthymia ', ['64572001', '35489007']), '366979004': ('clinical finding', 'Depressed mood ', ['250171008']), '255339005': ('qualifier value', 'Depression - motion ', ['272099008'])}}

2168038
abuse of alcohol
abuse of alcohol
['abuse of alcohol']
{'abuse of alcohol': {'15167005': 'Alcohol abuse '}}
{'abuse of alcohol': {'15167005': ('clinical finding', 'Alcohol abuse ', ['64572001'])}}

2171437
history of lung disease other than asthma
, lung disease other than asthma
['lung disease other than asthma']
{'lung disease other than asthma': {'19829001': 'Disorder of lung ', '195967001': 'Asthma ', '39607008': 'Lung structure '}}
{'lung disease other than asthma': {'19829001': ('clinical finding', 'Disorder of lung ', ['64572001', '118234003']), '195967001': ('clinical finding', 'Asthma ', ['64572001', '118234003'])}}

2172363
myocardial infarction within the previous 2 months.
myocardial infarction , .
['myocardial infarction']
{'myocardial infarction': {'22298006': 'Myocardial infarction ', '164865005': 'Electrocardiographic myocardial infarction '}}
{'myocardial infarction': {'22298006': ('clinical finding', 'Myocardial infarction ', ['64572001', '118234003']), '164865005': ('clinical finding', 'Electrocardiographic myocardial infarction ', ['441742003'])}}

2180016
history of psychotic disorders,
, psychotic disorders,
['psychotic disorders,']
{'psychotic disorders,': {'69322001': 'Psychotic disorder '}}
{'psychotic disorders,': {'69322001': ('clinical finding', 'Psychotic disorder ', ['64572001'])}}

2191374
history or presence of significant cardiovascular, pulmonary, hepatic, gallbladder or biliary tract, renal, hematologic, gastrointestinal, endocrine, immunologic, dermatologic, neurologic, or psychiatric disease
history or presence of significant cardiovascular, pulmonary, hepatic, gallbladder or biliary tract, renal, hematologic, gastrointestinal, endocrine, immunologic, dermatologic, neurologic, or psychiatric disease
['history', 'presence of significant cardiovascular, pulmonary, hepatic, gallbladder', 'biliary tract,', 'renal,', 'hematologic,', 'endocrine,', 'immunologic,', 'dermatologic,', 'neurologic,', 'psychiatric disease']
{'history': {'392521001': 'History of '}, 'presence of significant cardiovascular, pulmonary, hepatic, gallbladder': {'52101004': 'Present ', '386134007': 'Significant ', '113257007': 'Structure of cardiovascular system ', '39607008': 'Lung structure ', '32381004': 'Portal ', '28231008': 'Gallbladder structure ', '264164005': 'Pulmonary '}, 'biliary tract,': {'34707002': 'Biliary tract structure '}, 'renal,': {'64033007': 'Kidney structure '}, 'hematologic,': {'57407000': 'Hematologic '}, 'endocrine,': {'113331007': 'Structure of endocrine system '}, 'immunologic,': {'37523008': 'Immunologic '}, 'dermatologic,': {'64947008': 'Dermatologic '}, 'neurologic,': {'1199008': 'Neurologic '}, 'psychiatric disease': {'74732009': 'Mental disorder '}}
{'presence of significant cardiovascular, pulmonary, hepatic, gallbladder': {'32381004': ('qualifier value', 'Portal ', ['272099008'])}, 'hematologic,': {'57407000': ('qualifier value', 'Hematologic ', ['272099008'])}, 'immunologic,': {'37523008': ('qualifier value', 'Immunologic ', ['272099008'])}, 'dermatologic,': {'64947008': ('qualifier value', 'Dermatologic ', ['272099008'])}, 'neurologic,': {'1199008': ('qualifier value', 'Neurologic ', ['272099008'])}, 'psychiatric disease': {'74732009': ('clinical finding', 'Mental disorder ', ['64572001'])}}

2194243
life expectancy < 3 months.
life expectancy < 3 months.
['life expectancy', '< 3 months']
{'life expectancy': {'224130005': 'Household composition ', '385635001': 'Expectations ', '410517006': 'Expectation context '}, '< 3 months': {'260313008': '<3 ', '258706009': 'month '}}
{'life expectancy': {'224130005': ('observable entity', 'Household composition ', ['160476009'])}, '< 3 months': {'258706009': ('unit', 'month ', ['767524001'])}}

2195162
systemic conditions which predispose to candida specie infection such as uncontrolled diabetes and xerostomia.
systemic conditions .
['systemic conditions']
{'systemic conditions': {'264578000': 'Systemic illness ', '56019007': 'Systemic disease '}}
{'systemic conditions': {'264578000': ('qualifier value', 'Systemic illness ', ['272099008']), '56019007': ('clinical finding', 'Systemic disease ', ['250171008'])}}

2204324
subject disagrees to stop intake of other products containing probiotics during study time.
subject disagrees to stop intake of other products containing probiotics during study time.
['to', 'stop', 'containing', 'probiotics during study time']
{'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'stop': {'422117008': 'Stop '}, 'containing': {'42504009': 'Containing '}, 'probiotics during study time': {'224699009': 'Study ', '410669006': 'Time ', '410670007': 'time', '900000000000475002': 'time '}}
{'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'stop': {'422117008': ('qualifier value', 'Stop ', ['272099008'])}, 'containing': {'42504009': ('qualifier value', 'Containing ', ['272099008'])}}

2208535
ventilator dependency;
ventilator dependency;
['ventilator dependency']
{'ventilator dependency': {'79031000119101': 'Dependence on respirator '}}
{'ventilator dependency': {'79031000119101': ('clinical finding', 'Dependence on respirator ', ['250171008', '118234003'])}}

2211147
case history of antidepressant treatment
case , antidepressant treatment
['case', 'antidepressant treatment']
{'case': {'398241000': 'Case - situation '}, 'antidepressant treatment': {'36236003': 'Antidepressant ', '372720008': 'Antidepressant ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '416118004': 'Administration '}}
{'antidepressant treatment': {'36236003': ('product', 'Antidepressant ', ['763158003']), '276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '416118004': ('procedure', 'Administration ', ['128927009'])}}

2214672
has a history of diabetic ketoacidosis in the last 6 months.
has , diabetic ketoacidosis in the , .
['diabetic ketoacidosis in the']
{'diabetic ketoacidosis in the': {'420422005': 'Ketoacidosis in diabetes mellitus '}}
{'diabetic ketoacidosis in the': {'420422005': ('clinical finding', 'Ketoacidosis in diabetes mellitus ', ['64572001'])}}

2231053
verified og suspected other reason than mastectomy/lumpectomy for the pain.
verified og suspected other reason than mastectomy/lumpectomy for the pain.
['suspected', 'other reason than mastectomy/lumpectomy', 'for the pain']
{'suspected': {'415684004': 'Suspected '}, 'other reason than mastectomy/lumpectomy': {'230165009': 'Indication of ', '410665000': 'indication of ', '410666004': 'indication of ', '237370008': 'Segmentectomy of breast ', '64368001': 'Partial mastectomy ', '392021009': 'Lumpectomy of breast ', '392022002': 'Tylectomy ', '172043006': 'Simple mastectomy ', '22964006': 'Unilateral simple mastectomy ', '73359007': 'Unilateral mastectomy ', '69031006': 'Excision of breast tissue '}, 'for the pain': {'22253000': 'Pain '}}
{'other reason than mastectomy/lumpectomy': {'237370008': ('procedure', 'Segmentectomy of breast ', ['69031006', '64368001', '362958002', '128927009']), '64368001': ('procedure', 'Partial mastectomy ', ['69031006', '362958002', '128927009']), '392021009': ('procedure', 'Lumpectomy of breast ', ['362958002', '128927009', '69031006', '64368001', '392022002']), '392022002': ('procedure', 'Tylectomy ', ['128927009']), '172043006': ('procedure', 'Simple mastectomy ', ['69031006', '362958002', '128927009']), '69031006': ('procedure', 'Excision of breast tissue ', ['362958002', '128927009'])}, 'for the pain': {'22253000': ('clinical finding', 'Pain ', ['102957003'])}}

2236959
phototherapy for ad
phototherapy for ad
['phototherapy for ad']
{'phototherapy for ad': {'31394004': 'Light therapy '}}
{'phototherapy for ad': {'31394004': ('procedure', 'Light therapy ', ['128927009'])}}

2237555
history of gastro-intestinal ulcer, perforation or bleeding
, gastro-intestinal ulcer, perforation or bleeding
['gastro intestinal ulcer,', 'perforation', 'bleeding']
{'gastro intestinal ulcer,': {'40845000': 'Gastrointestinal ulcer '}, 'perforation': {'255312002': 'Perforating ', '263837003': 'Perforated ', '36191001': 'Perforation '}, 'bleeding': {'131148009': 'Bleeding ', '50960005': 'Hemorrhage '}}
{'gastro intestinal ulcer,': {'40845000': ('clinical finding', 'Gastrointestinal ulcer ', ['64572001', '118234003'])}, 'perforation': {'255312002': ('qualifier value', 'Perforating ', ['272099008']), '263837003': ('qualifier value', 'Perforated ', ['272099008'])}}

2252144
subject has known allergy against fe-products or dextranes
subject has known allergy against fe-products or dextranes
['known allergy against fe products']
{'known allergy against fe products': {'36692007': 'Known ', '408439002': 'Allergy - specialty ', '418634005': 'Allergic reaction caused by substance ', '421961002': 'Hypersensitivity reaction ', '419076005': 'Allergic reaction ', '609328004': 'Allergic disposition '}}
{'known allergy against fe products': {'418634005': ('clinical finding', 'Allergic reaction caused by substance ', ['64572001', '419076005', '421961002']), '421961002': ('clinical finding', 'Hypersensitivity reaction ', ['64572001']), '419076005': ('clinical finding', 'Allergic reaction ', ['64572001', '421961002'])}}

2261919
known or suspected abuse of alcohol or narcotics
known or suspected abuse of alcohol or narcotics
['known', 'suspected abuse of alcohol']
{'known': {'36692007': 'Known '}, 'suspected abuse of alcohol': {'415685003': 'Suspected alcohol abuse '}}
{'suspected abuse of alcohol': {'415685003': ('situation with explicit context', 'Suspected alcohol abuse ', ['413350009'])}}

2265408
previous treatment with compounds targeting cholesteryl ester transfer protein
, treatment with compounds targeting cholesteryl ester transfer protein
['treatment with compounds', 'cholesteryl ester transfer protein']
{'treatment with compounds': {'276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '62105006': 'Compound ', '416118004': 'Administration '}, 'cholesteryl ester transfer protein': {'259614003': 'Cholesterol ester transfer protein '}}
{'treatment with compounds': {'276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '62105006': ('qualifier value', 'Compound ', ['272099008']), '416118004': ('procedure', 'Administration ', ['128927009'])}, 'cholesteryl ester transfer protein': {'259614003': ('product', 'Cholesterol ester transfer protein ', ['312413002', '115668003'])}}

2265454
structural heart disease
structural heart disease
['structural heart disease']
{'structural heart disease': {'128599005': 'Structural disorder of heart '}}
{'structural heart disease': {'128599005': ('clinical finding', 'Structural disorder of heart ', ['64572001', '118234003'])}}

2272086
malignancies within the last 5 years, with the exception of adequately treated basal cell or squamous cell carcinoma of the skin or carcinoma in situ of the cervix.
malignancies , , with the exception of adequately treated basal cell or squamous cell carcinoma of the skin or carcinoma in situ of the cervix.
['malignancies', 'treated', 'basal cell', 'squamous cell carcinoma of the skin', 'carcinoma in situ of the cervix']
{'malignancies': {'363346000': 'Malignant neoplastic disease '}, 'treated': {'276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '116700008': 'treatment intent', '395077000': 'Treatment intent '}, 'basal cell': {'57195005': 'Basal ', '4421005': 'Cell structure '}, 'squamous cell carcinoma of the skin': {'254651007': 'Squamous cell carcinoma of skin '}, 'carcinoma in situ of the cervix': {'20365006': 'Squamous intraepithelial neoplasia, grade III ', '252991009': 'Cervical intraepithelial neoplasia grade III with severe dysplasia ', '254889004': 'Carcinoma of cervix stage 0 ', '92564006': 'Carcinoma in situ of uterine cervix '}}
{'malignancies': {'363346000': ('clinical finding', 'Malignant neoplastic disease ', ['64572001'])}, 'treated': {'276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '395077000': ('situation with explicit context', 'Treatment intent ', ['129125009'])}, 'basal cell': {'57195005': ('qualifier value', 'Basal ', ['272099008'])}, 'squamous cell carcinoma of the skin': {'254651007': ('clinical finding', 'Squamous cell carcinoma of skin ', ['64572001', '363346000', '118234003'])}, 'carcinoma in situ of the cervix': {'252991009': ('clinical finding', 'Cervical intraepithelial neoplasia grade III with severe dysplasia ', ['64572001', '92564006', '118234003']), '254889004': ('clinical finding', 'Carcinoma of cervix stage 0 ', ['64572001', '363346000', '118234003']), '92564006': ('clinical finding', 'Carcinoma in situ of uterine cervix ', ['64572001', '118234003'])}}

2276507
have very poor kidney function.
have very poor kidney function.
['very poor kidney function']
{'very poor kidney function': {'260358002': 'Very ', '11403006': 'Financially poor ', '11953005': 'Renal function ', '255351007': 'Poor - grade '}}
{'very poor kidney function': {'11403006': ('clinical finding', 'Financially poor ', ['118240005', '250171008']), '11953005': ('observable entity', 'Renal function ', ['246464006']), '255351007': ('qualifier value', 'Poor - grade ', ['272396007'])}}

2281038
is currently abusing alcohol and/or any other substance
is currently abusing alcohol and/or any other substance
['currently', 'abusing', 'alcohol', 'any other substance']
{'currently': {'15240007': 'Current '}, 'abusing': {'26416006': 'Drug abuse ', '386702006': 'Victim of abuse ', '417928002': 'Abuse '}, 'alcohol': {'398624005': 'Ethyl alcohol ', '419442005': 'Ethyl alcohol ', '53041004': 'Alcohol '}, 'any other substance': {'105590001': 'Substance ', '261217004': 'substance'}}
{'abusing': {'26416006': ('clinical finding', 'Drug abuse ', ['64572001']), '386702006': ('clinical finding', 'Victim of abuse ', ['250171008'])}, 'alcohol': {'398624005': ('product', 'Ethyl alcohol ', ['763158003']), '419442005': ('product', 'Ethyl alcohol ', ['406455002', '105590001', '53041004', '312413002']), '53041004': ('product', 'Alcohol ', ['406455002', '105590001', '312413002'])}}

2283663
complex injuries
complex injuries
['complex injuries']
{'complex injuries': {'103360007': 'Complex ', '19130008': 'Traumatic abnormality ', '417746004': 'Traumatic injury '}}
{'complex injuries': {'103360007': ('qualifier value', 'Complex ', ['272099008']), '417746004': ('clinical finding', 'Traumatic injury ', ['64572001'])}}

2286365
under the age of 18,
under the age of 18,
['under the age of 18,']
{'under the age of 18,': {'397669002': 'Age ', '424144002': 'Current chronological age '}}
{'under the age of 18,': {'397669002': ('qualifier value', 'Age ', ['272099008']), '424144002': ('observable entity', 'Current chronological age ', ['105727008'])}}

2293298
known history of a bilateral mastectomy
known , a bilateral mastectomy
['known', 'a bilateral mastectomy']
{'known': {'36692007': 'Known '}, 'a bilateral mastectomy': {'27865001': 'Bilateral mastectomy '}}
{'a bilateral mastectomy': {'27865001': ('procedure', 'Bilateral mastectomy ', ['362958002', '128927009'])}}

2293807-1
pregnancy.
pregnancy.
['pregnancy']
{'pregnancy': {'289908002': 'Pregnancy, function ', '77386006': 'Patient currently pregnant '}}
{'pregnancy': {'289908002': ('observable entity', 'Pregnancy, function ', ['246464006']), '77386006': ('clinical finding', 'Patient currently pregnant ', ['250171008'])}}

2293807-2
although beetroot juice has not knows teratogenic effects, we feel that not enough data exist in this regard.
although beetroot juice has not knows teratogenic effects, we feel .
['beetroot juice', 'teratogenic effects,', 'feel']
{'beetroot juice': {'227220000': 'Beetroot ', '129559002': 'Juice '}, 'teratogenic effects,': {'58694006': 'Teratogenesis '}, 'feel': {'285854004': 'Emotion '}}
{'teratogenic effects,': {'58694006': ('clinical finding', 'Teratogenesis ', ['118234003'])}, 'feel': {'285854004': ('observable entity', 'Emotion ', ['363788007'])}}

2293807-3
therefore, all females patients of reproductive age will be required to undergo a pregnancy test prior to enrollment.
therefore, all females patients of reproductive age will be required to undergo a pregnancy test prior to enrollment.
['all females patients of reproductive age', 'to', 'a pregnancy test prior to enrollment']
{'all females patients of reproductive age': {'1086007': 'Female structure ', '248152002': 'Female ', '116154003': 'Patient ', '397669002': 'Age ', '424144002': 'Current chronological age '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'a pregnancy test prior to enrollment': {'74036000': 'Pregnancy detection examination ', '236874000': 'Status pre- ', '288556008': 'before'}}
{'all females patients of reproductive age': {'248152002': ('clinical finding', 'Female ', ['365860008']), '397669002': ('qualifier value', 'Age ', ['272099008']), '424144002': ('observable entity', 'Current chronological age ', ['105727008'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'a pregnancy test prior to enrollment': {'74036000': ('procedure', 'Pregnancy detection examination ', ['128927009'])}}

2300636
inability by 1 of the investigators to obtain informed consent from the legally authorized representative
inability by 1 of the investigators to obtain informed consent from the legally authorized representative
['to', 'obtain', 'informed consent from the legally authorized representative']
{'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'obtain': {'398092000': 'obtain'}, 'informed consent from the legally authorized representative': {'108968006': 'Oprelvekin ', '410938009': 'Oprelvekin ', '223458004': 'Informing '}}
{'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'informed consent from the legally authorized representative': {'108968006': ('product', 'Oprelvekin ', ['406455002', '312413002', '115668003']), '410938009': ('product', 'Oprelvekin ', ['763158003'])}}

2306505
subjects who are enrolled in any other clinical trial using systemic medication; or any other treatment that might interfere with this study.
subjects who are enrolled in any other clinical trial using systemic medication; or any other treatment .
['other clinical trial', 'using', 'systemic medication']
{'other clinical trial': {'110465008': 'Clinical trial '}, 'using': {'260676000': 'use of'}, 'systemic medication': {'31099001': 'Systemic ', '105903003': 'General drug type ', '373873005': 'Pharmaceutical / biologic product ', '410942007': 'Drug or medicament '}}
{'systemic medication': {'31099001': ('qualifier value', 'Systemic ', ['272099008'])}}

2307090
former achilles tendon rupture
former achilles tendon rupture
['former achilles tendon rupture']
{'former achilles tendon rupture': {'9130008': 'Previous ', '429513001': 'Rupture of Achilles tendon '}}
{'former achilles tendon rupture': {'9130008': ('qualifier value', 'Previous ', ['272099008']), '429513001': ('clinical finding', 'Rupture of Achilles tendon ', ['64572001', '118234003'])}}

2313711
subjects who, through completion of this study, would have donated and/or lost > 400 ml of blood in past 2 months
subjects who, through completion of this study, would have donated and/or lost > 400 ml of blood in past 2 months
['through completion of this study,', '> 400 ml of blood', 'in past 2 months']
{'through completion of this study,': {'255594003': 'Complete ', '224699009': 'Study '}, '> 400 ml of blood': {'732733003': '400', '259035002': 'per milliliter ', '87612001': 'Blood ', '119273009': 'Peripheral blood '}, 'in past 2 months': {'410513005': 'In the past ', '258706009': 'month '}}
{'through completion of this study,': {'255594003': ('qualifier value', 'Complete ', ['272099008'])}, '> 400 ml of blood': {'259035002': ('unit', 'per milliliter ', ['767524001']), '87612001': ('product', 'Blood ', ['115669006', '115668003']), '119273009': ('product', 'Peripheral blood ', ['115669006', '87612001', '115668003'])}, 'in past 2 months': {'258706009': ('unit', 'month ', ['767524001'])}}

2314486
known hypersensitivity to any of the study drugs or excipients.
known hypersensitivity to any of the study drugs or excipients.
['known hypersensitivity to any of the study drugs', 'excipients']
{'known hypersensitivity to any of the study drugs': {'36692007': 'Known ', '224699009': 'Study '}, 'excipients': {'360215002': 'Pharmaceutical excipient ', '43747001': 'Drug excipient '}}
{'excipients': {'360215002': ('product', 'Pharmaceutical excipient ', ['312412007'])}}

2317413
sustained ventricular tachycardia or ventricular fibrillation within 14 days of screening.
sustained ventricular tachycardia or ventricular fibrillation , of screening.
['sustained ventricular tachycardia', 'ventricular fibrillation', 'of screening']
{'sustained ventricular tachycardia': {'426525004': 'Sustained ventricular tachycardia '}, 'ventricular fibrillation': {'71908006': 'Ventricular fibrillation ', '164896001': 'Electrocardiographic ventricular fibrillation '}, 'of screening': {'20135006': 'Screening procedure '}}
{'sustained ventricular tachycardia': {'426525004': ('clinical finding', 'Sustained ventricular tachycardia ', ['64572001', '118234003'])}, 'ventricular fibrillation': {'71908006': ('clinical finding', 'Ventricular fibrillation ', ['64572001', '118234003']), '164896001': ('clinical finding', 'Electrocardiographic ventricular fibrillation ', ['441742003', '118234003'])}, 'of screening': {'20135006': ('procedure', 'Screening procedure ', ['128927009'])}}

2318342
any condition associated with increased risk of metformin hydrochloride-associated lactic acidosis
any condition associated with increased risk of metformin hydrochloride-associated lactic acidosis
['any condition', 'associated with increased risk of metformin hydrochloride', 'associated', 'lactic acidosis']
{'any condition': {'64572001': 'Disease ', '260905004': 'condition'}, 'associated with increased risk of metformin hydrochloride': {'47429007': 'associated with', '35105006': 'Increased ', '30207005': 'Risk of ', '109083009': 'Metformin hydrochloride ', '325271001': 'Metformin hydrochloride product ', '260366006': 'Increase '}, 'associated': {'47429007': 'associated with'}, 'lactic acidosis': {'91273001': 'Lactic acidosis '}}
{'associated with increased risk of metformin hydrochloride': {'35105006': ('qualifier value', 'Increased ', ['272099008']), '109083009': ('product', 'Metformin hydrochloride ', ['406455002', '312413002'])}, 'lactic acidosis': {'91273001': ('clinical finding', 'Lactic acidosis ', ['64572001'])}}

2322228-1
self report of illicit drug use in the past.
self report of illicit drug use in the past.
['self report of illicit drug use', 'in the past']
{'self report of illicit drug use': {'77657003': 'Illegal drug ', '260676000': 'use of'}, 'in the past': {'410513005': 'In the past '}}
{}

2322228-2
use of marijuana during the last 3 month...
use of marijuana during the , ..
['use of marijuana']
{'use of marijuana': {'260676000': 'use of', '398705004': 'Cannabis ', '228998006': 'Cannabis leaves - non-pharmaceutical ', '10083006': 'Cannabis sativa '}}
{'use of marijuana': {'398705004': ('product', 'Cannabis ', ['115668003'])}}

2323299
uncontrolled intercurrent illness including, but not limited to, ongoing infection or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements
uncontrolled intercurrent illness including, but not limited to, ongoing infection or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations
['uncontrolled intercurrent illness', 'including', 'limited to,', 'ongoing infection', 'active infection,', 'symptomatic congestive heart failure,', 'unstable angina pectoris,', 'cardiac arrhythmia,', 'psychiatric illness/social situations']
{'uncontrolled intercurrent illness': {'19032002': 'Uncontrolled ', '39104002': 'Illness '}, 'including': {'55919000': 'Including '}, 'limited to,': {'255469002': 'Limited ', '900000000000486000': 'limited component '}, 'ongoing infection': {'255238004': 'Continuous ', '189822004': 'Contagious disease ', '191415002': 'Communicable disease ', '40733004': 'Infectious disease '}, 'active infection,': {'55561003': 'Active ', '189822004': 'Contagious disease ', '191415002': 'Communicable disease ', '40733004': 'Infectious disease '}, 'symptomatic congestive heart failure,': {'698594003': 'Symptomatic congestive heart failure '}, 'unstable angina pectoris,': {'25106000': 'Impending infarction ', '4557003': 'Preinfarction syndrome '}, 'cardiac arrhythmia,': {'698247007': 'Cardiac arrhythmia ', '44808001': 'Conduction disorder of the heart '}, 'psychiatric illness/social situations': {'74732009': 'Mental disorder '}}
{'uncontrolled intercurrent illness': {'19032002': ('qualifier value', 'Uncontrolled ', ['272099008']), '39104002': ('clinical finding', 'Illness ', ['250171008'])}, 'including': {'55919000': ('qualifier value', 'Including ', ['272099008'])}, 'limited to,': {'255469002': ('qualifier value', 'Limited ', ['272099008'])}, 'ongoing infection': {'255238004': ('qualifier value', 'Continuous ', ['272099008']), '40733004': ('clinical finding', 'Infectious disease ', ['64572001'])}, 'active infection,': {'55561003': ('qualifier value', 'Active ', ['272099008']), '40733004': ('clinical finding', 'Infectious disease ', ['64572001'])}, 'symptomatic congestive heart failure,': {'698594003': ('clinical finding', 'Symptomatic congestive heart failure ', ['64572001', '118234003'])}, 'unstable angina pectoris,': {'25106000': ('clinical finding', 'Impending infarction ', ['64572001', '118234003']), '4557003': ('clinical finding', 'Preinfarction syndrome ', ['64572001', '102957003', '118234003'])}, 'cardiac arrhythmia,': {'698247007': ('clinical finding', 'Cardiac arrhythmia ', ['64572001', '118234003']), '44808001': ('clinical finding', 'Conduction disorder of the heart ', ['64572001', '698247007', '118234003'])}, 'psychiatric illness/social situations': {'74732009': ('clinical finding', 'Mental disorder ', ['64572001'])}}

2325879
major surgery within 30 days or anticipated or planned major surgery during the study.
major surgery , or anticipated or planned major surgery during the study.
['major surgery', 'planned major surgery during the study']
{'major surgery': {'24484000': 'Severe ', '257556004': 'Surgery ', '387713003': 'Surgical procedure ', '83578000': 'Surgical ', '394609007': 'General surgery ', '255603008': 'Major '}, 'planned major surgery during the study': {'24484000': 'Severe ', '183976008': 'Operative procedure planned ', '224699009': 'Study ', '255603008': 'Major '}}
{'major surgery': {'24484000': ('qualifier value', 'Severe ', ['272396007']), '387713003': ('procedure', 'Surgical procedure ', ['128927009']), '83578000': ('qualifier value', 'Surgical ', ['272099008']), '255603008': ('qualifier value', 'Major ', ['272396007'])}, 'planned major surgery during the study': {'24484000': ('qualifier value', 'Severe ', ['272396007']), '183976008': ('situation with explicit context', 'Operative procedure planned ', ['129125009']), '255603008': ('qualifier value', 'Major ', ['272396007'])}}

2336172
ongoing antibiotic treatment
ongoing antibiotic treatment
['ongoing antibiotic treatment']
{'ongoing antibiotic treatment': {'255238004': 'Continuous ', '68322007': 'Administration of antibiotic '}}
{'ongoing antibiotic treatment': {'255238004': ('qualifier value', 'Continuous ', ['272099008']), '68322007': ('procedure', 'Administration of antibiotic ', ['128927009'])}}

2341648
subjects who are required to spend excessive time in the sun .
subjects who are required to spend excessive time in the sun .
['to', 'excessive time in the sun']
{'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'excessive time in the sun': {'260378005': 'Excessive ', '410669006': 'Time ', '410670007': 'time', '49926000': 'Light emitted by the sun ', '900000000000475002': 'time '}}
{'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}}

2351210
history of drug or alcohol abuse.
, drug or alcohol abuse.
['drug', 'alcohol abuse']
{'drug': {'105903003': 'General drug type ', '373873005': 'Pharmaceutical / biologic product ', '410942007': 'Drug or medicament '}, 'alcohol abuse': {'15167005': 'Alcohol abuse '}}
{'alcohol abuse': {'15167005': ('clinical finding', 'Alcohol abuse ', ['64572001'])}}

2351891
myocardial infarction documented as a clinical diagnosis or by ekg or any other test
myocardial infarction documented as a clinical diagnosis or by ekg or any other test
['myocardial infarction', 'documented as a clinical diagnosis', 'or by ekg', 'any other test']
{'myocardial infarction': {'22298006': 'Myocardial infarction ', '164865005': 'Electrocardiographic myocardial infarction '}, 'documented as a clinical diagnosis': {'397934002': 'Documented ', '39154008': 'Clinical diagnosis '}, 'or by ekg': {'29303009': 'Electrocardiographic procedure ', '46825001': 'Electrocardiographic monitoring '}, 'any other test': {'108252007': 'Laboratory procedure ', '15220000': 'Laboratory test ', '269814003': 'Laboratory procedures -general ', '272393004': 'Tests ', '277775005': 'Test finding '}}
{'myocardial infarction': {'22298006': ('clinical finding', 'Myocardial infarction ', ['64572001', '118234003']), '164865005': ('clinical finding', 'Electrocardiographic myocardial infarction ', ['441742003'])}, 'or by ekg': {'29303009': ('procedure', 'Electrocardiographic procedure ', ['363691001', '362958002', '128927009']), '46825001': ('procedure', 'Electrocardiographic monitoring ', ['363691001', '29303009', '362958002', '128927009'])}, 'any other test': {'15220000': ('procedure', 'Laboratory test ', ['128927009', '108252007']), '269814003': ('situation with explicit context', 'Laboratory procedures -general ', ['129125009'])}}

2357084
patients taking didanosine, azathioprine, or nucleoside reverse transcriptase inhibitors
patients taking didanosine, azathioprine, or nucleoside reverse transcriptase inhibitors
['patients', 'taking', 'didanosine,', 'azathioprine,', 'nucleoside reverse transcriptase inhibitors']
{'patients': {'116154003': 'Patient '}, 'taking': {'419652001': 'Take - dosing instruction imperative '}, 'didanosine,': {'19194001': 'Didanosine ', '387105006': 'Didanosine '}, 'azathioprine,': {'111165009': 'Azathioprine ', '372574004': 'Azathioprine '}, 'nucleoside reverse transcriptase inhibitors': {'47368004': 'Nucleoside ', '108709006': 'Reverse transcriptase inhibitor ', '372531002': 'Reverse transcriptase inhibitor '}}
{'didanosine,': {'19194001': ('product', 'Didanosine ', ['763158003', '108709006']), '387105006': ('product', 'Didanosine ', ['406455002', '47368004', '312413002', '372531002'])}, 'azathioprine,': {'111165009': ('product', 'Azathioprine ', ['763158003']), '372574004': ('product', 'Azathioprine ', ['312413002'])}, 'nucleoside reverse transcriptase inhibitors': {'47368004': ('product', 'Nucleoside ', ['312413002']), '108709006': ('product', 'Reverse transcriptase inhibitor ', ['763158003'])}}

2357648
endoscopic appearance of invasive malignancy
endoscopic appearance of invasive malignancy
['endoscopic appearance of invasive malignancy']
{'endoscopic appearance of invasive malignancy': {'423827005': 'Endoscopy ', '10179008': 'Invasive ', '363346000': 'Malignant neoplastic disease ', '372087000': 'Primary malignant neoplasm ', '86049000': 'Malignant neoplasm, primary ', '255412001': 'Appearances ', '703248002': 'Appearance ', '718498007': 'Appearance '}}
{'endoscopic appearance of invasive malignancy': {'423827005': ('procedure', 'Endoscopy ', ['363691001', '128927009']), '10179008': ('qualifier value', 'Invasive ', ['272099008']), '363346000': ('clinical finding', 'Malignant neoplastic disease ', ['64572001']), '372087000': ('clinical finding', 'Primary malignant neoplasm ', ['64572001', '363346000']), '255412001': ('qualifier value', 'Appearances ', ['272099008']), '703248002': ('observable entity', 'Appearance ', ['414237002'])}}

2359262
history of panretinal photocoagulation or macular laser photocoagulation in the study eye.
, panretinal photocoagulation or macular laser photocoagulation in the study eye.
['panretinal photocoagulation', 'macular laser photocoagulation in the study eye']
{'panretinal photocoagulation': {'312713003': 'Panretinal photocoagulation '}, 'macular laser photocoagulation in the study eye': {'23633002': 'Structure of macula densa ', '224699009': 'Study ', '371398005': 'Eye region structure ', '81745001': 'Structure of eye proper ', '112629002': 'Macule ', '82859000': 'Macula lutea structure '}}
{'panretinal photocoagulation': {'312713003': ('procedure', 'Panretinal photocoagulation ', ['362958002', '128927009'])}}

2362144
history or evidence of habitual use of tobacco- products or nicotine-containing products within 3 months of screening.
history or evidence of habitual use of tobacco- products or nicotine-containing products , of screening.
['history', 'evidence of habitual use of tobacco  products', 'nicotine containing products', 'of screening']
{'history': {'392521001': 'History of '}, 'evidence of habitual use of tobacco  products': {'18669006': 'Evidence of ', '40451002': 'Habitual ', '89765005': 'Tobacco dependence syndrome ', '1221000119103': 'History of tobacco use '}, 'nicotine containing products': {'323283001': 'Nicotine ', '373462006': 'Nicotine agent ', '68540007': 'Nicotine ', '42504009': 'Containing '}, 'of screening': {'20135006': 'Screening procedure '}}
{'evidence of habitual use of tobacco  products': {'40451002': ('qualifier value', 'Habitual ', ['272099008']), '89765005': ('clinical finding', 'Tobacco dependence syndrome ', ['64572001'])}, 'nicotine containing products': {'323283001': ('product', 'Nicotine ', ['763158003']), '68540007': ('product', 'Nicotine ', ['406455002', '115668003', '312413002', '312412007']), '42504009': ('qualifier value', 'Containing ', ['272099008'])}, 'of screening': {'20135006': ('procedure', 'Screening procedure ', ['128927009'])}}

2373215
history of hypersensitivity to a previous dose of influenza vaccine.
, hypersensitivity to a , dose of influenza vaccine.
['hypersensitivity to a ,', 'dose of influenza vaccine']
{'hypersensitivity to a ,': {'418634005': 'Allergic reaction caused by substance ', '421961002': 'Hypersensitivity reaction ', '421369008': 'Emotional hypersensitivity '}, 'dose of influenza vaccine': {'260911001': 'dosage', '277406006': 'Dosages ', '396425006': 'Influenza virus vaccine ', '46233009': 'Influenza virus vaccine ', '408102007': 'Unit dose '}}
{'hypersensitivity to a ,': {'418634005': ('clinical finding', 'Allergic reaction caused by substance ', ['64572001', '421961002']), '421961002': ('clinical finding', 'Hypersensitivity reaction ', ['64572001']), '421369008': ('clinical finding', 'Emotional hypersensitivity ', ['250171008'])}, 'dose of influenza vaccine': {'277406006': ('qualifier value', 'Dosages ', ['272099008']), '396425006': ('product', 'Influenza virus vaccine ', ['115668003']), '46233009': ('product', 'Influenza virus vaccine ', ['763158003']), '408102007': ('unit', 'Unit dose ', ['767524001'])}}

2375545
radiographic evidence suggestive of any of these infections is sufficient grounds for exclusion
radiographic evidence suggestive of any of these infections is sufficient grounds for exclusion
['radiographic evidence', 'suggestive of any of these infections', 'sufficient grounds for exclusion']
{'radiographic evidence': {'258106000': 'Radiographic '}, 'suggestive of any of these infections': {'7196007': 'suggestive of'}, 'sufficient grounds for exclusion': {'51117008': 'Sufficient '}}
{'radiographic evidence': {'258106000': ('qualifier value', 'Radiographic ', ['272099008'])}, 'sufficient grounds for exclusion': {'51117008': ('qualifier value', 'Sufficient ', ['272099008'])}}

2378481
drug interactions with any of the study drugs that are not manageable
drug interactions with any of the study drugs
['drug interactions with any of the study drugs']
{'drug interactions with any of the study drugs': {'404204005': 'Drug interaction with drug ', '79899007': 'Drug interaction ', '224699009': 'Study '}}
{}

2379324
participants with unstable or active cardiovascular illnesses , active or end-stage renal disease, unstable thyroid disease, etc.
participants with unstable or active cardiovascular illnesses , active or end-stage renal disease, unstable thyroid disease, etc.
['participants with unstable', 'active cardiovascular illnesses ,', 'active', 'end stage renal disease', 'unstable thyroid disease,']
{'participants with unstable': {'263922001': 'Unstable status '}, 'active cardiovascular illnesses ,': {'55561003': 'Active ', '113257007': 'Structure of cardiovascular system ', '39104002': 'Illness '}, 'active': {'55561003': 'Active '}, 'end stage renal disease': {'46177005': 'End stage renal disease ', '90688005': 'Chronic renal failure syndrome ', '433146000': 'Chronic kidney disease stage 5 '}, 'unstable thyroid disease,': {'263922001': 'Unstable status ', '14304000': 'Disorder of thyroid gland '}}
{'active cardiovascular illnesses ,': {'55561003': ('qualifier value', 'Active ', ['272099008']), '39104002': ('clinical finding', 'Illness ', ['250171008'])}, 'active': {'55561003': ('qualifier value', 'Active ', ['272099008'])}, 'end stage renal disease': {'46177005': ('clinical finding', 'End stage renal disease ', ['64572001', '441742003', '118234003']), '90688005': ('clinical finding', 'Chronic renal failure syndrome ', ['64572001', '441742003', '118234003']), '433146000': ('clinical finding', 'Chronic kidney disease stage 5 ', ['64572001', '441742003', '118234003'])}, 'unstable thyroid disease,': {'14304000': ('clinical finding', 'Disorder of thyroid gland ', ['64572001', '118234003'])}}

2386481
pci or cabg in last 3 months
pci or cabg in ,
['cabg in']
{'cabg in': {'232717009': 'Coronary artery bypass grafting ', '67166004': 'Aortocoronary artery bypass graft ', '90205004': 'Cardiac revascularization with bypass anastomosis '}}
{'cabg in': {'232717009': ('procedure', 'Coronary artery bypass grafting ', ['362958002', '128927009']), '67166004': ('procedure', 'Aortocoronary artery bypass graft ', ['362958002', '128927009']), '90205004': ('procedure', 'Cardiac revascularization with bypass anastomosis ', ['362958002', '128927009'])}}

2388112
intracranial hemorrhage within last 3 months
intracranial hemorrhage ,
['intracranial hemorrhage']
{'intracranial hemorrhage': {'1386000': 'Intracranial hemorrhage '}}
{'intracranial hemorrhage': {'1386000': ('clinical finding', 'Intracranial hemorrhage ', ['64572001', '118234003', '131148009'])}}

2394277
prior allogeneic stem cell transplantation within 2 months of trial enrollment.
prior allogeneic stem cell transplantation , of trial enrollment.
['prior allogeneic stem cell transplantation', 'of trial enrollment']
{'prior allogeneic stem cell transplantation': {'236874000': 'Status pre- ', '288556008': 'before', '50223000': 'Allogeneic transplantation ', '419758009': 'Stem cell '}, 'of trial enrollment': {'110465008': 'Clinical trial '}}
{'prior allogeneic stem cell transplantation': {'50223000': ('procedure', 'Allogeneic transplantation ', ['128927009'])}}

2399095
smoking ≥ 15 cigarettes daily
smoking ≥ 15 cigarettes daily
['smoking', '15 cigarettes daily']
{'smoking': {'365981007': 'Finding of tobacco smoking behavior '}, '15 cigarettes daily': {'722496004': 'Cigarette ', '69620002': 'Daily '}}
{'smoking': {'365981007': ('clinical finding', 'Finding of tobacco smoking behavior ', ['250171008'])}, '15 cigarettes daily': {'69620002': ('qualifier value', 'Daily ', ['272099008'])}}

2399518
aml evolving from mpd and/or secondary aml
aml evolving from mpd and/or secondary aml
['aml evolving from mpd', 'secondary aml']
{'aml evolving from mpd': {'17788007': 'Acute myeloid leukemia, no International Classification of Diseases for Oncology subtype ', '413443009': 'Acute myeloid leukemia - category ', '91861009': 'Acute myeloid leukemia, disease ', '59381007': 'Evolving ', '109993000': 'Chronic myeloproliferative disorder ', '115248004': 'Chronic myeloproliferative disorder ', '128842008': 'Chronic myeloproliferative disease, no International Classification of Diseases for Oncology subtype '}, 'secondary aml': {'2603003': 'Secondary ', '17788007': 'Acute myeloid leukemia, no International Classification of Diseases for Oncology subtype ', '413443009': 'Acute myeloid leukemia - category ', '91861009': 'Acute myeloid leukemia, disease ', '81170007': 'Second '}}
{'aml evolving from mpd': {'91861009': ('clinical finding', 'Acute myeloid leukemia, disease ', ['64572001', '118234003']), '59381007': ('qualifier value', 'Evolving ', ['272099008']), '109993000': ('clinical finding', 'Chronic myeloproliferative disorder ', ['64572001', '118234003'])}, 'secondary aml': {'2603003': ('qualifier value', 'Secondary ', ['272099008']), '91861009': ('clinical finding', 'Acute myeloid leukemia, disease ', ['64572001', '118234003']), '81170007': ('qualifier value', 'Second ', ['272099008'])}}

2400894
rash or arthropathy suggestive of scarlet fever
rash or arthropathy suggestive of scarlet fever
['rash', 'arthropathy', 'suggestive of scarlet fever']
{'rash': {'112625008': 'Cutaneous eruption ', '271807003': 'Eruption of skin '}, 'arthropathy': {'399269003': 'Arthropathy '}, 'suggestive of scarlet fever': {'7196007': 'suggestive of', '30242009': 'Scarlet fever '}}
{'rash': {'271807003': ('clinical finding', 'Eruption of skin ', ['64572001', '118234003'])}, 'arthropathy': {'399269003': ('clinical finding', 'Arthropathy ', ['64572001', '118234003'])}, 'suggestive of scarlet fever': {'30242009': ('clinical finding', 'Scarlet fever ', ['64572001', '271807003', '118234003'])}}

2409984
severe pulmonary hypertension or use of pulmonary hypertension drugs
severe pulmonary hypertension or use of pulmonary hypertension drugs
['severe pulmonary hypertension', 'use of pulmonary hypertension drugs']
{'severe pulmonary hypertension': {'24484000': 'Severe ', '70995007': 'Pulmonary hypertension '}, 'use of pulmonary hypertension drugs': {'260676000': 'use of', '70995007': 'Pulmonary hypertension ', '105903003': 'General drug type ', '373873005': 'Pharmaceutical / biologic product ', '410942007': 'Drug or medicament ', '418112009': 'Pulmonary medicine ', '38341003': 'Hypertensive disorder, systemic arterial '}}
{'severe pulmonary hypertension': {'24484000': ('qualifier value', 'Severe ', ['272396007']), '70995007': ('clinical finding', 'Pulmonary hypertension ', ['64572001', '118234003'])}, 'use of pulmonary hypertension drugs': {'70995007': ('clinical finding', 'Pulmonary hypertension ', ['64572001', '118234003']), '38341003': ('clinical finding', 'Hypertensive disorder, systemic arterial ', ['64572001', '118234003'])}}

2411647
unwillingness to participate.
unwillingness to participate.
['unwillingness', 'to']
{'unwillingness': {'225465005': 'Unwilling '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}}
{'unwillingness': {'225465005': ('clinical finding', 'Unwilling ', ['250171008'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}}

2414531
a history or presence of significant cardiovascular , neurological, hematological, psychiatric, hepatic, gastrointestinal, pulmonary, endocrine, immunologic disease or renal disease or other condition known to interfere with the absorption, distribution, metabolism, or excretion of drugs or place the subjects at increased risk as determined by the investigator.
a history or presence of significant cardiovascular , neurological, hematological, psychiatric, hepatic, gastrointestinal, pulmonary, endocrine, immunologic disease or renal disease or other condition known to interfere with the absorption, distribution, metabolism, or excretion of drugs or place the subjects at increased risk .
['a history', 'presence', 'of significant cardiovascular , neurological, hematological, psychiatric, hepatic, gastrointestinal, pulmonary, endocrine, immunologic disease', 'renal disease', 'other condition', 'known', 'to', 'interfere with the absorption,', 'metabolism,', 'excretion of drugs', 'place', 'the subjects at increased risk']
{'a history': {'392521001': 'History of '}, 'presence': {'52101004': 'Present ', '386397008': 'Providing presence ', '705057003': 'Presence '}, 'of significant cardiovascular , neurological, hematological, psychiatric, hepatic, gastrointestinal, pulmonary, endocrine, immunologic disease': {'386134007': 'Significant ', '113257007': 'Structure of cardiovascular system ', '1199008': 'Neurologic ', '27296002': 'Psychiatric ', '32381004': 'Portal ', '119292006': 'Disorder of gastrointestinal tract ', '25374005': 'Gastroenteritis ', '53619000': 'Disorder of digestive system ', '39607008': 'Lung structure ', '113331007': 'Structure of endocrine system ', '37523008': 'Immunologic ', '264164005': 'Pulmonary ', '33468001': 'Hematology procedure '}, 'renal disease': {'90708001': 'Kidney disease '}, 'other condition': {'64572001': 'Disease ', '260905004': 'condition'}, 'known': {'36692007': 'Known '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'interfere with the absorption,': {'78235001': 'Interferes with '}, 'metabolism,': {'47722004': 'General metabolic function '}, 'excretion of drugs': {'63911002': 'Excretory function ', '718500008': 'Excretory process ', '105903003': 'General drug type ', '373873005': 'Pharmaceutical / biologic product ', '410942007': 'Drug or medicament '}, 'place': {'246297005': 'place', '257557008': 'Place ', '421066005': 'Place - dosing instruction imperative '}, 'the subjects at increased risk': {'35105006': 'Increased ', '30207005': 'Risk of ', '260366006': 'Increase '}}
{'presence': {'386397008': ('procedure', 'Providing presence ', ['243120004'])}, 'of significant cardiovascular , neurological, hematological, psychiatric, hepatic, gastrointestinal, pulmonary, endocrine, immunologic disease': {'1199008': ('qualifier value', 'Neurologic ', ['272099008']), '27296002': ('qualifier value', 'Psychiatric ', ['272099008']), '32381004': ('qualifier value', 'Portal ', ['272099008']), '119292006': ('clinical finding', 'Disorder of gastrointestinal tract ', ['53619000', '64572001', '118234003']), '25374005': ('clinical finding', 'Gastroenteritis ', ['53619000', '64572001', '119292006', '118234003']), '53619000': ('clinical finding', 'Disorder of digestive system ', ['64572001', '118234003']), '37523008': ('qualifier value', 'Immunologic ', ['272099008']), '33468001': ('procedure', 'Hematology procedure ', ['128927009'])}, 'renal disease': {'90708001': ('clinical finding', 'Kidney disease ', ['64572001', '118234003'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'metabolism,': {'47722004': ('observable entity', 'General metabolic function ', ['246464006'])}, 'excretion of drugs': {'63911002': ('observable entity', 'Excretory function ', ['246464006'])}, 'the subjects at increased risk': {'35105006': ('qualifier value', 'Increased ', ['272099008'])}}

2419554
non-cooperative subjects.
non-cooperative subjects.
[]
{}
{}

2433411
smokers group:
smokers group:
['smokers group']
{'smokers group': {'77176002': 'Smoker ', '246261001': 'groups', '261586004': 'Groups ', '160481000': 'Social group ', '389109008': 'Group '}}
{'smokers group': {'77176002': ('clinical finding', 'Smoker ', ['250171008']), '261586004': ('qualifier value', 'Groups ', ['272396007']), '160481000': ('observable entity', 'Social group ', ['160476009'])}}

2441559
subjects taking medications on specified hourly intervals that may be affected by changes to gastric emptying
subjects taking medications on specified hourly intervals
['taking medications on specified hourly intervals']
{'taking medications on specified hourly intervals': {'129019007': 'Taking medication ', '69658003': 'Specific ', '225768006': 'Hourly ', '385673002': 'Interval '}}
{'taking medications on specified hourly intervals': {'129019007': ('observable entity', 'Taking medication ', ['246464006']), '69658003': ('qualifier value', 'Specific ', ['272099008']), '225768006': ('qualifier value', 'Hourly ', ['272099008'])}}

2444001
failure to culture until day 5
failure to culture until day 5
['failure to culture', 'until day 5']
{'failure to culture': {'76797004': 'Failure ', '252398009': 'Culture - general ', '61594008': 'Microbial culture ', '702658000': 'Microbial culture technique ', '703725008': 'Culture technique '}, 'until day 5': {'69620002': 'Daily ', '258703001': 'day ', '259032004': 'per day '}}
{'failure to culture': {'76797004': ('clinical finding', 'Failure ', ['250171008', '365860008']), '252398009': ('procedure', 'Culture - general ', ['61594008', '128927009']), '61594008': ('procedure', 'Microbial culture ', ['128927009'])}, 'until day 5': {'69620002': ('qualifier value', 'Daily ', ['272099008']), '258703001': ('unit', 'day ', ['767524001']), '259032004': ('unit', 'per day ', ['767524001'])}}

2444074
concomitant administration of any medications known to affect blood pressure, except medications allowed by the protocol
concomitant administration of any medications known to affect blood pressure, except medications allowed by the protocol
['concomitant administration of any medications', 'known', 'to', 'affect', 'blood pressure,', 'except medications', 'allowed by the protocol']
{'concomitant administration of any medications': {'79970003': 'Simultaneous ', '18629005': 'Administration of drug or medicament '}, 'known': {'36692007': 'Known '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'affect': {'4065008': 'Affect, function '}, 'blood pressure,': {'75367002': 'Blood pressure ', '392570002': 'Blood pressure finding ', '364090009': 'Systemic arterial pressure ', '386534000': 'Arterial blood pressure ', '386536003': 'Systemic blood pressure '}, 'except medications': {'105903003': 'General drug type ', '373873005': 'Pharmaceutical / biologic product ', '410942007': 'Drug or medicament '}, 'allowed by the protocol': {'258049002': 'Protocols '}}
{'concomitant administration of any medications': {'79970003': ('qualifier value', 'Simultaneous ', ['272099008']), '18629005': ('procedure', 'Administration of drug or medicament ', ['128927009'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'affect': {'4065008': ('observable entity', 'Affect, function ', ['246464006'])}, 'blood pressure,': {'75367002': ('observable entity', 'Blood pressure ', ['363788007']), '392570002': ('clinical finding', 'Blood pressure finding ', ['250171008', '118234003']), '364090009': ('observable entity', 'Systemic arterial pressure ', ['75367002', '363788007', '386536003', '386534000']), '386534000': ('observable entity', 'Arterial blood pressure ', ['75367002', '363788007']), '386536003': ('observable entity', 'Systemic blood pressure ', ['75367002', '363788007'])}}

2458863
women who have been diagnosed to have a fetus with a chromosomal or structural fetal anomaly and do not plan to continue their pregnancy
women who have been diagnosed to have a fetus with a chromosomal or structural fetal anomaly and do not plan to continue their pregnancy
['women', 'diagnosed', 'to', 'a fetus with a chromosomal', 'structural fetal anomaly', 'plan', 'continue', 'their pregnancy']
{'women': {'224526002': 'Woman '}, 'diagnosed': {'439401001': 'Diagnosis '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'a fetus with a chromosomal': {'4015004': 'Chromosomes, group A ', '83418008': 'Entire fetus '}, 'structural fetal anomaly': {'107656002': 'Congenital anomaly ', '21390004': 'Developmental anomaly ', '276654001': 'Congenital malformation ', '276655000': 'Congenital deformity ', '385297003': 'Congenital deformity ', '702709008': 'Congenital anomaly of fetus '}, 'plan': {'52713000': 'Infantile neuroaxonal dystrophy ', '397943006': 'Planned '}, 'continue': {'255238004': 'Continuous '}, 'their pregnancy': {'289908002': 'Pregnancy, function ', '77386006': 'Patient currently pregnant '}}
{'women': {'224526002': ('person', 'Woman ', ['133936004'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'structural fetal anomaly': {'276654001': ('clinical finding', 'Congenital malformation ', ['64572001']), '276655000': ('clinical finding', 'Congenital deformity ', ['64572001', '417893002', '276654001']), '702709008': ('clinical finding', 'Congenital anomaly of fetus ', ['64572001', '106112009', '118234003', '276654001'])}, 'plan': {'52713000': ('clinical finding', 'Infantile neuroaxonal dystrophy ', ['64572001', '118234003'])}, 'continue': {'255238004': ('qualifier value', 'Continuous ', ['272099008'])}, 'their pregnancy': {'289908002': ('observable entity', 'Pregnancy, function ', ['246464006']), '77386006': ('clinical finding', 'Patient currently pregnant ', ['250171008'])}}

2459104
patients needing diathermy treatment;
patients needing diathermy treatment;
['patients', 'needing', 'diathermy treatment']
{'patients': {'116154003': 'Patient '}, 'needing': {'103325001': 'Patient need for '}, 'diathermy treatment': {'21825005': 'Diathermy ', '428381003': 'Diathermy - action ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '416118004': 'Administration ', '31847002': 'Hyperthermia treatment '}}
{'diathermy treatment': {'21825005': ('procedure', 'Diathermy ', ['128927009']), '276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '416118004': ('procedure', 'Administration ', ['128927009'])}}

2463916
active bowels inflammatory disease
active bowels inflammatory disease
['active bowels inflammatory disease']
{'active bowels inflammatory disease': {'55561003': 'Active ', '24526004': 'Inflammatory bowel disease '}}
{'active bowels inflammatory disease': {'55561003': ('qualifier value', 'Active ', ['272099008']), '24526004': ('clinical finding', 'Inflammatory bowel disease ', ['64572001', '118234003'])}}

2475475
adhd identified as primary reason for seeking treatment at phone screen
adhd identified as primary reason for seeking treatment at phone screen
['adhd', 'identified as primary reason', 'for seeking treatment at phone screen']
{'adhd': {'406506008': 'Attention deficit hyperactivity disorder ', '7461003': 'Attention deficit hyperactivity disorder, predominantly hyperactive impulsive type '}, 'identified as primary reason': {'7882003': 'Identified ', '63161005': 'Principal ', '230165009': 'Indication of ', '410665000': 'indication of ', '410666004': 'indication of ', '263909009': 'True primary ', '261424001': 'Primary operation '}, 'for seeking treatment at phone screen': {'276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '734005006': 'telephone number', '20135006': 'Screening procedure ', '360156006': 'Screening - procedure intent ', '416118004': 'Administration '}}
{'adhd': {'406506008': ('clinical finding', 'Attention deficit hyperactivity disorder ', ['64572001']), '7461003': ('clinical finding', 'Attention deficit hyperactivity disorder, predominantly hyperactive impulsive type ', ['64572001', '406506008'])}, 'identified as primary reason': {'7882003': ('qualifier value', 'Identified ', ['272099008']), '63161005': ('qualifier value', 'Principal ', ['272099008']), '263909009': ('qualifier value', 'True primary ', ['272099008']), '261424001': ('qualifier value', 'Primary operation ', ['272099008'])}, 'for seeking treatment at phone screen': {'276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '20135006': ('procedure', 'Screening procedure ', ['128927009']), '360156006': ('qualifier value', 'Screening - procedure intent ', ['272099008']), '416118004': ('procedure', 'Administration ', ['128927009'])}}

2477133
diagnosis of severe osteoporosis/penia as proven with pqct or dxa.
diagnosis of severe osteoporosis/penia as proven with pqct or dxa.
['diagnosis of severe osteoporosis/penia', 'proven with pqct']
{'diagnosis of severe osteoporosis/penia': {'439401001': 'Diagnosis ', '24484000': 'Severe ', '64859006': 'Osteoporosis '}, 'proven with pqct': {'277025001': 'Proven '}}
{'diagnosis of severe osteoporosis/penia': {'24484000': ('qualifier value', 'Severe ', ['272396007']), '64859006': ('clinical finding', 'Osteoporosis ', ['64572001', '118234003'])}}

2485960
presence of clinically relevant fibroids that cannot be treated for technical reasons
presence of clinically relevant fibroids that cannot be treated for technical reasons
['presence of clinically relevant fibroids', 'treated for technical reasons']
{'presence of clinically relevant fibroids': {'52101004': 'Present ', '702978006': 'Leiomyofibroma ', '146801000119103': 'Leiomyoma ', '44598004': 'Leiomyoma, no International Classification of Diseases for Oncology subtype ', '95315005': 'Uterine leiomyoma '}, 'treated for technical reasons': {'69845001': 'Received therapy or drug for ', '246501002': 'techniques', '272394005': 'Technique ', '230165009': 'Indication of ', '410665000': 'indication of ', '410666004': 'indication of '}}
{'presence of clinically relevant fibroids': {'146801000119103': ('clinical finding', 'Leiomyoma ', ['64572001']), '95315005': ('clinical finding', 'Uterine leiomyoma ', ['64572001', '118234003', '146801000119103'])}}

2506309
women who are pregnant or breast feeding
women who are pregnant or breast feeding
['women', 'pregnant', 'breast feeding']
{'women': {'224526002': 'Woman '}, 'pregnant': {'77386006': 'Patient currently pregnant ', '127362006': 'Previous pregnancies ', '161732006': 'Gravida ', '364323006': 'Quantity of pregnancy ', '366321006': 'Finding of gravida '}, 'breast feeding': {'169741004': 'Breast fed ', '413712001': 'Breastfeeding '}}
{'women': {'224526002': ('person', 'Woman ', ['133936004'])}, 'pregnant': {'77386006': ('clinical finding', 'Patient currently pregnant ', ['250171008']), '127362006': ('clinical finding', 'Previous pregnancies ', ['250171008']), '161732006': ('observable entity', 'Gravida ', ['363788007']), '364323006': ('observable entity', 'Quantity of pregnancy ', ['363788007']), '366321006': ('clinical finding', 'Finding of gravida ', ['250171008'])}, 'breast feeding': {'169741004': ('clinical finding', 'Breast fed ', ['250171008']), '413712001': ('observable entity', 'Breastfeeding ', ['246464006'])}}

2517254
patients with previous history of extranodal lymphoma.
patients with , extranodal lymphoma.
['patients with', 'extranodal lymphoma']
{'patients with': {'116154003': 'Patient '}, 'extranodal lymphoma': {'115244002': 'Malignant lymphoma - category ', '118600007': 'Malignant lymphoma ', '188676008': 'Malignant lymphoma - mixed small and large cell ', '21964009': 'Malignant lymphoma, no International Classification of Diseases for Oncology subtype '}}
{'extranodal lymphoma': {'118600007': ('clinical finding', 'Malignant lymphoma ', ['64572001']), '188676008': ('clinical finding', 'Malignant lymphoma - mixed small and large cell ', ['64572001', '118600007'])}}

2517916
any other concurrent severe known disease or concurrent severe and/or uncontrolled medical condition which could compromise participation in the study
any other concurrent severe known disease or concurrent severe and/or uncontrolled medical condition
['other concurrent severe known disease', 'concurrent severe', 'uncontrolled medical condition']
{'other concurrent severe known disease': {'68405009': 'Concurrent ', '24484000': 'Severe ', '36692007': 'Known ', '64572001': 'Disease '}, 'concurrent severe': {'68405009': 'Concurrent ', '24484000': 'Severe '}, 'uncontrolled medical condition': {'19032002': 'Uncontrolled ', '373655009': 'Medical service ', '64572001': 'Disease ', '260905004': 'condition', '74188005': 'Medical '}}
{'other concurrent severe known disease': {'68405009': ('qualifier value', 'Concurrent ', ['272099008']), '24484000': ('qualifier value', 'Severe ', ['272396007'])}, 'concurrent severe': {'68405009': ('qualifier value', 'Concurrent ', ['272099008']), '24484000': ('qualifier value', 'Severe ', ['272396007'])}, 'uncontrolled medical condition': {'19032002': ('qualifier value', 'Uncontrolled ', ['272099008']), '74188005': ('qualifier value', 'Medical ', ['272099008'])}}

2519637
preoperative chemotherapy or hormone therapy for local relapse
preoperative chemotherapy or hormone therapy for local relapse
['preoperative chemotherapy', 'hormone therapy for local relapse']
{'preoperative chemotherapy': {'394894008': 'Pre-operative chemotherapy '}, 'hormone therapy for local relapse': {'169413002': 'Hormone therapy ', '309542002': 'Endocrine therapy ', '255470001': 'Local ', '263855007': 'Relapse phase ', '255318003': 'Relapsing course ', '58184002': 'Recurrent disease '}}
{'preoperative chemotherapy': {'394894008': ('procedure', 'Pre-operative chemotherapy ', ['128927009'])}, 'hormone therapy for local relapse': {'169413002': ('procedure', 'Hormone therapy ', ['128927009']), '255470001': ('qualifier value', 'Local ', ['272099008']), '263855007': ('qualifier value', 'Relapse phase ', ['272099008']), '255318003': ('qualifier value', 'Relapsing course ', ['272099008']), '58184002': ('clinical finding', 'Recurrent disease ', ['64572001'])}}

2520700
pr ≥210 msec
pr ≥210 msec
['pr 210 msec']
{'pr 210 msec': {'732594009': '210', '258697002': 'Millisecond '}}
{'pr 210 msec': {'258697002': ('unit', 'Millisecond ', ['767524001'])}}

2521634
bulbar dysfunction
bulbar dysfunction
['bulbar dysfunction']
{'bulbar dysfunction': {'26519002': 'Medulla oblongata structure ', '386585008': 'Functional disorder '}}
{'bulbar dysfunction': {'386585008': ('clinical finding', 'Functional disorder ', ['250171008'])}}

2524249
platelet count < 50 per microliter
platelet count < 50 per microliter
['platelet count', '< 50 per microliter']
{'platelet count': {'61928009': 'Platelet count ', '365632008': 'Finding of platelet count '}, '< 50 per microliter': {'258774008': 'microliter ', '396162003': 'cubic millimeter '}}
{'platelet count': {'61928009': ('procedure', 'Platelet count ', ['128927009']), '365632008': ('clinical finding', 'Finding of platelet count ', ['441742003', '250171008'])}, '< 50 per microliter': {'258774008': ('unit', 'microliter ', ['767524001'])}}

2536321
inability to sign written informed consent.
sign written informed consent.
['sign', 'written informed consent']
{'sign': {'72670004': 'Sign '}, 'written informed consent': {'12261009': 'Writing ', '108968006': 'Oprelvekin ', '410938009': 'Oprelvekin ', '223458004': 'Informing '}}
{'sign': {'72670004': ('clinical finding', 'Sign ', ['250171008'])}, 'written informed consent': {'12261009': ('observable entity', 'Writing ', ['246464006']), '108968006': ('product', 'Oprelvekin ', ['406455002', '312413002', '115668003']), '410938009': ('product', 'Oprelvekin ', ['763158003'])}}

2537725
congestive heart failure of nyha class 2 or worse
congestive heart failure of nyha class 2 or worse
['congestive heart failure of nyha class 2', 'worse']
{'congestive heart failure of nyha class 2': {'42343007': 'Congestive heart failure ', '420816009': 'New York Heart Association Classification ', '258393007': 'Class 2 '}, 'worse': {'230993007': 'Worsening ', '390772001': 'Deterioration of status ', '231877006': 'Worse '}}
{'congestive heart failure of nyha class 2': {'42343007': ('clinical finding', 'Congestive heart failure ', ['64572001', '118234003']), '258393007': ('qualifier value', 'Class 2 ', ['272396007'])}, 'worse': {'230993007': ('qualifier value', 'Worsening ', ['272099008'])}}

2538626
history of malignancy, except basal cell or squamous cell skin carcinoma.
, malignancy, except basal cell or squamous cell skin carcinoma.
['malignancy,', 'except basal cell', 'squamous cell skin carcinoma']
{'malignancy,': {'363346000': 'Malignant neoplastic disease ', '372087000': 'Primary malignant neoplasm ', '86049000': 'Malignant neoplasm, primary '}, 'except basal cell': {'57195005': 'Basal ', '4421005': 'Cell structure '}, 'squamous cell skin carcinoma': {'254651007': 'Squamous cell carcinoma of skin '}}
{'malignancy,': {'363346000': ('clinical finding', 'Malignant neoplastic disease ', ['64572001']), '372087000': ('clinical finding', 'Primary malignant neoplasm ', ['64572001', '363346000'])}, 'except basal cell': {'57195005': ('qualifier value', 'Basal ', ['272099008'])}, 'squamous cell skin carcinoma': {'254651007': ('clinical finding', 'Squamous cell carcinoma of skin ', ['64572001', '363346000', '118234003'])}}

2539106
initiated art other than pmtct prior to enrollment
initiated art other than pmtct prior to enrollment
[]
{}
{}

2539185
untreated proliferative diabetic retinopathy.
untreated proliferative diabetic retinopathy.
['untreated proliferative diabetic retinopathy']
{'untreated proliferative diabetic retinopathy': {'25265005': 'Did not receive therapy or drug for ', '59276001': 'Proliferative diabetic retinopathy '}}
{'untreated proliferative diabetic retinopathy': {'59276001': ('clinical finding', 'Proliferative diabetic retinopathy ', ['64572001', '118234003'])}}

2540775
3 vials 1.0 x 10^7/ml mononuclear peripheral blood cells
3 vials 1.0 x 10^7/ml mononuclear peripheral blood cells
['3 vials 1 0 x 10^7/ml mononuclear peripheral blood cells']
{'3 vials 1 0 x 10^7/ml mononuclear peripheral blood cells': {'732655003': '3.7', '415818006': 'Vial - unit of product usage ', '259035002': 'per milliliter ', '63370004': 'Blood cell '}}
{'3 vials 1 0 x 10^7/ml mononuclear peripheral blood cells': {'415818006': ('unit', 'Vial - unit of product usage ', ['767524001']), '259035002': ('unit', 'per milliliter ', ['767524001'])}}

2548180
age younger than 18 or older than 80 years, socio-pathology or inability to understand the study objectives
age younger than 18 or older than 80 years, socio-pathology or understand the study objectives
['age', 'younger than 18', 'older than 80 years,', 'socio pathology', 'understand', 'the study objectives']
{'age': {'397669002': 'Age ', '424144002': 'Current chronological age '}, 'younger than 18': {'84422007': 'Young '}, 'older than 80 years,': {'70753007': 'Old ', '258707000': 'year '}, 'socio pathology': {'394595002': 'Pathology '}, 'understand': {'66216009': 'Understanding, function '}, 'the study objectives': {'224699009': 'Study ', '410518001': 'Goal context '}}
{'age': {'397669002': ('qualifier value', 'Age ', ['272099008']), '424144002': ('observable entity', 'Current chronological age ', ['105727008'])}, 'younger than 18': {'84422007': ('qualifier value', 'Young ', ['272099008'])}, 'older than 80 years,': {'70753007': ('qualifier value', 'Old ', ['272099008']), '258707000': ('unit', 'year ', ['767524001'])}, 'understand': {'66216009': ('observable entity', 'Understanding, function ', ['246464006'])}}

2556700
treatment: osteoporosis medication.
treatment: osteoporosis medication.
['treatment', 'osteoporosis medication']
{'treatment': {'276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '416118004': 'Administration '}, 'osteoporosis medication': {'64859006': 'Osteoporosis ', '105903003': 'General drug type ', '373873005': 'Pharmaceutical / biologic product ', '410942007': 'Drug or medicament '}}
{'treatment': {'276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '416118004': ('procedure', 'Administration ', ['128927009'])}, 'osteoporosis medication': {'64859006': ('clinical finding', 'Osteoporosis ', ['64572001', '118234003'])}}

2563712
current life circumstances that would hinder the treatment
current life circumstances
['current life circumstances']
{'current life circumstances': {'15240007': 'Current ', '224130005': 'Household composition '}}
{'current life circumstances': {'224130005': ('observable entity', 'Household composition ', ['160476009'])}}

2568397
individuals with jobs which require night-time shift work.
individuals with jobs .
['individuals with jobs']
{'individuals with jobs': {'125676002': 'Person ', '14679004': 'Occupation ', '385435006': 'Individual '}}
{}

2575585
active bleeding
active bleeding
['active bleeding']
{'active bleeding': {'55561003': 'Active ', '131148009': 'Bleeding ', '50960005': 'Hemorrhage '}}
{'active bleeding': {'55561003': ('qualifier value', 'Active ', ['272099008'])}}

2596778-1
unstable patient conditions as daily variability of the blood arterial pressure >20%, arrhythmias, pao2/fio2 < 300, unsatisfactory respiratory pattern, haemoglobin < 7 g /dl, temperature > 38°c, presence of neurological side or orthopaedic side effects, and recent embolisms from tvp.
unstable patient conditions as daily variability of the blood arterial pressure >20%, arrhythmias, pao2/fio2 < 300, unsatisfactory respiratory pattern, haemoglobin < 7 g /dl, temperature > 38°c, presence of neurological side or orthopaedic side effects, and recent embolisms from tvp.
['unstable patient', 'conditions as daily variability of the blood arterial pressure', 'arrhythmias,', 'pao2/fio2', '< 300,', 'unsatisfactory respiratory pattern,', 'haemoglobin', '< 7 g /dl,', 'temperature', 'presence of neurological side', 'recent embolisms from tvp']
{'unstable patient': {'263922001': 'Unstable status ', '116154003': 'Patient '}, 'conditions as daily variability of the blood arterial pressure': {'64572001': 'Disease ', '69620002': 'Daily ', '255372005': 'Variable ', '364090009': 'Systemic arterial pressure ', '386534000': 'Arterial blood pressure ', '386536003': 'Systemic blood pressure ', '260905004': 'condition'}, 'arrhythmias,': {'698247007': 'Cardiac arrhythmia '}, 'pao2/fio2': {'25579001': 'Oxygen measurement, partial pressure, arterial '}, '< 300,': {'725125005': '300'}, 'unsatisfactory respiratory pattern,': {'255370002': 'Unsatisfactory ', '278907009': 'Respiratory pattern '}, 'haemoglobin': {'38082009': 'Hemoglobin '}, '< 7 g /dl,': {'258795003': 'Gram/deciliter '}, 'temperature': {'105723007': 'Body temperature finding ', '386725007': 'Body temperature ', '722490005': 'Temperature ', '246508008': 'temperature', '703421000': 'Temperature '}, 'presence of neurological side': {'52101004': 'Present ', '1199008': 'Neurologic ', '182353008': 'Side '}, 'recent embolisms from tvp': {'125302007': 'Recent embolus '}}
{'conditions as daily variability of the blood arterial pressure': {'69620002': ('qualifier value', 'Daily ', ['272099008']), '255372005': ('qualifier value', 'Variable ', ['272099008']), '364090009': ('observable entity', 'Systemic arterial pressure ', ['363788007', '386536003', '386534000']), '386534000': ('observable entity', 'Arterial blood pressure ', ['363788007']), '386536003': ('observable entity', 'Systemic blood pressure ', ['363788007'])}, 'arrhythmias,': {'698247007': ('clinical finding', 'Cardiac arrhythmia ', ['64572001', '118234003'])}, 'pao2/fio2': {'25579001': ('procedure', 'Oxygen measurement, partial pressure, arterial ', ['128927009'])}, 'unsatisfactory respiratory pattern,': {'255370002': ('qualifier value', 'Unsatisfactory ', ['272099008']), '278907009': ('observable entity', 'Respiratory pattern ', ['363788007'])}, 'haemoglobin': {'38082009': ('product', 'Hemoglobin ', ['312413002', '115668003'])}, '< 7 g /dl,': {'258795003': ('unit', 'Gram/deciliter ', ['767524001'])}, 'temperature': {'105723007': ('clinical finding', 'Body temperature finding ', ['250171008']), '386725007': ('observable entity', 'Body temperature ', ['363788007']), '703421000': ('observable entity', 'Temperature ', ['414237002'])}, 'presence of neurological side': {'1199008': ('qualifier value', 'Neurologic ', ['272099008'])}}

2596778-2
refusal.
refusal.
[]
{}
{}

2598647
active steroid and ongoing steroid use, except for non-systemically absorbed treatments .
active steroid and ongoing steroid use, except for non-systemically absorbed treatments .
['active steroid', 'ongoing steroid use,', 'except for non systemically absorbed treatments']
{'active steroid': {'55561003': 'Active ', '112113009': 'Steroid hormone ', '116566001': 'Steroid '}, 'ongoing steroid use,': {'255238004': 'Continuous ', '112113009': 'Steroid hormone ', '116566001': 'Steroid ', '277889008': 'usage', '419385000': 'Use - dosing instruction imperative '}, 'except for non systemically absorbed treatments': {'276239002': 'Therapy ', '277132007': 'Therapeutic procedure '}}
{'active steroid': {'55561003': ('qualifier value', 'Active ', ['272099008']), '112113009': ('product', 'Steroid hormone ', ['312413002', '116566001']), '116566001': ('product', 'Steroid ', ['312413002'])}, 'ongoing steroid use,': {'255238004': ('qualifier value', 'Continuous ', ['272099008']), '112113009': ('product', 'Steroid hormone ', ['312413002', '116566001']), '116566001': ('product', 'Steroid ', ['312413002'])}, 'except for non systemically absorbed treatments': {'276239002': ('procedure', 'Therapy ', ['277132007', '243120004'])}}

2602914
altered sensation at baseline reported as numbness or unusual feeling.
altered sensation at baseline reported as numbness or unusual feeling.
['altered sensation at baseline', 'reported as numbness', 'unusual feeling']
{'altered sensation at baseline': {'247325003': 'Altered sensation of skin '}, 'reported as numbness': {'229059009': 'Report ', '397974008': 'Hypesthesia ', '398026008': 'Reduced sensation of skin ', '59073000': 'Tactile hypesthesia ', '44077006': 'Numbness ', '223458004': 'Informing ', '733985002': 'reported'}, 'unusual feeling': {'285854004': 'Emotion '}}
{'altered sensation at baseline': {'247325003': ('clinical finding', 'Altered sensation of skin ', ['102957003', '118234003'])}, 'reported as numbness': {'397974008': ('clinical finding', 'Hypesthesia ', ['102957003']), '398026008': ('clinical finding', 'Reduced sensation of skin ', ['102957003', '247325003', '397974008', '118234003']), '59073000': ('clinical finding', 'Tactile hypesthesia ', ['118234003', '102957003', '247325003', '397974008', '398026008']), '44077006': ('clinical finding', 'Numbness ', ['102957003'])}, 'unusual feeling': {'285854004': ('observable entity', 'Emotion ', ['363788007'])}}

2603180
left ventricular assist device
left ventricular assist device
['left ventricular assist device']
{'left ventricular assist device': {'360066001': 'Left ventricular assist device '}}
{}

2603610
hb <4.0 g/dl
hb <4.0 g/dl
['hb <4 0 g/dl']
{'hb <4 0 g/dl': {'38082009': 'Hemoglobin ', '258795003': 'Gram/deciliter '}}
{'hb <4 0 g/dl': {'38082009': ('product', 'Hemoglobin ', ['312413002', '115668003']), '258795003': ('unit', 'Gram/deciliter ', ['767524001'])}}

2605296
currently on continuous positive airway pressure or on cpap during the last 3 months before stroke
currently on continuous positive airway pressure or on cpap during the , before stroke
['currently on continuous positive airway pressure', 'or on cpap', 'stroke']
{'currently on continuous positive airway pressure': {'15240007': 'Current ', '47545007': 'Continuous positive airway pressure ventilation treatment '}, 'or on cpap': {'47545007': 'Continuous positive airway pressure ventilation treatment '}, 'stroke': {'230690007': 'Cerebrovascular accident '}}
{'currently on continuous positive airway pressure': {'47545007': ('procedure', 'Continuous positive airway pressure ventilation treatment ', ['362958002', '243120004'])}, 'or on cpap': {'47545007': ('procedure', 'Continuous positive airway pressure ventilation treatment ', ['362958002', '243120004'])}, 'stroke': {'230690007': ('clinical finding', 'Cerebrovascular accident ', ['64572001', '118234003'])}}

2624178
severe aortic stenosis
severe aortic stenosis
['severe aortic stenosis']
{'severe aortic stenosis': {'24484000': 'Severe ', '60573004': 'Aortic valve stenosis '}}
{'severe aortic stenosis': {'24484000': ('qualifier value', 'Severe ', ['272396007']), '60573004': ('clinical finding', 'Aortic valve stenosis ', ['64572001', '118234003'])}}

2630682
treatment with insulin
treatment with insulin
['treatment with insulin']
{'treatment with insulin': {'39543009': 'Administration of insulin '}}
{'treatment with insulin': {'39543009': ('procedure', 'Administration of insulin ', ['128927009'])}}

2631982
family is unlikely to be available for long-term follow-up
family is unlikely to be available for long-term follow-up
['family', 'to', 'available for long term follow up']
{'family': {'35359004': 'Family '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'available for long term follow up': {'103328004': 'Availability of ', '308273005': 'Follow-up status '}}
{'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}}

2644144
patients who have had a respiratory tract infection.
patients who have had a respiratory tract infection.
['patients', 'a respiratory tract infection']
{'patients': {'116154003': 'Patient '}, 'a respiratory tract infection': {'275498002': 'Respiratory tract infection '}}
{'a respiratory tract infection': {'275498002': ('clinical finding', 'Respiratory tract infection ', ['64572001', '118234003'])}}

2644605
significant heart involvement
significant heart involvement
['significant heart involvement']
{'significant heart involvement': {'386134007': 'Significant ', '80891009': 'Heart structure ', '248448006': 'Involved ', '278112009': 'involvement with'}}
{'significant heart involvement': {'248448006': ('qualifier value', 'Involved ', ['272099008'])}}

2653225
allergy to antiplatelet drugs, heparin, stainless steel, contrast agents, sirolimus, or paclitaxel; participation in another coronary-device study; and terminal illness.
allergy to antiplatelet drugs, heparin, stainless steel, contrast agents, sirolimus, or paclitaxel; participation in another coronary-device study; and terminal illness.
['allergy to antiplatelet drugs,', 'heparin,', 'stainless steel,', 'contrast agents,', 'sirolimus,', 'paclitaxel']
{'allergy to antiplatelet drugs,': {'416093006': 'Allergic reaction caused by drug ', '416098002': 'Drug allergy '}, 'heparin,': {'372877000': 'Heparin ', '84812008': 'Heparin ', '96382006': 'Unfractionated heparin ', '412201008': 'Porcine heparin ', '412401006': 'Porcine heparin '}, 'stainless steel,': {'256506002': 'Stainless steel material '}, 'contrast agents,': {'385420005': 'Contrast media ', '407935004': 'Contrast media '}, 'sirolimus,': {'116109004': 'Sirolimus ', '387014003': 'Sirolimus '}, 'paclitaxel': {'387374002': 'Paclitaxel ', '67735003': 'Paclitaxel '}}
{'allergy to antiplatelet drugs,': {'416093006': ('clinical finding', 'Allergic reaction caused by drug ', ['64572001'])}, 'heparin,': {'372877000': ('product', 'Heparin ', ['406455002', '312413002', '115668003', '312412007']), '84812008': ('product', 'Heparin ', ['763158003']), '412201008': ('product', 'Porcine heparin ', ['406455002', '312413002', '115668003', '312412007']), '412401006': ('product', 'Porcine heparin ', ['763158003'])}, 'contrast agents,': {'407935004': ('product', 'Contrast media ', ['763158003'])}, 'sirolimus,': {'116109004': ('product', 'Sirolimus ', ['763158003']), '387014003': ('product', 'Sirolimus ', ['406455002', '312413002', '312412007'])}, 'paclitaxel': {'387374002': ('product', 'Paclitaxel ', ['406455002', '115668003', '312413002']), '67735003': ('product', 'Paclitaxel ', ['763158003'])}}

2656383
known hypersensitivity to drugs of the same class as the study treatment, or any excipients of the drug formulation.
known hypersensitivity to drugs of the same class as the study treatment, or any excipients of the drug formulation.
['known hypersensitivity to drugs of the same class', 'as the study treatment,', 'any excipients of the drug formulation']
{'known hypersensitivity to drugs of the same class': {'36692007': 'Known ', '262126009': 'Same ', '258391009': 'Classes ', '277046005': 'class'}, 'as the study treatment,': {'224699009': 'Study ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '416118004': 'Administration '}, 'any excipients of the drug formulation': {'360215002': 'Pharmaceutical excipient ', '43747001': 'Drug excipient '}}
{'known hypersensitivity to drugs of the same class': {'262126009': ('qualifier value', 'Same ', ['272099008']), '258391009': ('qualifier value', 'Classes ', ['272396007'])}, 'as the study treatment,': {'276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '416118004': ('procedure', 'Administration ', ['128927009'])}, 'any excipients of the drug formulation': {'360215002': ('product', 'Pharmaceutical excipient ', ['312412007'])}}

2672375
pregnant or breast feeding.
pregnant or breast feeding.
['pregnant', 'breast feeding']
{'pregnant': {'77386006': 'Patient currently pregnant ', '127362006': 'Previous pregnancies ', '161732006': 'Gravida ', '364323006': 'Quantity of pregnancy ', '366321006': 'Finding of gravida '}, 'breast feeding': {'169741004': 'Breast fed ', '413712001': 'Breastfeeding '}}
{'pregnant': {'77386006': ('clinical finding', 'Patient currently pregnant ', ['250171008']), '127362006': ('clinical finding', 'Previous pregnancies ', ['250171008']), '161732006': ('observable entity', 'Gravida ', ['363788007']), '364323006': ('observable entity', 'Quantity of pregnancy ', ['363788007']), '366321006': ('clinical finding', 'Finding of gravida ', ['250171008'])}, 'breast feeding': {'169741004': ('clinical finding', 'Breast fed ', ['250171008']), '413712001': ('observable entity', 'Breastfeeding ', ['246464006'])}}

2679516
history of, diagnosed or suspected genital malignancy or other malignancy , and untreated cervical dysplasia.
, , diagnosed or suspected genital malignancy or other malignancy , and untreated cervical dysplasia.
['diagnosed', 'suspected genital malignancy', 'other malignancy ,', 'untreated cervical dysplasia']
{'diagnosed': {'439401001': 'Diagnosis '}, 'suspected genital malignancy': {'162572001': 'Suspected malignancy ', '263767004': 'Genital ', '71934003': 'Genital structure '}, 'other malignancy ,': {'363346000': 'Malignant neoplastic disease ', '372087000': 'Primary malignant neoplasm ', '86049000': 'Malignant neoplasm, primary '}, 'untreated cervical dysplasia': {'25265005': 'Did not receive therapy or drug for ', '73391008': 'Dysplasia of cervix ', '285636001': 'Cervical intraepithelial neoplasia '}}
{'suspected genital malignancy': {'162572001': ('situation with explicit context', 'Suspected malignancy ', ['413350009'])}, 'other malignancy ,': {'363346000': ('clinical finding', 'Malignant neoplastic disease ', ['64572001']), '372087000': ('clinical finding', 'Primary malignant neoplasm ', ['64572001', '363346000'])}, 'untreated cervical dysplasia': {'73391008': ('clinical finding', 'Dysplasia of cervix ', ['64572001', '118234003']), '285636001': ('clinical finding', 'Cervical intraepithelial neoplasia ', ['64572001', '118234003', '73391008'])}}

2692964
life expectancy of any member in the family is shorter than 6 months in doctor's opinion
life expectancy of any member in the family is shorter than 6 months in doctor's opinion
['life expectancy of any member', 'in the family', 'shorter than 6 months', "in doctor's opinion"]
{'life expectancy of any member': {'224130005': 'Household composition ', '385635001': 'Expectations ', '410517006': 'Expectation context ', '394852005': 'member'}, 'in the family': {'35359004': 'Family '}, 'shorter than 6 months': {'359530003': 'Shortened ', '258706009': 'month ', '367450005': 'Short '}, "in doctor's opinion": {'112247003': 'Medical doctor ', '158965000': 'Medical practitioner ', '309343006': 'Physician '}}
{'life expectancy of any member': {'224130005': ('observable entity', 'Household composition ', ['160476009'])}, 'shorter than 6 months': {'359530003': ('qualifier value', 'Shortened ', ['272099008']), '258706009': ('unit', 'month ', ['767524001']), '367450005': ('qualifier value', 'Short ', ['272099008'])}}

2695963
an acute infection requiring ongoing antibiotic therapy of infection)
an acute infection requiring ongoing antibiotic therapy of infection)
['an acute infection requiring ongoing antibiotic therapy of infection']
{'an acute infection requiring ongoing antibiotic therapy of infection': {'63171007': 'Acute infectious disease ', '255238004': 'Continuous ', '281789004': 'Antibiotic therapy '}}
{'an acute infection requiring ongoing antibiotic therapy of infection': {'63171007': ('clinical finding', 'Acute infectious disease ', ['64572001']), '255238004': ('qualifier value', 'Continuous ', ['272099008']), '281789004': ('procedure', 'Antibiotic therapy ', ['128927009'])}}

2697102
intractable severe diarrhea.
intractable severe diarrhea.
['intractable severe diarrhea']
{'intractable severe diarrhea': {'20646008': 'Intractable ', '409587002': 'Severe diarrhea '}}
{'intractable severe diarrhea': {'20646008': ('qualifier value', 'Intractable ', ['272099008']), '409587002': ('clinical finding', 'Severe diarrhea ', ['118234003'])}}

2697359
missing informed consent
missing informed consent
['missing informed consent']
{'missing informed consent': {'108968006': 'Oprelvekin ', '410938009': 'Oprelvekin ', '223458004': 'Informing '}}
{'missing informed consent': {'108968006': ('product', 'Oprelvekin ', ['406455002', '312413002', '115668003']), '410938009': ('product', 'Oprelvekin ', ['763158003'])}}

2700283
blood products within 56 days prior to study vaccination.
blood products , prior to study vaccination.
['blood products', 'prior to study vaccination']
{'blood products': {'410652009': 'Blood product '}, 'prior to study vaccination': {'224699009': 'Study ', '33879002': 'Administration of vaccine to produce active immunity '}}
{'prior to study vaccination': {'33879002': ('procedure', 'Administration of vaccine to produce active immunity ', ['128927009'])}}

2709236
prospective participants or their legal guardians who, based on the judgment of the team, appear to have impaired ability to understand and appropriately use complex medical information and genetic information, or to cope with potentially life altering medical information, will be ineligible.
prospective participants or their legal guardians who, based on the judgment of the team, appear to have impaired understand and appropriately use complex medical information and genetic information, or to cope with potentially life altering medical information, will be ineligible.
['their legal guardians', 'based on the judgment of the team,', 'appear', 'to', 'impaired', 'understand', 'use', 'complex medical information', 'genetic information,', 'cope with potentially life', 'altering', 'medical information,']
{'their legal guardians': {'58626002': 'Legal guardian '}, 'based on the judgment of the team,': {'63813000': 'Alkali ', '61254005': 'Judgement '}, 'appear': {'255412001': 'Appearances ', '703248002': 'Appearance ', '718498007': 'Appearance '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'impaired': {'260379002': 'Impaired '}, 'understand': {'66216009': 'Understanding, function '}, 'use': {'277889008': 'usage', '419385000': 'Use - dosing instruction imperative '}, 'complex medical information': {'103360007': 'Complex ', '373655009': 'Medical service ', '74188005': 'Medical '}, 'genetic information,': {'394613000': 'Gene therapy '}, 'cope with potentially life': {'405056001': 'Coping behavior ', '224130005': 'Household composition '}, 'altering': {'18307000': 'Altered ', '243326001': 'Changing '}, 'medical information,': {'373655009': 'Medical service ', '74188005': 'Medical '}}
{'based on the judgment of the team,': {'63813000': ('product', 'Alkali ', ['312413002']), '61254005': ('observable entity', 'Judgement ', ['363788007'])}, 'appear': {'255412001': ('qualifier value', 'Appearances ', ['272099008']), '703248002': ('observable entity', 'Appearance ', ['414237002'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'understand': {'66216009': ('observable entity', 'Understanding, function ', ['246464006'])}, 'complex medical information': {'103360007': ('qualifier value', 'Complex ', ['272099008']), '74188005': ('qualifier value', 'Medical ', ['272099008'])}, 'cope with potentially life': {'405056001': ('observable entity', 'Coping behavior ', ['363788007']), '224130005': ('observable entity', 'Household composition ', ['160476009'])}, 'altering': {'18307000': ('qualifier value', 'Altered ', ['272099008']), '243326001': ('qualifier value', 'Changing ', ['272099008'])}, 'medical information,': {'74188005': ('qualifier value', 'Medical ', ['272099008'])}}

2720544
myopathy, history of rhabdomyolysis or myopathy due to statins or fibrates, or elevated ck level ≥ 5 x upper limit of normal during the previous statin treatment
myopathy, , rhabdomyolysis or myopathy due to statins or fibrates, or elevated ck level ≥ 5 x upper limit of normal during the , statin treatment
['myopathy,', 'rhabdomyolysis', 'myopathy due to statins', 'elevated ck level  5 x upper limit of normal', 'statin treatment']
{'myopathy,': {'129565002': 'Disorder of skeletal AND/OR smooth muscle '}, 'rhabdomyolysis': {'240131006': 'Rhabdomyolysis ', '89010004': 'Rhabdomyolysis '}, 'myopathy due to statins': {'129565002': 'Disorder of skeletal AND/OR smooth muscle ', '42752001': 'due to', '372912004': '3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor ', '96302009': 'Hydroxymethylglutaryl-coenzyme A reductase inhibitor '}, 'elevated ck level  5 x upper limit of normal': {'75540009': 'High ', '75828004': 'Creatine kinase ', '277737005': 'Level 5 ', '261183002': 'Upper ', '264217000': 'Superior ', '352730000': 'Supra- ', '260394003': 'Normal limits '}, 'statin treatment': {'372912004': '3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor ', '96302009': 'Hydroxymethylglutaryl-coenzyme A reductase inhibitor ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '416118004': 'Administration '}}
{'myopathy,': {'129565002': ('clinical finding', 'Disorder of skeletal AND/OR smooth muscle ', ['64572001', '118234003'])}, 'rhabdomyolysis': {'240131006': ('clinical finding', 'Rhabdomyolysis ', ['64572001', '118234003', '129565002'])}, 'myopathy due to statins': {'129565002': ('clinical finding', 'Disorder of skeletal AND/OR smooth muscle ', ['64572001', '118234003']), '96302009': ('product', 'Hydroxymethylglutaryl-coenzyme A reductase inhibitor ', ['763158003'])}, 'elevated ck level  5 x upper limit of normal': {'75540009': ('qualifier value', 'High ', ['272099008']), '75828004': ('product', 'Creatine kinase ', ['312413002', '115668003', '312412007']), '277737005': ('qualifier value', 'Level 5 ', ['272396007']), '352730000': ('qualifier value', 'Supra- ', ['272099008'])}, 'statin treatment': {'96302009': ('product', 'Hydroxymethylglutaryl-coenzyme A reductase inhibitor ', ['763158003']), '276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '416118004': ('procedure', 'Administration ', ['128927009'])}}

2725995
currently using nicotine replacement therapies or other pharmacotherapies as cessation aid
currently using nicotine replacement therapies or other pharmacotherapies as cessation aid
['currently', 'using', 'nicotine replacement therapies', 'other pharmacotherapies as cessation aid']
{'currently': {'15240007': 'Current '}, 'using': {'260676000': 'use of'}, 'nicotine replacement therapies': {'313396002': 'Nicotine replacement therapy '}, 'other pharmacotherapies as cessation aid': {'416608005': 'Drug therapy ', '246088000': 'manufactured aid', '116697009': 'assisted ', '371152001': 'Assisted '}}
{'nicotine replacement therapies': {'313396002': ('situation with explicit context', 'Nicotine replacement therapy ', ['129125009'])}, 'other pharmacotherapies as cessation aid': {'416608005': ('procedure', 'Drug therapy ', ['128927009'])}}

2733243
> 7 alcoholic drinks a week for females or 14 alcoholic drinks a week for males.
> 7 alcoholic drinks a week for females or 14 alcoholic drinks a week for males.
['> 7 alcoholic', 'drinks', 'a week for females', '14 alcoholic', 'a week for males']
{'> 7 alcoholic': {'228281002': 'Problem drinker '}, 'drinks': {'226465004': 'Drinks ', '230118003': 'drink '}, 'a week for females': {'14497002': 'Weekly ', '259038000': 'per week ', '1086007': 'Female structure ', '248152002': 'Female ', '258705008': 'week '}, '14 alcoholic': {'228281002': 'Problem drinker '}, 'a week for males': {'14497002': 'Weekly ', '259038000': 'per week ', '10052007': 'Male structure ', '248153007': 'Male ', '258705008': 'week '}}
{'> 7 alcoholic': {'228281002': ('clinical finding', 'Problem drinker ', ['250171008'])}, 'a week for females': {'14497002': ('qualifier value', 'Weekly ', ['272099008']), '259038000': ('unit', 'per week ', ['767524001']), '248152002': ('clinical finding', 'Female ', ['365860008']), '258705008': ('unit', 'week ', ['767524001'])}, '14 alcoholic': {'228281002': ('clinical finding', 'Problem drinker ', ['250171008'])}, 'a week for males': {'14497002': ('qualifier value', 'Weekly ', ['272099008']), '259038000': ('unit', 'per week ', ['767524001']), '248153007': ('clinical finding', 'Male ', ['365860008']), '258705008': ('unit', 'week ', ['767524001'])}}

2733872
have had hiv-1 vaccines in a clinical study.
have had hiv-1 vaccines in a clinical study.
['hiv 1 vaccines in a clinical study']
{'hiv 1 vaccines in a clinical study': {'89293008': 'Human immunodeficiency virus type I ', '398827000': 'Vaccine ', '71181003': 'Vaccine ', '58147004': 'Clinical ', '224699009': 'Study '}}
{'hiv 1 vaccines in a clinical study': {'89293008': ('clinical finding', 'Human immunodeficiency virus type I ', ['49872002']), '398827000': ('product', 'Vaccine ', ['115668003']), '71181003': ('product', 'Vaccine ', ['763158003']), '58147004': ('qualifier value', 'Clinical ', ['272099008'])}}

2737994
patients not treated adequately for soil-transmitted helminthic diseases
patients not treated adequately for soil-transmitted helminthic diseases
['patients', 'treated', 'adequately for soil', 'transmitted', 'helminthic diseases']
{'patients': {'116154003': 'Patient '}, 'treated': {'276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '116700008': 'treatment intent', '395077000': 'Treatment intent '}, 'adequately for soil': {'415555003': 'Soil '}, 'transmitted': {'60117003': 'transmitted by', '258150004': 'Transmission '}, 'helminthic diseases': {'37017009': 'Helminth ', '704663000': 'Parasitic worm specimen ', '64572001': 'Disease '}}
{'treated': {'276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '395077000': ('situation with explicit context', 'Treatment intent ', ['129125009'])}, 'adequately for soil': {'415555003': ('product', 'Soil ', ['115669006'])}}

2769104
recent tooth extraction or major dental procedure within 3 weeks of study entry
recent tooth extraction or major dental procedure , of study entry
['recent tooth extraction', 'major dental procedure', 'of study entry']
{'recent tooth extraction': {'263852005': 'Recent episode ', '6493001': 'Recent ', '55162003': 'Tooth extraction '}, 'major dental procedure': {'24484000': 'Severe ', '108306002': 'Dental-oral procedure AND/OR service ', '225362009': 'Dental care ', '255603008': 'Major '}, 'of study entry': {'224699009': 'Study '}}
{'recent tooth extraction': {'263852005': ('qualifier value', 'Recent episode ', ['272099008']), '55162003': ('procedure', 'Tooth extraction ', ['362958002', '128927009'])}, 'major dental procedure': {'24484000': ('qualifier value', 'Severe ', ['272396007']), '225362009': ('procedure', 'Dental care ', ['243120004']), '255603008': ('qualifier value', 'Major ', ['272396007'])}}

2770554
tumor markers
tumor markers
['tumor markers']
{'tumor markers': {'108369006': 'Neoplasm '}}
{}

2773204
body mass index ≥ 35.
body mass index ≥ 35.
['body mass index  35']
{'body mass index  35': {'301331008': 'Finding of body mass index ', '732694002': '35', '60621009': 'Body mass index '}}
{'body mass index  35': {'301331008': ('clinical finding', 'Finding of body mass index ', ['250171008']), '60621009': ('observable entity', 'Body mass index ', ['363788007'])}}

2778838
current or recent respiratory infection
current or recent respiratory infection
['current', 'recent respiratory infection']
{'current': {'15240007': 'Current '}, 'recent respiratory infection': {'263852005': 'Recent episode ', '6493001': 'Recent ', '275498002': 'Respiratory tract infection '}}
{'recent respiratory infection': {'263852005': ('qualifier value', 'Recent episode ', ['272099008']), '275498002': ('clinical finding', 'Respiratory tract infection ', ['64572001', '118234003'])}}

2784069-1
a recognised significant co-existing respiratory disease, defined as a respiratory condition that exhibits a clinically relevant effect on respiratory symptoms and disease progression as determined by the principal investigator following multi-disciplinary discussion.
a recognised significant co-existing respiratory disease, defined as a respiratory condition determined by the principal investigator following multi-disciplinary discussion.
['a recognised significant', 'co existing', 'respiratory disease,', 'defined as a respiratory condition', 'determined by the principal investigator', 'following', 'multi disciplinary discussion']
{'a recognised significant': {'386134007': 'Significant '}, 'co existing': {'223717005': 'Colombia '}, 'respiratory disease,': {'50043002': 'Disorder of respiratory system '}, 'defined as a respiratory condition': {'900000000000073002': 'sufficiently defined concept definition status ', '50043002': 'Disorder of respiratory system '}, 'determined by the principal investigator': {'436000': 'Determined by ', '63161005': 'Principal ', '302311007': 'Teaching principal '}, 'following': {'237679004': 'Status post ', '255234002': 'status post', '255260001': 'following'}, 'multi disciplinary discussion': {'255204007': 'Multiple ', '260396001': 'Numerous ', '223482009': 'Discussion ', '2081000124103': 'multiple chronic conditions'}}
{'respiratory disease,': {'50043002': ('clinical finding', 'Disorder of respiratory system ', ['64572001', '118234003'])}, 'defined as a respiratory condition': {'50043002': ('clinical finding', 'Disorder of respiratory system ', ['64572001', '118234003'])}, 'determined by the principal investigator': {'63161005': ('qualifier value', 'Principal ', ['272099008'])}, 'multi disciplinary discussion': {'255204007': ('qualifier value', 'Multiple ', ['272099008']), '260396001': ('qualifier value', 'Numerous ', ['272099008']), '223482009': ('procedure', 'Discussion ', ['128927009']), '2081000124103': ('situation with explicit context', 'multiple chronic conditions', ['413350009'])}}

2784069-2
for example, patients with bronchiectasis will only be included if the bronchiectasis is deemed to be traction bronchiectasis as a result of idiopathic pulmonary fibrosis.
for example, patients with bronchiectasis will only be included if the bronchiectasis is deemed to be traction bronchiectasis as a result of idiopathic pulmonary fibrosis.
['patients with bronchiectasis', 'only', 'included', 'the bronchiectasis', 'to', 'traction bronchiectasis as a result of idiopathic pulmonary fibrosis']
{'patients with bronchiectasis': {'116154003': 'Patient ', '12295008': 'Bronchiectasis '}, 'only': {'50607009': 'Singular ', '420295001': 'Only - dosing instruction fragment '}, 'included': {'55919000': 'Including '}, 'the bronchiectasis': {'12295008': 'Bronchiectasis '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'traction bronchiectasis as a result of idiopathic pulmonary fibrosis': {'19325002': 'Traction bronchiectasis ', '394617004': 'Result ', '196125002': 'Diffuse interstitial pulmonary fibrosis ', '236302005': 'Acute interstitial pneumonia ', '700250006': 'Idiopathic pulmonary fibrosis ', '426437004': 'Familial idiopathic pulmonary fibrosis '}}
{'patients with bronchiectasis': {'12295008': ('clinical finding', 'Bronchiectasis ', ['64572001', '118234003'])}, 'only': {'50607009': ('qualifier value', 'Singular ', ['272099008'])}, 'included': {'55919000': ('qualifier value', 'Including ', ['272099008'])}, 'the bronchiectasis': {'12295008': ('clinical finding', 'Bronchiectasis ', ['64572001', '118234003'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'traction bronchiectasis as a result of idiopathic pulmonary fibrosis': {'19325002': ('clinical finding', 'Traction bronchiectasis ', ['64572001', '12295008', '118234003']), '196125002': ('clinical finding', 'Diffuse interstitial pulmonary fibrosis ', ['64572001', '118234003']), '236302005': ('clinical finding', 'Acute interstitial pneumonia ', ['64572001', '118234003']), '700250006': ('clinical finding', 'Idiopathic pulmonary fibrosis ', ['64572001', '118234003']), '426437004': ('clinical finding', 'Familial idiopathic pulmonary fibrosis ', ['64572001', '700250006', '118234003'])}}

2784160-1
breast feeding infants whose mothers are taking acyclovir, valacyclovir, or famciclovir for >120 hours .
breast feeding infants whose mothers are taking acyclovir, valacyclovir, or famciclovir for >120 hours .
['breast feeding infants', 'whose mothers', 'taking acyclovir,', 'valacyclovir,', 'famciclovir for', '>120 hours']
{'breast feeding infants': {'413711008': 'Breastfeeding '}, 'whose mothers': {'72705000': 'Mother '}, 'taking acyclovir,': {'419652001': 'Take - dosing instruction imperative ', '372729009': 'Acyclovir ', '41193000': 'Acyclovir ', '425884003': 'Ophthalmic form acyclovir '}, 'valacyclovir,': {'324820003': 'Valacyclovir product ', '96098007': 'Valacyclovir '}, 'famciclovir for': {'387557001': 'Famciclovir ', '96097002': 'Famciclovir '}, '>120 hours': {'732474002': '120', '258702006': 'hour '}}
{'breast feeding infants': {'413711008': ('observable entity', 'Breastfeeding ', ['246464006'])}, 'taking acyclovir,': {'372729009': ('product', 'Acyclovir ', ['406455002', '312413002']), '41193000': ('product', 'Acyclovir ', ['763158003'])}, 'valacyclovir,': {'324820003': ('product', 'Valacyclovir product ', ['763158003']), '96098007': ('product', 'Valacyclovir ', ['406455002', '312413002'])}, 'famciclovir for': {'387557001': ('product', 'Famciclovir ', ['406455002', '312413002']), '96097002': ('product', 'Famciclovir ', ['763158003'])}, '>120 hours': {'258702006': ('unit', 'hour ', ['767524001'])}}

2784160-2
if at any point following enrollment the mother takes these antiviral drugs for >120 hours , she will be asked to refrain from breast feeding while taking the drug.
if at any point following enrollment the mother takes these antiviral drugs for >120 hours , she will be asked to refrain from breast feeding while taking the drug.
['following', 'the mother', 'takes', 'these antiviral drugs for', '>120 hours ,', 'to', 'refrain from breast feeding', 'taking', 'the drug']
{'following': {'237679004': 'Status post ', '255234002': 'status post', '255260001': 'following'}, 'the mother': {'72705000': 'Mother '}, 'takes': {'419652001': 'Take - dosing instruction imperative '}, 'these antiviral drugs for': {'32249005': 'Antiviral agent ', '372701006': 'Antiviral agent '}, '>120 hours ,': {'732474002': '120', '258702006': 'hour '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'refrain from breast feeding': {'169741004': 'Breast fed ', '413712001': 'Breastfeeding '}, 'taking': {'419652001': 'Take - dosing instruction imperative '}, 'the drug': {'105903003': 'General drug type ', '373873005': 'Pharmaceutical / biologic product ', '410942007': 'Drug or medicament '}}
{'these antiviral drugs for': {'32249005': ('product', 'Antiviral agent ', ['373873005', '763158003'])}, '>120 hours ,': {'258702006': ('unit', 'hour ', ['767524001'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'refrain from breast feeding': {'169741004': ('clinical finding', 'Breast fed ', ['250171008']), '413712001': ('observable entity', 'Breastfeeding ', ['246464006'])}}

2786282
patients undergoing therapeutic upper endoscopy
patients undergoing therapeutic upper endoscopy
['patients', 'therapeutic upper endoscopy']
{'patients': {'116154003': 'Patient '}, 'therapeutic upper endoscopy': {'385423007': 'Therapeutic endoscopic procedure ', '261183002': 'Upper ', '264217000': 'Superior ', '352730000': 'Supra- ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '386831001': 'Endoscopy of stomach ', '262202000': 'Therapeutic intent '}}
{'therapeutic upper endoscopy': {'385423007': ('procedure', 'Therapeutic endoscopic procedure ', ['277132007', '363691001']), '352730000': ('qualifier value', 'Supra- ', ['272099008']), '276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '386831001': ('procedure', 'Endoscopy of stomach ', ['363691001', '362958002', '128927009']), '262202000': ('qualifier value', 'Therapeutic intent ', ['272099008'])}}

2786530
subjects belonging to 1 of the following groups will be excluded from the study:
subjects belonging to 1 of the following groups will be excluded from the study:
['belonging to 1 of the following groups', 'excluded from the study']
{'belonging to 1 of the following groups': {'367409002': 'followed by', '258366009': 'Group 1 ', '421939007': 'Follow - dosing instruction imperative '}, 'excluded from the study': {'77765009': 'Exclude ', '224699009': 'Study '}}
{'belonging to 1 of the following groups': {'258366009': ('qualifier value', 'Group 1 ', ['272396007'])}, 'excluded from the study': {'77765009': ('qualifier value', 'Exclude ', ['272099008'])}}

2788084
direct bilirubin > or = 2 times uln.
direct bilirubin > or = 2 times uln.
['direct bilirubin', '= 2 times uln']
{'direct bilirubin': {'54462003': 'Direct reacting bilirubin ', '79706000': 'Bilirubin '}, '= 2 times uln': {'260306008': 'Integer +2 ', '410669006': 'Time ', '410670007': 'time', '417929005': 'Times '}}
{'direct bilirubin': {'54462003': ('product', 'Direct reacting bilirubin ', ['312413002']), '79706000': ('product', 'Bilirubin ', ['312413002', '312412007'])}}

2790651
eating disorder
eating disorder
['eating disorder']
{'eating disorder': {'72366004': 'Eating disorder '}}
{'eating disorder': {'72366004': ('clinical finding', 'Eating disorder ', ['64572001'])}}

2810403
women of child bearing potential patients must demonstrate a negative pregnancy test performed within 24 hours before ct
women of child bearing potential patients must demonstrate a negative pregnancy test performed within 24 hours before ct
['women of child bearing potential patients', 'a negative pregnancy test', 'performed within 24 hours', 'before ct']
{'women of child bearing potential patients': {'224526002': 'Woman ', '160499008': 'Child of ', '106970005': 'Family Ursidae ', '116154003': 'Patient '}, 'a negative pregnancy test': {'250425007': 'Pregnancy test negative '}, 'performed within 24 hours': {'398166005': 'Performed ', '123027009': '24 hours ', '259029002': 'per 24 hours '}, 'before ct': {'223522008': 'Central African Republic '}}
{'women of child bearing potential patients': {'224526002': ('person', 'Woman ', ['133936004']), '160499008': ('clinical finding', 'Child of ', ['118240005'])}, 'a negative pregnancy test': {'250425007': ('clinical finding', 'Pregnancy test negative ', ['441742003'])}, 'performed within 24 hours': {'123027009': ('qualifier value', '24 hours ', ['272099008']), '259029002': ('unit', 'per 24 hours ', ['767524001'])}}

2812325
some artificial heart valves
some artificial heart valves
['some artificial heart valves']
{'some artificial heart valves': {'25510005': 'Cardiac valve prosthesis, device '}}
{}

2813640
impairment of gastrointestinal function, or a gi disease that may significantly alter the absorption of study drugs .
impairment of gastrointestinal function, or a gi disease .
['impairment of gastrointestinal function,', 'a gi disease']
{'impairment of gastrointestinal function,': {'260379002': 'Impaired ', '246464006': 'Function ', '277064003': 'function', '40226000': 'Impairment '}, 'a gi disease': {'119292006': 'Disorder of gastrointestinal tract ', '25374005': 'Gastroenteritis ', '53619000': 'Disorder of digestive system '}}
{'impairment of gastrointestinal function,': {'40226000': ('clinical finding', 'Impairment ', ['250171008', '365860008'])}, 'a gi disease': {'119292006': ('clinical finding', 'Disorder of gastrointestinal tract ', ['53619000', '64572001', '118234003']), '25374005': ('clinical finding', 'Gastroenteritis ', ['53619000', '64572001', '119292006', '118234003']), '53619000': ('clinical finding', 'Disorder of digestive system ', ['64572001', '118234003'])}}

2816499
myopia >6.0 d
myopia >6.0 d
['myopia']
{'myopia': {'57190000': 'Myopia '}}
{'myopia': {'57190000': ('clinical finding', 'Myopia ', ['64572001', '118234003'])}}

2833166
history of urinary retention
, urinary retention
['urinary retention']
{'urinary retention': {'130951007': 'Bladder retention of urine ', '267064002': 'Retention of urine ', '449491000124101': 'urinary retention'}}
{'urinary retention': {'130951007': ('observable entity', 'Bladder retention of urine ', ['363788007']), '267064002': ('clinical finding', 'Retention of urine ', ['64572001', '118234003']), '449491000124101': ('clinical finding', 'urinary retention', ['250171008', '118234003'])}}

2847031
be serum positive for hiv, hepatitis bsag or viremic hepatitis c.
be serum positive for hiv, hepatitis bsag or viremic hepatitis c.
['serum positive for hiv,', 'hepatitis bsag', 'viremic hepatitis c']
{'serum positive for hiv,': {'67922002': 'Serum ', '10828004': 'Positive ', '19030005': 'Human immunodeficiency virus ', '165816005': 'Human immunodeficiency virus positive ', '119364003': 'Serum specimen '}, 'hepatitis bsag': {'128241005': 'Inflammatory disease of liver ', '40468003': 'Viral hepatitis, type A '}, 'viremic hepatitis c': {'2528003': 'Viremia ', '186634008': 'Hepatitis non-A non-B ', '50711007': 'Viral hepatitis type C ', '62944002': 'Hepatitis C virus '}}
{'serum positive for hiv,': {'67922002': ('product', 'Serum ', ['115669006', '115668003']), '10828004': ('qualifier value', 'Positive ', ['272099008']), '19030005': ('clinical finding', 'Human immunodeficiency virus ', ['49872002']), '165816005': ('clinical finding', 'Human immunodeficiency virus positive ', ['441742003'])}, 'hepatitis bsag': {'128241005': ('clinical finding', 'Inflammatory disease of liver ', ['64572001', '118234003']), '40468003': ('clinical finding', 'Viral hepatitis, type A ', ['64572001', '118234003', '128241005'])}, 'viremic hepatitis c': {'2528003': ('clinical finding', 'Viremia ', ['118234003']), '50711007': ('clinical finding', 'Viral hepatitis type C ', ['64572001', '118234003', '128241005']), '62944002': ('clinical finding', 'Hepatitis C virus ', ['49872002'])}}

2847638
bone disease
bone disease
['bone disease']
{'bone disease': {'76069003': 'Disorder of bone '}}
{'bone disease': {'76069003': ('clinical finding', 'Disorder of bone ', ['64572001', '118234003'])}}

2853595
results of complementary laboratorial exams outside the values considered normal according to this protocol rules, unless they are considered non-clinically significant by the researcher.
results of complementary laboratorial exams outside the values considered normal according to this protocol rules, unless they are considered non-clinically significant by the researcher.
['results of complementary laboratorial exams', 'outside', 'normal according to this protocol rules,', 'non clinically significant by the researcher']
{'results of complementary laboratorial exams': {'394617004': 'Result ', '261904005': 'Laboratory ', '225886003': 'Medical assessment '}, 'outside': {'261074009': 'External '}, 'normal according to this protocol rules,': {'17621005': 'Normal ', '258049002': 'Protocols ', '102304005': 'Measuring ruler, device ', '10828004': 'Positive ', '8117002': 'Gait normal ', '258744000': '% normal '}, 'non clinically significant by the researcher': {'386134007': 'Significant '}}
{'results of complementary laboratorial exams': {'225886003': ('procedure', 'Medical assessment ', ['128927009'])}, 'normal according to this protocol rules,': {'17621005': ('qualifier value', 'Normal ', ['272099008']), '10828004': ('qualifier value', 'Positive ', ['272099008']), '8117002': ('clinical finding', 'Gait normal ', ['250171008']), '258744000': ('unit', '% normal ', ['767524001'])}}

2876517
any previous treatment with a programmed cell death protein 1 or pd-l1 inhibitor, including durvalumab.
any , treatment with a programmed cell death protein 1 or pd-l1 inhibitor, including durvalumab.
['treatment with a programmed cell death protein 1', 'pd l1 inhibitor', 'including']
{'treatment with a programmed cell death protein 1': {'276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '20663007': 'Apoptosis ', '413542001': 'Annexin A2 ', '416118004': 'Administration '}, 'pd l1 inhibitor': {'74139005': 'L1 stage '}, 'including': {'55919000': 'Including '}}
{'treatment with a programmed cell death protein 1': {'276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '413542001': ('product', 'Annexin A2 ', ['312413002', '115668003']), '416118004': ('procedure', 'Administration ', ['128927009'])}, 'pd l1 inhibitor': {'74139005': ('clinical finding', 'L1 stage ', ['250171008', '441742003'])}, 'including': {'55919000': ('qualifier value', 'Including ', ['272099008'])}}

2889073
abdominal / thoracic surgery
abdominal / thoracic surgery
['abdominal / thoracic surgery']
{'abdominal / thoracic surgery': {'113345001': 'Abdominal structure ', '277112006': 'Abdominal ', '408456005': 'Thoracic surgery ', '385487005': 'Surgical procedure on thorax '}}
{'abdominal / thoracic surgery': {'385487005': ('procedure', 'Surgical procedure on thorax ', ['362958002', '128927009'])}}

2890161
nephropathy (serum creatinine >150 µm and/or albuminuria
nephropathy (serum creatinine >150 µm and/or albuminuria
['nephropathy', '(serum creatinine', '>150 m', 'albuminuria']
{'nephropathy': {'90708001': 'Kidney disease '}, '(serum creatinine': {'113075003': 'Creatinine measurement, serum ', '365757006': 'Finding of serum creatinine level '}, '>150 m': {'258311008': 'M+ ', '277318003': 'm) '}, 'albuminuria': {'274769005': 'Albuminuria '}}
{'nephropathy': {'90708001': ('clinical finding', 'Kidney disease ', ['64572001', '118234003'])}, '(serum creatinine': {'113075003': ('procedure', 'Creatinine measurement, serum ', ['128927009']), '365757006': ('clinical finding', 'Finding of serum creatinine level ', ['441742003'])}, '>150 m': {'258311008': ('staging and scales', 'M+ ', ['254292007']), '277318003': ('staging and scales', 'm) ', ['254292007'])}, 'albuminuria': {'274769005': ('clinical finding', 'Albuminuria ', ['441742003'])}}

2891576
known resistance to >2 classes of art
known resistance to >2 classes of art
['known resistance to', '>2 classes of art']
{'known resistance to': {'36692007': 'Known ', '30714006': 'Resistant '}, '>2 classes of art': {'258393007': 'Class 2 '}}
{'>2 classes of art': {'258393007': ('qualifier value', 'Class 2 ', ['272396007'])}}

2900979
cardiac pacemakers, implanted medication pumps, intracardiac lines
cardiac pacemakers, implanted medication pumps, intracardiac lines
['cardiac pacemakers,', 'implanted medication pumps,', 'intracardiac lines']
{'cardiac pacemakers,': {'14106009': 'Cardiac pacemaker, device '}, 'implanted medication pumps,': {'40388003': 'Implant, device ', '105903003': 'General drug type ', '373873005': 'Pharmaceutical / biologic product ', '410942007': 'Drug or medicament ', '44668000': 'Pump, device ', '450841000124100': 'implanted medical device '}, 'intracardiac lines': {'264044002': 'Intracardiac ', '91744000': 'Cardiac chamber structure ', '50009006': 'Linear '}}
{'intracardiac lines': {'50009006': ('qualifier value', 'Linear ', ['272099008'])}}

2901744
has not recovered to grade 1 or better from any adverse events related to previous therapy.
has not recovered to grade 1 or better from any adverse events related to , therapy.
['recovered', 'to grade 1', 'better from any adverse events', 'related to', 'therapy']
{'recovered': {'74822006': 'Recovering from '}, 'to grade 1': {'223570002': 'Togo ', '54102005': 'G1 grade ', '9986007': 'Tryptophanase '}, 'better from any adverse events': {'3442003': 'Better ', '272379006': 'Event '}, 'related to': {'263498003': 'relationships', '272151006': 'Relationships ', '262094002': 'Related '}, 'therapy': {'276239002': 'Therapy ', '277132007': 'Therapeutic procedure '}}
{'to grade 1': {'54102005': ('clinical finding', 'G1 grade ', ['250171008', '441742003']), '9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'better from any adverse events': {'3442003': ('qualifier value', 'Better ', ['272099008'])}, 'related to': {'272151006': ('qualifier value', 'Relationships ', ['272099008']), '262094002': ('clinical finding', 'Related ', ['118240005'])}, 'therapy': {'276239002': ('procedure', 'Therapy ', ['277132007', '243120004'])}}

2901988
delayed gastric emptying syndrome
delayed gastric emptying syndrome
['delayed gastric emptying syndrome']
{'delayed gastric emptying syndrome': {'196753007': 'Gastric atonia ', '235675006': 'Gastroparesis ', '64572001': 'Disease ', '314944001': 'Delayed gastric emptying '}}
{'delayed gastric emptying syndrome': {'196753007': ('clinical finding', 'Gastric atonia ', ['64572001', '118234003']), '235675006': ('clinical finding', 'Gastroparesis ', ['64572001', '118234003']), '314944001': ('clinical finding', 'Delayed gastric emptying ', ['64572001', '118234003'])}}

2903174
chronic medication which could affect the results of the study (e.g., insulin, corticosteroids, antihistimines, steroidal or non-steroidal anti-inflammatory drugs [except for therapeutic maintenance dosage of aspirin], antibiotics, steroid inhalers, etc.)
chronic medication which could affect the results of the study (e.g., insulin, corticosteroids, antihistimines, steroidal or non-steroidal anti-inflammatory drugs [except for therapeutic maintenance dosage of aspirin], antibiotics, steroid inhalers, etc.)
['chronic medication', 'affect', 'the results of the study', 'insulin,', 'corticosteroids,', 'steroidal', 'non steroidal anti inflammatory drugs', 'except for therapeutic maintenance dosage of aspirin', 'antibiotics,', 'steroid inhalers,']
{'chronic medication': {'90734009': 'Chronic ', '105903003': 'General drug type ', '373873005': 'Pharmaceutical / biologic product ', '410942007': 'Drug or medicament '}, 'affect': {'4065008': 'Affect, function '}, 'the results of the study': {'394617004': 'Result ', '224699009': 'Study '}, 'insulin,': {'39487003': 'Insulin product ', '412222002': 'Regular insulin ', '67866001': 'Insulin '}, 'corticosteroids,': {'21568003': 'Adrenal cortical hormone ', '79440004': 'Corticoid preparation '}, 'steroidal': {'112113009': 'Steroid hormone ', '116566001': 'Steroid '}, 'non steroidal anti inflammatory drugs': {'16403005': 'Non-steroidal anti-inflammatory agent ', '372665008': 'Non-steroidal anti-inflammatory agent '}, 'except for therapeutic maintenance dosage of aspirin': {'5185003': 'except for', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '260911001': 'dosage', '277406006': 'Dosages ', '387458008': 'Aspirin ', '7947003': 'Aspirin ', '262202000': 'Therapeutic intent '}, 'antibiotics,': {'255631004': 'Antibiotic ', '417927007': 'Antibiotic antituberculosis agent '}, 'steroid inhalers,': {'112113009': 'Steroid hormone ', '116566001': 'Steroid ', '334980009': 'Inhaler ', '420317006': 'Inhaler '}}
{'chronic medication': {'90734009': ('qualifier value', 'Chronic ', ['272099008'])}, 'affect': {'4065008': ('observable entity', 'Affect, function ', ['246464006'])}, 'insulin,': {'39487003': ('product', 'Insulin product ', ['373873005', '763158003']), '412222002': ('product', 'Regular insulin ', ['410942007', '115668003', '67866001', '312413002']), '67866001': ('product', 'Insulin ', ['410942007', '115668003', '312413002'])}, 'corticosteroids,': {'79440004': ('product', 'Corticoid preparation ', ['373873005', '763158003'])}, 'steroidal': {'112113009': ('product', 'Steroid hormone ', ['312413002', '410942007', '116566001']), '116566001': ('product', 'Steroid ', ['312413002'])}, 'non steroidal anti inflammatory drugs': {'16403005': ('product', 'Non-steroidal anti-inflammatory agent ', ['373873005', '763158003'])}, 'except for therapeutic maintenance dosage of aspirin': {'276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '277406006': ('qualifier value', 'Dosages ', ['272099008']), '387458008': ('product', 'Aspirin ', ['410942007', '406455002', '312413002']), '7947003': ('product', 'Aspirin ', ['373873005', '763158003']), '262202000': ('qualifier value', 'Therapeutic intent ', ['272099008'])}, 'antibiotics,': {'255631004': ('product', 'Antibiotic ', ['373873005', '763158003'])}, 'steroid inhalers,': {'112113009': ('product', 'Steroid hormone ', ['312413002', '410942007', '116566001']), '116566001': ('product', 'Steroid ', ['312413002'])}}

2903568
experienced in the care of community children
experienced in the care of community children
['experienced in the care of community children']
{'experienced in the care of community children': {'133928008': 'Community ', '160870005': 'Child in care '}}
{'experienced in the care of community children': {'160870005': ('clinical finding', 'Child in care ', ['118240005'])}}

2903644
prior treatment with rociletinib, or other drugs that target t790m positive mutant egfr with sparing of wild type egfr
prior treatment with rociletinib, or other drugs
['prior treatment with rociletinib,', 'other drugs']
{'prior treatment with rociletinib,': {'236874000': 'Status pre- ', '288556008': 'before', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '416118004': 'Administration '}, 'other drugs': {'105903003': 'General drug type ', '373873005': 'Pharmaceutical / biologic product ', '410942007': 'Drug or medicament '}}
{'prior treatment with rociletinib,': {'276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '416118004': ('procedure', 'Administration ', ['128927009'])}}

2934026
subjects who had previously entered into this study or simultaneously participated in another clinical drug trial
subjects who had , ly entered into this study or simultaneously participated in another clinical drug trial
['ly', 'entered into this study', 'simultaneously', 'participated in another clinical drug trial']
{'ly': {'223512002': 'Libya '}, 'entered into this study': {'417985001': 'Enteral route ', '224699009': 'Study '}, 'simultaneously': {'79970003': 'Simultaneous '}, 'participated in another clinical drug trial': {'185922005': 'Clinical drug trial '}}
{'simultaneously': {'79970003': ('qualifier value', 'Simultaneous ', ['272099008'])}}

2937366
presence of severe renal disease or hepatic disease.
presence of severe renal disease or hepatic disease.
['presence of severe renal disease', 'hepatic disease']
{'presence of severe renal disease': {'52101004': 'Present ', '24484000': 'Severe ', '90708001': 'Kidney disease '}, 'hepatic disease': {'235856003': 'Disorder of liver '}}
{'presence of severe renal disease': {'24484000': ('qualifier value', 'Severe ', ['272396007']), '90708001': ('clinical finding', 'Kidney disease ', ['64572001', '118234003'])}, 'hepatic disease': {'235856003': ('clinical finding', 'Disorder of liver ', ['64572001', '118234003'])}}

2937445
history of revascularization or prior diagnosis of myocardial infarction
, revascularization or prior diagnosis of myocardial infarction
['revascularization', 'prior diagnosis of myocardial infarction']
{'revascularization': {'297183000': 'Revascularization - action '}, 'prior diagnosis of myocardial infarction': {'1755008': 'Old myocardial infarction ', '439401001': 'Diagnosis '}}
{'prior diagnosis of myocardial infarction': {'1755008': ('clinical finding', 'Old myocardial infarction ', ['64572001', '118234003'])}}

2941189
patient or patient's legal representative has been informed of the nature of the study and agrees to its provisions and has provided written informed consent as notified / approved by the institutional review board/ethics committee of the clinical site.
patient or patient's legal representative has been informed of the nature of the study and agrees to its provisions and has provided written informed consent as notified / approved by the institutional review board/ethics committee of the clinical site.
['patient', "patient's legal representative", 'informed of the nature of the study', 'written informed consent as notified /', 'approved by the institutional review board/ethics committee of the clinical site']
{'patient': {'116154003': 'Patient '}, "patient's legal representative": {'116154003': 'Patient ', '398165009': 'Legal '}, 'informed of the nature of the study': {'108968006': 'Oprelvekin ', '410938009': 'Oprelvekin ', '246425008': 'natures', '277302009': 'Natures ', '224699009': 'Study ', '223458004': 'Informing '}, 'written informed consent as notified /': {'12261009': 'Writing ', '108968006': 'Oprelvekin ', '410938009': 'Oprelvekin ', '185087000': 'Notifications ', '223458004': 'Informing '}, 'approved by the institutional review board/ethics committee of the clinical site': {'9571008': 'Approved ', '257622000': 'Healthcare facility ', '55210009': 'Review of ', '58147004': 'Clinical ', '10546003': 'site', '385437003': 'Institution '}}
{"patient's legal representative": {'398165009': ('qualifier value', 'Legal ', ['272099008'])}, 'informed of the nature of the study': {'108968006': ('product', 'Oprelvekin ', ['406455002', '312413002', '115668003']), '410938009': ('product', 'Oprelvekin ', ['763158003']), '277302009': ('qualifier value', 'Natures ', ['272099008'])}, 'written informed consent as notified /': {'12261009': ('observable entity', 'Writing ', ['246464006']), '108968006': ('product', 'Oprelvekin ', ['406455002', '312413002', '115668003']), '410938009': ('product', 'Oprelvekin ', ['763158003'])}, 'approved by the institutional review board/ethics committee of the clinical site': {'9571008': ('qualifier value', 'Approved ', ['272099008']), '58147004': ('qualifier value', 'Clinical ', ['272099008'])}}

2951802
laser photocoagulation in the study within 90 days of baseline
laser photocoagulation in the study , of baseline
['laser photocoagulation in the study , of baseline']
{'laser photocoagulation in the study , of baseline': {'224699009': 'Study '}}
{}

2953403
high risk for an acute cardiovascular event
high risk for an acute cardiovascular event
['high risk for an acute cardiovascular event']
{'high risk for an acute cardiovascular event': {'75540009': 'High ', '272118002': 'Acuteness ', '395112001': 'Cardiovascular event risk ', '371879000': 'Abnormally high '}}
{'high risk for an acute cardiovascular event': {'75540009': ('qualifier value', 'High ', ['272099008']), '272118002': ('qualifier value', 'Acuteness ', ['272099008']), '395112001': ('clinical finding', 'Cardiovascular event risk ', ['365860008']), '371879000': ('qualifier value', 'Abnormally high ', ['75540009', '272099008'])}}

2955102
grade iii/iv diarrhea in the screening period.
grade iii/iv diarrhea in the screening period.
['grade iii/iv diarrhea in the screening period']
{'grade iii/iv diarrhea in the screening period': {'263843001': 'Poorly differentiated ', '223561000': 'Ivory Coast ', '267060006': 'Diarrhea symptom ', '62315008': 'Diarrhea ', '20135006': 'Screening procedure ', '259037005': 'per period ', '272117007': 'Time periods ', '61026006': 'G3 grade ', '257471003': 'Roman numeral III '}}
{'grade iii/iv diarrhea in the screening period': {'263843001': ('qualifier value', 'Poorly differentiated ', ['272396007']), '267060006': ('clinical finding', 'Diarrhea symptom ', ['418799008', '62315008', '118234003']), '62315008': ('clinical finding', 'Diarrhea ', ['118234003']), '20135006': ('procedure', 'Screening procedure ', ['128927009']), '259037005': ('unit', 'per period ', ['767524001']), '272117007': ('qualifier value', 'Time periods ', ['272099008']), '61026006': ('clinical finding', 'G3 grade ', ['250171008', '441742003'])}}

2956214
patients who have received any investigational drugs within the last 3 months
patients who have received any investigational drugs ,
['patients', 'any investigational drugs']
{'patients': {'116154003': 'Patient '}, 'any investigational drugs': {'185922005': 'Clinical drug trial '}}
{}

2966512
equivalent) or other immunosuppressive medications within 14 days of first treatment.
equivalent) or other immunosuppressive medications , of first treatment.
['equivalent', 'other immunosuppressive medications', 'of first treatment']
{'equivalent': {'258726008': 'equivalent - unit ', '9726003': 'Equal '}, 'other immunosuppressive medications': {'372823004': 'Immunosuppressant ', '69431002': 'Immunosuppressant ', '105903003': 'General drug type ', '373873005': 'Pharmaceutical / biologic product ', '410942007': 'Drug or medicament '}, 'of first treatment': {'255216001': 'First ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '416118004': 'Administration ', '232714002': 'Firstly '}}
{'equivalent': {'258726008': ('unit', 'equivalent - unit ', ['767524001']), '9726003': ('qualifier value', 'Equal ', ['272099008'])}, 'other immunosuppressive medications': {'69431002': ('product', 'Immunosuppressant ', ['373873005', '763158003'])}, 'of first treatment': {'276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '416118004': ('procedure', 'Administration ', ['128927009']), '232714002': ('qualifier value', 'Firstly ', ['272099008'])}}

2966938
recent cardiovascular diseases
recent cardiovascular diseases
['recent cardiovascular diseases']
{'recent cardiovascular diseases': {'263852005': 'Recent episode ', '6493001': 'Recent ', '49601007': 'Disorder of cardiovascular system '}}
{'recent cardiovascular diseases': {'263852005': ('qualifier value', 'Recent episode ', ['272099008']), '49601007': ('clinical finding', 'Disorder of cardiovascular system ', ['64572001', '118234003'])}}

2977565
axial myopia of greater than -8 diopters in the eye that is to be implanted
axial myopia of greater than -8 diopters in the eye
['axial myopia of greater', 'than  8 diopters in the eye']
{'axial myopia of greater': {'408757002': 'Axial myopia ', '263768009': 'Greater '}, 'than  8 diopters in the eye': {'259047008': 'diopters ', '371398005': 'Eye region structure ', '81745001': 'Structure of eye proper ', '259048003': 'diopters + ', '259049006': 'diopters - '}}
{'axial myopia of greater': {'408757002': ('clinical finding', 'Axial myopia ', ['64572001', '118234003']), '263768009': ('qualifier value', 'Greater ', ['272099008'])}, 'than  8 diopters in the eye': {'259047008': ('unit', 'diopters ', ['767524001']), '259048003': ('unit', 'diopters + ', ['259047008', '767524001']), '259049006': ('unit', 'diopters - ', ['259047008', '767524001'])}}

2977584
presence of anatomical abnormalities in the neck or pharyngeal region
presence of anatomical abnormalities in the neck or pharyngeal region
['presence of anatomical abnormalities', 'in the neck', 'pharyngeal region']
{'presence of anatomical abnormalities': {'43261007': 'Abnormal presence of ', '36298004': 'Anatomic '}, 'in the neck': {'45048000': 'Neck structure '}, 'pharyngeal region': {'54066008': 'Pharyngeal structure ', '410673009': 'regional', '410674003': 'Regional '}}
{'presence of anatomical abnormalities': {'43261007': ('qualifier value', 'Abnormal presence of ', ['272099008']), '36298004': ('qualifier value', 'Anatomic ', ['272099008'])}, 'pharyngeal region': {'410674003': ('qualifier value', 'Regional ', ['272099008'])}}

2977620
inability to take and absorb orally administered medication.
take and absorb orally administered medication.
['take', 'orally administered medication']
{'take': {'419652001': 'Take - dosing instruction imperative '}, 'orally administered medication': {'260548002': 'Oral ', '418283001': 'Administer - dosing instruction imperative ', '105903003': 'General drug type ', '373873005': 'Pharmaceutical / biologic product ', '410942007': 'Drug or medicament '}}
{}

2981863
use of any drugs known to induce or inhibit hepatic drug metabolism , use of an investigational drug or participation in an investigational study within 30 days prior to administration of the study medication.
use of any drugs known to induce or inhibit hepatic drug metabolism , use of an investigational drug or participation in an investigational study , prior to administration of the study medication.
['use of any drugs', 'known', 'to', 'induce', 'inhibit', 'hepatic drug metabolism ,', 'use of an investigational drug', 'participation in an investigational study', 'prior to administration of the study medication']
{'use of any drugs': {'260676000': 'use of', '105903003': 'General drug type ', '373873005': 'Pharmaceutical / biologic product ', '410942007': 'Drug or medicament '}, 'known': {'36692007': 'Known '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'induce': {'16404004': 'Induced '}, 'inhibit': {'397829000': 'Asystole ', '410429000': 'Cardiac arrest ', '26036001': 'Obstruction ', '2899008': 'Thought block ', '6155003': 'Arrested ', '112232007': 'Blocking ', '19367006': 'Retarded ', '732985006': 'block '}, 'hepatic drug metabolism ,': {'32381004': 'Portal ', '105903003': 'General drug type ', '373873005': 'Pharmaceutical / biologic product ', '410942007': 'Drug or medicament ', '47722004': 'General metabolic function '}, 'use of an investigational drug': {'260676000': 'use of', '185922005': 'Clinical drug trial '}, 'participation in an investigational study': {'129265001': 'Evaluation - action ', '386053000': 'Evaluation procedure ', '224699009': 'Study '}, 'prior to administration of the study medication': {'236874000': 'Status pre- ', '288556008': 'before', '18629005': 'Administration of drug or medicament ', '224699009': 'Study '}}
{'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'induce': {'16404004': ('qualifier value', 'Induced ', ['272099008'])}, 'inhibit': {'397829000': ('clinical finding', 'Asystole ', ['64572001', '410429000', '118234003']), '410429000': ('clinical finding', 'Cardiac arrest ', ['64572001', '118234003']), '2899008': ('clinical finding', 'Thought block ', ['250171008']), '6155003': ('qualifier value', 'Arrested ', ['272099008']), '112232007': ('qualifier value', 'Blocking ', ['272099008']), '732985006': ('unit', 'block ', ['767524001'])}, 'hepatic drug metabolism ,': {'32381004': ('qualifier value', 'Portal ', ['272099008']), '47722004': ('observable entity', 'General metabolic function ', ['246464006'])}, 'participation in an investigational study': {'386053000': ('procedure', 'Evaluation procedure ', ['128927009'])}, 'prior to administration of the study medication': {'18629005': ('procedure', 'Administration of drug or medicament ', ['128927009'])}}

2985322
subject mentioned in articles l1121-5 to l1121-8 of "code de la santé publique"
subject mentioned in articles l1121-5 to l1121-8 of "code de la santé publique"
['to l1121 8 of "code de la sant publique"']
{'to l1121 8 of "code de la sant publique"': {'224046004': 'Delaware ', '414568004': 'Lanthanum ', '368208006': 'Left upper arm structure ', '223637004': 'Germany '}}
{'to l1121 8 of "code de la sant publique"': {'414568004': ('product', 'Lanthanum ', ['312413002'])}}

2996183
patients with a documented history of hiv, active hepatitis b, hepatitis c infections
patients with a documented , hiv, active hepatitis b, hepatitis c infections
['patients with a documented  hiv,', 'active hepatitis b,', 'hepatitis c infections']
{'patients with a documented  hiv,': {'116154003': 'Patient ', '397934002': 'Documented ', '19030005': 'Human immunodeficiency virus ', '165816005': 'Human immunodeficiency virus positive '}, 'active hepatitis b,': {'55561003': 'Active ', '66071002': 'Viral hepatitis type B '}, 'hepatitis c infections': {'186634008': 'Hepatitis non-A non-B ', '50711007': 'Viral hepatitis type C '}}
{'patients with a documented  hiv,': {'19030005': ('clinical finding', 'Human immunodeficiency virus ', ['49872002']), '165816005': ('clinical finding', 'Human immunodeficiency virus positive ', ['441742003'])}, 'active hepatitis b,': {'55561003': ('qualifier value', 'Active ', ['272099008']), '66071002': ('clinical finding', 'Viral hepatitis type B ', ['64572001', '118234003'])}, 'hepatitis c infections': {'50711007': ('clinical finding', 'Viral hepatitis type C ', ['64572001', '118234003'])}}

3000170
having a history of diseases stimulated by heat, such as recurrent herpes simplex in the treated area, unless treatment is conducted following a prophylactic regimen.
having , diseases stimulated by heat, such as recurrent herpes simplex in the treated area, unless treatment is conducted following a prophylactic regimen.
['diseases', 'stimulated by heat,', 'such as recurrent herpes simplex in the treated area,', 'treatment', 'conducted', 'following', 'a prophylactic regimen']
{'diseases': {'64572001': 'Disease '}, 'stimulated by heat,': {'88999006': 'Heat '}, 'such as recurrent herpes simplex in the treated area,': {'223621005': 'Australia ', '37323009': 'Recurrent herpes simplex ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '42798000': 'Area ', '116700008': 'treatment intent', '395077000': 'Treatment intent ', '432410005': 'Artesunate ', '432555000': 'Artesunate '}, 'treatment': {'276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '416118004': 'Administration '}, 'conducted': {'844005': 'Behavior finding '}, 'following': {'237679004': 'Status post ', '255234002': 'status post', '255260001': 'following'}, 'a prophylactic regimen': {'706506000': 'Condom ', '322837006': 'Drugs used in migraine prophylaxis ', '262073000': 'Prophylactic '}}
{'such as recurrent herpes simplex in the treated area,': {'37323009': ('clinical finding', 'Recurrent herpes simplex ', ['64572001']), '276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '42798000': ('qualifier value', 'Area ', ['272099008']), '395077000': ('situation with explicit context', 'Treatment intent ', ['129125009']), '432410005': ('product', 'Artesunate ', ['115668003', '312413002']), '432555000': ('product', 'Artesunate ', ['763158003'])}, 'treatment': {'276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '416118004': ('procedure', 'Administration ', ['128927009'])}, 'conducted': {'844005': ('clinical finding', 'Behavior finding ', ['250171008'])}, 'a prophylactic regimen': {'322837006': ('product', 'Drugs used in migraine prophylaxis ', ['763158003']), '262073000': ('qualifier value', 'Prophylactic ', ['272099008'])}}

3002721
patients had non-plaque forms or drug-induced forms of psoriasis, total body surface involvement of > 60%
patients had non-plaque forms or drug-induced forms of psoriasis, total body surface involvement of > 60%
['patients', 'non plaque forms', 'drug induced forms of psoriasis', 'total body surface involvement of']
{'patients': {'116154003': 'Patient '}, 'non plaque forms': {'4522001': 'Dental plaque ', '246176004': 'qualitative form', '128177006': 'Cutaneous plaque ', '276322001': 'Skin plaque ', '1522000': 'Plaque ', '38551001': 'Senile plaque '}, 'drug induced forms of psoriasis': {'278993004': 'Drug-induced ', '246176004': 'qualitative form', '9014002': 'Psoriasis '}, 'total body surface involvement of': {'91035006': '90 percent of body surface or more ', '248448006': 'Involved ', '278112009': 'involvement with'}}
{'non plaque forms': {'4522001': ('clinical finding', 'Dental plaque ', ['64572001', '118234003']), '276322001': ('clinical finding', 'Skin plaque ', ['118234003'])}, 'drug induced forms of psoriasis': {'278993004': ('qualifier value', 'Drug-induced ', ['272099008']), '9014002': ('clinical finding', 'Psoriasis ', ['64572001', '118234003'])}, 'total body surface involvement of': {'248448006': ('qualifier value', 'Involved ', ['272099008'])}}

3010204
dementia,
dementia,
['dementia,']
{'dementia,': {'12348006': 'Presenile dementia ', '52448006': 'Dementia '}}
{'dementia,': {'12348006': ('clinical finding', 'Presenile dementia ', ['64572001', '118234003', '52448006']), '52448006': ('clinical finding', 'Dementia ', ['64572001', '118234003'])}}

3020160
age-related macular degeneration
age-related macular degeneration
['age related macular degeneration']
{'age related macular degeneration': {'267718000': 'Age-related macular degeneration '}}
{'age related macular degeneration': {'267718000': ('clinical finding', 'Age-related macular degeneration ', ['64572001', '118234003'])}}

3024168
uncontrolled hypertension
uncontrolled hypertension
['uncontrolled hypertension']
{'uncontrolled hypertension': {'19032002': 'Uncontrolled ', '38341003': 'Hypertensive disorder, systemic arterial '}}
{'uncontrolled hypertension': {'19032002': ('qualifier value', 'Uncontrolled ', ['272099008']), '38341003': ('clinical finding', 'Hypertensive disorder, systemic arterial ', ['64572001', '118234003'])}}

3024758
any condition which, in the opinion of the investigator, would interfere with the evaluation of the vaccine or pose a health risk to the subject.
any condition which, in the opinion of the investigator, would interfere with the evaluation of the vaccine or pose a health risk to the subject.
['any condition', 'interfere with the evaluation of the vaccine', 'a health risk to the subject']
{'any condition': {'64572001': 'Disease ', '260905004': 'condition'}, 'interfere with the evaluation of the vaccine': {'78235001': 'Interferes with ', '129265001': 'Evaluation - action ', '386053000': 'Evaluation procedure ', '398827000': 'Vaccine ', '71181003': 'Vaccine '}, 'a health risk to the subject': {'263775005': 'Health ', '30207005': 'Risk of '}}
{'interfere with the evaluation of the vaccine': {'386053000': ('procedure', 'Evaluation procedure ', ['128927009']), '398827000': ('product', 'Vaccine ', ['115668003']), '71181003': ('product', 'Vaccine ', ['763158003'])}}

3028992
patient judged inappropriate for randomization due to other condition requiring chronic thienopyridine use.
patient judged inappropriate for randomization due to other condition requiring chronic thienopyridine use.
['patient', 'judged', 'inappropriate for randomization', 'due to other condition', 'chronic thienopyridine use']
{'patient': {'116154003': 'Patient '}, 'judged': {'11205001': 'Judge '}, 'inappropriate for randomization': {'900000000000494007': 'inappropriate component '}, 'due to other condition': {'64572001': 'Disease ', '260905004': 'condition'}, 'chronic thienopyridine use': {'90734009': 'Chronic ', '277889008': 'usage', '419385000': 'Use - dosing instruction imperative '}}
{'chronic thienopyridine use': {'90734009': ('qualifier value', 'Chronic ', ['272099008'])}}

3031683
oral steroid use
oral steroid use
['oral steroid use']
{'oral steroid use': {'26643006': 'Oral route ', '112113009': 'Steroid hormone ', '116566001': 'Steroid '}}
{'oral steroid use': {'112113009': ('product', 'Steroid hormone ', ['312413002', '116566001']), '116566001': ('product', 'Steroid ', ['312413002'])}}

3033807
patients with a history of severe hypersensitivity reaction to compounds of similar chemical or biologic composition to carboplatin, paclitaxel, bevacizumab or other agents used in the study.
patients with , severe hypersensitivity reaction to compounds of similar chemical or biologic composition to carboplatin, paclitaxel, bevacizumab or other agents used in the study.
['patients with', 'severe hypersensitivity reaction to compounds of similar chemical', 'biologic composition to carboplatin,', 'paclitaxel,', 'bevacizumab', 'other agents', 'used in the study']
{'patients with': {'116154003': 'Patient '}, 'severe hypersensitivity reaction to compounds of similar chemical': {'24484000': 'Severe ', '418634005': 'Allergic reaction caused by substance ', '421961002': 'Hypersensitivity reaction ', '441900009': 'Chemical '}, 'biologic composition to carboplatin,': {'115668003': 'Biological substance ', '418980009': 'Biological agent ', '69509008': 'Biological agent ', '733996005': 'composition', '108759002': 'Carboplatin ', '386905002': 'Carboplatin ', '12893009': 'Biologic '}, 'paclitaxel,': {'387374002': 'Paclitaxel ', '67735003': 'Paclitaxel '}, 'bevacizumab': {'409405006': 'Bevacizumab ', '409406007': 'Bevacizumab '}, 'other agents': {'260872001': 'agent'}, 'used in the study': {'394850002': 'used by', '224699009': 'Study '}}
{'severe hypersensitivity reaction to compounds of similar chemical': {'24484000': ('qualifier value', 'Severe ', ['272396007']), '418634005': ('clinical finding', 'Allergic reaction caused by substance ', ['64572001', '421961002']), '421961002': ('clinical finding', 'Hypersensitivity reaction ', ['64572001']), '441900009': ('product', 'Chemical ', ['312413002'])}, 'biologic composition to carboplatin,': {'108759002': ('product', 'Carboplatin ', ['763158003']), '386905002': ('product', 'Carboplatin ', ['406455002', '441900009', '312413002']), '12893009': ('qualifier value', 'Biologic ', ['272099008'])}, 'paclitaxel,': {'387374002': ('product', 'Paclitaxel ', ['406455002', '441900009', '312413002', '115668003']), '67735003': ('product', 'Paclitaxel ', ['763158003'])}, 'bevacizumab': {'409405006': ('product', 'Bevacizumab ', ['763158003']), '409406007': ('product', 'Bevacizumab ', ['312413002', '441900009', '115668003'])}}

3035159
trauma with vision loss
trauma with vision loss
['trauma with vision loss']
{'trauma with vision loss': {'19130008': 'Traumatic abnormality ', '417746004': 'Traumatic injury ', '397540003': 'Visual impairment ', '7973008': 'Abnormal vision '}}
{'trauma with vision loss': {'417746004': ('clinical finding', 'Traumatic injury ', ['64572001']), '397540003': ('clinical finding', 'Visual impairment ', ['64572001', '118234003']), '7973008': ('clinical finding', 'Abnormal vision ', ['118234003'])}}

3038858
any other hormone treatment contraindications;
any other hormone treatment contraindications;
['other hormone treatment contraindications']
{'other hormone treatment contraindications': {'169413002': 'Hormone therapy ', '309542002': 'Endocrine therapy ', '397745006': 'Medical contraindication '}}
{'other hormone treatment contraindications': {'169413002': ('procedure', 'Hormone therapy ', ['128927009']), '397745006': ('clinical finding', 'Medical contraindication ', ['250171008'])}}

3039492
the patient has any clinically significant uncontrolled medical condition, treated or untreated.
the patient has any clinically significant uncontrolled medical condition, treated or untreated.
['the patient', 'any clinically significant uncontrolled medical condition,', 'treated', 'untreated']
{'the patient': {'116154003': 'Patient '}, 'any clinically significant uncontrolled medical condition,': {'386134007': 'Significant ', '19032002': 'Uncontrolled ', '373655009': 'Medical service ', '64572001': 'Disease ', '260905004': 'condition', '74188005': 'Medical '}, 'treated': {'276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '116700008': 'treatment intent', '395077000': 'Treatment intent '}, 'untreated': {'25265005': 'Did not receive therapy or drug for '}}
{'any clinically significant uncontrolled medical condition,': {'19032002': ('qualifier value', 'Uncontrolled ', ['272099008']), '74188005': ('qualifier value', 'Medical ', ['272099008'])}, 'treated': {'276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '395077000': ('situation with explicit context', 'Treatment intent ', ['129125009'])}}

3039947
creatinine clearance < 30 ml/min
creatinine clearance < 30 ml/min
['creatinine clearance', '< 30 ml/min']
{'creatinine clearance': {'15373003': 'Creatinine ', '260695007': 'clearance'}, '< 30 ml/min': {'259030007': 'per 30 minutes ', '259035002': 'per milliliter ', '1071000175108': '30 minutes', '258859000': 'Milliliter/minute '}}
{'creatinine clearance': {'15373003': ('product', 'Creatinine ', ['312413002', '312412007'])}, '< 30 ml/min': {'259030007': ('unit', 'per 30 minutes ', ['767524001']), '259035002': ('unit', 'per milliliter ', ['767524001']), '1071000175108': ('qualifier value', '30 minutes', ['272099008']), '258859000': ('unit', 'Milliliter/minute ', ['767524001'])}}

3042767
pregnant or nursing women
pregnant or nursing women
['pregnant', 'nursing women']
{'pregnant': {'77386006': 'Patient currently pregnant ', '127362006': 'Previous pregnancies ', '161732006': 'Gravida ', '364323006': 'Quantity of pregnancy ', '366321006': 'Finding of gravida '}, 'nursing women': {'169741004': 'Breast fed ', '224526002': 'Woman ', '265937000': 'Nursing occupation ', '722165004': 'Nursing '}}
{'pregnant': {'77386006': ('clinical finding', 'Patient currently pregnant ', ['250171008']), '127362006': ('clinical finding', 'Previous pregnancies ', ['250171008']), '161732006': ('observable entity', 'Gravida ', ['363788007']), '364323006': ('observable entity', 'Quantity of pregnancy ', ['363788007']), '366321006': ('clinical finding', 'Finding of gravida ', ['250171008'])}, 'nursing women': {'169741004': ('clinical finding', 'Breast fed ', ['250171008']), '224526002': ('person', 'Woman ', ['133936004'])}}

3050464
inability to obtain informed consent from the patient or a health care proxy.
obtain informed consent from the patient or a health care proxy.
['obtain', 'informed consent from the patient', 'a health care proxy']
{'obtain': {'398092000': 'obtain'}, 'informed consent from the patient': {'310866003': 'Informing patient ', '419733004': 'Patient notified '}, 'a health care proxy': {'263775005': 'Health '}}
{'informed consent from the patient': {'419733004': ('situation with explicit context', 'Patient notified ', ['129125009'])}}

3055489
gcs of 3 with bilaterally fixed and dilated pupils
gcs of 3 with bilaterally fixed and dilated pupils
['fixed', 'dilated pupils']
{'fixed': {'261010008': 'Fixed '}, 'dilated pupils': {'37125009': 'Dilated pupil '}}
{'fixed': {'261010008': ('qualifier value', 'Fixed ', ['272099008'])}, 'dilated pupils': {'37125009': ('clinical finding', 'Dilated pupil ', ['118234003'])}}

3058314
received a blood transfusion or blood products within 6 months to first dose
received a blood transfusion or blood products , to first dose
['a blood transfusion', 'blood products', 'to first dose']
{'a blood transfusion': {'116859006': 'Transfusion of blood product ', '161664006': 'History of blood transfusion '}, 'blood products': {'410652009': 'Blood product '}, 'to first dose': {'255216001': 'First ', '260911001': 'dosage', '277406006': 'Dosages ', '408102007': 'Unit dose ', '232714002': 'Firstly '}}
{'a blood transfusion': {'116859006': ('procedure', 'Transfusion of blood product ', ['128927009']), '161664006': ('situation with explicit context', 'History of blood transfusion ', ['129125009'])}, 'to first dose': {'277406006': ('qualifier value', 'Dosages ', ['272099008']), '408102007': ('unit', 'Unit dose ', ['767524001']), '232714002': ('qualifier value', 'Firstly ', ['272099008'])}}

3067188
inability to return for follow up appointments at 3 and 6 weeks
return for follow up appointments at 3 and 6 weeks
['return for follow up appointments', 'at 3', '6 weeks']
{'return for follow up appointments': {'7528007': 'Return to ', '308273005': 'Follow-up status '}, 'at 3': {'260313008': '<3 '}, '6 weeks': {'258705008': 'week '}}
{'6 weeks': {'258705008': ('unit', 'week ', ['767524001'])}}

3076264
low-risk prostate cancer after curative therapy
low-risk prostate cancer after curative therapy
['low risk prostate cancer after curative therapy']
{'low risk prostate cancer after curative therapy': {'723505004': 'low risk', '399068003': 'Malignant tumor of prostate ', '373808002': 'Curative - procedure intent ', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '254900004': 'Carcinoma of prostate '}}
{'low risk prostate cancer after curative therapy': {'723505004': ('qualifier value', 'low risk', ['272099008']), '399068003': ('clinical finding', 'Malignant tumor of prostate ', ['64572001', '118234003']), '373808002': ('qualifier value', 'Curative - procedure intent ', ['272099008']), '276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '254900004': ('clinical finding', 'Carcinoma of prostate ', ['64572001', '399068003', '118234003'])}}

3078723
lactose intolerance
lactose intolerance
['lactose intolerance']
{'lactose intolerance': {'267425008': 'Lactose intolerance ', '700094005': 'Milk intolerance '}}
{'lactose intolerance': {'267425008': ('clinical finding', 'Lactose intolerance ', ['64572001', '118234003'])}}

3081109
history of regular alcohol consumption exceeding, on average, 14 drinks/week within 6 months of screening
, regular alcohol consumption exceeding, on average, 14 drinks/week , of screening
['regular alcohol consumption exceeding,', '14 drinks/week', 'of screening']
{'regular alcohol consumption exceeding,': {'17854005': 'Regular ', '160573003': 'Alcohol intake '}, '14 drinks/week': {'226465004': 'Drinks ', '230118003': 'drink ', '14497002': 'Weekly ', '259038000': 'per week ', '258705008': 'week '}, 'of screening': {'20135006': 'Screening procedure '}}
{'regular alcohol consumption exceeding,': {'17854005': ('qualifier value', 'Regular ', ['272099008']), '160573003': ('observable entity', 'Alcohol intake ', ['363788007'])}, '14 drinks/week': {'14497002': ('qualifier value', 'Weekly ', ['272099008']), '259038000': ('unit', 'per week ', ['767524001']), '258705008': ('unit', 'week ', ['767524001'])}, 'of screening': {'20135006': ('procedure', 'Screening procedure ', ['128927009'])}}

3083883
woman patients of childbearing potential unwilling to use a medically acceptable form of contraception (i.e., hormonal birth control, intrauterine device [iud], double barrier [man condom or woman condom with a diaphragm], or a barrier method plus a spermicidal agent [contraceptive foam, jelly, or cream]) woman patients are considered to be of childbearing potential unless they have been postmenopausal for >= 1 year, are biologically sterile, or are surgically sterile (history of hysterectomy, bilateral oophorectomy, or bilateral tubal ligation.
woman patients of childbearing potential unwilling to use a medically acceptable form of contraception (i.e., hormonal birth control, intrauterine device [iud], double barrier [man condom or woman condom with a diaphragm], or a barrier method plus a spermicidal agent [contraceptive foam, jelly, or cream]) woman patients are considered to be of childbearing potential unless they have been postmenopausal for >= 1 year, are biologically sterile, or are surgically sterile ( , hysterectomy, bilateral oophorectomy, or bilateral tubal ligation.
['woman patients of childbearing potential unwilling', 'to', 'use', 'a medically acceptable form of contraception', '(i e  hormonal birth control,', 'intrauterine device [iud],', 'double barrier', '[man condom', 'woman condom with a diaphragm', 'a barrier method plus a spermicidal agent', '[contraceptive foam,', 'jelly,', 'cream', 'woman patients', 'postmenopausal for', '= 1 year,', 'biologically sterile,', 'surgically sterile', 'hysterectomy,', 'bilateral oophorectomy,', 'bilateral tubal ligation']
{'woman patients of childbearing potential unwilling': {'224526002': 'Woman ', '116154003': 'Patient ', '225465005': 'Unwilling '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'use': {'277889008': 'usage', '419385000': 'Use - dosing instruction imperative '}, 'a medically acceptable form of contraception': {'900000000000549004': 'acceptable ', '246176004': 'qualitative form', '13197004': 'Contraception '}, '(i e  hormonal birth control,': {'42146005': 'Iodide salt ', '278994005': 'Hormonal ', '13197004': 'Contraception ', '22971001': 'Blood group antibody I '}, 'intrauterine device [iud],': {'268460000': 'Intrauterine contraceptive device '}, 'double barrier': {'1305003': 'Double '}, '[man condom': {'339947000': 'Man ', '706506000': 'Condom ', '278412004': 'Human - origin ', '337915000': 'Homo sapiens ', '10052007': 'Male structure ', '248153007': 'Male '}, 'woman condom with a diaphragm': {'224526002': 'Woman ', '706506000': 'Condom ', '263734003': 'Diaphragmatic ', '5798000': 'Diaphragm structure ', '20359006': 'Contraceptive diaphragm, device ', '336704008': 'Vaginal contraceptive diaphragm ', '469119008': 'Diaphragm pessary '}, 'a barrier method plus a spermicidal agent': {'225370004': 'Barrier contraception method ', '108901002': 'Spermicides ', '260872001': 'agent', '466945004': 'Spermicide '}, '[contraceptive foam,': {'108899006': 'Contraceptives ', '421166008': 'Foam ', '348649005': 'Contraceptive device '}, 'jelly,': {'227722009': 'Jello '}, 'cream': {'255621006': 'Cream ', '385099005': 'Cream '}, 'woman patients': {'224526002': 'Woman ', '116154003': 'Patient '}, 'postmenopausal for': {'76498008': 'Postmenopausal state '}, '= 1 year,': {'451231000124103': 'greater than one', '258707000': 'year ', '259039008': 'per year '}, 'biologically sterile,': {'12893009': 'Biologic ', '15296000': 'Sterility ', '8619003': 'Infertile ', '260984003': 'Aseptic ', '261029002': 'Sterile '}, 'surgically sterile': {'257556004': 'Surgery ', '387713003': 'Surgical procedure ', '83578000': 'Surgical ', '15296000': 'Sterility ', '8619003': 'Infertile ', '260984003': 'Aseptic ', '261029002': 'Sterile '}, 'hysterectomy,': {'236886002': 'Hysterectomy '}, 'bilateral oophorectomy,': {'76876009': 'Bilateral oophorectomy '}, 'bilateral tubal ligation': {'287664005': 'Bilateral tubal ligation '}}
{'woman patients of childbearing potential unwilling': {'224526002': ('person', 'Woman ', ['133936004']), '225465005': ('clinical finding', 'Unwilling ', ['250171008'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'a medically acceptable form of contraception': {'13197004': ('clinical finding', 'Contraception ', ['250171008'])}, '(i e  hormonal birth control,': {'42146005': ('product', 'Iodide salt ', ['406455002', '312413002', '115668003']), '278994005': ('qualifier value', 'Hormonal ', ['272099008']), '13197004': ('clinical finding', 'Contraception ', ['250171008']), '22971001': ('product', 'Blood group antibody I ', ['312413002', '115668003'])}, 'double barrier': {'1305003': ('qualifier value', 'Double ', ['272099008'])}, '[man condom': {'339947000': ('person', 'Man ', ['133936004']), '278412004': ('qualifier value', 'Human - origin ', ['272099008']), '248153007': ('clinical finding', 'Male ', ['365860008'])}, 'woman condom with a diaphragm': {'224526002': ('person', 'Woman ', ['133936004'])}, 'a barrier method plus a spermicidal agent': {'225370004': ('clinical finding', 'Barrier contraception method ', ['250171008', '13197004'])}, '[contraceptive foam,': {'108899006': ('product', 'Contraceptives ', ['763158003'])}, 'cream': {'255621006': ('product', 'Cream ', ['406455002'])}, 'woman patients': {'224526002': ('person', 'Woman ', ['133936004'])}, 'postmenopausal for': {'76498008': ('clinical finding', 'Postmenopausal state ', ['118234003'])}, '= 1 year,': {'258707000': ('unit', 'year ', ['767524001']), '259039008': ('unit', 'per year ', ['767524001'])}, 'biologically sterile,': {'12893009': ('qualifier value', 'Biologic ', ['272099008']), '15296000': ('clinical finding', 'Sterility ', ['118234003']), '8619003': ('clinical finding', 'Infertile ', ['118234003']), '260984003': ('qualifier value', 'Aseptic ', ['272099008'])}, 'surgically sterile': {'387713003': ('procedure', 'Surgical procedure ', ['128927009']), '83578000': ('qualifier value', 'Surgical ', ['272099008']), '15296000': ('clinical finding', 'Sterility ', ['118234003']), '8619003': ('clinical finding', 'Infertile ', ['118234003']), '260984003': ('qualifier value', 'Aseptic ', ['272099008'])}, 'hysterectomy,': {'236886002': ('procedure', 'Hysterectomy ', ['387713003', '362958002', '128927009'])}, 'bilateral oophorectomy,': {'76876009': ('procedure', 'Bilateral oophorectomy ', ['387713003', '362958002', '128927009'])}, 'bilateral tubal ligation': {'287664005': ('procedure', 'Bilateral tubal ligation ', ['387713003', '362958002', '128927009'])}}

3094694
history of hypersensitivity to compounds of similar chemical or biologic composition to the antibody women how are pregnant or breastfeeding
, hypersensitivity to compounds of similar chemical or biologic composition to the antibody women how are pregnant or breastfeeding
['hypersensitivity to compounds of similar chemical', 'biologic composition to the antibody women', 'pregnant', 'breastfeeding']
{'hypersensitivity to compounds of similar chemical': {'418634005': 'Allergic reaction caused by substance ', '421961002': 'Hypersensitivity reaction ', '441900009': 'Chemical ', '421369008': 'Emotional hypersensitivity '}, 'biologic composition to the antibody women': {'115668003': 'Biological substance ', '418980009': 'Biological agent ', '69509008': 'Biological agent ', '733996005': 'composition', '68498002': 'Antibody ', '224526002': 'Woman ', '112133008': 'Immunoglobulin ', '333710000': 'Immunoglobulin products ', '399771004': 'Immunoglobulin structure ', '12893009': 'Biologic '}, 'pregnant': {'77386006': 'Patient currently pregnant ', '127362006': 'Previous pregnancies ', '161732006': 'Gravida ', '364323006': 'Quantity of pregnancy ', '366321006': 'Finding of gravida '}, 'breastfeeding': {'169741004': 'Breast fed ', '413712001': 'Breastfeeding '}}
{'hypersensitivity to compounds of similar chemical': {'418634005': ('clinical finding', 'Allergic reaction caused by substance ', ['64572001', '421961002']), '421961002': ('clinical finding', 'Hypersensitivity reaction ', ['64572001']), '441900009': ('product', 'Chemical ', ['312413002']), '421369008': ('clinical finding', 'Emotional hypersensitivity ', ['250171008'])}, 'biologic composition to the antibody women': {'68498002': ('product', 'Antibody ', ['312413002', '441900009', '115668003']), '224526002': ('person', 'Woman ', ['133936004']), '112133008': ('product', 'Immunoglobulin ', ['312413002', '441900009', '115668003']), '333710000': ('product', 'Immunoglobulin products ', ['763158003']), '399771004': ('product', 'Immunoglobulin structure ', ['312413002', '441900009', '115668003', '112133008']), '12893009': ('qualifier value', 'Biologic ', ['272099008'])}, 'pregnant': {'77386006': ('clinical finding', 'Patient currently pregnant ', ['250171008']), '127362006': ('clinical finding', 'Previous pregnancies ', ['250171008']), '161732006': ('observable entity', 'Gravida ', ['363788007']), '364323006': ('observable entity', 'Quantity of pregnancy ', ['363788007']), '366321006': ('clinical finding', 'Finding of gravida ', ['250171008'])}, 'breastfeeding': {'169741004': ('clinical finding', 'Breast fed ', ['250171008']), '413712001': ('observable entity', 'Breastfeeding ', ['246464006'])}}

3105226
subjects with history or known presence of gastrointestinal bleeding.
subjects with history or known presence of gastrointestinal bleeding.
['subjects with history', 'known presence of gastrointestinal bleeding']
{'subjects with history': {'392521001': 'History of '}, 'known presence of gastrointestinal bleeding': {'36692007': 'Known ', '52101004': 'Present ', '74474003': 'Gastrointestinal hemorrhage '}}
{'known presence of gastrointestinal bleeding': {'74474003': ('clinical finding', 'Gastrointestinal hemorrhage ', ['64572001', '118234003', '131148009'])}}

3121925
history of or current inflammatory joint disease other than ra
, or current inflammatory joint disease other than ra
['current inflammatory joint disease other than ra']
{'current inflammatory joint disease other than ra': {'15240007': 'Current ', '298160000': 'Inflamed joint ', '64572001': 'Disease ', '39352004': 'Joint structure ', '128139000': 'Inflammatory disorder ', '399269003': 'Arthropathy ', '81087007': 'Articular system structure '}}
{'current inflammatory joint disease other than ra': {'298160000': ('clinical finding', 'Inflamed joint ', ['118234003']), '128139000': ('clinical finding', 'Inflammatory disorder ', ['64572001']), '399269003': ('clinical finding', 'Arthropathy ', ['64572001', '118234003'])}}

3140586
hemoglobin <9 g/dl
hemoglobin <9 g/dl
['hemoglobin', '<9 g/dl']
{'hemoglobin': {'38082009': 'Hemoglobin '}, '<9 g/dl': {'258795003': 'Gram/deciliter '}}
{'hemoglobin': {'38082009': ('product', 'Hemoglobin ', ['312413002', '115668003'])}, '<9 g/dl': {'258795003': ('unit', 'Gram/deciliter ', ['767524001'])}}

3143298
a positive test for human immunodeficiency virus antibody.
a positive test for human immunodeficiency virus antibody.
['a positive test for human immunodeficiency virus antibody']
{'a positive test for human immunodeficiency virus antibody': {'10828004': 'Positive ', '108252007': 'Laboratory procedure ', '15220000': 'Laboratory test ', '269814003': 'Laboratory procedures -general ', '120841000': 'Human immunodeficiency virus type 1 antibody ', '259855002': 'Human immunodeficiency virus antibody ', '272393004': 'Tests ', '277775005': 'Test finding '}}
{'a positive test for human immunodeficiency virus antibody': {'10828004': ('qualifier value', 'Positive ', ['272099008']), '15220000': ('procedure', 'Laboratory test ', ['128927009', '108252007']), '269814003': ('situation with explicit context', 'Laboratory procedures -general ', ['129125009']), '120841000': ('product', 'Human immunodeficiency virus type 1 antibody ', ['312413002', '115668003', '259855002']), '259855002': ('product', 'Human immunodeficiency virus antibody ', ['312413002', '115668003'])}}

3146986
previous history of allergic reactions to the products used in the bat
, allergic reactions to the products used in the bat
['allergic reactions to the products', 'used in the bat']
{'allergic reactions to the products': {'418634005': 'Allergic reaction caused by substance ', '421961002': 'Hypersensitivity reaction ', '419076005': 'Allergic reaction '}, 'used in the bat': {'394850002': 'used by', '388074005': 'Order Chiroptera '}}
{'allergic reactions to the products': {'418634005': ('clinical finding', 'Allergic reaction caused by substance ', ['64572001', '419076005', '421961002']), '421961002': ('clinical finding', 'Hypersensitivity reaction ', ['64572001']), '419076005': ('clinical finding', 'Allergic reaction ', ['64572001', '421961002'])}}

3148967
clinics were the intervention was only partially implemented
clinics were the intervention was only partially implemented
['clinics', 'the intervention', 'only']
{'clinics': {'257585005': 'Clinic '}, 'the intervention': {'71388002': 'Procedure ', '225334002': 'Intervention regime '}, 'only': {'50607009': 'Singular ', '420295001': 'Only - dosing instruction fragment '}}
{'the intervention': {'225334002': ('procedure', 'Intervention regime ', ['71388002', '243120004'])}, 'only': {'50607009': ('qualifier value', 'Singular ', ['272099008'])}}

3155646
sensory neuropathy , unresolved toxicity > ctcae grade 1 attributed to any prior therapy/procedure excluding alopecia
sensory neuropathy , unresolved toxicity > ctcae grade 1 attributed to any prior therapy/procedure excluding alopecia
['sensory neuropathy ,', 'unresolved toxicity', '> ctcae grade 1', 'attributed to any prior therapy/procedure excluding alopecia']
{'sensory neuropathy ,': {'95662005': 'Sensory neuropathy '}, 'unresolved toxicity': {'263921008': 'Unresolved ', '75478009': 'Poisoning '}, '> ctcae grade 1': {'446411000124101': 'mild adverse event'}, 'attributed to any prior therapy/procedure excluding alopecia': {'246061005': 'concept attribute', '236874000': 'Status pre- ', '288556008': 'before', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '71388002': 'Procedure ', '77765009': 'Exclude ', '278040002': 'Loss of hair ', '56317004': 'Alopecia '}}
{'sensory neuropathy ,': {'95662005': ('clinical finding', 'Sensory neuropathy ', ['64572001', '118234003'])}, 'unresolved toxicity': {'263921008': ('qualifier value', 'Unresolved ', ['272099008']), '75478009': ('clinical finding', 'Poisoning ', ['64572001'])}, 'attributed to any prior therapy/procedure excluding alopecia': {'276239002': ('procedure', 'Therapy ', ['277132007', '71388002', '243120004']), '77765009': ('qualifier value', 'Exclude ', ['272099008']), '278040002': ('clinical finding', 'Loss of hair ', ['118234003']), '56317004': ('clinical finding', 'Alopecia ', ['64572001', '118234003'])}}

3165721
severe diseases
severe diseases
['severe diseases']
{'severe diseases': {'24484000': 'Severe ', '64572001': 'Disease '}}
{'severe diseases': {'24484000': ('qualifier value', 'Severe ', ['272396007'])}}

3165737
patients with history of hypersensitivity to α receptor blockers, a/b receptor blockers, or anticholinergic drugs
patients with , hypersensitivity to α receptor blockers, a/b receptor blockers, or anticholinergic drugs
['patients with', 'hypersensitivity to  receptor blockers', 'a/b receptor blockers,', 'anticholinergic drugs']
{'patients with': {'116154003': 'Patient '}, 'hypersensitivity to  receptor blockers': {'418634005': 'Allergic reaction caused by substance ', '421961002': 'Hypersensitivity reaction ', '116647005': 'Receptor ', '421369008': 'Emotional hypersensitivity '}, 'a/b receptor blockers,': {'259039008': 'per year ', '116647005': 'Receptor '}, 'anticholinergic drugs': {'14601000': 'Anticholinergic agent ', '373246003': 'Anticholinergic agent '}}
{'hypersensitivity to  receptor blockers': {'418634005': ('clinical finding', 'Allergic reaction caused by substance ', ['64572001', '421961002']), '421961002': ('clinical finding', 'Hypersensitivity reaction ', ['64572001']), '116647005': ('product', 'Receptor ', ['115668003']), '421369008': ('clinical finding', 'Emotional hypersensitivity ', ['250171008'])}, 'a/b receptor blockers,': {'259039008': ('unit', 'per year ', ['767524001']), '116647005': ('product', 'Receptor ', ['115668003'])}, 'anticholinergic drugs': {'14601000': ('product', 'Anticholinergic agent ', ['763158003']), '373246003': ('product', 'Anticholinergic agent ', ['406455002'])}}

3172380-1
the guardian or child do not understand the study procedures.
the guardian or child do not understand the study procedures.
['the guardian', 'child', 'understand', 'the study procedures']
{'the guardian': {'58626002': 'Legal guardian ', '394619001': 'Guardian '}, 'child': {'410601007': 'Childhood age person ', '67822003': 'Child ', '160499008': 'Child of '}, 'understand': {'66216009': 'Understanding, function '}, 'the study procedures': {'224699009': 'Study ', '71388002': 'Procedure '}}
{'child': {'160499008': ('clinical finding', 'Child of ', ['118240005'])}, 'understand': {'66216009': ('observable entity', 'Understanding, function ', ['246464006'])}}

3172380-2
this will be verified by asking both guardian and child to repeat the study procedures.
this will be verified by asking both guardian and child to repeat the study procedures.
['both guardian', 'child', 'to', 'repeat', 'the study procedures']
{'both guardian': {'58626002': 'Legal guardian ', '394619001': 'Guardian '}, 'child': {'410601007': 'Childhood age person ', '67822003': 'Child ', '160499008': 'Child of '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'repeat': {'27582007': 'Repeat '}, 'the study procedures': {'224699009': 'Study ', '71388002': 'Procedure '}}
{'child': {'160499008': ('clinical finding', 'Child of ', ['118240005'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'repeat': {'27582007': ('qualifier value', 'Repeat ', ['272099008'])}}

3180048
pregnant or nursing women;
pregnant or nursing women;
['pregnant', 'nursing women']
{'pregnant': {'77386006': 'Patient currently pregnant ', '127362006': 'Previous pregnancies ', '161732006': 'Gravida ', '364323006': 'Quantity of pregnancy ', '366321006': 'Finding of gravida '}, 'nursing women': {'169741004': 'Breast fed ', '224526002': 'Woman ', '265937000': 'Nursing occupation ', '722165004': 'Nursing '}}
{'pregnant': {'77386006': ('clinical finding', 'Patient currently pregnant ', ['250171008']), '127362006': ('clinical finding', 'Previous pregnancies ', ['250171008']), '161732006': ('observable entity', 'Gravida ', ['363788007']), '364323006': ('observable entity', 'Quantity of pregnancy ', ['363788007']), '366321006': ('clinical finding', 'Finding of gravida ', ['250171008'])}, 'nursing women': {'169741004': ('clinical finding', 'Breast fed ', ['250171008']), '224526002': ('person', 'Woman ', ['133936004'])}}

3181065-1
woman patients of childbearing potential are not eligible unless a negative pregnancy test result has been obtained.
woman patients of childbearing potential are not eligible unless a negative pregnancy test result has been obtained.
['woman patients of childbearing potential', 'a negative pregnancy test result', 'obtained']
{'woman patients of childbearing potential': {'224526002': 'Woman ', '116154003': 'Patient '}, 'a negative pregnancy test result': {'250425007': 'Pregnancy test negative ', '394617004': 'Result ', '260385009': 'Negative ', '250421003': 'Pregnancy test finding '}, 'obtained': {'398092000': 'obtain'}}
{'woman patients of childbearing potential': {'224526002': ('person', 'Woman ', ['133936004'])}, 'a negative pregnancy test result': {'250425007': ('clinical finding', 'Pregnancy test negative ', ['441742003', '250421003']), '250421003': ('clinical finding', 'Pregnancy test finding ', ['441742003'])}}

3181065-2
lactating females are not eligible unless they have agreed not to breastfeed their infants for the duration of protocol therapy.
lactating females are not eligible unless they have agreed not to breastfeed their infants for the duration of protocol therapy.
['lactating females', 'to', 'breastfeed', 'their infants for the duration of protocol therapy']
{'lactating females': {'83036002': 'Lactate ', '1086007': 'Female structure ', '248152002': 'Female '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'breastfeed': {'169741004': 'Breast fed '}, 'their infants for the duration of protocol therapy': {'133931009': 'Infant ', '261773006': 'Duration of therapy ', '258049002': 'Protocols '}}
{'lactating females': {'83036002': ('product', 'Lactate ', ['312413002']), '248152002': ('clinical finding', 'Female ', ['365860008'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'breastfeed': {'169741004': ('clinical finding', 'Breast fed ', ['250171008'])}, 'their infants for the duration of protocol therapy': {'261773006': ('qualifier value', 'Duration of therapy ', ['272099008'])}}

3181065-3
sexually active patients of reproductive potential are not eligible unless they have agreed to use an effective contraceptive method for the duration of protocol therapy.
sexually active patients of reproductive potential are not eligible unless they have agreed to use an effective contraceptive method for the duration of protocol therapy.
['sexually active patients of reproductive potential', 'to', 'use', 'an effective contraceptive method for the duration of protocol therapy']
{'sexually active patients of reproductive potential': {'228453005': 'Sexually active ', '116154003': 'Patient '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'use': {'277889008': 'usage', '419385000': 'Use - dosing instruction imperative '}, 'an effective contraceptive method for the duration of protocol therapy': {'255403003': 'Effectiveness ', '13197004': 'Contraception ', '261773006': 'Duration of therapy ', '258049002': 'Protocols ', '254648000': 'Effective '}}
{'sexually active patients of reproductive potential': {'228453005': ('clinical finding', 'Sexually active ', ['250171008'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'an effective contraceptive method for the duration of protocol therapy': {'255403003': ('qualifier value', 'Effectiveness ', ['272099008']), '13197004': ('clinical finding', 'Contraception ', ['250171008']), '261773006': ('qualifier value', 'Duration of therapy ', ['272099008']), '254648000': ('qualifier value', 'Effective ', ['272099008'])}}

3181223
patients with short-gut syndrome or a serum albumin < 32 g/l
patients with short-gut syndrome or a serum albumin < 32 g/l
['patients with short gut syndrome', 'a serum albumin', '< 32 g/l']
{'patients with short gut syndrome': {'116154003': 'Patient ', '26629001': 'Short bowel syndrome '}, 'a serum albumin': {'67922002': 'Serum ', '52454007': 'Albumin ', '119364003': 'Serum specimen '}, '< 32 g/l': {'258794004': 'Gram/liter ', '258798001': 'Milligram/milliliter ', '396153000': 'Kilogram/cubic meter ', '277288007': '10*9/liter '}}
{'patients with short gut syndrome': {'26629001': ('clinical finding', 'Short bowel syndrome ', ['64572001', '118234003'])}, 'a serum albumin': {'67922002': ('product', 'Serum ', ['115669006', '115668003']), '52454007': ('product', 'Albumin ', ['406455002', '312413002', '115668003'])}, '< 32 g/l': {'258794004': ('unit', 'Gram/liter ', ['767524001']), '258798001': ('unit', 'Milligram/milliliter ', ['767524001']), '396153000': ('unit', 'Kilogram/cubic meter ', ['767524001']), '277288007': ('qualifier value', '10*9/liter ', ['272099008'])}}

3182811
cardiac insufficiency or high blood pressure without controlled
cardiac insufficiency or high blood pressure without controlled
['cardiac insufficiency', 'high blood pressure without controlled']
{'cardiac insufficiency': {'84114007': 'Heart failure '}, 'high blood pressure without controlled': {'38341003': 'Hypertensive disorder, systemic arterial ', '246106000': 'control function', '31509003': 'Controlled '}}
{'cardiac insufficiency': {'84114007': ('clinical finding', 'Heart failure ', ['64572001', '118234003'])}, 'high blood pressure without controlled': {'38341003': ('clinical finding', 'Hypertensive disorder, systemic arterial ', ['64572001', '118234003']), '31509003': ('qualifier value', 'Controlled ', ['272099008'])}}

3185347
known cow's milk allergy
known cow's milk allergy
["known cow's milk allergy"]
{"known cow's milk allergy": {'36692007': 'Known ', '15911003': 'Cows milk protein sensitivity '}}
{}

3188125
known infection with hiv, hepatitis b, or hepatitis c
known infection with hiv, hepatitis b, or hepatitis c
['known infection with hiv,', 'hepatitis b,', 'hepatitis c']
{'known infection with hiv,': {'36692007': 'Known ', '86406008': 'Human immunodeficiency virus infection '}, 'hepatitis b,': {'66071002': 'Viral hepatitis type B '}, 'hepatitis c': {'186634008': 'Hepatitis non-A non-B ', '50711007': 'Viral hepatitis type C ', '62944002': 'Hepatitis C virus '}}
{'known infection with hiv,': {'86406008': ('clinical finding', 'Human immunodeficiency virus infection ', ['64572001'])}, 'hepatitis b,': {'66071002': ('clinical finding', 'Viral hepatitis type B ', ['64572001', '118234003'])}, 'hepatitis c': {'50711007': ('clinical finding', 'Viral hepatitis type C ', ['64572001', '118234003']), '62944002': ('clinical finding', 'Hepatitis C virus ', ['49872002'])}}

3190447
the participant has ongoing side effects ≥ grade 2 due to prior anticancer therapy
the participant has ongoing side effects ≥ grade 2 due to prior anticancer therapy
['ongoing side effects', 'grade', '2 due to prior anticancer therapy']
{'ongoing side effects': {'255238004': 'Continuous '}, 'grade': {'103421006': 'grade', '246228008': 'grade', '258349007': 'Grades ', '371469007': 'Histologic grade '}, '2 due to prior anticancer therapy': {'260306008': 'Integer +2 ', '42752001': 'due to', '236874000': 'Status pre- ', '288556008': 'before', '276239002': 'Therapy ', '277132007': 'Therapeutic procedure '}}
{'ongoing side effects': {'255238004': ('qualifier value', 'Continuous ', ['272099008'])}, 'grade': {'258349007': ('qualifier value', 'Grades ', ['272396007']), '371469007': ('observable entity', 'Histologic grade ', ['395531003'])}, '2 due to prior anticancer therapy': {'276239002': ('procedure', 'Therapy ', ['277132007', '243120004'])}}

3192147
serum ferritin > 15 mcg/l
serum ferritin > 15 mcg/l
['serum ferritin', '> 15 mcg/l']
{'serum ferritin': {'269821003': 'Serum ferritin measurement ', '489004': 'Ferritin measurement '}, '> 15 mcg/l': {'258799009': 'Microgram/liter ', '258806002': 'Nanogram/milliliter '}}
{'serum ferritin': {'269821003': ('procedure', 'Serum ferritin measurement ', ['489004', '128927009']), '489004': ('procedure', 'Ferritin measurement ', ['128927009'])}, '> 15 mcg/l': {'258799009': ('unit', 'Microgram/liter ', ['767524001']), '258806002': ('unit', 'Nanogram/milliliter ', ['767524001'])}}

3197507
unable to sign consent form
unable to sign consent form
['unable', 'to', 'sign', 'consent form']
{'unable': {'289001005': 'Unable to feed self ', '371151008': 'Unable '}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'sign': {'72670004': 'Sign '}, 'consent form': {'246176004': 'qualitative form'}}
{'unable': {'289001005': ('clinical finding', 'Unable to feed self ', ['250171008'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'sign': {'72670004': ('clinical finding', 'Sign ', ['250171008'])}}

3197741
patients who have abnormalities of the uterus
patients who have abnormalities of the uterus
['patients', 'abnormalities of the uterus']
{'patients': {'116154003': 'Patient '}, 'abnormalities of the uterus': {'37849005': 'Congenital uterine anomaly '}}
{'abnormalities of the uterus': {'37849005': ('clinical finding', 'Congenital uterine anomaly ', ['64572001', '118234003'])}}

3204562
any of severe comorbid medical conditions according to asa score ≥ 3
any of severe comorbid medical conditions according to asa score ≥ 3
['any of severe comorbid medical conditions', 'according to asa score  3']
{'any of severe comorbid medical conditions': {'24484000': 'Severe ', '398192003': 'Co-morbid conditions ', '373655009': 'Medical service ', '74188005': 'Medical '}, 'according to asa score  3': {'387458008': 'Aspirin ', '7947003': 'Aspirin ', '246262008': 'score', '278061009': 'Scores '}}
{'any of severe comorbid medical conditions': {'24484000': ('qualifier value', 'Severe ', ['272396007']), '398192003': ('clinical finding', 'Co-morbid conditions ', ['250171008']), '74188005': ('qualifier value', 'Medical ', ['272099008'])}, 'according to asa score  3': {'387458008': ('product', 'Aspirin ', ['406455002', '312413002']), '7947003': ('product', 'Aspirin ', ['763158003']), '278061009': ('qualifier value', 'Scores ', ['272396007'])}}

3211150
pregnant or nursing
pregnant or nursing
['pregnant', 'nursing']
{'pregnant': {'77386006': 'Patient currently pregnant ', '127362006': 'Previous pregnancies ', '161732006': 'Gravida ', '364323006': 'Quantity of pregnancy ', '366321006': 'Finding of gravida '}, 'nursing': {'169741004': 'Breast fed ', '265937000': 'Nursing occupation ', '722165004': 'Nursing '}}
{'pregnant': {'77386006': ('clinical finding', 'Patient currently pregnant ', ['250171008']), '127362006': ('clinical finding', 'Previous pregnancies ', ['250171008']), '161732006': ('observable entity', 'Gravida ', ['363788007']), '364323006': ('observable entity', 'Quantity of pregnancy ', ['363788007']), '366321006': ('clinical finding', 'Finding of gravida ', ['250171008'])}, 'nursing': {'169741004': ('clinical finding', 'Breast fed ', ['250171008'])}}

3215831
recent or current intensive mld and/or short stretch bandage use
recent or current intensive mld and/or short stretch bandage use
['recent', 'current intensive mld', 'short stretch bandage use']
{'recent': {'263852005': 'Recent episode ', '6493001': 'Recent '}, 'current intensive mld': {'15240007': 'Current ', '367565008': 'intention - mental process', '396338004': 'Metachromatic leucodystrophy ', '44359008': 'Metachromatic leukodystrophy, juvenile type ', '103370009': 'with intensity', '361269008': 'Intentional ', '363703001': 'intent'}, 'short stretch bandage use': {'359530003': 'Shortened ', '122546009': 'Stretching procedure ', '229070002': 'Stretching exercises ', '386292004': 'Exercise promotion: stretching ', '63995005': 'Bandage, device ', '277889008': 'usage', '419385000': 'Use - dosing instruction imperative ', '367450005': 'Short '}}
{'recent': {'263852005': ('qualifier value', 'Recent episode ', ['272099008'])}, 'current intensive mld': {'396338004': ('clinical finding', 'Metachromatic leucodystrophy ', ['64572001']), '44359008': ('clinical finding', 'Metachromatic leukodystrophy, juvenile type ', ['64572001', '396338004'])}, 'short stretch bandage use': {'359530003': ('qualifier value', 'Shortened ', ['272099008']), '122546009': ('procedure', 'Stretching procedure ', ['128927009']), '229070002': ('procedure', 'Stretching exercises ', ['243120004']), '386292004': ('procedure', 'Exercise promotion: stretching ', ['408766003']), '367450005': ('qualifier value', 'Short ', ['272099008'])}}

3216261
arthroplasty present infection
arthroplasty present infection
['arthroplasty present infection']
{'arthroplasty present infection': {'442095009': 'Repair of joint ', '70805003': 'Reconstruction of joint ', '260976002': 'Presence of infection '}}
{'arthroplasty present infection': {'442095009': ('procedure', 'Repair of joint ', ['362958002', '128927009']), '70805003': ('procedure', 'Reconstruction of joint ', ['442095009', '362958002', '128927009'])}}

3218631
current use of warfarin .
current use of warfarin .
['current use of warfarin']
{'current use of warfarin': {'15240007': 'Current ', '260676000': 'use of', '372756006': 'Warfarin ', '48603004': 'Warfarin '}}
{'current use of warfarin': {'372756006': ('product', 'Warfarin ', ['406455002', '312413002', '312412007']), '48603004': ('product', 'Warfarin ', ['763158003'])}}

3238233
uncontrolled psychiatric disorders, such as major depression or psychosis
uncontrolled psychiatric disorders, such as major depression or psychosis
['uncontrolled psychiatric disorders,', 'such as major depression', 'psychosis']
{'uncontrolled psychiatric disorders,': {'19032002': 'Uncontrolled ', '74732009': 'Mental disorder ', '25786006': 'Abnormal behavior ', '277843001': 'Problem behavior '}, 'such as major depression': {'370143000': 'Major depressive disorder '}, 'psychosis': {'69322001': 'Psychotic disorder ', '191525009': 'Non-organic psychosis '}}
{'uncontrolled psychiatric disorders,': {'19032002': ('qualifier value', 'Uncontrolled ', ['272099008']), '74732009': ('clinical finding', 'Mental disorder ', ['64572001']), '25786006': ('clinical finding', 'Abnormal behavior ', ['250171008']), '277843001': ('clinical finding', 'Problem behavior ', ['250171008'])}, 'such as major depression': {'370143000': ('clinical finding', 'Major depressive disorder ', ['64572001', '74732009'])}, 'psychosis': {'69322001': ('clinical finding', 'Psychotic disorder ', ['64572001', '74732009']), '191525009': ('clinical finding', 'Non-organic psychosis ', ['64572001', '69322001', '74732009'])}}

3258439
poorly controlled arterial hypertension with standard treatment
poorly controlled arterial hypertension with standard treatment
['poorly', 'controlled', 'arterial hypertension with standard treatment']
{'poorly': {'556001': 'Bad '}, 'controlled': {'246106000': 'control function', '31509003': 'Controlled '}, 'arterial hypertension with standard treatment': {'302192008': 'On treatment for hypertension '}}
{'poorly': {'556001': ('qualifier value', 'Bad ', ['272099008'])}, 'controlled': {'31509003': ('qualifier value', 'Controlled ', ['272099008'])}, 'arterial hypertension with standard treatment': {'302192008': ('procedure', 'On treatment for hypertension ', ['362958002', '243120004', '128927009'])}}

3259522
subject has received rifampin within 4 days prior to first dose of study drug in arm a or arm c and within 7 days prior to first dose of study drug in arm b .
subject has received rifampin , prior to first dose of study drug in arm a or arm c and within 7 days prior to first dose of study drug in arm b .
['received rifampin', 'prior to first dose of study drug', 'in arm', 'arm c', 'and within 7 days', 'in arm b']
{'received rifampin': {'29175007': 'Rifampin ', '387159009': 'Rifampin '}, 'prior to first dose of study drug': {'236874000': 'Status pre- ', '288556008': 'before', '255216001': 'First ', '398232005': 'Drug dose ', '224699009': 'Study ', '260911001': 'dosage', '277406006': 'Dosages ', '185922005': 'Clinical drug trial ', '408102007': 'Unit dose ', '232714002': 'Firstly '}, 'in arm': {'40983000': 'Upper arm structure '}, 'arm c': {'40983000': 'Upper arm structure '}, 'and within 7 days': {'258703001': 'day '}, 'in arm b': {'40983000': 'Upper arm structure '}}
{'received rifampin': {'29175007': ('product', 'Rifampin ', ['763158003']), '387159009': ('product', 'Rifampin ', ['312413002'])}, 'prior to first dose of study drug': {'398232005': ('clinical finding', 'Drug dose ', ['250171008']), '277406006': ('qualifier value', 'Dosages ', ['272099008']), '408102007': ('unit', 'Unit dose ', ['767524001']), '232714002': ('qualifier value', 'Firstly ', ['272099008'])}, 'and within 7 days': {'258703001': ('unit', 'day ', ['767524001'])}}

3261110
primary tumors developed 5 years previous to the inclusion, except in situ cervix carcinoma or skin basocellular cancer properly treated
primary tumors developed 5 years , to the inclusion, except in situ cervix carcinoma or skin basocellular cancer properly treated
['primary tumors', '5 years', 'to the inclusion,', 'except in situ cervix carcinoma', 'skin basocellular cancer', 'treated']
{'primary tumors': {'63161005': 'Principal ', '108369006': 'Neoplasm ', '263909009': 'True primary ', '261424001': 'Primary operation '}, '5 years': {'264606005': '-5 ', '258707000': 'year ', '264706000': '>5 ', '264605009': 'Integer +5 '}, 'to the inclusion,': {'55919000': 'Including '}, 'except in situ cervix carcinoma': {'20365006': 'Squamous intraepithelial neoplasia, grade III ', '252991009': 'Cervical intraepithelial neoplasia grade III with severe dysplasia ', '254889004': 'Carcinoma of cervix stage 0 ', '92564006': 'Carcinoma in situ of uterine cervix '}, 'skin basocellular cancer': {'372130007': 'Malignant neoplasm of skin '}, 'treated': {'276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '116700008': 'treatment intent', '395077000': 'Treatment intent '}}
{'primary tumors': {'63161005': ('qualifier value', 'Principal ', ['272099008']), '263909009': ('qualifier value', 'True primary ', ['272099008']), '261424001': ('qualifier value', 'Primary operation ', ['272099008'])}, '5 years': {'258707000': ('unit', 'year ', ['767524001'])}, 'to the inclusion,': {'55919000': ('qualifier value', 'Including ', ['272099008'])}, 'except in situ cervix carcinoma': {'252991009': ('clinical finding', 'Cervical intraepithelial neoplasia grade III with severe dysplasia ', ['64572001', '92564006', '118234003']), '254889004': ('clinical finding', 'Carcinoma of cervix stage 0 ', ['64572001', '118234003']), '92564006': ('clinical finding', 'Carcinoma in situ of uterine cervix ', ['64572001', '118234003'])}, 'skin basocellular cancer': {'372130007': ('clinical finding', 'Malignant neoplasm of skin ', ['64572001', '118234003'])}, 'treated': {'276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '395077000': ('situation with explicit context', 'Treatment intent ', ['129125009'])}}

3269576
other medical condition likely to cause death within 24 months
other medical condition likely to cause death ,
['other medical condition', 'likely', 'to', 'death']
{'other medical condition': {'373655009': 'Medical service ', '64572001': 'Disease ', '260905004': 'condition', '74188005': 'Medical '}, 'likely': {'2931005': 'Probable diagnosis ', '452201000124102': 'probable diagnosis'}, 'to': {'223570002': 'Togo ', '9986007': 'Tryptophanase '}, 'death': {'419620001': 'Death ', '268923008': 'On examination - dead ', '397709008': 'Patient died '}}
{'other medical condition': {'74188005': ('qualifier value', 'Medical ', ['272099008'])}, 'to': {'9986007': ('product', 'Tryptophanase ', ['312413002', '115668003'])}, 'death': {'268923008': ('clinical finding', 'On examination - dead ', ['118240005', '365860008']), '397709008': ('clinical finding', 'Patient died ', ['365860008'])}}

3270419
requiring therapeutic anti-coagulant therapy .
requiring therapeutic anti-coagulant therapy .
['therapeutic anti coagulant therapy']
{'therapeutic anti coagulant therapy': {'276239002': 'Therapy ', '277132007': 'Therapeutic procedure ', '15117003': 'Coagulant ', '373746004': 'Coagulant ', '262202000': 'Therapeutic intent '}}
{'therapeutic anti coagulant therapy': {'276239002': ('procedure', 'Therapy ', ['277132007', '243120004']), '262202000': ('qualifier value', 'Therapeutic intent ', ['272099008'])}}

3275101
being in exclusion on the national volunteers data file
being in exclusion on the national volunteers data file
['on the national volunteers data file']
{'on the national volunteers data file': {'160772005': 'Voluntary worker ', '276035002': 'Voluntary helper ', '276037005': 'Volunteer helper ', '12953007': 'File, device '}}
{}

3284100
patients with diverticulitis, intra-abdominal abscess, or gi obstruction
patients with diverticulitis, intra-abdominal abscess, or gi obstruction
['patients with diverticulitis,', 'intra abdominal abscess', 'gi obstruction']
{'patients with diverticulitis,': {'116154003': 'Patient ', '18126004': 'Diverticulitis ', '307496006': 'Diverticulitis '}, 'intra abdominal abscess': {'75100008': 'Abdominal abscess '}, 'gi obstruction': {'26036001': 'Obstruction '}}
{'patients with diverticulitis,': {'307496006': ('clinical finding', 'Diverticulitis ', ['64572001'])}, 'intra abdominal abscess': {'75100008': ('clinical finding', 'Abdominal abscess ', ['64572001', '118234003'])}}
